PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	EY	PG	WC	SC	GA	UT	PM	OA	HC	HP	DA
J	Lagatie, O; Ediage, EN; Pikkemaat, JA; Djuardi, Y; Stuyver, LJ				Lagatie, Ole; Ediage, Emmanuel Njumbe; Pikkemaat, Jeroen A.; Djuardi, Yenny; Stuyver, Lieven J.			2-methyl butyramide, a previously identified urine biomarker for Ascaris lumbricoides, is not present in infected Indonesian individuals	PARASITES & VECTORS			English	Letter						Ascaris lumbricoides; Soil-transmitted helminths; Biomarker; Urine; 2-methyl butyramide; 2-methyl valeramide	HELMINTH INFECTIONS	Previous reports suggest that the 2-methyl butyramide and 2-methyl valeramide metabolites of Ascaris lumbricoides in urine of infected individuals could be considered as urinary biomarkers for active infection. We have developed an LC-MS method with a detection limit of 10 ng/mL using synthetic chemicals as reference material. Urine samples (n = 21) of infected individuals were analyzed for the presence of these metabolites, but they were not detected in any of the samples. Furthermore, the recorded H-1-NMR spectrum for reference 2-methyl butyramide did not match with the spectrum that was described for the Ascaris metabolite. Based on these two observations, we concluded that the urinary biomarkers that were detected for A. lumbricoides infection are not 2-methyl butyramide nor 2-methylvaleramide. New discovery efforts will be required to identify the structure of these metabolite biomarkers in urine of infected individuals.	[Lagatie, Ole; Stuyver, Lieven J.] Janssen R&D, Janssen Diagnost, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Ediage, Emmanuel Njumbe] Janssen R&D, Bioanal, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Pikkemaat, Jeroen A.] Janssen R&D, Pharmaceut Dev & Mfg Sci, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Djuardi, Yenny] Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia	Lagatie, O (reprint author), Janssen R&D, Janssen Diagnost, Turnhoutseweg 30, B-2340 Beerse, Belgium.	olagatie@its.jnj.com		Lagatie, Ole/0000-0002-0638-1313			DEJONGE N, 1990, T ROY SOC TROP MED H, V84, P815, DOI 10.1016/0035-9203(90)90094-U; HALL A, 1990, EXP PARASITOL, V70, P35, DOI 10.1016/0014-4894(90)90083-O; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; O'Connell EM, 2016, AM J TROP MED HYG, V95, P508, DOI 10.4269/ajtmh.16-0266; Tahapary DL, 2015, BMC INFECT DIS, V15, P1, DOI 10.1186/s12879-015-0873-4; van Dam GJ, 2004, J CLIN MICROBIOL, V42, P5458, DOI 10.1128/JCM.42.12.5458-5461.2004	7	0	0	1	1	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 29	2017	10								629	10.1186/s13071-017-2600-z				3	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FR7GG	WOS:000419235100004	29284514	DOAJ Gold, Green Published			2019-04-02	
J	Gower, CM; Gehre, F; Marques, SR; Lamberton, PHL; Lwambo, NJ; Webster, JP				Gower, Charlotte M.; Gehre, Florian; Marques, Sara R.; Lamberton, Poppy H. L.; Lwambo, Nicholas J.; Webster, Joanne P.			Phenotypic and genotypic monitoring of Schistosoma mansoni in Tanzanian schoolchildren five years into a preventative chemotherapy national control programme	PARASITES & VECTORS			English	Article						Density-dependence; Neglected tropical diseases; Schistosomiasis; Population genetics; Drug resistance; Praziquantel	PRAZIQUANTEL; PARASITES; TRANSMISSION; HIERFSTAT; EFFICACY; IMPACT	Background: Schistosoma mansoni is a parasite of profound medical importance. Current control focusses on mass praziquantel (PZQ) treatment of populations in endemic areas, termed Preventative Chemotherapy (PC). Large-scale PC programmes exert prolonged selection pressures on parasites with the potential for, direct and/or indirect, emergence of drug resistance. Molecular methods can help monitor genetic changes of schistosome populations over time and in response to drug treatment, as well as estimate adult worm burdens through parentage analysis. Furthermore, methods such as in vitro drug sensitivity assays help phenotype in vivo parasite genotypic drug efficacy. Methods: We conducted combined in vitro PZQ efficacy testing with population genetic analyses of S. mansoni collected from children from two schools in 2010, five years after the introduction of a National Control Programme. Children at one school had received four annual PZQ treatments and the other school had received two mass treatments in total. We compared genetic differentiation, indices of genetic diversity, and estimated adult worm burden from parasites collected in 2010 with samples collected in 2005 (before the control programme began) and in 2006 (six months after the first PZQ treatment). Using 2010 larval samples, we also compared the genetic similarity of those with high and low in vitro sensitivity to PZQ. Results: We demonstrated that there were individual parasites with reduced PZQ susceptibility in the 2010 collections, as evidenced by our in vitro larval behavioural phenotypic assay. There was no evidence, however, that miracidia showing phenotypically reduced susceptibility clustered together genetically. Molecular analysis also demonstrated a significant reduction of adult worm load over time, despite little evidence of reduction in parasite infection intensity, as measured by egg output. Genetic diversity of infections did not reduce over time, despite changes in the genetic composition of the parasite populations. Conclusions: Genotypic and phenotypic monitoring did not indicate a selective sweep, as may be expected if PZQ treatment was selecting a small number of related "resistant" parasites, but there was evidence of genetic changes at the population level over time. Genetic data were used to estimate adult worm burdens, which unlike parasite infection intensity, showed reductions over time, suggesting the relaxation of negative density-dependent constraints on parasite fecundity with PZQ treatment. We thereby demonstrated that density-dependence in schistosome populations may complicate evaluation and monitoring of control programmes.	[Gower, Charlotte M.; Webster, Joanne P.] Univ London, Royal Vet Coll, Ctr Endem Emerging & Exot Dis, London AL9 7TA, England; [Gower, Charlotte M.; Gehre, Florian; Lamberton, Poppy H. L.; Webster, Joanne P.] Imperial Coll, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [Gehre, Florian] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Marques, Sara R.] Imperial Coll, Fac Med, Dept Life Sci, London, England; [Lamberton, Poppy H. L.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow G12 8QQ, Lanark, Scotland; [Lamberton, Poppy H. L.] Univ Glasgow, Wellcome Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Lwambo, Nicholas J.] Mwanza Res Ctr, Natl Inst Med Res, Mwanza, Tanzania	Gower, CM (reprint author), Univ London, Royal Vet Coll, Ctr Endem Emerging & Exot Dis, London AL9 7TA, England.; Gower, CM (reprint author), Imperial Coll, Fac Med, Dept Infect Dis Epidemiol, London W2 1PG, England.	c.gower@imperial.ac.uk		Lamberton, Poppy/0000-0003-1048-6318	Royal Society Dorothy Hodgkin Clore Fellowship	This work was supported by a Royal Society Dorothy Hodgkin Clore Fellowship to CMG. PZQ and albendazole was supplied by the Schistosomiasis Control Initiative and the National Schistosomiasis Control Programme.	Aemero M, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0297-6; Anderson RM, 2016, ADV PARASIT, V94, P199, DOI 10.1016/bs.apar.2016.06.003; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P53; Barbosa LM, 2016, INT J PARASITOL, V46, P343, DOI 10.1016/j.ijpara.2016.01.007; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233; CHEEVER AW, 1968, AM J TROP MED HYG, V17, P38, DOI 10.4269/ajtmh.1968.17.38; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Crellen T, 2016, CLIN INFECT DIS, V63, P1151, DOI 10.1093/cid/ciw506; Criscione CD, 2005, MOL ECOL, V14, P2247, DOI 10.1111/j.1365-294X.2005.02587.x; de Meeus T, 2007, INFECT GENET EVOL, V7, P731, DOI 10.1016/j.meegid.2007.07.005; Felsenstein J, PHYLIP PHYLOGENY INF; Fenwick A, 2009, PARASITOLOGY, V136, P1719, DOI 10.1017/S0031182009990400; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8278.2004.00828.x; Goudet J., FSTAT COMPUTER PROGR; Gower CM, 2007, PARASITOLOGY, V134, P523, DOI 10.1017/S0031182006001685; Gower CM, 2011, PARASITOLOGY, V138, P978, DOI 10.1017/S0031182011000722; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Huyse T, 2013, INFECT GENET EVOL, V18, P100, DOI 10.1016/j.meegid.2013.05.007; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281; Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515; Lamberton PH, 2014, PLOS NEGLECT TROP D, V8, P3139; Lamberton PHL, 2010, AM J TROP MED HYG, V83, P1340, DOI 10.4269/ajtmh.2010.10-0413; Lelo AE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003221; Liang YS, 2001, INT J PARASITOL, V31, P1227, DOI 10.1016/S0020-7519(01)00246-6; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Norton AJ, 2010, AM J TROP MED HYG, V83, P951, DOI 10.4269/ajtmh.2010.10-0283; Rudge JW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000340; Steinauer ML, 2009, INT J PARASITOL, V39, P1157, DOI 10.1016/j.ijpara.2009.02.019; Wang JL, 2003, GENETICS, V163, P429; Webster JP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0434; Webster JP, 2008, EVOL APPL, V1, P66, DOI 10.1111/j.1752-4571.2007.00012.x; William S, 2001, INT J PARASITOL, V31, P1093, DOI 10.1016/S0020-7519(01)00215-6; World Health Organization, 2012, ACC WORK OV GLOB IMP; Zwang J, 2014, PLOS NEGLECT TROP D, V20, P3286	35	3	3	1	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 2	2017	10								593	10.1186/s13071-017-2533-6				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FO6HX	WOS:000416965200003	29197426	DOAJ Gold, Green Published			2019-04-02	
J	Rahmouni, C; Vanhove, MPM; Simkova, A				Rahmouni, Chahrazed; Vanhove, Maarten P. M.; Simkova, Andrea			Underexplored diversity of gill monogeneans in cichlids from Lake Tanganyika: eight new species of Cichlidogyrus Paperna, 1960 (Monogenea: Dactylogyridae) from the northern basin of the lake, with remarks on the vagina and the heel of the male copulatory organ	PARASITES & VECTORS			English	Article						Africa; Burundi; Cichlidae; Cyprichromini; Ectodini; Eretmodini; Platyhelminthes; Monogenea; Cichlidogyrus	LEONE WEST-AFRICA; FRESH-WATER FISH; GENUS CICHLIDOGYRUS; ANCYROCEPHALIDAE MONOGENEA; CONGENERIC MONOGENEANS; PARASITE DIVERSITY; TELEOSTEI; PISCES; SAROTHERODON; PHYLOGENY	Background: Lake Tanganyika harbours the most diverse cichlid assemblage of the Great African Lakes. Considering its cichlid flocks consist of approximately 250 endemic species, we can hypothesize a high species-richness in their often quite host-specific monogenean ectoparasites belonging to Cichlidogyrus Paperna, 1960. Yet, only 24 species were described from Tanganyikan hosts and some host tribes have never been investigated for monogeneans. This study presents the first parasitological examination of species of the tribes Cyprichromini (Cyprichromis microlepidotus (Poll, 1956)), Eretmodini (Eretmodus marksmithi Burgess, 2012 and Tanganicodus irsacae Poll, 1950) and Ectodini (Aulonocranus dewindti (Boulenger, 1899)). Specimens of the ectodine Ophthalmotilapia nasuta (Poll & Matthes, 1962) from which four Cichlidogyrus spp. have been previously described from more southern localities were also studied. Further, we discuss the haptor configuration in Tanganyikan Cichlidogyrus spp. and highlight the morphological diversity of the vagina, and that of the heel, a sclerotized part of the male copulatory organ, absent in some species of Cichlidogyrus. Methods: Cichlidogyrus spp. were isolated from gills and fixed using GAP. Haptoral and genital hard parts were measured and drawn by means of a phase contrast microscopic examination. Results: We describe eight new species: Cichlidogyrus milangelnari n. sp. on C. microlepidotus; C. jeanloujustinei n. sp. on E. marksmithi; C. evikae n. sp. on T. irsacae; C. aspiralis n. sp., C. glacicremoratus n. sp. and C. rectangulus n. sp. on O. nasuta; and C. pseudoaspiralis n. sp. and C. discophonum n. sp. on A. dewindti. Three haptoral morphotypes were recognized among the new species. Species of Cichlidogyrus from closely related hosts exhibited the same morphotypes. Geographical variation in Cichlidogyrus spp. fauna as observed in O. nasuta and three morphotypes were distinguished. Finally, we listed 111 Cichlidogyrus species, of which 27 and three Tanganyikan species lack sclerotized vagina and heel, respectively, just like 19 and seven species outside of the lake. Conclusions: Haptoral and genital features in the Tanganyikan Cichlidogyrus fauna reflect the phylogenetic relationships of their cichlid hosts. It seems that several lineages of Cichlidogyrus spp. exist in Lake Tanganyika but further studies are necessary to confirm this hypothesis and answer questions related to Lake Tanganyika and its cichlids.	[Rahmouni, Chahrazed; Vanhove, Maarten P. M.; Simkova, Andrea] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CZ-61137 Brno, Czech Republic; [Vanhove, Maarten P. M.] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, Capac Biodivers & Sustainable Dev CEBioS, Vautierstr 29, B-1000 Brussels, Belgium; [Vanhove, Maarten P. M.] Univ Leuven, Dept Biol, Lab Biodivers & Evolutionary Genom, Charles Deberiotstr 32, B-3000 Leuven, Belgium; [Vanhove, Maarten P. M.] Hasselt Univ, Ctr Environm Sci, Res Grp Zool Biodivers & Toxicol, B-3590 Diepenbeek, Belgium	Rahmouni, C (reprint author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CZ-61137 Brno, Czech Republic.	rahmouni.chahrazed@gmail.com	Simkova, Andrea/F-7636-2019	Simkova, Andrea/0000-0002-5995-6766	Czech Science Foundation - European Centre of Ichtyoparasitology (ECIP) [P505/12/G112]	This research was funded by the Czech Science Foundation project no. P505/12/G112 - European Centre of Ichtyoparasitology (ECIP).	Barluenga M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-326; BIRGI E, 1986, ANN PARASIT HUM COMP, V61, P521, DOI 10.1051/parasite/1986615521; BIRGI E, 1983, B SOC ZOOL FR, V108, P101; Bukinga FM, 2012, PARASITOL RES, V111, P2049, DOI 10.1007/s00436-012-3052-1; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; DOSSOU C, 1984, ANN SCI NAT ZOOL, V6, P101; DOSSOU C, 1982, Bulletin de l'Institut Fondamental d'Afrique Noire Serie A Sciences Naturelles, V44, P295; DOUELLOU L, 1993, SYST PARASITOL, V25, P159, DOI 10.1007/BF00007007; ERGENS R, 1981, FOLIA PARASIT, V28, P205; Froese R., FISHBASE; Gillardin C, 2012, PARASITOL RES, V110, P305, DOI 10.1007/s00436-011-2490-5; Gregoir AF, 2015, FRESHWATER BIOL, V60, P323, DOI 10.1111/fwb.12492; Gussev AV, 1983, NAUK LENINGR, V48; Hanssens M, 1999, ZOOL J LINN SOC-LOND, V125, P487, DOI 10.1111/j.1096-3642.1999.tb00602.x; Hizelle J. D., 1936, American Midland Naturalist, V17, P785; Jorissen MWP, 2018, J HELMINTHOL, V92, P417, DOI 10.1017/S0022149X17000712; Kmentova N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39605; Kmentova N, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1696-x; Kmentova N, 2016, PEERJ, V4, DOI 10.7717/peerj.1629; Koblmuller S, 2004, J MOL EVOL, V58, P79, DOI 10.1007/s00239-003-2527-1; Konings A., 2015, TANGANYIKA CICHLIDS; KRITSKY DC, 1986, P HELM SOC WASH, V53, P1; Maan ME, 2013, SEMIN CELL DEV BIOL, V24, P516, DOI 10.1016/j.semcdb.2013.05.003; Malmberg G., 1957, Skr Sverig Fisk Foren, V1956, P19; MANDENG FDM, 2015, PARASIT VECTORS, V8; Mendlova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037268; Meyer BS, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140498; Meyer BS, 2015, MOL PHYLOGENET EVOL, V83, P56, DOI 10.1016/j.ympev.2014.10.009; Musilova N, 2009, ZOOTAXA, P47; N'Douba Valentin, 1997, Journal of African Zoology, V111, P429; Nevado B, 2011, MOL BIOL EVOL, V28, P2253, DOI 10.1093/molbev/msr043; Paperna I., 1969, Revue de Zoologie et de Botanique Africaines, V79, P15; PAPERNA I, 1969, Bulletin de l'Institut Fondamental d'Afrique Noire Serie A Sciences Naturelles, V31, P840; PAPERNA I, 1964, ISRAEL J ZOOL, V13, P1; Paperna I, 1968, BAMIDGEH B FISH CULT, V20, P80; PAPERNA ILAN, 1960, BAMIDGEH, V12, P20; PAPERNA ILAN, 1965, BAMIDGEH, V17, P107; Pariselle A, 1998, FOLIA PARASIT, V45, P275; PARISELLE A, 1995, PARASITE, V2, P203, DOI 10.1051/parasite/199502s2203; PARISELLE A, 1994, SYST PARASITOL, V29, P229, DOI 10.1007/BF00009678; Pariselle A, 2004, PARASITE, V11, P359, DOI 10.1051/parasite/2004114359; Pariselle A, 1997, SYST PARASITOL, V38, P221, DOI 10.1023/A:1005803202543; Pariselle A, 2003, SYST PARASITOL, V56, P201, DOI 10.1023/B:SYPA.0000003807.27452.bd; Pariselle A, 1996, SYST PARASITOL, V34, P109, DOI 10.1007/BF00009685; Pariselle A, 2003, FOLIA PARASIT, V50, P195, DOI 10.14411/fp.2003.035; PARISELLE A, 1995, SYST PARASITOL, V30, P187, DOI 10.1007/BF00010469; Pariselle A., 2011, INT J EVOL BIOL, V2011, DOI DOI 10.4061/2011/471480; Pariselle A, 2015, CONTRIB ZOOL, V84, P25; Pariselle A, 2015, HYDROBIOLOGIA, V748, P99, DOI 10.1007/s10750-014-1975-5; Pariselle A, 2014, ZOOTAXA, V3881, P258, DOI 10.11646/zootaxa.3881.3.4; Pariselle A, 2013, ZOOTAXA, V3599, P78, DOI 10.11646/zootaxa.3599.1.7; Pariselle Antoine, 2003, P147; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; Poulin R, 2002, INT J PARASITOL, V32, P245, DOI 10.1016/S0020-7519(01)00329-0; Pouyaud L, 2006, MOL PHYLOGENET EVOL, V38, P242; Price C. E., 1967, Revue de Zoologie et de Botanique Africaines, V76, P137; Price C. E., 1969, Revue de Zoologie et de Botanique Africaines, V79, P117; Rehulkova E, 2013, PARASITOL RES, V112, P1399, DOI 10.1007/s00436-013-3291-9; Simkova A, 2008, J FISH BIOL, V73, P2210, DOI 10.1111/j.1095-8649.2008.02064.x; Simkova A, 2006, EVOLUTION, V60, P1023, DOI 10.1554/05-521.1; Snoeks J, 2000, ADV ECOL RES, V31, P17, DOI 10.1016/S0065-2504(00)31005-4; Sturmbauer C, 2001, MOL BIOL EVOL, V18, P144, DOI 10.1093/oxfordjournals.molbev.a003788; Takahashi T, 2011, INT J EVOLUTIONARY B, V2011, DOI DOI 10.4061/2011/620754; Takahashi T, 2016, MOL PHYLOGENET EVOL, V100, P234, DOI 10.1016/j.ympev.2016.04.012; Van Steenberge M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124474; Van Steenberge M, 2011, ACTA ICHTHYOL PISCAT, V41, P201, DOI 10.3750/AIP2011.41.3.08; Vanhove MPM, 2016, TRENDS PARASITOL, V32, P820, DOI 10.1016/j.pt.2016.07.002; Vanhove MPM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13669; Vanhove MPM, 2011, ZOOLOGIA-CURITIBA, V28, P253, DOI 10.1590/S1984-46702011000200016; Vanhove MPM, 2012, THESIS; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x	71	2	2	2	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 2	2017	10								591	10.1186/s13071-017-2460-6				21	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FO6HX	WOS:000416965200001	29197419	DOAJ Gold, Green Published			2019-04-02	
J	Nkanga, MSN; Longo-Mbenza, B; Vandenberghe, P; Verdonck, F; Tchokonte-Nana, V; Nlandu, NC; Miakassissa, RLM; Kazadi, PRB; Katawandja, AL; Ngwidiwo, JB; Mufuta, NJP; Solo, KT; Beia, MACO				Nkanga, Mireille Solange Nganga; Longo-Mbenza, Benjamin; Vandenberghe, Peter; Verdonck, Fons; Tchokonte-Nana, Venant; Nlandu, Nkama Claude; Miakassissa, Roth Laure Mapapa; Kazadi, Paul Roger Beia; Katawandja, Antoine Lufimbo; Ngwidiwo, Jacques Bikaula; Mufuta, Ntolo Jean-Pierre; Solo, Kuanda Thomas; Beia, Mbombo Aurore Cecilia Orphee			Feasibility of iFISH patterns in hematologic malignancies among Congolese patients at Kinshasa University clinics	ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE			English	Article								Objective: To analyze the feasibility of detecting Ph-1 in leukemia patients in the Kinshasa University Clinics in the Democratic Republic of Congo, at KU Leuven, Belgium. Methods: Bone marrow and peripheral blood samples with chronic myeloid leukemia, acute myeloid leukemia or acute leukocytes leukemia were obtained from 32 patients in Kinshasa University clinics in the Democratic Republic of Congo and transferred to KU Leuven in Belgium for iFISH feasibility. Ph-1 was detected by using a remote analysis of interphase fluorescence in situ hybridization (iFISH). Results: Out of the 32 patients involved in this study, 65.6% (n = 21) of the cases were successfully tested, of which 52.4% (n = 11) were iFISH positives for the variant t(9; 22) (presence of Ph-1) in chronic myeloid leukemia samples and 47.6% (n = 10) negatives in all subtypes of hematological malignancies. However, there was a female predominance in chronic myeloid leukemia samples Ph-1-positives by iFISH, whereas no sexual influence was observed on acute subtypes of leukemia. Conclusions: iFISH analysis is feasible on samples obtained from remote sites in the Democratic Republic of Congo. However, the optimization of the sample storage is necessary to further improve iFISH's performance.	[Nkanga, Mireille Solange Nganga; Katawandja, Antoine Lufimbo; Ngwidiwo, Jacques Bikaula; Beia, Mbombo Aurore Cecilia Orphee] Univ Kinshasa, Fac Med, Kinshasa, DEM REP CONGO; [Longo-Mbenza, Benjamin] Univ President Kasa Vubu, Boma, DEM REP CONGO; [Vandenberghe, Peter; Verdonck, Fons] Katholieke Univ Leuven, UZ Gasthuisberg, Leuven, Belgium; [Tchokonte-Nana, Venant] Stellenbosch Univ, Fac Med & Hlth Sci, Stellenbosch, South Africa; [Miakassissa, Roth Laure Mapapa] Univ Hosp Brazzaville, Pediatr Serv, Brazzaville, DEM REP CONGO; [Mufuta, Ntolo Jean-Pierre] Ngaliema Clin, Kinshasa, DEM REP CONGO; [Solo, Kuanda Thomas] Univ Kinshasa, Reg Ctr Nucl Studies Kinshasa, Kinshasa, DEM REP CONGO	Tchokonte-Nana, V (reprint author), Stellenbosch Univ, Fac Med & Hlth Sci, Stellenbosch, South Africa.	venant@sun.ac.za		Tchokonte-Nana, Venant/0000-0003-2240-3735			Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Asif M, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00124; Avet-Loiseau H., 2007, SPECTRA BIOL, V26, P82; Chinese Society of Hematology Chinese Medical Association, 2016, Zhonghua Xue Ye Xue Za Zhi, V37, P846, DOI 10.3760/cma.j.issn.0253-2727.2016.10.004; Deininger M, 2005, BLOOD, V105, P2640, DOI 10.1182/blood-2004-08-3097; Demyda-Peyras S, 2013, CYTOGENET GENOME RES, V141, P277, DOI 10.1159/000351225; Diagnekpo T, 1992, MED AFR NOIRE, V39, P268; Diallo D A, 2005, Mali Med, V20, P1; DRACH J, 1995, BLOOD, V86, P3915; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Errahhali ME, 2016, BMC CANCER, P159; Hossain MS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-438; Ivey A, 2016, NEW ENGL J MED, V374, P422, DOI [10.1056/NEJMoa1507471, 10.1056/NEJMc1603847]; Kantarjian HM, 2006, BLOOD, V108, P1835, DOI 10.1182/blood-2006-02-004325; Lee YK, 2002, INT J HEMATOL, V76, P180, DOI 10.1007/BF02982582; Marum JE, 2016, THER ADV HEMATOL, V7, P237, DOI 10.1177/2040620716657994; Mashinda KD, 2012, ANN AFR MED, V6, P1087; Mireille NN, 2017, J INNOV RES HEAL SCI, V2, P345; Mounkaila B, 1996, MED AFR NOIRE, V43, P8; Mufuta JP, 2014, RMJ, V71, P5; Najfeld V., 2008, MOL GENETIC PATHOLOG, P303; Nkanga MSN, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3547-3; Nwannadi IA, 2011, J EPIDEMIOL, V9, P2; Omoti CE, 2012, PAN AFR MED J, V11; Palandri F, 2009, CLIN CANCER RES, V15, P1059, DOI 10.1158/1078-0432.CCR-08-1195; Sabatini E, 2010, PATHOLOGICA, V102, P83; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Sarwar Sohail, 2015, J Ayub Med Coll Abbottabad, V27, P371; Schmid C, 2005, J CLIN ONCOL, V23, P5675, DOI 10.1200/JCO.2005.07.061; Sreekantaiah C, 2007, CYTOGENET GENOME RES, V118, P284, DOI 10.1159/000108312; Wang JN, 2016, ADV CARDIOVASC DIS, V37, P412; Zamecnikova A, 2010, EXPERT REV HEMATOL, V3, P45, DOI [10.1586/ehm.09.66, 10.1586/EHM.09.66]; Zhou H, 2015, PROTEIN CELL, V6, P403, DOI 10.1007/s13238-015-0143-7	33	0	0	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2221-1691	2588-9222		ASIAN PAC J TROP BIO	Asian Pac. Trop. Biomed.	DEC	2017	7	12					1116	1119		10.1016/j.apjtb.2017.10.014				4	Tropical Medicine	Tropical Medicine	FR6YT	WOS:000419214100010		DOAJ Gold			2019-04-02	
J	Fontes, ANB; Lima, LNGC; Mota, RMS; Almeida, RLF; Pontes, MA; Goncalves, HD; Frota, CC; Vissa, VD; Brennan, PJ; Guimaraes, RJPS; Kendall, C; Kerr, LRFS; Suffys, PN				Fontes, Amanda N. B.; Lima, Luana N. G. C.; Mota, Rosa M. S.; Almeida, Rosa L. F.; Pontes, Maria A.; Goncalves, Heitor de S.; Frota, Cristiane C.; Vissa, Varalakshmi D.; Brennan, Patrick J.; Guimaraes, Ricardo J. P. S.; Kendall, Carl; Kerr, Ligia R. F. S.; Suffys, Philip N.			Genotyping of Mycobacterium leprae for better understanding of leprosy transmission in Fortaleza, Northeastern Brazil	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SHORT TANDEM REPEATS; MOLECULAR EPIDEMIOLOGY; NORTHERN INDIA; RISK-FACTORS; SKIN BIOPSY; STRAINS; POPULATION; REGION; DIVERSITY; CHINA	Leprosy is endemic in large part of Brazil with 28,761 new patients in 2015, the second largest number worldwide and reaches 9/10.000 in highly endemic regions and 2.7/10.000 in the city of Fortaleza, Ceara A, Northeast Brazil. For better understanding of risk factors for leprosy transmission, we conducted an epidemiologic study supplemented by 17 locus VNTR and SNP 1-4 typing of Mycobacterium leprae in skin biopsy samples from new multibacillary (MB) patients diagnosed at a reference center in 2009 and 2010. Among the 1,519 new patients detected during the study period, 998 (65.7%) were MB and we performed DNA extraction and genotyping on 160 skin biopsy samples, resulting in 159 (16%) good multilocus VNTR types. Thirty-eight of these patients also provided VNTR types from M. leprae in nasal swabs. The SNP-Type was obtained for 157 patients and 87% were of type 4. Upon consideration all VNTR markers, 156 different genotypes and three pairs with identical genotypes were observed; no epidemiologic relation could be observed between individuals in these pairs. Considerable variability in differentiating index (DI) was observed between the different markers and the four with highest DI [(AT) 15, (TA) 18, (AT) 17 and (GAA) 21] frequently demonstrated differences in copy number when comparing genotypes from both type of samples. Excluding these markers from analysis resulted in 83 genotypes, 20 of which included 96 of the patients (60.3%). These clusters were composed of two (n = 8), three (n = 6), four (n = 1), five (n = 2), six (n = 1), 19 (n = 1) and 23 (n = 23) individuals and suggests that recent transmission is contributing to the maintenance of leprosy in Fortaleza. When comparing epidemiological and clinical variables among patients within clustered or with unique M. leprae genotypes, a positive bacterial index in skin biopsies and knowledge of working with someone with the disease were significantly associated with clustering. A tendency to belong to a cluster was observed with later notification of disease (mean value of 3.4 months) and having disability grade 2. A tendency for lack of clustering was observed for patients who reported to have lived with another leprosy case but this might be due to lack of inclusion of household contacts in the study. Although clusters were spread over the city, kernel analysis revealed that some of the patients belonging to the two major clusters were spatially related to some neighborhoods that report poverty and high disease incidence in children. Finally, inclusion of genotypes from nasal swabs might be warranted. A major limitation of the study is that sample size of 160 patients from a two year period represents only 15% of the new patients and this could have weakened statistical outcomes. This is the first molecular epidemiology study of leprosy in Brazil and although the high clustering level suggests that recent transmission is the major cause of disease in Fortaleza; the existence of two large clusters needs further investigation.	[Fontes, Amanda N. B.; Suffys, Philip N.] Oswaldo Cruz Inst, Lab Mol Biol Appl Mycobacteria, Rio De Janeiro, Brazil; [Lima, Luana N. G. C.] State Hlth Off, Dept Pathol, Fortaleza, Ceara, Brazil; [Mota, Rosa M. S.] Univ Fed Ceara, Dept Stat & Appl Math, Fortaleza, Ceara, Brazil; [Almeida, Rosa L. F.] Univ Fortaleza, Post Grad Program Publ Hlth, Fortaleza, Ceara, Brazil; [Pontes, Maria A.; Goncalves, Heitor de S.] State Hlth Off, Reference Ctr Dermatol Dona Libania, Fortaleza, Ceara, Brazil; [Frota, Cristiane C.] Univ Fed Ceara, Dept Pathol, Fortaleza, Ceara, Brazil; [Vissa, Varalakshmi D.; Brennan, Patrick J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Guimaraes, Ricardo J. P. S.] Evandro Chagas Inst, Lab Geoproc, Belem, Para, Brazil; [Kendall, Carl] Tulane Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA; [Kendall, Carl; Kerr, Ligia R. F. S.] Univ Fed Ceara, Coll Med, Dept Community Hlth, Fortaleza, Ceara, Brazil; [Suffys, Philip N.] Trop Inst Med, Mycobacteriol Unit, Dept Biomed Sci, Antwerp, Belgium	Suffys, PN (reprint author), Oswaldo Cruz Inst, Lab Mol Biol Appl Mycobacteria, Rio De Janeiro, Brazil.; Suffys, PN (reprint author), Trop Inst Med, Mycobacteriol Unit, Dept Biomed Sci, Antwerp, Belgium.	psuffys@gmail.com	Almeida, Rosa/M-7962-2018; Frota, Cristiane/M-7424-2018; Guimaraes, Ricardo/F-7182-2015; KERR, LIGIA/F-9250-2012	Almeida, Rosa/0000-0001-6423-543X; Frota, Cristiane/0000-0003-0018-7736; Guimaraes, Ricardo/0000-0002-5767-4765; KERR, LIGIA/0000-0003-4941-408X	Ministerio de Ciencia e Tecnologia (MCT)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Ministerio de Saude (MS)- Secretaria de Ciencia, Tecnologia e Insumos Estrategicos (SCTIE)-Departamento de Ciencia e Tecnologia (DECIT) [410573/2006-0]; Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) [CI1-0050-00057.01.00/11-003/2011 PNP-0058-00121.01.01/11-007/201]; Damien Foundation-International Federation of Anti-Leprosy Associations (ILEP); National Institute of Health NIH (NIH)/ National Institute of Allergy and Infectious Diseases (NIAID) [AI 47197]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Programa Estrategico de Apoio a Pesquisa em Saude (PAPES) [407624/2012-0]	This project was supported by the following funding agencies: "Ministerio de Ciencia e Tecnologia (MCT)/Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Ministerio de Saude (MS)- Secretaria de Ciencia, Tecnologia e Insumos Estrategicos (SCTIE)-Departamento de Ciencia e Tecnologia (DECIT) (410573/2006-0)(LRFSKP); Fundacao Cearense de Apoio ao Desenvolvimento Cientifico e Tecnologico (FUNCAP) (CI1-0050-00057.01.00/11-003/2011 PNP-0058-00121.01.01/11-007/201)(LRFSKP); Damien Foundation-International Federation of Anti-Leprosy Associations (ILEP) (PNS); National Institute of Health NIH (NIH)/ National Institute of Allergy and Infectious Diseases (NIAID) (grant AI 47197) (PJB VDV PNS) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)/Programa Estrategico de Apoio a Pesquisa em Saude (PAPES) (407624/2012-0) (PNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allix-Beguec C, 2008, J CLIN MICROBIOL, V46, P1398, DOI 10.1128/JCM.02089-07; Araujo S, 2016, CLIN INFECT DIS; Ferreira SMB, 2011, REV SAUDE PUBL, V45, P756, DOI 10.1590/s0034-89102011005000043; Boletim Epidemiologico Hanseniase, 2016, COORD PROM PROT SAUD; Bratschi MW, 2015, LEPROSY REV, V86, P142; Brito Aline Lima, 2016, Rev. bras. epidemiol., V19, P194, DOI 10.1590/1980-5497201600010017; Fontes ANB, 2012, MEM I OSWALDO CRUZ, V107, P143, DOI 10.1590/S0074-02762012000900021; Fontes ANB, 2009, LEPROSY REV, V80, P302; Cardona-Castro N, LEPR REV, V80, P316; Cardona-Castro N, 2013, INFECT GENET EVOL, V14, P375, DOI 10.1016/j.meegid.2012.12.015; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; De Lamano LR, 2013, 18 INT LEPR C BRUSS, P158; Ferreira MLLT, 2008, CAD SAUDE COLETIVA, V16, P243; Fine PEM, 1997, AM J EPIDEMIOL, V146, P91; FRANCOPAREDES C, 2016, ANN CLIN MICROB ANTI, V15, P45825; Frota CC, 2010, T ROY SOC TROP MED H, V104, P490, DOI 10.1016/j.trstmh.2010.03.006; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Lima LNGC, 2015, MEM I OSWALDO CRUZ, V110, P898, DOI 10.1590/0074-02760150178; Groathouse NA, 2004, J CLIN MICROBIOL, V42, P1666, DOI 10.1128/JCM.42.4.1666-1672.2004; HARTSKEERL RA, 1989, J GEN MICROBIOL, V135, P2357; Heukelbach J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001031; IBGE, 2017, CID CEAR FORT; Kazda J., 2000, ECOLOGY MYCOBACTERIU; Kerr-Pontes LRS, 2006, INT J EPIDEMIOL, V35, P994, DOI 10.1093/ije/dyl072; Kerr-Pontes LRS, 2004, INT J EPIDEMIOL, V33, P262, DOI 10.1093/ije/dyh002; Kimura M, 2009, J CLIN MICROBIOL, V47, P1757, DOI 10.1128/JCM.02019-08; Lavania M, 2007, INFECT GENET EVOL, V7, P627, DOI 10.1016/j.meegid.2007.05.011; Lavania M, 2015, INFECT GENET EVOL, V36, P256, DOI 10.1016/j.meegid.2015.10.001; Lavania M, 2011, INDIAN J MED RES, V133, P618; Li W, 2011, ANTIMICROB AGENTS CH, V55, P5384, DOI 10.1128/AAC.05236-11; LIESACK W, 1990, LETT APPL MICROBIOL, V11, P96, DOI 10.1111/j.1472-765X.1990.tb01285.x; Lima LNGC, 2016, LEPROSY REV, V87, P486; Matsuoka M, 2000, INT J LEPROSY, V68, P121; Matsuoka M, 2009, LEPROSY REV, V80, P322; Monot M, 2005, SCIENCE, V308, P1040, DOI [10.1126/science/1109759, 10.1126/science.1109759]; Monot M, 2009, NAT GENET, V41, P1282, DOI 10.1038/ng.477; Montenegro ACD, 2004, MEM I OSWALDO CRUZ, V99, P683, DOI 10.1590/S0074-02762004000700003; Murto M, 2013, PLOS NEGLECT TROP D, V7, pe2422; Phetsuksiri B, 2012, JPN J INFECT DIS, V65, P52; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Rocha AD, 2012, J CLIN MICROBIOL, V50, P1912, DOI 10.1128/JCM.06561-11; Rocha AD, 2011, J MED MICROBIOL, V60, P1441, DOI 10.1099/jmm.0.029389-0; Rosa PS, 2013, 18 INT LEPR C BRUSS, P139; Sakamuri RM, 2009, LEPROSY REV, V80, P272; Sakamuri RM, 2009, J CLIN MICROBIOL, V47, P2844, DOI 10.1128/JCM.02021-08; Santos SM, 2007, TEXTOS BASICOS SAU B, V3; SESA-Secretaria da Saude do Estado do Ceara, 2014, INF EP HAN; Sharma R, 2015, EMERG INFECT DIS, V21, P2127, DOI 10.3201/eid2112.150501; Shin YC, 2000, J CLIN MICROBIOL, V38, P4535; Shinde V, 2009, LEPROSY REV, V80, P290; Singh P, 2011, ANTIMICROB AGENTS CH, V55, P2971, DOI 10.1128/AAC.00201-11; Srisungnam S, 2009, LEPROSY REV, V80, P280; Suffys PN, 2013, 18 INT LEPR C BRUSS, P156; Truman R, 2004, J CLIN MICROBIOL, V42, P2558, DOI 10.1128/JCM.42.6.2558-2565.2004; van Beers SM, 1999, INT J LEPROSY, V67, P119; Visschedijk J, 2000, TROP MED INT HEALTH, V5, P388, DOI 10.1046/j.1365-3156.2000.00572.x; Weng XM, 2007, J CLIN MICROBIOL, V45, P1728, DOI 10.1128/JCM.00018-07; Weng XM, 2013, INFECT GENET EVOL, V14, P361, DOI 10.1016/j.meegid.2012.12.009; Weng XM, 2011, INFECT GENET EVOL, V11, P363, DOI 10.1016/j.meegid.2010.11.014; Xing Y, 2009, LEPROSY REV, V80, P261; Young SK, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000214; Zhang LF, 2005, J CLIN MICROBIOL, V43, P5221, DOI 10.1128/JCM.43.10.5221-5229.2005	62	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2017	11	12							e0006117	10.1371/journal.pntd.0006117				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FR5LR	WOS:000419108500028	29244821	DOAJ Gold, Green Published			2019-04-02	
J	Ponte-Sucre, A; Gamarro, F; Dujardin, JC; Barrett, MP; Lopez-Velez, R; Garcia-Hernandez, R; Pountain, AW; Mwenechanya, R; Papadopoulou, B				Ponte-Sucre, Alicia; Gamarro, Francisco; Dujardin, Jean-Claude; Barrett, Michael P.; Lopez-Velez, Rogelio; Garcia-Hernandez, Raquel; Pountain, Andrew W.; Mwenechanya, Roy; Papadopoulou, Barbara			Drug resistance and treatment failure in leishmaniasis: A 21st century challenge	PLOS NEGLECTED TROPICAL DISEASES			English	Review							AMPHOTERICIN-B RESISTANCE; PROTOZOAN PARASITE LEISHMANIA; ABC-TRANSPORTER MRPA; VISCERAL LEISHMANIASIS; DONOVANI PROMASTIGOTES; CUTANEOUS LEISHMANIASIS; MILTEFOSINE RESISTANCE; ANTIMONY-RESISTANT; MEGLUMINE ANTIMONIATE; SODIUM STIBOGLUCONATE	Reevaluation of treatment guidelines for Old and New World leishmaniasis is urgently needed on a global basis because treatment failure is an increasing problem. Drug resistance is a fundamental determinant of treatment failure, although other factors also contribute to this phenomenon, including the global HIV/AIDS epidemic with its accompanying impact on the immune system. Pentavalent antimonials have been used successfully worldwide for the treatment of leishmaniasis since the first half of the 20th century, but the last 10 to 20 years have witnessed an increase in clinical resistance, e.g., in North Bihar in India. In this review, we discuss the meaning of "resistance" related to leishmaniasis and discuss its molecular epidemiology, particularly for Leishmania donovani that causes visceral leishmaniasis. We also discuss how resistance can affect drug combination therapies. Molecular mechanisms known to contribute to resistance to antimonials, amphotericin B, and miltefosine are also outlined.	[Ponte-Sucre, Alicia] Univ Cent Venezuela, Inst Expt Med, Luis Razetti Sch Med, Dept Physiol Sci,Lab Mol Physiol, Caracas, Venezuela; [Gamarro, Francisco; Garcia-Hernandez, Raquel] Spanish Natl Res Council IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, Dept Biochem & Mol Pharmacol, Granada, Spain; [Dujardin, Jean-Claude] Inst Trop Med, Dept Biomed Sci, Mol Parasitol Unit, Antwerp, Belgium; [Barrett, Michael P.; Pountain, Andrew W.] Univ Glasgow, Inst Infect Immun & Inflammat, Wellcome Ctr Mol Parasitol, Glasgow, Lanark, Scotland; [Lopez-Velez, Rogelio] Ramon & Cajal Univ Hosp, Dept Infect Dis, Natl Referral Unit Trop Dis, Madrid, Spain; [Mwenechanya, Roy] Univ Zambia, Sch Vet Med, Dept Biomed Sci, Lusaka, Zambia; [Papadopoulou, Barbara] CHU Quebec Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada; [Papadopoulou, Barbara] Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada	Ponte-Sucre, A (reprint author), Univ Cent Venezuela, Inst Expt Med, Luis Razetti Sch Med, Dept Physiol Sci,Lab Mol Physiol, Caracas, Venezuela.; Papadopoulou, B (reprint author), CHU Quebec Res Ctr, Res Ctr Infect Dis, Quebec City, PQ, Canada.; Papadopoulou, B (reprint author), Univ Laval, Dept Microbiol Infect Dis & Immunol, Quebec City, PQ, Canada.	aiponte@gmail.com; barbara.papadopoulou@crchudequebec.ulaval.ca		Pountain, Andrew/0000-0001-9651-5145	Canadian Institutes of Health Research [MOP-12182]; Spanish Grant Proyecto de Excelencia, Junta de Andalucia [CTS-7282]; Wellcome Trust [104111/Z/14/Z]; Alexander von Humboldt Foundation, Germany;  [SAF2015-68042-R]	Research reported in this publication was supported by the Canadian Institutes of Health Research operating grant MOP-12182 awarded to BP; the Spanish Grant Proyecto de Excelencia, Junta de Andalucia Ref. CTS-7282 awarded to FG; the Spanish Grant SAF2015-68042-R awarded to FG; the Wellcome Trust (104111/Z/14/Z) awarded to MPB; and the Alexander von Humboldt Foundation, Germany awarded to APS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaui V, 2016, J INFECT DIS, V213, P112, DOI 10.1093/infdis/jiv354; Al-Mohammed HI, 2005, ANTIMICROB AGENTS CH, V49, P3274, DOI 10.1128/AAC.49.8.3274-3280.2005; Alam MZ, 2009, INFECT GENET EVOL, V9, P24, DOI 10.1016/j.meegid.2008.09.005; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Anderson TM, 2014, NAT CHEM BIOL, V10, P400, DOI 10.1038/nchembio.1496; Andrade-Narvaez FJ, 2016, MEM I OSWALDO CRUZ, V111, P599, DOI 10.1590/0074-02760160138; Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Azas N, 2001, PARASITE, V8, P335, DOI 10.1051/parasite/2001084335; Barratt G, 2009, CURR DRUG METAB, V10, P247, DOI 10.2174/138920009787846332; Berg M, 2015, ANTIMICROB AGENTS CH, V59, P2242, DOI 10.1128/AAC.04231-14; Berg M, 2013, PARASITOLOGY, V140, P1492, DOI 10.1017/S0031182013000140; Bhandari V, 2014, ANTIMICROB AGENTS CH, V58, P2580, DOI 10.1128/AAC.01574-13; BHATTACHARYYA T, 2014, PLOS NEGLECT TROP D, V8, P45825; Bourreau E, 2016, J INFECT DIS, V213, P105, DOI 10.1093/infdis/jiv355; Brochu C, 2003, ANTIMICROB AGENTS CH, V47, P3073, DOI 10.1128/AAC.47.10.3073-3079.2003; Brotherton MC, 2014, INT J PARASITOL-DRUG, V4, P126, DOI 10.1016/j.ijpddr.2014.05.002; Castanys S., 2013, DRUG RESISTANCE LEIS; Castanys-Munoz E, 2008, ANTIMICROB AGENTS CH, V52, P3573, DOI 10.1128/AAC.00587-08; Castanys-Munoz E, 2007, MOL MICROBIOL, V64, P1141, DOI 10.1111/j.1365-2958.2007.05653.x; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Coelho AC, 2003, MOL BIOCHEM PARASIT, V130, P83, DOI 10.1016/S0166-6851(03)00162-2; COELHO AC, 2012, PLOS NEGLECT TROP D, V6, P45825; Cojean S, 2012, EMERG INFECT DIS, V18, P704, DOI 10.3201/eid1804.110841; Coutinho Sergio G, 2002, Trans R Soc Trop Med Hyg, V96 Suppl 1, pS173; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; Das M, 2013, FEBS J, V280, P4807, DOI 10.1111/febs.12449; De Gaudenzi JG, 2011, ESSAYS BIOCHEM, V51, P31, DOI [10.1042/BSE0510031, 10.1042/bse0510031]; Deep DK, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005641; Dickens NJ, 2017, PLOS NEGLECT TROP D, V11; Dorlo TPC, 2014, J INFECT DIS, V210, P146, DOI 10.1093/infdis/jiu039; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Dorlo TPC, 2012, ANTIMICROB AGENTS CH, V56, P3864, DOI 10.1128/AAC.00292-12; Dumetz F, 2017, MBIO, V8, DOI [10.1128/mbio.00599-17, 10.1128/mBio.00599-17]; Eichenberger A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2192-4; El Fadili K, 2005, ANTIMICROB AGENTS CH, V49, P1988, DOI 10.1128/AAC.49.5.1988-1993.2005; Fernandez-Prada C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005171; Forastiero A, 2013, ANTIMICROB AGENTS CH, V57, P4769, DOI 10.1128/AAC.00477-13; GALLIS HA, 1990, REV INFECT DIS, V12, P308; Garcia-Hernandez R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003704; GARCIAHERNANDEZ R, 2012, PLOS NEGL TROP DIS, V6, P45825; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Hartley MA, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00099; Hasker E, 2010, TROP MED INT HEALTH, V15, P55, DOI 10.1111/j.1365-3156.2010.02562.x; Hefnawy A, 2017, TRENDS PARASITOL, V33, P162, DOI 10.1016/j.pt.2016.11.003; Hendrickx S, 2016, J ANTIMICROB CHEMOTH, V71, P1914, DOI 10.1093/jac/dkw096; Imamura H, 2016, ELIFE, V5, DOI 10.7554/eLife.12613; Jhingran A, 2009, MOL BIOCHEM PARASIT, V164, P111, DOI 10.1016/j.molbiopara.2008.12.007; Kulshrestha A, 2014, PARASITOL RES, V113, P1171, DOI 10.1007/s00436-014-3755-6; Kumar A, 2014, ANTIMICROB AGENTS CH, V58, P6172, DOI 10.1128/AAC.02834-14; Kundig C, 1999, NUCLEIC ACIDS RES, V27, P3653, DOI 10.1093/nar/27.18.3653; Laffitte Marie-Claude N, 2016, F1000Res, V5, P2350, DOI 10.12688/f1000research.9218.1; Legare D, 2001, J BIOL CHEM, V276, P26301, DOI 10.1074/jbc.M102351200; Lemke A, 2005, APPL MICROBIOL BIOT, V68, P151, DOI 10.1007/s00253-005-1955-9; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Lindoso JA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003136; Lopez-Velez R, 1998, AM J TROP MED HYG, V58, P436, DOI 10.4269/ajtmh.1998.58.436; Lux H, 2000, MOL BIOCHEM PARASIT, V111, P1, DOI 10.1016/S0166-6851(00)00278-4; Machado PR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000912; Maltezou HC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/617521; Mandal G, 2007, PARASITOLOGY, V134, P1679, DOI 10.1017/S0031182007003150; Mandal S, 2010, J ANTIMICROB CHEMOTH, V65, P496, DOI 10.1093/jac/dkp468; Mannaert A, 2012, TRENDS PARASITOL, V28, P370, DOI 10.1016/j.pt.2012.06.003; Manzano JI, 2013, ANTIMICROB AGENTS CH, V57, P3719, DOI 10.1128/AAC.00211-13; Marquis N, 2005, MOL MICROBIOL, V57, P1690, DOI 10.1111/j.1365-2958.2005.04782.x; Martinez-Valencia AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005713; Mbongo N, 1998, ANTIMICROB AGENTS CH, V42, P352; Melaku Y, 2007, AM J TROP MED HYG, V77, P89, DOI 10.4269/ajtmh.2007.77.89; Mishra J, 2013, EXP PARASITOL, V135, P397, DOI 10.1016/j.exppara.2013.08.004; Mitropoulos P, 2010, J AM ACAD DERMATOL, V63, P309, DOI 10.1016/j.jaad.2009.06.088; Mittal MK, 2007, AM J TROP MED HYG, V76, P681, DOI 10.4269/ajtmh.2007.76.681; Mohebali M, 2007, ACTA TROP, V103, P33, DOI 10.1016/j.actatropical.2007.05.005; Mondal D, 2014, LANCET GLOB HEALTH, V2, pE51, DOI 10.1016/S2214-109X(13)70118-9; Mondelaers A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154101; Morizot G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004304; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukherjee B, 2013, P NATL ACAD SCI USA, V110, pE575, DOI [10.1073/pnas.1213839110, 10.]; Musa A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001674; Newton PN, 2010, TRENDS PHARMACOL SCI, V31, P99, DOI 10.1016/j.tips.2009.11.005; OMOLLO R, 2011, TRIALS, V12, P45825; OSTYN B, 2011, PLOS NEGLECT TROP D, V5, P45825; Ostyn B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100220; OUELLETTE M, 1990, EMBO J, V9, P1027, DOI 10.1002/j.1460-2075.1990.tb08206.x; PAPADOPOULOU B, 1993, NUCLEIC ACIDS RES, V21, P4305, DOI 10.1093/nar/21.18.4305; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Perea A, 2016, ANTIMICROB AGENTS CH, V60, P3489, DOI 10.1128/AAC.02813-15; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Perez-Victoria FJ, 2003, J BIOL CHEM, V278, P49965, DOI 10.1074/jbc.M308352200; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Perez-Victoria JM, 2001, ANTIMICROB AGENTS CH, V45, P2468, DOI 10.1128/AAC.45.9.2468-2474.2001; Perry MR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003518; Perry MR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001227; Ponte-Sucre A, 2013, DRUG RESISTANCE LEIS, P431; Ponte-Sucre A., 2003, KINETOPLASTID BIOL D, V28, P2, DOI DOI 10.1186/1475-9292-2-14; Pourshafie M, 2004, ANTIMICROB AGENTS CH, V48, P2409, DOI 10.1128/AAC.48.7.2409-2414.2004; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Rai K, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005420; Rai K, 2013, MBIO, V4, DOI 10.1128/mBio.00611-13; Rakotomanga M, 2005, ANTIMICROB AGENTS CH, V49, P2677, DOI 10.1128/AAC.49.7.2677-2686.2005; Ramos H, 1996, J MEMBRANE BIOL, V152, P65, DOI 10.1007/s002329900086; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Luque-Ortega JR, 2007, ANTIMICROB AGENTS CH, V51, P1327, DOI 10.1128/AAC.01415-06; Romero GAS, 2001, AM J TROP MED HYG, V65, P456, DOI 10.4269/ajtmh.2001.65.456; Roychoudhury J, 2008, INDIAN J BIOCHEM BIO, V45, P16; Seifert K, 2003, INT J ANTIMICROB AG, V22, P380, DOI 10.1016/S0924-8579(03)00125-0; Seifert K, 2007, INT J ANTIMICROB AG, V30, P229, DOI 10.1016/j.ijantimicag.2007.05.007; Singh N, 2006, INDIAN J MED RES, V123, P411; Sinha PK, 2014, LANCET GLOB HEALTH, V2, pE7, DOI 10.1016/S2214-109X(13)70151-7; SOKOLANDERSON M, 1988, ANTIMICROB AGENTS CH, V32, P702, DOI 10.1128/AAC.32.5.702; Soto J, 2004, CLIN INFECT DIS, V38, P1266, DOI 10.1086/383321; Srivastava P, 2011, J CLIN MICROBIOL, V49, P3088, DOI 10.1128/JCM.00173-11; Srivastava S, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1969-z; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Sterkers Y, 2014, TRENDS PARASITOL, V30, P429, DOI 10.1016/j.pt.2014.07.002; Sundar S, 2000, CLIN INFECT DIS, V31, P1110, DOI 10.1086/318122; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2012, CLIN INFECT DIS, V55, P543, DOI 10.1093/cid/cis474; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8; Sundar S, 2011, T ROY SOC TROP MED H, V105, P115, DOI 10.1016/j.trstmh.2010.10.008; Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627; Sundar Shyam, 2007, Ther Clin Risk Manag, V3, P733; Ubeda JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001868; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115; Vacchina P, 2016, ANTIMICROB AGENTS CH, V60, P4089, DOI 10.1128/AAC.00478-16; Valencia C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001656; van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556; van Griensven J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004495; Vanaerschot M, 2014, FEMS MICROBIOL REV, V38, P41, DOI 10.1111/1574-6976.12032; Verma NK, 2004, ANTIMICROB AGENTS CH, V48, P3010, DOI 10.1128/AAC.48.8.3010-3015.2004; Verma S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2318-8; Victoir K, 2002, TRENDS PARASITOL, V18, P81, DOI 10.1016/S1471-4922(01)02199-7; Vincent BM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001692; Wasunna M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004880; Wyllie S, 2008, ANTIMICROB AGENTS CH, V52, P1359, DOI 10.1128/AAC.01563-07; Young LY, 2003, ANTIMICROB AGENTS CH, V47, P2717, DOI 10.1128/AAC.47.9.2717-2724.2003; Zerpa O, 2013, DRUG RESISTANCE LEIS, P199; Zerpa O, 2009, GAZETA MED BAHIA S3, V79, P30; 2010, WHO TECHNICAL REPORT, V949, P1	140	49	49	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2017	11	12							e0006052	10.1371/journal.pntd.0006052				24	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FR5LR	WOS:000419108500008	29240765	DOAJ Gold, Green Published			2019-04-02	
J	Dao, TTH; Nguyen, TTG; Gabriel, S; Bui, KL; Dorny, P; Le, TH				Thanh Thi Ha Dao; Thanh Thi Giang Nguyen; Gabriel, Sarah; Khanh Linh Bui; Dorny, Pierre; Thanh Hoa Le			Updated molecular phylogenetic data for Opisthorchis spp. (Trematoda: Opisthorchioidea) from ducks in Vietnam	PARASITES & VECTORS			English	Article						Mitochondrial gene; Ribosomal transcription unit; Opisthorchis sp BD2013; Opisthorchiid; 18S rDNA; 28S rDNA; Phylogenetic analysis	COMPLETE MITOCHONDRIAL GENOMES; CLONORCHIS-SINENSIS TREMATODA; RIBOSOMAL DNA-SEQUENCES; AVIAN LIVER FLUKE; FAMILIES OPISTHORCHIIDAE; DIGENEA FASCIOLIDAE; FASCIOLOPSIS-BUSKI; GENE ORGANIZATION; VIVERRINI; PLATYHELMINTHES	Background: An opisthorchiid liver fluke was recently reported from ducks (Anas platyrhynchos) in Binh Dinh Province of Central Vietnam, and referred to as "Opisthorchis viverrini-like". This species uses common cyprinoid fishes as second intermediate hosts as does Opisthorchis viverrini, with which it is sympatric in this province. In this study, we refer to the liver fluke from ducks as "Opisthorchis sp. BD2013", and provide new sequence data from the mitochondrial (mt) genome and the nuclear ribosomal transcription unit. A phylogenetic analysis was conducted to clarify the basal taxonomic position of this species from ducks within the genus Opisthorchis (Digenea: Opisthorchiidae). Methods: Adults and eggs of liver flukes were collected from ducks, metacercariae from fishes (Puntius brevis, Rasbora aurotaenia, Esomus metallicus) and cercariae from snails (Bithynia funiculata) in different localities in Binh Dinh Province. From four developmental life stage samples (adults, eggs, metacercariae and cercariae), the complete cytochrome b (cob), nicotinamide dehydrogenase subunit 1 (nad1) and cytochrome c oxidase subunit 1 (cox1) genes, and near-complete 18S and partial 28S ribosomal DNA (rDNA) sequences were obtained by PCR-coupled sequencing. The alignments of nucleotide sequences of concatenated cob + nad1 + cox1, and of concatenated 18S + 28S were separately subjected to phylogenetic analyses. Homologous sequences from other trematode species were included in each alignment. Results: Phylogenetic trees were inferred from concatenated (cob + nad1 + cox1) nucleotide sequences and combined 18S + 28S nucleotide sequences of five Opisthorchis sp. BD2013 samples and additional reference taxa. Both trees demonstrated the anticipated clustering of taxa within the superfamily Opisthorchioidea, the paraphyly of the genus Opisthorchis and the sister-species relationship of Opisthorchis sp. BD2013 with O. viverrini. Conclusions: While it is likely that Opisthorchis sp. BD2013 is distinct from O. viverrini, it is clearly a sister taxon of O. viverrini within the limited number of Opisthorchis species for which appropriate sequence data are available. The new sequences provided here will assist the diagnosis and the taxonomic clarification of the opisthorchiid species.	[Thanh Thi Ha Dao; Thanh Thi Giang Nguyen] Natl Inst Vet Res, 86 Truong Chinh St, Hanoi, Vietnam; [Thanh Thi Ha Dao; Thanh Thi Giang Nguyen; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium; [Thanh Thi Ha Dao; Dorny, Pierre] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, 133 Salisburylaan, B-9820 Merelbeke, Belgium; [Gabriel, Sarah] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, 133 Salisburylaan, B-9820 Merelbeke, Belgium; [Khanh Linh Bui] Vietnam Natl Univ Agr, Dept Parasitol, Fac Vet Med, Hanoi, Vietnam; [Thanh Hoa Le] Inst Biotechnol, Dept Immunol, 18 Hoang Quoc Viet Rd, Hanoi, Vietnam; [Thanh Hoa Le] Grad Univ Sci & Technol, Vietnam Acad Sci & Technol, 18 Hoang Quoc Viet Rd, Hanoi, Vietnam	Dorny, P (reprint author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.; Dorny, P (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, 133 Salisburylaan, B-9820 Merelbeke, Belgium.	pdorny@itg.be		Dorny, Pierre/0000-0001-5381-7987	Directorate General for Development Cooperation (DGD) Belgium, through the individual PhD Programme (THT Dao) of the Institute of Tropical Medicine Belgium under the DGD-ITM [3, 4]	This work was funded by the Directorate General for Development Cooperation (DGD) Belgium, through the individual PhD Programme (THT Dao) of the Institute of Tropical Medicine Belgium under the DGD-ITM Framework agreements 3 and 4.	Cai XQ, 2012, PARASITOL RES, V110, P235, DOI 10.1007/s00436-011-2477-2; Dao TH, 2014, J HELMINTHOL, V88, P441, DOI 10.1017/S0022149X13000400; Doanh PN, 2016, T ROY SOC TROP MED H, V110, P13, DOI 10.1093/trstmh/trv103; Dorny P, 2015, J HELMINTHOL, V89, P257, DOI 10.1017/S0022149X13000722; Dao HTT, 2017, ACTA TROP, V170, P120, DOI 10.1016/j.actatropica.2017.02.028; JOHNSTON DA, 1993, PARASITOLOGY, V107, P147, DOI 10.1017/S0031182000067251; Kostadinova A, 2014, ADV EXP MED BIOL, V766, P21, DOI 10.1007/978-1-4939-0915-5_2; Le NT, 2000, FAUNA OF VIETNAM, P236; Le TH, 2004, T ROY SOC TROP MED H, V98, P193, DOI 10.1016/S0035-9203(03)00022-1; Le TH, 2001, PARASITOLOGY, V123, P609, DOI 10.1017/S0031182001008733; Lee D, 2013, KOREAN J PARASITOL, V51, P719, DOI 10.3347/kjp.2013.51.6.719; Littlewood DTJ, 2006, MOL PHYLOGENET EVOL, V39, P452, DOI 10.1016/j.ympev.2005.12.012; Liu GH, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-150; Lockyer AE, 2003, PARASITOLOGY, V126, P203, DOI 10.1017/S0031182002002792; Lotfy WM, 2008, AM J TROP MED HYG, V79, P248, DOI 10.4269/ajtmh.2008.79.248; Ma J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2039-2; Ma J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1699-7; Na L, 2016, INFECT GENET EVOL, V39, P45, DOI 10.1016/j.meegid.2016.01.010; Nawa Y, 2015, J HELMINTHOL, V89, P255, DOI 10.1017/S0022149X13000709; Olson PD, 2003, INT J PARASITOL, V33, P733, DOI 10.1016/S0020-7519(03)00049-3; OSHMARIN P. G., 1970, Trematodes of domestic and wild birds in the Democratic Republic of Viet Nam. Helminths of animals in south-eastern Asia., P5; Petney TN, 2013, INT J PARASITOL, V43, P1031, DOI 10.1016/j.ijpara.2013.07.007; Pornruseetairatn S, 2016, PARASITOL RES, V115, P1123, DOI 10.1007/s00436-015-4843-y; Scholz T, 2008, KEYS TREMATODA, V3, P9; Shekhovtsov SV, 2010, PARASITOL INT, V59, P100, DOI 10.1016/j.parint.2009.10.012; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan ND, 2017, J VET SCI TECHN, V3, P58; Thaenkham U, 2012, PARASITOL INT, V61, P90, DOI 10.1016/j.parint.2011.06.004; Thaenkham U, 2011, PARASITOL INT, V60, P521, DOI 10.1016/j.parint.2011.07.015; Thaenkham U, 2010, PARASITOL INT, V59, P460, DOI 10.1016/j.parint.2010.06.009; Le TH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1968-0; Dao TTH, 2016, KOREAN J PARASITOL, V54, P357, DOI 10.3347/kjp.2016.54.3.357; Dao TTH, 2016, ACTA TROP, V157, P151, DOI 10.1016/j.actatropica.2016.01.029; Tkach VV, 2016, INT J PARASITOL, V46, P171, DOI 10.1016/j.ijpara.2015.11.001	35	4	4	2	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 21	2017	10								575	10.1186/s13071-017-2514-9				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FN6IA	WOS:000416116300003	29157282	DOAJ Gold, Green Published			2019-04-02	
J	Chembensofu, M; Mwape, KE; Van Damme, I; Hobbs, E; Phiri, IK; Masuku, M; Zulu, G; Colston, A; Willingham, AL; Devleesschauwer, B; Van Hul, A; Chota, A; Speybroeck, N; Berkvens, D; Dorny, P; Gabriel, S				Chembensofu, Mwelwa; Mwape, K. E.; Van Damme, I.; Hobbs, E.; Phiri, I. K.; Masuku, M.; Zulu, G.; Colston, A.; Willingham, A. L.; Devleesschauwer, B.; Van Hul, A.; Chota, A.; Speybroeck, N.; Berkvens, D.; Dorny, P.; Gabriel, S.			Re-visiting the detection of porcine cysticercosis based on full carcass dissections of naturally Taenia solium infected pigs	PARASITES & VECTORS			English	Article						Taenia solium; Cysticercosis; Pig carcass; Dissection; Liver; Antigen ELISA; Tongue palpation	PREVALENCE; DIAGNOSIS; ANTIGENS; TANZANIA; NECROPSY; WESTERN	Background: Taenia solium is a neglected zoonotic parasite. The performances of existing tools for the diagnosis of porcine cysticercosis need further assessment, and their shortcomings call for alternatives. The objective of this study was to evaluate the performance of tongue palpation and circulating antigen detection for the detection of porcine cysticercosis in naturally infected pigs of slaughter age compared to full carcass dissections (considered the gold standard). Additionally, alternative postmortem dissection procedures were investigated. A total of 68 rural pigs of slaughter age randomly selected in the Eastern Province of Zambia were dissected. Dissections were conducted on full carcasses (or half carcass in case cysticerci were already detected in the first half), including all the organs. Total cysticercus counts, location and stages were recorded and collected cysticerci were identified morphologically and molecularly. All sera were analysed with the B158/B60 antigen detecting ELISA (Ag-ELISA). Results: Key findings were the high occurrence of T. solium infected pigs (56%) and the presence of T. solium cysticerci in the livers of 26% of infected animals. More than half of the infected carcasses contained viable cysticerci. Seven carcasses had T. hydatigena cysticerci (10%), out of which five carcasses were co-infected with T. hydatigena and T. solium; two carcasses (3%) had only T. hydatigena cysticerci. Compared to full carcass dissection, the specificity of the Ag-ELISA to detect infected carcasses was estimated at 67%, the sensitivity at 68%, increasing to 90% and 100% for the detection of carcasses with one or more viable cysticerci, and more than 10 viable cysts, respectively. Tongue palpation only detected 10% of the cases, half carcass dissection 84%. Selective dissection of the diaphragm, tongue and heart or masseters can be considered, with an estimated sensitivity of 71%, increasing to 86% in carcasses with more than 10 cysticerci. Conclusions: Depending on the aim of the diagnosis, a combination of Ag-ELISA and selective dissection, including investigating the presence of T. hydatigena, can be considered. Full carcass dissection should include the dissection of the liver, kidneys, spleen and lungs, and results should be interpreted carefully, as small cysticerci can easily be overlooked.	[Chembensofu, Mwelwa; Chota, A.] Univ Zambia, Sch Vet Med, Dept Paraclin Studies, POB 32379, Lusaka, Zambia; [Mwape, K. E.; Phiri, I. K.; Masuku, M.] Univ Zambia, Sch Vet Med, Dept Clin Studies, POB 32379, Lusaka, Zambia; [Van Damme, I.; Hobbs, E.; Dorny, P.; Gabriel, S.] Univ Ghent, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium; [Hobbs, E.; Willingham, A. L.] Ross Univ, Sch Vet Med, Hlth Ctr Zoonoses & Trop Vet Med 1, POB 334, Basseterre, St Kitts, St Kitts & Nevi; [Hobbs, E.; Van Hul, A.; Berkvens, D.; Dorny, P.] Inst Trop Med, Dept Biomed Sci, Kronenburgstr 25, B-2000 Antwerp, Belgium; [Zulu, G.] Minist Hlth, Dist Med Off, POB 30205, Lusaka, Zambia; [Colston, A.] Global Alliance Livestock Vet Med, POB 52773-00100, Nairobi, Kenya; [Devleesschauwer, B.] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Rue Juliette Wytsman 14, B-1050 Brussels, Belgium; [Speybroeck, N.] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Sch Publ Hlth, 1200 Woluwe St Lambert, Brussels, Belgium	Gabriel, S (reprint author), Univ Ghent, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.	sarah.gabriel@ugent.be	Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892	Institute of Tropical Medicine, Antwerp via Flemish Ministry of Research; Ross University School of Veterinary Medicine; Bill AMP; Melinda Gates Foundation; UK aid from UK Government through GALVmed; Institute of Tropical Medicine in Antwerp, Belgium; University of Pretoria, Pretoria, South Africa	The study received financial support from the Institute of Tropical Medicine, Antwerp via the Flemish Ministry of Research. Funding for the PhD study was provided by the Ross University School of Veterinary Medicine. Support was also obtained from the Belgian Cooperation in the framework of the Institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium, and the University of Pretoria, Pretoria, South Africa. This publication is also based on research funded in part by the Bill & Melinda Gates Foundation and with UK aid from the UK Government through GALVmed. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation nor the UK Government.	Assana E, 2010, INT J PARASITOL, V40, P515, DOI 10.1016/j.ijpara.2010.01.006; Boa ME, 2002, VET PARASITOL, V106, P155, DOI 10.1016/S0304-4017(02)00037-7; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Dermauw V, 2016, VET PARASITOL, V230, P9, DOI 10.1016/j.vetpar.2016.10.022; Donadeu M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005875; Dorny P, 2017, VET PARASITOL, V245, P39, DOI 10.1016/j.vetpar.2017.08.008; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Flecker RH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005282; Gabriel S, 2017, ACTA TROP, V165, P252, DOI 10.1016/j.actatropica.2016.04.010; GONZALEZ AE, 1990, AM J TROP MED HYG, V43, P194, DOI 10.4269/ajtmh.1990.43.194; Jayashi CM, 2014, VET PARASITOL, V199, P42, DOI 10.1016/j.vetpar.2013.10.004; Lightowlers MW, 2016, PARASITE IMMUNOL, V38, P158, DOI 10.1111/pim.12291; Lightowlers MW, 2015, INT J PARASITOL, V45, P815, DOI 10.1016/j.ijpara.2015.08.004; Murrell KD, 2005, WHO OIE FAO GUIDELIN, P57; Mwape KE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003972; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Phiri IK, 2006, J HELMINTHOL, V80, P69, DOI 10.1079/JOH2005314; Sciutto E, 1998, VET PARASITOL, V79, P299, DOI 10.1016/S0304-4017(98)00180-0; Sikasunge CS, 2008, VET J, V176, P240, DOI 10.1016/j.tvjl.2007.02.030; SOKAL R, 1981, BIOMETRY PRINCIPALS; Trevisan C, 2017, ACTA TROP, V165, P141, DOI 10.1016/j.actatropica.2015.12.021; World Health Organisation (WHO), 2015, EST GLOB BURD FOODB; Zoli A, 2003, ACTA TROP, V87, P35, DOI 10.1016/S0001-706X(02)00289-9	26	3	3	0	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 16	2017	10								572	10.1186/s13071-017-2520-y				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FM8RB	WOS:000415356100002	29145875	DOAJ Gold			2019-04-02	
J	Muzyamba, C; Groot, W; Tomini, SM; Pavlova, M				Muzyamba, Choolwe; Groot, Wim; Tomini, Sonila M.; Pavlova, Milena			The usefulness of traditional birth attendants to women living with HIV in resource-poor settings: the case of Mfuwe, Zambia	TROPICAL MEDICINE AND HEALTH			English	Article						Maternal health; Traditional birth attendants (TBAs); HIV/aids		Background: Although there is increased attention on the role of trained traditional birth attendants (TBAs) in maternal care, most of the research has mainly focused on providing evidence of the relevance of trained TBAs to women in general without a specific focus on women who are HIV positive, despite them being most vulnerable. Therefore, the aim of this study is to fill this gap by assessing the relevance of trained TBAs to women living with HIV in resource-poor settings by using Zambia as a case study. Methods: Our data collection consisted of two focus group discussions, one involving HIV-positive women utilizing trained TBAs and the other with women not utilizing TBAs. Additionally, in-depth interviews were conducted with trained TBAs and health workers. Thematic analysis was used to analyze the data. Results: In general, women living with HIV positively characterized the services of TBAs. In the face of an inefficient health system, trained TBAs were seen to be useful in providing efficient, cheap and quality care, counseling, and referral and logistical support, including treatment adherence support. Conclusion: In Zambia, trained TBAs and professional care are not mutually exclusive but complementary. There is no doubt that HIV-positive women need professionals to handle complications and offer antiretroviral treatment to ensure prevention of mother to child transmission (PMTCT). However, additional "soft" services offered by trained TBAs are equally important in the promotion of maternal health care among HIV-positive women. Thus, it seems there is more to gain by systematically allowing trained TBAs to work alongside professionals in a well-coordinated and complementary manner.	[Muzyamba, Choolwe; Tomini, Sonila M.] Maastricht Univ, Maastricht Grad Sch Governance UNU Merit, Maastricht, Netherlands; [Muzyamba, Choolwe] A9 Marshlands Village,POB 32379, Lusaka, Zambia; [Groot, Wim; Pavlova, Milena] Maastricht Univ, Fac Hlth Med & Life Sci, Dept Hlth Serv Res, CAPHRI,Med Ctr, Maastricht, Netherlands; [Groot, Wim] Maastricht Univ, Top Inst Evidence Based Educ Res TIER, Maastricht, Netherlands; [Tomini, Sonila M.] Univ Liege, Dept Econ, Liege, Belgium	Muzyamba, C (reprint author), Maastricht Univ, Maastricht Grad Sch Governance UNU Merit, Maastricht, Netherlands.; Muzyamba, C (reprint author), A9 Marshlands Village,POB 32379, Lusaka, Zambia.	muzyamba@merit.unu.edu	Pavlova, Milena/B-4778-2011	Pavlova, Milena/0000-0002-6082-8446				0	0	0	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1348-8945	1349-4147		TROP MED HEALTH	Trop. Med. Health	NOV 13	2017	45								37	10.1186/s41182-017-0076-3				8	Tropical Medicine	Tropical Medicine	FM4FD	WOS:000414967100001	29158723	DOAJ Gold, Green Published			2019-04-02	
J	Klotz, C; Soba, B; Skvarc, M; Gabriel, S; Robertson, LJ				Klotz, Christian; Soba, Barbara; Skvarc, Miha; Gabriel, Sarah; Robertson, Lucy J.			A European network for food-borne parasites (Euro-FBP): meeting report on 'Analytical methods for food-borne parasites in human and veterinary diagnostics and in food matrices'	PARASITES & VECTORS			English	Article						Food-borne parasites; Diagnosis; Multi-pathogen detection; Euro-FBP; CYSTINET	CRYPTOSPORIDIUM	Food-borne parasites (FBPs) are a neglected topic in food safety, partly due to a lack of awareness of their importance for public health, especially as symptoms tend not to develop immediately after exposure. In addition, methodological difficulties with both diagnosis in infected patients and detection in food matrices result in under-detection and therefore the potential for underestimation of their burden on our societies. This, in consequence, leads to lower prioritization for basic research, e.g. for development new and more advanced detection methods for different food matrices and diagnostic samples, and thus a vicious circle of neglect and lack of progress is propagated. The COST Action FA1408, A European Network for Foodborne Parasites (Euro-FBP) aims to combat the impact of FBP on public health by facilitating the multidisciplinary cooperation and partnership between groups of researchers and between researchers and stakeholders. The COST Action TD1302, the European Network for cysticercosis/taeniosis, CYSTINET, has a specific focus on Taenia solium and T. saginata, two neglected FBPs, and aims to advance knowledge and understanding of these zoonotic disease complexes via collaborations in a multidisciplinary scientific network. This report summarizes the results of a meeting within the Euro-FBP consortium entitled 'Analytical methods for food-borne parasites in human and veterinary diagnostics and in food matrices' and of the joined Euro-FBP and CYSTINET meeting.	[Klotz, Christian] Robert Koch Inst, Dept Infect Dis, Mycot & Parasit Agents & Mycobacteria Unit 16, Seestr 10, D-13353 Berlin, Germany; [Soba, Barbara; Skvarc, Miha] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Zaloska 4, Ljubljana 1000, Slovenia; [Gabriel, Sarah] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium; [Robertson, Lucy J.] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Fac Vet Med, POB 8146 Dep, N-0033 Oslo, Norway	Klotz, C (reprint author), Robert Koch Inst, Dept Infect Dis, Mycot & Parasit Agents & Mycobacteria Unit 16, Seestr 10, D-13353 Berlin, Germany.	klotzc@rki.de			COST (European Cooperation in Science and Technology) Action FA1408 "A European Network for Foodborne Parasites: Euro-FBP"; COST (European Cooperation in Science and Technology) Action TD1302 "European Network on Taeniosis/Cysticercosis: CYSTINET"	The meeting was supported by COST (European Cooperation in Science and Technology) Actions FA1408 "A European Network for Foodborne Parasites: Euro-FBP" and TD1302 "European Network on Taeniosis/Cysticercosis: CYSTINET".	[Anonymous], TD1302 COST; [Anonymous], FA1408 COST; Aurrecoechea C, 2017, NUCLEIC ACIDS RES, V45, pD581, DOI 10.1093/nar/gkw1105; Bouwknegt M, 2017, EURO SURVEI IN PRESS; Chalmers R, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.37.30338; Chalmers RM, 2015, J MED MICROBIOL, V64, P688, DOI 10.1099/jmm.0.000089; Edvinsson B, 2006, CLIN MICROBIOL INFEC, V12, P131, DOI 10.1111/j.1469-0691.2005.01332.x; Hohweyer J, 2016, FOOD MICROBIOL, V57, P36, DOI 10.1016/j.fm.2016.01.002; Opsteegh M, 2016, EFSA SUPP PUBL, V13, P294, DOI [10.2903/sp.efsa.2016.EN-996, DOI 10.2903/SP.EFSA.2016.EN-996]; Opsteegh M, 2016, EFSA SUPPORTING PUBL, V13, DOI [10.2903/sp.efsa.2016.EN-995, DOI 10.2903/SP.EFSA.2016.EN-995]; Ortega YR, 2017, FOODBORNE PARASITES; Rossi P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1532-3; STAJNER T, 2016, MEDICINE BALTIMORE, V95; Troell K, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2815-y; van Dommelen L, 2012, J CLIN MICROBIOL, V50, P1818, DOI 10.1128/JCM.06355-11	15	0	0	3	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 9	2017	10								559	10.1186/s13071-017-2506-9				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FM2AY	WOS:000414786900005	29122002	DOAJ Gold, Green Published			2019-04-02	
J	Di Luca, M; Toma, L; Severini, F; Boccolini, D; D'Avola, S; Todaro, D; Stancanelli, A; Antoci, F; La Russa, F; Casano, S; Sotera, SD; Carraffa, E; Versteirt, V; Schaffner, F; Romi, R; Torina, A				Di Luca, Marco; Toma, Luciano; Severini, Francesco; Boccolini, Daniela; D'Avola, Salvatore; Todaro, Diego; Stancanelli, Alessandra; Antoci, Francesco; La Russa, Francesco; Casano, Sandro; Sotera, Salvatore D.; Carraffa, Eugenio; Versteirt, Veerle; Schaffner, Francis; Romi, Roberto; Torina, Alessandra			First record of the invasive mosquito species Aedes (Stegomyia) albopictus (Diptera: Culicidae) on the southernmost Mediterranean islands of Italy and Europe	PARASITES & VECTORS			English	Article						Aedes albopictus; First record; Invasive mosquito; Entry routes; Lampedusa; Linosa; Pantelleria; Italy	DENGUE VIRUS; INFECTION; CROATIA	Background: Aedes albopictus, a known worldwide vector of several mosquito-borne disease pathogens including dengue, chikungunya and Zika viruses, was introduced into Europe in the late 1970s through global trade. First recorded in northern Italy in 1990, this mosquito species has rapidly spread throughout the country, where it was responsible for an outbreak of chikungunya in 2007 that affected more than 200 people. As part of the VectorNet project, which is aimed at improving preparedness and responsiveness for animal and human vector-borne diseases in Europe, a mosquito targeted study was carried out on the three southernmost Italian islands. The objective was to verify the current European southern distribution limits of Ae. albopictus and the potential occurrence of other invasive mosquito species, in the light of the introduction of high risk for vector-borne disease pathogens into Europe via migration flows. Results: In the summer 2015, six surveys for container-breeding mosquitoes were carried out by setting up a network of oviposition traps and BG Sentinel traps in selected areas on the islands of Pantelleria, Lampedusa and Linosa. Aedes albopictus was found on all three islands under investigation. The consequences on public health with regard to the presence of this mosquito vector and the migrant people entering the country from Africa and the Middle East are also discussed here. Conclusions: The detection of the Asian tiger mosquito on these islands, which represent the last European strip of land facing Africa, has important implications for public health policy and should prompt the national authorities to implement tailored surveillance activities and reinforce plans for preparedness strategies in such contexts.	[Di Luca, Marco; Toma, Luciano; Severini, Francesco; Boccolini, Daniela; Romi, Roberto] Ist Super Sanita, Dept Infect Dis, Unit Vectorborne Dis, Rome, Italy; [D'Avola, Salvatore; Todaro, Diego] ASP Trapani, Unit Anim Hlth Serv, Dept Vet Prevent, Pantelleria, Italy; [Stancanelli, Alessandra; Antoci, Francesco; La Russa, Francesco; Torina, Alessandra] Ist Zooprofilatt Sperimentale Sicilia, Lab Entomol & Environm Vectors Control, Palermo, Italy; [Casano, Sandro] City Council Pantelleria, Pantelleria, Italy; [Carraffa, Eugenio] City Council Lampedusa & Linosa, Linosa, Italy; [Versteirt, Veerle] Avia GIS, Risschotlei 33, B-2980 Zoersel, Belgium; [Schaffner, Francis] Francis Schaffner Consultancy, Riehen, Switzerland; [Schaffner, Francis] Univ Zurich, Switzerland & Inst Parasitol, Zurich, Switzerland	Di Luca, M (reprint author), Ist Super Sanita, Dept Infect Dis, Unit Vectorborne Dis, Rome, Italy.	marco.diluca@iss.it		Torina, Alessandra/0000-0003-1555-8309; Schaffner, Francis/0000-0001-9166-7617	VectorNet; ECDC; EFSA [OC/EFSA/AHAW/2013/02]; European Commission Framework Program Seven Award "InfraVec" [228421]; Elanco Animal Health [BIOIT140021]	This study was supported by VectorNet and its funding agencies ECDC and EFSA (contract number OC/EFSA/AHAW/2013/02). FS was partially funded by the European Commission Framework Program Seven Award "InfraVec" (project number 228421), and by Elanco Animal Health (project number BIOIT140021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhami J., 1987, REV MJEKESORE, V1, P13; Barcelo Carlos, 2015, Journal of the European Mosquito Control Association, V33, P1; Bengoa Mikel, 2016, Journal of the European Mosquito Control Association, V34, P5; Buhagiar Joseph A., 2009, European Mosquito Bulletin, V27, P65; Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543; Cuffaro S, 2008, PARASSITOLOGIA, V50, P145; Dalla Pozza G., 1992, Journal of the American Mosquito Control Association, V8, P318; Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108; Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223; European Centre for Disease Prevention and Control, 2012, GUID SURV INV MOSQ E; Gatt Paul, 2009, European Mosquito Bulletin, V27, P56; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437; Knudsen A. B., 1995, Parassitologia (Rome), V37, P91; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Madon MB, 2002, J VECTOR ECOL, V27, P149; Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661; Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Miquel Margalida, 2013, Journal of the European Mosquito Control Association, V31, P8; Pasta L, 2015, EPIDEMIOL PREV, V39, P55; Prestileo Tullio, 2013, Infez Med, V21, P21; REITER P, 1987, J AM MOSQUITO CONTR, V3, P494; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Romi R., 2008, EUR INF DIS, V2, P98; Romi Roberto, 1997, Fragmenta Entomologica, V29, P1; Sabatini A, 1990, PARASSITOLOGIA, V32, p30l; Schaffner F, 2001, MOSQUITOES EUROPE ID; Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209; Schmidt-Chanasit J, 2010, EUROSURVEILLANCE, V15, P2; Scholte EJ, 2008, MED VET ENTOMOL, V22, P352, DOI 10.1111/j.1365-2915.2008.00763.x; Severini Francesco, 2009, Fragmenta Entomologica, V41, P213; Torina A., 2006, Parassitologia (Rome), V48, P145	35	1	1	5	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 2	2017	10								543	10.1186/s13071-017-2488-7				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FL6BX	WOS:000414331300002	29096677	DOAJ Gold, Green Published			2019-04-02	
J	Botero-Garcia, CA; Faccini-Martinez, AA; Uribe, E; Calixto, OJ; Perez-Diaz, CE; Osejo-Diago, PP; Franco-Maz, PG				Andres Botero-Garcia, Carlos; Adolfo Faccini-Martinez, Alvaro; Uribe, Erika; Calixto, Omar-Javier; Eduardo Perez-Diaz, Carlos; Pablo Osejo-Diago, Pedro; Gabriel Franco-Maz, Pedro			Epididymo-orchitis caused by Histoplasma capsulatum in a Colombian patient	REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL			English	Article						Histoplasma; Epididymitis; Orchitis; Colombia		Although histoplasmosis is generally a self-limited disease, disseminated infection can occur in patients lacking effective cell-mediated immunity, reaching virtually every organ, even the genitourinary tract in rare cases. We report a case of epididymo-orchitis in an immunocompetent 38-year-old bricklayer from the rural area of Villeta, Cundinamarca, Colombia. The patient presented with testicular pain and macroscopic scrotal changes requiring a left orchiectomy, with microbiological isolation and molecular confirmation of Histoplasma capsulatum.	[Andres Botero-Garcia, Carlos] Hosp Militar Cent GREINMIL, Grp Invest Enfermedades Infecciosas, Bogota, Colombia; [Adolfo Faccini-Martinez, Alvaro] Univ Fed Espirito Santo, Hlth Sci Ctr, Postgrad Program Infect Dis, Vitoria, ES, Brazil; [Adolfo Faccini-Martinez, Alvaro] Asociac Colombiana Infectol, Comm Trop Med Zoonoses & Travel Med, Bogota, Colombia; [Uribe, Erika; Eduardo Perez-Diaz, Carlos] Serv & Asesorias Infectol, Bogota, Colombia; [Calixto, Omar-Javier] Hasselt Univ, Brussels, Belgium; [Eduardo Perez-Diaz, Carlos] Hosp Univ Samaritana, Infect Dis Dept, Bogota, Colombia; [Pablo Osejo-Diago, Pedro; Gabriel Franco-Maz, Pedro] Hosp Univ Samaritana, Pathol Dept, Bogota, Colombia; [Gabriel Franco-Maz, Pedro] Univ Nacl Colombia, Sch Med, Bogota, Colombia	Faccini-Martinez, AA (reprint author), Univ Fed Espirito Santo, Hlth Sci Ctr, Postgrad Program Infect Dis, Vitoria, ES, Brazil.	afaccini@gmail.com					Arango M, 2011, BIOMEDICA, V31, P344, DOI 10.1590/S0120-41572011000300007; Baig WW, 2011, TRANSPL INFECT DIS, V13, P489, DOI 10.1111/j.1399-3062.2011.00660.x; Friskel E, 2000, CLIN INFECT DIS, V31, P189, DOI 10.1086/313904; Horwath MC, 2015, FUTURE MICROBIOL, V10, P967, DOI [10.2217/FMB.15.25, 10.2217/fmb.15.25]; Kauffman CA, 2007, CLIN MICROBIOL REV, V20, P115, DOI 10.1128/CMR.00027-06; Kiggundu Reuben, 2016, Autops Case Rep, V6, P27, DOI 10.4322/acr.2016.048; Robayo CAM, 2014, COLOMB MEDICA, V45, P186; Neder L, 2015, REV BRAS REUMATOL, V55, P414, DOI 10.1016/j.rbr.2014.12.013; Negroni R, 2011, BIOMEDICA, V31, P301, DOI 10.7705/biomedica.v31i3.597; Randhawa HS, 1995, MYCOPATHOLOGIA, V131, P173, DOI 10.1007/BF01102897; Sizemore TC, 2013, RHEUMATOL INT, V33, P2963, DOI 10.1007/s00296-013-2816-y; Tichindelean C, 2009, AM J MED SCI, V338, P238, DOI 10.1097/MAJ.0b013e3181a779fa	12	0	0	0	3	SOC BRASILEIRA MEDICINA TROPICAL	BRASILIA	UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356, BRASILIA, DF 70919-970, BRAZIL	0037-8682			REV SOC BRAS MED TRO	Rev. Soc. Bras. Med. Trop.	NOV-DEC	2017	50	6					868	870		10.1590/0037-8682-0267-2017				3	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FT2CF	WOS:000422945300023	29340471	DOAJ Gold			2019-04-02	
J	Toledo, ME; Vanlerberghe, V; Rosales, JP; Mirabal, M; Cabrera, P; Fonseca, V; Padron, TG; Menzies, MP; Montada, D; Van der Stuyft, P				Eugenia Toledo, Maria; Vanlerberghe, Veerle; Popa Rosales, Julio; Mirabal, Mayelin; Cabrera, Pedro; Fonseca, Viviana; Gomez Padron, Tania; Perez Menzies, Mirtha; Montada, Domingo; Van der Stuyft, Patrick			The additional benefit of residual spraying and insecticide-treated curtains for dengue control over current best practice in Cuba: Evaluation of disease incidence in a cluster randomized trial in a low burden setting with intensive routine control	PLOS NEGLECTED TROPICAL DISEASES			English	Article							AEDES-AEGYPTI CONTROL; VECTOR CONTROL; PYRETHROID RESISTANCE; VIRUS TRANSMISSION; INCREMENTAL COST; EFFICACY; DELTAMETHRIN; EPIDEMIC; THAILAND; SANTIAGO	Background Aedes control interventions are considered the cornerstone of dengue control programmes, but there is scarce evidence on their effect on disease. We set-up a cluster randomized controlled trial in Santiago de Cuba to evaluate the entomological and epidemiological effectiveness of periodical intra-and peri-domiciliary residual insecticide (deltamethrin) treatment (RIT) and long lasting insecticide treated curtains (ITC). Methodology/Principal findings Sixty three clusters (around 250 households each) were randomly allocated to two intervention (RIT and ITC) and one control arm. Routine Aedes control activities (entomological surveillance, source reduction, selective adulticiding, health education) were applied in the whole study area. The outcome measures were clinical dengue case incidence and immature Aedes infestation. Effectiveness of tools was evaluated using a generalized linear regression model with a negative binomial link function. Despite significant reduction in Aedes indices (Rate Ratio (RR) 0.54 (95% CI 0.32-0.89) in the first month after RIT, the effect faded out over time and dengue incidence was not reduced. Overall, in this setting there was no protective effect of RIT or ITC over routine in the 17months intervention period, with for house index RR of 1.16 (95% CI 0.96-1.40) and 1.25 (95% CI 1.03-1.50) and for dengue incidence RR of 1.43 (95% CI 1.08-1.90) and 0.96 (95% CI 0.72-1.28) respectively. The monthly dengue incidence rate (IR) at cluster level was best explained by epidemic periods (Incidence Rate Ratio (IRR) 5.50 (95% CI 4.14-7.31)), the IR in bordering houseblocks (IRR 1.03 (95% CI 1.02-1.04)) and the IR pre-intervention (IRR 1.02 (95% CI 1.00-1.04)). Conclusions Adding RIT to an intensive routine Aedes control programme has a transient effect on the already moderate low entomological infestation levels, while ITC did not have any effect. For both interventions, we didn't evidence impact on disease incidence. Further studies are needed to evaluate impact in settings with high Aedes infestation and arbovirus case load.	[Eugenia Toledo, Maria; Montada, Domingo] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Vanlerberghe, Veerle; Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Popa Rosales, Julio; Cabrera, Pedro; Fonseca, Viviana; Perez Menzies, Mirtha] Prov Ctr Surveillance & Vector Control, Santiago De Cuba, Cuba; [Mirabal, Mayelin] Ctr Vaccines Res & Prod, Finlay Inst, Havana, Cuba; [Gomez Padron, Tania] Prov Ctr Epidemiol, Santiago De Cuba, Cuba; [Van der Stuyft, Patrick] Univ Ghent, Ghent, Belgium	Toledo, ME (reprint author), Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba.	mariaeugenia@ipk.sld.cu		Vanlerberghe, Veerle/0000-0002-6531-0793	Institute of Tropical Medicine; Belgian Directorate General for Development Co-operation	This study received partial funding from the framework agreement between the Institute of Tropical Medicine and the Belgian Directorate General for Development Co-operation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Agwu EJ, 2016, ACTA TROP, V161, P18, DOI 10.1016/j.actatropica.2016.05.005; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P349; Anshebo GY, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-80; Baly A, 2016, REV SOC BRAS MED TRO, V49, P418, DOI 10.1590/0037-8682-0368-2015; Baly A, 2016, TROP MED INT HEALTH, V21, P597, DOI 10.1111/tmi.12693; Baly A, 2011, AM J TROP MED HYG, V84, P747, DOI 10.4269/ajtmh.2011.10-0532; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551; Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848; Cattand P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P451; CDC, SURV CONTR AED AEG A; Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255; Chandre F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-65; Christofferson RC, 2015, VACCINE, V33, P7069, DOI 10.1016/j.vaccine.2015.09.114; CIPAC, CIPAC4907 HPLC; Corbel V, 2012, LANCET INFECT DIS, V12, P617, DOI 10.1016/S1473-3099(12)70081-6; Toledo ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119373; Faria NR, 2016, PLOS CURR, V8; Guzman MG, 2006, REV PANAM SALUD PUBL, V19, P282, DOI 10.1590/S1020-49892006000400014; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; KO YC, 1992, AM J EPIDEMIOL, V136, P214, DOI 10.1093/oxfordjournals.aje.a116487; Kroeger A, 2006, BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247; Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423; Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424; Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533; Marcombe S, 2009, AM J TROP MED HYG, V80, P745, DOI 10.4269/ajtmh.2009.80.745; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; PAHO, 2016, QUEST ANSW VECT CONT; Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020; Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541; Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201; Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588; Ritchie S. A., 2002, Dengue Bulletin, V26, P7; Rizzo N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-931; Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Singer M., 2016, GLOB PUBLIC HEALTH, P1; Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110; Thammapalo S, 2012, J TROP MED, DOI 10.1155/2012/652564; Toledo ME, 2007, T ROY SOC TROP MED H, V101, P56, DOI 10.1016/j.trstmh.2006.03.006; Toledo ME, 2011, TROP MED INT HEALTH, V16, P744, DOI 10.1111/j.1365-3156.2011.02762.x; Valdés G Luis, 2002, Rev Cubana Med Trop, V54, P220; Vanlerberghe V, 2011, TROP MED INT HEALTH, V16, P162, DOI 10.1111/j.1365-3156.2010.02668.x; Vanlerberghe V, 2010, TROP MED INT HEALTH, V15, P1067, DOI 10.1111/j.1365-3156.2010.02582.x; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; Vanlerberghe V, 2017, REV PANAM SALUD PUBL, P41; Vanlerberghe V, 2013, AM J TROP MED HYG, V89, P93, DOI 10.4269/ajtmh.13-0015; Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994; Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920; WHO, 1998, TEST PROC INS RES MO; WHO, 2009, WHOHTMNTDDEN2009; WHO [World Health Organization], 2006, WHOCDSNTDWHOPESGCDPP; Wilder-Smith A, 2016, EXPERT REV VACCINES, V15, P437, DOI 10.1586/14760584.2016.1143366; Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015; World Health Organization, 2002, WHOCDSWHOPES20026; World Health Organization, 2004, WHOCDSCPEPVC200410; World Health Organization, 1981, WHOVBC81806; 2015, VACCINE, V33, P76	59	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2017	11	11							e0006031	10.1371/journal.pntd.0006031				19	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FO4RM	WOS:000416832800021	29117180	DOAJ Gold, Green Published			2019-04-02	
J	Nina, PM; Mugisha, S; Leirs, H; Basuta, GI; Van Damme, P				Nina, Pius Mbuya; Mugisha, Samuel; Leirs, Herwig; Basuta, Gilbert Isabirye; Van Damme, Patrick			Brucellosis in cattle and micro-scale spatial variability of pastoral household income from dairy production in south western Uganda	ACTA TROPICA			English	Article						Brucellosis; Spatial pattern; Dairy production; Household income; Uganda	MBURO NATIONAL-PARK; ZOONOTIC TUBERCULOSIS; BOVINE BRUCELLOSIS; AFRICAN BUFFALO; RISK-FACTORS; WILDLIFE; DISEASES; AREAS; PERCEPTION; INTERFACE	Brucellosis in cattle and humans has received world-wide research attention as a neglected and reemerging zoonotic disease with many routes of transmission. Studies of brucellosis in Uganda have emphasized occupational exposures and also revealed variations in prevalence levels by region and cattle production systems. To date, research linking pastoralist household income from dairy production to brucellosis and its transmission risk pathways do not exist in Uganda. We assessed whether spatial differences in unit milk prices can be explained by brucellosis prevalence in cattle along a distance gradient from Lake Mburo National Park in Uganda. Semi-structured interviews administered to 366 randomly selected household heads were supplemented with serological data on brucellosis in cattle. Statistical analysis included Pearson correlation test, multiple regression and analysis of variance (ANOVA) using SPSS version 17. Serological results showed that 44% of cattle blood samples were sero-positive for brucellosis. The results obtained from interviews put the statistical mean of household reported cattle abortions at 5.39 (5.08-5.70 at 95% CI, n=366). Post -hoc analysis of variance revealed that both sero-positive cattle and reported cattle abortions significantly were much lower when moving outwards from the park boundary (p <0.05), while the price of milk increased significantly (p <0.05) along the same distance gradient. Further studies should identify public and private partnerships needed to create and strengthen good zoonotic brucellosis management practices at the nexus of wildlife and livestock in Uganda. (C) 2016 Elsevier B.V. All rights reserved.	[Nina, Pius Mbuya; Van Damme, Patrick] Univ Ghent, Fac Biosci Engn, Dept Plant Prod, Ghent, Belgium; [Nina, Pius Mbuya; Mugisha, Samuel; Basuta, Gilbert Isabirye] Makerere Univ, Dept Biol, Coll Nat Sci, Kampala, Uganda; [Leirs, Herwig] Univ Antwerp, Evolutionary Ecol Grp, Dept Biol, Antwerp, Belgium; [Nina, Pius Mbuya] Int Univ East Africa, Dept Environm Sci & Management, Kampala, Uganda; [Van Damme, Patrick] Czech Univ Life Sci, Fac Trop AgriSci, Prague, Czech Republic	Nina, PM (reprint author), Makerere Univ, Dept Biol, Coll Nat Sci, Kampala, Uganda.	ninapius@yahoo.co.uk	Van Damme, Patrick/H-6693-2018	Van Damme, Patrick/0000-0002-2548-633X	International Development Research Centre (IDRC_CANADA) [106152-001]; VLIR-UOS via HEFS Platform harvest call [ZIUS2013VOA0902]	We would like to return our appreciation and gratitude to the pastoralist communities around Lake Mburo National Park in Uganda for their cooperation. This study was supported by funding from International Development Research Centre (IDRC_CANADA) through zoonotic project number 106152-001 in the Department of Biology, Makerere University. The collection of data was carried out with the help of veterinary assistants and research assistants whose efforts are greatly appreciated. We also wish to thank Dr. Richard Apecu of Mbarara University for the laboratory work and Dr. Joseph Ssebuliba for guidance on statistical analysis. The final manuscript preparation was done at the University of Antwerp, Belgium, supported by VLIR-UOS via HEFS Platform harvest call (ZIUS2013VOA0902).	Alton G.G., 1988, TECHNIQUES BRUCELLOS; [Anonymous], 2006, CONTR NEGL ZOON DIS; Averbeck C, 2009, AFR J ECOL, V47, P756, DOI 10.1111/j.1365-2028.2009.01076.x; Bengis RG, 2002, REV SCI TECH OIE, V21, P53; Bernard F, 2005, PREV VET MED, V67, P267, DOI 10.1016/j.prevetmed.2004.11.002; Corbel M., 1998, FERTILITY INFERTILIT, P190; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; DAVIS DS, 1990, J WILDLIFE DIS, V26, P360, DOI 10.7589/0090-3558-26.3.360; Faye B., 2005, PREV VET MED, V67, p267 , DOI DOI 10.1016/J.PREVETMED.2004.11.002; Food and Agriculture Organization (FAO), 2009, STAT FOOD AGR; Godfroid J, 2013, REV SCI TECH OIE, V32, P27; Godfroid J, 2002, VET MICROBIOL, V90, P135, DOI 10.1016/S0378-1135(02)00217-1; Gomo C., 2011, TROP ANIM HLTH PROD, V5, P1; GRADWELL DV, 1977, J S AFR VET ASSOC, V48, P41; Grunert KG, 2005, EUR REV AGRIC ECON, V32, P369, DOI 10.1093/eurrag/jbi011; HERR S, 1981, ONDERSTEPOORT J VET, V48, P133; Holt H. R., 2011, BMC PUBLIC HLTH, V341; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kabagambe EK, 2001, PREV VET MED, V52, P91, DOI 10.1016/S0167-5877(01)00251-3; Kalema-Zikusoka G., 2005, PRELIMINARY INVESTIG; Kansiime C., 2010, ZOONOTIC PATHOGENS F; Kungu J. M., 2010, AFR J ANIM BIOMED SC, V5, P36; Lobb AE, 2007, FOOD QUAL PREFER, V18, P384, DOI 10.1016/j.foodqual.2006.04.004; Lopes L. B., 2010, Open Veterinary Science Journal, V4, P72; Mangen M. J., 2002, 8 FAO; Marcotty T, 2009, ANN TROP MED PARASIT, V103, P401, DOI 10.1179/136485909X451771; Mugisha S., 2011, 106152001 IDRC, P25; Muma JB, 2007, PREV VET MED, V80, P306, DOI 10.1016/j.prevetmed.2007.03.003; Muma JB, 2006, TROP ANIM HEALTH PRO, V38, P195, DOI 10.1007/s11250-006-4320-9; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; Mwebe R, 2011, TROP ANIM HEALTH PRO, V43, P603, DOI 10.1007/s11250-010-9739-3; Mwiine F. N., 2004, THESIS; Nabukenya I, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-901; Nakavuma J., 1999, UGANDA J AGR SCI, V4, P13; Narrod C, 2012, ECOHEALTH, V9, P150, DOI 10.1007/s10393-012-0747-9; Nasinyama G, 2014, AFR HEALTH SCI, V14, DOI 10.4314/ahs.v14i4.3; Nicoletti P, 1980, Adv Vet Sci Comp Med, V24, P69; Nina P. M., 2015, INT J BIOL RES, V3, P12; Nizeyimana G, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.943; Ocaido M, 1996, S AFR J WILDL RES, V26, P133; Ocaido M, 2009, TROP ANIM HEALTH PRO, V41, P731, DOI 10.1007/s11250-008-9245-z; Olsen S, 2010, VET CLIN N AM-FOOD A, V26, P15, DOI 10.1016/j.cvfa.2009.10.006; Onwujekwe OE, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-67; Rannestad OT, 2006, J TROP ECOL, V22, P675, DOI 10.1017/S0266467406003610; Sheik-Mohamed A, 1999, TROP MED INT HEALTH, V4, P695, DOI 10.1046/j.1365-3156.1999.00473.x; TESSARO SV, 1986, CAN VET J, V27, P119; Verbeke W, 2007, ANAL CHIM ACTA, V586, P2, DOI 10.1016/j.aca.2006.07.065; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001	48	2	2	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	NOV	2017	175				SI		130	137		10.1016/j.actatropica.2016.11.030				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FJ3DZ	WOS:000412612000015	27894608				2019-04-02	
J	Siling, K; Dierickx, S; Mwesigwa, J; D'Alessandro, U; Grietens, KP				Siling, Katja; Dierickx, Susan; Mwesigwa, Julia; D'Alessandro, Umberto; Grietens, Koen Peeters			IGNORING PEOPLE `WHO ARE NOT THERE' MAY MITIGATE SUCCESS OF MASS DRUG ADMINISTRATION FOR MALARIA: FINDINGS FROM A MIXED-METHOD STUDY IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Siling, Katja; Grietens, Koen Peeters] Inst Trop Med Antwerp, Antwerp, Belgium; [Dierickx, Susan] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Mwesigwa, Julia; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		20	7	7						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501020					2019-04-02	
J	Dermauw, V; Carabin, H; Ganaba, R; Cisse, A; Gabriel, S; Tarnagda, Z; Dorny, P; Millogo, A				Dermauw, Veronique; Carabin, Helene; Ganaba, Rasmane; Cisse, Assana; Gabriel, Sarah; Tarnagda, Zekiba; Dorny, Pierre; Millogo, Athanase			TAENIA SOLIUM CYSTICERCOSIS SEROCONVERSION AND SEROREVERSION CUMULATIVE INCIDENCE IN A LARGE-SCALE COMMUNITY TRIAL IN BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Dermauw, Veronique; Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Antwerp, Belgium; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA; [Ganaba, Rasmane] AFRICSante, Bobo Dioulasso, Burkina Faso; [Cisse, Assana] Inst Res Hlth Sci, Bobo Dioulasso, Burkina Faso; [Tarnagda, Zekiba] Inst Res Hlth Sci, Bobo Dioulasso, Belgium; [Millogo, Athanase] Univ Ouagadougou, Bobo Dioulasso, Belgium								0	0	0	0	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		32	11	12						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501032					2019-04-02	
J	Colebunders, R; Tepage, F; Mandro, M; Pfarr, K; Kashama, JM; Levick, B; Rossy, D; Tagoto, A; Laudisoit, A				Colebunders, Robert; Tepage, Floribert; Mandro, Michel; Pfarr, Kenneth; Kashama, Jean Marie; Levick, Bethanie; Rossy, Deogratias; Tagoto, Alliance; Laudisoit, Anne			HIGH PREVALENCE OF EPILEPSY IN ONCHOCERCIASIS ENDEMIC REGIONS IN THE DEMOCRATIC REPUBLIC OF THE CONGO (DRC)	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Colebunders, Robert; Laudisoit, Anne] Univ Antwerp, Antwerp, Belgium; [Tepage, Floribert] Programme Natl Iutte Onchocercose, Kisangani, DEM REP CONGO; [Mandro, Michel; Rossy, Deogratias] Prov Hlth Div Ituri, Bunia, DEM REP CONGO; [Pfarr, Kenneth] Univ Hosp Bonn, Bonn, Germany; [Kashama, Jean Marie] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Levick, Bethanie] Univ Liverpool, Liverpool, Merseyside, England; [Tagoto, Alliance] Minist Hlth, Kisangani, DEM REP CONGO			Pfarr, Kenneth/X-9175-2018	Pfarr, Kenneth/0000-0003-3096-2465				0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		52	17	18						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501052					2019-04-02	
J	Denoeud-Ndam, L; Dicko, A; Baudin, E; Guindo, O; Grandesso, F; Diawara, H; Sissoko, S; Sanogo, K; Traore, S; Keta, S; Barry, A; de Smet, M; Lasry, E; Smit, M; Wiesner, L; Barnes, KI; Djimde, AA; Grais, RF; Doumbo, OK; Etard, JF				Denoeud-Ndam, Lise; Dicko, Alassane; Baudin, Elisabeth; Guindo, Ousmane; Grandesso, Francesco; Diawara, Halimatou; Sissoko, Sibiri; Sanogo, Koualy; Traore, Seydou; Keta, Sekouba; Barry, Amadou; de Smet, Martin; Lasry, Estrella; Smit, Michiel; Wiesner, Lubbe; Barnes, Karen I.; Djimde, Abdoulaye A.; Grais, Rebecca F.; Doumbo, Ogobara K.; Etard, Jean-Francois			CLINICAL EFFICACY OF ARTEMETHER-LUMEFANTRINE IN RELATION TO DRUG EXPOSURE IN CHILDREN WITH UNCOMPLICATED SEVERE ACUTE MALNUTRITION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Denoeud-Ndam, Lise; Baudin, Elisabeth; Grandesso, Francesco; Grais, Rebecca F.; Etard, Jean-Francois] Epicentre, Paris, France; [Dicko, Alassane; Diawara, Halimatou; Sissoko, Sibiri; Sanogo, Koualy; Traore, Seydou; Keta, Sekouba; Barry, Amadou; Djimde, Abdoulaye A.; Doumbo, Ogobara K.] Malaria Res & Training Ctr, Bamako, Mali; [Guindo, Ousmane] Epicentre, Niamey, Niger; [de Smet, Martin] Med Sans Frontieres, Brussels, Belgium; [Lasry, Estrella] Med Sans Frontieres, Paris, France; [Smit, Michiel; Wiesner, Lubbe] Univ Cape Town, Div Clin Pharmacol, Cape Town, South Africa; [Barnes, Karen I.] WorldWide Antimalarial Resistance Network, Oxford, England								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		67	23	23						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501067					2019-04-02	
J	Silber, S; Diro, E; Workneh, N; Mekonnen, Z; Levecke, B; Steinmann, P; Umulisa, I; Engelen, M; Baeten, B; Hu, P; Friedman, A; Baseman, A; Mrus, J				Silber, Steven; Diro, Ermias; Workneh, Netsanet; Mekonnen, Zeleke; Levecke, Bruno; Steinmann, Peter; Umulisa, Irenee; Engelen, Marc; Baeten, Benny; Hu, Peter; Friedman, Andrew; Baseman, Alan; Mrus, Joseph			EFFICACY AND SAFETY OF A SINGLE-DOSE MEBENDAZOLE 500 MG CHEWABLE TABLET IN THE TREATMENT OF ASCARIS LUMBRICOIDES AND TRICHURIS TRICHIURA INFECTION IN PEDIATRIC PATIENTS: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3 STUDY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Silber, Steven; Hu, Peter; Friedman, Andrew; Baseman, Alan; Mrus, Joseph] Janssen Res & Dev LLC, Raritan, NJ USA; [Diro, Ermias] Univ Gondar, Gondar, Ethiopia; [Workneh, Netsanet; Mekonnen, Zeleke] Jimma Univ, Jimma, Ethiopia; [Levecke, Bruno] Univ Ghent, Merelbeke, Belgium; [Steinmann, Peter] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Steinmann, Peter] Univ Basel, Basel, Switzerland; [Umulisa, Irenee] Rwanda Biomed Ctr, Kingali, Rwanda; [Engelen, Marc; Baeten, Benny] Janssen Pharmaceut NV, Beerse, Belgium								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		82	28	28						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501082					2019-04-02	
J	Gave, A; Manrique, P; Alava, F; Sanchez, D; Tenorio, R; Serra, E; Rosanas, A; Gonzalez, I; Ding, X; Gamboa, D				Gave, Anthony; Manrique, Paulo; Alava, Freddy; Sanchez, Daniel; Tenorio, Roy; Serra, Elisa; Rosanas, Anna; Gonzalez, Iveth; Ding, Xavier; Gamboa, Dionicia			ASSESSMENT OF LOOP MEDIATED ISOTHERMAL DNA AMPLIFICATION (LAMP) METHOD FOR ASYMPTOMATIC MALARIA SCREENING IN THE PERUVIAN AMAZON SETTINGS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Gave, Anthony; Manrique, Paulo; Alava, Freddy; Sanchez, Daniel; Tenorio, Roy; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Lima, Peru; [Serra, Elisa; Rosanas, Anna] Inst Trop Med, Antwerp, Belgium; [Gonzalez, Iveth] Caucaseco Sci Res Cente, Cali, Colombia; [Ding, Xavier] FIND Diag, Geneva, Switzerland								0	0	0	2	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		268	84	84						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501268					2019-04-02	
J	Bannister-Tyrrell, M; Xa, NX; Dung, VKA; Duong, TT; Ngoc, NTH; Rovira-Vallbona, E; Erhart, A; Rosanas-Urgell, A; Grietens, KP				Bannister-Tyrrell, Melanie; Nguyen Xuan Xa; Vu Khac Anh Dung; Tran Thanh Duong; Nguyen Thi Hong Ngoc; Rovira-Vallbona, Eduard; Erhart, Annette; Rosanas-Urgell, Anna; Grietens, Koen Peeters			FINDING THE LAST FEW CASES: MOST EXPOSED INDIVIDUALS LESS LIKELY TO PARTICIPATE IN MALARIA SCREENING IN A PRE-ELIMINATION SETTING IN VIETNAM	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Bannister-Tyrrell, Melanie; Rovira-Vallbona, Eduard; Rosanas-Urgell, Anna; Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium; [Nguyen Xuan Xa; Vu Khac Anh Dung; Tran Thanh Duong; Nguyen Thi Hong Ngoc] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Erhart, Annette] MRC, Fajara, Gambia								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		305	95	95						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501305					2019-04-02	
J	Dorny, P; Ouedraogo, B; Dermauw, V; Cisse, A; Millogo, A; Tarnagda, Z; Ganaba, R; Carabin, H; Gabriel, S				Dorny, Pierre; Ouedraogo, Boubacar; Dermauw, Veronique; Cisse, Assana; Millogo, Athanase; Tarnagda, Zekiba; Ganaba, Rasmane; Carabin, Helene; Gabriel, Sarah			A CROSS-SECTIONAL ABATTOIR STUDY ON TAENIA HYDATIGENA INFECTIONS IN PIGS IN BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Dorny, Pierre; Dermauw, Veronique; Gabriel, Sarah] Inst Trop Med, Antwerp, Belgium; [Ouedraogo, Boubacar; Ganaba, Rasmane] AFRICSante, Bobo Dioulasso, Burkina Faso; [Cisse, Assana; Tarnagda, Zekiba] Res Inst Hlth Sci, Bobo Dioulasso, Burkina Faso; [Millogo, Athanase] Ctr Hosp Univ Souro Sanou, Bobo Dioulasso, Burkina Faso; [Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		444	138	138						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501444					2019-04-02	
J	O'Neal, SE; Moyano, LM; Ayvar, V; Vilchez, P; Gamboa, R; Muro, C; Dorny, P; Gilman, RH; Gonzalez, AE; Garcia, HH				O'Neal, Seth E.; Maria Moyano, Luz; Ayvar, Viterbo; Vilchez, Percy; Gamboa, Ricardo; Muro, Claudio; Dorny, Pierre; Gilman, Robert H.; Gonzalez, Armando E.; Garcia, Hector H.		Cysticercosis Working Grp Peru	NEUROCYSTICERCOSIS AND EPILEPSY AMONG PEOPLE LIVING NEARBY PIGS HEAVILY-INFECTED WITH CYSTICERCOSIS IN RURAL ENDEMIC PERU	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[O'Neal, Seth E.] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [O'Neal, Seth E.] Portland State Univ, Portland, OR 97207 USA; [Maria Moyano, Luz; Ayvar, Viterbo; Vilchez, Percy; Gamboa, Ricardo; Muro, Claudio] Univ Peruana Cayetano Heredia, Ctr Global Hlth Tumbes, Tumbes, Peru; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Gonzalez, Armando E.] Univ Nacl Mayor San Marcos, Sch Vet Med, Lima, Peru; [Garcia, Hector H.] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru; [Cysticercosis Working Grp Peru] Univ Peruana Cayetano Heredia, Lima, Peru								0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		446	139	139						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851501446					2019-04-02	
J	Hubner, MP; Quirynen, L; Lachau-Durand, S; Engelen, M; Hoerauf, A				Huebner, Marc P.; Quirynen, Ludo; Lachau-Durand, Sophie; Engelen, Marc; Hoerauf, Achim			EFFICACY OF SINGLE AND REPEATED ORAL AND SUBCUTANEOUS DOSES OF FLUBENDAZOLE IN LITOMOSOIDES SIGMODONTIS INFECTED JIRDS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Huebner, Marc P.; Hoerauf, Achim] Univ Hosp Bonn, Bonn, Germany; [Quirynen, Ludo; Lachau-Durand, Sophie; Engelen, Marc] Janssen Pharmaceut, Beerse, Belgium			Hubner, Marc/W-9529-2018	Hubner, Marc/0000-0001-8885-418X				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		485	153	153						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502008					2019-04-02	
J	Sjoberg, H; Pionnier, N; Steven, A; Alyyoussi, G; Quirynen, L; Engelen, M; Baeten, B; Ward, SA; Taylor, MJ; Turner, JD				Sjoberg, Hanna; Pionnier, Nicolas; Steven, Andrew; Alyyoussi, Ghaith; Quirynen, Ludo; Engelen, Marc; Baeten, Benny; Ward, Stephen A.; Taylor, Mark J.; Turner, Joseph D.			LACK OF SIGNIFICANT MICROFILARICIDAL EFFICACY OF PARENTERAL OR ORAL BIOAVAILABLE FLUBENDAZOLE FORMULATIONS IN A BRUGIA MALAYI MICROFILARAEMIC MOUSE MODEL	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Sjoberg, Hanna; Pionnier, Nicolas; Steven, Andrew; Alyyoussi, Ghaith; Ward, Stephen A.; Taylor, Mark J.; Turner, Joseph D.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Quirynen, Ludo; Engelen, Marc; Baeten, Benny] Janssen Pharmaceut, Beerse, Belgium			Ward, Steve/G-6003-2015	Ward, Steve/0000-0003-2331-3192				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		486	153	153						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502009					2019-04-02	
J	Biamonte, M; Van Dorst, B; Lagatie, O; Canestrelli, I; Ji, YC; Stuyver, L				Biamonte, Marco; Van Dorst, Bieke; Lagatie, Ole; Canestrelli, Ilona; Ji, Yongchang; Stuyver, Lieven			INTEGRATING NOVEL PEPTIDES AND REPORTER NANOPARTICLES IN A RAPID TEST FOR ONCHOCERCIASIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Biamonte, Marco; Canestrelli, Ilona; Ji, Yongchang] Drugs & Diagnost Trop Dis, San Diego, CA USA; [Van Dorst, Bieke; Lagatie, Ole; Stuyver, Lieven] Janssen Diagnost, Beerse, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		495	156	156						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502018					2019-04-02	
J	Lagatie, O; Verheyen, A; Nijs, E; Van Dorst, B; Debrah, LB; Debrah, A; Stuyver, LJ				Lagatie, Ole; Verheyen, Ann; Nijs, Erik; Van Dorst, Bieke; Debrah, Linda Batsa; Debrah, Alex; Stuyver, Lieven J.			IMMUNOREACTIVITY OF AN ONCHOCERCA VOLVULUS LINEAR EPITOPE IN INDIVIDUALS FROM DIFFERENT REGIONS IN GHANA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Lagatie, Ole; Verheyen, Ann; Nijs, Erik; Van Dorst, Bieke; Stuyver, Lieven J.] Janssen Diagnost, Beerse, Belgium; [Debrah, Linda Batsa] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res, Kumasi, Ghana; [Debrah, Alex] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Kumasi, Ghana								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		496	156	157						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502019					2019-04-02	
J	Irani, J; Ronse, M; Njamnshi, AK; Hendy, A; Siling, K; Kamgno, J; Colebunders, B; Verdonck, T; O'Neill, S; Grietens, KP				Irani, Julia; Ronse, Maya; Njamnshi, Alfred K.; Hendy, Adam; Siling, Katja; Kamgno, Joseph; Colebunders, Bob; Verdonck, Tine; O'Neill, Sarah; Grietens, Koen P.			HEALTH-SEEKING BEHAVIOR FOR EPILEPSY IN AN ONCHOCERCIASIS ENDEMIC AREA OF CAMEROON	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Irani, Julia; Ronse, Maya; Hendy, Adam; Siling, Katja; Verdonck, Tine; O'Neill, Sarah; Grietens, Koen P.] Inst Trop Med, Antwerp, Belgium; [Njamnshi, Alfred K.] Univ Yaounde I, Yaounde, Cameroon; [Kamgno, Joseph] Ctr Res Filariasis & Other Trop Dis, Yaounde, Cameroon; [Colebunders, Bob] Univ Antwerp, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		510	161	161						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502033					2019-04-02	
J	Lagatie, O; Van Dorst, B; Stuyver, LJ				Lagatie, Ole; Van Dorst, Bieke; Stuyver, Lieven J.			ONCHOCERCA VOLVULUS PROTEOME-WIDE LINEAR EPITOPE SCANNING USING HIGH-DENSITY PEPTIDE MICROARRAYS AND CONFIRMATION OF IMMUNODOMINANT MOTIFS BY ELISA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Lagatie, Ole; Van Dorst, Bieke; Stuyver, Lieven J.] Janssen Diagnost, Beerse, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		600	188	188						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502123					2019-04-02	
J	Hamer, DH; Barbre, K; Anderson, S; Barnett, ED; Boggild, A; Bottieau, E; Brunette, G; Caumes, E; Cetron, M; Chen, LH; Eperon, G; Gautret, P; Goorhuis, A; Grobusch, MP; Hagmann, S; Hynes, N; Kozarsky, P; Jespersen, S; Libman, M; Lopez-Velez, R; Malvy, D; Mockenhaupt, F; Molina, I; Perret, C; Rothe, C; Schlagenhauff, P; Schwartz, E; Van Genderen, P; Wilder-Smith, A; Esposito, D				Hamer, Davidson H.; Barbre, Kira; Anderson, Susan; Barnett, Elizabeth D.; Boggild, Andrea; Bottieau, Emmanuel; Brunette, Gary; Caumes, Eric; Cetron, Marty; Chen, Lin H.; Eperon, Gilles; Gautret, Philippe; Goorhuis, Abraham; Grobusch, Martin P.; Hagmann, Stefan; Hynes, Noreen; Kozarsky, Phyllis; Jespersen, Sanne; Libman, Michael; Lopez-Velez, Rogelio; Malvy, Denis; Mockenhaupt, Frank; Molina, Israel; Perret, Cecilia; Rothe, Camilla; Schlagenhauff, Patricia; Schwartz, Eli; Van Genderen, Perry; Wilder-Smith, Annelies; Esposito, Doug			ZIKA VIRUS DISEASE AMONG TRAVELERS RETURNING FROM THE AMERICAS BETWEEN JANUARY 2013 AND FEBRUARY 2016: A GEOSENTINEL ANALYSIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Hamer, Davidson H.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Barbre, Kira] Task Force Global Hlth, Decatur, GA USA; [Anderson, Susan] Palo Alto Med Fdn, Travel Med & Emergency Urgent Care, Palo Alto, CA USA; [Barnett, Elizabeth D.] Boston Med Ctr, Maxwell Finland Lab Infect Dis, Boston, MA USA; [Boggild, Andrea] Toronto Gen Hosp, Ctr Travel & Trop Med, Toronto, ON, Canada; [Bottieau, Emmanuel] Inst Trop Med, Antwerp, Belgium; [Brunette, Gary; Cetron, Marty; Esposito, Doug] Ctr Dis Control & Prevent, Atlanta, GA USA; [Caumes, Eric] Hop La Pitie Salpetriere, Serv Malad Infect & Trop, Paris, France; [Chen, Lin H.] Mt Auburn Hosp, Travel Med Ctr, Cambridge, MD USA; [Eperon, Gilles] Geneva Univ Hosp, Div Trop & Humanitarian Med, Travel & Trop Med, Geneva, Switzerland; [Gautret, Philippe] Hop Nord Marseille, Infect & Trop Dis Unit, Marseille, France; [Goorhuis, Abraham; Grobusch, Martin P.] Univ Amsterdam, Ctr Trop & Travel Med, Amsterdam, Netherlands; [Hagmann, Stefan] Bronx Lebanon Hosp Ctr, Div Pediat Infect Dis, Bronx, NY 10456 USA; [Hynes, Noreen] Johns Hopkins Univ, Sch Med, Div Infect Dis, Geog Med Ctr, Baltimore, MD 21205 USA; [Kozarsky, Phyllis] TravelWell, Atlanta, GA USA; [Jespersen, Sanne] Aarhus Univ Hostpital, Dept Infect Dis, Arrhus, Denmark; [Libman, Michael] McGill Univ, Ctr Trop Dis, Montreal Gen Hosp, Montreal, PQ, Canada; [Lopez-Velez, Rogelio] Hosp Ramon & Cajal, Serv Enfermedades Infecciosas, Unidad Med Trop, Madrid, Spain; [Malvy, Denis] Hop St Andre, Sante Voyages & Med Trop Niveau, Bordeaux, France; [Mockenhaupt, Frank] Charite, Inst Trop Med & Int Hlth, Berlin, Germany; [Molina, Israel] Hosp Gen Valle Hebron, Anexos Planta 6, Barcelona, Spain								0	1	1	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		691	218	218						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502214					2019-04-02	
J	Mofid, LS; Casapia, M; Aguilar, E; Silva, H; Montresor, A; Rahme, E; Fraser, WD; Marquis, GS; Vercruysse, J; Allen, L; Blouin, B; Razuri, H; Pezo, L; Gyorkos, TW				Mofid, Layla S.; Casapia, Martin; Aguilar, Eder; Silva, Hermann; Montresor, Antonio; Rahme, Elham; Fraser, William D.; Marquis, Grace S.; Vercruysse, Jozef; Allen, Lindsay; Blouin, Brittany; Razuri, Hugo; Pezo, Lidsky; Gyorkos, Theresa W.			MATERNAL POSTPARTUM DEWORMING AS A MEANS OF IMPROVING INFANT GROWTH AND MORBIDITY IN AREAS ENDEMIC FOR SOIL-TRANSMITTED HELMINTHIASIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Mofid, Layla S.; Blouin, Brittany; Gyorkos, Theresa W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Casapia, Martin; Pezo, Lidsky] Asociac Civil Selva Amazon, Iquitos, Peru; [Aguilar, Eder; Silva, Hermann] Hosp Iquitos Cesar Garayar Garcia, Iquitos, Peru; [Montresor, Antonio] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland; [Rahme, Elham; Razuri, Hugo] McGill Univ, Hlth Ctr, Div Clin Epidemiol, Res Inst, Montreal, PQ, Canada; [Fraser, William D.] Univ Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada; [Fraser, William D.] Univ Sherbrooke, Dept Obstet & Gynecol, Sherbrooke, PQ, Canada; [Marquis, Grace S.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada; [Vercruysse, Jozef] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Allen, Lindsay] Univ Calif Davis, USDA, ARS Western Human Nutr Res Ctr, Davis, CA 95616 USA								0	0	0	0	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		701	221	221						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502224					2019-04-02	
J	Cromwell, EA; Stoddard, ST; Barker, C; Meshnick, S; Messer, W; Van Rie, A; Morrison, AC; Scott, TW				Cromwell, Elizabeth A.; Stoddard, Steven T.; Barker, Chris; Meshnick, Steven; Messer, William; Van Rie, Annelies; Morrison, Amy C.; Scott, Thomas W.			THE RELATIONSHIP BETWEEN ENTOMOLOGICAL INDICATORS OF AEDES AEGYPTI ABUNDANCE AND DENGUE INFECTION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Cromwell, Elizabeth A.; Meshnick, Steven] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Stoddard, Steven T.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Barker, Chris; Morrison, Amy C.; Scott, Thomas W.] Univ Calif Davis, Davis, CA 95616 USA; [Messer, William] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Van Rie, Annelies] Univ Antwerp, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		807	253	253						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502330					2019-04-02	
J	Zavala, GA; Doak, CM; Portrait, F; Garcia, OP; Rosado, JL; Jarquin, T; Polman, K; Campos-Ponce, M				Zavala, Gerardo A.; Doak, Colleen M.; Portrait, France; Garcia, Olga P.; Rosado, Jorge L.; Jarquin, Tatiana; Polman, Katja; Campos-Ponce, Maiza			IS INTESTINAL PARASITE INFECTION ASSOCIATED WITH OBESITY? AN ECOLOGICAL ANALYSIS IN MEXICO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Zavala, Gerardo A.; Doak, Colleen M.; Portrait, France; Campos-Ponce, Maiza] VU Amsterdam Univ, Amsterdam, Netherlands; [Garcia, Olga P.; Rosado, Jorge L.; Jarquin, Tatiana] Univ Autonoma Queretaro, Queretaro, Mexico; [Polman, Katja] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		809	254	254						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502332					2019-04-02	
J	Ravinetto, R; Van Assche, K; Pouget, C; Caudron, JM; Cann, JM; Melotte, V; Giralt, AN; Meessen, B				Ravinetto, Raffaella; Van Assche, Kerlijn; Pouget, Corinne; Caudron, Jean-Michel; Cann, Jean-Michel; Melotte, Vera; Giralt, Ariadna Nebot; Meessen, Bruno			THE IMPACT OF LOCAL DISTRIBUTORS ON THE QUALITY OF MEDICINES IN RESOURCE-LIMITED SETTINGS: FIELD-BASED RECOMMENDATIONS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Ravinetto, Raffaella; Van Assche, Kerlijn; Pouget, Corinne; Caudron, Jean-Michel; Cann, Jean-Michel; Melotte, Vera; Giralt, Ariadna Nebot; Meessen, Bruno] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		818	257	257						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502341					2019-04-02	
J	Gryseels, C; Uk, S; Suon, S; Set, S; Delvaux, T; Lek, D; Ouk, V; Grietens, KP				Gryseels, Charlotte; Uk, Sambunny; Suon, Sokha; Set, Srun; Delvaux, Therese; Lek, Dysoley; Ouk, Vichea; Grietens, Koen Peeters			CAN WE TARGET MOBILE POPULATIONS WITH AN INTEGRATED DISEASE CONTROL APPROACH? A QUALITATIVE STUDY ON RISK BEHAVIOR FOR MALARIA AND HIV ALONG THE THAI-CAMBODIA BORDER	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Gryseels, Charlotte; Delvaux, Therese; Grietens, Koen Peeters] Inst Trop Med Antwerp, Antwerp, Belgium; [Uk, Sambunny; Suon, Sokha; Set, Srun; Lek, Dysoley] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Ouk, Vichea] Natl Ctr HIV AIDS Dermatol & STD, Phnom Penh, Cambodia								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		827	260	260						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502350					2019-04-02	
J	Payne, R; Silk, SE; Elias, SC; Miura, K; Diouf, A; Alanine, DG; Jin, J; Labbe, GM; Brian, IJ; Poulton, ID; Griffiths, O; Edwards, NJ; Berrie, E; Siani, L; Douglas, AD; Roberts, R; Vekemans, J; Nugent, F; Hill, AV; Long, CA; Lawrie, AM; Draper, SJ				Payne, Ruth; Silk, Sarah E.; Elias, Sean C.; Miura, Kazutoyo; Diouf, Ababacar; Alanine, Daniel G.; Jin, Jing; Labbe, Genevieve M.; Brian, Iona J.; Poulton, Ian D.; Griffiths, Oliver; Edwards, Nick J.; Berrie, Eleanor; Siani, Loredana; Douglas, Alexander D.; Roberts, Rachel; Vekemans, Johan; Nugent, Fay; Hill, Adrian V.; Long, Carole A.; Lawrie, Alison M.; Draper, Simon J.			SAFETY AND IMMUNOGENICITY OF THE NOVEL PLASMODIUM FALCIPARUM BLOOD-STAGE VACCINE CHAD63-MVA RH5 IN A PHASE IA CLINICAL TRIAL	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Payne, Ruth; Silk, Sarah E.; Elias, Sean C.; Alanine, Daniel G.; Jin, Jing; Labbe, Genevieve M.; Brian, Iona J.; Poulton, Ian D.; Griffiths, Oliver; Edwards, Nick J.; Douglas, Alexander D.; Roberts, Rachel; Nugent, Fay; Hill, Adrian V.; Lawrie, Alison M.; Draper, Simon J.] Univ Oxford, Oxford, England; [Miura, Kazutoyo; Diouf, Ababacar; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Berrie, Eleanor] Clin Biomfg Facil, Oxford, England; [Siani, Loredana] Reithera Srl, Rome, Italy; [Vekemans, Johan] GSK Vaccines, Rixensart, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1000	313	313						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502523					2019-04-02	
J	Sing'oei, VC; Otieno, L; Oneko, M; Otieno, W; Abuodha, J; Odero, C; Mendoza, Y; Andagalu, B; Owino, N; Ivinson, K; Otsyula, N; Oziemkowska, M; Otieno, A; Otieno, K; Cowden, J; Kariuki, S; Oyieko, J; Slutsker, L; Lievens, M; Ogutu, B; Hamel, MJ				Sing'oei, Valentine C.; Otieno, Lucas; Oneko, Martina; Otieno, Walter; Abuodha, Joseph; Odero, Chris; Mendoza, Yolanda; Andagalu, Ben; Owino, Nobert; Ivinson, Karen; Otsyula, Nekoye; Oziemkowska, Maria; Otieno, Allan; Otieno, Kephas; Cowden, Jessica; Kariuki, Simon; Oyieko, Janet; Slutsker, Laurence; Lievens, Marc; Ogutu, Bernhards; Hamel, Mary J.			ANTIBODY RESPONSES TO HEPATITIS B SURFACE ANTIGEN FOLLOWING ADMINISTRATION OF RTS, S/ASO1E TO HIV-INFECTED AFRICAN INFANTS AND CHILDREN	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Sing'oei, Valentine C.; Otieno, Lucas; Otieno, Walter; Andagalu, Ben; Otsyula, Nekoye; Otieno, Allan; Cowden, Jessica; Oyieko, Janet; Ogutu, Bernhards] US Army, Med Res Directorate, Walter Reed Project, Kenya Med Res Intitute, Kisumu, Kenya; [Oneko, Martina; Abuodha, Joseph; Odero, Chris; Owino, Nobert; Oziemkowska, Maria; Otieno, Kephas; Kariuki, Simon; Hamel, Mary J.] Ctr Dis Control & Prevent, Kenya Med Res Inst, Kisumu, Kenya; [Mendoza, Yolanda; Lievens, Marc] GlaxoSmithKline, Wavre, Belgium; [Ivinson, Karen] PATH Malaria Vaccine Initiat, Washington, WA USA; [Slutsker, Laurence] US Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1009	316	316						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502532					2019-04-02	
J	Levecke, B; Ghebretinsae, AH; Anderson, RM; Berkvens, D; Vlaminck, J; Devleesschauwer, B; Speybroeck, N; Vercruysse, J; Van Aelst, S				Levecke, Bruno; Ghebretinsae, Aklilu H.; Anderson, Roy M.; Berkvens, Dirk; Vlaminck, Johnny; Devleesschauwer, Brecht; Speybroeck, Niko; Vercruysse, Jozef; Van Aelst, Stefan			GUIDANCE IN DESIGNING SURVEYS FOR MONITORING SURVEYS FOR MONITORING THE PROGRESS OF SCHOOL-BASED DEWORMING PROGRAMS TO CONTROL SOIL-TRANSMITTED HELMINTHIASIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Levecke, Bruno; Ghebretinsae, Aklilu H.; Vlaminck, Johnny; Vercruysse, Jozef] Univ Ghent, Merelbeke, Belgium; [Anderson, Roy M.] Imperial Coll, London, England; [Berkvens, Dirk] Inst Trop Med, Antwerp, Belgium; [Devleesschauwer, Brecht] Sci Inst Publ Hlth, Brussels, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Brussels, Belgium; [Van Aelst, Stefan] KU Leuven Univ Leuven, Leuven, Belgium; [Van Aelst, Stefan] Univ Ghent, Ghent, Belgium			Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1136	356	356						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502659					2019-04-02	
J	Mwesigwa, J; Achan, J; Affara, M; Sainey, C; Worwui, A; Grietens, KP; Van Geertruyden, JP; D'Alessandro, U				Mwesigwa, Julia; Achan, Jane; Affara, Muna; Sainey, Cessay; Worwui, Archibald; Grietens, Koen Peeters; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			IMPACT OF MASS DRUG ADMINISTRATION WITH DIHYDROARTEMISININ-PIPERAQUINE ON MALARIA TRANSMISSION IN A HIGHLY SEASONAL TRANSMISSION SETTING IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Mwesigwa, Julia] Univ Antwerp, Gambia & Epidemiol Global Hlth Inst, Med Res Council Unit, Banjul, Gambia; [Achan, Jane; Affara, Muna; Sainey, Cessay; Worwui, Archibald; D'Alessandro, Umberto] MRC Unit, Banjul, Gambia; [Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium; [Van Geertruyden, Jean-Pierre] Univ Antwerp, Epidemiol Global Hlth Inst, Antwerp, Belgium; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, Banjul, Gambia			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1218	382	382						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502740					2019-04-02	
J	Dierickx, S; Siling, K; Mwesigwa, J; Gryseels, C; Jaiteh, F; Gerrets, R; D'Alessandro, U; Peeters, KG				Dierickx, Susan; Siling, Katja; Mwesigwa, Julia; Gryseels, Charlotte; Jaiteh, Fatou; Gerrets, Rene; D'Alessandro, Umberto; Peeters, Koen Grietens			THE RELEVANCE OF OUTDOOR RESTING AND SLEEPING FOR BED NET USE IN THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Dierickx, Susan] Vrije Univ Brussel, Brussels, Belgium; [Siling, Katja; Gryseels, Charlotte; Peeters, Koen Grietens] Inst Trop Med, Antwerp, Belgium; [Mwesigwa, Julia; Jaiteh, Fatou; D'Alessandro, Umberto] MRC, Fajara, Gambia; [Gerrets, Rene] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1286	404	404						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502808					2019-04-02	
J	Bebell, LM; Ngonzi, J; Bazira, J; Fajardo, Y; Boatin, AA; Boatin, AA; Jacquemyn, Y; van Geertruyden, JP; Schiff, SJ; Riley, LE; Bangsberg, DR; Boum, Y				Bebell, Lisa M.; Ngonzi, Joseph; Bazira, Joel; Fajardo, Yarine; Boatin, Adeline A.; Boatin, Adeline A.; Jacquemyn, Yves; van Geertruyden, Jean-Pierre; Schiff, Steven J.; Riley, Laura E.; Bangsberg, David R.; Boum, Yap			POSTPARTUM INFECTION AT A UGANDAN REGIONAL REFERRAL HOSPITAL: MICROBIOLOGY AND ANTIMICROBIAL RESISTANCE PATTERNS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Bebell, Lisa M.; Boatin, Adeline A.; Boatin, Adeline A.; Riley, Laura E.; Bangsberg, David R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ngonzi, Joseph; Bazira, Joel; Fajardo, Yarine] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Jacquemyn, Yves; van Geertruyden, Jean-Pierre] Univ Antwerp, Antwerp, Belgium; [Schiff, Steven J.] Penn State Univ, Hershey, PA USA; [Boum, Yap] Epictr Res Base, Mbarara, Uganda			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1293	406	406						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502815					2019-04-02	
J	Wright, D; Giza, M; Rampling, T; Zeltina, A; Bowyer, G; Powlson, J; Venkatraman, N; Imoukhuede, E; Payne, R; Nicosia, A; Sullivan, N; Graham, B; Volkmann, A; Ballou, WR; Gilbert, S; Hill, A; Ewer, K				Wright, Danny; Giza, Mark; Rampling, Tommy; Zeltina, Antra; Bowyer, Georgina; Powlson, Jonathan; Venkatraman, Navin; Imoukhuede, Egeruan; Payne, Ruth; Nicosia, Alfredo; Sullivan, Nancy; Graham, Barney; Volkmann, Ariane; Ballou, W. Ripley; Gilbert, Sarah; Hill, Adrian; Ewer, Katie			IDENTIFICATION OF HUMAN T CELL EPITOPES IN THE EBOLAVIRUS GLYCOPROTEIN FOLLOWING VACCINATION WITH CHAD3 EBO Z GP AND MVA BN	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Wright, Danny; Giza, Mark; Rampling, Tommy; Bowyer, Georgina; Powlson, Jonathan; Venkatraman, Navin; Imoukhuede, Egeruan; Payne, Ruth; Nicosia, Alfredo; Gilbert, Sarah; Hill, Adrian; Ewer, Katie] Univ Oxford, Jenner Inst, Oxford, England; [Zeltina, Antra] Univ Oxford, STRUBI, Oxford, England; [Sullivan, Nancy; Graham, Barney] NIH, Bldg 10, Bethesda, MD 20892 USA; [Volkmann, Ariane] Bavarian Nordic, Martinried, Germany; [Ballou, W. Ripley] GlaxoSmithKline Biol, Rixensart, Belgium			Ewer, Katie/B-4328-2011	Ewer, Katie/0000-0001-9827-9836				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1311	412	412						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502834					2019-04-02	
J	Lin, LY; Lyke, KE; Jarman, RG; Eckels, KH; Lepine, E; Collard, A; McArthur, MA; Keiser, P; De La Barrera, R; Innis, BL; Thomas, SJ; Schmidt, AC				Lin, Leyi; Lyke, Kirsten E.; Jarman, Richard G.; Eckels, Kenneth H.; Lepine, Edith; Collard, Alix; McArthur, Monica A.; Keiser, Paul; De La Barrera, Rafael; Innis, Bruce L.; Thomas, Stephen J.; Schmidt, Alexander C.			SAFETY AND IMMUNOGENICITY OF AN AS03(B)-ADJUVANTED DENGUE PURIFIED INACTIVATED VACCINE ADMINISTERED ON THREE SCHEDULES TO HEALTHY US ADULTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Lin, Leyi; Jarman, Richard G.; Eckels, Kenneth H.; Keiser, Paul; De La Barrera, Rafael; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD USA; [Lyke, Kirsten E.; McArthur, Monica A.] Univ Maryland, Ctr Vaccine Dev, Inst Global Hlth, Baltimore, MD 21201 USA; [Lepine, Edith; Innis, Bruce L.] GlaxoSmithKline Vaccines, Rockville, MD USA; [Collard, Alix; Schmidt, Alexander C.] GlaxoSmithKline Vaccines, Rixensart, Belgium								0	0	0	3	3	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1350	424	425						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502873					2019-04-02	
J	Cromwell, EA; Stoddard, ST; Barker, CM; Meshnick, S; Van Rie, A; Messer, W; Morrison, AC; Scott, TW; Serre, M				Cromwell, Elizabeth A.; Stoddard, Steven T.; Barker, Chris M.; Meshnick, Steven; Van Rie, Annelies; Messer, William; Morrison, Amy C.; Scott, Thomas W.; Serre, Marc			APPLICATION OF BAYESIAN MAXIMUM ENTROPY TO ESTIMATE THE ASSOCIATION BETWEEN ADULT AEDES AEGYPTI DENSITY AND SIX-MONTH RISK OF DENGUE VIRUS SEROCONVERSION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Cromwell, Elizabeth A.; Meshnick, Steven; Serre, Marc] Univ North Carolina Chapel Hill, Chapel Hill, NC USA; [Stoddard, Steven T.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Barker, Chris M.; Morrison, Amy C.; Scott, Thomas W.] Univ Calif Davis, Davis, CA 95616 USA; [Van Rie, Annelies] Univ Antwerp, Antwerp, Belgium; [Messer, William] Oregon Hlth & Sci Univ, Portland, OR 97201 USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1433	449	450						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851502956					2019-04-02	
J	Canavati, SE; Lawpoolsri, S; Quintero, CE; Ly, P; Nguon, C; Pukrittayakamee, S; Sintasath, D; Singhasivanon, P; Grietens, KP; Whittaker, MA				Canavati, Sara E.; Lawpoolsri, Saranath; Quintero, Cesia E.; Ly, Po; Nguon, Chea; Pukrittayakamee, Sasithon; Sintasath, David; Singhasivanon, Pratap; Grietens, Koen Peeters; Whittaker, Maxine Anne			VILLAGE MALARIA WORKER PERFORMANCE KEY TO THE ELIMINATION OF ARTEMISININ-RESISTANT MALARIA: A WESTERN CAMBODIA HEALTH SYSTEM ASSESSMENT	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Canavati, Sara E.; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Canavati, Sara E.; Quintero, Cesia E.] Burnet Inst, Ctr Biomed Res, Melbourne, Vic, Australia; [Lawpoolsri, Saranath; Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [Ly, Po; Nguon, Chea] Minist Hlth, Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Pukrittayakamee, Sasithon] Burnet Inst, Ctr Biomed Res, Bangkok, Thailand; [Sintasath, David] Mahidol Univ, Fac Trop Med, Malaria Consortium Asia, Bangkok, Thailand; [Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Antwerp, Belgium; [Whittaker, Maxine Anne] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Whittaker, Maxine Anne] James Cook Univ, Div Trop Hlth & Med, Townsville, Qld, Australia; [Whittaker, Maxine Anne] Univ Queensland, Sch Publ Hlth, Herston, Qld, Australia								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1544	484	484						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503097					2019-04-02	
J	Bannister-Tyrrell, M; Grietens, KP				Bannister-Tyrrell, Melanie; Grietens, Koen Peeters			DEFINING THE MICRO-EPIDEMIOLOGY OF MALARIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Bannister-Tyrrell, Melanie; Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1583	497	497						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503137					2019-04-02	
J	Chaudhury, S; Ockenhouse, CF; Regules, JA; Dutta, S; Wallqvist, A; Jongert, E; Paris, R; Waters, NC; Lemiale, F; Bergmann-Leitner, ES				Chaudhury, Sidhartha; Ockenhouse, Christian F.; Regules, Jason A.; Dutta, Sheetij; Wallqvist, Anders; Jongert, Erik; Paris, Robert; Waters, Norman C.; Lemiale, Franck; Bergmann-Leitner, Elke S.			THE BIOLOGICAL FUNCTION OF ANTIBODIES INDUCED BY THE RTS,S/AS01 MALARIA VACCINE CANDIDATE IS DETERMINED BY THEIR FINE SPECIFICITY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Chaudhury, Sidhartha; Wallqvist, Anders] Telemed & Adv Technol Res Ctr, Biotechnol High Performance Comp Software Applica, Ft Detrick, MD USA; [Ockenhouse, Christian F.; Lemiale, Franck] PATH Malaria Vaccine Initiat, Washington, DC USA; [Regules, Jason A.] US Army Med Res Inst Infect Dis, Ft Detrick, MD USA; [Dutta, Sheetij; Paris, Robert; Waters, Norman C.; Bergmann-Leitner, Elke S.] Walter Reed Army Inst, Silver Spring, MD USA; [Jongert, Erik] GlaxoSmithKline Vaccine, Rixensart, Belgium			Bergmann-Leitner, Elke/B-3548-2011	Bergmann-Leitner, Elke/0000-0002-8571-8956				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1605	503	504						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503159					2019-04-02	
J	Early, AM; Gilbert, PB; Lievens, M; MacInnis, B; Ockenhouse, CF; Volkman, SK; Wirth, DF; Neafsey, DE				Early, Angela M.; Gilbert, Peter B.; Lievens, Marc; MacInnis, Bronwyn; Ockenhouse, Christian F.; Volkman, Sarah K.; Wirth, Dyann F.; Neafsey, Daniel E.		RTS S Clinical Trials Partnership	USING DEEP POPULATION SEQUENCING TO INVESTIGATE IMMUNE-BASED SELECTION ON ANTIGENIC LOCI IN PLASMODIUM FALCIPARUM	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Early, Angela M.; MacInnis, Bronwyn; Neafsey, Daniel E.] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA; [Gilbert, Peter B.] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Lievens, Marc] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Ockenhouse, Christian F.] PATH Malaria Vaccine Initiat, Washington, DC USA; [Volkman, Sarah K.; Wirth, Dyann F.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA								0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1619	508	508						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503173					2019-04-02	
J	Dutta, S; Dlugosz, L; Miura, K; Long, C; Hoyt, N; Franco, D; Vanloubbeeck, Y; Waters, NC; Batchelor, A				Dutta, Sheetij; Dlugosz, Lisa; Miura, Kazutoyo; Long, Carol; Hoyt, Nathan; Franco, David; Vanloubbeeck, Yannick; Waters, Norman C.; Batchelor, Adrian			OVERCOMING DIVERSITY OF AMA1: EVIDENCE OF POLYMORPHISM DILUTION MEDIATED REFOCUSING OF RESPONSES TOWARDS CONSERVED EPITOPES IN RHESUS MONKEYS VACCINATED WITH QUADVAX+AS01	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Dutta, Sheetij; Dlugosz, Lisa; Hoyt, Nathan; Waters, Norman C.; Batchelor, Adrian] Walter Reed Army Inst Res, Silver Spring, MD USA; [Miura, Kazutoyo; Long, Carol] NIAID, NIH, Rockville, MD USA; [Franco, David] GlaxoSmithKline Vaccines, Rixensaart, Belgium; [Vanloubbeeck, Yannick] GlaxoSmithKline Vaccines, Vanloubbeeck, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1643	515	515						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503197					2019-04-02	
J	Irani, J; Ronse, M; Njamnshi, AK; Hendy, A; Boussinesq, M; Kamgno, J; Colebunders, B; Siling, K; Verdonck, T; Grietens, KP; O'Neill, S				Irani, Julia; Ronse, Maya; Njamnshi, Alfred K.; Hendy, Adam; Boussinesq, Michel; Kamgno, Joseph; Colebunders, Bob; Siling, Katja; Verdonck, Tine; Grietens, Koen Peeters; O'Neill, Sarah			NODDING SYNDROME/EPILEPSY IN THE SANAGA RIVER BASIN (CAMEROON): AN UNNOTICED EPIDEMIC?	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Irani, Julia; Ronse, Maya; Hendy, Adam; Siling, Katja; Verdonck, Tine; Grietens, Koen Peeters; O'Neill, Sarah] Inst Trop Med, Antwerp, Belgium; [Njamnshi, Alfred K.] Univ Yaounde I, Yaounde, Cameroon; [Boussinesq, Michel] IRD, Montpellier, France; [Kamgno, Joseph] Ctr Res Filariasis & Other Trop Dis CRFilMT, Yaounde, Cameroon; [Colebunders, Bob] Univ Antwerp, Antwerp, Belgium								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1705	535	535						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503259					2019-04-02	
J	Afolabi, MO; McGrath, N; D'Alessandro, U; Kampmann, B; Imoukhuede, E; Ravinetto, R; Alexander, N; Larson, HJ; Chandramohan, D; Bojang, K				Afolabi, Muhammed O.; McGrath, Nuala; D'Alessandro, Umberto; Kampmann, Beate; Imoukhuede, Egeruan; Ravinetto, Raffaella; Alexander, Neal; Larson, Heidi J.; Chandramohan, Daniel; Bojang, Kalifa			MULTIMEDIA TOOL FOR OBTAINING INFORMED CONSENT IN THE GAMBIA: A MIXED METHOD STUDY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Afolabi, Muhammed O.; D'Alessandro, Umberto; Kampmann, Beate; Bojang, Kalifa] MRC, Banjul, Gambia; [McGrath, Nuala] Univ Southampton, Southampton, Hants, England; [Imoukhuede, Egeruan] Univ Oxford, Oxford, England; [Ravinetto, Raffaella] Inst Trop Med, Antwerp, Belgium; [Alexander, Neal; Larson, Heidi J.; Chandramohan, Daniel] London Sch Hyg & Trop Med, London, England								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1809	566	566						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503363					2019-04-02	
J	Trindade, S; Rijo-Ferreira, F; Carvalho, T; Pinto-Neves, D; Guegan, F; Aresta-Branco, F; Bento, F; Young, SA; Pinto, A; Van den Abbeele, J; Ribeiro, RM; Dias, S; Smith, TK; Figueiredo, LM				Trindade, Sandra; Rijo-Ferreira, Filipa; Carvalho, Tania; Pinto-Neves, Daniel; Guegan, Fabien; Aresta-Branco, Francisco; Bento, Fabio; Young, Simon A.; Pinto, Andreia; Van den Abbeele, Jan; Ribeiro, Ruy M.; Dias, Sergio; Smith, Terry K.; Figueiredo, Luisa M.			ADIPOSE TISSUE IS A MAJOR RESERVOIR OF FUNCTIONALLY DISTINCT TRYPANOSOMA BRUCEI PARASITES	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	65th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 13-16, 2016	Atlanta, GA	Amer Soc Trop Med & Hygiene, Bill & Melinda Gates Fdn, Takeda Pharamaceut Int AG, ClinicalRM, Techlab Inc, Bayer, Sanofi Pasteur, ACS Infectious Diseases, New England Biolabs					[Trindade, Sandra; Rijo-Ferreira, Filipa; Carvalho, Tania; Pinto-Neves, Daniel; Guegan, Fabien; Aresta-Branco, Francisco; Bento, Fabio; Pinto, Andreia; Dias, Sergio; Figueiredo, Luisa M.] Inst Med Mol, Lisbon, Portugal; [Young, Simon A.; Smith, Terry K.] Univ St Andrews, St Andrews, Fife, Scotland; [Van den Abbeele, Jan] Inst Trop Med Antwerp, Antwerp, Belgium; [Ribeiro, Ruy M.] Los Alamos Natl Lab, Los Alamos, NM USA				Young, Simon/0000-0003-1072-905X				0	0	0	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2017	95	5		S		1932	606	606						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6FS	WOS:000412851503486					2019-04-02	
J	da Luz, RI; Linsuke, S; Lutumba, P; Hasker, E; Boelaert, M				da Luz, R. Inocencio; Linsuke, S.; Lutumba, P.; Hasker, E.; Boelaert, M.			Assessment of schistosomiasis and soil-transmitted helminths prevalence in school-aged children and opportunities for integration of control in local health services in Kwilu Province, the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						NTD; parasites; helminths; schistosomiasis; MNT; parasites; helminthes; schistosomiase	INTERNATIONAL SURVEY	ObjectiveTo determine the prevalence of schistosomiasis (SCH) and soil-transmitted helminths (STH) in the Democratic Republic of Congo, and to assess the capacity of the local health centres for diagnosis and treatment. MethodsCross-sectional school-based survey in two health districts in the Province of Kwilu. We collected a stool and a urine sample for parasitological examination. Urine filtration and duplicate Kato-Katz thick smears were used for the diagnosis of SCH. Health centres were evaluated using a structured questionnaire. ResultsIn total, 526 children participated in the study and the overall prevalence of Schistosoma mansoni infection was 8.9% (95% CI: 3.5-13.2) in both districts. The prevalence was higher in Mosango (11.7%; 95% CI: 8.9-14.8) than Yasa Bonga district (6.2%; 95% CI: 1.1-11.4). Urine filtration showed that Schistosoma haematobium infection was not present. The combined STH infection prevalence was 58.1% in both districts; hookworm infection was the most common STH found in 52.9% (95% CI: 29.3-62.4) of subjects, followed by Ascaris lumbricoides 9.3% (95% CI: 5.8-15.5) and Trichuris trichiura 2.1% (95% CI: 0.9-4.9). Mixed STH infections were observed as well as SCH-STH coinfection. ConclusionFurther mapping of both SCH and STH burden is needed, and coverage of preventive chemotherapy in school-aged children should be increased. ObjectifDeterminer la prevalence de la schistosomiase (SCH) et des helminthes transmises par le sol (HTS) dans la Republique Democratique du Congo et evaluer la capacite des centres de sante locaux pour le diagnostic et le traitement. MethodesEnquete transversale menee en milieu scolaire dans deux districts de sante dans la province de Kwilu. Nous avons recueilli un echantillon de selles et un d'urine pour un examen parasitologique. La filtration d'urine et les frottis epais de Kato-Katz dupliques ont ete utilises pour le diagnostic de la SCH. Les centres de sante ont ete evalues a l'aide d'un questionnaire structure. ResultatsAu total, 526 enfants ont participe a l'etude et la prevalence globale de l'infection a S. mansoni etait de 8,9% (IC95%: 3,5 a 13,2) dans les deux districts. La prevalence etait plus elevee dans le district de Mosango (11,7%; IC95%: 8,9 a 14,8) que dans celui de Yasa Bonga (6,2%; IC95%: 01,01 a 11,04). La filtration d'urine a montre que l'infection par S. haematobium n'etait pas presente. La prevalence combinee de la STH etait de 58,1% dans les deux districts; l'ankylostomiase etait la STH la plus repandue trouvee chez 52,9% (IC95%: 29,3 a 62,4) des sujets, suivi par A. lumbricoides 9,3% (IC95%: 5,8 a 15,5) et T. trichiura 2,1% (IC95%: 0,9-4,9). Des infections a STH mixtes ainsi que des coinfections SCH/HTS ont ete observees. ConclusionLa cartographie de la SCH et des HTS est necessaire, et la couverture de la chimiotherapie preventive chez les enfants d'age scolaire devrait etre augmentee.	[da Luz, R. Inocencio; Hasker, E.; Boelaert, M.] Inst Trop Med Antwerp, Dept Publ Hlth, Antwerp, Belgium; [Linsuke, S.; Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO	da Luz, RI (reprint author), Inst Trop Med, Dept Publ Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	rinocencio@itg.be	Inocencio da Luz, Raquel/L-9676-2016	Inocencio da Luz, Raquel/0000-0002-2870-0311; Boelaert, Marleen/0000-0001-8051-6776	Margaret A. Cargill Philanthropies	We thank the Margaret A. Cargill Philanthropies for funding the study. We thank the Medecin Chef de Zone from Mosango and Yasa Bonga and their team for facilitating the study in their Health District. Finally, we thank the school directors for their cooperation and all the parents and children who participated in the study.	[Anonymous], 2016, Wkly Epidemiol Rec, V91, P585; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DAZO BC, 1974, B WORLD HEALTH ORGAN, V51, P399; de Silva N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000655; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Kabore A, 2017, ACTA TROP, V166, P177, DOI 10.1016/j.actatropica.2016.11.023; Kane RA, 2003, PARASITOLOGY, V127, P131, DOI 10.1017/S0031182003003421; Knoblauch AM, 2016, T ROY SOC TROP MED H, V110, P424, DOI 10.1093/trstmh/trw040; Linsuke S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003387; Madinga J, 2017, ACTA TROP, V171, P186, DOI 10.1016/j.actatropica.2017.03.019; Madinga J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1206-6; MATANGILA JR, 2014, PLOS ONE, V0009; Montresor A, 2011, LUTTE CONTRE HELMINT; POLDERMAN AM, 1985, ANN SOC BELG MED TR, V65, P243; Rimoin AW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002118; Statistique INdl, 2015, ANN STAT 2014 STAT I; Stothard JR, 2014, PARASITOLOGY, V141, P1947, DOI 10.1017/S0031182014001152; WHO, 2006, PREV CHEM HUM HELM C, P74; WHO, 2011, WHONMHNHDMNM111; WHO, PREV CHEM TRANSM CON; World Health Organization, 2013, SCHIST PROGR REP 200	22	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2017	22	11					1442	1450		10.1111/tmi.12965				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FL6IC	WOS:000414347400010	28853206	Bronze			2019-04-02	
J	Masha, SC; Cools, P; Crucitti, T; Sanders, EJ; Vaneechoutte, M				Masha, Simon C.; Cools, Piet; Crucitti, Tania; Sanders, Eduard J.; Vaneechoutte, Mario			Molecular typing of Trichomonas vaginalis isolates by actin gene sequence analysis and carriage of T-vaginalis viruses	PARASITES & VECTORS			English	Article						Trichomonas vaginalis; Trichomonas vaginalis viruses; actin gene; Typing; Kilifi; Kenya	DOUBLE-STRANDED-RNA; FEMALE SEX WORKERS; VIRAL-INFECTION; DSRNA VIRUS; WOMEN; PREVALENCE; KENYA; POLYMORPHISM; SENSITIVITY; DIAGNOSIS	Background: The protozoan parasite Trichomonas vaginalis is the most common non-viral, sexually transmitted pathogen. Although T. vaginalis is highly prevalent among women in Kenya, there is lack of data regarding genetic diversity of isolates currently in circulation in Kenya. Methods: Typing was performed on 22 clinical isolates of T. vaginalis collected from women attending the antenatal care clinic at Kilifi County Hospital, Kenya, in 2015. Genotyping followed a previously proposed restriction fragment length polymorphism (RFLP) scheme, which involved in silico cleavage of the amplified actin gene by HindII, MseI and RsaI restriction enzymes. Phylogenetic analysis of all the sequences was performed to confirm the results obtained by RFLP-analysis and to assess the diversity within the RFLP genotypes. Additionally, we determined carriage of the four different types of Trichomonas vaginalis viruses (TVVs) by polymerase chain reaction. Results: In silico RFLP-analysis revealed five actin genotypes; 50.0% of the isolates were of actin genotype E, 27.3% of actin genotype N, 13.6% of actin genotype G and 4.5% of actin genotypes I and P. Phylogenetic analysis was in agreement with the RFLP-analysis, with the different actin genotypes clustering together. Prevalence of TVVs was 43.5% (95% confidence interval, CI: 23.2-65.5). TVV1 was the most prevalent, present in 39.1% of the strains and 90% of the T. vaginalis isolates which harbored TVVs had more than one type of TVV. None of the isolates of actin genotype E harbored any TVV. Conclusion: The presence of five actin genotypes in our study suggests notable diversity among T. vaginalis isolates occurring among pregnant women in Kilifi, Kenya. Isolates of the most prevalent actin genotype E lacked TVVs. We found no association between T. vaginalis genotype, carriage of TVVs and symptoms. Further studies with higher number of strains should be conducted in order to corroborate these results.	[Masha, Simon C.; Sanders, Eduard J.] Kenya Med Res Inst KEMRI, Ctr Geog Med Res Coast, POB 230-80108, Kilifi, Kenya; [Masha, Simon C.; Cools, Piet; Vaneechoutte, Mario] Univ Ghent, Fac Med & Hlth Sci, Lab Bacteriol Res, De Pintelaan 185, B-9000 Ghent, Belgium; [Masha, Simon C.] Pwani Univ, Fac Pure & Appl Sci, Dept Biol Sci, POB 195-80108, Kilifi, Kenya; [Crucitti, Tania] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, Natl Str 155, B-2000 Antwerp, Belgium	Masha, SC (reprint author), Kenya Med Res Inst KEMRI, Ctr Geog Med Res Coast, POB 230-80108, Kilifi, Kenya.; Masha, SC (reprint author), Univ Ghent, Fac Med & Hlth Sci, Lab Bacteriol Res, De Pintelaan 185, B-9000 Ghent, Belgium.; Masha, SC (reprint author), Pwani Univ, Fac Pure & Appl Sci, Dept Biol Sci, POB 195-80108, Kilifi, Kenya.	schengo@kemri-wellcome.org	Masha, Simon/R-4419-2017	Masha, Simon/0000-0002-6283-2430	Belgian Development Cooperation through VLIR-UOS; Wellcome Trust [077092]	This research has been supported by a PhD Scholarship for SCM from the Belgian Development Cooperation through VLIR-UOS. The Kenya Medical Research Institute-Wellcome Trust Research Programme (KWTRP) at the Centre for Geographical Medicine Research-Kilifi is supported by core funding from the Wellcome Trust (#077092). The funders had no role in the in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. The views expressed here are those of the authors and do not necessarily represent the views of the Belgian Development Cooperation, or the Wellcome Trust.	Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Conrad M, 2011, MOL BIOCHEM PARASIT, V175, P30, DOI 10.1016/j.molbiopara.2010.08.006; Conrad MD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001573; Crucitti T, 2008, CLIN MICROBIOL INFEC, V14, P844, DOI 10.1111/j.1469-0691.2008.02034.x; Drouin G, 1995, J MOL EVOL, V41, P841, DOI 10.1007/BF00173163; Fichorova R, 2017, RES MICROBIOL, V168, P882, DOI 10.1016/j.resmic.2017.03.005; Fichorova RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048418; Fraga Jorge, 2005, Braz J Infect Dis, V9, P521, DOI 10.1590/S1413-86702005000600012; Fraga J, 2011, EXP PARASITOL, V127, P593, DOI 10.1016/j.exppara.2010.09.005; Gomih-Alakija A, 2014, J CLIN MICROBIOL, V52, P3660, DOI 10.1128/JCM.00850-14; Goodman RP, 2011, J VIROL, V85, P4258, DOI 10.1128/JVI.00220-11; Goodman RP, 2011, ARCH VIROL, V156, P171, DOI 10.1007/s00705-010-0832-8; Heidary S, 2013, IRAN J PARASITOL, V8, P60; Hokororo A, 2015, SEX TRANSM INFECT, V91, P473, DOI 10.1136/sextrans-2014-051952; KABSCH W, 1992, ANNU REV BIOPH BIOM, V21, P49, DOI 10.1146/annurev.biophys.21.1.49; Kaul P, 2004, PARASITOL INT, V53, P255, DOI 10.1016/j.parint.2004.02.003; Kerubo E, 2016, SEX TRANSM INFECT, V92, P251, DOI 10.1136/sextrans-2015-052371; KHOSHNAN A, 1994, J VIROL, V68, P4035; KRIEGER JN, 1984, SEX TRANSM DIS, V11, P100, DOI 10.1097/00007435-198404000-00011; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054; Luo L, 2016, INT J STD AIDS, V27, P469, DOI 10.1177/0956462415585449; Malla N, 2011, INDIAN J MED MICROBI, V29, P152, DOI 10.4103/0255-0857.81801; Masha SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175166; McClelland RS, 2007, J INFECT DIS, V195, P698, DOI 10.1086/511278; Momeni Z, 2015, EXP PARASITOL, V159, P259, DOI 10.1016/j.exppara.2015.10.011; Nakubulwa Sarah, 2015, BMC Res Notes, V8, P573, DOI 10.1186/s13104-015-1545-6; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Petrin D, 1998, CLIN MICROBIOL REV, V11, P300, DOI 10.1128/CMR.11.2.300; Provenzano D, 1997, ARCH VIROL, V142, P939, DOI 10.1007/s007050050130; Rivera WL, 2017, J MICROBIOL IMMUNOL, V50, P669, DOI 10.1016/j.jmii.2015.07.016; Sangkomkamhang US, 2015, COCHRANE DB SYST REV, V2; Silver BJ, 2014, SEX TRANSM DIS, V41, P369, DOI 10.1097/OLQ.0000000000000134; Sorvillo F, 1998, LANCET, V351, P213, DOI 10.1016/S0140-6736(05)78181-2; Swygard H, 2004, SEX TRANSM INFECT, V80, P91, DOI 10.1136/sti.2003.005124; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; TORIAN BE, 1988, J PROTOZOOL, V35, P273, DOI 10.1111/j.1550-7408.1988.tb04343.x; Unger JA, 2015, SEX TRANSM DIS, V42, P637, DOI 10.1097/OLQ.0000000000000355; Upcroft JA, 2006, INT J PARASITOL, V36, P821, DOI 10.1016/j.ijpara.2006.02.018; VOHRA H, 1991, INDIAN J MED RES-A, V93, P37; WANG AL, 1986, P NATL ACAD SCI USA, V83, P7956, DOI 10.1073/pnas.83.20.7956; Weber B, 2003, J CLIN PATHOL, V56, P542, DOI 10.1136/jcp.56.7.542; Wendel KA, 2002, J INFECT DIS, V186, P558, DOI 10.1086/341832	42	1	1	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 30	2017	10								537	10.1186/s13071-017-2496-7				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FL3WS	WOS:000414157300002	29084570	DOAJ Gold, Green Published			2019-04-02	
J	Drakeley, C; Abdulla, S; Agnandji, ST; Fernandes, JF; Kremsner, P; Lell, B; Mewono, L; Bache, BE; Mihayo, MG; Juma, O; Tanner, M; Tahita, MC; Tinto, H; Diallo, S; Lompo, P; D'Alessandro, U; Ogutu, B; Otieno, L; Otieno, S; Otieno, W; Oyieko, J; Asante, KP; Dery, DBE; Adjei, G; Adeniji, E; Atibilla, D; Owusu-Agyei, S; Greenwood, B; Gesase, S; Lusingu, J; Mahende, C; Mongi, R; Segeja, M; Adjei, S; Agbenyega, T; Agyekum, A; Ansong, D; Bawa, JT; Boateng, HO; Dandalo, L; Escamilla, V; Hoffman, I; Maenje, P; Martinson, F; Carter, T; Leboulleux, D; Kaslow, DC; Usuf, E; Pircon, JY; Bahmanyar, ER				Drakeley, Chris; Abdulla, Salim; Agnandji, Selidji Todagbe; Fernandes, Jose Francisco; Kremsner, Peter; Lell, Bertrand; Mewono, Ludovic; Bache, Bache Emmanuel; Mihayo, Michael Gabriel; Juma, Omar; Tanner, Marcel; Tahita, Marc Christian; Tinto, Halidou; Diallo, Salou; Lompo, Palpouguini; D'Alessandro, Umberto; Ogutu, Bernhards; Otieno, Lucas; Otieno, Solomon; Otieno, Walter; Oyieko, Janet; Asante, Kwaku Poku; Dery, Dominic Bon-Ereme; Adjei, George; Adeniji, Elisha; Atibilla, Dorcas; Owusu-Agyei, Seth; Greenwood, Brian; Gesase, Samwel; Lusingu, John; Mahende, Coline; Mongi, Robert; Segeja, Method; Adjei, Samuel; Agbenyega, Tsiri; Agyekum, Alex; Ansong, Daniel; Bawa, John Tanko; Boateng, Harry Owusu; Dandalo, Leonard; Escamilla, Veronica; Hoffman, Irving; Maenje, Peter; Martinson, Francis; Carter, Terrell; Leboulleux, Didier; Kaslow, David C.; Usuf, Effua; Pircon, Jean-Yves; Bahmanyar, Edith Roset			Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries	MALARIA JOURNAL			English	Article						Epidemiology; Malaria; Transmission; Prevalence; Plasmodium falciparum; Anaemia	INSECTICIDE-TREATED BEDNETS; PARASITE PREVALENCE; BURKINA-FASO; TRANSMISSION INTENSITY; ASYMPTOMATIC PARASITEMIA; WESTERN KENYA; CHILDREN; MORBIDITY; MORTALITY; COVERAGE	Background: Plasmodium falciparum prevalence (PfPR) is a widely used metric for assessing malaria transmission intensity. This study was carried out concurrently with the RTS, S/AS01 candidate malaria vaccine Phase III trial and estimated PfPR over <= 4 standardized cross-sectional surveys. Methods: This epidemiology study (NCT01190202) was conducted in 8 sites from 6 countries (Burkina Faso, Gabon, Ghana, Kenya, Malawi, and Tanzania), between March 2011 and December 2013. Participants were enrolled in a 2:1:1 ratio according to age category:6 months-4 years, 5-19 years, and >= 20 years, respectively, per year and per centre. All sites carried out surveys 1-3 while survey 4 was conducted only in 3 sites. Surveys were usually performed during the peak malaria parasite transmission season, in one home visit, when medical history and malaria risk factors/prevention measures were collected, and a blood sample taken for rapid diagnostic test, microscopy, and haemoglobin measurement. PfPR was estimated by site and age category. Results: Overall, 6401 (survey 1), 6411 (survey 2), 6400 (survey 3), and 2399 (survey 4) individuals were included in the analyses. In the 6 months-4 years age group, the lowest prevalence (assessed using microscopy) was observed in 2 Tanzanian centres (4.6% for Korogwe and 9.95% for Bagamoyo) and Lambarene, Gabon (6.0%), while the highest PfPR was recorded for Nanoro, Burkina Faso (52.5%). PfPR significantly decreased over the 3 years in Agogo (Ghana), Kombewa (Kenya), Lilongwe (Malawi), and Bagamoyo (Tanzania), and a trend for increased PfPR was observed over the 4 surveys for Kintampo, Ghana. Over the 4 surveys, for all sites, PfPR was predominantly higher in the 5-19 years group than in the other age categories. Occurrence of fever and anaemia was associated with high P. falciparum parasitaemia. Univariate analyses showed a significant association of anti-malarial treatment in 4 surveys (odds ratios [ORs]: 0.52, 0.52, 0.68, 0.41) and bed net use in 2 surveys (ORs:0.63, 0.68, 1.03, 1.78) with lower risk of malaria infection. Conclusion: Local PfPR differed substantially between sites and age groups. In children 6 months-4 years old, a significant decrease in prevalence over the 3 years was observed in 4 out of the 8 study sites.	[Drakeley, Chris; D'Alessandro, Umberto; Owusu-Agyei, Seth; Greenwood, Brian] London Sch Hyg & Trop Med, London, England; [Abdulla, Salim; Mihayo, Michael Gabriel; Juma, Omar; Tanner, Marcel] Bagamoyo Dist Hosp, Ifakara Inst Hlth, Bagamoyo Res & Training Ctr, POB 74, Bagamoyo, Tanzania; [Agnandji, Selidji Todagbe; Fernandes, Jose Francisco; Lell, Bertrand; Mewono, Ludovic; Bache, Bache Emmanuel] Albert Schweitzer Hosp, Lambarene, Gabon; [Agnandji, Selidji Todagbe; Fernandes, Jose Francisco; Kremsner, Peter; Lell, Bertrand; Mewono, Ludovic; Bache, Bache Emmanuel] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Tanner, Marcel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Tanner, Marcel] Univ Basel, Basel, Switzerland; [Tahita, Marc Christian; Tinto, Halidou; Diallo, Salou; Lompo, Palpouguini] Inst Rech Sci Sante, Nanoro, Burkina Faso; [D'Alessandro, Umberto; Usuf, Effua] Gambia, Med Res Council Unit, Banjul, Gambia; [Ogutu, Bernhards; Otieno, Lucas; Otieno, Solomon; Otieno, Walter; Oyieko, Janet] KEMRI Walter Reed Project, Kombewa, Kenya; [Asante, Kwaku Poku; Dery, Dominic Bon-Ereme; Adjei, George; Adeniji, Elisha; Atibilla, Dorcas; Owusu-Agyei, Seth; Greenwood, Brian] Kintampo Hlth Res Ctr, Kintampo, Ghana; [Gesase, Samwel; Lusingu, John; Mahende, Coline; Mongi, Robert; Segeja, Method] Natl Inst Med Res, Korogwe, Tanzania; [Adjei, Samuel; Agbenyega, Tsiri; Agyekum, Alex; Ansong, Daniel; Bawa, John Tanko] Kwame Nkrumah Univ Sci & Technol, Agogo, Ghana; [Dandalo, Leonard; Escamilla, Veronica; Hoffman, Irving; Maenje, Peter; Martinson, Francis] Univ North Carolina Project, Lilongwe, Malawi; [Carter, Terrell; Leboulleux, Didier; Kaslow, David C.] PATH Malaria Vaccine Initiat, Washington, DC USA; [Usuf, Effua; Pircon, Jean-Yves; Bahmanyar, Edith Roset] GSK Vaccines, Wavre, Belgium	Abdulla, S (reprint author), Bagamoyo Dist Hosp, Ifakara Inst Hlth, Bagamoyo Res & Training Ctr, POB 74, Bagamoyo, Tanzania.	sabdulla@ihi.or.tz		Tinto, Halidou/0000-0002-0472-3586; Atibilla, Dorcas/0000-0002-0462-0499	GlaxoSmithKline Biologicals SA (GSK) - GSK; GlaxoSmithKline Biologicals SA (GSK) - PATH Malaria Vaccine Initiative (MVI)	The study was sponsored by GlaxoSmithKline Biologicals SA (GSK) and funded by both GSK and the PATH Malaria Vaccine Initiative (MVI). GSK also funded all costs associated with the development and the publishing of the present manuscript.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; Asante KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-211; Asante KP, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1654-4; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Buchwald AG, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1686-2; Clarke SE, 2004, AM J TROP MED HYG, V71, P732, DOI 10.4269/ajtmh.2004.71.732; Clinical S., 2015, LANCET, V386, P31; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Diallo A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1715-1; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Filipe JAN, 2007, PLOS COMPUT BIOL, V3, P2569, DOI 10.1371/journal.pcbi.0030255; FREEMAN MF, 1950, ANN MATH STAT, V21, P607, DOI 10.1214/aoms/1177729756; Geiger C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-27; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; GREENWOOD BM, 1991, T ROY SOC TROP MED H, V85, P186, DOI 10.1016/0035-9203(91)90015-Q; Hay SI, 2008, LANCET INFECT DIS, V8, P369, DOI 10.1016/S1473-3099(08)70069-0; Idris ZM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36958; International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), 1996, GUID IND E6 GOOD CLI, V38-42, P50; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-19; Leach A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-224; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Lindblade KA, 2006, J MED ENTOMOL, V43, P428, DOI 10.1603/0022-2585(2006)043[0428:IOSUOI]2.0.CO;2; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/ERI.13.45, 10.1586/eri.13.45]; Louis VR, 2015, B WORLD HEALTH ORGAN, V93, P750, DOI 10.2471/BLT.14.147702; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Mawili-Mboumba DP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-3; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MILLER JJ, 1978, AM STAT, V32, P138, DOI 10.2307/2682942; Ministry of Health Republic of Ghana., 2010, STAND TREATM GUID; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Mwingira F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-433; Namountougou M, 2012, ACTA TROP, V7, P48412, DOI DOI 10.1371/J0URNAL.P0NE.0048412; Namountougou M, 2013, ACTA TROP, V125, P123, DOI 10.1016/j.actatropica.2012.10.012; O'Meara WP, 2007, AM J TROP MED HYG, V77, P246, DOI 10.4269/ajtmh.2007.77.246; Olumese P, 2016, ACCESS SMC M TRANSF, DOI [10.1002/14651858.CD000363.pub2, DOI 10.1002/14651858.CD000363.PUB2]; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Parr JB, 2016, AM J TROP MED HYG, V95, P373, DOI 10.4269/ajtmh.16-0156; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; RTS, 2011, NEW ENGL J MED, V365, P1863, DOI DOI 10.1056/NEJM0A1102287; Saute F, 2003, T ROY SOC TROP MED H, V97, P661, DOI 10.1016/S0035-9203(03)80098-6; Shaukat AM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-122; Shiff C, 2002, CLIN MICROBIOL REV, V15, P278, DOI 10.1128/CMR.15.2.278-293.2002; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Snow RW, 2002, ADV PARASIT, V52, P235, DOI 10.1016/S0065-308X(02)52013-3; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Snow RW, 1996, PARASITOL TODAY, V12, P455, DOI 10.1016/S0169-4758(96)30032-X; Stoltzfus RJ, 1993, GUIDELINES USE IRON; Tanzania Commission for AIDS (TACAIDS) Zanzibar AIDS Commission (ZAC) National Bureau of Statistics (NBS) Office of Chief Government Statistician (OCGS) and ICF International, 2013, TANZ HIV AIDS MAL IN; Vandoolaeghe P, 2016, EXPERT REV VACCINES, V15, P1481, DOI 10.1080/14760584.2016.1236689; WHO, 2006, WHO TECH REP SER, V936, P1; WHO, MAL CHILDR 5; World Health Organization, MAL FACT SHEET; World Health Organization (WHO), 2001, WHONHD013; Yakasai AM, 2015, J TROP MED, DOI 10.1155/2015/189232; Zhou G, 2011, PLOS ONE, V6, P20318, DOI DOI 10.1371/J0URNAL.P0NE.0020318	57	2	2	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 27	2017	16								433	10.1186/s12936-017-2078-3				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FL4HJ	WOS:000414189500002	29078773	DOAJ Gold, Green Published			2019-04-02	
J	Heylen, D; Fonville, M; van Leeuwen, AD; Stroo, A; Duisterwinkel, M; van Wieren, S; Diuk-Wasser, M; de Bruin, A; Sprong, H				Heylen, Dieter; Fonville, Manoj; van Leeuwen, Arieke Docters; Stroo, Arjan; Duisterwinkel, Martin; van Wieren, Sip; Diuk-Wasser, Maria; de Bruin, Arnout; Sprong, Hein			Pathogen communities of songbird-derived ticks in Europe's low countries	PARASITES & VECTORS			English	Article						Co-infection; Bird; Ixodes ricinus; Borrelia burgdorferi (s.l.); Borrelia miyamotoi; Rickettsiales	CANDIDATUS NEOEHRLICHIA MIKURENSIS; BORRELIA-BURGDORFERI S.L.; IXODES-RICINUS TICKS; LYME BORRELIOSIS; ANAPLASMA-PHAGOCYTOPHILUM; TRANSMISSION DYNAMICS; BORNE PATHOGENS; CLINICAL-MANIFESTATIONS; RICKETTSIA-HELVETICA; MIGRATING BIRDS	Background: Birds play a major role in the maintenance of enzootic cycles of pathogens transmitted by ticks. Due to their mobility, they affect the spatial distribution and abundance of both ticks and pathogens. In the present study, we aim to identify members of a pathogen community [Borrelia burgdorferi (s.l.), B. miyamotoi, 'Ca. Neoehrlichia mikurensis', Anaplasma phagocytophilum and Rickettsia helvetica] in songbird-derived ticks from 11 locations in the Netherlands and Belgium (2012-2014). Results: Overall, 375 infested songbird individuals were captured, belonging to 35 species. Thrushes (Turdus iliacus, T. merula and T. philomelos) were trapped most often and had the highest mean infestation intensity for both Ixodes ricinus and I. frontalis. Of the 671 bird-derived ticks, 51% contained DNA of at least one pathogenic agent and 13% showed co-infections with two or more pathogens. Borrelia burgdorferi (s.l.) DNA was found in 34% of the ticks of which majority belong to so-called avian Borrelia species (distribution in Borrelia-infected ticks: 47% B. garinii, 34% B. valaisiana, 3% B. turdi), but also the mammal-associated B. afzelii (16%) was detected. The occurrence of B. miyamotoi was low (1%). Prevalence of R. helvetica in ticks was high (22%), while A. phagocytophilum and 'Ca. N. mikurensis' prevalences were 5% and 4%, respectively. The occurrence of B. burgdorferi (s.l.) was positively correlated with the occurrence of 'Ca. N. mikurensis', reflecting variation in susceptibility among birds and/or suggesting transmission facilitation due to interactions between pathogens. Conclusions: Our findings highlight the contribution of European songbirds to co-infections in tick individuals and consequently to the exposure of humans to multiple pathogens during a tick bite. Although poorly studied, exposure to and possibly also infection with multiple tick-borne pathogens in humans seems to be the rule rather than the exception.	[Heylen, Dieter] Univ Antwerp, Evolutionary Ecol Grp, Antwerp, Belgium; [Fonville, Manoj; van Leeuwen, Arieke Docters; de Bruin, Arnout; Sprong, Hein] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Stroo, Arjan] Minist Econ Affairs, Netherlands Food & Consumer Prod Safety Author, Ctr Monitoring Vectors, Wageningen, Netherlands; [Duisterwinkel, Martin] Independent Agr Entrepreneur, Groningen, Netherlands; [van Wieren, Sip] Wageningen Univ, Resource Ecol Grp, Wageningen, Netherlands; [Diuk-Wasser, Maria] Columbia Univ, EcoEpidemiol Lab, New York, NY USA	Heylen, D (reprint author), Univ Antwerp, Evolutionary Ecol Grp, Antwerp, Belgium.	dieter.heylen@uantwerpen.be			Dutch Ministry of Health, Welfare and Sport (VWS); Fund for Scientific Research - Flanders Belgium (FWO) [G0.049.10]; University of Antwerp (KP BOF UA)	This study was financially supported by the Dutch Ministry of Health, Welfare and Sport (VWS), the Fund for Scientific Research - Flanders Belgium (FWO) (grant G0.049.10) and the University of Antwerp (KP BOF UA 2015). This work was done under the frame of EurNegVec Cost Action TD1303. Dieter Heylen is a postdoctoral fellow at the Fund for Scientific Research - Flanders Belgium (FWO). The funders had no role in study design, data collection, interpretation and analysis, decision to publish or preparation of the manuscript.	Acari Manila G., 1998, IXODIDA; Andersson M, 2014, APPL ENVIRON MICROB, V80, P1645, DOI 10.1128/AEM.03469-13; Arthur D.R., 1963, BRIT TICKS; Beati L, 1999, S AFR J SCI, V95, P448; Berthova L, 2016, EXP APPL ACAROL, V68, P299, DOI 10.1007/s10493-015-9975-3; Bjoersdorff A, 2001, EMERG INFECT DIS, V7, P877; Burri C, 2014, TICKS TICK-BORNE DIS, V5, P245, DOI 10.1016/j.ttbdis.2013.11.007; Capligina V, 2014, TICKS TICK-BORNE DIS, V5, P75, DOI 10.1016/j.ttbdis.2013.08.007; Coipan EC, 2016, INFECT GENET EVOL, V42, P66, DOI 10.1016/j.meegid.2016.04.019; Coipan EC, INFECT GENET EVOL; Coipan EC, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00036; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; de Bruin A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0764-y; Dubska L, 2011, APPL ENVIRON MICROB, V77, P1115, DOI 10.1128/AEM.02278-10; Dumler JS, 2005, EMERG INFECT DIS, V11, P1828, DOI 10.3201/eid1112.050898; Duncan AB, 2015, J ANIM ECOL, V84, P498, DOI 10.1111/1365-2656.12302; Dunn JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115494; Elfving K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008572; Franke J, 2010, TICKS TICK-BORNE DIS, V1, P109, DOI 10.1016/j.ttbdis.2010.03.001; Geller J, 2013, VECTOR-BORNE ZOONOT, V13, P443, DOI 10.1089/vbz.2012.1054; Ginsberg HS, 2008, EXP APPL ACAROL, V46, P29, DOI 10.1007/s10493-008-9175-5; Graham RI, 2010, MED VET ENTOMOL, V24, P340, DOI 10.1111/j.1365-2915.2010.00886.x; Gray JS, 1998, EXP APPL ACAROL, V22, P249, DOI 10.1023/A:1006070416135; Hamer SA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-231; Hanincova K, 2003, PARASITOLOGY, V126, P11, DOI 10.1017/S0031182002002548; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Heylen D., 2016, ECOLOGICAL INTERACTI, V4; Heylen D, 2017, SCI REP, V7; Heylen D, 2017, ENVIRON MICROBIOL, V19, P1857, DOI 10.1111/1462-2920.13685; Heylen D, 2016, ENVIRON MICROBIOL, V18, P988, DOI 10.1111/1462-2920.13164; Heylen D, 2014, TICKS TICK-BORNE DIS, V5, P693, DOI 10.1016/j.ttbdis.2014.05.006; Heylen D, 2014, ENVIRON MICROBIOL, V16, P2859, DOI 10.1111/1462-2920.12304; Heylen D, 2013, ENVIRON MICROBIOL, V15, P663, DOI 10.1111/1462-2920.12059; Hildebrandt A, 2010, TICKS TICK-BORNE DIS, V1, P105, DOI 10.1016/j.ttbdis.2009.12.003; Hillyard PD, 1996, TICKS N W EUROPE; Hofmeester TR, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/043001; Holden K, 2005, INFECT IMMUN, V73, P3440, DOI 10.1128/IAI.73.6.3440-3444.2005; Hornok S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-128; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; HUDDE H, 1988, Vogelwarte, V34, P201; Humair PF, 2000, MICROBES INFECT, V2, P915, DOI 10.1016/S1286-4579(00)00393-2; Humair PF, 1999, PARASITOLOGY, V118, P33, DOI 10.1017/S0031182098003564; Humair PF, 1998, ZBL BAKT-INT J MED M, V287, P521, DOI 10.1016/S0934-8840(98)80194-1; Jahfari S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-365; Jahfari S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-74; Kocan KA, 2003, VET PARASITOL, V112, P295, DOI 10.1016/S0304-4017(03)00018-9; Kurtenbach K, 2002, INFECT IMMUN, V70, P5893, DOI 10.1128/IAI.70.10.5893-5895.2002; Lipsker D, 2009, LYME BORRELIOSIS BIO; Lommano E, 2014, TICKS TICK-BORNE DIS, V5, P871, DOI 10.1016/j.ttbdis.2014.07.001; Lundqvist L, 1998, MED VET ENTOMOL, V12, P215, DOI 10.1046/j.1365-2915.1998.00101.x; Marsot M, 2012, INT J PARASITOL, V42, P781, DOI 10.1016/j.ijpara.2012.05.010; Maurer FP, 2013, J CLIN MICROBIOL, V51, P169, DOI 10.1128/JCM.01955-12; Montoya C., 2012, MODELS DISCRETE LONG; Moro MH, 2002, J INFECT DIS, V186, P428, DOI 10.1086/341452; Nilsson K, 1999, LANCET, V354, P1169, DOI 10.1016/S0140-6736(99)04093-3; Nilsson K, 2010, EMERG INFECT DIS, V16, P490, DOI 10.3201/eid1603.090184; Palomar AM, 2015, MED VET ENTOMOL, V29, P349, DOI 10.1111/mve.12124; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Richter D, 2012, VECTOR-BORNE ZOONOT, V12, P21, DOI 10.1089/vbz.2011.0668; Rollend L, 2013, TICKS TICK-BORNE DIS, V4, P46, DOI 10.1016/j.ttbdis.2012.06.008; Sandelin LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133250; Scoles GA, 2001, VECTOR-BORNE ZOONOT, V1, P21, DOI 10.1089/153036601750137624; Snow DW, 1998, BIRDS W PALEARCTIC C, V2; Spitalska E, 2011, VECTOR-BORNE ZOONOT, V11, P1235, DOI 10.1089/vbz.2010.0210; Sprong H, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-41; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Strle Franc, 2009, V37, P51, DOI 10.1159/000213070; Susi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6975; Szekeres S, 2015, TICKS TICK-BORNE DIS, V6, P111, DOI 10.1016/j.ttbdis.2014.10.004; Taragel'ova V, 2008, APPL ENVIRON MICROB, V74, P1289, DOI 10.1128/AEM.01060-07; Thomas V, 2001, INFECT IMMUN, V69, P3359, DOI 10.1128/IAI.69.5.3359-3371.2001; ULMANEN I, 1977, OIKOS, V28, P20, DOI 10.2307/3543318; van Duijvendijk G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1389-5; Verbeke G., 2001, LINEAR MIXED MODELS; Voordouw MJ, 2015, PARASITOLOGY, V142, P290, DOI 10.1017/S0031182014001486; Waldenstrom J, 2007, EMERG INFECT DIS, V13, P1215, DOI 10.3201/eid1308.061416; Wallmenius K, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-318; Zemtsova G, 2010, EXP APPL ACAROL, V52, P383, DOI 10.1007/s10493-010-9375-7	78	2	3	5	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 18	2017	10								497	10.1186/s13071-017-2423-y				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FK4KG	WOS:000413461900003	29047399	DOAJ Gold, Green Published			2019-04-02	
J	De Koninck, AS; Cnops, L; Hofmans, M; Jacobs, J; Van den Bossche, D; Philippe, J				De Koninck, Anne-Sophie; Cnops, Lieselotte; Hofmans, Mattias; Jacobs, Jan; Van den Bossche, Dorien; Philippe, Jan			Diagnostic performance of the loop-mediated isothermal amplification (LAMP) based illumigene (R) malaria assay in a non-endemic region	MALARIA JOURNAL			English	Article						Illumigene malaria assay; LAMP assay; Plasmodium; Loop-mediated isothermal amplification; Malaria	REAL-TIME PCR; IMPORTED MALARIA; MOLECULAR DIAGNOSIS; TESTS; INFECTIONS; TRAVEL; TOOL	Background: Light microscopy and antigen-based rapid diagnostic tests are the primary diagnostic tools for detecting malaria, although being labour-intensive and frequently challenged by lack of personnel's experience and low levels of parasite density. The latter being especially important in non-endemic settings. Novel molecular techniques aim to overcome this drawback. The objective of this study was to assess the diagnostic performance of the illumigene malaria assay (R) (Meridian Bioscience) compared to microscopy, RDT and real-time PCR. This loop-mediated isothermal amplification (LAMP) assay is a qualitative in vitro diagnostic test for the direct detection of Plasmodium spp. DNA in human venous whole blood samples. Methods: The illumigene assay was assessed on a retrospective panel of stored blood samples (n = 103) from returned travellers and external quality control samples (n = 12). Additionally the assay was prospectively assessed on 30 fresh routine samples with a request for malaria diagnosis. The illumigene assay was compared to microscopy, RDT and Plasmodium species specific real-time PCR. Results: In the retrospective evaluation, the illumigene assay showed 100% agreement with the real-time PCR, RDT and microscopy yielding a sensitivity and specificity of 100% (95% CI 95.1-100% and 89.7-100%, respectively). Seven samples from patients recently treated for Plasmodium falciparum infection that were RDT positive and microscopy negative yielded positive test results. The performance of the illumigene assay equals that of microscopy combined with RDT in the prospective panel with three false negative RDT results and one false negative microscopy result. Excellent concordance with PCR was observed. The limit of detection of the assay approached 0.5 parasites/mu L for both P. falciparum and Plasmodium vivax. Conclusion: In non-endemic regions where the diagnostic process for malaria infections is questioned by lack of experience and low levels of parasite densities, the illumigene assay can be of value. Due to its high sensitivity, the LAMP assay may be considered as primary diagnostic test. The results of this study indicate that negative screen results do not need further confirmation. However, before implementation, this approach needs to be confirmed in larger, prospective studies. A shortcoming of this assay is that no species identification nor determination of parasite density are possible.	[De Koninck, Anne-Sophie; Hofmans, Mattias; Philippe, Jan] Ghent Univ Hosp, Dept Lab Med, De Pintelaan 185, B-9000 Ghent, Belgium; [Cnops, Lieselotte; Jacobs, Jan; Van den Bossche, Dorien] Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium	Philippe, J (reprint author), Ghent Univ Hosp, Dept Lab Med, De Pintelaan 185, B-9000 Ghent, Belgium.	jan.philippe@uzgent.be			Agency for Innovation by Science and Technology (VLAIO) from the Flemish Government	We would like to thank Meridian Bioscience for providing study instrumentation and corresponding disposables for this evaluation. Research funding: LC holds an innovation mandate from the Agency for Innovation by Science and Technology (VLAIO) from the Flemish Government. Honorarium: None declared.	Abanyie FA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-340; Alam MS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-175; [Anonymous], ILL MAL PACK INS; Askling HH, 2012, MALARIA J, V11, P328; Bourgeois N, 2010, CLIN MICROBIOL INFEC, V16, P1305, DOI 10.1111/j.1469-0691.2009.02933.x; Cnops L, 2011, CLIN MICROBIOL INFEC, V17, P1101, DOI 10.1111/j.1469-0691.2010.03344.x; Das DK, 2015, J MICROSC-OXFORD, V260, P1, DOI 10.1111/jmi.12270; Gamboa D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008091; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-271; Gillet P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-262; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Han ET, 2013, EXPERT REV MOL DIAGN, V13, P205, DOI [10.1586/ERM.12.144, 10.1586/erm.12.144]; Hanscheid T, 2003, CLIN MICROBIOL INFEC, V9, P497, DOI 10.1046/j.1469-0691.2003.00640.x; Huang ZJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-269; Lucchi NW, 2016, SCI REP-UK, V6, DOI 10.1038/srep36808; Lucchi NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013733; Maltha J, 2013, CLIN MICROBIOL INFEC, V19, P408, DOI 10.1111/1469-0691.12152; Maltha J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043094; Maltha J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-7; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-171; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Oriero EC, 2015, EXPERT REV MOL DIAGN, V15, P1419, DOI 10.1586/14737159.2015.1090878; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Ponaka C., 2015, ASS MOL PATHOLOGY AM; Tatem AJ, 2017, LANCET INFECT DIS, V17, P98, DOI 10.1016/S1473-3099(16)30326-7; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, POL BRIEF MAL DIAGN; World Health Organization, WORLD MAL REP 2016	30	5	5	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 17	2017	16								418	10.1186/s12936-017-2065-8				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FK3CZ	WOS:000413363700002	29041927	DOAJ Gold, Green Published			2019-04-02	
J	Beaufay, C; Herent, MF; Quetin-Leclercq, J; Bero, J				Beaufay, Claire; Herent, Marie-France; Quetin-Leclercq, Joelle; Bero, Joanne			In vivo anti-malarial activity and toxicity studies of triterpenic esters isolated form Keetia leucantha and crude extracts	MALARIA JOURNAL			English	Article						Keetia leucantha; Triterpene esters; Anti-malarial; Plasmodium; Oleanolic; Ursolic; Rubiaceae	BETULINIC ACID; ANTIPLASMODIAL ACTIVITY; PLASMODIUM-FALCIPARUM; MEDICINAL-PLANTS; OLEANOLIC ACID; PHARMACOLOGICAL-ACTIVITIES; PENTACYCLIC TRITERPENES; TRADITIONAL MEDICINE; DRUG DISCOVERY; VITRO	Background: Considering the need for new anti-malarial drugs, further investigations on Keetia leucantha (Rubiaceae), an in vitro antiplasmodial plant traditionally used to treat malaria, were carried out. This paper aimed to assess the in vivo anti-malarial efficacy of K. leucantha triterpenic esters previously identified as the most in vitro active components against Plasmodium falciparum and their potential toxicity as well as those of anti-malarial extracts. Results: These eight triterpenic esters and the major antiplasmodial triterpenic acids, ursolic and oleanolic acids, were quantified in the twigs dichloromethane extract by validated HPLC-UV methods. They account for about 19% of this extract (16.9% for acids and 1.8% for esters). These compounds were also identified in trace in the twigs decoction by HPLC-HRMS. Results also showed that extracts and esters did not produce any haemolysis, and were devoid of any acute toxicity at a total cumulative dose of 800 and 150 mg/kg respectively. Moreover, esters given intraperitoneally at 50 mg/kg/day to Plasmodium berghei-infected mice showed a very significant (p < 0.01) parasitaemia inhibition (27.8 +/- 5.4%) on day 4 post-infection compared to vehicle-treated mice. Conclusions: These results bring out new information on the safety of K. leucantha use and on the identification of anti-malarial compounds from its dichloromethane extract. Its activity can be explained by the presence of triterpenic acids and esters which in vivo activity and safety were demonstrated for the first time.	[Beaufay, Claire; Herent, Marie-France; Quetin-Leclercq, Joelle; Bero, Joanne] Catholic Univ Louvain, Pharmacognosy Res Grp, Louvain Drug Res Inst, Ave E Mounier 72,B1-72-03, B-1200 Brussels, Belgium	Beaufay, C (reprint author), Catholic Univ Louvain, Pharmacognosy Res Grp, Louvain Drug Res Inst, Ave E Mounier 72,B1-72-03, B-1200 Brussels, Belgium.	Claire.beaufay@uclouvain.be		Leclercq, Joelle/0000-0002-2278-6206	Belgian National Fund for Scientific Research (FNRS) [FRFC 2.4555.08, PDR T.0190.13]; Faculty of Pharmacy and Biomedical Sciences of UCL	This work was supported by the Belgian National Fund for Scientific Research (FNRS) (FRFC 2.4555.08 and PDR T.0190.13) and the Faculty of Pharmacy and Biomedical Sciences of UCL.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bero J, 2013, PHYTOMEDICINE, V20, P270, DOI 10.1016/j.phymed.2012.10.010; Bero J, 2013, J ETHNOPHARMACOL, V149, P176, DOI 10.1016/j.jep.2013.06.018; Bero J, 2011, J ETHNOPHARMACOL, V137, P998, DOI 10.1016/j.jep.2011.07.022; Bero J, 2009, J ETHNOPHARMACOL, V122, P439, DOI 10.1016/j.jep.2009.02.004; Broniatowski M, 2014, BBA-BIOMEMBRANES, V1838, P2530, DOI 10.1016/j.bbamem.2014.05.027; Broniatowski M, 2012, J COLLOID INTERF SCI, V381, P116, DOI 10.1016/j.jcis.2012.05.020; Cao F, 2012, MOL PHARMACEUT, V9, P2127, DOI 10.1021/mp200447r; Chinaeke EE, 2015, DRUG DELIV, V22, P652, DOI 10.3109/10717544.2014.881633; Cimanga RK, 2006, PHARM BIOL, V44, P677, DOI 10.1080/13880200601009123; da Silva GNS, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-89; de Sa MS, 2009, PARASITOL RES, V105, P275, DOI 10.1007/s00436-009-1394-0; Deharo E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S5; Drag-Zalesinska M, 2009, BIOORG MED CHEM LETT, V19, P4814, DOI 10.1016/j.bmcl.2009.06.046; Dzubak P, 2006, NAT PROD REP, V23, P394, DOI 10.1039/b515312n; Fajardo-Sanchez E, 2017, J BIOMOL STRUCT DYN, V35, P2688, DOI 10.1080/07391102.2016.1229219; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Ginsburg H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S1; Gnoatto SCB, 2008, BIOORGAN MED CHEM, V16, P771, DOI 10.1016/j.bmc.2007.10.031; Habila JD, 2011, AFR J PHARM PHARMACO, V5, P2667, DOI 10.5897/AJPP11.589; Innocente AM, 2012, MOLECULES, V17, P12003, DOI 10.3390/molecules171012003; Ioset J. R., 2009, DRUG SCREENING KINET; Isah MB, 2016, PARASITOLOGY, V143, P1219, DOI 10.1017/S0031182016000718; Koga K, 2013, DRUG DES DEV THER, V7, P1235, DOI 10.2147/DDDT.S51638; Mavondo GA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1278-6; Moneriz C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-103; Muganga R, 2014, PLANTA MED, V80, P482, DOI 10.1055/s-0034-1368322; Mutai C, 2008, AFR J TRADIT COMPLEM, V5, P46; Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055; Vo NNQ, 2017, J NAT MED-TOKYO, V71, P50, DOI 10.1007/s11418-016-1026-9; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Pink R, 2005, NAT REV DRUG DISCOV, V4, P727, DOI 10.1038//nrd1824; Pollier J, 2012, PHYTOCHEMISTRY, V77, P10, DOI 10.1016/j.phytochem.2011.12.022; Rasoanaivo P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S4; Sairafianpour M, 2003, PLANTA MED, V69, P846, DOI 10.1055/s-2003-43212; Schmidt TJ, 2012, CURR MED CHEM, V19, P2128; Simelane MBC, 2013, MOLECULES, V18, P12313, DOI 10.3390/molecules181012313; Steele JCP, 1999, PHYTOTHER RES, V13, P115, DOI 10.1002/(SICI)1099-1573(199903)13:2<115::AID-PTR404>3.0.CO;2-1; Sultana Nighat, 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P3; Sun WZ, 2011, CHEM BIOL DRUG DES, V77, P206, DOI 10.1111/j.1747-0285.2010.01077.x; Suneela D, 2012, BIOORG MED CHEM LETT, V22, P7582, DOI 10.1016/j.bmcl.2012.10.017; Tagboto S, 2001, ADV PARASIT, V50, P199, DOI 10.1016/S0065-308X(01)50032-9; Thakkar M, 2016, DRUG DELIV TRANSL RE, V6, P414, DOI 10.1007/s13346-016-0290-2; World Health Organization, 2015, WORLD MAL REP 2015; Wozniak L, 2015, MOLECULES, V20, P20614, DOI 10.3390/molecules201119721; Yu ZJ, 2016, MOL PHARMACEUT, V13, P1699, DOI 10.1021/acs.molpharmaceut.6b00129; Zhai X, 2016, LANCET, V387, P1722, DOI 10.1016/S0140-6736(16)30261-6; Zhang B, 2012, J AGR FOOD CHEM, V60, P10278, DOI 10.1021/jf303160y; Ziegler HL, 2004, BIOORGAN MED CHEM, V12, P119, DOI 10.1016/j.bmc.2003.10.010	50	3	3	1	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 10	2017	16								406	10.1186/s12936-017-2054-y				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FJ3VN	WOS:000412660600003	29017554	DOAJ Gold, Green Published			2019-04-02	
J	Ramanantsoa, A; Wilson-Barthes, M; Rahenintsoa, R; Hoibak, S; Ranaivoharimina, H; Rahelimalala, MD; Rakotomanga, A; Finlay, A; Ribera, JM; Grietens, KP				Ramanantsoa, Ambinina; Wilson-Barthes, Marta; Rahenintsoa, Rindra; Hoibak, Sarah; Ranaivoharimina, Harilala; Rahelimalala, Martha Delphine; Rakotomanga, Avotiana; Finlay, Alyssa; Ribera, Joan Muela; Grietens, Koen Peeters			Can the collection of expired long-lasting insecticidal nets reduce their coverage and use? Sociocultural aspects related to LLIN life cycle management and use in four districts in Madagascar	MALARIA JOURNAL			English	Article						Malaria; Recycling; Disposal; Net collection campaign; Insecticide treated nets (ITNs); Long lasting insecticide treated nets (LLINs)	TREATED BED NETS; MALARIA TRANSMISSION; WESTERN KENYA; BEDNETS; IMPACT	Background: There is growing awareness of the likely impact increased numbers of LLINs will have on the environment, if not disposed of or recycled appropriately. As part of a World Health Organization (WHO) and United Nations Environment Programme (UNEP) pilot study to assess environmentally-sound and cost-effective LLIN recycling strategies, the USAID-Deliver Project collected 22,559 used bed nets in Madagascar. A social science study was conducted to provide data on socio-cultural factors related to collection and replacement of LLINs, including impact on primary and other net uses. Methods: Ethnographic exploratory research was carried out following the pilot USAID-Deliver net collection and recycling campaign in Betioky, Tsihombe, Fenerive Est and Ambanja districts of Madagascar, triangulating participant observation, interviewing and group discussions. Sampling was theoretical and data analysis was a continuous and iterative process concurrent to data collection. Final analysis was conducted using NVivo10. Results: The following themes emerged as contributing to the success of collecting expired LLINs in the community for recycling purposes: (i) net adequacy and preference: characteristic differences between collected and newly distributed nets lead to communities' reticence to relinquish old nets before confirming new nets were appropriate for intended use. Where newly distributed nets failed to meet local requirements, this was expected to increase alternative uses and decrease household turn over. (ii) Net collection strategies: the net collection campaign brought net use out of the private sphere and into the public arena. Net owners reported feeling ashamed when presenting damaged nets in public for collection, leading to reduced net relinquishment. (iii) Net lifecycle: communities perceived nets as being individually owned and economic value was attributed both to good-condition nets for sleeping and to worn nets for alternative/secondary purposes. Collecting nets at the stage of waste rather than at their prescribed end of life was locally acceptable. Conclusion: The collection of LLINs for recycling/disposal can lead to lower coverage under certain conditions. Collecting used LLINs may be appropriate under the following conditions: (i) nets are collected at the stage of waste; (ii) new nets are in line with community preferences; and (iii) collection strategies have been agreed upon within the community prior to replacement activities. Any collection/recycling of old LLINs should be based on in-depth understanding of the local context and include participatory processes to prevent reduced coverage.	[Ramanantsoa, Ambinina; Rahenintsoa, Rindra] Focus Dev Agcy, Antananarivo, Madagascar; [Ramanantsoa, Ambinina; Rahenintsoa, Rindra] Univ Antananarivo, Dept Sociol, Antananarivo, Madagascar; [Wilson-Barthes, Marta] Emmanuel Int, Zomba, Malawi; [Hoibak, Sarah] Global Fund, Geneva, Switzerland; [Ranaivoharimina, Harilala] Minist Hlth, Antananarivo, Madagascar; [Rahelimalala, Martha Delphine] Minist Environm, Antananarivo, Madagascar; [Rakotomanga, Avotiana] USAID Deliver Project, Antananarivo, Madagascar; [Finlay, Alyssa] CDC, Div Parasit Dis & Malaria, Atlanta, GA 30333 USA; [Ribera, Joan Muela; Grietens, Koen Peeters] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [Grietens, Koen Peeters] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Grietens, Koen Peeters] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium	Grietens, KP (reprint author), Partners Appl Social Sci PASS Int, Tessenderlo, Belgium.; Grietens, KP (reprint author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan.; Grietens, KP (reprint author), Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium.	kpeeters@itg.be		Peeters Grietens, Koen/0000-0001-6570-9887	UNEP; WHO Strategic Approach to International Chemicals Management (SAICM) Quick Start Programme Trust Fund project	This research is part of a UNEP and WHO Strategic Approach to International Chemicals Management (SAICM) Quick Start Programme Trust Fund project being implemented in Madagascar.	Afolabi BM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-30; Albrecht Terrance L., 1993, SUCCESSFUL FOCUS GRO, P51, DOI DOI 10.4135/9781483349008; American Anthropological Association, 1998, COD ETH AM ANTHR ASS; [Anonymous], 2016, WORLD MAL REP 2016; [Anonymous], 2011, ALLIANCE MALARIA PRE; [Anonymous], 2016, WHOPES 13 WORK GROUP; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; Baume CA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-264; Clarke SE, 2001, T ROY SOC TROP MED H, V95, P457, DOI 10.1016/S0035-9203(01)90001-X; Das ML, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000100; Gimnig JE, 2003, AM J TROP MED HYG, V68, P16, DOI 10.4269/ajtmh.2003.68.16; Gobena T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-914; Green J, 2004, QUALITATIVE METHODS; Grietens KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050294; Hakizimana E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-344; Korenromp EL, 2003, TROP MED INT HEALTH, V8, P693, DOI 10.1046/j.1365-3156.2003.01084.x; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; Lindlof T. R, 2002, QUALITATIVE COMMUNIC; Lover AA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-199; Milliner J., 2010, NET MAPPING PROJECT; Minakawa N, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-165; Nelson M, 2011, LLIN RECYCLING PILOT, P3; Parker JEA, 2015, SCI REP-UK, V5, DOI 10.1038/srep13392; SEXTON JD, 1990, AM J TROP MED HYG, V43, P11, DOI 10.4269/ajtmh.1990.43.11; ter Kuile FO, 2003, AM J TROP MED HYG, V68, P100, DOI 10.4269/ajtmh.2003.68.100; The Global Fund to Fight AIDS Tuberculosis and Malaria, RES REP 2016; Vanden EL, 2010, MALARIA J, V9, P133; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2008, SALT VEH FORT REP WH, P1; WHO, 2007, INS TREAT MOSQ NETS; World Health Organisation. WHO Global Malaria Programme, 2014, WHO GLOB MAL PROGR; World Health Organization, 2008, GLOB MAL ACT PLAN; World Health Organization, 2015, WORLD MAL REP 2015	33	1	1	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 10	2017	16								404	10.1186/s12936-017-2053-z				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FJ3VN	WOS:000412660600001	29017531	DOAJ Gold, Green Published			2019-04-02	
J	Tihon, E; Imamura, H; Dujardin, JC; Van Den Abbeele, J				Tihon, Eliane; Imamura, Hideo; Dujardin, Jean-Claude; Van Den Abbeele, Jan			Evidence for viable and stable triploid Trypanosoma congolense parasites	PARASITES & VECTORS			English	Article						Trypanosoma congolense; Triploidy; Whole genome sequencing	GENETIC EXCHANGE; DRUG-RESISTANCE; TSETSE-FLY; LEISHMANIA; BRUCEI; CHROMOSOME; PLOIDY; MECHANISMS	Background: Recent whole genome sequencing (WGS) analysis identified a viable triploid strain of Trypanosoma congolense. This triploid strain BANANCL2 was a clone of the field isolate BANAN/83/CRTRA/64 that was collected from cattle in Burkina Faso in 1983. Results: We demonstrated the viability and stability of triploidy throughout the complete life-cycle of the parasite by infecting tsetse flies with the triploid clone BANANCL2. Proboscis-positive tsetse flies efficiently transmitted the parasites to mice resulting in systemic infections. WGS of the parasites was performed at all life-cycle stages, and a method based on a block alternative allele frequency spectrum was developed to efficiently detect the ploidy profiles of samples with low read depth. This approach confirmed the triploid profile of parasites throughout their life-cycle in the tsetse fly and the mammalian host, demonstrating that triploidy is present at all stages and is stable over time. Conclusion: The presence of viable field-isolated triploid parasites indicates another possible layer of genetic diversity in natural T. congolense populations. The comparison between triploid and diploid parasites provides a unique model system to study the impact of chromosome copy number variations in African trypanosomes. In addition, the consequences of triploidy can be further investigated using this stable triploid model.	[Tihon, Eliane; Imamura, Hideo; Dujardin, Jean-Claude; Van Den Abbeele, Jan] Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium	Van Den Abbeele, J (reprint author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	jvdabbeele@itg.be		Van Den Abbeele, Jan/0000-0002-4533-4480; Imamura, Hideo/0000-0002-3282-1319	EU-GPARD [TRYRAC/DCI-FOOD/2011/279-754]; Department of Economy, Science and Innovation in Flanders, ITM-SOFIB GemiNI	This work was financed by the EU-GPARD, Grant reference number: TRYRAC/DCI-FOOD/2011/279-754, and the Department of Economy, Science and Innovation in Flanders, ITM-SOFIB GemiNI.	Bennett R. J., 2014, COLD SPRING HARB PER, V4; BORST P, 1982, MOL BIOCHEM PARASIT, V6, P13, DOI 10.1016/0166-6851(82)90049-4; Caljon G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005744; CLAUSEN PH, 1992, ACTA TROP, V51, P229, DOI 10.1016/0001-706X(92)90041-U; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Elsen P., 1993, REV ZOOL AFRICAINE, V107, P439; Gerstein AC, 2015, MBIO, V6, DOI 10.1128/mBio.01340-15; GIBSON W, 1992, MOL BIOCHEM PARASIT, V51, P189, DOI 10.1016/0166-6851(92)90069-V; Gibson W, 1999, ADV PARASIT, V43, P1, DOI 10.1016/S0065-308X(08)60240-7; GIBSON WC, 1985, MOL BIOCHEM PARASIT, V16, P231, DOI 10.1016/0166-6851(85)90066-0; Gibson W, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-4; Hope M, 1999, MOL BIOCHEM PARASIT, V104, P1, DOI 10.1016/S0166-6851(99)00103-6; Jackson AP, 2012, P NATL ACAD SCI USA, V109, P3416, DOI 10.1073/pnas.1117313109; Leprohon P, 2009, NUCLEIC ACIDS RES, V37, P1387, DOI 10.1093/nar/gkn1069; Lima FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063738; MacLeod A, 2007, SYSTEM GENETIC EXCHA, P2007; Martinez-Calvillo S, 2005, INT J PARASITOL, V35, P419, DOI 10.1016/j.ijpara.2004.12.014; Masumu J, 2009, RES VET SCI, V87, P265, DOI 10.1016/j.rvsc.2009.03.003; Peacock L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-78; Peacock L, 2014, CURR BIOL, V24, P181, DOI 10.1016/j.cub.2013.11.044; Peacock L, 2011, P NATL ACAD SCI USA, V108, P3671, DOI 10.1073/pnas.1019423108; PINDER M, 1984, ACTA TROP, V41, P247; POTAPOVA T, 2017, BIOL BASEL, V6; Rogers MB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004092; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Selmecki AM, 2015, NATURE, V519, P349, DOI 10.1038/nature14187; Souza RT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023042; Tihon E, 2017, MOL ECOL, V26, P6524, DOI 10.1111/mec.14271; Ubeda JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r115	29	1	1	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 10	2017	10								468	10.1186/s13071-017-2406-z				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FJ4GE	WOS:000412693600011	29017575	DOAJ Gold, Green Published			2019-04-02	
J	Ntsambi-Eba, G; Kalubye, AB; Okito, JPK				Ntsambi-Eba, G.; Kalubye, Beltchika A.; Okito, Kalala J. P.			Need for surgical treatment of epilepsy and excision of tumors and posttraumatic epileptogenic lesions in Kinshasa, RDC	MEDECINE ET SANTE TROPICALES			French	Article						epilepsy; presurgical evaluation; developing countries; surgical treatment; DRC	SUB-SAHARAN AFRICA; DEVELOPING-COUNTRIES; ANTIEPILEPTIC DRUGS; SURGERY; EPIDEMIOLOGY; PREVALENCE; SELECTION; SEIZURES; OUTCOMES; WORLD	Surgery is a treatment to consider in epilepsy when the condition is refractory or epileptic events are related to a clearly identified brain abnormality. The tropical climate of the DRC explains the high risk of epilepsy and the potentially large number of refractory cases. The number of patients with epilepsy in Kinshasa is estimated to be at least 120 000, and almost one third may be refractory. Hence, the need to integrate the use of surgery in the treatment of this disease. Most neurosurgical techniques used for treating epilepsy are practiced with a neurosurgical microscope and neuronavigation. In most developing countries, neither the material conditions for optimum realization of these surgical techniques nor the equipment for epilepsy investigation are close to fully available. Nonetheless, the selection of a large number of patients for surgery often does not require the use of all these explorations. The current availability in Kinshasa of the equipment for the basic investigation of epilepsy, such as EEG and MRI instruments, and the experience of the local neurological/neurosurgical team together make it possible to diagnose this pathology and treat it surgically when necessary. The creation of a multidisciplinary team for epilepsy will enable the selection of candidates who can most effectively benefit from surgical treatment. This surgery should focus initially on well circumscribed lesions that do not require sophisticated methods of investigation and can be removed relatively easily, with a high probability of seizure suppression.	[Ntsambi-Eba, G.] Univ Kinshasa, Clin Univ Kinshasa, Serv Neurochirurg, BP 133, Kinshasa, DEM REP CONGO; [Kalubye, Beltchika A.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Okito, Kalala J. P.] Univ Gant, Ghent, Belgium	Ntsambi-Eba, G (reprint author), Univ Kinshasa, Clin Univ Kinshasa, Serv Neurochirurg, BP 133, Kinshasa, DEM REP CONGO.	nebaglen@gmail.com					Almu S, 2006, SEIZURE-EUR J EPILEP, V15, P211, DOI 10.1016/j.seizure.2006.01.004; Asadi-Pooya AA, 2012, INJURY VIOLENCE, V4, P16; Asadi-Pooya AA, 2008, EPILEPSIA, V49, P381, DOI 10.1111/j.1528-1167.2007.01383.x; Ba-Diop A, 2014, LANCET NEUROL, V13, P1029, DOI 10.1016/S1474-4422(14)70114-0; Bano S, 2011, J PEDIATR NEUROSCI, V6, P19, DOI 10.4103/1817-1745.84401; Berg AT, 2003, EPILEPSIA, V44, P1425, DOI 10.1046/j.1528-1157.2003.24203.x; Birbeck G, 2007, LANCET NEUROL, V6, P39, DOI 10.1016/S1474-4422(06)70629-9; Blumcke I, 2014, ACTA NEUROPATHOL, V128, P1, DOI 10.1007/s00401-014-1301-3; Boling W, 2009, EPILEPSIA, V50, P1256, DOI 10.1111/j.1528-1167.2008.01984.x; Chang F, 2011, ANN INDIAN ACAD NEUR, V14, P225, DOI 10.4103/0972-2327.85918; Cherian PJ, 2002, NEUROL INDIA, V50, P11; Engrad N, 2009, REANIMATION, V18, P21; Gallo Dio A, 2003, ACTA TROP, V87, P149; Gavin CA, 2002, MJA, V176, P410; Guenot M, 2004, REV NEUROL-FRANCE, V160, pS185; Hauptman JS, 2012, EPILEPSIA, V53, P98, DOI 10.1111/j.1528-1167.2012.03619.x; Kwan P, 2009, EPILEPSIA, V50, P57, DOI 10.1111/j.1528-1167.2009.02237.x; Mansouri A, 2012, EPILEPSY RES TREAT; MATONDA M N, 2011, ACTA PSYCHIAT BELG, V113, P26; Mirsattari SM, 2011, EPILEPSY RES, V94, P39, DOI 10.1016/j.eplepsyres.2011.01.001; Moulinier MB, 2001, ANN FR ANESTH, V20, P97; Nei M, 2006, EPILEPSIA, V47, P115, DOI 10.1111/j.1528-1167.2006.00377.x; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngoungou E.B., 2006, EPILEPSIES, V18, P25; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Novy J, 2010, Rev Med Suisse, V6, P918; Ntsambi-Eba G, 2013, NEUROSURGERY, V72, P890, DOI 10.1227/NEU.0b013e31828ba750; Nuhu FT, 2012, S AFR J CHILD HEALTH, V6, P132, DOI 10.7196/SAJCH.512; Paul Abigail, 2012, J Glob Health, V2, P020405, DOI 10.7189/jogh.02.020405; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; Ronsenfeld JV, 2002, JR COLL EDINB, V47, P653; Sanyal SK, 2007, NEUROLOGY ASIA S2, V12, P23; Scott RA, 2001, B ORG MONDE SANTE, V5, P80; Sylaja PN, 2003, EPILEPSIA, V44, P48, DOI 10.1046/j.1528-1157.44.s.1.11.x; Tellez-Zenteno JF, 2007, BRAIN, V130, P334, DOI 10.1093/brain/awl316; Unnwongse K, 2010, CURR NEUROL NEUROSCI, V10, P299, DOI 10.1007/s11910-010-0114-6; Velez-Ruiz NJ, 2012, SEMIN NEUROL, V32, P361, DOI 10.1055/s-0032-1331809; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; You G, 2012, NEURO-ONCOLOGY, V14, P230, DOI 10.1093/neuonc/nor205	39	0	0	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	OCT-DEC	2017	27	4					415	420		10.1684/mst.2017.0742				6	Tropical Medicine	Tropical Medicine	FW3UM	WOS:000425236300017	29313510				2019-04-02	
J	Fitzpatrick, C; Asiedu, K; Sands, A; Pena, TG; Marks, M; Mitja, O; Meheus, F; Van der Stuyft, P				Fitzpatrick, Christopher; Asiedu, Kingsley; Sands, Anita; Pena, Tita Gonzalez; Marks, Michael; Mitja, Oriol; Meheus, Filip; Van der Stuyft, Patrick			The cost and cost-effectiveness of rapid testing strategies for yaws diagnosis and surveillance	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SUB-SAHARAN AFRICA; OF-CARE TEST; SYPHILIS	Background Yaws is a non-venereal treponemal infection caused by Treponema pallidum subspecies pertenue. The disease is targeted by WHO for eradication by 2020. Rapid diagnostic tests (RDTs) are envisaged for confirmation of clinical cases during treatment campaigns and for certification of the interruption of transmission. Yaws testing requires both treponemal (trep) and non-treponemal (non-trep) assays for diagnosis of current infection. We evaluate a sequential testing strategy (using a treponemal RDT before a trep/non-trep RDT) in terms of cost and cost-effectiveness, relative to a single-assay combined testing strategy (using the trep/non-trep RDT alone), for two use cases: individual diagnosis and community surveillance. Methods We use cohort decision analysis to examine the diagnostic and cost outcomes. We estimate cost and cost-effectiveness of the alternative testing strategies at different levels of prevalence of past/current infection and current infection under each use case. We take the perspective of the global yaws eradication programme. We calculate the total number of correct diagnoses for each strategy over a range of plausible prevalences. We employ probabilistic sensitivity analysis (PSA) to account for uncertainty and report 95% intervals. Results At current prices of the treponemal and trep/non-trep RDTs, the sequential strategy is cost-saving for individual diagnosis at prevalence of past/current infection less than 85% (81-90); it is cost-saving for surveillance at less than 100%. The threshold price of the trep/non-trep RDT (below which the sequential strategy would no longer be cost-saving) is US$1.08 (1.02-1.14) for individual diagnosis at high prevalence of past/current infection (51%) and US$ 0.54 (0.52-0.56) for community surveillance at low prevalence (15%). Discussion We find that the sequential strategy is cost-saving for both diagnosis and surveillance in most relevant settings. In the absence of evidence assessing relative performance (sensitivity and specificity), cost-effectiveness is uncertain. However, the conditions under which the combined test only strategy might be more cost-effective than the sequential strategy are limited. A cheaper trep/non-trep RDT is needed, costing no more than US$0.5-1.00, depending on the use case. Our results will help enhance the cost-effectiveness of yaws programmes in the 13 countries known to be currently endemic. It will also inform efforts in the much larger group of 71 countries with a history of yaws, many of which will have to undertake surveillance to confirm the interruption of transmission.	[Fitzpatrick, Christopher; Asiedu, Kingsley; Sands, Anita; Pena, Tita Gonzalez] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland; [Pena, Tita Gonzalez] Univ North Carolina Chapel Hill, Dept Chem, Chapel Hill, NC USA; [Marks, Michael] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Clin Res Dept, London, England; [Mitja, Oriol] Univ Barcelona, Barcelona Inst Global Hlth, Hosp Clin, Barcelona, Spain; [Meheus, Filip] Inst Trop Med, Unit Epidemiol & Control Neglected Trop Dis, Antwerp, Belgium; [Meheus, Filip] Int Agcy Res Canc, Prevent & Implementat Grp, Lyon, France; [Van der Stuyft, Patrick] Inst Trop Med, Unit Gen Epidemiol & Dis Control, Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, Ghent, Belgium	Fitzpatrick, C (reprint author), WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland.	fitzpatrickc@who.int	Mitja, Oriol/W-4181-2018	Mitja, Oriol/0000-0003-3266-8868; Marks, Michael/0000-0002-7585-4743; Sands, Anita/0000-0002-8424-754X	Wellcome Trust Clinical Research Fellowship [102807]	MM is supported by a Wellcome Trust Clinical Research Fellowship 102807. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P189; Asiedu K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003016; Ayove T, 2014, LANCET GLOB HEALTH, V2, pE415, DOI 10.1016/S2214-109X(14)70231-1; Cejkova D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001471; Fitzpatrick C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003165; Giacani L, 2014, CLIN MICROBIOL REV, V27, P89, DOI 10.1128/CMR.00070-13; Jafari Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054695; Marks M, 2016, CLIN INFECT DIS, V63, P627, DOI 10.1093/cid/ciw348; Marks M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003988; Marks M, 2015, AM J TROP MED HYG, V92, P129, DOI 10.4269/ajtmh.14-0438; Mitja O, 2016, NEW ENGL J MED, V375, P1094, DOI 10.1056/NEJMc1503442; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P997, DOI 10.1097/OLQ.0b013e3182260987; Owusu-Edusei K, 2011, SEX TRANSM DIS, V38, P448, DOI 10.1097/OLQ.0b013e3182036a0f; R Core Team, 2012, R LANG ENV STAT COMP; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Terris-Prestholt Fern, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS73, DOI 10.1016/j.ijgo.2015.04.007; Vickerman P, 2006, SEX TRANSM INFECT, V82, pV38, DOI 10.1136/sti.2006.021824	17	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2017	11	10							e0005985	10.1371/journal.pntd.0005985				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FL5JJ	WOS:000414271400045	29073145	DOAJ Gold, Green Published, Green Accepted			2019-04-02	
J	N'Djetchi, MK; Ilboudo, H; Koffi, M; Kabore, J; Kabore, JW; Kaba, D; Courtin, F; Coulibaly, B; Fauret, P; Kouakou, LA; Ravel, S; Deborggraeve, S; Solano, P; De Meeus, T; Bucheton, B; Jamonneau, V				N'Djetchi, Martial Kassi; Ilboudo, Hamidou; Koffi, Mathurin; Kabore, Jacques; Kabore, Justin Windingoudi; Kaba, Dramane; Courtin, Fabrice; Coulibaly, Bamoro; Fauret, Pierre; Kouakou, Lingue; Ravel, Sophie; Deborggraeve, Stijn; Solano, Philippe; De Meeus, Thierry; Bucheton, Bruno; Jamonneau, Vincent			The study of trypanosome species circulating in domestic animals in two human African trypanosomiasis foci of Cote d'Ivoire identifies pigs and cattle as potential reservoirs of Trypanosoma brucei gambiense	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SLEEPING SICKNESS FOCUS; APARASITEMIC SEROLOGICAL SUSPECTS; GLOSSINA-PALPALIS-PALPALIS; POLYMERASE-CHAIN-REACTION; TSETSE-FLIES; IVORY-COAST; EQUATORIAL-GUINEA; DNA AMPLIFICATION; BURKINA-FASO; ELIMINATION	Background Important control efforts have led to a significant reduction of the prevalence of human African trypanosomiasis (HAT) in Cote d'Ivoire, but the disease is still present in several foci. The existence of an animal reservoir of Trypanosoma brucei gambiense may explain disease persistence in these foci where animal breeding is an important source of income but where the prevalence of animal African trypanosomiasis (AAT) is unknown. The aim of this study was to identify the trypanosome species circulating in domestic animals in both Bonon and Sinfra HAT endemic foci. Methodology/Principal findings 552 domestic animals (goats, pigs, cattle and sheep) were included. Blood samples were tested for trypanosomes by microscopic observation, species-specific PCR for T. brucei sl, T. congolense, T. vivax and subspecies-specific PCR for T. b. gambiense and T. b. gambiense immune trypanolysis (TL). Infection rates varied significantly between animal species and were by far the highest in pigs (30%). T. brucei s. l was the most prevalent trypanosome species (13.7%) followed by T. congolense. No T. b. gambiense was identified by PCR while high TL positivity rates were observed using T. b. gambiense specific variants (up to 27.6% for pigs in the Bonon focus). Conclusion This study shows that domestic animals are highly infected by trypanosomes in the studied foci. This was particularly true for pigs, possibly due to a higher exposure of these animals to tsetse flies. Whereas T. brucei s.l. was the most prevalent species, discordant results were obtained between PCR and TL regarding T. b. gambiense identification. It is therefore crucial to develop better tools to study the epidemiological role of potential animal reservoir for T. b. gambiense. Our study illustrates the importance of "one health" approaches to reach HAT elimination and contribute to AAT control in the studied foci.	[N'Djetchi, Martial Kassi; Koffi, Mathurin] Univ Jean Lorougnon Guede, Unite Format & Rech Environm, Lab Interact Hote Microorganisme Environm & Evolu, Daloa, Cote Ivoire; [Ilboudo, Hamidou; Kabore, Jacques; Kabore, Justin Windingoudi] Ctr Int Rech Dev Elevage Zone Subhumide, Unite Rech Bases Biol Lutte Integree, Bobo Dioulasso, Burkina Faso; [Kabore, Jacques] Univ Nazi Boni, Unite Format & Rech Sci & Tech, Bobo Dioulasso, Burkina Faso; [Kaba, Dramane; Courtin, Fabrice; Coulibaly, Bamoro; Fauret, Pierre; Jamonneau, Vincent] Inst Pierre Richet, Unite Rech Trypanosomoses, Bouake, Cote Ivoire; [Courtin, Fabrice; Fauret, Pierre; Ravel, Sophie; Solano, Philippe; De Meeus, Thierry; Bucheton, Bruno; Jamonneau, Vincent] IRD, INTERTRYP, Unite Mixte Rech IRD CIRAD 177, Montpellier, France; [Kouakou, Lingue] Minist Sante & Hyg Publ, Programme Natl Eliminat Trypanosomose Humaine Afr, Abidjan, Cote Ivoire; [Deborggraeve, Stijn] Inst Trop Med, Biomed Sci Dept, Antwerp, Belgium	Jamonneau, V (reprint author), Inst Pierre Richet, Unite Rech Trypanosomoses, Bouake, Cote Ivoire.; Jamonneau, V (reprint author), IRD, INTERTRYP, Unite Mixte Rech IRD CIRAD 177, Montpellier, France.	Vincent.jamonneau@ird.fr	Jamonneau, Vincent/K-1124-2016	Jamonneau, Vincent/0000-0001-8427-0769; solano, philippe/0000-0002-4351-3506; Deborggraeve, Stijn/0000-0003-1501-5355; ILBOUDO, Hamidou/0000-0003-3936-7718; KABORE, Windingoudi Justin/0000-0002-1865-813X	Programme d'Appui a l'Enseignement superieur/Union Economique et Monetaire Ouest Africaine; Word Health Organization (WHO) - Institut de Recherche pour le Developpement (IRD) collaborative project; "Jeunes Equipes AIRD" JEAI program (ERHATryp project)	This study was funded by Programme d'Appui a l'Enseignement superieur/Union Economique et Monetaire Ouest Africaine (http://www.uemoa.int/) to MK. This study also received support from a Word Health Organization (WHO) - Institut de Recherche pour le Developpement (IRD) collaborative project to VJ. MK, DK, HI, and JK are supported by the "Jeunes Equipes AIRD" JEAI program (ERHATryp project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, CAHIERS ORSTOMSERIE; [Anonymous], 2003, LUTTE MALADIE SOMMEI; [Anonymous], 2015, MONITORING PROGR ELI, DOI DOI 10.1371/J0URNAL.PNTD.0003785; Balyeidhusa ASP, 2012, VET PARASITOL, V187, P157, DOI 10.1016/j.vetpar.2011.12.005; Bengaly Z, 2002, VET PARASITOL, V108, P1, DOI 10.1016/S0304-4017(02)00164-4; Berberof M, 2001, MOL BIOCHEM PARASIT, V113, P127, DOI 10.1016/S0166-6851(01)00208-0; Biteau N, 2000, MOL BIOCHEM PARASIT, V105, P185, DOI 10.1016/S0166-6851(99)00171-1; BROMIDGE T, 1993, ACTA TROP, V53, P107, DOI 10.1016/0001-706X(93)90023-5; Caljon G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005744; Capewell P., 2016, ELIFE, V5; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233; Cordon-Obras C, 2009, TROP MED INT HEALTH, V14, P535, DOI 10.1111/j.1365-3156.2009.02271.x; Cordon-Obras C, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00765; Cordon-Obras C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000704; Courtin Fabrice, 2005, Int J Health Geogr, V4, P27, DOI 10.1186/1476-072X-4-27; Deborggraeve S, 2012, EXPERT REV MOL DIAGN, V12, P719, DOI [10.1586/erm.12.72, 10.1586/ERM.12.72]; Deborggraeve S, 2010, LANCET INFECT DIS, V10, P433, DOI 10.1016/S1473-3099(10)70077-3; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dje NN, 2003, B SOC PATHOL EXOT, V95, P359; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Funk S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002855; GOUTEUX JP, 1985, ANN PARASIT HUM COMP, V60, P329, DOI 10.1051/parasite/1985603329; Hoare C.A., 1972, ZOOLOGICAL MONOGRAPH, P749; Jamonneau V, 2004, PARASITOLOGY, V129, P693, DOI 10.1017/S0031182004005876; Jamonneau V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000917; Kaba D, 2006, TROP MED INT HEALTH, V11, P136, DOI 10.1111/j.1365-3156.2005.01549.x; Kabore J, 2013, INFECT GENET EVOL, V20, P171, DOI 10.1016/j.meegid.2013.08.006; Kabore J, 2011, INFECT GENET EVOL, V11, P1250, DOI 10.1016/j.meegid.2011.04.014; Kagbadouno M, 2009, PARASITE, V16, P29, DOI 10.1051/parasite/2009161029; Kagbadouno MS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001949; Kambire R, 2012, PARASITE, V19, P389, DOI 10.1051/parasite/2012194389; Kiendrebeogo D, 2012, PARASITE, V19, P397, DOI 10.1051/parasite/2012194397; Koffi M, 2006, ACTA TROP, V98, P183, DOI 10.1016/j.actatropica.2006.04.001; Koffi M., 2014, Journal of Applied Biosciences, V83, P7570; Koffi M, 2009, P NATL ACAD SCI USA, V106, P209, DOI 10.1073/pnas.0811080106; Koffi M, 2007, INFECT GENET EVOL, V7, P675, DOI 10.1016/j.meegid.2007.07.001; Koffi M, 2016, PARASITE, V23, DOI 10.1051/parasite/2016059; LAVEISSIERE C, 1985, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V23, P297; Laveissiere C, 2003, LUTTE MALADIE SOMMEI; Lehane M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004437; MacLeod A, 2005, NUCLEIC ACIDS RES, V33, P6688, DOI 10.1093/nar/gki980; MAJIWA PAO, 1994, PARASITOLOGY, V108, P313, DOI 10.1017/S0031182000076150; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; MEHLITZ D, 1985, TROP MED PARASITOL, V36, P18; Molyneux D H, 1973, Ann Soc Belg Med Trop, V53, P605; MOSER DR, 1989, PARASITOLOGY, V99, P57, DOI 10.1017/S0031182000061023; MURRAY M, 1977, T ROY SOC TROP MED H, V71, P325, DOI 10.1016/0035-9203(77)90110-9; Nimpaye H, 2011, PARASITE, V18, P171, DOI 10.1051/parasite/2011182171; Njiokou F, 2006, INFECT GENET EVOL, V6, P147, DOI 10.1016/j.meegid.2005.04.003; Njiokou F, 2010, PARASITE, V17, P61, DOI 10.1051/parasite/2010171061; Njitchouang GR, 2011, MED VET ENTOMOL, V25, P289, DOI 10.1111/j.1365-2915.2010.00936.x; NOIREAU F, 1989, TROP MED PARASITOL, V40, P9; Radwanska M, 2002, AM J TROP MED HYG, V67, P289, DOI 10.4269/ajtmh.2002.67.289; Ravel S, 2007, INFECT GENET EVOL, V7, P116, DOI 10.1016/j.meegid.2006.07.002; Ravel S, 2015, FOLIA PARASIT, V62, DOI 10.14411/fp.2015.044; Rayaisse JB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001332; RUIZ JP, 2015, PARASIT VECTORS, V8; Sane B, 2000, TROP MED INT HEALTH, V5, P73, DOI 10.1046/j.1365-3156.2000.00488.x; Simarro PP, 2013, RES REP TROP MED, V4, P1, DOI 10.2147/RRTM.S40157; Simarro PP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003785; Simo G, 2008, INFECT GENET EVOL, V8, P34, DOI 10.1016/j.meegid.2007.09.005; Simo G, 2006, VET PARASITOL, V139, P57, DOI 10.1016/j.vetpar.2006.02.026; Simo G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1254-y; Simukoko H, 2007, VET PARASITOL, V147, P231, DOI 10.1016/j.vetpar.2007.04.005; Takezaki N, 1996, GENETICS, V144, P389; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trindade S, 2016, CELL HOST MICROBE, V19, P837, DOI 10.1016/j.chom.2016.05.002; VanMeirvenne N, 1995, ACTA TROP, V60, P189, DOI 10.1016/0001-706X(95)00127-Z; Welburn SC, 2006, TRENDS PARASITOL, V22, P123, DOI 10.1016/j.pt.2006.01.011; WHO, 2016, LOW CAS REC WORLD PR	71	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2017	11	10							e0005993	10.1371/journal.pntd.0005993				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FL5JJ	WOS:000414271400051	29045405	DOAJ Gold, Green Published			2019-04-02	
J	Vergote, V; Laenen, L; Vanmechelen, B; Van Ranst, M; Verbeken, E; Hooper, JW; Maes, P				Vergote, Valentijn; Laenen, Lies; Vanmechelen, Bert; Van Ranst, Marc; Verbeken, Erik; Hooper, Jay W.; Maes, Piet			A lethal disease model for New World hantaviruses using immunosuppressed Syrian hamsters	PLOS NEGLECTED TROPICAL DISEASES			English	Article							PULMONARY SYNDROME; HEMORRHAGIC-FEVER; DENSITY-LIPOPROTEINS; NUCLEOCAPSID PROTEIN; VIRUS-INFECTION; GOLDEN-HAMSTER; ACTIVATION; MODULATION; RESPONSES; CELLS	Background Hantavirus, the hemorrhagic causative agent of two clinical diseases, is found worldwide with variation in severity, incidence and mortality. The most lethal hantaviruses are found on the American continent where the most prevalent viruses like Andes virus and Sin Nombre virus are known to cause hantavirus pulmonary syndrome. New World hantavirus infection of immunocompetent hamsters results in an asymptomatic infection except for Andes virus and Maporal virus; the only hantaviruses causing a lethal disease in immunocompetent Syrian hamsters mimicking hantavirus pulmonary syndrome in humans. Methodology/Principal findings Hamsters, immunosuppressed with dexamethasone and cyclophosphamide, were infected intramuscularly with different New World hantavirus strains (Bayou virus, Black Creek Canal virus, Cano Delgadito virus, Choclo virus, Laguna Negra virus, and Maporal virus). In the present study, we show that immunosuppression of hamsters followed by infection with a New World hantavirus results in an acute disease that precisely mimics both hantavirus disease in humans and Andes virus infection of hamsters. Conclusions/Significance Infected hamsters showed specific clinical signs of disease and moreover, histological analysis of lung tissue showed signs of pulmonary edema and inflammation within alveolar septa. In this study, we were able to infect immunosuppressed hamsters with different New World hantaviruses reaching a lethal outcome with signs of disease mimicking human disease. Author summary Hemorrhagic fever viruses have become of much greater importance in recent years. The more prominent presence of these viruses in a day-to-day setting and their impact on global health has had a positive impact on studying these viruses. Resolving their disease mechanisms and ways to intervene in their replication and associated health burden will stay a challenge for the upcoming decades. This challenge also counts for hantavirus, an emerging zoonosis. No vaccine or antiviral treatment is WHO prequalifled or has shown to elicit a good protective or therapeutic antiviral response in humans. One of the main reasons is the lack of good animal disease models and the research focusing on this topic. Without a representative model, it is difficult to investigate new potential drugs. Within this setting we focused on establishing a disease model for the most prominent New World hantaviruses.	[Vergote, Valentijn; Laenen, Lies; Vanmechelen, Bert; Van Ranst, Marc; Maes, Piet] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Lab Clin Virol, Zoonot Infect Dis Unit, Leuven, Belgium; [Verbeken, Erik] KU Leuven Univ Leuven, Dept Imaging & Pathol, Translat Cell & Tissue Res, Leuven, Belgium; [Hooper, Jay W.] US Army, Med Res Inst Infect Dis, Dept Mol Virol, Virol Div, Ft Detrick, MD 21702 USA	Maes, P (reprint author), KU Leuven Univ Leuven, Dept Microbiol & Immunol, Lab Clin Virol, Zoonot Infect Dis Unit, Leuven, Belgium.	piet.maes@kuleuven.be	Vergote, Valentijn/F-5831-2018; Laenen, Lies/F-7864-2018; Ucar, Abdullah/P-8329-2017; Van Ranst, Marc/P-7522-2017; Maes, Piet/P-7782-2017; Vanmechelen, Bert/E-7680-2018	Vergote, Valentijn/0000-0002-4436-3212; Laenen, Lies/0000-0001-9118-8608; Van Ranst, Marc/0000-0002-1674-4157; Maes, Piet/0000-0002-4571-5232; Vanmechelen, Bert/0000-0002-8350-4356	KU LEUVEN grant [CREA/11/027]; Military Infectious Disease Research Program; Program Area T	This project was funded in part by KU LEUVEN grant CREA/11/027 awarded to PM (www.kuleuven.be/english/research). JWH is partially funded by Military Infectious Disease Research Program, Program Area T (midrib.amedd.army.mil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avsic-Zupanc T, 2015, CLIN MICROBIOL INFEC; Brocato RL, 2014, J VIROL, V88, P811, DOI 10.1128/JVI.02906-13; Buys Kristin K., 2011, Antiviral Chemistry & Chemotherapy, V21, P193, DOI 10.3851/IMP1729; Chiang CF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164768; Chyu KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092095; Cimica V, 2014, MBIO, V5, DOI 10.1128/mBio.01088-13; Clement J, 2012, EUR J CLIN MICROBIOL, V31, P1, DOI 10.1007/s10096-011-1456-y; CUTHBERT JA, 1984, P NATL ACAD SCI-BIOL, V81, P4539, DOI 10.1073/pnas.81.14.4539; CUTHBERT JA, 1986, J BIOL CHEM, V261, P3620; De Palma AM, 2009, J PATHOL, V217, P633, DOI 10.1002/path.2501; DUCHIN JS, 1994, NEW ENGL J MED, V330, P949, DOI 10.1056/NEJM199404073301401; Dutta D, 2012, CELL LOGIST, V2, P203, DOI DOI 10.4161/CL.23967; Eyzaguirre EJ, 2008, AM J TROP MED HYG, V78, P669, DOI 10.4269/ajtmh.2008.78.669; Gack MU, 2014, J VIROL, V88, P5213, DOI 10.1128/JVI.03370-13; Golden JW, 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/793257; Gorbunova EE, 2016, MBIO, V7, DOI 10.1128/mBio.01747-16; Gowen BB, 2017, J MICROBIOL, V55, P183, DOI 10.1007/s12275-017-7029-8; Hammerbeck CD, 2011, J VIROL, V85, P9929, DOI 10.1128/JVI.05356-11; Hardcastle K, 2016, VET PATHOL, V53, P182, DOI 10.1177/0300985815570071; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hooper JW, 2001, VIROLOGY, V289, P6, DOI 10.1006/viro.2001.1133; Kang HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006149; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; Laenen L, 2016, MOL ECOL, V25, P5994, DOI 10.1111/mec.13887; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; LEVY H, 1994, AM J RESP CRIT CARE, V149, P1710, DOI 10.1164/ajrccm.149.6.8004332; Maes P, 2004, VIRAL IMMUNOL, V17, P315, DOI 10.1089/0882824041310540; Milazzo ML, 2002, J INFECT DIS, V186, P1390, DOI 10.1086/344735; MORZUNOV SP, 1995, J VIROL, V69, P1980; NIKLASSON B, 1991, AM J TROP MED HYG, V45, P660, DOI 10.4269/ajtmh.1991.45.660; Ogg M, 2013, VIRUSES-BASEL, V5, P2704, DOI 10.3390/v5112704; Pan W, 2015, VIRAL IMMUNOL, V28, P448, DOI 10.1089/vim.2015.0004; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; Prescott J, 2013, IMMUNOLOGY, V140, P168, DOI 10.1111/imm.12116; Rang A, 2010, CRIT REV IMMUNOL, V30, P515, DOI 10.1615/CritRevImmunol.v30.i6.20; RAVKOV EV, 1995, VIROLOGY, V210, P482, DOI 10.1006/viro.1995.1366; Safronetz D, 2013, ANTIMICROB AGENTS CH, V57, P4673, DOI 10.1128/AAC.00886-13; Simpson SQ, 2010, INFECT DIS CLIN N AM, V24, P159, DOI 10.1016/j.idc.2009.10.011; Song JW, 2007, EMERG INFECT DIS, V13, P980, DOI 10.3201/eid1307.070031; Weiss S, 2012, EMERG INFECT DIS, V18, P159, DOI 10.3201/eid1801.111026; Witkowski PT, 2016, VIROLOGY, V493, P189, DOI 10.1016/j.virol.2016.03.018; Yoneyama M, 2007, CYTOKINE GROWTH F R, V18, P545, DOI 10.1016/j.cytogfr.2007.06.023	42	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2017	11	10							e0006042	10.1371/journal.pntd.0006042				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FL5JJ	WOS:000414271400078	29077702	DOAJ Gold, Green Published			2019-04-02	
J	Hinckel, BCB; Marlais, T; Airs, S; Imamura, H; Dujardin, JC; Falconar, AK; Bhattacharyya, T; Andersson, B; Mertens, P; Miles, MA				Hinckel, B. C. Bremer; Marlais, T.; Airs, S.; Imamura, H.; Dujardin, J. C.; Falconar, A. K.; Bhattacharyya, T.; Andersson, B.; Mertens, P.; Miles, M. A.			Visceral leishmaniasis: a combined wet-lab and in silico approach to the discovery of biomarkers of disease progression and post-chemotherapy relapse	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hinckel, B. C. Bremer] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Hinckel, B. C. Bremer; Mertens, P.] Coris BioConcept, Gembloux, Belgium; [Marlais, T.; Airs, S.; Miles, M. A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Imamura, H.; Dujardin, J. C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Falconar, A. K.] Univ Norte, Dept Med, Barranquilla, Colombia; [Andersson, B.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S1.4	3	3		10.1111/tmi.12985				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900005		Bronze			2019-04-02	
J	Kuhne, V; Diro, E; El-Safi, S; Buscher, P				Kuhne, V.; Diro, E.; El-Safi, S.; Buscher, P.			Finding Mimo: Developing an alternative rapid test for the serodiagnosis of visceral leishmaniasis in Eastern African populations	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kuhne, V.; Buscher, P.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Diro, E.] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [El-Safi, S.] Univ Khartoum, Fac Med, Khartoum, Sudan					European Union's H2020 Programme under the MSCA GA [642609]	This research is funded by the European Union's H2020 Programme under the MSCA GA no. 642609.		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S1.3	3	3		10.1111/tmi.12984				1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900004		Bronze			2019-04-02	
J	Serra-Casas, E; Manrique, P; Ding, XC; Carrasco, G; Alava, F; Gave, A; Contreras, JJ; Rosas-Aguirre, A; Gonzalez, IJ; Gamboa, D; Rosanas-Urgell, A				Serra-Casas, E.; Manrique, P.; Ding, X. C.; Carrasco, G.; Alava, F.; Gave, A.; Contreras, J. J.; Rosas-Aguirre, A.; Gonzalez, I. J.; Gamboa, D.; Rosanas-Urgell, A.			Loop-mediated isothermal amplification for asymptomatic malaria diagnosis in the Peruvian Amazon: technical performance and pilot implementation in challenging field settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Serra-Casas, E.; Rosanas-Urgell, A.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Manrique, P.; Carrasco, G.; Alava, F.; Gave, A.; Contreras, J. J.; Gamboa, D.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, LID, Lima, Peru; [Ding, X. C.; Gonzalez, I. J.] FIND, Geneva, Switzerland; [Rosas-Aguirre, A.; Gamboa, D.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Gamboa, D.] Univ Peruana Cayetano Heredia, Dept Ciencias Celulares & Mol, Fac Ciencias & Filosofia, Lima, Peru								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S2.2	4	4						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900007					2019-04-02	
J	Tadesse, M; Abebe, G; de Rijk, P; Meehan, C; de Jong, BC; Rigouts, L				Tadesse, M.; Abebe, G.; de Rijk, P.; Meehan, C.; de Jong, B. C.; Rigouts, L.			Revealing the genetic diversity of mycobacterium tuberculosis strains causing tuberculous lymphadenitis in southwest Ethiopia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Tadesse, M.; Abebe, G.] Jimma Univ, Mycobacteriol Res Ctr, Jimma, Ethiopia; [Tadesse, M.; Rigouts, L.] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [de Rijk, P.; Meehan, C.; de Jong, B. C.; Rigouts, L.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S3.4	7	7						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900013					2019-04-02	
J	Eddyani, M; Vandelannoote, K; Meehan, C; Affolabi, D; Aguiar, J; Marion, E; Sopoh, G; Portaels, F; de Jong, BC; Stinear, T				Eddyani, M.; Vandelannoote, K.; Meehan, C.; Affolabi, D.; Aguiar, J.; Marion, E.; Sopoh, G.; Portaels, F.; de Jong, B. C.; Stinear, T.			Micro-epidemiological approach to understanding transmission dynamics of Mycobacterium ulcerans in the Oueme river valley in southern Benin	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Eddyani, M.; Vandelannoote, K.; Meehan, C.; Portaels, F.; de Jong, B. C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Affolabi, D.] Lab Reference Mycobacteries, Cotonou, Benin; [Aguiar, J.] Ctr Depistage & Traitement Ulcere Buruli Gbemotin, Zagnanado, Benin; [Marion, E.] Univ Angers, Angers, France; [Sopoh, G.] Ctr Depistage & Traitement Ulcere Buruli, Allada, Benin; [Stinear, T.] Univ Melbourne, Melbourne, Vic, Australia								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S4.1	8	8						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900015					2019-04-02	
J	Cuypers, L; Libin, P; Abecasis, A; Vandamme, AM; Theys, K				Cuypers, L.; Libin, P.; Abecasis, A.; Vandamme, A. -M.; Theys, K.			Zika virus genetic diversity and selective pressure: importance for diagnostics, vaccines and therapeutics	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cuypers, L.; Libin, P.; Vandamme, A. -M.; Theys, K.] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium; [Libin, P.] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium; [Abecasis, A.; Vandamme, A. -M.] Univ Nova Lisboa, Inst Hyg & Trop Med, Ctr Global Hlth & Trop Med, Lisbon, Portugal			Abecasis, Ana/B-6295-2009; Vandamme, Anne-Mieke/I-4127-2012	Abecasis, Ana/0000-0002-3903-5265; Vandamme, Anne-Mieke/0000-0002-6594-2766				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S4.3	9	9						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900017					2019-04-02	
J	Domagalska, MA; Imamura, H; Sanders, M; Rijal, S; Berriman, M; Cotton, J; Dujardin, JC				Domagalska, M. A.; Imamura, H.; Sanders, M.; Rijal, S.; Berriman, M.; Cotton, J.; Dujardin, J. -C.			Direct sequencing of Leishmania genome in clinical samples	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Domagalska, M. A.; Imamura, H.; Dujardin, J. -C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Sanders, M.; Berriman, M.; Cotton, J.] Wellcome Trust Sanger Inst, Hinxton, England; [Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Dujardin, J. -C.] Univ Antwerp, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S4.4	9	9						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900018					2019-04-02	
J	Dallmeier, K; Mishra, N; Marques, RE; Ae-Choi, J; Kum, DB; Felipe, LS; Julander, JG; Neyts, J				Dallmeier, K.; Mishra, N.; Marques, R. E.; Ae-Choi, J.; Kum, D. B.; Felipe, L. Sanchez; Julander, J. G.; Neyts, J.			Efficient immunization and full protection from lethal challenge by PLLAV-YF17D, a novel thermostable and readily scalable plasmid-launched life-attenuated yellow fever vaccine candidate produced in E. coli	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dallmeier, K.; Mishra, N.; Marques, R. E.; Kum, D. B.; Felipe, L. Sanchez; Neyts, J.] KU Leuven Univ Leuven, Rega Inst, Leuven, Belgium; [Marques, R. E.] Lab Nacl Biociencias, Campinas, SP, Brazil; [Ae-Choi, J.; Julander, J. G.] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA			Neyts, Johan/U-8267-2017	Neyts, Johan/0000-0002-0033-7514				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S5.1	10	10						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900019					2019-04-02	
J	Schmid, MA; Mishra, N; Neyts, J; Dallmeier, K				Schmid, M. A.; Mishra, N.; Neyts, J.; Dallmeier, K.			Dendritic cells, macophages, and fibroblasts are the initial targets for replication of the live-attenuated yellow fever vaccine in the dermis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Schmid, M. A.; Mishra, N.; Neyts, J.; Dallmeier, K.] KU Leuven Univ Leuven, Rega Inst Med Res, Dept Immunol & Microbiol, Virol & Chemotherapy, Leuven, Belgium			Neyts, Johan/U-8267-2017	Neyts, Johan/0000-0002-0033-7514				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S5.2	10	10						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900020					2019-04-02	
J	Abdelnabi, R; Jochmans, D; Verbeken, E; Delang, L; Neyts, J				Abdelnabi, R.; Jochmans, D.; Verbeken, E.; Delang, L.; Neyts, J.			Antiviral treatment efficiently inhibits Chikungunya virus replication in the joints of mice during the acute but not during the chronic phase of infection	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Abdelnabi, R.; Jochmans, D.; Delang, L.; Neyts, J.] Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Lab Virol & Chemotherapy, Leuven, Belgium; [Verbeken, E.] Univ Leuven, Leuven, Belgium; [Verbeken, E.] Leuven Univ Hosp, Dept Pathol, Leuven, Belgium			Delang, Leen/D-9548-2018; Neyts, Johan/U-8267-2017	Delang, Leen/0000-0002-8874-675X; Neyts, Johan/0000-0002-0033-7514			Hawman DW, 2013, J VIROL, V87, P13878, DOI 10.1128/JVI.02666-13	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1S6.4	13	13						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900027					2019-04-02	
J	Delang, L; Yen, P; Vazeille, M; Neyts, J; Failloux, A				Delang, L.; Yen, P.; Vazeille, M.; Neyts, J.; Failloux, A.			Antiviral drug-resistant Chikungunya viruses can be transmitted by their mosquito vectors	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Delang, L.; Neyts, J.] Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Yen, P.; Vazeille, M.; Failloux, A.] Inst Pasteur, Dept Virol, URE Arboviruses & Insect Vectors, Paris, France			Delang, Leen/D-9548-2018; Neyts, Johan/U-8267-2017	Delang, Leen/0000-0002-8874-675X; Neyts, Johan/0000-0002-0033-7514				0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S2.1	15	16						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900033					2019-04-02	
J	Jansen, F; Berkvens, N; Deblauwe, I; Van Loo, T; Casteels, H; Witters, J; Van Damme, V; Berkvens, D				Jansen, F.; Berkvens, N.; Deblauwe, I.; Van Loo, T.; Casteels, H.; Witters, J.; Van Damme, V.; Berkvens, D.			HarmVect: A simulation based tool for pathway risk maps of invasive arthropods in Belgium - Case study: Aedes albopictus	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jansen, F.; Deblauwe, I.; Van Loo, T.; Berkvens, D.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Berkvens, N.; Casteels, H.; Witters, J.; Van Damme, V.] Inst Agr & Fisheries Res, Crop Protect Unit, Merelbeke, Belgium; [Berkvens, D.] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Ghent, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S2.2	16	16						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900034					2019-04-02	
J	Dao, T; Nguyen, T; Dermauw, V; Gabriel, S; Dorny, P				Dao, T.; Nguyen, T.; Dermauw, V.; Gabriel, S.; Dorny, P.			Opisthorchis viverrini and a novel sister species in ducks share the same intermediate snail and fish hosts in Central Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dao, T.; Nguyen, T.] Natl Inst Vet Res, Dept Parasitol, Hanoi, Vietnam; [Dao, T.; Dermauw, V.; Dorny, P.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Dao, T.; Gabriel, S.; Dorny, P.] Univ Ghent, Vet Med, Ghent, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S3.1	17	18						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900038					2019-04-02	
J	Deblauwe, I; Demeulemeester, J; Sohier, C; Van Loo, T; De Witte, J; Madder, M; Coosemans, M				Deblauwe, I.; Demeulemeester, J.; Sohier, C.; Van Loo, T.; De Witte, J.; Madder, M.; Coosemans, M.			Invasive mosquito species surveillance in Belgium: towards a structural plan	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Deblauwe, I.; Demeulemeester, J.; Van Loo, T.; De Witte, J.; Coosemans, M.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Sohier, C.] CODA CERVA, Brussels, Belgium; [Madder, M.] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa; [Madder, M.] Clinglobal, Oosterhout, Netherlands								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S2.4	17	17						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900036					2019-04-02	
J	Meurs, L; Mbow, M; Vereecken, K; Van den Broeck, F; Mpabanzi, L; Boon, N; Huyse, T; Polman, K				Meurs, L.; Mbow, M.; Vereecken, K.; Van den Broeck, F.; Mpabanzi, L.; Boon, N.; Huyse, T.; Polman, K.			Dynamics of S. haematobium and s. mansoni infection and morbidity: an eight-year follow-up study in a rural community in the north of Senegal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Meurs, L.; Vereecken, K.; Van den Broeck, F.; Mpabanzi, L.; Boon, N.; Huyse, T.; Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Mbow, M.] Aristide le Dantec Univ Hosp, Lab Bacteriol & Virol, Dept Immunol, Dakar, Senegal; [Boon, N.; Huyse, T.] Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [Huyse, T.] Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2S3.3	18	19						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900040					2019-04-02	
J	Cnops, L; Nakayama, EE; Caron, E; Eggermont, K; Van Esbroeck, M; Bottieau, E; Jacobs, J; Shioda, T; Huits, R				Cnops, L.; Nakayama, E. E.; Caron, E.; Eggermont, K.; Van Esbroeck, M.; Bottieau, E.; Jacobs, J.; Shioda, T.; Huits, R.			Detection of zika virus NS1 antigen in semen by a prototype rapid test	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cnops, L.; Caron, E.; Eggermont, K.; Van Esbroeck, M.; Bottieau, E.; Jacobs, J.; Huits, R.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Nakayama, E. E.; Shioda, T.] Osaka Univ, Microbial Dis Res Inst, MOCID, Osaka, Japan								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S1.3	27	27						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900062					2019-04-02	
J	Huits, R; De Kort, J; Van den Berg, R; Chong, L; Eggermont, K; Arien, K; Cnops, L; Jacobs, J; Van Esbroeck, M; Bottieau, E				Huits, R.; De Kort, J.; Van den Berg, R.; Chong, L.; Eggermont, K.; Arien, K.; Cnops, L.; Jacobs, J.; Van Esbroeck, M.; Bottieau, E.			Clinical features of Chikungunya infection and chronic polyarthralgia after the 2014-2015 outbreak on Aruba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Huits, R.; Eggermont, K.; Cnops, L.; Jacobs, J.; Van Esbroeck, M.; Bottieau, E.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [De Kort, J.] Horacio Oduber Hosp, Oranjestad, Aruba; [Van den Berg, R.; Chong, L.] Landslab Aruba, Oranjestad, Aruba; [Arien, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Jacobs, J.] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S1.2	27	27						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900061					2019-04-02	
J	Caluwaerts, S; Axelle, R; Daphne, L; Annick, A				Caluwaerts, S.; Axelle, R.; Daphne, L.; Annick, A.		Ebola Invest Platform	Inclusion of pregnant women in Ebola clinical trials	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Caluwaerts, S.; Axelle, R.; Daphne, L.; Annick, A.] Medecins Sans Frontieres, Dept Med, Brussels, Belgium; [Caluwaerts, S.] Inst Trop Med, Antwerp, Belgium; [Ebola Invest Platform] Medecins Sans Frontieres, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S2.2	29	30						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900067					2019-04-02	
J	Huits, R; Van den Bossche, D; Feyen, A; Potters, I; Lotgering, E; Eggermont, K; Cnops, L; Jacobs, J; Van Esbroeck, M; Bottieau, E				Huits, R.; Van den Bossche, D.; Feyen, A.; Potters, I.; Lotgering, E.; Eggermont, K.; Cnops, L.; Jacobs, J.; Van Esbroeck, M.; Bottieau, E.			Incidence of travel-associated zika virus infection in 2016: preliminary results of a prospective cohort study in Belgian travellers to the Americas	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Huits, R.; Van den Bossche, D.; Feyen, A.; Potters, I.; Lotgering, E.; Eggermont, K.; Cnops, L.; Jacobs, J.; Van Esbroeck, M.; Bottieau, E.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, J.] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S1.6	29	29						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900065					2019-04-02	
J	Verdonck, K; Mukendi, D; Barbe, B; Arien, K; Yansouni, CP; Lutumba, P; Boelaert, M; Chappuis, F; Muyembe, JJ; Bottieau, E				Verdonck, K.; Mukendi, D.; Barbe, B.; Arien, K.; Yansouni, C. P.; Lutumba, P.; Boelaert, M.; Chappuis, F.; Muyembe, J. J.; Bottieau, E.			Human T-Lymphotropic virus 1 and 2 infections among patients with neurological disorders in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Verdonck, K.; Barbe, B.; Arien, K.; Boelaert, M.; Bottieau, E.] Inst Trop Med, Antwerp, Belgium; [Mukendi, D.; Lutumba, P.; Muyembe, J. J.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mukendi, D.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Yansouni, C. P.] McGill Univ, Ctr Hlth, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S2.3	30	30						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900068					2019-04-02	
J	Schwartz, IS; Kenyon, CR; Claasens, S; Spengane, Z; Lehloenya, R; Prozesky, HW; Colebunders, R; Dlamini, S				Schwartz, I. S.; Kenyon, C. R.; Claasens, S.; Spengane, Z.; Lehloenya, R.; Prozesky, H. W.; Colebunders, R.; Dlamini, S.			AIDS-related systemic mycoses endemic to Western Cape, South Africa and clinical mimics: a cross-sectional study of adults with advanced HIV and recent-onset, widespread skin lesions	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Schwartz, I. S.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Fac Med & Hlth Sci, Antwerp, Belgium; [Schwartz, I. S.] Univ Manitoba, Dept Med Microbiol, Max Rady Coll Med, Winnipeg, MB, Canada; [Kenyon, C. R.; Spengane, Z.; Lehloenya, R.; Dlamini, S.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Kenyon, C. R.] Inst Trop Med, Sexually Transmitted Infect Unit, Antwerp, Belgium; [Claasens, S.; Prozesky, H. W.] Stellenbosch Univ, Dept Med, Cape Town, South Africa							Schwartz IS, 2015, CLIN INFECT DIS, V61, P1004, DOI 10.1093/cid/civ439	1	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S2.6	31	31						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900071					2019-04-02	
J	Annette, E; Veronica, SC; Christopher, D; Angel, R; Jean-Pierre, VG; Anna, R; Niko, S; Dioni, G; Umberto, D; Alejandro, L				Annette, E.; Veronica, S. -C.; Christopher, D.; Angel, R.; Jean-Pierre, V. G.; Anna, R.; Niko, S.; Dioni, G.; Umberto, D.; Alejandro, L.			P. vivax recurrences after radical treatment in the Peruvian Amazon: a 2-year cohort study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Annette, E.; Anna, R.] Inst Trop Med, Antwerp, Belgium; [Veronica, S. -C.; Christopher, D.; Angel, R.; Dioni, G.; Alejandro, L.] Univ Peruana Cayetano Heredia, Lima, Peru; [Christopher, D.; Jean-Pierre, V. G.] Univ Antwerp, Antwerp, Belgium; [Angel, R.; Niko, S.] Catholic Univ Louvain, Louvain, Belgium; Minist Salud, Direcc Reg Salud Loreto, Lima, Peru; [Umberto, D.] MRC Unit, Fajara, Gambia								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S3.2	32	32						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900073					2019-04-02	
J	Thanh, PV; Hong, NV; Xa, NX; Van, NV; Cleves, MA; Duong, TT; Xuan, HL; Anna, RU; Umberto, D; Niko, S; Annette, E				Thanh, P. V.; Hong, N. V.; Xa, N. X.; Van, N. V.; Cleves, M. A.; Duong, T. T.; Xuan, H. Le; Anna, R. -U.; Umberto, D.; Niko, S.; Annette, E.			Vivax malaria morbidity after radical treatment: a 2-year cohort study in central Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thanh, P. V.; Xa, N. X.; Duong, T. T.; Xuan, H. Le] NIMPE, Dept Epidemiol, Hanoi, Vietnam; [Hong, N. V.] NIMPE, Dept Clin Res, Hanoi, Vietnam; [Van, N. V.] Prov Malaria Stn Quang Nam, Tam Ky, Vietnam; [Cleves, M. A.] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Little Rock, AR 72205 USA; [Anna, R. -U.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Umberto, D.] MRC Unit, Fajara, Gambia; [Niko, S.] Catholic Univ Louvain, Brussels, Belgium; [Annette, E.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S3.1	32	32						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900072					2019-04-02	
J	Issa, G; Palpouguini, L; Post, A; Barbara, B; Tinto, H; Jacobs, J				Issa, G.; Palpouguini, L.; Post, A.; Barbara, B.; Tinto, H.; Jacobs, J.			Asymptomatic bacteriuria in pregnant women as a proxy for antibiotic resistance surveillance in the community: preliminary results from a study in Nanoro, rural Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Issa, G.; Palpouguini, L.; Tinto, H.] IRSS Clin Res Unit Nanoro CRUN, Nanoro, Burkina Faso; [Issa, G.; Jacobs, J.] Katholieke Univ Leuven, Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Post, A.; Barbara, B.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S4.1	33	34						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900077					2019-04-02	
J	Vlieghe, E				Vlieghe, E.			Antibiotics under pressure	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vlieghe, E.] Univ Hosp Antwerp, Dept Gen Internal Med Infect Dis & Trop Med, Antwerp, Belgium; [Vlieghe, E.] Univ Antwerp, Fac Med & Life Sci, Antwerp, Belgium; [Vlieghe, E.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S4.3	34	34						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900079					2019-04-02	
J	Leopold, B; Samuel, N; Aimable, D; Joannes, C				Leopold, B.; Samuel, N.; Aimable, D.; Joannes, C.			New diagnostic tests for tuberculosis: Performance of LAM and Xpert MTB/RIF in urine of hospitalized patients on intensive phase of TB treatment, and its association with TB dissemination and HIV status. Preliminary results from an observational cohort study in Kigali, Rwanda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Leopold, B.; Samuel, N.; Aimable, D.] Ctr Hosp Univ Kigali, Dept Internal Med, Kigali, Rwanda; [Joannes, C.] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S5.2	35	35						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900081					2019-04-02	
J	Ng, KS; Meehan, CJ; Torrea, G; Goeminne, L; Diels, M; Rigouts, L; de Jong, B; Andre, E				Ng, K. S.; Meehan, C. J.; Torrea, G.; Goeminne, L.; Diels, M.; Rigouts, L.; de Jong, B.; Andre, E.			Association between rpoB mutations and probe profiles, and potential application of WHO-endorsed rapid diagnostic tests for rifampicin resistant-TB control	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ng, K. S.; Meehan, C. J.; Torrea, G.; Diels, M.; Rigouts, L.; de Jong, B.] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Goeminne, L.; Andre, E.] Catholic Univ Louvain, Inst Rech Expt & Clin, Brussels, Belgium; [Andre, E.] Clin Univ St Luc, Microbiol Unit, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S5.3	35	36						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900082					2019-04-02	
J	Cnops, L; Maniewski, U; Soentjens, P; Huyse, T; Bottieau, E; Clerinx, J; Van Esbroeck, M				Cnops, L.; Maniewski, U.; Soentjens, P.; Huyse, T.; Bottieau, E.; Clerinx, J.; Van Esbroeck, M.			Early diagnosis of acute schistosomiasis by schistosome DNA detection in serum in a cluster cohort of 34 travelers exposed in South Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cnops, L.; Maniewski, U.; Soentjens, P.; Bottieau, E.; Clerinx, J.; Van Esbroeck, M.] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium; [Huyse, T.] Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S6.1	37	37						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900085					2019-04-02	
J	Makhado, NA; Colebunders, R; Nchabeleng, M; de Jong, BC				Makhado, N. A.; Colebunders, R.; Nchabeleng, M.; de Jong, B. C.			Identification of non-tuberculous mycobacteria isolated from clinical specimens at Dr George Mukhari Tertiary Laboratory, South Africa, using the genotype mycobacterium CM/AS assay and 16S RRNA gene sequencing	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract							DIAGNOSIS		[Makhado, N. A.; Nchabeleng, M.] Dr George Mukhari Tertiary Lab, Dept Med Microbiol, Natl Hlth Lab Serv, Pretoria, South Africa; [Makhado, N. A.; Nchabeleng, M.] Sefako Makgatho Hlth Sci Univ, Dept Microbiol Pathol, Pretoria, South Africa; [Makhado, N. A.; Colebunders, R.; de Jong, B. C.] Univ Antwerp, Dept Med & Hlth Sci, Antwerp, Belgium; [Makhado, N. A.; de Jong, B. C.] Inst Trop Med, Dept Mycobacteriol, Antwerp, Belgium							Couto I, 2010, CLIN MICROBIOL INFEC, V16, P1161, DOI 10.1111/j.1469-0691.2009.03076.x; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Sookan L, 2014, SAMJ S AFR MED J, V104, P766, DOI [10.7196/SAMJ.8017, 10.7196/samj.8017]; van Ingen J, 2013, SEMIN RESP CRIT CARE, V34, P103, DOI 10.1055/s-0033-1333569	4	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S5.5	37	37						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900084					2019-04-02	
J	Florian, B; Justin, KC; Joel, AY; Jean, TC; von Lutz, M; Katja, P; Marleen, B; Eliezer, KN; Jurg, U; Soren, LB				Florian, B.; Justin, K. C.; Joel, A. Y.; Jean, T. C.; von Lutz, M.; Katja, P.; Marleen, B.; Eliezer, K. N.; Jurg, U.; Soren, L. B.			Polymerase chain reaction for the diagnosis of Clostridium difficile infection in patients with persistent digestive disorders and asymptomatic controls in Cote d'Ivoire	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Florian, B.; von Lutz, M.; Soren, L. B.] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany; [Justin, K. C.] Hop Methodiste Dabou, Dabou, Cote Ivoire; [Joel, A. Y.; Jean, T. C.; Eliezer, K. N.] Univ Felix Houphouet Boigny, UFR Biosci, Abidjan, Cote Ivoire; [Joel, A. Y.; Jean, T. C.; Eliezer, K. N.] Ctr Suisse Rech Sci Cote Ivoire, Abidjan, Cote Ivoire; [Jean, T. C.; Jurg, U.; Soren, L. B.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Jean, T. C.; Jurg, U.; Soren, L. B.] Univ Basel, Basel, Switzerland; [Katja, P.; Marleen, B.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S7.1	40	40						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900090					2019-04-02	
J	Mbuyi, KL; Barbara, B; Joule, M; Clementine, R; Gaelle, N; Katja, P; Pascal, L; Marie-France, P; Octavie, L; Jan, J				Mbuyi, K. Lisette; Barbara, B.; Joule, M.; Clementine, R.; Gaelle, N.; Katja, P.; Pascal, L.; Marie-France, P.; Octavie, L.; Jan, J.			No association between Salmonella intestinal carriage and Schistosoma mansoni infection in healthy individuals, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mbuyi, K. Lisette; Marie-France, P.; Octavie, L.] Natl Inst Biomed Res, Dept Clin Microbiol, Kinshasa, DEM REP CONGO; [Mbuyi, K. Lisette; Gaelle, N.; Marie-France, P.; Octavie, L.] Univ Hosp Kinshasa, Microbiol Serv, Kinshasa, DEM REP CONGO; [Barbara, B.; Jan, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Joule, M.; Clementine, R.; Katja, P.; Pascal, L.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Joule, M.; Pascal, L.] Natl Inst Biomed Res, Dept Epidemiol, Kinshasa, DEM REP CONGO; [Joule, M.] Catholic Univ Louvain, Inst Hlth & Soc, Brussels, Belgium; [Pascal, L.] Univ Hosp Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Jan, J.] Katholieke Univ Leuven, Microbiol & Immunol, Leuven, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S7.2	40	40						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900091					2019-04-02	
J	Koirala, KD; Verdonck, K; Barbe, B; Khanal, B; Bhattarai, NR; Pradhan, B; Bhatta, NK; Karki, P; Rijal, S; Boelaert, M; Chappuis, F; Jacobs, J				Koirala, K. D.; Verdonck, K.; Barbe, B.; Khanal, B.; Bhattarai, N. R.; Pradhan, B.; Bhatta, N. K.; Karki, P.; Rijal, S.; Boelaert, M.; Chappuis, F.; Jacobs, J.			Use of antibiotics prior to blood culture sampling in Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Koirala, K. D.] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Koirala, K. D.; Verdonck, K.; Boelaert, M.] Inst Trop Med, Unit Epidemiol & Control Trop Dis, Antwerp, Belgium; [Koirala, K. D.; Chappuis, F.] Univ Geneva, Geneva, Switzerland; [Barbe, B.; Jacobs, J.] Inst Trop Med, Unit Trop Lab Med, Antwerp, Belgium; [Khanal, B.; Bhattarai, N. R.] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Pradhan, B.; Karki, P.; Rijal, S.] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Bhatta, N. K.] BP Koirala Inst Hlth Sci, Dept Paediat & Adolescent Med, Dharan, Nepal								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S7.3	41	41						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900092					2019-04-02	
J	Phe, T; Lim, K; Leng, L; Verdonck, K; Barbe, B; Jacobs, J; Parola, P; Rijal, S; Boelaert, M; Chappuis, F				Phe, T.; Lim, K.; Leng, L.; Verdonck, K.; Barbe, B.; Jacobs, J.; Parola, P.; Rijal, S.; Boelaert, M.; Chappuis, F.			Prevalence of neglected infectious diseases in patients with persistent fever in Sihanouk Hospital Center of HOPE, Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Phe, T.; Lim, K.; Leng, L.] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Verdonck, K.; Barbe, B.; Jacobs, J.; Boelaert, M.] Inst Trop Med, Antwerp, Belgium; [Parola, P.] Univ Hosp Inst Mediterranee Infect, Marseille, France; [Rijal, S.] BP Koirala Inst Trop Med, Dharan, Nepal; [Chappuis, F.] Geneva Univ Hosp, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S8.3	42	43						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900096					2019-04-02	
J	Lenaerts, E; Mukendi, D; Mandro, M; Dolo, H; Wonya'Rossi, DU; Ngave, F; Colebunders, R; Suykerbuyk, P				Lenaerts, E.; Mukendi, D.; Mandro, M.; Dolo, H.; Wonya'Rossi, D. Ucima; Ngave, F.; Colebunders, R.; Suykerbuyk, P.			Epidemiology of onchocerciasis and epilepsy in Ituri Province in the Democratic Republic of the Congo (DRC)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lenaerts, E.; Mandro, M.; Dolo, H.; Colebunders, R.; Suykerbuyk, P.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Mukendi, D.] Univ Kinshasa CNPP UNIKIN, Ctr Neuro Psycho Pathol, Kinshasa, DEM REP CONGO; [Mandro, M.] Minist Hlth, Prov Hlth Div Ituri, Bunia, DEM REP CONGO; [Dolo, H.] Fac Med & Odonto Stomatol, Int Ctr Excellence Res, Bamako, Mali; [Wonya'Rossi, D. Ucima] Minist Hlth, Neglected Trop Dis Control Program, Bunia, DEM REP CONGO; [Wonya'Rossi, D. Ucima; Ngave, F.] Hop Gen Reference Rethy, Ctr Rech Malad Trop, Rethy, DEM REP CONGO								0	0	0	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S8.4	43	43						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900097					2019-04-02	
J	Martinez, DY; Verdonck, K; Adaui, V; Jara, M; Alba, M; Arevalo, J; Polman, K; Llanos-Cuentas, A; Dujardin, JC; Boelaert, M				Martinez, D. Y.; Verdonck, K.; Adaui, V.; Jara, M.; Alba, M.; Arevalo, J.; Polman, K.; Llanos-Cuentas, A.; Dujardin, J. C.; Boelaert, M.			Intestinal helminthiasis as a determinant of response to pentavalent antimony treatment in Peruvian patients with cutaneous leishmaniasis: a case-control study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Martinez, D. Y.; Llanos-Cuentas, A.] HCH, Dept Enfermedades Infecciosas Dermatol & Trop, Lima, Peru; [Martinez, D. Y.; Adaui, V.; Jara, M.; Alba, M.; Arevalo, J.; Llanos-Cuentas, A.] UPCH, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Martinez, D. Y.] UPCH, Fac Med Alberto Hurtado, Lima, Peru; [Verdonck, K.; Polman, K.; Dujardin, J. C.; Boelaert, M.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S8.5	43	44						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900098					2019-04-02	
J	Vogt, F; Mekonnen, T; Fikre, H; Takele, Y; Adem, E; Mohammed, R; Ritmeijer, K; Adriaensen, W; Diro, E; Van Griensven, J				Vogt, F.; Mekonnen, T.; Fikre, H.; Takele, Y.; Adem, E.; Mohammed, R.; Ritmeijer, K.; Adriaensen, W.; Diro, E.; Van Griensven, J.			Accuracy of antigen detection in urine using Katex for non-invasive visceral leishmaniasis diagnosis and treatment monitoring in HIV-coinfected patients	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vogt, F.; Adriaensen, W.; Van Griensven, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Mekonnen, T.; Fikre, H.; Takele, Y.; Adem, E.; Mohammed, R.; Diro, E.] Univ Gondar, Leishmania Res & Training Ctr, Gondar, Ethiopia; [Ritmeijer, K.] Doctors Borders, Operat Ctr Amsterdam, Amsterdam, Netherlands								0	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S9.1	44	45						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900100					2019-04-02	
J	van Griensven, J; Van Henten, S; Mengesha, B; Endris, M; Van Den Bossche, D; Cnops, L; Adriaensen, W; Gedamu, Y; Vogt, F; Diro, E				van Griensven, J.; Van Henten, S.; Mengesha, B.; Endris, M.; Van Den Bossche, D.; Cnops, L.; Adriaensen, W.; Gedamu, Y.; Vogt, F.; Diro, E.			Prevalence and risk factors of asymptomatic Leishmania infection in HIV-infected individuals in North West Ethiopia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[van Griensven, J.; Van Henten, S.; Van Den Bossche, D.; Cnops, L.; Adriaensen, W.; Vogt, F.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Mengesha, B.; Endris, M.; Gedamu, Y.; Diro, E.] Univ Gondar Hosp, Gondar, Ethiopia; Metema Hosp, Gondar, Ethiopia								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S9.5	46	46						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900104					2019-04-02	
J	van Griensven, J; Simegn, T; Endris, M; Diro, E				van Griensven, J.; Simegn, T.; Endris, M.; Diro, E.			Visceral leishmaniasis and HIV co-infection in northwest Ethiopia: uptake of antiretroviral treatment and burden of disease amongst patients enrolled in HIV care	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[van Griensven, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Simegn, T.] Metema Hosp, Gondar, Ethiopia; [Endris, M.; Diro, E.] Univ Gondar Hosp, Gondar, Ethiopia								0	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S9.6	46	47						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900105					2019-04-02	
J	Cools, P; Vlaminck, J; Albonico, M; Ame, S; Ayana, M; Keiser, J; Mekonnen, Z; Montresor, A; Sayasone, S; Verweij, J; Vercruysse, J; Levecke, B				Cools, P.; Vlaminck, J.; Albonico, M.; Ame, S.; Ayana, M.; Keiser, J.; Mekonnen, Z.; Montresor, A.; Sayasone, S.; Verweij, J.; Vercruysse, J.; Levecke, B.			Comparison of single Kato-Katz, duplicate Kato-Katz, mini-FLOTAC and FECPAK(G2) for the assessment of anthelminthic efficacy of single dose albendazole	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cools, P.; Vlaminck, J.; Vercruysse, J.; Levecke, B.] Dept Virol, Parasitol Lab, Parasitol, Immunol, Merelbeke, Belgium; [Albonico, M.; Montresor, A.] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland; [Ame, S.] Publ Hlth Lab Ivo de Carneri, Chake Chake, Tanzania; [Ayana, M.; Mekonnen, Z.] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Keiser, J.] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Sayasone, S.] Minist Hlth, Natl Inst Publ Hlth, Viangchan, Laos; [Verweij, J.] St Elizabeth Hosp, Tilburg, Netherlands								0	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3S10.1	47	47						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900106					2019-04-02	
J	Mpanya, A; Claeys, Y; Fukinsia, A; Snijders, R; Makabuza, J; Boelaert, M; Lutumba, P; Lumbala, C; Hasker, E				Mpanya, A.; Claeys, Y.; Fukinsia, A.; Snijders, R.; Makabuza, J.; Boelaert, M.; Lutumba, P.; Lumbala, C.; Hasker, E.			Innovative methods of case finding to achieve elimination of human African trypanosomiasis in the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mpanya, A.; Fukinsia, A.; Makabuza, J.; Lumbala, C.] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Claeys, Y.; Snijders, R.; Boelaert, M.; Hasker, E.] Inst Med Trop Anvers, Antwerp, Belgium; [Lutumba, P.] Univ Kinshasa, Dept Med Trop, Kinshasa, DEM REP CONGO								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S1.1	49	49						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900111					2019-04-02	
J	Willem, L; Verelst, F; Kuylen, E; Abboud, LA; Bicke, J; Hens, N; Broeckhove, J; Beutels, P				Willem, L.; Verelst, F.; Kuylen, E.; Abboud, L. A.; Bicke, J.; Hens, N.; Broeckhove, J.; Beutels, P.			Catching the risk of measles outbreaks in a clustered society	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Willem, L.; Verelst, F.; Abboud, L. A.; Bicke, J.; Hens, N.; Beutels, P.] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modeling Infect Dis, Antwerp, Belgium; [Kuylen, E.; Broeckhove, J.] Univ Antwerp, Dept Math & Comp Sci, Modeling Syst & Internet Commun, Antwerp, Belgium; [Hens, N.] Hasselt Univ, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Beutels, P.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia			Beutels, Philippe/A-1919-2010	Beutels, Philippe/0000-0001-5034-3595				0	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S2.3	52	52						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900118					2019-04-02	
J	Laudisoit, A; Verheyen, E; Baelo, P; Akonda, I; Nebesse, C; Ngoy, S; Gembu, G; Tepage, F; Muyembe, JJ; Alworonga, O; Mande, D; Angotolwa, Z; Leirs, H; Ngbonda, D; Colebunders, R				Laudisoit, A.; Verheyen, E.; Baelo, P.; Akonda, I.; Nebesse, C.; Ngoy, S.; Gembu, G.; Tepage, F.; Muyembe, J. J.; Alworonga, O.; Mande, D.; Angotolwa, Z.; Leirs, H.; Ngbonda, D.; Colebunders, R.			A One Health team to improve Monkeypox virus outbreak response: an example from the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Laudisoit, A.; Verheyen, E.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Laudisoit, A.; Verheyen, E.; Leirs, H.] Univ Antwerp, Evolutionary Biol Grp, Antwerp, Belgium; [Laudisoit, A.] Univ Liverpool, Inst Integrat Biol, Sch Biol Sci, Liverpool, Merseyside, England; [Verheyen, E.] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Baelo, P.; Nebesse, C.; Ngoy, S.; Gembu, G.] Univ Kisangani, Biodivers Monitoring Ctr, Fac Sci, Kisangani, DEM REP CONGO; [Baelo, P.; Nebesse, C.; Ngoy, S.; Gembu, G.] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Akonda, I.; Tepage, F.] Minist Hlth, Bas Uele Prov Hlth Div, Kisangani, DEM REP CONGO; [Muyembe, J. J.] Inst Natl Rech Biomed Kinshasa, Kinshasa, DEM REP CONGO; [Alworonga, O.; Mande, D.; Angotolwa, Z.; Ngbonda, D.] Univ Kisangani, Fac Med, Kisangani, DEM REP CONGO								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S2.5	53	53						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900120					2019-04-02	
J	Claeys, Y; Makabuza, J; Mpanya, A; Boelaert, M; Lutumba, P; Lebuki, J; Hasker, E; Lumbala, C				Claeys, Y.; Makabuza, J.; Mpanya, A.; Boelaert, M.; Lutumba, P.; Lebuki, J.; Hasker, E.; Lumbala, C.			Digitalization and planning of active HAT screening in the Democratic Republic of Congo to reach elimination	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Claeys, Y.; Boelaert, M.; Hasker, E.] Inst Trop Med Antwerp, Dept Publ Hlth, Antwerp, Belgium; [Makabuza, J.; Mpanya, A.; Lutumba, P.; Lebuki, J.; Lumbala, C.] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; Kinshasa Univ, Dept Trop Med, Kinshasa, DEM REP CONGO								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S3.2	54	54						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900123					2019-04-02	
J	Vanlerberghe, V; Toledo, ME; Ocampo, C; Manrique-Saide, P; Honorio, N; Vazquez-Prokopec, G; Mirabal, M; Alexander, N; Frutuoso, RL; Stuyft, PVD				Vanlerberghe, V.; Toledo, M. E.; Ocampo, C.; Manrique-Saide, P.; Honorio, N.; Vazquez-Prokopec, G.; Mirabal, M.; Alexander, N.; Frutuoso, R. L.; Stuyft, P. V. der			Considering the spatial heterogeneity of Dengue transmission for designing an Aedes control strategy	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vanlerberghe, V.; Stuyft, P. V. der] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Toledo, M. E.] Inst Trop Med Pedro Kouri, Dept Epidemiol, Havana, Cuba; [Ocampo, C.; Alexander, N.] Int Training & Med Res Ctr, Cali, Colombia; [Manrique-Saide, P.] Univ Yucatan, Dept Entomol, Merida, Mexico; [Honorio, N.] Fiocruz MS, Rio De Janeiro, Brazil; [Vazquez-Prokopec, G.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Mirabal, M.] Finlay Vaccine Inst, Clin Res & Impact Evaluat Div, Havana, Cuba; [Frutuoso, R. L.] Minist Hlth, Natl Program Prevent & Control Malaria & Dis Tran, Brasilia, DF, Brazil; [Stuyft, P. V. der] Univ Ghent, Dept Publ Hlth, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S3.1	54	54						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900122					2019-04-02	
J	Hasker, E; Baco, A; Younoussa, A; Mzembaba, A; Salim, Z; Amidy, M; Grillone, S; Demeulenaere, T; Ortuno-Gutierrez, N; Groenen, G; Suffys, P; de Jong, B				Hasker, E.; Baco, A.; Younoussa, A.; Mzembaba, A.; Salim, Z.; Amidy, M.; Grillone, S.; Demeulenaere, T.; Ortuno-Gutierrez, N.; Groenen, G.; Suffys, P.; de Jong, B.			Mapping of leprosy cases as a tool for rationalizing contact screening	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hasker, E.; de Jong, B.] Inst Trop Med, Antwerp, Belgium; [Baco, A.; Younoussa, A.; Mzembaba, A.; Salim, Z.; Amidy, M.; Grillone, S.] Leprosy & TB Control Program, Brussels, Belgium; [Demeulenaere, T.; Ortuno-Gutierrez, N.] Damien Fdn, Brussels, Belgium; [Groenen, G.] BELTA TBnet, Brussels, Belgium; [Suffys, P.] Fiocruz MS, Rio De Janeiro, Brazil								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S3.4	55	55						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900125					2019-04-02	
J	Bannister-Tyrrell, M; Xa, NX; Van, NV; Dung, VA; Hieu, TM; Hong, NV; Kattenberg, JH; Rovira-Vallbona, E; Duong, TT; Urgell, AR; Grietens, KP; Erhart, A				Bannister-Tyrrell, M.; Xa, N. X.; Van, N. V.; Dung, V. A.; Hieu, T. M.; Hong, N. V.; Kattenberg, J. H.; Rovira-Vallbona, E.; Duong, T. T.; Urgell, A. R.; Grietens, K. P.; Erhart, A.			Micro-epidemiology of malaria exposure in central Vietnam: a mixed-methods case study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bannister-Tyrrell, M.; Grietens, K. P.; Erhart, A.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Xa, N. X.; Dung, V. A.; Hieu, T. M.; Hong, N. V.; Duong, T. T.] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Van, N. V.] Quang Nam Prov Hlth Serv, Tam Ky, Vietnam; [Kattenberg, J. H.; Rovira-Vallbona, E.; Urgell, A. R.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Erhart, A.] MRC, Fajara, Gambia								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S4.1	56	56						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900127					2019-04-02	
J	Sommerland, N; Wouters, E; Masquillier, C; Rau, A; Engelbrecht, M; Kigozi, G; Uebel, K				Sommerland, N.; Wouters, E.; Masquillier, C.; Rau, A.; Engelbrecht, M.; Kigozi, G.; Uebel, K.			Stigma among healthcare workers as a barrier to the use of TB services at occupational health units in South Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sommerland, N.; Wouters, E.; Masquillier, C.] Univ Antwerp, Dept Sociol, Antwerp, Belgium; [Rau, A.; Engelbrecht, M.; Kigozi, G.; Uebel, K.] Univ Free State, Dept Hlth Syst Res & Dev, Bloemfontein, South Africa			Wouters, Edwin/G-9073-2012	Wouters, Edwin/0000-0003-2268-3829				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S4.2	56	57						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900128					2019-04-02	
J	Mukumbang, FC; Van Belle, S; Marchal, B; Van Wyk, B				Mukumbang, F. C.; Van Belle, S.; Marchal, B.; Van Wyk, B.			Why would antiretroviral treatment adherence clubs work in the Western Cape Province, South Africa?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mukumbang, F. C.; Marchal, B.; Van Wyk, B.] Univ Western Cape, Sch Publ Hlth, Bellville, South Africa; [Mukumbang, F. C.; Van Belle, S.; Marchal, B.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S4.3	57	57						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900129					2019-04-02	
J	Mmbando, BP; Mnacho, M; Makunde, M; Kakorozya, A; Matuja, W; Greter, H; Suykerbuyk, P; Colebunders, R				Mmbando, B. P.; Mnacho, M.; Makunde, M.; Kakorozya, A.; Matuja, W.; Greter, H.; Suykerbuyk, P.; Colebunders, R.			High prevalence of epilepsy and onchocerciasis after 20 years of ivermectin use in four villages of the Mahenge area in Tanzania	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mmbando, B. P.; Makunde, M.] Natl Inst Med Res, Tanga Res Ctr, Tanga, Tanzania; [Mnacho, M.; Matuja, W.] Muhimbili Univ Hlth Sci, Dar Es Salaam, Tanzania; [Kakorozya, A.] Enhance Tanzania Fdn, Dar Es Salaam, Tanzania; [Greter, H.; Suykerbuyk, P.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S6.4	61	61						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900139					2019-04-02	
J	van den Bergh, R; Panunzi, I; Benedetti, G; Mandi, H; Beijnsberger, J; Bachy, C; Pineda, S; Lambert, V; Zachariah, R; Van Herp, M				van den Bergh, R.; Panunzi, I.; Benedetti, G.; Mandi, H.; Beijnsberger, J.; Bachy, C.; Pineda, S.; Lambert, V.; Zachariah, R.; Van Herp, M.			Hit early, hit hard: feasibility and effectiveness of the focused "Coup de Poing" measles outbreak response in the democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[van den Bergh, R.; Panunzi, I.; Benedetti, G.; Bachy, C.; Pineda, S.; Zachariah, R.; Van Herp, M.] Med Sans Frontieres, Operat Ctr Brussels, Med Dept, Brussels, Belgium; [Mandi, H.; Beijnsberger, J.] Med Sans Frontieres Democrat Republ Congo, Operat Ctr Brussels, Kinshasa, DEM REP CONGO; [Lambert, V.] Med Sans Frontieres, Operat Ctr Brussels, Operat Dept, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S7.4	63	63						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900144					2019-04-02	
J	Vorsters, A; Pattyn, J; Van Keer, S; Biesmans, S; Van Damme, P				Vorsters, A.; Pattyn, J.; Van Keer, S.; Biesmans, S.; Van Damme, P.			The use of first void urine to monitor HPV vaccination impact, results from Bhutan and Rwanda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vorsters, A.; Pattyn, J.; Van Keer, S.; Biesmans, S.; Van Damme, P.] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Evaluat Vaccinat, Antwerp, Belgium							Franceschi S, 2016, INT J CANCER, V139, P518, DOI 10.1002/ijc.30092	1	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S7.3	63	63						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900143					2019-04-02	
J	Coulborn, RM; Nackers, F; Panunzi, I; Bachy, C; Porten, K; Vochten, H; Van Herp, M; Bibala-Faray, E; Cohuet, S				Coulborn, R. M.; Nackers, F.; Panunzi, I.; Bachy, C.; Porten, K.; Vochten, H.; Van Herp, M.; Bibala-Faray, E.; Cohuet, S.			Field challenges to measles elimination in the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Coulborn, R. M.; Nackers, F.; Porten, K.; Cohuet, S.] Epicentre, Paris, France; [Panunzi, I.; Bachy, C.; Van Herp, M.] Med Sans Frontieres, Brussels, Belgium; [Vochten, H.] Med Sans Frontieres, Kinshasa, DEM REP CONGO; [Bibala-Faray, E.] Minist Publ Hlth, Maniema, DEM REP CONGO								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S8.2	64	65						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900147					2019-04-02	
J	Verelst, F; Willem, L; Kessels, R; Beutels, P				Verelst, F.; Willem, L.; Kessels, R.; Beutels, P.			Extracting the incentives: vaccination behavior as a multicriteria decision	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Verelst, F.; Willem, L.; Beutels, P.] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis CHERMID, Antwerp, Belgium; [Kessels, R.] Univ Antwerp, Fac Appl Econ, Antwerp, Belgium; [Beutels, P.] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia			Kessels, Roselinde/N-8479-2016; Beutels, Philippe/A-1919-2010	Kessels, Roselinde/0000-0002-4534-0047; Beutels, Philippe/0000-0001-5034-3595				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S8.1	64	64						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900146					2019-04-02	
J	De Kesel, T; Rudelsheim, P				De Kesel, T.; Rudelsheim, P.			WHO GAP III roadmap to compliance for poliovirus-essessential facilities	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Kesel, T.] Febris Biorisk Consult BVBA, Aalter, Belgium; [Rudelsheim, P.] Perseus BVBA, St Martens Latem, Belgium							WHO GAP III, 2015, WHO GLOB ACT PLAN MI	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S8.3	65	65						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900148					2019-04-02	
J	Sunyoto, T; Atia, AM; Khalid, G; Alcoba, G; den Boer, M; Boelaert, M				Sunyoto, T.; Atia, A. M.; Khalid, G.; Alcoba, G.; den Boer, M.; Boelaert, M.			Suffering in silence: a qualitative study on reasons of delay in seeking care for visceral leishmaniasis in southern Gedaref, Sudan	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sunyoto, T.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Sunyoto, T.] Med Sans Frontieres Campaign Access Med, Geneva, Switzerland; [Atia, A. M.; den Boer, M.] KalaCORE WHO, Khartoum, Sudan; [Khalid, G.] Univ Gedaref, Fac Med, Al Qadarif, Sudan; [Alcoba, G.] Med Sans Frontieres, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S9.4	67	68						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900154					2019-04-02	
J	Atia, AM; Den Boer, M; Elhag, MS; Ahmed, R; Alcoba, G; Chappuis, F; van Griensven, J; Rony, Z				Atia, A. M.; Den Boer, M.; Elhag, M. Siddig; Ahmed, R.; Alcoba, G.; Chappuis, F.; van Griensven, J.; Rony, Z.			What are the true outcomes of patients declared lost to follow up in a visceral Leishmaniasis program in Sudan?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Atia, A. M.] KalaCORE, Khartoum, Sudan; [Den Boer, M.] Med Sans Frontieres UK, London, England; [Elhag, M. Siddig] Fed Minist Hlth, Khartoum, Sudan; [Ahmed, R.] Minist Hlth, Gedaref, Gedaref State, Sudan; [Alcoba, G.; Chappuis, F.] Med Sans Frontieres Switzerland, Operat Ctr, Geneva, Switzerland; [Chappuis, F.] Geneva Univ Hosp, Geneva, Switzerland; [van Griensven, J.] Inst Trop Med, Antwerp, Belgium; [Rony, Z.] Med Sans Frontieres Brussels, Operat Ctr, Luxembourg, Luxembourg								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S9.5	68	68						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900155					2019-04-02	
J	Le Rutte, EA; Chapman, LAC; Coffeng, LE; Jervis, S; Hasker, EC; Dwivedi, S; Karthick, MP; Mahapatra, T; Chaudhury, I; Boelaert, MC; Medley, GF; Srikantiah, S; Hollingsworth, TD; de Vlas, SJ				Le Rutte, E. A.; Chapman, L. A. C.; Coffeng, L. E.; Jervis, S.; Hasker, E. C.; Dwivedi, S.; Karthick, M. P.; Mahapatra, T.; Chaudhury, I.; Boelaert, M. C.; Medley, G. F.; Srikantiah, S.; Hollingsworth, T. Deirdre; de Vlas, S. J.			Elimination of visceral leishmaniasis on the Indian subcontinent: a comparison of multiple transmission models	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Le Rutte, E. A.; Coffeng, L. E.; de Vlas, S. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Chapman, L. A. C.; Jervis, S.; Hollingsworth, T. Deirdre] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Hasker, E. C.; Boelaert, M. C.] Inst Trop Med, Antwerp, Belgium; [Dwivedi, S.; Karthick, M. P.; Mahapatra, T.; Chaudhury, I.; Srikantiah, S.] CARE India Solut Sustainable Dev, Patna, Bihar, India; [Medley, G. F.] London Sch Hyg & Trop Med, Keppel St, London, England			Hollingsworth, Deirdre/D-2421-2009; Medley, Graham/B-7289-2008	Hollingsworth, Deirdre/0000-0001-5962-4238; Medley, Graham/0000-0002-0030-7278				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S10.2	68	69						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900157					2019-04-02	
J	Malviya, P; Hasker, E; Boelaert, M; Sundar, S				Malviya, P.; Hasker, E.; Boelaert, M.; Sundar, S.			Health seeking behavior of patients in Muzaffarpur-TMRC HDSS may hinder Kala-azar elimination in Bihar, India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Malviya, P.] Banaras Hindu Univ, Varanasi, Uttar Pradesh, India; [Hasker, E.; Boelaert, M.] ITM, Antwerp, Belgium; [Sundar, S.] BHU, IMS, Varanasi, Uttar Pradesh, India								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4S10.4	69	70						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900159					2019-04-02	
J	Lurton, G; Antony, M; Legrand, A; de Borman, N				Lurton, G.; Antony, M.; Legrand, A.; de Borman, N.			Defining a supervision strategy using artificial intelligence (AI). The case of data supervision for the results based financing intervention in Benin	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lurton, G.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Antony, M.] European Agcy Dev & Hlth, Brussels, Belgium; [Legrand, A.; de Borman, N.] BlueSquare, Brussels, Belgium								0	0	0	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S1.2	70	70						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900161					2019-04-02	
J	Verbeke, F; Karara, G; Van Bastelaere, S				Verbeke, F.; Karara, G.; Van Bastelaere, S.			Primitive metrics for predicting clinical documentation performance in Burundian public hospitals	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Verbeke, F.; Karara, G.] Vrije Univ Brussel, Dept Biostat & Med Informat, Brussels, Belgium; [Van Bastelaere, S.] Belgian Dev Agcy, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S1.3	70	71						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900162					2019-04-02	
J	Verbeke, F; Van Laere, S; Nyssen, M				Verbeke, F.; Van Laere, S.; Nyssen, M.			An open source API for real time drug prescription monitoring at the point of care in low resource settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Verbeke, F.; Van Laere, S.; Nyssen, M.] Vrije Univ Brussel, Dept Biostat & Med Informat, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S1.1	70	70						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900160					2019-04-02	
J	Legrand, A; Nembetwa, N				Legrand, A.; Nembetwa, N.			Digitizing routine health facility assessment in low-resource settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Legrand, A.; Nembetwa, N.] Bluesquare, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S1.5	71	72						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900164					2019-04-02	
J	Meyanti, F; Verdonck, K; Polman, K; Mahendradhata, Y				Meyanti, F.; Verdonck, K.; Polman, K.; Mahendradhata, Y.			Reasons for not attending a health care centre for soil-transmitted helminth infections in a rural village in Indonesia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Meyanti, F.; Mahendradhata, Y.] Univ Gadjah Mada, Fac Med, Ctr Trop Med, Yogyakarta, Indonesia; [Verdonck, K.; Polman, K.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S2.3	72	73						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900167					2019-04-02	
J	Dossou, JP; Marchal, B				Dossou, J. P.; Marchal, B.			State to the test of trust: implementation of a public fee exemption policy in non-state facilities in Benin	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dossou, J. P.; Marchal, B.] Res Ctr Human Reprod & Demog, Dept Publ Hlth, Cotonou, Benin; [Dossou, J. P.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S3.4	75	75						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900173					2019-04-02	
J	Landu, DJM; Liegeois, S; Kuwekita, JM; Mbinze, J; Nsiona, JM; Hubert, P; Michel, B; Reginster, JY; Frederich, M; Djang'Eing'A, RM				Landu, D. J. Mavungu; Liegeois, S.; Kuwekita, J. Manzambi; Mbinze, J.; Nsiona, J. Mavungu; Hubert, P.; Michel, B.; Reginster, J-Y.; Frederich, M.; Djang'Eing'A, R. Marini			The quality of Artemether-Lumefantrine combination and characteristics of pharmacies in the Periurban areas of Kinshasa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Landu, D. J. Mavungu; Liegeois, S.; Hubert, P.; Frederich, M.; Djang'Eing'A, R. Marini] Univ Liege, Dept Pharm, Liege, Belgium; [Landu, D. J. Mavungu; Michel, B.] Ecole Reg Postuniv Amenagement & Gest Integres Fo, Kinshasa, DEM REP CONGO; [Liegeois, S.; Kuwekita, J. Manzambi; Reginster, J-Y.] Univ Liege, Dept Sci Sante Publ, Liege, Belgium; [Kuwekita, J. Manzambi] Inst Super Tech Med Kinshasa, Sect Sante Communautaire, Kinshasa, DEM REP CONGO; [Mbinze, J.] Univ Kinshasa, Dept Galen & Anal Medicaments, Kinshasa, DEM REP CONGO; [Nsiona, J. Mavungu] Div Prov Sante, Kinshasa, DEM REP CONGO; [Michel, B.] Univ Liege, Fac Univ Sci Agron Gembloux, Gembloux, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S4.1	76	76						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900175					2019-04-02	
J	Ravinetto, R; Lotay, PS; De Santi, O				Ravinetto, R.; Lotay, P. Singh; De Santi, O.			How the quality strategy can tackle the challenges of procuring medicines in weak regulatory environments: the experience of a sub-Saharan African procurement centre	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ravinetto, R.; Lotay, P. Singh; De Santi, O.] Inst Trop Med, Antwerp, Belgium; [Ravinetto, R.; Lotay, P. Singh; De Santi, O.] Cent Humanitaire Med Pharmaceut, Nairobi, Kenya								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S4.3	76	77						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900177					2019-04-02	
J	Van Assche, K; Giralt, AN; Caudron, JM; Ravinetto, R				Van Assche, K.; Giralt, A. Nebot; Caudron, J. M.; Ravinetto, R.			The impact of local private distributors on quality of medicines available in non African low- and middle-income countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Giralt, A. Nebot; Ravinetto, R.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Caudron, J. M.] QUAMED, Castres, France								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S4.2	76	76						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900176					2019-04-02	
J	Carasso, KB; Naylor, M; Ngwaru, T; Caffrey, M; Witter, S				Carasso, K. B.; Naylor, M.; Ngwaru, T.; Caffrey, M.; Witter, S.			A health system perspective to improving pharmaceutical supply: lessons from Zimbabwe	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Carasso, K. B.] Hera, Reet, Belgium; [Naylor, M.] Oxford Policy Management, Oxford, England; [Ngwaru, T.] Oxford Policy Management, Pretoria, South Africa; [Caffrey, M.] Univ Liverpool Liverpool Sch Trop Med, CMNH, Liverpool, Merseyside, England; [Witter, S.] Queen Margaret Univ, IGHD, Edinburgh, Midlothian, Scotland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S4.4	77	77						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900178					2019-04-02	
J	Agudelo, EL; Salva, AR; Jo, AS; Pinera, AD; Cantillo, GM; Acosta, SB; Van der Stuyft, P				Agudelo, E. Londono; Salva, A. Rodriguez; Jo, A. Seuc; Pinera, A. Diaz; Cantillo, G. Maldonado; Acosta, S. Balcindes; Van der Stuyft, P.			Assessment of diabetes care in the municipalities of Cardenas and Santiago (Cuba)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Agudelo, E. Londono] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Salva, A. Rodriguez; Jo, A. Seuc; Pinera, A. Diaz; Cantillo, G. Maldonado; Acosta, S. Balcindes] Inst Nacl Higiene Epidemiol & Microbiol, Dept Salud Publ, Havana, Cuba; [Van der Stuyft, P.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [Van der Stuyft, P.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S5.2	78	78						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900180					2019-04-02	
J	Adepoju, IOO; Douwes, R; Abugnaba-Abanga, R; van der Heiden, M; Apentibadek, N; Zweekhorst, M; Bardaji, A; van Roosmalen, J; De Brouwere, V				Adepoju, I. O. O.; Douwes, R.; Abugnaba-Abanga, R.; van der Heiden, M.; Apentibadek, N.; Zweekhorst, M.; Bardaji, A.; van Roosmalen, J.; De Brouwere, V.			mHealth for improving quality of antenatal care in northern Ghana: the Bliss4Midwives project	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Adepoju, I. O. O.; Zweekhorst, M.; van Roosmalen, J.] Vrije Univ, Athena Inst, Amsterdam, Netherlands; [Adepoju, I. O. O.; De Brouwere, V.] Inst Trop Med, Dept Publ Hlth, Maternal & Reprod Hlth Unit, Antwerp, Belgium; [Adepoju, I. O. O.; Bardaji, A.] Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Douwes, R.] Simavi, Amsterdam, Netherlands; [Abugnaba-Abanga, R.] Presbyterian Hlth Serv North, Bolgatanga, Ghana; [van der Heiden, M.] TNO Org Appl Sci Res, Delft, Netherlands; [Apentibadek, N.] Assoc Church Dev Projects ACDEP, Tamale, Ghana; [van Roosmalen, J.] Leiden Univ, Med Ctr, Dept Obstet, Leiden, Netherlands								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S7.2	81	81						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900187					2019-04-02	
J	Philippe, V; Laurent, A; Nathalie, C; Mit, P				Philippe, V.; Laurent, A.; Nathalie, C.; Mit, P.			Financial access barriers for HIV patients in Kinshasa, DRC and possible mitigation by patient associations' managed vouchers	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Philippe, V.] ALTER, Montpellier, France; [Laurent, A.] ECOSAN, Montpellier, France; [Nathalie, C.; Mit, P.] Med Sans Frontieres, Dept Anal, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S8.4	83	84						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900194					2019-04-02	
J	Renmans, D; Holvoet, N; Criel, B				Renmans, D.; Holvoet, N.; Criel, B.			It takes two to own - the policy process behind the implementation of PBF in Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Renmans, D.; Holvoet, N.] Univ Antwerp, Inst Dev Policy & Management, Antwerp, Belgium; [Renmans, D.; Criel, B.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S8.2	83	83						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900192					2019-04-02	
J	Eerens, P				Eerens, P.			Translation of multiple health systems flows in the language of complex networks	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Eerens, P.] Living Hlth Syst, Brussels, Belgium							Pfadenhauer LM, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0552-5; Rajaram R, 2012, COMPLEXITY, V18, P8, DOI 10.1002/cplx.21412; Ramalingam B., 2008, DEVELOPMENT, V16, P89	3	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5S9.3	85	85						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900197					2019-04-02	
J	Steurs, L; Delputte, S; Orbie, J				Steurs, L.; Delputte, S.; Orbie, J.			The love-hate relationship between European donors and the global health initiatives	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Steurs, L.; Delputte, S.; Orbie, J.] Univ Ghent, Dept Polit Sci, Ctr EU Studies, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S1.1	85	85						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900198					2019-04-02	
J	Steurs, L; Delputte, S; Orbie, J				Steurs, L.; Delputte, S.; Orbie, J.			European donors and health system strengthening: a distinct approach?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Steurs, L.; Delputte, S.; Orbie, J.] Univ Ghent, Dept Polit Sci, Ctr EU Studies, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S1.3	86	86						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900200					2019-04-02	
J	De Buck, E; Van Remoortel, H; Veegaete, AV; Singhal, M; Vandekerckhove, P; Agarwal, SP				De Buck, E.; Van Remoortel, H.; Veegaete, A. Vande; Singhal, M.; Vandekerckhove, P.; Agarwal, S. P.			Evidence-based guidelines and training materials for first aid by laypeople: the example of India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Buck, E.; Van Remoortel, H.; Veegaete, A. Vande] Belgian Red Cross, Ctr Evidence Based Practice, Mechelen, Belgium; [De Buck, E.; Vandekerckhove, P.] Katholieke Univ Leuven, Fac Med, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Singhal, M.] All India Inst Med Sci, Dept Trauma Surg, New Delhi, India; [Vandekerckhove, P.] Belgian Red Cross, Mechelen, Belgium; [Vandekerckhove, P.] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium; [Agarwal, S. P.] Indian Red Cross Soc, New Delhi, India								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S2.4	87	88						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900204					2019-04-02	
J	Kennis, J; Van den Broucke, S; Clerinx, J; Huits, R; Zolfo, M; Bottieau, E				Kennis, J.; Van den Broucke, S.; Clerinx, J.; Huits, R.; Zolfo, M.; Bottieau, E.			WikiTropica: a concept for a knowledge management platform in the field of tropical medicine and travel health	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kennis, J.; Van den Broucke, S.; Clerinx, J.; Huits, R.; Zolfo, M.; Bottieau, E.] Inst Trop Med, Clin Sci Dept, Antwerp, Belgium			Kennis, Jan/D-4064-2018; Zolfo, Maria/B-9787-2015	Kennis, Jan/0000-0002-6431-1372; Zolfo, Maria/0000-0001-9756-9380				0	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S2.3	87	87						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900203					2019-04-02	
J	Jiang, L; Qui, QHN; Simpson, G; Quesada, F; Artama, WT; Joseph, J; Thys, S				Jiang, L.; Qui, Q. H. Nguyen; Simpson, G.; Quesada, F.; Artama, W. T.; Joseph, J.; Thys, S.			Mapping One health curriculum for better disease prevention and control: what and why	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jiang, L.] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Qui, Q. H. Nguyen] Natl Inst Anim Sci, Dept Anim Physiol Biochem & Behav, Hanoi, Vietnam; [Simpson, G.] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa; [Quesada, F.] Wild Spirit, Hoedspruit, South Africa; [Artama, W. T.] Univ Gadjah Mada, Hlth Resource Ctr 1, Yogyakarta, Indonesia; [Joseph, J.] Publ Hlth Fdn India, New Delhi, India; [Thys, S.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S2.5	88	88						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900205					2019-04-02	
J	Sunyoto, T; Potet, J; Torrellee, E; Boelaert, M				Sunyoto, T.; Potet, J.; Torrellee, E.; Boelaert, M.			Miltefosine: a case study of a product development partnership and why a life-saving drug is not available to patients who need it most	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sunyoto, T.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Sunyoto, T.; Potet, J.; Torrellee, E.] Med Sans Frontieres Campaign Access Med, Geneva, Switzerland								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6S3.2	89	89						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900207					2019-04-02	
J	Arsenijevic, J; Contenta, A; Moissaing, S; Ponthie, A; Malvisi, L; Zamatto, F; Severy, N; Manzi, M; de Vingne, B; Zachariah, R				Arsenijevic, J.; Contenta, A.; Moissaing, S.; Ponthie, A.; Malvisi, L.; Zamatto, F.; Severy, N.; Manzi, M.; de Vingne, B.; Zachariah, R.			A crisis of protection and humane treatment: violence, physical trauma and deaths among migrants/refugees travelling along the Western Balkan corridor to Northern Europe	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Arsenijevic, J.; Contenta, A.; Moissaing, S.] Med Sans Frontieres, Lekari Bez Granica Strahinica Ban, Belgrade, Serbia; [Ponthie, A.] Med Sans Frontieres, Anal & Advocacy Unit, MSF Brussels Operat Ctr, Brussels, Belgium; [Malvisi, L.; Zamatto, F.; Severy, N.; de Vingne, B.] Med Sans Frontieres, Operat Dept, Brussels Operat Ctr, Rome, Italy; [Malvisi, L.; Zamatto, F.; Severy, N.; de Vingne, B.] Med Sans Frontieres, Med Dept, Brussels Operat Ctr, Rome, Italy; [Malvisi, L.; Zamatto, F.; Severy, N.; de Vingne, B.] Med Sans Frontieres, Operat Dept, Brussels Operat Ctr, Brussels, Belgium; [Malvisi, L.; Zamatto, F.; Severy, N.; de Vingne, B.] Med Sans Frontieres, Med Dept, Brussels Operat Ctr, Brussels, Belgium; [Manzi, M.; Zachariah, R.] Med Sans Frontieres, Operat Res Unit LuxOR, MSF Brussels Operat Ctr, Luxembourg, Luxembourg								0	0	0	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	7S2.1	92	92						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900215					2019-04-02	
J	Lafaut, D				Lafaut, D.			Needs versus rights: moral understandings of healthcare workers and undocumented migrants in Belgium regarding access to healthcare	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lafaut, D.] VUB, Dept Philosophy & Eth, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	7S2.3	93	93						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900217					2019-04-02	
J	Kotsioni, I; Kastrissianaki, A; Haziri, I; Papachristou, A; Kokkiniotis, M; Zerva, E; Vallianou, A; Zamatto, F; Van den Bergh, R; Gionakis, N; Sarantou, E				Kotsioni, I.; Kastrissianaki, A.; Haziri, I.; Papachristou, A.; Kokkiniotis, M.; Zerva, E.; Vallianou, A.; Zamatto, F.; Van den Bergh, R.; Gionakis, N.; Sarantou, E.			Comprehensive care for migrants and refugees who have suffered torture and other forms of ill-treatment - the MSF experience in Athens	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kotsioni, I.; Kastrissianaki, A.; Haziri, I.; Papachristou, A.; Kokkiniotis, M.; Zerva, E.; Vallianou, A.; Zamatto, F.; Van den Bergh, R.] Med Sans Frontieres, Operat Ctr Brussels, Brussels, Belgium; [Gionakis, N.] Day Ctr BABEL, Athens, Greece; [Sarantou, E.] Greek Council Refugees, Athens, Greece								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	7S2.5	94	94						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900219					2019-04-02	
J	Natama, HM; Rovira-Vallbona, E; Sorgho, H; Some, MA; Coulibaly-Traore, M; Schallig, HDFH; D'Alessandro, U; Kestens, L; Tinto, H; Rosanas-Urgell, A				Natama, H. M.; Rovira-Vallbona, E.; Sorgho, H.; Some, M. A.; Coulibaly-Traore, M.; Schallig, H. D. F. H.; D'Alessandro, U.; Kestens, L.; Tinto, H.; Rosanas-Urgell, A.			Malaria in pregnancy preventive treatments may provide additional protection against febrile illnesses during the first year of life	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Natama, H. M.; Sorgho, H.; Some, M. A.; Coulibaly-Traore, M.; Tinto, H.] Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Natama, H. M.; Rovira-Vallbona, E.; Kestens, L.; Rosanas-Urgell, A.] Inst Trop Med, Antwerp, Belgium; [Natama, H. M.; Kestens, L.] Univ Antwerp, Antwerp, Belgium; [Schallig, H. D. F. H.] Acad Med Ctr, Amsterdam, Netherlands; [D'Alessandro, U.] MRC Unit, Banjul, Gambia; [Tinto, H.] Ctr Muraz, Bobo Dioulasso, Burkina Faso							Scott S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-340	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S1.1	94	95						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900220					2019-04-02	
J	Rouamba, T; Kpoda, H; Valea, I; Mens, PF; Gomes, M; Tinto, H; Kirakoya-Samadoulougou, F				Rouamba, T.; Kpoda, H.; Valea, I.; Mens, P. F.; Gomes, M.; Tinto, H.; Kirakoya-Samadoulougou, F.			Safety of antimalarial drug use during early pregnancy in Bobo Dioulasso: Examining low birth weight and congenital malformations as potential adverse outcomes	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rouamba, T.; Valea, I.; Tinto, H.] IRSS CRUN, Nanoro, Burkina Faso; [Rouamba, T.; Kirakoya-Samadoulougou, F.] Univ Libre Bruxelles, Ctr Rech Epidemiol Biostat & Rech Clin, Brussels, Belgium; [Kpoda, H.; Valea, I.; Tinto, H.] Ctr Muraz, Dept Clin Res, Bobo Dioulasso, Burkina Faso; [Mens, P. F.] Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [Gomes, M.] World Hlth Org WHO TDR, Geneva, Switzerland								0	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S1.2	95	95						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900221					2019-04-02	
J	Bahizire, E; Tugirimana, PL; Dramaix, M; Zozo, D; Bahati, M; Mwale, A; Meuris, S; Donnen, P				Bahizire, E.; Tugirimana, P. L.; Dramaix, M.; Zozo, D.; Bahati, M.; Mwale, A.; Meuris, S.; Donnen, P.			Malaria is more prevalent than iron deficiency among anemic pregnant women at the first antenatal visit in rural South-Kivu	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bahizire, E.; Zozo, D.] Ctr Rech Sci Nat Lwiro, Bukavu, DEM REP CONGO; [Bahizire, E.; Dramaix, M.; Donnen, P.] Univ Libre Bruxelles, Ctr Res Epidemiol Biostat & Clin Res, Brussels, Belgium; [Bahizire, E.; Mwale, A.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Tugirimana, P. L.] Natl Univ Rwanda, Dept Biol Clin, Kigali, Rwanda; [Tugirimana, P. L.] Univ Goma, Fac Med, Goma, DEM REP CONGO; [Bahati, M.] Div Prov Sante Sud Kivu, Bukavu, DEM REP CONGO; [Meuris, S.] Univ Libre Bruxelles, Lab Expt Hormonol, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S1.5	96	96						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900224					2019-04-02	
J	Ruizendaal, E; Schallig, HDFH; Traore, M; Lompo, P; Magloire, NH; Traore, O; Valea, I; Pagnoni, F; Dierickx, S; Scott, S; Bradley, J; d'Alessandro, U; Tinto, H; Mens, PF				Ruizendaal, E.; Schallig, H. D. F. H.; Traore, M.; Lompo, P.; Magloire, N. H.; Traore, O.; Valea, I.; Pagnoni, F.; Dierickx, S.; Scott, S.; Bradley, J.; d'Alessandro, U.; Tinto, H.; Mens, P. F.			Malaria screening during pregnancy with RDTs performed by community health workers in Nanoro, Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ruizendaal, E.; Schallig, H. D. F. H.; Mens, P. F.] Acad Med Ctr, Parasitol Unit, Dept Med Microbiol, Amsterdam, Netherlands; [Traore, M.; Lompo, P.; Magloire, N. H.; Traore, O.; Valea, I.; Tinto, H.] IRSS URCN, Nanoro, Burkina Faso; [Pagnoni, F.] WHO TDR, Geneva, Switzerland; [Dierickx, S.] Inst Trop Med, Antwerp, Belgium; [Scott, S.; d'Alessandro, U.] MRC, Banjul, Senegal; [Bradley, J.] London Sch Trop Med & Hyg, London, England								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S1.4	96	96						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900223					2019-04-02	
J	Compaore, A; Gies, S; Brabin, BJ; Tinto, H; Brabin, L				Compaore, A.; Gies, S.; Brabin, B. J.; Tinto, H.; Brabin, L.			A qualitative study of the acceptability of weekly iron supplementation prior to the first pregnancy in Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Compaore, A.; Tinto, H.] Inst Res Hlth Sci IRSS URCN, Clin Res Unit, Nanoro, Burkina Faso; [Gies, S.] Prince Leopold Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gies, S.] Med Mission Inst, Wurzburg, Germany; [Brabin, B. J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Brabin, B. J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Brabin, B. J.] Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Amsterdam, Netherlands; [Brabin, L.] Univ Manchester, Fac Biol Med & Hlth, Inst Canc Sci, Manchester, Lancs, England								0	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S2.4	98	98						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900228					2019-04-02	
J	Gies, S; Diallo, S; Tinto, H; Brabin, L; Roberts, S; D'Alessandro, U; Brabin, J				Gies, S.; Diallo, S.; Tinto, H.; Brabin, L.; Roberts, S.; D'Alessandro, U.; Brabin, J.			Malaria risk in young children after periconceptional iron supplementation of mothers in rural Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gies, S.] Prince Leopold Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gies, S.] Med Mission Inst, Wurzburg, Germany; [Diallo, S.; Tinto, H.] Inst Res Hlth Sci IRSS URCN, Clin Res Unit, Nanoro, Burkina Faso; [Brabin, L.] Univ Manchester, Fac Biol Med & Hlth, Inst Canc Sci, Manchester, Lancs, England; [Roberts, S.] Univ Manchester, Ctr Biostat, Fac Biol Med & Hlth, Manchester, Lancs, England; [D'Alessandro, U.] Med Res Council Unit MRC, Banjul, Gambia; [D'Alessandro, U.] London Sch Hyg & Trop Med, London, England; [Brabin, J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Brabin, J.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Brabin, J.] Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Amsterdam, Netherlands								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S2.5	98	98						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900229					2019-04-02	
J	Bosmans, M; Gyselinck, K; Van Bastelaere, S; Bossyns, P				Bosmans, M.; Gyselinck, K.; Van Bastelaere, S.; Bossyns, P.			Critical reflections on SRHR policies and law	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bosmans, M.; Gyselinck, K.; Van Bastelaere, S.; Bossyns, P.] BTC Belgian Dev Agcy, Hlth Unit, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.1	99	99						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900231					2019-04-02	
J	Mayhew, S; Van Belle, S				Mayhew, S.; Van Belle, S.			Evaluating DANIDA's global SRHR policy: Tracing accountability pathways at the global policy level	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mayhew, S.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Van Belle, S.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.2	99	100						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900232					2019-04-02	
J	Degomme, O; Michielsen, K; Van Braeckel, D				Degomme, O.; Michielsen, K.; Van Braeckel, D.			Academic network for sexual and reproductive health and rights policy (ANSER)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Degomme, O.; Michielsen, K.; Van Braeckel, D.] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.4	100	101						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900234					2019-04-02	
J	Van de Voorde, W; Blondeel, K				Van de Voorde, W.; Blondeel, K.		Working Grp Sexual Reprod Hlth; Belgian Platform Int Hlth	Body & Rights - E-learning on sexual and reproductive health and rights for stakeholders of development cooperation	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van de Voorde, W.] Flemish Expertise Ctr Sexual Hlth, Sensoa, Antwerp, Belgium; [Blondeel, K.] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium							[Anonymous], 2013, DEV COOP; FAO, 2011, E LEARN METH GUID DE; Fee K, 2009, DELIVERING E LEARNIN	3	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.3	100	100						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900233					2019-04-02	
J	Dossou, JP; Kanhonou, L; Bello, K; Goufodji, S				Dossou, J. P.; Kanhonou, L.; Bello, K.; Goufodji, S.			Addressing unsafe abortion in Benin: why is the current policy inappropriate?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dossou, J. P.; Kanhonou, L.; Bello, K.; Goufodji, S.] Res Ctr Human Reprod & Demog, Dept Publ Hlth, Cotonou, Benin; [Dossou, J. P.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S3.5	101	101						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900235					2019-04-02	
J	Zewolde, S; Florquin, S; Bos, M; Dubourg, D; Richard, F; O'Neill, S				Zewolde, S.; Florquin, S.; Bos, M.; Dubourg, D.; Richard, F.; O'Neill, S.			"Never trust an open door" - Controversies of sexual pleasure, pain and female genital mutilation among African migrants in Belgium, the Netherlands and the UK	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Zewolde, S.] UCL IOE, London, England; [Zewolde, S.] FORWARD, London, England; [Florquin, S.; Richard, F.] GAMS Belgique, Brussels, Belgium; [Florquin, S.] HIMILO Fdn, Amsterdam, Netherlands; [Dubourg, D.] Observ Wallon Sante, Antwerp, Belgium; [O'Neill, S.] ITM, Dept Publ Hlth, Antwerp, Belgium								0	0	0	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S4.4	102	103						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900239					2019-04-02	
J	Van Malderen, C; Amouzou, A; Masquelier, B; Van Oyen, H; Speybroeck, N				Van Malderen, C.; Amouzou, A.; Masquelier, B.; Van Oyen, H.; Speybroeck, N.			Country-specific pathways from socioeconomic determinants to under-five mortality in sub-Saharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Malderen, C.; Speybroeck, N.] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium; [Amouzou, A.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Masquelier, B.] Catholic Univ Louvain, Ctr Rech Demog, Louvain La Neuve, Belgium; [Van Oyen, H.] Sci Inst Publ Hlth, Publ Hlth & Surveillance, Brussels, Belgium; [Van Oyen, H.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8S6.3	106	106						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900247					2019-04-02	
J	Hinckel, BCB				Hinckel, B. C. Bremer			Reality versus idealism: was Rutherford right?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hinckel, B. C. Bremer] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Hinckel, B. C. Bremer] Coris BioConcept, Gembloux, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S3.2	111	112						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900260					2019-04-02	
J	Sunyoto, T; Potet, J; Picado, A; Boelaert, M				Sunyoto, T.; Potet, J.; Picado, A.; Boelaert, M.			Access to leishmaniasis care - bridging research and humanitarian needs: a Euroleish experience	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sunyoto, T.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Sunyoto, T.; Potet, J.] Med Sans Frontieres Campaign Access Med, Geneva, Switzerland; [Picado, A.] ISGlobal, Barcelona, Spain								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S3.1	111	111						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900259					2019-04-02	
J	Hefnawy, A; Cantizani, J; Pena, I; Dujardin, JC; de Muylder, G; Martin, J				Hefnawy, A.; Cantizani, J.; Pena, I.; Dujardin, J. C.; de Muylder, G.; Martin, J.			The challenges and motivations for doing a PhD in a neglected tropical disease	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hefnawy, A.; Dujardin, J. C.; de Muylder, G.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Cantizani, J.; Pena, I.; Martin, J.] GlaxoSmithKline, Dis Developing World, Tres Cantos, Spain								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S3.3	112	112						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900261					2019-04-02	
J	Bannister-Tyrrell, M				Bannister-Tyrrell, M.			Micro-epidemiology of malaria in three villages in a low-transmission setting in north-eastern Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bannister-Tyrrell, M.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S4.2	114	114						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900266					2019-04-02	
J	Sarkar, N				Sarkar, N.			The perceived social aetiologies and solutions of perinatal common mental disorders in rural Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sarkar, N.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	9S4.4	114	114						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900268					2019-04-02	
J	De Koninck, AS; Cnops, L; Hofmans, M; Jacobs, J; Van den Bossche, D; Philippe, J				De Koninck, A-S.; Cnops, L.; Hofmans, M.; Jacobs, J.; Van den Bossche, D.; Philippe, J.			Diagnostic performance of the Loop-Mediated Isothermal Amplification (LAMP) based illumigene (R) Malaria assay in a non-endemic region	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Koninck, A-S.; Hofmans, M.; Philippe, J.] Ghent Univ Hosp GUH, Dept Lab Med, Ghent, Belgium; [Cnops, L.; Jacobs, J.; Van den Bossche, D.] Inst Trop Med ITM Antwerp, Antwerp, Belgium								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P3	116	116						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900271					2019-04-02	
J	Hefnawy, A; Cantizani, J; Pena, I; Dujardin, JC; de Muylder, G; Martin, J				Hefnawy, A.; Cantizani, J.; Pena, I.; Dujardin, J. C.; de Muylder, G.; Martin, J.			Evaluation of the leishbox compounds on nepalese clinical isolates of Leishmania donovani, an industrial/academic collaboration	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hefnawy, A.; Dujardin, J. C.; de Muylder, G.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Cantizani, J.; Pena, I.; Martin, J.] GlaxoSmithKline, Dis Developing World, Tres Cantos, Spain					European Union's H2020 Programme under the MSCA GA [642609]	This research is funded by the European Union's H2020 Programme under the MSCA GA no 642609.	Hefnawy A, 2017, TRENDS PARASITOL, V33, P162, DOI 10.1016/j.pt.2016.11.003; Pena I, 2015, SCI REP-UK, V5, DOI 10.1038/srep08771	2	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P5	116	117						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900273					2019-04-02	
J	Lanko, K; Kaptein, S; Eggermont, K; Patel, A; Claes, C; Guo, W; Van Damme, P; Van den Bosch, L; Delang, L; Verfaillie, C; Neyts, J				Lanko, K.; Kaptein, S.; Eggermont, K.; Patel, A.; Claes, C.; Guo, W.; Van Damme, P.; Van den Bosch, L.; Delang, L.; Verfaillie, C.; Neyts, J.			Induced pluripotent stem cell-derived neuronal cultures as a model to study ZIKA virus infections and antivirals	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lanko, K.; Kaptein, S.; Delang, L.; Neyts, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Eggermont, K.; Patel, A.; Claes, C.; Verfaillie, C.] Katholieke Univ Leuven, Stem Cell Inst, Leuven, Belgium; [Guo, W.; Van Damme, P.; Van den Bosch, L.] Katholieke Univ Leuven, Lab Neurobiol, Leuven, Belgium			Neyts, Johan/U-8267-2017; Lanko, Kristina/D-9579-2018; Delang, Leen/D-9548-2018	Neyts, Johan/0000-0002-0033-7514; Lanko, Kristina/0000-0002-0749-0079; Delang, Leen/0000-0002-8874-675X				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P8	117	118						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900276					2019-04-02	
J	Tricot, T; Helsen, N; Kaptein, S; Neyts, J; Verfaillie, C				Tricot, T.; Helsen, N.; Kaptein, S.; Neyts, J.; Verfaillie, C.			Human stem cell-derived hepatocyte-like cells support Zika virus replication and provide a relevant model to assess efficacy of potential antivirals	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Tricot, T.; Helsen, N.; Verfaillie, C.] Katholieke Univ Leuven, Stem Cell Inst, Dept Dev & Regenerat, Leuven, Belgium; [Kaptein, S.; Neyts, J.] Katholieke Univ Leuven, Rega Inst Med Res, Lab Virol & Expt Chemotherapy, Leuven, Belgium			Neyts, Johan/U-8267-2017	Neyts, Johan/0000-0002-0033-7514				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P6	117	117						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900274					2019-04-02	
J	Vlaminck, J; Dana, D; Demeyer, L; Mekonnen, Z; Weil, GJ; Geldhof, P; Levecke, B				Vlaminck, J.; Dana, D.; Demeyer, L.; Mekonnen, Z.; Weil, G. J.; Geldhof, P.; Levecke, B.			An immunomics approach detects promising candidate antigens for Ascaris serodiagnosis in pigs and humans	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vlaminck, J.; Dana, D.; Demeyer, L.; Geldhof, P.; Levecke, B.] Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Dana, D.; Mekonnen, Z.] Jimma Univ, Lab Parasitol, Jimma, Ethiopia; [Weil, G. J.] Washington Univ, Dept Internal Med, Div Infect Dis, St Louis, MO USA								0	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P9	118	118						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900277					2019-04-02	
J	Hoekstra, PT; Madinga, J; Lutumba, P; Corstjens, PLAM; van Dam, GJ; Polman, K; van Lieshout, L				Hoekstra, P. T.; Madinga, J.; Lutumba, P.; Corstjens, P. L. A. M.; van Dam, G. J.; Polman, K.; van Lieshout, L.			Diagnosis of schistosomiasis without a microscope: a community-based survey using PCR and CCA-CAA detection on banked stool and urine samples from Dr Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hoekstra, P. T.; van Dam, G. J.; van Lieshout, L.] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Madinga, J.] Catholic Univ Louvain, Inst Hlth & Soc, Brussels, Belgium; [Madinga, J.; Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, P.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Corstjens, P. L. A. M.] Leiden Univ, Dept Mol Cell Biol, Med Ctr, Leiden, Netherlands								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P17	121	121						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900285					2019-04-02	
J	Van den Bossche, D; Foque, N; Michiels, J; Arien, KK; Van Esbroeck, M				Van den Bossche, D.; Foque, N.; Michiels, J.; Arien, K. K.; Van Esbroeck, M.			Can a ZIKA IGM and IGG immunoblot replace the virus neutralisation test to confirm screening test results?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van den Bossche, D.; Foque, N.; Van Esbroeck, M.] Inst Trop Med, Dept Clin Sci, Natl Reference Ctr Arboviruses, Antwerp, Belgium; [Michiels, J.; Arien, K. K.] Inst Trop Med, Dept Biomed Sci, Virol Unit, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P18	122	122						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900286					2019-04-02	
J	Braet, S; Vandelannoote, K; Meehan, C; Rigouts, L; Fontes, AB; Rosa, P; Suffys, P; De Jong, B				Braet, S.; Vandelannoote, K.; Meehan, C.; Rigouts, L.; Fontes, A. Brum; Rosa, P.; Suffys, P.; De Jong, B.			Analysis of the specificity of a Mycobacterium leprae diagnostic qPCR	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Braet, S.; Vandelannoote, K.; Meehan, C.; Rigouts, L.; De Jong, B.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Fontes, A. Brum; Suffys, P.] Oswaldo Cruz Inst, Rio De Janeiro, Brazil; [Rosa, P.] Inst Lauro de Souza Lima, Bauru, Brazil							Martinez AN, 2009, J CLIN MICROBIOL, V47, P2124, DOI 10.1128/JCM.00512-09	1	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P20	123	123						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900288					2019-04-02	
J	Morales-Yanez, FJ; Sariego, I; De Wael, K; Polman, K; Muylermans, S; Trashin, S				Morales-Yanez, F. J.; Sariego, I.; De Wael, K.; Polman, K.; Muylermans, S.; Trashin, S.			Development of a nanobody-based amperometric immunocapturing assay for sensitive and specific detection of Toxocara canis excretory-secretory antigen	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Morales-Yanez, F. J.; Muylermans, S.] Vrije Univ Brussel, Lab Mol & Cellular Immunol CMIM, Brussels, Belgium; [Morales-Yanez, F. J.; Polman, K.] Inst Trop Med Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Sariego, I.] Inst Med Trop Pedro Kouri, Dept Parasitol, Havana, Cuba; [De Wael, K.; Trashin, S.] Univ Antwerp, Dept Chem, Antwerp, Belgium			De Wael, Karolien/U-5545-2018					0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P21	123	123						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900289					2019-04-02	
J	Rutanga, JP; Van Puyvelde, S; De Block, T; Jacobs, J; Muvunyi, CM; Deborggraeve, S				Rutanga, J. P.; Van Puyvelde, S.; De Block, T.; Jacobs, J.; Muvunyi, C. M.; Deborggraeve, S.			Optimization of the PAXgene Blood RNA system to store Salmonella cells for subsequent RNA analysis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rutanga, J. P.] Univ Rwanda, Coll Sci & Technol, Kigali, Rwanda; [Rutanga, J. P.; Van Puyvelde, S.; De Block, T.; Deborggraeve, S.] Inst Trop Med, Dept Biomed Sci, Unit Diagnost Bacteriol, Antwerp, Belgium; [Rutanga, J. P.; Jacobs, J.] Katholieke Univ Leuven, Microbiol & Immunol, Biomed Sci, Leuven, Belgium; [Jacobs, J.] Inst Trop Med, Dept Clin Sci, Unit Trop Lab Med, Antwerp, Belgium; [Muvunyi, C. M.] Univ Rwanda, Coll Med & Hlth Sci, Kigali, Rwanda								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P24	124	125						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900292					2019-04-02	
J	Sariego, I; Rojas, L; Cantillo, J; Falcon, R; Polman, K				Sariego, I.; Rojas, L.; Cantillo, J.; Falcon, R.; Polman, K.			Usefulness of TOXOCARA CANIS larval low molecular weight excretory-secretory products for diagnosis of human toxocariasis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sariego, I.; Rojas, L.] Inst Trop Med Pedro Kouri, Dept Parasitol, Havana, Cuba; [Cantillo, J.] Inst Trop Med Pedro Kouri, Anim House, Havana, Cuba; [Falcon, R.] Inst Trop Med Pedro Kouri, Bacteriol Mycol Dept, Havana, Cuba; [Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P26	125	125						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900294					2019-04-02	
J	Nakiwala, JK; Walker, NF; Diedrich, CR; Meintjes, G; Wilkinson, RJ; Mayanja-Kizza, H; Colebunders, R; Kestens, L; Wilkinson, KA; Lowe, DM				Nakiwala, J. K.; Walker, N. F.; Diedrich, C. R.; Meintjes, G.; Wilkinson, R. J.; Mayanja-Kizza, H.; Colebunders, R.; Kestens, L.; Wilkinson, K. A.; Lowe, D. M.			Neutrophil activation and enhanced release of granule products in HIV-TB immune reconstitution inflammatory syndrome	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Nakiwala, J. K.; Walker, N. F.; Diedrich, C. R.; Meintjes, G.; Wilkinson, R. J.; Wilkinson, K. A.; Lowe, D. M.] Univ Cape Town, Wellcome Ctr Infect Dis Res Africa, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Nakiwala, J. K.; Walker, N. F.; Diedrich, C. R.; Meintjes, G.; Wilkinson, R. J.; Wilkinson, K. A.; Lowe, D. M.] Univ Cape Town, Dept Med, Cape Town, South Africa; [Nakiwala, J. K.; Colebunders, R.; Kestens, L.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Nakiwala, J. K.; Kestens, L.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Walker, N. F.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Diedrich, C. R.] Univ Pittsburgh, Childrens Hosp, UPMC, Pediat,Div Infect Dis, Pittsburgh, PA 15260 USA; [Meintjes, G.; Wilkinson, R. J.; Lowe, D. M.] Imperial Coll London, Dept Med, London, England; [Wilkinson, R. J.; Wilkinson, K. A.] Francis Crick Inst, London, England; [Mayanja-Kizza, H.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Lowe, D. M.] UCL, Inst Immun & Transplantat, Royal Free Campus, London, England								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P28	126	126						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900296					2019-04-02	
J	Adriaensen, W; Diro, E; Abdellati, S; Gedamu, Y; Mengesha, B; Adem, E; Vogt, F; van Henten, S; Kestens, L; Van Griensven, J				Adriaensen, W.; Diro, E.; Abdellati, S.; Gedamu, Y.; Mengesha, B.; Adem, E.; Vogt, F.; van Henten, S.; Kestens, L.; Van Griensven, J.			Low levels of soluble CD40 ligand in asymptomatic leishmania donovani co-infected HIV patients	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Adriaensen, W.; Abdellati, S.; Vogt, F.; van Henten, S.; Van Griensven, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Diro, E.; Gedamu, Y.; Mengesha, B.; Adem, E.] Univ Gondar, Leishmaniasis Res & Treatment Ctr, Gondar, Ethiopia; [Kestens, L.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P30	127	127						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900298					2019-04-02	
J	Cisse, M; Awandare, GA; Soulama, A; Tinto, H; Hayette, MP; Guiguemde, RT				Cisse, M.; Awandare, G. A.; Soulama, A.; Tinto, H.; Hayette, M. P.; Guiguemde, R. T.			Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine- pyrimethamine is associated with selection of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cisse, M.; Soulama, A.; Guiguemde, R. T.] Ctr MURAZ, Lab Parasitol & Entomol, Bobo Dioulasso, Burkina Faso; [Cisse, M.] Univ Polytech Bobo Dioulasso, Lab Parasitol & Mycol, Bobo Dioulasso, Burkina Faso; [Awandare, G. A.] Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens, Legon, Accra, Ghana; [Tinto, H.] Ctr MURAZ, Dept Clin Res, Bobo Dioulasso, Burkina Faso; [Hayette, M. P.] Univ Hosp Liege, Lab Clin Microbiol, Liege, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P36	130	130						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900304					2019-04-02	
J	Soulama, A; Cisse, M; Awandare, AG; Hayette, MP; Guiguemde, TR				Soulama, A.; Cisse, M.; Awandare, A. G.; Hayette, M-P.; Guiguemde, T. R.			High prevalence of Pfdhfr and Pfdhps genes mutations in pregnant women in Bobo-Dioulasso, Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Soulama, A.; Cisse, M.; Guiguemde, T. R.] Ctr MURAZ, Bobo Dioulasso, Burkina Faso; [Cisse, M.; Guiguemde, T. R.] Univ Nazi Boni Bobo Dioulasso, Inst Super Sci Sante, Bobo Dioulasso, Burkina Faso; [Awandare, A. G.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Accra, Ghana; [Hayette, M-P.] Ctr Hosp Univ Liege, Lab Microbiol Clin, Liege, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P39	131	131						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900307					2019-04-02	
J	Baraka, V; Hansson, H; Mavoko, HM; Nabasumba, C; Francis, F; Lutumba, P; Alifrangis, M; Geertruyden, JPV				Baraka, V.; Hansson, H.; Mavoko, H. M.; Nabasumba, C.; Francis, F.; Lutumba, P.; Alifrangis, M.; Geertruyden, J-P. V.			Pharmacogenetic profile of P450 2B6, 2C8 and 3A4 genetic variants and the clinical association with malaria recurrent infections in DR Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Baraka, V.; Francis, F.] Tanga Res Ctr, Natl Inst Med Res, POB 5004, Tanga, Tanzania; [Baraka, V.; Mavoko, H. M.; Nabasumba, C.; Geertruyden, J-P. V.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Hansson, H.; Alifrangis, M.] Univ Copenhagen, Dept Immunol & Microbiol, Ctr Med Parasitol, Copenhagen, Denmark; [Hansson, H.; Alifrangis, M.] Rigshosp, Natl Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Mavoko, H. M.; Lutumba, P.] Univ Kinshasa, Fac Med, Dept Med Trop, BP 747 Kin 11, Kinshasa, DEM REP CONGO; [Nabasumba, C.] Epictr Mbarara Res Base, POB 930, Mbarara, Uganda								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P44	133	133						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900312					2019-04-02	
J	Cuypers, WL; Dougan, G; Jacobs, J; Laukens, K; Deborggraeve, S; Van Puyvelde, S				Cuypers, W. L.; Dougan, G.; Jacobs, J.; Laukens, K.; Deborggraeve, S.; Van Puyvelde, S.			First genome of Salmonella concord, a highly resistant and virulent salmonella serotype in the Horn of Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract							CHILDREN		[Cuypers, W. L.; Deborggraeve, S.; Van Puyvelde, S.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Dougan, G.] Wellcome Trust Sanger Inst, Microbial Pathogenesis, Hinxton Cambridge, England; [Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Laukens, K.] Univ Antwerp, Dept Math & Comp Sci, Antwerp, Belgium				Cuypers, Wim/0000-0002-1895-3526			Fabre L, 2009, ANTIMICROB AGENTS CH, V53, P1808, DOI 10.1128/AAC.00451-08; Hendriksen RS, 2009, PEDIATR INFECT DIS J, V28, P814, DOI 10.1097/INF.0b013e3181a3aeac	2	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P50	135	136						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900318					2019-04-02	
J	Sun, L; Tijsma, A; Thibaut, HJ; Mirabelli, C; Delang, L; Neyts, J				Sun, L.; Tijsma, A.; Thibaut, H. J.; Mirabelli, C.; Delang, L.; Neyts, J.			The establishment of an Enterovirus 71 (EV71) infection model with robust lethal neuro-pathogenicity in adult mice	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sun, L.; Tijsma, A.; Thibaut, H. J.; Mirabelli, C.; Delang, L.; Neyts, J.] Katholieke Univ Leuven, Lab Virol & Chemotherapy, Leuven, Belgium			Thibaut, Hendrik Jan/D-9505-2018; Delang, Leen/D-9548-2018; Neyts, Johan/U-8267-2017; Mirabelli, Carmen/D-9441-2018	Thibaut, Hendrik Jan/0000-0001-5785-8276; Delang, Leen/0000-0002-8874-675X; Neyts, Johan/0000-0002-0033-7514; Mirabelli, Carmen/0000-0002-4785-5482				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P55	138	138						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900323					2019-04-02	
J	Willen, L; Mertens, P; Volf, P				Willen, L.; Mertens, P.; Volf, P.			Preparation of colloidal gold immunochromatigraphic test to detect dog exposure to Phlebotomus Perniciosus in endemic settings of canine Leishmaniasis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Willen, L.; Volf, P.] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Mertens, P.] Coris BioConcept, Crealys Pk, Gembloux, Belgium			Willen, Laura/B-2977-2018; Volf, Petr/C-4300-2012	Willen, Laura/0000-0002-8027-8621; Volf, Petr/0000-0003-1790-1123				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	1P66	142	142						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900334					2019-04-02	
J	Vinueza, C; De Zutter, L				Vinueza, C.; De Zutter, L.			Important foodborne bacteria and their antimicrobial resistances in Ecuadorian poultry	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vinueza, C.] Univ Cent Ecuador, Fac Med Vet & Zootecnia, Quito, Ecuador; [De Zutter, L.] Univ Ghent, Fac Vet, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium							Vinueza C., 2016, PLOS ONE, V11, P1; Vinueza-Burgos C, 2017, ECUADORIAN BROILERS, P1	2	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P4	144	144						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900338					2019-04-02	
J	Johansen, MV; Braae, UC; Trevisan, C; Lekule, F; Magnussen, P; Ngowi, H				Johansen, M. V.; Braae, U. C.; Trevisan, C.; Lekule, F.; Magnussen, P.; Ngowi, H.			A one health approach to Taenia Solium control in subSaharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Johansen, M. V.; Magnussen, P.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark; [Braae, U. C.] Ross Univ, One Hlth Ctr Zoonoses & Trop Vet Med, Sch Vet Med, Basseterre, St Kitts & Nevi; [Trevisan, C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Lekule, F.] Sokoine Univ Agr, Fac Agr, Morogoro, Tanzania; [Magnussen, P.] Univ Copenhagen, Ctr Med Parasitol, Copenhagen, Denmark; [Ngowi, H.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, Morogoro, Tanzania				Magnussen, Pascal/0000-0001-7372-0250				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P6	145	145						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900340					2019-04-02	
J	Trevisan, C; Fevre, EM; Owinyi, M; Ngere, I; Johansen, MV				Trevisan, C.; Fevre, E. M.; Owinyi, M.; Ngere, I.; Johansen, M. V.			Minyoo Matata - The Vicious Worm - A Taenia Solium taeniosis/cysticercosis health education tool - in Swahili	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Trevisan, C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Fevre, E. M.; Owinyi, M.; Ngere, I.] Int Livestock Res Inst, Nairobi, Kenya; [Fevre, E. M.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Owinyi, M.; Ngere, I.] Kenya Field Epidemiol & Lab Training Programme, Nairobi, Kenya; [Johansen, M. V.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Copenhagen, Denmark								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P7	145	145						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900341					2019-04-02	
J	Chamlagain, D; Aryal, A; Pokhrel, KN; Poudel, KN; Kattel, B; Kakkar, M; Thys, S; Jiang, L; Agrawal, Y; Kattel, V				Chamlagain, D.; Aryal, A.; Pokhrel, K. N.; Poudel, K. N.; Kattel, B.; Kakkar, M.; Thys, S.; Jiang, L.; Agrawal, Y.; Kattel, V.			Gaps in the control of zoonoses In Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Chamlagain, D.] Minist Hlth, Dept Hlth Serv, Kathmandu, Nepal; [Aryal, A.] Cent Vet Hosp, Dept Livestock Dev, Kathmandu, Nepal; [Pokhrel, K. N.] UN, Populat Funds, Sunsari, Nepal; [Poudel, K. N.] Mid Western Reg Hosp, Dept Internal Med, Surkhet, Nepal; [Kattel, B.] Cent Collage Technol, Dept Food Engn, Dharan, Nepal; [Kakkar, M.] Publ Hlth Fdn India, Delhi, India; [Thys, S.; Jiang, L.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Agrawal, Y.; Kattel, V.] BPKIHS, Dept Internal Med, Dharan, Nepal								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P10	146	147						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900344					2019-04-02	
J	Jansen, F; Dorny, P; Makay, C; van den Broeck, N; Berkvens, D; Gabrie, S				Jansen, F.; Dorny, P.; Makay, C.; van den Broeck, N.; Berkvens, D.; Gabrie, S.			Evaluation of post-mortem detection techniques for bovine cysticercosis in Belgium	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jansen, F.; Dorny, P.; Makay, C.; van den Broeck, N.; Berkvens, D.; Gabrie, S.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gabrie, S.] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Merelbeke, Belgium								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P20	150	151						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900354					2019-04-02	
J	Manzambi, E; Ilombe, G; Mampangulu, T; Madinga, J; Likwela, J; Lutumba, P; Van Geertruyden, JP; Seth, I; Muyembe, JJ; Wat'senga, TF				Manzambi, E.; Ilombe, G.; Mampangulu, T.; Madinga, J.; Likwela, J.; Lutumba, P.; Van Geertruyden, J. P.; Seth, I.; Muyembe, J. J.; Wat'senga, T. F.			Anopheles mosquitoes and transmission of malaria in the mountainous region of Rutshuru, in eastern Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Manzambi, E.; Ilombe, G.; Mampangulu, T.; Muyembe, J. J.; Wat'senga, T. F.] Inst Natl Rech Biomed, Dept Ecol Vectorielle & Environm, Kinshasa, DEM REP CONGO; [Madinga, J.] Univ Kinshasa, Dept Parasitol, Fac Med, Kinshasa, DEM REP CONGO; [Likwela, J.] Programme Natl Lutte Paludisme, Kinshasa, DEM REP CONGO; [Lutumba, P.] Inst Natl Rech Biomed, Dept Epidemiol, Kinshasa, DEM REP CONGO; [Seth, I.] Ctr Dis Control & Prevent, Entomol Branch, Atlanta, GA USA; [Van Geertruyden, J. P.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P31	155	155						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900365					2019-04-02	
J	Theodorakos, K; Broeckhove, J; Willem, L				Theodorakos, K.; Broeckhove, J.; Willem, L.			Examination of influencing factors and high-risk regions of dengue In Nicaragua, using spatiotemporal compartmental simulations	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Theodorakos, K.; Broeckhove, J.] Univ Antwerp, Dept Math & Comp Sci, Modeling Syst & Internet Commun, Antwerp, Belgium; [Willem, L.] Univ Antwerp, Ctr Hlth Econ Res & Modelling Infect Dis, Vaccine & Infect Dis Inst, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P35	156	157						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900369					2019-04-02	
J	Falay, D; Peeters, M; Tanzito, J; Akaibe, D; Lunguya, O; Matheus, W; Bertrand, S; Van Geet, C; Ngbonda, D; Jacobs, J				Falay, D.; Peeters, M.; Tanzito, J.; Akaibe, D.; Lunguya, O.; Matheus, W.; Bertrand, S.; Van Geet, C.; Ngbonda, D.; Jacobs, J.			Rats as a potential reservoir of invasive non-Typhi Salmonella: a field study in Kisangani, Province of Tshopo, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Falay, D.; Ngbonda, D.] Univ Hosp Kisangani, Dept Pediat, Kisangani, DEM REP CONGO; [Peeters, M.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Tanzito, J.; Akaibe, D.] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Lunguya, O.] Natl Inst Biomed Res, Dept Clin Microbiol, Kinshasa, DEM REP CONGO; [Matheus, W.; Bertrand, S.] Belgian Natl Ctr Salmonella, Sci Inst Publ Hlth, Brussels, Belgium; [Van Geet, C.] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Cardiovasc Med & Pediat, Leuven, Belgium; [Jacobs, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P40	159	159						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900374					2019-04-02	
J	Sungirai, M; Moyo, DZ; De Clercq, P; Madder, M				Sungirai, M.; Moyo, D. Z.; De Clercq, P.; Madder, M.			Expansion in the distributional range of ixodid ticks parasitising cattle in Zimbabwe	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sungirai, M.] Midlands State Univ, Dept Livestock & Wildlife Management, Gweru, Zimbabwe; [Moyo, D. Z.] Midlands State Univ, Dept Biol Sci, Gweru, Zimbabwe; [De Clercq, P.] Univ Ghent, Dept Crop Protect, Ghent, Belgium; [Madder, M.] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa			De Clercq, Patrick/B-5721-2015	De Clercq, Patrick/0000-0003-0664-1602				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P46	162	162						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900380					2019-04-02	
J	Ilombe, G; Metelo, E; Binene, G; Tona, G; Maniania, J; Nagahuedi, J; Muyembe, JJ; Masiangi, P; Van Greertruyden, JP; Wondji, C				Ilombe, G.; Metelo, E.; Binene, G.; Tona, G.; Maniania, J.; Nagahuedi, J.; Muyembe, J. J.; Masiangi, P.; Van Greertruyden, J. P.; Wondji, C.			Status of insecticide resistance of Anopheles populations and identification of resistance mechanisms in Kwilu Province in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ilombe, G.; Metelo, E.; Binene, G.; Muyembe, J. J.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Ilombe, G.; Tona, G.] Univ Kinshasa, Clin Pharmacol Unit, Kinshasa, DEM REP CONGO; [Metelo, E.] Univ Bandundu, Fac Med, Bandundu, DEM REP CONGO; [Maniania, J.] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Nagahuedi, J.] Univ Kinshasa, Fac Sci, Kinshasa, DEM REP CONGO; [Muyembe, J. J.; Masiangi, P.] Univ Kinshasa, Fac Med, Kinshasa, DEM REP CONGO; [Van Greertruyden, J. P.] Antwerp Univ, Fac Med, Int Hlth Epidemiol & Social Med, Antwerp, Belgium; [Wondji, C.] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P49	163	163						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900383					2019-04-02	
J	Hendy, A; Sluydts, V; Tushar, T; De Witte, J; Odonga, P; Lakwo, T; Dujardin, JC; Post, RJ; Kalinga, A; Echodu, R				Hendy, A.; Sluydts, V.; Tushar, T.; De Witte, J.; Odonga, P.; Lakwo, T.; Dujardin, J. C.; Post, R. J.; Kalinga, A.; Echodu, R.			Esperanza window traps for the collection of anthropophilic blackflies (Diptera: Simuliidae) in Uganda and Tanzania	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hendy, A.; De Witte, J.; Dujardin, J. C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Sluydts, V.] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, Antwerp, Belgium; [Tushar, T.; Post, R. J.] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Odonga, P.; Lakwo, T.] Minist Hlth, Vector Control Div, Kampala, Uganda; [Post, R. J.] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Kalinga, A.] Natl Inst Med Res, Tukuyu Res Ctr, Tukuyu, Tanzania; [Echodu, R.] Gulu Univ, Fac Sci, Gulu, Uganda								0	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P51	164	164						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900385					2019-04-02	
J	Huyse, T; Boon, N; Smitz, N; De Sciscio, A; Kanage, B; Polman, K; Volckaert, F; Van den Broeck, F				Huyse, T.; Boon, N.; Smitz, N.; De Sciscio, A.; Kanage, B.; Polman, K.; Volckaert, F.; Van den Broeck, F.			Don't overlook the snail: the role of the intermediate snail host in the dynamic epidemiology of schistosomiasis in Northern Senegal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Huyse, T.; Boon, N.; Kanage, B.; Volckaert, F.] Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium; [Huyse, T.; Smitz, N.; De Sciscio, A.] Royal Museum Cent Africa, Dept Biol, Tervuren, Belgium; [Boon, N.; Polman, K.; Van den Broeck, F.] Inst Trop Med, Dept Biomed Sci, Unit Med Helminthol, Antwerp, Belgium								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	2P57	166	166						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900391					2019-04-02	
J	Adem, E; Auwera, GV; Doleckova, K; Adriaensen, W; Van den Bossche, D; Diro, E; van Griensven, J; Cnops, L				Adem, E.; Auwera, G. Vander; Doleckova, K.; Adriaensen, W.; Van den Bossche, D.; Diro, E.; van Griensven, J.; Cnops, L.			Optimization of the Dna extraction and real-time PCR for low parasitemia Leishmania Infections	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Adem, E.; Diro, E.] Univ Gondar Hosp, Gondar, Ethiopia; [Auwera, G. Vander] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Doleckova, K.; Adriaensen, W.; Van den Bossche, D.; van Griensven, J.; Cnops, L.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P15	172	172						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900406					2019-04-02	
J	Buscher, P; Mertens, P; Gilleman, Q; Rooney, B; Roge, S				Buscher, P.; Mertens, P.; Gilleman, Q.; Rooney, B.; Roge, S.			rHAT Sero-Strip, a new rapid diagnostic test for gambiense sleeping sickness using recombinant antigens	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Buscher, P.; Roge, S.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Mertens, P.; Gilleman, Q.] Coris BioConcept, Gembloux, Belgium; [Rooney, B.] Univ Kent, Canterbury, Kent, England								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P14	172	172						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900405					2019-04-02	
J	Bennis, I; Verdonck, K; Riyad, M; El Khalfaoui, N; Fellah, H; Sahibi, H; Van der Auwera, G; Dujardin, JC; Boelaert, M				Bennis, I.; Verdonck, K.; Riyad, M.; El Khalfaoui, N.; Fellah, H.; Sahibi, H.; Van der Auwera, G.; Dujardin, J-C.; Boelaert, M.			Accuracy of a rapid test for the diagnosis of cutaneous leishmaniasis in patients with suggestive skin lesions in Morocco	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bennis, I.] Minist Hlth, Natl Sch Publ Hlth, Rabat, Morocco; [Bennis, I.; Verdonck, K.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Bennis, I.; Dujardin, J-C.] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Biomed Sci, Antwerp, Belgium; [Riyad, M.; El Khalfaoui, N.] Univ Hassan II Casablanca, Lab Parasitol, Casablanca, Morocco; [Riyad, M.; El Khalfaoui, N.] Univ Hassan II Casablanca, Fac Med & Pharm, Res Team Immunopathol Infect & Syst Dis, Casablanca, Morocco; [Fellah, H.] Natl Inst Hlth, Lab Leishmaniasis, Rabat, Morocco; [Sahibi, H.] Hassan II Agron & Vet Inst, Dept Parasitol, Rabat, Morocco; [Van der Auwera, G.; Dujardin, J-C.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P17	173	173						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900408					2019-04-02	
J	Peeters, M; Chung, P; Lin, H; Mortelmans, K; Phe, C; San, C; Kuijpers, L; Teav, S; Phe, T; Jacobs, J				Peeters, M.; Chung, P.; Lin, H.; Mortelmans, K.; Phe, C.; San, C.; Kuijpers, L.; Teav, S.; Phe, T.; Jacobs, J.			Diagnostic performance of the InBiOS rapid diagnostic test for the detection of Burkholderia pseudomallei in blood culture broth: results of a phase II evaluation study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Peeters, M.; Kuijpers, L.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Chung, P.; Phe, C.; San, C.; Teav, S.; Phe, T.] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Lin, H.; Mortelmans, K.] SRI Int, 333 Ravenswood Ave, Menlo Pk, CA 94025 USA; [Jacobs, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P19	174	174						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900410					2019-04-02	
J	Cox, JA; Jacobs, J; Vlieghe, E				Cox, J. A.; Jacobs, J.; Vlieghe, E.			Antibiotic stewardship programs in hospitals in low-and middle income countries: current status, priorities and barriers	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cox, J. A.; Jacobs, J.] Inst Trop Med, Unit Clin Sci, Antwerp, Belgium; [Vlieghe, E.] Univ Hosp Antwerp, Dept Gen Internal Med Infect Dis & Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P22	175	176						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900413					2019-04-02	
J	Fofana, HKM; Saye, R; Becker, SL; Landoure, A; Polman, K; Chappuis, F; Boelaert, M; Traore, MS; Utzinger, J; Sacko, M				Fofana, H. K. M.; Saye, R.; Becker, S. L.; Landoure, A.; Polman, K.; Chappuis, F.; Boelaert, M.; Traore, M. S.; Utzinger, J.; Sacko, M.			Diagnostic accuracy of point-of-care circulating cathodic antigen, formalin-ether concentration and Kato-Katz techniques for Schistosoma mansoni infection in Niono, Mali	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Fofana, H. K. M.; Saye, R.; Landoure, A.; Traore, M. S.; Sacko, M.] Inst Natl Rech Sante Publ, Bamako, Mali; [Saye, R.; Becker, S. L.; Utzinger, J.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Saye, R.; Becker, S. L.; Utzinger, J.] Univ Basel, Basel, Switzerland; [Becker, S. L.] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany; [Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P20	175	175						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900411					2019-04-02	
J	Diallo, S; Gies, S; Ki, A; Pagbelguem, JG; Tinto, H; Ouedraogo, GA; Brabin, BJ				Diallo, S.; Gies, S.; Ki, A.; Pagbelguem, J. G.; Tinto, H.; Ouedraogo, G. A.; Brabin, B. J.			Cross-sectional analysis in young non-pregnant and pregnant women in Burkina Faso of associations between biomarkers of iron status and effect modification by inflammation and P. falciparum infection	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Diallo, S.; Ki, A.; Pagbelguem, J. G.; Tinto, H.] Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Gies, S.] Inst Trop Med, Antwerp, Belgium; [Gies, S.] Med Mission Inst, Wurzburg, Germany; [Brabin, B. J.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Ouedraogo, G. A.] Univ Polytech Bobo Dioulasso, Bobo Dioulasso, Burkina Faso								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P29	178	179						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900420					2019-04-02	
J	Michel, K; Laudisoit, A; Tepage, F; Mandro, M; Levick, B; Suykerbuyk, P; Nicaise, AD; Tagoto, A; Falay, D; Colebunders, R				Michel, K.; Laudisoit, A.; Tepage, F.; Mandro, M.; Levick, B.; Suykerbuyk, P.; Nicaise, A. Drazo; Tagoto, A.; Falay, D.; Colebunders, R.			Onchocerciasis associated epilepsy and blackflies in the Democratic Republic of the Congo (DRC)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Michel, K.] Univ Kisangani, Fac Sci, Biodivers Monitoring Ctr, Kisangani, DEM REP CONGO; [Michel, K.; Nicaise, A. Drazo] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Laudisoit, A.; Suykerbuyk, P.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Laudisoit, A.; Suykerbuyk, P.; Colebunders, R.] Univ Antwerp, Evolutionary Biol Grp, Antwerp, Belgium; [Tepage, F.] Minist Hlth, Natl Onchocerciasis Control Program PNLO, Kinshasa, DEM REP CONGO; [Mandro, M.] Minist Hlth, Ituri Prov Hlth Div, Kinshasa, DEM REP CONGO; [Levick, B.] Univ Liverpool, Inst Integrat Biol, Sch Biol Sci, Liverpool, Merseyside, England; [Tagoto, A.] Minist Hlth, Natl HIV Program, Kinshasa, DEM REP CONGO; [Falay, D.] Univ Kisangani, Dept Pediat, Fac Med, Kisangani, DEM REP CONGO								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P31	179	180						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900422					2019-04-02	
J	Sow, MS; Versporten, A; Goossens, H; Sylla, AO				Sow, M. S.; Versporten, A.; Goossens, H.; Sylla, A. O.			The Global Point Prevalence Survey of antimicrobial consumption and resistance (Global-PPS): first results of antimicrobial prescribing in a tertiary care hospital in Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sow, M. S.; Sylla, A. O.] CHU Conakry, Hop Natl Donka, Serv Malad Infect, Conakry, Guinea; [Versporten, A.; Goossens, H.] Univ Antwerp, Fac Med & Hlth Sci, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P30	179	179						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900421					2019-04-02	
J	Bottieau, E; Mukendi, D; Barbe, B; Yansouni, CP; Dorny, P; Gabriel, S; Winkler, AS; Lutumba, P; Chappuis, F; Boelaert, M				Bottieau, E.; Mukendi, D.; Barbe, B.; Yansouni, C. P.; Dorny, P.; Gabriel, S.; Winkler, A. S.; Lutumba, P.; Chappuis, F.; Boelaert, M.			Frequency of Taenia solium antigen positivity in patients admitted for neurological disorders in the Rural Hospital of Mosango, Province of Kwilu, the Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bottieau, E.; Barbe, B.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Mukendi, D.; Lutumba, P.] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mukendi, D.; Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Yansouni, C. P.] McGill Univ, Ctr Hlth, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada; [Dorny, P.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gabriel, S.] Univ Ghent, Dept Vet Publ Hlth, Ghent, Belgium; [Winkler, A. S.] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkler, A. S.] Univ Oslo, Ctr Global Hlth, Oslo, Norway; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P33	180	180						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900424					2019-04-02	
J	Clerinx, J; Maniewski, U; Cnops, L; Soentjens, P; Van Esbroeck, M; Bottieau, E				Clerinx, J.; Maniewski, U.; Cnops, L.; Soentjens, P.; Van Esbroeck, M.; Bottieau, E.			Treatment issues with acute schistosomiasis in a cluster cohort of 34 travelers infected in South Africa - an observational study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Clerinx, J.; Maniewski, U.; Cnops, L.; Soentjens, P.; Van Esbroeck, M.; Bottieau, E.] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P34	181	181						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900425					2019-04-02	
J	Rouamba, T; Nakanabo, DS; Tarnagda, Z; Derra, K; Kazienga, A; Valea, I; Pagnoni, F; Kirakoya-Samandoulougou, F; Tinto, H				Rouamba, T.; Nakanabo, D. S.; Tarnagda, Z.; Derra, K.; Kazienga, A.; Valea, I.; Pagnoni, F.; Kirakoya-Samandoulougou, F.; Tinto, H.			Incidence of adverse drug reactions resulting from the use of Amodiaquine-Artesunate in Nanoro, Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rouamba, T.; Tarnagda, Z.; Derra, K.; Kazienga, A.; Valea, I.; Tinto, H.] IRSS CRUN, Nanoro, Burkina Faso; [Rouamba, T.; Kirakoya-Samandoulougou, F.] Univ Libre Bruxelles, Ctr Rech Epidemiol Biostat & Rech Clin, Ecole Sante Publ, Brussels, Belgium; [Nakanabo, D. S.; Valea, I.; Tinto, H.] Ctr Muraz, Dept Clin Res, Bobo Dioulasso, Burkina Faso								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P38	182	182						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900429					2019-04-02	
J	Stassijns, J; Vlieghe, E; Caluwaerts, A; Zolfo, M; Jacobs, J				Stassijns, J.; Vlieghe, E.; Caluwaerts, A.; Zolfo, M.; Jacobs, J.			Antibiotic resistance: the need for interdisciplinary education tailored to low-resource settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Stassijns, J.; Zolfo, M.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Vlieghe, E.] Univ Hosp Antwerp, Dept Gen Internal Med Infect Dis & Trop Med, Antwerp, Belgium; [Caluwaerts, A.] Med Sans Frontieres, Dept Med, Operat Ctr Brussels, Brussels, Belgium			Zolfo, Maria/B-9787-2015	Zolfo, Maria/0000-0001-9756-9380				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P37	182	182						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900428					2019-04-02	
J	Abongomera, C; Diro, E; Vogt, F; Tsoumanis, A; Mekonnen, Z; Admassu, H; Colebunders, R; Mohammed, R; Ritmeijer, K; van Griensven, J				Abongomera, C.; Diro, E.; Vogt, F.; Tsoumanis, A.; Mekonnen, Z.; Admassu, H.; Colebunders, R.; Mohammed, R.; Ritmeijer, K.; van Griensven, J.			The risk and predictors of visceral Leishmaniasis relapse in HIV co-infected patients in Ethiopia: a retrospective cohort study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Abongomera, C.; Mekonnen, Z.; Admassu, H.] Med Sans Frontieres, Abdurafi, Ethiopia; [Abongomera, C.; Vogt, F.; Tsoumanis, A.; van Griensven, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Diro, E.; Mohammed, R.] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Ritmeijer, K.] Med Sans Frontieres, Dept Publ Hlth, Amsterdam, Netherlands								0	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P39	183	183						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900430					2019-04-02	
J	Lula, Y; Engo, A; Nsimba, G; Mbo, J; Mulongo, R; Bisuta, S; Bakaswa, G; Mesia, G; Tona, G; Van Geertruyden, JP				Lula, Y.; Engo, A.; Nsimba, G.; Mbo, J.; Mulongo, R.; Bisuta, S.; Bakaswa, G.; Mesia, G.; Tona, G.; Van Geertruyden, J. P.			Safety and tolerability of two regimens used to treat multi-drug resistant tuberculosis in Kinshasa: a prospective cohort	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lula, Y.; Engo, A.; Nsimba, G.; Mesia, G.; Tona, G.] Univ Kinshasa, Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO; [Lula, Y.; Van Geertruyden, J. P.] Univ Antwerp, Global Hlth Inst, Fac Med, Antwerp, Belgium; [Mbo, J.; Mulongo, R.] Management Sci Hlth, Kinshasa, DEM REP CONGO; [Bisuta, S.; Bakaswa, G.] Natl Programme TB Control, Kinshasa, DEM REP CONGO			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P53	188	189						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900444					2019-04-02	
J	Laranjo-Gonzalez, M; Devleesschauwer, B; Trevisan, C; Allepuz, A; Sotiraki, S; Dorny, P; Gabriel, S; Dermauw, V				Laranjo-Gonzalez, M.; Devleesschauwer, B.; Trevisan, C.; Allepuz, A.; Sotiraki, S.; Dorny, P.; Gabriel, S.; Dermauw, V.			The epidemiology of Taenia Saginata and Taenia Solium in Western Europe: a systematic review	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Laranjo-Gonzalez, M.; Allepuz, A.] UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Bellaterra, Spain; [Devleesschauwer, B.] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Trevisan, C.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg C, Denmark; [Allepuz, A.] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Bellaterra, Spain; [Sotiraki, S.] HAO DEMETER, Vet Res Inst, Campus Thermi, Thessaloniki, Greece; [Dorny, P.; Dermauw, V.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Dorny, P.] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Gabriel, S.] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Merelbeke, Belgium			Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892				0	1	1	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P55	189	190						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900446					2019-04-02	
J	Lula, Y; Nzolo, D; Ntamabyaliro, PM; Nanga, T; Mesia, G; Tona, G; Van geertruyden, JP				Lula, Y.; Nzolo, D.; Ntamabyaliro, P. M.; Nanga, T.; Mesia, G.; Tona, G.; Van geertruyden, J. P.			Safety and tolerability of artesunate and amodiaquine combination in the treatment of uncomplicated malaria in Kinshasa: a pilot cohort event monitoring study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lula, Y.; Mesia, G.; Tona, G.] Univ Kinshasa, Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO; [Lula, Y.; Van geertruyden, J. P.] Univ Antwerp, Global Hlth Inst, Fac Med, Antwerp, Belgium; [Nzolo, D.; Ntamabyaliro, P. M.; Nanga, T.] Management Sci Hlth, Kinshasa, DEM REP CONGO; [Nzolo, D.; Ntamabyaliro, P. M.; Nanga, T.] Natl Programme TB Control, Kinshasa, DEM REP CONGO			Nanga Mfwawunu, Tom/E-9308-2019; Van geertruyden, Jean-Pierre/K-6425-2014	Nanga Mfwawunu, Tom/0000-0002-8926-0006; Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P54	189	189						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900445					2019-04-02	
J	Van Dijck, C; Vlieghe, E; Cox, JA				Van Dijck, C.; Vlieghe, E.; Cox, J. A.			Systematic literature review of antibiotic stewardship interventions in hospitalized patients in low- and middle-income countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Dijck, C.; Vlieghe, E.] Univ Hosp Antwerp, Dept Gen Internal Med Infect Dis & Trop Med, Antwerp, Belgium; [Vlieghe, E.; Cox, J. A.] Inst Trop Med, Dept Clin Sci, Unit Trop Lab Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P57	190	190						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900448					2019-04-02	
J	Saye, R; Landoue, A; Doumbia, MN; Becker, SL; Polman, K; Boelaert, M; Chappuis, F; Utzinger, J; Sacko, M; Traore, MS				Saye, R.; Landoure, A.; Doumbia, M. N.; Becker, S. L.; Polman, K.; Boelaert, M.; Chappuis, F.; Utzinger, J.; Sacko, M.; Traore, M. S.			Digestive disorders in Mali: assessment of a neglected public health issue	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Saye, R.; Landoure, A.; Doumbia, M. N.; Sacko, M.; Traore, M. S.] Inst Natl Rech Sante Publ, Bamako, Mali; [Saye, R.; Becker, S. L.; Utzinger, J.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Saye, R.; Becker, S. L.; Utzinger, J.] Univ Basel, Basel, Switzerland; [Becker, S. L.] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany; [Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P64	193	193						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900455					2019-04-02	
J	Saye, R; Becker, SL; Fofana, HKM; Doumbia, MN; Polman, K; Boelaert, M; Chappuis, F; Traore, MS; Utzinger, J; Sacko, M				Saye, R.; Becker, S. L.; Fofana, H. K. M.; Doumbia, M. N.; Polman, K.; Boelaert, M.; Chappuis, F.; Traore, M. S.; Utzinger, J.; Sacko, M.			Infectious aetiology of persistent digestive disorders (>= 2 weeks) in Niono, Mali, and implications for treatment	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Saye, R.; Fofana, H. K. M.; Doumbia, M. N.; Traore, M. S.; Sacko, M.] Inst Natl Rech Sante Publ, Bamako, Mali; [Saye, R.; Becker, S. L.; Utzinger, J.] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Saye, R.; Becker, S. L.; Utzinger, J.] Univ Basel, Basel, Switzerland; [Becker, S. L.] Saarland Univ, Inst Med Microbiol & Hyg, Homburg, Germany; [Polman, K.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Chappuis, F.] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P63	193	193						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900454					2019-04-02	
J	Falay, D; Peeters, M; Mapendo, B; Hasivirwe, E; Phoba, MF; Lunguya, O; Devlieger, H; Van Geet, C; Ngbonda, D; Jacobs, J				Falay, D.; Peeters, M.; Mapendo, B.; Hasivirwe, E.; Phoba, M. -F.; Lunguya, O.; Devlieger, H.; Van Geet, C.; Ngbonda, D.; Jacobs, J.			Multicenter surveillance of bloodstream infections in Kisangani, Oriental Province, Democratic Republic of the Congo: auality indicators from blood cultures	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Falay, D.; Mapendo, B.; Ngbonda, D.] Univ Hosp Kisangani, Dept Pediat, Kisangani, DEM REP CONGO; [Peeters, M.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Hasivirwe, E.] Univ Kisangani, Fac Sci, Kisangani, DEM REP CONGO; [Phoba, M. -F.; Lunguya, O.] Natl Inst Biomed Res, Dept Clin Microbiol, Kinshasa, DEM REP CONGO; [Devlieger, H.; Van Geet, C.] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Cardiovasc Med & Pediat, Leuven, Belgium; [Jacobs, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P65	194	194						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900456					2019-04-02	
J	Mukadi, P; Gillet, P; Barbe, B; Luamba, J; Lukuka, A; Likwela, J; Mumba, D; Muyembe, JJ; Lutumba, P; Jacobs, J				Mukadi, P.; Gillet, P.; Barbe, B.; Luamba, J.; Lukuka, A.; Likwela, J.; Mumba, D.; Muyembe, J. J.; Lutumba, P.; Jacobs, J.			SMS photograph-based external quality assessment of reading and interpretation of malaria rapid diagnostic tests in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract							PERFORMANCE		[Mukadi, P.; Mumba, D.; Muyembe, J. J.; Lutumba, P.] Natl Inst Biomed Res, Dept Parasitol, Kinshasa, DEM REP CONGO; [Mukadi, P.; Luamba, J.] Natl Pedag Univ, Dept Hlth Sci, Kinshasa, DEM REP CONGO; [Gillet, P.; Barbe, B.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Lukuka, A.; Likwela, J.] Natl Malaria Control Programme, Kinshasa, DEM REP CONGO; [Mumba, D.; Muyembe, J. J.; Lutumba, P.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Lutumba, P.] Univ Lubumbashi, Dept Biomed Sci, Lubumbashi, DEM REP CONGO; [Jacobs, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium							Moonasar D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-74; Mukadi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071442; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011	3	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P68	195	195						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900459					2019-04-02	
J	Vernelen, K; Barbe, B; Gillet, P; Van Esbroeck, M; China, B; Jacobs, J				Vernelen, K.; Barbe, B.; Gillet, P.; Van Esbroeck, M.; China, B.; Jacobs, J.			Photo-based external quality assessment of malaria rapid diagnostic tests in a non-endemic setting	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vernelen, K.; China, B.] Inst Publ Hlth, Qual Med Labs, Brussels, Belgium; [Barbe, B.; Gillet, P.; Van Esbroeck, M.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, J.] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P70	196	196						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900461					2019-04-02	
J	Ferreira, MF; Dauby, N; Konopnicki, D; Nguyen, VTP; Cantinieaux, B; Martin, C				Ferreira, M. F.; Dauby, N.; Konopnicki, D.; Nguyen, V. T. Phuong; Cantinieaux, B.; Martin, C.			Delayed Plasmodium falciparum malaria in three migrants	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ferreira, M. F.] CHU St Pierre, Dept Internal Med, St Pierre, St Pierre & Miq, France; [Dauby, N.; Konopnicki, D.; Martin, C.] ULB, CHU St Pierre, Dept Infect Dis, Brussels, Belgium; [Nguyen, V. T. Phuong; Cantinieaux, B.] LHUB ULB, Dept Hematol, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P81	201	201						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900472					2019-04-02	
J	Coudere, K; Wouters, K; Erven, G; Van den Heuvel, A; Fransen, K				Coudere, K.; Wouters, K.; Erven, G.; Van den Heuvel, A.; Fransen, K.			First results of an HIV counselling and testing project in the irregular migrant population of Doctors of the World, Antwerp	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract							ACCESS		[Coudere, K.] Doctors World, Brussels, Belgium; [Wouters, K.] Inst Trop Med, Helpctr, Antwerp, Belgium; [Erven, G.] Doctors World, Antwerp, Belgium; [Van den Heuvel, A.; Fransen, K.] Inst Trop Med, HIV STI Reference Lab, Antwerp, Belgium							Deblonde J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2571-y; Fakoya I, 2016, JMIR RES PROTOC, V5, DOI 10.2196/resprot.5085	2	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	3P91	205	205						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900482					2019-04-02	
J	Baly, A; Abadi, A; Cabrera, P; Van der Stuyft, P				Baly, A.; Abadi, A.; Cabrera, P.; Van der Stuyft, P.			Economic and disease and burden of dengue from the perspective of the patients and their families	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Baly, A.] Inst Trop Med Pedro Kouri, Havana, Cuba; [Abadi, A.; Cabrera, P.] Ctr Prov Higiene & Epidemiol Santiago de Cuba, Santiago De Cuba, Cuba; [Van der Stuyft, P.] Inst Trop Med, Antwerp, Belgium; [Van der Stuyft, P.] Univ Ghent, Ghent, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P1	206	207						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900485					2019-04-02	
J	Gil, AB; Fonseca, V; Figarola, R; Cabrera, P; Van der Stuyft, P				Gil, A. B.; Fonseca, V.; Figarola, R.; Cabrera, P.; Van der Stuyft, P.			Micro costing of an Aedes aegypti control programme	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gil, A. B.] Inst Med Trop Pedro Kouri, Havana, Cuba; [Fonseca, V.; Figarola, R.; Cabrera, P.] Ctr Prov Higiene & Epidemiol Santiago de Cuba, Santiago De Cuba, Cuba; [Van der Stuyft, P.] Inst Trop Med, Antwerp, Belgium; [Van der Stuyft, P.] Univ Ghent, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P3	207	207						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900487					2019-04-02	
J	Perez, D; Castro, M; Rifkin, SB; Lloyd, LS; Zabala, MC; Van der Stuyft, P; Ridde, V; Lefevre, P				Perez, D.; Castro, M.; Rifkin, S. B.; Lloyd, L. S.; Zabala, M. C.; Van der Stuyft, P.; Ridde, V.; Lefevre, P.			Towards knowledge translation of community empowerment strategies in dengue prevention: a fresh look at a Cuban experience	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Perez, D.; Castro, M.] Pedro Kouri Inst, Epidemiol Div, Havana, Cuba; [Rifkin, S. B.] London Sch Hyg & Trop Med, London, England; [Lloyd, L. S.] Publ Hlth Consultant, San Diego, CA USA; [Zabala, M. C.] Havana Univ, Latin Amer Fac Social Sci, Havana, Cuba; [Van der Stuyft, P.; Lefevre, P.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Van der Stuyft, P.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [Ridde, V.] Univ Montreal, Publ Hlth Res Inst, Montreal, PQ, Canada								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P4	208	208						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900488					2019-04-02	
J	Toledo, ME; Vanlerberghe, V; Popa, J; Mirabal, M; Cabrera, P; Fonseca, V; Gomez, T; Perez, M; Montada, D; Van der Stuyft, P				Toledo, M. E.; Vanlerberghe, V.; Popa, J.; Mirabal, M.; Cabrera, P.; Fonseca, V.; Gomez, T.; Perez, M.; Montada, D.; Van der Stuyft, P.			Insecticide-treated curtains and residual spraying for dengue control: disappointing effects on disease incidence in a cluster randomized controlled trial in Santiago de Cuba	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Toledo, M. E.; Montada, D.] Trop Med Inst Pedro Kouri, Epidemiol Dept, Havana, Cuba; [Vanlerberghe, V.] Trop Med Inst Antwerp, Epidemiol Unit, Antwerp, Belgium; [Popa, J.] Ctr Hyg Epidemiol & Microbiol, Santiago De Cuba, Cuba; [Mirabal, M.] Finlay Vaccine Inst, Clin Res & Impact Evaluat Div, Havana, Cuba; [Cabrera, P.; Perez, M.] Prov Ctr Vector Control, Santiago De Cuba, Cuba; [Fonseca, V.; Gomez, T.; Van der Stuyft, P.] Municipal Unit Hyg & Epidemiol, Santiago De Cuba, Cuba; [Van der Stuyft, P.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P5	208	208						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900489					2019-04-02	
J	Bele, A; Musala, S; Okenge, L; Kasereka, JC; Baleka, JF; Bakoko, B; Van Deun, A; Kaswa, M				Bele, A.; Musala, S.; Okenge, L.; Kasereka, J. C.; Baleka, J. F.; Bakoko, B.; Van Deun, A.; Kaswa, M.			Exploratory results of intensification of the use of the GeneXpert (R) MTB/RIF as support in the tracking the TB and TB-RR in Kinshasa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bele, A.; Musala, S.] Univ Kinshasa, Microbiol, Kinshasa, DEM REP CONGO; [Okenge, L.; Kasereka, J. C.; Baleka, J. F.; Kaswa, M.] Minist Publ Hlth, Natl TB Program, Kinshasa, DEM REP CONGO; [Bakoko, B.] NTP, Prov TB & Leprosy Coordinat, Kinshasa, DEM REP CONGO; [Van Deun, A.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P14	212	212						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900498					2019-04-02	
J	Musala, S; Bele, A; Okenge, L; Kasereka, JC; Aloni, M; Van Deun, A; Kaswa, M				Musala, S.; Bele, A.; Okenge, L.; Kasereka, J. C.; Aloni, M.; Van Deun, A.; Kaswa, M.			Detection of Rifampicine resistance mutations in the 81 bp RRDR of rpoBGene in Mycobacterium tuberculosis using Xpert MTB/RIF in Kinshasa, DRC: a retrospective study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Musala, S.; Bele, A.; Okenge, L.] Univ Kinshasa, Microbiol, Kinshasa, DEM REP CONGO; [Kasereka, J. C.; Aloni, M.; Kaswa, M.] Minist Publ Hlth, Natl TB Program, Kinshasa, DEM REP CONGO; [Van Deun, A.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P15	212	212						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900499					2019-04-02	
J	Ngabonziza, JCS; Habimana, MY; Migambi, P; Mazarati, JB; de Jong, BC; Torrea, G				Ngabonziza, J. C. S.; Habimana, M. Y.; Migambi, P.; Mazarati, J. B.; de Jong, B. C.; Torrea, G.			Impact of prompt MDR-TB treatment initiation: significant reduction of MDR-TB mortality rate in Rwanda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ngabonziza, J. C. S.; Mazarati, J. B.] Rwanda Biomed Ctr, Biomed Serv Dept, Kigali, Rwanda; [Habimana, M. Y.; Migambi, P.] Rwanda Biomed Ctr, Inst HIV AIDS Dis Prevent & Control, Kigali, Rwanda; [de Jong, B. C.; Torrea, G.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P21	214	215						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900505					2019-04-02	
J	Ortuno-Gutierrez, N; Cherif, GF; Loua, F; Souleymane, HH; Bangoura, A; Camara, LM				Ortuno-Gutierrez, N.; Cherif, G. -F.; Loua, F.; Souleymane, H. Harouna; Bangoura, A.; Camara, L. -M.			Performance of community tracing system of people affected by Tuberculosis during Ebola epidemic in Conakry, Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ortuno-Gutierrez, N.] Damien Fdn Belgium, Brussels, Belgium; [Cherif, G. -F.; Loua, F.; Souleymane, H. Harouna] Damien Fdn Guinea, Conakry, Guinea; [Bangoura, A.] Natl TB Program, Conakry, Guinea; [Camara, L. -M.] Gamal Abdel Nasser Univ, Fac Med, Conakry, Guinea								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P28	217	217						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900512					2019-04-02	
J	Reyes, MDB; Perez, M; Bongaerts, T; Ortuno-Gutierrez, N				Reyes, M. de Jesus Bravo; Perez, M.; Bongaerts, T.; Ortuno-Gutierrez, N.			Successful integrated biomedical and social support to vulnerable people affected by Tuberculosis in Nicaragua	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ortuno-Gutierrez, N.] Damien Fdn Belgium, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P30	218	218						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900514					2019-04-02	
J	Sanchez-Bustamante, L; Bailon, Z; Bongaerts, T; Ortuno-Gutierrez, N				Sanchez-Bustamante, L.; Bailon, Z.; Bongaerts, T.; Ortuno-Gutierrez, N.			Biomedical and social support to vulnerable people affected by Tuberculosis in Guatemala: an effective Governmental and Non-Governmental partnership implementation	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sanchez-Bustamante, L.; Bailon, Z.; Bongaerts, T.] Damien Fdn Guatemala, Guatemala City, Guatemala; [Ortuno-Gutierrez, N.] Damien Fdn Belgium, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P29	218	218						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900513					2019-04-02	
J	Thanh, DT; Xuan, XN; Thi, TN; Truc, QN; D'Alessandro, U; Erhart, A; Grietens, KP				Thanh, D. Tran; Xuan, X. Nguyen; Thi, T. Nguyen; Truc, Q. Nguyen; D'Alessandro, U.; Erhart, A.; Grietens, K. Peeters			Characteristics of malaria infection among the Jarai ethnic minority in central Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thanh, D. Tran; Xuan, X. Nguyen; Thi, T. Nguyen; Truc, Q. Nguyen] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Erhart, A.; Grietens, K. Peeters] Inst Trop Med, Antwerp, Belgium; [D'Alessandro, U.; Erhart, A.] MRC Unit, Serekunda, Gambia								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P41	222	222						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900525					2019-04-02	
J	Xuan, XN; Thi, TN; Thanh, DT; Truc, QN; D'Alessandro, U; Erhart, A; Grietens, KP				Xuan, X. Nguyen; Thi, T. Nguyen; Thanh, D. Tran; Truc, Q. Nguyen; D'Alessandro, U.; Erhart, A.; Grietens, K. Peeters			Risk factors for persisting malaria among the Jarai ethnic minority along the Vietnam-Cambodia border	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Xuan, X. Nguyen; Thi, T. Nguyen; Thanh, D. Tran; Truc, Q. Nguyen] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Erhart, A.; Grietens, K. Peeters] Inst Trop Med, Antwerp, Belgium; [D'Alessandro, U.; Erhart, A.] MRC Unit, Serekunda, Gambia								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P40	222	222						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900524					2019-04-02	
J	Njunju, M; Manyando, C; Mwakazanga, D; Claeys, Y; Schurmans, C; Van Overmeir, C; Erhart, A; Ravinetto, R; D'Alessandro, U; Geertruyden, JP				Njunju, M.; Manyando, C.; Mwakazanga, D.; Claeys, Y.; Schurmans, C.; Van Overmeir, C.; Erhart, A.; Ravinetto, R.; D'Alessandro, U.; Geertruyden, J. Pvan			Sulfadoxine-pyrimethamine versus Cotrimoxazole in pregnant women: effect on birth weight-findings from a randomized, open-label, non-inferiority trial in Zambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Njunju, M.] Copperbelt Univ, Sch Med, Basic Sci, Ndola, Zambia; [Manyando, C.; Mwakazanga, D.] Trop Dis Res Ctr, Publ Hlth, Ndola, Zambia; [Claeys, Y.; Schurmans, C.; Van Overmeir, C.; Erhart, A.; Ravinetto, R.; D'Alessandro, U.] ITM, Antwerp, Belgium; [Erhart, A.; D'Alessandro, U.] MRC, Fajara, Gambia; [Ravinetto, R.] Katholieke Univ Leuven, Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Geertruyden, J. Pvan] Univ Antwerp, Int Hlth, Antwerp, Belgium							Cohee LM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-274; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Feng GA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012012	3	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P46	224	225						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900530					2019-04-02	
J	Rouamba, T; Nakanabo-Diallo, S; Derra, K; Rouamba, E; Kankoe, S; Yaka, P; Valea, I; Tinto, H; Kirakoya-Samandoulougou, F; Gaudart, J				Rouamba, T.; Nakanabo-Diallo, S.; Derra, K.; Rouamba, E.; Kankoe, S.; Yaka, P.; Valea, I.; Tinto, H.; Kirakoya-Samandoulougou, F.; Gaudart, J.			Environmental characteristics and evolution of malaria hotspots in a rural area, Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rouamba, T.; Derra, K.; Rouamba, E.; Valea, I.; Tinto, H.] CRUN, Nanoro, Burkina Faso; [Rouamba, T.; Kankoe, S.; Gaudart, J.] Aix Marseille Univ, IRD, INSERM, UMR912,SESSTIM, Marseille, France; [Nakanabo-Diallo, S.; Valea, I.; Tinto, H.] Ctr Muraz, Dept Clin Res, Bobo Dioulasso, Burkina Faso; [Yaka, P.] Direct Gen Meteorol Burkina Faso, Ouagadougou, Burkina Faso; [Kirakoya-Samandoulougou, F.] Univ Libre Bruxelles, Ctr Rech Epidemiol Biostat & Rech Clin, Ecole Sante Publ, Brussels, Belgium								0	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P45	224	224						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900529					2019-04-02	
J	Masunaga, Y; Jaiteh, F; D'Alessandro, U; Okebe, J; Ribera, JM; Grietens, KP				Masunaga, Y.; Jaiteh, F.; D'Alessandro, U.; Okebe, J.; Ribera, J. Muela; Grietens, K. Peeters			Community participation as part of formative research to design innovative malaria elimination strategies in The Gambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Masunaga, Y.; Grietens, K. Peeters] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium; [Jaiteh, F.; D'Alessandro, U.; Okebe, J.] Med Res Council Unit Gambia, Fajara, Gambia; [Ribera, J. Muela] PASS Suisse, Neuchatel, Switzerland								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P50	226	226						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900534					2019-04-02	
J	Mavoko, HM; Nabasumba, C; Delgado-Ratto, C; Baraka, V; Rosanas-Urgell, A; Kambugu, A; da Luz, RI; Tinto, H; Lutumba, P; Van Geertruyden, JP				Mavoko, H. Muhindo; Nabasumba, C.; Delgado-Ratto, C.; Baraka, V.; Rosanas-Urgell, A.; Kambugu, A.; da Luz, R. Inocencio; Tinto, H.; Lutumba, P.; Van Geertruyden, J. P.			Repeated Artemisinin-based combination treatment and dynamics of Plasmodium falciparum strains in Uganda and the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mavoko, H. Muhindo; Lutumba, P.] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Mavoko, H. Muhindo; Nabasumba, C.; Delgado-Ratto, C.; Baraka, V.; da Luz, R. Inocencio; Van Geertruyden, J. P.] Univ Antwerp, Global Hlth Inst, Fac Med & Hlth Sci, Antwerp, Belgium; [Nabasumba, C.] Mbarara Univ Sci & Technol, Fac Med, Mbarara, Uganda; [Nabasumba, C.; Kambugu, A.] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Baraka, V.] Tanga Res Ctr, Natl Inst Med Res, Tanga, Tanzania; [Rosanas-Urgell, A.] Inst Trop Med, Antwerp, Belgium; [Tinto, H.] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P57	229	229						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900541					2019-04-02	
J	Jaiteh, F; Masunaga, Y; Ribera, JM; Okebe, J; D'Alessandro, U; Balen, J; Grietens, KP				Jaiteh, F.; Masunaga, Y.; Ribera, J. M.; Okebe, J.; D'Alessandro, U.; Balen, J.; Grietens, K. Peeters			Defining the unit of intervention for targeted treatment of asymptomatic malaria carriers: a transdisciplinarity approach	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Jaiteh, F.; Okebe, J.; D'Alessandro, U.] Med Res Council Unit Gambia, Fajara, Gambia; [Jaiteh, F.; Masunaga, Y.; Grietens, K. Peeters] Inst Trop Med, Med Anthropol Unit, Antwerp, Belgium; [Ribera, J. M.] PASS Suisse, Neuchatel, Switzerland; [Balen, J.] Univ Sheffield, Sheffield, S Yorkshire, England								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P59	230	230						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900543					2019-04-02	
J	Thuan, TN; Xa, XN; Duong, TT; Dung, KAV; Ky, VP; Erhart, A; Grietens, KP				Thuan, T. Nguyen; Xa, X. Nguyen; Duong, T. Tran; Dung, K. A. Vu; Ky, V. Pham; Erhart, A.; Grietens, K. Peeters			Factors limiting the effectiveness of standardized malaria control strategies in forested highlands of Vietnam: a qualitative study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thuan, T. Nguyen; Xa, X. Nguyen; Duong, T. Tran; Dung, K. A. Vu] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Thuan, T. Nguyen; Erhart, A.; Grietens, K. Peeters] Inst Trop Med, Med Anthropol Unit, Antwerp, Belgium; [Erhart, A.] MRC Unit, Serekunda, Gambia								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P62	231	231						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900546					2019-04-02	
J	Delgado-Ratto, C; Soto-Calle, V; Van den Eede, P; Rossanas-Urgell, A; D'Alessandro, U; Llanos-Cuentas, A; Erhart, A; Geertruyden, JV; Gamboa, D				Delgado-Ratto, C.; Soto-Calle, V.; Van den Eede, P.; Rossanas-Urgell, A.; D'Alessandro, U.; Llanos-Cuentas, A.; Erhart, A.; Geertruyden, J. V.; Gamboa, D.			Dynamics of Plasmodium vivax infections during a 2-year monthly follow up in the Peruvian Amazon	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Delgado-Ratto, C.; Geertruyden, J. V.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Soto-Calle, V.; Llanos-Cuentas, A.; Gamboa, D.] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru; [Van den Eede, P.; Rossanas-Urgell, A.; D'Alessandro, U.; Erhart, A.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P64	232	232						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900548					2019-04-02	
J	Kattenberg, JH; Erhart, A; Hieu, TM; Rovira-Vallbona, E; Dung, VKA; Ngoc, NTH; Hong, NV; Van, NV; Tetteh, K; Theisen, M; Soares, I; Bennet, A; Lover, A; Duong, TT; Xa, NX; Rosanas-Urgell, A				Kattenberg, J. H.; Erhart, A.; Hieu, T. M.; Rovira-Vallbona, E.; Dung, V. K. A.; Ngoc, N. T. H.; Hong, N. V.; Van, N. V.; Tetteh, K.; Theisen, M.; Soares, I.; Bennet, A.; Lover, A.; Duong, T. T.; Xa, N. X.; Rosanas-Urgell, A.			Characterization of the human malaria reservoir throughout the dry season in a forested area of central Vietnam: a pilot study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kattenberg, J. H.; Erhart, A.; Rovira-Vallbona, E.; Rosanas-Urgell, A.] Inst Trop Med, Antwerp, Belgium; [Hieu, T. M.; Dung, V. K. A.; Ngoc, N. T. H.; Hong, N. V.; Duong, T. T.; Xa, N. X.] Natl Inst Malaria Parasitol & Epidemiol, Hanoi, Vietnam; [Van, N. V.] Prov Malaria Stn Quang Nam, Quang Nam, Vietnam; [Tetteh, K.] London Sch Trop Med & Hyg, London, England; [Theisen, M.] Statens Serum Inst, Copenhagen, Denmark; [Soares, I.] Univ Sao Paulo, Sao Paulo, Brazil; [Bennet, A.; Lover, A.] Univ Calif San Francisco, San Francisco, CA 94143 USA								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P65	232	233						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900549					2019-04-02	
J	Buscher, P; Hasker, E; Lejon, V				Buscher, P.; Hasker, E.; Lejon, V.			The development of an application for digital recording of DiTECT-HAT study participant data, including macroscopic and microscopic images	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Buscher, P.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Hasker, E.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Lejon, V.] Dept Inst Rech Dev, Montpellier, France								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P72	235	235						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900556					2019-04-02	
J	Lejon, V; Mumba, D; Ngay, I; Camara, M; Camara, O; Kaba, D; Kone, M; Lumbala, C; Makabuza, J; Ilboudo, H; Dama, E; Fevre, E; Jamonneau, V; Bucheton, B; Buscher, P				Lejon, V.; Mumba, D.; Ngay, I.; Camara, M.; Camara, O.; Kaba, D.; Kone, M.; Lumbala, C.; Makabuza, J.; Ilboudo, H.; Dama, E.; Fevre, E.; Jamonneau, V.; Bucheton, B.; Buscher, P.			Diagnostic tools for human African trypanosomiasis elimination and clinical trials	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Lejon, V.; Jamonneau, V.; Bucheton, B.] IRD, Intertryp, Montpellier, France; [Mumba, D.; Ngay, I.] INRB, Kinshasa, DEM REP CONGO; [Camara, M.; Camara, O.; Bucheton, B.] PNLTHA, Conakry, Guinea; [Kaba, D.; Kone, M.; Jamonneau, V.] IPR, Bouake, Cote Ivoire; [Lumbala, C.; Makabuza, J.] PNLTHA, Kinshasa, DEM REP CONGO; [Ilboudo, H.; Dama, E.] CIRDES, Bobo Dioulasso, Burkina Faso; [Fevre, E.] Univ Liverpool, Liverpool, Merseyside, England; [Buscher, P.] ITM, Antwerp, Belgium			Jamonneau, Vincent/K-1124-2016	Jamonneau, Vincent/0000-0001-8427-0769				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P73	235	236						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900557					2019-04-02	
J	Dolo, H; Wonya'Rossi, DU; Mandro, NM; Ngave, F; Fraeyman, J; Suykerbuyk, P; Colebunders, R				Dolo, H.; Wonya'Rossi, D. Ucima; Mandro, N. M.; Ngave, F.; Fraeyman, J.; Suykerbuyk, P.; Colebunders, R.			Epilepsy perceptions and experiences of different stakeholders prior to the implementation of an epilepsy treatment programme in an onchocerciasis endemic region in Ituri, Democratic Republic of the Congo (DRC)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dolo, H.; Mandro, N. M.; Suykerbuyk, P.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Dolo, H.] Fac Med & Odonto Stomatol, Int Ctr Excellence Res, Bamako, Mali; [Wonya'Rossi, D. Ucima; Ngave, F.] Hop Gen Reference Rethy, Ctr Rech Malad Trop, Rethy, DEM REP CONGO; [Wonya'Rossi, D. Ucima] Neglected Trop Dis Control Program, Bunia, DEM REP CONGO; [Mandro, N. M.] Prov Minist Hlth, Ituri, Bunia, DEM REP CONGO; [Fraeyman, J.] Univ Antwerp, Res Grp Med Sociol & Hlth Policy, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P75	236	236						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900559					2019-04-02	
J	Uranw, S; Bhattarai, NR; Ostyn, B; Acharya, B; Yogi, K; Karki, P; Boelaert, M; Das, ML				Uranw, S.; Bhattarai, N. R.; Ostyn, B.; Acharya, B.; Yogi, K.; Karki, P.; Boelaert, M.; Das, M. L.			Visceral leishmaniasis cases in the non-endemic districts: challenges to ongoing elimination programme in Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Uranw, S.; Karki, P.] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Bhattarai, N. R.; Das, M. L.] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Ostyn, B.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Acharya, B.] Govt Nepal, Epidemiol & Dis Control Div, Kathmandu, Nepal; [Yogi, K.] WHO Country Off Nepal, Kathmandu, Nepal								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P74	236	236						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900558					2019-04-02	
J	Claeys, Y; Lutumba, P; Mpanya, A; Hasker, E; Buscher, P; Da Luz, RI; Snijders, R; Boelaert, M; Lumbala, C				Claeys, Y.; Lutumba, P.; Mpanya, A.; Hasker, E.; Buescher, P.; Da Luz, R. Inocencio; Snijders, R.; Boelaert, M.; Lumbala, C.			Quality assurance of active screening for Human African Trypanosomiasis elimination in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Claeys, Y.; Hasker, E.; Da Luz, R. Inocencio; Snijders, R.; Boelaert, M.] Inst Trop Med Antwerp, Dept Publ Hlth, Antwerp, Belgium; [Lutumba, P.; Snijders, R.] Kinshasa Univ, Dept Trop Med, Kinshasa, DEM REP CONGO; [Mpanya, A.; Snijders, R.; Lumbala, C.] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Buescher, P.; Snijders, R.] Inst Trop Med Antwerp, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P80	238	238						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900564					2019-04-02	
J	Snijders, R; Fukinsia, A; Baka, O; Claeys, Y; Hasker, E; Mpanya, A; Lumbala, C; Boelaert, M; Lutumba, P				Snijders, R.; Fukinsia, A.; Baka, O.; Claeys, Y.; Hasker, E.; Mpanya, A.; Lumbala, C.; Boelaert, M.; Lutumba, P.			6 Costing of large scale strategies for active case finding of Human African Trypanosomiasis (HAT) in the Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Snijders, R.; Claeys, Y.; Hasker, E.; Boelaert, M.] Inst Trop Med Antwerp, Dept Publ Hlth, Antwerp, Belgium; [Fukinsia, A.; Baka, O.; Mpanya, A.; Lumbala, C.] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Lutumba, P.] Kinshasa Univ, Dept Trop Med, Kinshasa, DEM REP CONGO								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P79	238	238						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900563					2019-04-02	
J	Cloots, K; Uranw, S; Rijal, S; Boelaert, M				Cloots, K.; Uranw, S.; Rijal, S.; Boelaert, M.			Tracking the progress: visceral leishmaniasis elimination in Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cloots, K.; Boelaert, M.] ITM, Dept Publ Hlth, Antwerp, Belgium; [Uranw, S.; Rijal, S.] BP Koirala Inst Hlth Sci, Dharan, Nepal								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P83	239	240						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900567					2019-04-02	
J	Sunyoto, T; Verdonck, K; el Safi, S; Potet, J; Picado, A; Boelaert, M				Sunyoto, T.; Verdonck, K.; el Safi, S.; Potet, J.; Picado, A.; Boelaert, M.			Epidemiology and burden of cutaneous leishmaniasis in sub-saharan Africa: evidence from a systematic review	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sunyoto, T.; Verdonck, K.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Sunyoto, T.; Potet, J.] Med Sans Frontieres Campaign Access Med, Geneva, Switzerland; [el Safi, S.] Univ Khartoum, Khartoum, Sudan; [Picado, A.] ISGlobal, Barcelona, Spain								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P87	241	241						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900571					2019-04-02	
J	Phanzu, DM; Luzolo, EK; Kiabanzawoko, ON; Mintsey, NM; Vandelannoote, K; Eddyani, M; Suykerbuyk, P; van der Grinten, E; Portaels, F; de Jong, B; Boelaert, M				Phanzu, D. M.; Luzolo, E. K.; Kiabanzawoko, O. N.; Mintsey, N. M.; Vandelannoote, K.; Eddyani, M.; Suykerbuyk, P.; van der Grinten, E.; Portaels, F.; de Jong, B.; Boelaert, M.			Persistence of Mycobacterium ulcerans disease (buruli ulcer) in the historical foci of Kongo Central Province, The Democratic Republic of Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Phanzu, D. M.; Luzolo, E. K.; Kiabanzawoko, O. N.] Inst Med Evangel, Ctr Rech Sanit Kimpese, Kimpese, DEM REP CONGO; [Mintsey, N. M.] Inst Natl Rech Biomed, Dept Microbiol, Kinshasa, DEM REP CONGO; [Vandelannoote, K.; Eddyani, M.; Portaels, F.; de Jong, B.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Suykerbuyk, P.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [van der Grinten, E.] Amer Leprosy Missions, Greenville, SC USA; [Boelaert, M.] ITM, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P90	242	242						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900574					2019-04-02	
J	da Luz, RI; Linsuke, S; Lutumba, P; Hasker, E; Boelaert, M				da Luz, R. Inocencio; Linsuke, S.; Lutumba, P.; Hasker, E.; Boelaert, M.			Schistosomiasis and soil-transmitted helminths prevalence in school-aged children and opportunities for integration of control in health services in Kwilu province, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[da Luz, R. Inocencio; Hasker, E.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Linsuke, S.; Lutumba, P.] Inst Natl Rech Biomed, Unit Epidemiol, Kinshasa, DEM REP CONGO								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P93	243	244						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900577					2019-04-02	
J	Mulenga, P; Chenge, F; Mpanya, A; Criel, B; Lutumba, P; Luboya, O; Lumbala, C; Coppieters, Y; Boelaert, M				Mulenga, P.; Chenge, F.; Mpanya, A.; Criel, B.; Lutumba, P.; Luboya, O.; Lumbala, C.; Coppieters, Y.; Boelaert, M.			Feasibility of integration of activities of human African trypanosomiasis control in basic health services in the Democratic Republic of the Congo: preliminary results from an action research	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mulenga, P.; Chenge, F.; Luboya, O.] Univ Lubumbashi, Fac Med, Lubumbashi, DEM REP CONGO; [Mulenga, P.; Chenge, F.; Luboya, O.] Univ Lubumbashi, Sch Publ Hlth, Lubumbashi, DEM REP CONGO; [Mulenga, P.; Criel, B.; Boelaert, M.] Antwerp Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Mpanya, A.; Lumbala, C.] Natl Program Control Human African Trypanosomiasi, Kinshasa, DEM REP CONGO; [Lutumba, P.] Univ Kinshasa, Dept Trop Med, Fac Med, Kinshasa, DEM REP CONGO; [Coppieters, Y.] Univ Brussels, Sch Publ Hlth, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P91	243	243						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900575					2019-04-02	
J	Mulenga, P; Vander Kelen, C; Lutumb, P; Coppieters, Y; Chenge, F; Lumbala, C; Luboya, O; Boelaert, M; Mpanya, A				Mulenga, P.; Vander Kelen, C.; Lutumb, P.; Coppieters, Y.; Chenge, F.; Lumbala, C.; Luboya, O.; Boelaert, M.; Mpanya, A.			Perception of the integration of activities of African human trypanosomiasis control into basic health services: a qualitative study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mulenga, P.; Chenge, F.; Luboya, O.] Univ Lubumbashi, Fac Med, Lubumbashi, DEM REP CONGO; [Mulenga, P.; Chenge, F.; Luboya, O.] Univ Lubumbashi, Sch Publ Hlth, Lubumbashi, DEM REP CONGO; [Mulenga, P.; Vander Kelen, C.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Lutumb, P.] Univ Kinshasa, Dept Trop Med, Fac Med, Kinshasa, DEM REP CONGO; [Coppieters, Y.] Univ Brussels, Sch Publ Hlth, Brussels, Belgium; [Lumbala, C.; Mpanya, A.] Natl Program Control Human African Trypanosomiasi, Kinshasa, DEM REP CONGO								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P92	243	243						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900576					2019-04-02	
J	Bizimana, P; Van Geertruyden, JP; Polman, K; Niyongabo, P; Munezero, F; Ortu, G				Bizimana, P.; Van Geertruyden, J. P.; Polman, K.; Niyongabo, P.; Munezero, F.; Ortu, G.			Temporal trends in schistosomiasis in Burundi, from 2011 to 2015	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bizimana, P.; Munezero, F.] Inst Natl Sante Publ, Dept Sci Sante Publ, Bujumbura, Burundi; [Bizimana, P.] Univ Burundi, Fac Med Bujumbura, Bujumbura, Burundi; [Bizimana, P.; Van Geertruyden, J. P.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Bizimana, P.; Van Geertruyden, J. P.] Hlth Sci, Antwerp, Belgium; [Polman, K.] Inst Trop Med, Dept Biomed Sci, Med Helmintolgy Unit, Antwerp, Belgium; [Niyongabo, P.] Inst Natl Sante Publ, Direct Rech, Bujumbura, Burundi; [Ortu, G.] Malaria Consortium, London, England			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364			de Beve F., 1935, ANN SOC BELG MED TR, VXV, P3; GRYSEELS B, 1991, T ROY SOC TROP MED H, V85, P626, DOI 10.1016/0035-9203(91)90371-5; Ndayishimiye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002684	3	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P95	244	245						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900579					2019-04-02	
J	Dolo, H; Wonya'Rossi, DU; Mandro, NM; Ngave, F; Fraeyman, J; Suykerbuyk, P; Colebunders, R				Dolo, H.; Wonya'Rossi, D. Ucima; Mandro, N. M.; Ngave, F.; Fraeyman, J.; Suykerbuyk, P.; Colebunders, R.			Knowledge, attitude and perception about onchocerciasis and ivermectin in the onchocerciasis endemic health zone of rethy in Ituri, Democratic Republic of the Congo (DRC)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dolo, H.; Mandro, N. M.; Suykerbuyk, P.; Colebunders, R.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Dolo, H.] Fac Med & Odonto Stomatol, Int Ctr Excellence Res, Bamako, Mali; [Wonya'Rossi, D. Ucima; Ngave, F.] Hop Gen Reference Rethy, Ctr Rech Malad Trop, Kinshasa, DEM REP CONGO; [Wonya'Rossi, D. Ucima] Neglected Trop Dis Control Program, Bunia, DEM REP CONGO; [Mandro, N. M.] Prov Minist Hlth, Ituri, Bunia, DEM REP CONGO; [Fraeyman, J.] Univ Antwerp, Res Grp Med Sociol & Hlth Policy, Antwerp, Belgium								0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P97	245	246						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900581					2019-04-02	
J	Hobbs, EC; Mwape, KE; Zulu, G; Mambwe, M; Chembensofu, M; Phiri, IK; Masuku, M; Berkvens, D; Van Damme, I; Bottieau, E; Devleesschauwer, B; Speybroeck, N; Colston, A; Willingham, AL; Dorny, P; Gabriel, S				Hobbs, E. C.; Mwape, K. E.; Zulu, G.; Mambwe, M.; Chembensofu, M.; Phiri, I. K.; Masuku, M.; Berkvens, D.; Van Damme, I.; Bottieau, E.; Devleesschauwer, B.; Speybroeck, N.; Colston, A.; Willingham, A. L.; Dorny, P.; Gabriel, S.			Preliminary assessment of the computer-based Taenia solium educational program 'The Vicious Worm' in rural primary school children in eastern Zambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Hobbs, E. C.; Willingham, A. L.] Ross Univ Sch Vet Med, Basseterre, St Kitts & Nevi; [Hobbs, E. C.; Berkvens, D.; Bottieau, E.; Dorny, P.] Inst Trop Med, Antwerp, Belgium; [Hobbs, E. C.; Van Damme, I.; Gabriel, S.] Univ Ghent, Ghent, Belgium; [Mwape, K. E.; Chembensofu, M.; Phiri, I. K.] Univ Zambia, Lusaka, Zambia; [Zulu, G.; Mambwe, M.] Minist Hlth, Lusaka, Zambia; [Devleesschauwer, B.] Sci Inst Publ Hlth, Brussels, Belgium; [Speybroeck, N.] Global Alliance Livestock Vet Med, Nairobi, Kenya; [Colston, A.] Catholic Univ Louvain, Louvain La Neuve, Belgium			Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P96	245	245						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900580					2019-04-02	
J	Kamga, GR; Dissak-Delon, FN; Nana-Djeunga, HC; Biholong, BD; Ghogomu, SM; Souopgui, J; Kamgno, J; Robert, A				Kamga, G-R.; Dissak-Delon, F. N.; Nana-Djeunga, H. C.; Biholong, B. D.; Ghogomu, S. Mbigha; Souopgui, J.; Kamgno, J.; Robert, A.			Important progress towards elimination of onchocerciasis in the West Region of Cameroon	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kamga, G-R.; Dissak-Delon, F. N.; Biholong, B. D.] Minist Publ Hlth, Yaounde, Cameroon; [Kamga, G-R.; Dissak-Delon, F. N.; Nana-Djeunga, H. C.; Kamgno, J.] Ctr Res Filariasis & Other Trop Dis CRFilMT, Yaounde, Cameroon; [Kamga, G-R.; Robert, A.] Catholic Univ Louvain, Inst Rech Expt & Clin, Fac Sante Publ, Brussels, Belgium; [Dissak-Delon, F. N.; Souopgui, J.] Univ Libre Bruxelles, Inst Biol Mol Med, Brussels, Belgium; [Nana-Djeunga, H. C.; Kamgno, J.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Ghogomu, S. Mbigha] Univ Buea, Dept Biochem & Mol Biol, Mol & Cell Biol Lab, Buea, Cameroon								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P101	247	247						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900585					2019-04-02	
J	Kamga, GR; Dissak-Delon, FN; Nana-Djeunga, HC; Biholong, BD; Mbigha-Ghogomu, S; Souopgui, J; Zoure, HGM; Boussinesq, M; Kamgno, J; Robert, A				Kamga, G-R.; Dissak-Delon, F. N.; Nana-Djeunga, H. C.; Biholong, B. D.; Mbigha-Ghogomu, S.; Souopgui, J.; Zoure, H. G. M.; Boussinesq, M.; Kamgno, J.; Robert, A.			Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kamga, G-R.; Dissak-Delon, F. N.; Biholong, B. D.] Minist Publ Hlth, Yaounde, Cameroon; [Kamga, G-R.; Dissak-Delon, F. N.; Nana-Djeunga, H. C.; Kamgno, J.] Ctr Res Filariasis & Other Trop Dis CRFilMT, Yaounde, Cameroon; [Kamga, G-R.; Robert, A.] Catholic Univ Louvain, Inst Rech Expt & Clin, Fac Sante Publ, Brussels, Belgium; [Dissak-Delon, F. N.; Souopgui, J.] Univ Libre Bruxelles, Inst Biol Mol Med, Brussels, Belgium; [Nana-Djeunga, H. C.; Kamgno, J.] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Mbigha-Ghogomu, S.] Univ Buea, Dept Biochem & Mol Biol, Mol & Cell Biol Lab, Buea, Cameroon; [Zoure, H. G. M.] WHO, APOC, Ouagadougou, Burkina Faso; [Boussinesq, M.] Univ Montpellier, INSERM, IRD, UMI 233,TransVIHMI,U1175, Montpellier 5, France								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P102	248	248						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900586					2019-04-02	
J	Linsuke, S; Matangila, JR; Doua, J; Van Geertruyden, JP; Lutumba, P				Linsuke, S.; Matangila, J. R.; Doua, J.; Van Geertruyden, J. P.; Lutumba, P.			Impact of anthelmintic treatment on the burden of schistosomiasis and soil transmitted helminths in primary schoolchildren in Biyela health zone in Kinshasa, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Linsuke, S.; Lutumba, P.] Natl Inst Biomed Res INRB, Dept Epidemiol, Kinshasa, DEM REP CONGO; [Matangila, J. R.; Lutumba, P.] Univ Kinshasa, Dept Trop Med, Fac Med, Kinshasa, DEM REP CONGO; [Doua, J.; Van Geertruyden, J. P.] Univ Antwerp, Epidemiol Global Hlth Inst, Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P105	249	249						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900589					2019-04-02	
J	Bof, JCM; Maketa, V; KBakajika, D; Ntumba, F; Mpunga, D; Murdochand, ME; Lutumba, Y; Coppieters				Bof, J-C. Makenga; Maketa, V.; KBakajika, D.; Ntumba, F.; Mpunga, D.; Murdochand, M. E.; Lutumba P, Y.; Coppieters			Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bof, J-C. Makenga; Maketa, V.; KBakajika, D.; Ntumba, F.; Mpunga, D.; Murdochand, M. E.; Lutumba P, Y.; Coppieters] Univ Libre Bruxelles, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P107	250	250						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900591					2019-04-02	
J	Gomez, SA; Courtenay, O; Chapman, LAC; Dilger, E; Marcotty, T; Picado, A				Gomez, S. A.; Courtenay, O.; Chapman, L. A. C.; Dilger, E.; Marcotty, T.; Picado, A.			Modeling the mass use of systemic insecticides in dogs to control zoonotic visceral leishmaniasis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gomez, S. A.; Picado, A.] Hosp Clin Barcelona, Barcelona Inst Global Hlth, Barcelona, Spain; [Courtenay, O.; Chapman, L. A. C.; Dilger, E.] Univ Warwick, Coventry, W Midlands, England; [Marcotty, T.] VERDI R&D, Liege, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P112	252	252						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900596					2019-04-02	
J	Menschaert, D; Hoyoux, M; Moerman, F; Daron, A; Frere, J				Menschaert, D.; Hoyoux, M.; Moerman, F.; Daron, A.; Frere, J.			Echinococcosis, a global economic and health burden	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Menschaert, D.] Univ Liege, Liege, Belgium; [Hoyoux, M.; Frere, J.] Ctr Hosp Reg Liege, Univ Dept Pediat, Liege, Belgium; [Hoyoux, M.; Moerman, F.; Frere, J.] Ctr Hosp Reg Liege, Travel Clin, Liege, Belgium; [Moerman, F.] Ctr Hosp Reg Liege, Dept Infectiol, Liege, Belgium; [Daron, A.] Ctr Hosp Reg Liege, Univ Dept Pediat Neurol, Liege, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	4P113	252	253						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900597					2019-04-02	
J	Ku, GMV				Ku, G. M. V.			Factors affecting use of generics drugs in the Philippines	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ku, G. M. V.] Vrije Univ Brussel, Dept Gerontol, Fac Med & Pharm, Med Sans Frontieres Int Off, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P4	258	258						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900611					2019-04-02	
J	Deville, C; Poncelet, M; Vancolen, O				Deville, C.; Poncelet, M.; Vancolen, O.			Implementation and results of an indigents' healthcare exemption scheme in the district of lokossa-athieme (Benin)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Deville, C.; Poncelet, M.] Univ Liege, Liege, Belgium; [Vancolen, O.] Univ Libre Bruxelles, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P11	261	261						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900618					2019-04-02	
J	Sunyoto, T; Potet, J; Picado, A; Boelaert, M				Sunyoto, T.; Potet, J.; Picado, A.; Boelaert, M.			Evaluating access barriers to visceral Leishmaniasis diagnostic and drugs in 6 endemic countries in eastern Africa: is regional approach the solution?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sunyoto, T.; Boelaert, M.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Sunyoto, T.; Potet, J.] Med Sans Frontieres Campaign Access Med, Geneva, Switzerland; [Picado, A.] ISGlobal, Barcelona, Spain								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P22	265	265						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900629					2019-04-02	
J	Ha, DT; Huong, NT; Le, NH; Thuy, HT; Van, TT; Anne, B				Ha, D. T.; Huong, N. T.; Le, N. H.; Thuy, H. T.; Van, T. T.; Anne, B.			Willingness to pay for HPV vaccines among married women aged 15-49 years in 2 locations in Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ha, D. T.; Huong, N. T.; Le, N. H.; Thuy, H. T.] Hanoi Univ Publ Hlth, Fac Social Sci Behav & Hlth Educ, Dept Hlth Sociol, Hanoi, Vietnam; [Van, T. T.] Vietnam Acad Tradit Med, Hanoi, Vietnam; [Anne, B.] Inst Trop Med Antwerp, Dept Publ Hlth, Antwerp, Belgium							Bruni L, HUMAN PAPILLOMAVIRUS; Molly D., 2011, PATH 2011; Vu LTH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-53	3	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P24	266	266						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900631					2019-04-02	
J	Kannan, D; Kiyan, C; Zolfo, M; Lal, D; Prashanth, S; Harish, HN; Kumar, M; Devadasan, N				Kannan, D.; Kiyan, C.; Zolfo, M.; Lal, D.; Prashanth, S.; Harish, H. N.; Kumar, M.; Devadasan, N.			eLearning in public health education in India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kannan, D.; Lal, D.; Prashanth, S.; Harish, H. N.; Kumar, M.; Devadasan, N.] Inst Publ Hlth, Bangalore, Karnataka, India; [Kiyan, C.; Zolfo, M.] Inst Trop Med, Antwerp, Belgium			Zolfo, Maria/B-9787-2015	Zolfo, Maria/0000-0001-9756-9380				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P35	270	270						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900642					2019-04-02	
J	Laokri, S; Soelaeman, R; Hotchkiss, D				Laokri, S.; Soelaeman, R.; Hotchkiss, D.			Do under-resourced health systems have the ability to offer financial risk protection for primary healthcare? A baseline study of outpatient expenditure to inform health financing and universal coverage reform in the Democratic Republic of Congo (DRC)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Laokri, S.] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Laokri, S.; Soelaeman, R.; Hotchkiss, D.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P38	271	272						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900645					2019-04-02	
J	Vermandere, H; Galle, A; Grifin, S; de Melo, M; Machaieie, L; Van Braeckel, D; Degomme, O				Vermandere, H.; Galle, A.; Grifin, S.; de Melo, M.; Machaieie, L.; Van Braeckel, D.; Degomme, O.			Improving contraceptives supply management by addressing the human factor	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Vermandere, H.; Galle, A.; Grifin, S.; de Melo, M.; Machaieie, L.; Van Braeckel, D.; Degomme, O.] Univ Ghent, Ghent, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P36	271	271						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900643					2019-04-02	
J	Laokri, S; Eozenou, P; Eloko, G; Minga, G; Miteo, R; Samaha, HD				Laokri, S.; Eozenou, P.; Eloko, G.; Minga, G.; Miteo, R.; Samaha, H. D.			Assessing health equity in the Democratic Republic of Congo (DRC) - A focus on financial protection	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Laokri, S.] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Laokri, S.; Eozenou, P.; Samaha, H. D.] World Bank Inst, Washington, DC USA; [Laokri, S.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA 70118 USA; [Eloko, G.] Minist Heath, Programme Natl Comptes Nationaux Sante, Kinshasa, DEM REP CONGO; [Minga, G.] Minist Heath, Direct Etud & Planificat, Kinshasa, DEM REP CONGO; [Miteo, R.] Univ Libre Bruxelles, Sch Publ Hlth, Hlth Policy & Syst Int Hlth, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P39	272	272						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900646					2019-04-02	
J	Rijal, S; Karki, P; Bhatta, N; Sharma, SK; Uranw, S; Koirala, P; Chhetri, R; Boelaert, M; Marasini, B; Kattel, V				Rijal, S.; Karki, P.; Bhatta, N.; Sharma, S. K.; Uranw, S.; Koirala, P.; Chhetri, R.; Boelaert, M.; Marasini, B.; Kattel, V.			Impact of short term clinical training on tropical and infectious disease to medical doctors working at remote part of Nepal	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Rijal, S.] DNDI, New Delhi, India; [Karki, P.; Bhatta, N.; Sharma, S. K.; Uranw, S.; Koirala, P.; Chhetri, R.; Kattel, V.] BPKIHS, Dept Internal Med, Dharan, Nepal; [Boelaert, M.] ITM, Dept Publ Hlth, Antwerp, Belgium; [Marasini, B.] Minist Hlth, Dept Hlth Serv, Epidemiol & Dis Control Div, Kathmandu, Nepal								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P45	274	274						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900652					2019-04-02	
J	Belrhiti, Z; Ariadna, NG; Marchal, B				Belrhiti, Z.; Ariadna, N. G.; Marchal, B.			Complex leadership in health	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Belrhiti, Z.] Natl Sch Publ Hlth, Rabat, Morocco; [Belrhiti, Z.; Ariadna, N. G.; Marchal, B.] Inst Trop Med, Dept Publ Hlth, Hlth Serv Org Unit, Antwerp, Belgium							Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616	1	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P52	277	277						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900659					2019-04-02	
J	De Vos, P; Apers, L; Zolfo, M; Vuylsteke, B				De Vos, P.; Apers, L.; Zolfo, M.; Vuylsteke, B.			Postgraduate training in tropical medicine and international health - Results of an alumni survey on career development and implications for course content needs	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[De Vos, P.; Vuylsteke, B.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Apers, L.; Zolfo, M.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium			Zolfo, Maria/B-9787-2015	Zolfo, Maria/0000-0001-9756-9380				0	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P51	277	277						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900658					2019-04-02	
J	Chinsakaso, B; Jackson, N; Banda, A; Kestens, W; Philips, M; Bemelmans, M				Chinsakaso, B.; Jackson, N.; Banda, A.; Kestens, W.; Philips, M.; Bemelmans, M.			Health surveillance Assistants remain critical to fill health workforce gaps in Malawi	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Chinsakaso, B.; Jackson, N.; Kestens, W.] Med Sans Frontieres, Operat Ctr Brussels, Lilongwe, Malawi; [Banda, A.] Med Sans Frontieres, Operat Ctr Brussels, Johannesburg, South Africa; [Philips, M.; Bemelmans, M.] Med Sans Frontieres, Operat Ctr Brussels, Anal & Advocacy Unit, Brussels, Belgium; [Bemelmans, M.] Independent Publ Hlth Consultant, Baltimore, MD USA								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P60	280	280						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900667					2019-04-02	
J	Bemelmans, M; van Adrichem, E; Rehfeld, R; Maikere, J; Philips, M				Bemelmans, M.; van Adrichem, E.; Rehfeld, R.; Maikere, J.; Philips, M.			In post-Ebola era, still waiting for the strengthening of health workforce in Sierra Leone	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bemelmans, M.; Philips, M.] Independent Publ Hlth Consultant, Baltimore, MD USA; [Bemelmans, M.; van Adrichem, E.] Med Sans Frontieres, Operat Ctr Brussels, Anal Dept, Brussels, Belgium; [Rehfeld, R.] Med Sans Frontieres, Operat Ctr Amsterdam, Sierra Leone Mission, Freetown, Sierra Leone; [Maikere, J.] Med Sans Frontieres, Operat Ctr Brussels, Sierra Leone Mission, Freetown, Sierra Leone								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P61	281	281						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900668					2019-04-02	
J	Ocquet, HS; Labat, A; Dujardin, B; Maimouna, HD; Janssen, W; Weber, L				Ocquet, H. S.; Labat, A.; Dujardin, B.; Maimouna, H. D.; Janssen, W.; Weber, L.			A solidarity fund to improve emergency obstetric and neonatal care in Mirriah department, Niger	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ocquet, H. S.] Minist Publ Hlth, Niamey., Niger; [Labat, A.; Dujardin, B.; Maimouna, H. D.; Weber, L.] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium; [Janssen, W.] Belgian Tech Cooperat, Projet Appui Inst, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P63	281	282						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900670					2019-04-02	
J	Bhojani, U; Devadasan, N; Kolsteren, P; DeHenauw, S; Criel, B				Bhojani, U.; Devadasan, N.; Kolsteren, P.; DeHenauw, S.; Criel, B.			Enhancing chronic condition care for urban poor: role of the local health systems	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bhojani, U.; Devadasan, N.] Inst Publ Hlth, Bengaluru, India; [Kolsteren, P.] Univ Ghent, Dept Food Safety & Food Qual, Ghent, Belgium; [DeHenauw, S.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [Criel, B.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P65	282	282						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900672					2019-04-02	
J	Sorensen, S; Codjia, P; Vreeke, E; Jille-Traas, I				Sorensen, S.; Codjia, P.; Vreeke, E.; Jille-Traas, I.			Integrating nutrition products into health system supply chains: making the case	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sorensen, S.] UNICEF ESARO, Supply Dept, Nairobi, Kenya; [Codjia, P.] UNICEF ESARO, Nutr Dept, Nairobi, Kenya; [Vreeke, E.; Jille-Traas, I.] Hera, Reet, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P67	283	283						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900674					2019-04-02	
J	Idrissi, A; Leveque, A				Idrissi, A.; Leveque, A.			Factors associated with poor glycaemic control among diabetic patients in primary health care services in Morocco	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Idrissi, A.] Minist Hlth, Natl Sch Publ Hlth, Rabat, Morocco; [Leveque, A.] Free Univ Brussels, Sch Publ Hlth, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P69	284	284						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900676					2019-04-02	
J	Ramirez, C; Villalobos, J; Versporten, A; Goossens, H; Pelaez, M				Ramirez, C.; Villalobos, J.; Versporten, A.; Goossens, H.; Pelaez, M.			The global point prevalence survey of antimicrobialconsumption in one Costa Rican hospital	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ramirez, C.; Villalobos, J.] Hosp Mexico, Dept Infect Dis, CCSS, San Jose, Costa Rica; [Versporten, A.; Goossens, H.] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Med Microbiol, Fac Med & Hlth Sci, Antwerp, Belgium; [Pelaez, M.] Hosp Mexico, Dept Infect Dis, CCSS, San Jose, Costa Rica								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P78	287	287						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900685					2019-04-02	
J	Adamou, H; Magagi, IA; Habou, O; Karimou, S; Halidou, M; Adamou, M; Labat, A				Adamou, H.; Magagi, I. Amadou; Habou, O.; Karimou, S.; Halidou, M.; Adamou, M.; Labat, A.			Strengthen digestive surgical emergency care: Experience of an action-research in Zinder National Hospital, Niger	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Adamou, H.; Habou, O.; Halidou, M.] Fac Hlth Sci, Zinder, Niger; [Adamou, H.; Magagi, I. Amadou; Habou, O.; Halidou, M.; Adamou, M.] Zinder Natl Hosp, Zinder, Niger; [Karimou, S.] Reg Direct Publ Hlth, Tahoua, Niger; [Labat, A.] Univ Libre Bruxelles, Sch Publ Hlth, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P80	288	288						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900686					2019-04-02	
J	Nkurunziza, S; Van Geertruyden, JP; Korachais, C; Anthierens, S				Nkurunziza, S.; Van Geertruyden, J. P.; Korachais, C.; Anthierens, S.			Understanding factors that influence the implementation of the performance-based financing scheme at community level for nutrition services in Burundi	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Nkurunziza, S.] Univ Burundi, Dept Community Hlth, Bujumbura, Burundi; [Nkurunziza, S.; Van Geertruyden, J. P.; Anthierens, S.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Korachais, C.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P86	290	290						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900692					2019-04-02	
J	Ku, GMV; Dalmacion, G; Baja, M				Ku, G. M. V.; Dalmacion, G.; Baja, M.			Strategies to institutionalise patient engagement in the public health sector	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ku, G. M. V.] Vrije Univ Brussel, Medecins Sans Frontieres Int Off, Fac Med & Pharm, Dept Gerontol, Brussels, Belgium; [Dalmacion, G.; Baja, M.] Univ Philippines Manila, Coll Med, Dept Clin Epidemiol, Manila, Philippines								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P88	291	291						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900694					2019-04-02	
J	Dispas, H; Marganne, M; Drielsma, P; Somasse, YE				Dispas, H.; Marganne, M.; Drielsma, P.; Somasse, Y. E.			Interdisciplinary team work in primary health care: Experience of Belgian community health center	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dispas, H.; Marganne, M.; Drielsma, P.; Somasse, Y. E.] Federat Maisons Med, Brussels, Belgium; [Somasse, Y. E.] Univ Libre Bruxelles, Sch Publ Health, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P92	292	292						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900698					2019-04-02	
J	Enimil, A; Versporten, A; Goossens, H; Frimpong, JA; Agbedinu, K; Nkyi, CA; Yeboah, M; Ansong, D				Enimil, A.; Versporten, A.; Goossens, H.; Frimpong, J. A.; Agbedinu, K.; Nkyi, C. A.; Yeboah, M.; Ansong, D.			Global point prevalence survey on antimicrobial use and resistance (global-PPS): implications for antibiotic stewardship programme for Komfo Anokye teaching hospital in Ghana	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Enimil, A.; Ansong, D.] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana; [Enimil, A.; Frimpong, J. A.; Agbedinu, K.; Nkyi, C. A.; Yeboah, M.; Ansong, D.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Versporten, A.; Goossens, H.] Univ Antwerp, Lab Med Microbiol, Fac Med & Hlth Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P95	294	294						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900701					2019-04-02	
J	Bassalia, D; Porignon, DG; Teya, K; Kouakou, BI; Aka, EJ; Kouassi, D; Dosso, M; Sondag-Thull, D				Bassalia, D.; Porignon, D. G.; Teya, K.; Kouakou, B. I.; Aka, E. J.; Kouassi, D.; Dosso, M.; Sondag-Thull, D.			Accreditation at district level in Cote d'Ivoire: Are the actors informed enough to mobilize their capacity?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract						Knowledge; actors; accreditation; health districts; Cote d'Ivoire			[Bassalia, D.; Porignon, D. G.] Univ Liege, Dept Publ Hlth, Liege, Belgium; [Bassalia, D.; Aka, E. J.; Kouassi, D.] Natl Inst Publ Hlth, Dept Polit & Hlth Syst, Abidjan, Cote Ivoire; [Teya, K.] Univ Allassane Ouattara, Ctr Entomol, Bouake, Cote Ivoire; [Kouakou, B. I.] Natl Polytech Inst Houphouet Boigny, Dept Languages & Humans Sci, Yamoussokro, Cote Ivoire; [Aka, E. J.; Dosso, M.] Univ Felix Houphouet Boigny Cocody, Dept Med Sci, Abidjan, Cote Ivoire; [Kouassi, D.] Univ Felix Houphouet Boigny Cocody, Dept Med Sci, Abidjan, Cote Ivoire; [Dosso, M.] Pasteurs Inst, Dept Microbiol, Abidjan, Cote Ivoire; [Sondag-Thull, D.] Univ Liege, Dept Immunohematol & Tranfus, Liege, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	5P98	295	295						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900704					2019-04-02	
J	Van Remoortel, H; Veegaete, AV; Naidoo, S; Avau, B; Govender, T; Vandekerckhove, P; Young, T; De Buck, E				Van Remoortel, H.; Veegaete, A. Vande; Naidoo, S.; Avau, B.; Govender, T.; Vandekerckhove, P.; Young, T.; De Buck, E.			Measuring behavioral outcomes in development aid: a call for standardization to improve the evidence synthesis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Van Remoortel, H.; Veegaete, A. Vande; Avau, B.; De Buck, E.] Belgian Red Cross, Ctr Evidence Based Practice, Mechelen, Belgium; [Naidoo, S.; Young, T.] Stellenbosch Univ, Ctr Evidence Based Hlth Care, Cape Town, South Africa; [Avau, B.] Cochrane Belgium, Ctr Evidence Based Med, Leuven, Belgium; [Govender, T.] Stellenbosch Univ, Div Hlth Syst & Publ Hlth, Cape Town, South Africa; [Vandekerckhove, P.] Belgian Red Cross, Mechelen, Belgium; [Vandekerckhove, P.; De Buck, E.] Katholieke Univ Leuven, Fac Med, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Vandekerckhove, P.] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6P7	299	299						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900714					2019-04-02	
J	Delamou, A; Delvaux, T; Beavogui, AH; Sow, A; Van Bastelaere, S; Criel, B; Van Damme, W				Delamou, A.; Delvaux, T.; Beavogui, A. H.; Sow, A.; Van Bastelaere, S.; Criel, B.; Van Damme, W.			Building training and research capacities in Ebola affected countries: the case of the Belgian Cooperation in Guinea	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Delamou, A.; Beavogui, A. H.] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, A.; Delvaux, T.; Criel, B.; Van Damme, W.] Inst Trop Med, Antwerp, Belgium; [Sow, A.] Fratern Med Guinee, Conakry, Guinea; [Van Bastelaere, S.] Belgian Tech Cooperat, Brussels, Belgium					Belgian Directorate-General for Development Cooperation and Humanitarian Aid (DGD); Belgian Technical Cooperation (BTC) supports e-Courses development and running	The Program is funded by the Belgian Directorate-General for Development Cooperation and Humanitarian Aid (DGD) and additional funding from the Belgian Technical Cooperation (BTC) supports e-Courses development and running.		0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	6P11	301	301						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900718					2019-04-02	
J	Kabaria, CW; Gilbert, M; Noor, AM; Snow, RW; Linard, C				Kabaria, C. W.; Gilbert, M.; Noor, A. M.; Snow, R. W.; Linard, C.			The impact of urbanization and population density on childhood plasmodium falciparum parasite prevalence rates in Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kabaria, C. W.] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Gilbert, M.; Linard, C.] Univ Libre Bruxelles, Spatial Epidemiol Lab, Brussels, Belgium; [Gilbert, M.] Fonds Natl Rech Sci FRS FNRS, Brussels, Belgium; [Noor, A. M.; Snow, R. W.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Spatial Hlth Metr Grp, Nairobi, Kenya; [Noor, A. M.; Snow, R. W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Linard, C.] Univ Namur, Dept Geog, Namur, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	7P2	302	303						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900720					2019-04-02	
J	Mutombo, A; Ndua, J; Mukuku, O; Tshibanda, C; Mukomena, E; Wembonyama, S; Luboya, O; Van Geertruyden, JP; Lutumba, P				Mutombo, A.; Ndua, J.; Mukuku, O.; Tshibanda, C.; Mukomena, E.; Wembonyama, S.; Luboya, O.; Van Geertruyden, J-P.; Lutumba, P.			Severe malaria and risk factors associated to the lethality in children admitted in Jason Sendwe Hospital, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mutombo, A.; Ndua, J.; Mukomena, E.; Wembonyama, S.; Luboya, O.] Univ Lubumbashi, Lubumbashi, DEM REP CONGO; [Mutombo, A.; Van Geertruyden, J-P.] Antwerpen Univ, Int Hlth Unity, Antwerp, Belgium; [Mukuku, O.; Tshibanda, C.; Luboya, O.] Inst Super Tech Med, Lubumbashi, DEM REP CONGO; [Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P6	307	307						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900732					2019-04-02	
J	Mutombo, A; Tshibanda, C; Kanteng, G; Mukomena, E; Wembonyama, S; Luboya, O; Lutumba, P; Ntambue, A				Mutombo, A.; Tshibanda, C.; Kanteng, G.; Mukomena, E.; Wembonyama, S.; Luboya, O.; Lutumba, P.; Ntambue, A.			Home-based management of presumptive malaria in children under 5 years old in an urban health area, Democratic Republic of the Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mutombo, A.; Kanteng, G.; Mukomena, E.; Wembonyama, S.; Luboya, O.] Univ Lubumbashi, Fac Med, Lubumbashi, DEM REP CONGO; [Mutombo, A.] Antwerpen Univ, Int Hlth Unity, Antwerp, Belgium; [Tshibanda, C.; Luboya, O.] Inst Super Tech Med, Lubumbashi, DEM REP CONGO; [Mukomena, E.; Luboya, O.; Ntambue, A.] Ecole Sante Publ, Lubumbashi, DEM REP CONGO; [Lutumba, P.] Univ Kinshasa, Kinshasa, DEM REP CONGO								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P7	308	308						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900733					2019-04-02	
J	Thielemans, L; Trip-Hoving, M; Landier, J; Hanboonkunupakarn, B; Po, C; Wah, T; Beau, C; Van Overmeire, B; McGready, R; Carrara, V				Thielemans, L.; Trip-Hoving, M.; Landier, J.; Hanboonkunupakarn, B.; Po, C.; Wah, Ts.; Beau, C.; Van Overmeire, B.; McGready, R.; Carrara, V.			Neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: an audit of neonatal medical records from 2009 to 2014	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Thielemans, L.; Trip-Hoving, M.; Landier, J.; Po, C.; Wah, Ts.; Beau, C.; McGready, R.; Carrara, V.] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Thielemans, L.; Van Overmeire, B.] Univ Libre Bruxelles, Fac Med, Dept Paediat, Brussels, Belgium; [Hanboonkunupakarn, B.; McGready, R.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Mae Sot, Thailand; [McGready, R.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England							National Telecommunications and Information Administration Office of Spectrum Management, 2010, FULL CLIN GUID, p[14, 40]	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P11	309	309						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900737					2019-04-02	
J	Wouda, EMN; Thielemans, L; Ngerseng, T; Darakamon, MC; Nge, AA; Say, WW; Mawker, N; van Rheenen, PF; McGready, R; Carrara, VI				Wouda, E. M. N.; Thielemans, L.; Ngerseng, T.; Darakamon, M. C.; Nge, A. A.; Say, W. W.; Mawker, N.; van Rheenen, P. F.; McGready, R.; Carrara, V. I.			Clinical and neurodevelopmental outcome of newborns with excessively high levels of serum bilirubin in a limited-resource setting: a matched case-control study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Wouda, E. M. N.; Thielemans, L.; Darakamon, M. C.; Nge, A. A.; Say, W. W.; Mawker, N.; McGready, R.; Carrara, V. I.] Mahidol Univ, Fac Trop Med, Shoklo Malaria Res Unit, Mae Sot, Thailand; [Wouda, E. M. N.; van Rheenen, P. F.] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Thielemans, L.] Univ Libre Bruxelles, Fac Med, Dept Paediat, Brussels, Belgium; [Ngerseng, T.; McGready, R.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit MORU, Mae Sot, Thailand; [McGready, R.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England							National Telecommunications and Information Administration Office of Spectrum Management, 2010, FULL CLIN GUID, p[14, 40]	1	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P12	309	310						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900738					2019-04-02	
J	Beyene, T; Zolfo, M; Mhango, J; Simon, K; Kizito, W; Chu, S; Peno, W; Kumwenda, J; Amberbir, A; Ahmed, S; Kim, M; Kazembe, PN				Beyene, T.; Zolfo, M.; Mhango, J.; Simon, K.; Kizito, W.; Chu, S.; Peno, W.; Kumwenda, J.; Amberbir, A.; Ahmed, S.; Kim, M.; Kazembe, P. N.			Does the deployment of HIV diagnostic assistants in Malawi improve early infant HIV diagnosis and enrollment to care?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Beyene, T.; Mhango, J.; Simon, K.; Chu, S.; Ahmed, S.; Kim, M.; Kazembe, P. N.] Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi; [Beyene, T.; Simon, K.; Ahmed, S.; Kim, M.; Kazembe, P. N.] Texas Childrens Hosp, Baylor Coll Med, Baylor Int Pediat AIDS Initiat, Houston, TX 77030 USA; [Zolfo, M.] Inst Trop Med Antwerp, Antwerp, Belgium; [Kizito, W.] Med Sans Frontiers, Mombasa, Kenya; [Peno, W.; Kumwenda, J.] Mangochi Dist Hlth Off, Mulanje, Malawi; [Amberbir, A.] Dignitas Int, Zomba, Malawi			Zolfo, Maria/B-9787-2015	Zolfo, Maria/0000-0001-9756-9380				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P15	311	311						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900741					2019-04-02	
J	Ouedraogo, O; Doudou, MH; Drabo, KM; Ouaro, B; Donnen, P				Ouedraogo, O.; Doudou, M. H.; Drabo, K. M.; Ouaro, B.; Donnen, P.			Integrating nutrition into local development plans: a challenge for Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ouedraogo, O.; Doudou, M. H.; Donnen, P.] ULB, Ecole Sante Publ, Brussels, Belgium; [Drabo, K. M.] CNRST, IRSS, Ouagadougou, Burkina Faso; [Ouaro, B.] Minist Sante, Direct Nutr, Ouagadougou, Burkina Faso								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P17	312	312						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900743					2019-04-02	
J	Nkurunziza, S; Meessen, B; Van Geertruyden, JP; Korachais, C				Nkurunziza, S.; Meessen, B.; Van Geertruyden, J. -P.; Korachais, C.			Determinants of stunting and severe stunting among Burundian children aged 6-23 months: evidence from a national cross-sectional household survey, 2014	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Nkurunziza, S.; Van Geertruyden, J. -P.] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Nkurunziza, S.] Univ Burundi, Dept Community Hlth, Bujumbura, Burundi; [Meessen, B.; Korachais, C.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P25	315	315						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900751					2019-04-02	
J	Bisimwa, B; Nkemba, B; Cobohwa, N; Bashonja, M; Mirindi, P; Bwija, J; Bwenge, M; Donnen, P				Bisimwa, B.; Nkemba, B.; Cobohwa, N.; Bashonja, M.; Mirindi, P.; Bwija, J.; Bwenge, M.; Donnen, P.			Stunting in extreme nutritional vulnerability: Eastern of Democratic Republic of Congo crisis case	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bisimwa, B.; Nkemba, B.; Cobohwa, N.] Ctr Rech Sci Nat Lwiro, Lwiro, DEM REP CONGO; [Bisimwa, B.; Bashonja, M.; Mirindi, P.; Bwija, J.; Bwenge, M.] Univ Catholique Bukavu, Bukavu, DEM REP CONGO; [Bisimwa, B.; Mirindi, P.] Univ Catholique Bukavu, Ecole Reg Sante Publ, Bukavu, DEM REP CONGO; [Bisimwa, B.; Donnen, P.] Univ Libre Bruxelles Ses Act Cooperat, Ctr Sci & Med, Brussels, Belgium; [Donnen, P.] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P29	317	317						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900755					2019-04-02	
J	Somasse, YE; Savadogo, LGB; Donnen, P				Somasse, Y. E.; Savadogo, L. G. B.; Donnen, P.			Impeding factors regarding appropriate feeding of infants and young children in Burkina Faso: infant colic is a forgotten problem to manage	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Somasse, Y. E.; Donnen, P.] Univ Libre Bruxelles, Ctr Rech Polit & Syst Sante Sante Int, Ecole Sante Publ, Brussels, Belgium; [Somasse, Y. E.; Donnen, P.] Ctr Rech Epidemiol Biostat & Rech Clin, Brussels, Belgium; [Savadogo, L. G. B.] Univ Polytech Bobo Dioulasso, Inst Super Sci Sante, Dept Sante Publ, Bobo Dioulasso, Burkina Faso								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P35	319	319						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900761					2019-04-02	
J	Ninsiima, BA; Coene, G; Najjuka, S; Michielsen, K; Nyakato, NV; Leye, E				Ninsiima, B. A.; Coene, G.; Najjuka, S.; Michielsen, K.; Nyakato, N. V.; Leye, E.			Implementation of sexuality education policies in Uganda; obstacles and challenges	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ninsiima, B. A.; Coene, G.; Leye, E.] Vrije Univ Brussel, RHEA, Ctr Expertise Gender Divers & Intersect, Brussels, Belgium; [Najjuka, S.] Uganda Martyrs Univ, Kampala, Uganda; [Michielsen, K.; Leye, E.] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium; [Nyakato, N. V.] Mbarara Univ Sci & Technol, Dept Human Dev & Relat Sci, Kampala, Uganda								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P47	324	324						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900773					2019-04-02	
J	Siling, K; Grietens, KP; O'Neill, S; Verdonck, K				Siling, K.; Grietens, K. Peeters; O'Neill, S.; Verdonck, K.			Systematic review and meta-analysis of risk factors for epilepsy and nodding syndrome in Sub-Saharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Siling, K.; Grietens, K. Peeters; O'Neill, S.; Verdonck, K.] Inst Trop Med, Antwerp, Belgium; [Siling, K.] London Sch Hyg & Trop Med, London, England								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P49	324	325						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900775					2019-04-02	
J	Benedetti, G; White, RA; Pasquale, HA; Stassijns, J; van den Boogaard, W; Owiti, P; van Den Bergh, R				Benedetti, G.; White, R. A.; Pasquale, H. Akello; Stassijns, J.; van den Boogaard, W.; Owiti, P.; van Den Bergh, R.			Identifying unusual malaria events in the absence of historical data. Speculations from malaria-free Norway to endemic south Sudan	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Benedetti, G.; Stassijns, J.; van den Boogaard, W.; van Den Bergh, R.] Medecins Sans Frontieres, Dept Med, Operat Ctr Brussels, Brussels, Belgium; [White, R. A.] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol & Modelling, Oslo, Norway; [Pasquale, H. Akello] Natl Minist Hlth, Natl Malaria Control Programme, Juba, Sudan; [Owiti, P.] Acad Model Providing Access Healthcare, Eldoret, Kenya								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P53	326	326						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900779					2019-04-02	
J	Kim, T; Peeters, A				Kim, T.; Peeters, A.			Beliefs about mental problems and treatment seeking in rural communities in Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Peeters, A.] Louvain Cooperat Dev, Louvain La Neuve, Belgium					Maryknoll Cambodia; Deutsche Gesellschaft fur Internationale Zusammenarbeit; Belgian Development Cooperation	This research was financially supported by Maryknoll Cambodia, Deutsche Gesellschaft fur Internationale Zusammenarbeit, and the Belgian Development Cooperation with the technical support of the University NGO Louvain Cooperation.	McLaughlin D, 2012, SPECIAL REPORT MENTA; Prigent S., 2009, MENTAL HLTH CAMBODIA; Somasundaram DJ, 1999, SOC SCI MED, V48, P1029, DOI 10.1016/S0277-9536(98)00415-8	3	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P58	328	328						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900784					2019-04-02	
J	Galle, A; Degomme, O; Roelens, K; Griffin, S; Osman, N				Galle, A.; Degomme, O.; Roelens, K.; Griffin, S.; Osman, N.			Policymaker, health provider and community perspectives on male involvement in maternal health in Mozambique: A qualitative study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Galle, A.; Degomme, O.; Roelens, K.] Univ Ghent, Dept Obstet & Gynaecol, Int Ctr Reprod Hlth, Fac Med & Hlth Sci, Ghent, Belgium; [Griffin, S.; Osman, N.] Int Ctr Reprod Hlth Mozambique, Maputo, Mozambique								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P62	329	330						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900788					2019-04-02	
J	Dierickx, S; Rahbari, L; Longman, C; Coene, G				Dierickx, S.; Rahbari, L.; Longman, C.; Coene, G.			Socio-cultural aspects of vaginal practices: a systematic and cross-cultural review of qualitative research	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Dierickx, S.; Rahbari, L.; Coene, G.] Vrije Univ Brussel, Ctr Expertise Gender Divers & Intersect RHEA, Brussels, Belgium; [Dierickx, S.; Rahbari, L.; Longman, C.] Univ Ghent, Ctr Res Culture & Gender, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P63	330	330						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900789					2019-04-02	
J	Bihoun, B; Zango, SH; Kabore, B; Traore, MM; Valea, I; Umberto, DA; Tinto, H; Robert, A				Bihoun, B.; Zango, S. H.; Kabore, B.; Traore, M. M.; Valea, I.; Umberto, D. A.; Tinto, H.; Robert, A.			Low birth weight or prematurity in teenage mothers from rural areas of Burkina Faso	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bihoun, B.; Zango, S. H.; Kabore, B.; Traore, M. M.; Valea, I.; Tinto, H.] IRSS DRCO, Clin Res Unit Nanoro, Ouagadougou, Burkina Faso; [Bihoun, B.; Robert, A.] Catholic Univ Louvain, IREC EPID, Brussels, Belgium; [Umberto, D. A.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P68	332	332						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900794					2019-04-02	
J	Mutombo, BA; Kanyiki, H; Tozin, R; Bogers, J; Van Geertruyden, J; Jacquemyn, Y				Mutombo, B. A.; Kanyiki, H.; Tozin, R.; Bogers, J.; Van Geertruyden, J.; Jacquemyn, Y.			Difficulties in implementing a HPV/cervical cancer screening programme in Kinshasa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mutombo, B. A.; Tozin, R.] Univ Kinshasa, Dept Obstet & Gynaecol, Kinshasa, DEM REP CONGO; [Kanyiki, H.] Ctr Hosp Mt Amba, Kinshasa, DEM REP CONGO; [Bogers, J.] Univ Antwerp, Lab Cell Biol & Histol, AMBIOR, Antwerp, Belgium; [Mutombo, B. A.; Van Geertruyden, J.] Univ Antwerp, Global Hlth Inst, Fac Med & Hlth Sci, Antwerp, Belgium; [Jacquemyn, Y.] UZA Antwerp Univ Hosp, Dept Obstet & Gynaecol, Edegem, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P74	334	335						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900800					2019-04-02	
J	Kemigisha, E; Nyakato, VN; Ruzaaza, GN; Mlahagwa, W; Leye, E; Coene, G; Degomme, O; Michielsen, K				Kemigisha, E.; Nyakato, V. N.; Ruzaaza, G. Ndaruhutse; Mlahagwa, W.; Leye, E.; Coene, G.; Degomme, O.; Michielsen, K.			Assessing sexual health of very young adolescents in SW Uganda	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kemigisha, E.; Nyakato, V. N.; Ruzaaza, G. Ndaruhutse; Mlahagwa, W.] Mbarara Univ Sci & Technol, Dept Human Dev & Relat Sci, Kampala, Uganda; [Leye, E.; Coene, G.] Free Univ Brussels, Ctr Expertise Gender Divers & Intersect, Brussels, Belgium; [Kemigisha, E.; Leye, E.; Degomme, O.; Michielsen, K.] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P76	335	335						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900802					2019-04-02	
J	Ngo, TTD; Tran, TT; Nguyen, TD; Goyens, P; Robert, A				Ngo, T. T. D.; Tran, T. T.; Nguyen, T. D.; Goyens, P.; Robert, A.			Misuse of antenatal care and its association with adverse outcome of pregnancy in a southern rural area of Vietnam	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Ngo, T. T. D.; Nguyen, T. D.] Pham Ngoc Thach Univ Med, Ho Chi Minh City, Vietnam; [Tran, T. T.] Hlth Ctr Trang Bom Dist, Trang Bom, Dong Nai Provin, Vietnam; [Goyens, P.] Univ Libre Bruxelles, Nutr & Metab Unit, Brussels, Belgium; [Goyens, P.] Univ Libre Bruxelles, Pediat Lab, Brussels, Belgium; [Ngo, T. T. D.; Robert, A.] Catholic Univ Louvain, Inst Rech Expt & Clin, Pole Epidemiol & Biostat EPID, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P75	335	335						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900801					2019-04-02	
J	Mutombo, BA; Tozin, R; Benoy, I; Bogers, J; Vandenbroeck, D; Ramokone, LL; Van Geertruyden, J; Jacquemyn, Y				Mutombo, B. A.; Tozin, R.; Benoy, I.; Bogers, J.; Vandenbroeck, D.; Ramokone, L. L.; Van Geertruyden, J.; Jacquemyn, Y.			Prevalence and distribution of hpv genotypes found in Kinshasa versus Flanders	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mutombo, B. A.; Tozin, R.] Univ Kinshasa, Dept Obstet & Gynaecol, Kinshasa, DEM REP CONGO; [Benoy, I.; Bogers, J.] AML Lab, Antwerp, Belgium; [Vandenbroeck, D.] Univ Ghent, Ghent, Belgium; [Ramokone, L. L.] Sefako Makgatho Hlth Sci Univ, Virol Lab, Pretoria, South Africa; [Mutombo, B. A.; Van Geertruyden, J.] Univ Antwerp, Global Hlth Inst, Fac Med & Hlth Sci, Antwerp, Belgium; [Jacquemyn, Y.] UZA Antwerp Univ Hosp, Dept Obstet & Gynaecol, Edegem, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P77	336	336						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900803					2019-04-02	
J	Abouchadi, S; Zhang, WH; Englert, Y; Nejjari, C; De Brouwere, V				Abouchadi, S.; Zhang, W. -H.; Englert, Y.; Nejjari, C.; De Brouwere, V.			Maternal deaths surveillance system: a tool to guide action at regional level in Morocco?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Abouchadi, S.] Ecole Natl Sante Publ, Rabat, Morocco; [Zhang, W. -H.] ULB, Sch Publ Hlth, Brussels, Belgium; [Englert, Y.] ULB, Lab Rech Reprod Humaine, Hop Erasme, Brussels, Belgium; [Nejjari, C.] Univ Mohamed VI Sci Sante UM6SS, Casablanca, Morocco; [De Brouwere, V.] Inst Trop Med, Dept Publ Hlth, Maternal & Reprod Hlth Unit, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P82	337	337						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900807					2019-04-02	
J	Cikuru, MN; Bosmans, M				Cikuru, M. N.; Bosmans, M.			The importance of a community based approach in reaching out to survivors of sexual violence. The experience of two coffee cooperatives in the DR Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cikuru, M. N.] Act Espoir, Bukavu, DEM REP CONGO; [Bosmans, M.] BTC Belgian Dev Agcy, Hlth Unit, Brussels, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P81	337	337						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900806					2019-04-02	
J	Cools, P; Jespers, V; Hardy, L; Crucitti, T; Delany-Moretlwe, S; Mwaura, M; Ndayisaba, GF; de Wijgert, JHHMV; Vaneechoutte, M				Cools, P.; Jespers, V.; Hardy, L.; Crucitti, T.; Delany-Moretlwe, S.; Mwaura, M.; Ndayisaba, G. F.; de Wijgert, J. H. H. M. van; Vaneechoutte, M.			Vaginal carriage prevalence of group B streptococcus (GBS), GBS serodistribution, risk factors for carriage of GBS and Escherichia coli, and microbiological and immune correlates of vaginal GBS carriage in three African populations	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cools, P.; Vaneechoutte, M.] Univ Ghent, Dept Microbiol Immunol & Clin Chem, Lab Bacteriol Res, Fac Med & Hlth Sci, Ghent, Belgium; [Jespers, V.; Hardy, L.] Inst Trop Med, Dept Publ Hlth, Unit Epidemiol & Control HIV STD, Antwerp, Belgium; [Crucitti, T.] Inst Trop Med, Dept Clin Sci, HIV STI Reference Lab, Antwerp, Belgium; [Delany-Moretlwe, S.] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Mwaura, M.] ICRH Kenya, Mombasa, Kenya; [Ndayisaba, G. F.] Rinda Ubuzima, Kigali, Rwanda; [de Wijgert, J. H. H. M. van] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P88	340	340						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900813					2019-04-02	
J	Cartier, N; Kerstin, A; Amanda, B; Mit, P				Cartier, N.; Kerstin, A.; Amanda, B.; Mit, P.			Priority fast tracking HIV response in West and Central Africa to halt human and medical consequences of low ARV coverage	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cartier, N.; Kerstin, A.; Mit, P.] Med Sans Frontieres, Brussels, Belgium; [Amanda, B.] Med Sans Frontieres, Johannesburg, South Africa								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P90	341	341						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900815					2019-04-02	
J	Johm, P; Jaiteh, F; Clarke, E; Grietens, KP				Johm, P.; Jaiteh, F.; Clarke, E.; Grietens, K. Peeters			Understanding maternal and neonatal vaccination acceptance in the Gambia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Johm, P.; Clarke, E.] MRC Unit Gambia, Vaccines & Immun Theme, Banjul, Gambia; [Johm, P.; Jaiteh, F.; Grietens, K. Peeters] Inst Trop Med, Dept Publ Heath, Antwerp, Belgium; [Jaiteh, F.] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands								0	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P95	342	343						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900820					2019-04-02	
J	Chim, JV; Ceballos, MR; Gambia, LV; Ruz, NP; Agudelo, EL; Van der Stuyft, P				Villegas Chim, J.; Rafful Ceballos, M.; Vera Gambia, L.; Pavia Ruz, N.; Agudelo, E. Londono; Van der Stuyft, P.			Sociocultural dimensions of hypertension in Merida (Yucatan, Mexico): preliminary findings of an anthropological research	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Villegas Chim, J.; Rafful Ceballos, M.; Vera Gambia, L.; Pavia Ruz, N.] Univ Autonoma Yucatan, Ctr Invest Reg Area Biomed, Merida, Mexico; [Agudelo, E. Londono] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Van der Stuyft, P.] Univ Ghent, Dept Publ Hlth, Ghent, Belgium; [Van der Stuyft, P.] Inst Trop Med, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P100	344	345						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900825					2019-04-02	
J	Compaore, A; Dierickx, S; Jaiteh, F; Nahum, A; D'Alessandro, U; Shallig, H; Halidou, T; Grietens, P				Compaore, A.; Dierickx, S.; Jaiteh, F.; Nahum, A.; D'Alessandro, U.; Shallig, H.; Halidou, T.; Grietens, P.			How rumours of 'placentas sellers' led to the decline of a malaria in pregnancy trial in Benin: an ethnographic study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Compaore, A.; Halidou, T.] Inst Res Hlth Sci IRSS URCN, Clin Res Unit, Nanoro, Burkina Faso; [Dierickx, S.; Jaiteh, F.] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Nahum, A.] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Dierickx, S.; Jaiteh, F.; D'Alessandro, U.; Grietens, P.] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium; [Dierickx, S.] Vrije Univ Brussel, Res Ctr Gender Divers & Intersect RHEA, Brussels, Belgium; [Jaiteh, F.; D'Alessandro, U.] MRC Unit, Fajara, Gambia; [D'Alessandro, U.] London Sch Trop Med & Hyg, London, England; [Grietens, P.] Partners Appl Social Sci PASS Int, Tessenderlo, Belgium; [Grietens, P.] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan; [Shallig, H.] Royal Trop Inst, Amsterdam, Netherlands								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	8P101	345	345						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900826					2019-04-02	
J	Kum, DB; Mishra, N; Schmid, MA; Boudewijns, R; Kaptein, S; Neyts, J; Dallmeier, K				Kum, D. Buh; Mishra, N.; Schmid, M. A.; Boudewijns, R.; Kaptein, S.; Neyts, J.; Dallmeier, K.			Full protection from fatal Zika virus infection by a novel chimeric live-attenuated Zika virus vaccine	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									KU Leuven Univ Leuven, Rega Inst Med Res, Lab Virol Antiviral Drug & Vaccine Dev, Leuven, Belgium; KU Leuven Univ Leuven, Leuven, Belgium			Neyts, Johan/U-8267-2017	Neyts, Johan/0000-0002-0033-7514				0	0	0	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBS1.1	346	346						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900828					2019-04-02	
J	Saleh, S; Staes, A; Van Puyvelde, S; Kuijpers, L; Barbe, B; Jacobs, J; Gevaert, K; Deborggraeve, S				Saleh, S.; Staes, A.; Van Puyvelde, S.; Kuijpers, L.; Barbe, B.; Jacobs, J.; Gevaert, K.; Deborggraeve, S.			Targeted proteomics identifies novel candidate antigens for the diagnosis of invasive salmonellosis	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Saleh, S.; Van Puyvelde, S.; Deborggraeve, S.] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Saleh, S.; Staes, A.; Gevaert, K.] VIB UGent Ctr Med Biotechnol, Ghent, Belgium; [Saleh, S.; Staes, A.; Gevaert, K.] Univ Ghent, Dept Biochem, Ghent, Belgium; [Kuijpers, L.; Barbe, B.; Jacobs, J.] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBS1.2	346	346						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900829					2019-04-02	
J	Cuypers, L; Libin, PJK; Simmonds, P; Nowe, A; Munoz-Jordan, JL; Alcantara, LCJ; Vandamme, A; Santiago, GA; Theys, K				Cuypers, L.; Libin, P. J. K.; Simmonds, P.; Nowe, A.; Munoz-Jordan, J. L.; Alcantara, L. C. J.; Vandamme, A.; Santiago, G. A.; Theys, K.			Time to harmonize Dengue nomenclature and classification	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Cuypers, L.; Libin, P. J. K.; Vandamme, A.; Theys, K.] KU Leuven Univ Leuven, Rega Inst Med Res Clin & Epidemiol Virol, Dept Microbiol & Immunol, Leuven, Belgium; [Libin, P. J. K.; Nowe, A.] Vrije Univ Brussel, Dept Comp Sci, Artificial Intelligence Lab, Brussels, Belgium; [Simmonds, P.] Univ Oxford, Nuffield Dept Med, Oxford, England; [Munoz-Jordan, J. L.; Santiago, G. A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR USA; [Alcantara, L. C. J.] Fundacao Oswaldo Cruz, Lab Hematol Genet & Computat Biol, Salvador, BA, Brazil; [Vandamme, A.] Univ Nova Lisboa, Inst Higiene & Med Trop, Unidade Microbiolgia, Global Hlth & Trop Med, Lisbon, Portugal			Vandamme, Anne-Mieke/I-4127-2012	Vandamme, Anne-Mieke/0000-0002-6594-2766				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBS2.2	348	349						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900834					2019-04-02	
J	Libin, PJK; Vanden Eynden, E; Incardona, F; Nowe, A; Bezenchek, A; Sonnerborg, A; Vandamme, A; Theys, K; Baele, G				Libin, P. J. K.; Vanden Eynden, E.; Incardona, F.; Nowe, A.; Bezenchek, A.; Sonnerborg, A.; Vandamme, A.; Theys, K.; Baele, G.		Euco HIV Study Grp	Interactively exploring the global Dengue phylogeny with PhyloGeoTool	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Libin, P. J. K.; Vanden Eynden, E.; Vandamme, A.; Theys, K.; Baele, G.] KU Leuven Univ Leuven, Dept Microbiol & Immunol, Rega Inst Med Res Clin & Epidemiol Virol, Leuven, Belgium; [Libin, P. J. K.; Nowe, A.] Vrije Univ Brussel, Dept Comp Sci, Brussels, Belgium; [Incardona, F.] EuResist Network, Rome, Italy; [Bezenchek, A.] InformaPRO, Rome, Italy; [Sonnerborg, A.] Karolinska Univ Hosp, Karolinska Inst, Stockholm, Sweden; [Vandamme, A.] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Global Hlth & Trop Med, Unidade Microbiol, Lisbon, Portugal			Vandamme, Anne-Mieke/I-4127-2012; Baele, Guy/R-8157-2017	Vandamme, Anne-Mieke/0000-0002-6594-2766; Baele, Guy/0000-0002-1915-7732				0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBS2.1	348	348						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900833					2019-04-02	
J	Gryseels, C; Bannister-Tyrrell, M; Suon, S; Set, S; Uk, S; Silling, K; Lek, D; Grietens, KP				Gryseels, C.; Bannister-Tyrrell, M.; Suon, S.; Set, S.; Uk, S.; Silling, K.; Lek, D.; Grietens, K. P.			Can forest malaria be addressed with community-based interventions? Evidence from a multidrug resistance region in Western Cambodia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Gryseels, C.; Bannister-Tyrrell, M.; Silling, K.; Grietens, K. P.] Inst Trop Med, Antwerp, Belgium; [Suon, S.; Set, S.; Uk, S.; Lek, D.] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBS2.4	349	349						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900836					2019-04-02	
J	Kitenge, TK; Van Brusselen, D; Kasole, TL; Ngombe, LK; Musanzayi, SM; Obadia, PM; Mukoma, KKW; Kakompe, S; Van Herck, K; Avonts, D; Devriendt, K; Smolders, E; Nkulu, CBL; Nemery, B				Kitenge, T. Kayembe; Van Brusselen, D.; Kasole, T. Lubala; Ngombe, L. Kabamba; Musanzayi, S. Mbuyi; Obadia, P. Musa; Mukoma, K. Kyanika Wa; Kakompe, S.; Van Herck, K.; Avonts, D.; Devriendt, K.; Smolders, E.; Nkulu, C. Banza Lubaba; Nemery, B.			Congenital malformations and trace metals: a case-control study from Lubumbashi, DR Congo	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Kitenge, T. Kayembe; Kasole, T. Lubala; Ngombe, L. Kabamba; Musanzayi, S. Mbuyi; Obadia, P. Musa; Mukoma, K. Kyanika Wa; Kakompe, S.; Nkulu, C. Banza Lubaba] Univ Lubumbashi, Lubumbashi, DEM REP CONGO; [Van Brusselen, D.; Van Herck, K.; Avonts, D.] Univ Ghent, Ghent, Belgium; [Devriendt, K.; Smolders, E.; Nemery, B.] Univ Leuven, Leuven, Belgium			Van Herck, Koen/G-5223-2013	Van Herck, Koen/0000-0003-0717-2406	VLIR-UOS;  [11.11.11]	TKK and DVB contributed equally to this abstract. The study was supported financially by grants from 11.11.11 and VLIR-UOS.		0	0	0	5	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBS2.5	349	350						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900837					2019-04-02	
J	Payedimarri, AB; Dierickx, K; Gaidano, G; Ravinetto, R				Payedimarri, A. B.; Dierickx, K.; Gaidano, G.; Ravinetto, R.			Globalization of clinical trials for breast cancer with innovative and highly priced drugs: ethical implications in resource-limited settings	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Payedimarri, A. B.; Gaidano, G.] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Dierickx, K.] Katholieke Univ Leuven, Ctr Biomed Eth & Law, Leuven, Belgium; [Ravinetto, R.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBS3.2	350	351						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900839					2019-04-02	
J	Sileshi, B; Sultan, S; Wynendaele, E; Anne, K; Duchateau, L; De Spiegeleer, B; Levecke, B				Sileshi, B.; Sultan, S.; Wynendaele, E.; Anne, K.; Duchateau, L.; De Spiegeleer, B.; Levecke, B.			Poor dissolution of anthelminthic medicines: a risk for reduced efficacy	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Sileshi, B.; Wynendaele, E.; Anne, K.; De Spiegeleer, B.] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat DruQuaR Grp, Ghent, Belgium; [Sileshi, B.; Sultan, S.] Jimma Univ, Sch Pharm, Jimma, Ethiopia; [Duchateau, L.] Univ Ghent, Dept Biometr, Fac Vet Med, Ghent, Belgium; [Levecke, B.] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Ghent, Belgium								0	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBP.1	353	353						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900842					2019-04-02	
J	Bhattacharyya, T; Messenger, LA; Bern, C; Gilleman, Q; Zeippen, N; Hinckel, BCB; Mertens, P; Gilman, RH; Miles, MA				Bhattacharyya, T.; Messenger, L. A.; Bern, C.; Gilleman, Q.; Zeippen, N.; Hinckel, B. C. Bremer; Mertens, P.; Gilman, R. H.; Miles, M. A.		Chagas Working Grp Bolivia Peru	A low-cost, rapid diagnostic test for Trypanosoma cruzi II/V/VI can replace ELISA for lineage specific serology in Chagas disease	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Bhattacharyya, T.; Messenger, L. A.; Miles, M. A.] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Bern, C.] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Gilleman, Q.; Zeippen, N.; Hinckel, B. C. Bremer; Mertens, P.] Coris BioConcept, Gembloux, Belgium; [Hinckel, B. C. Bremer] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Gilman, R. H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA					NIH [R01-AI087776, 5R01AI107028, D43TW006581]	We thank collaborators in Bolivia, Peru, USA, including Jorge Flores, Roni Colanzi, Ricardo Bozo, Gerson Galdos, Manuela Verastegui, Gerardo Sanchez, Emi Okamoto, Jackie Sherbuck, Toria Rendell, Vishal Shah, Malasa Jois, Diana Martin, and NIH for awards R01-AI087776, 5R01AI107028, D43TW006581.		0	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBP.11	356	357						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900852					2019-04-02	
J	Mina, NJ; Vanlerberghe, V; Echavarria, MI; Alexander, N; Ocampo, C				Mina, N. J.; Vanlerberghe, V.; Echavarria, M. I.; Alexander, N.; Ocampo, C.			Dengue risk stratification of transmission in three municipalities in Colombia, using data collected routinely by the local ETV control programs	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Mina, N. J.; Echavarria, M. I.; Alexander, N.; Ocampo, C.] Ctr Int Entrenamiento & Invest Med CIDEIM, Santiago De Cali, Colombia; [Vanlerberghe, V.] Inst Trop Med Antwerp ITM, Antwerp, Belgium								0	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBP.26	362	362						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900866					2019-04-02	
J	Belemsaga, DY; Goujon, A; Degomme, O; Nassa, S; Duysburgh, E; Kouanda, S; Temmerman, M				Belemsaga, D. Y.; Goujon, A.; Degomme, O.; Nassa, S.; Duysburgh, E.; Kouanda, S.; Temmerman, M.			The cost of integrating maternal postpartum care to infant immunization service in Kaya health district (Burkina Faso)	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Meeting Abstract									[Belemsaga, D. Y.; Kouanda, S.] Inst Rech Sci Sante, Biomed & Publ Hlth Dept, Ouagadougou, Burkina Faso; [Belemsaga, D. Y.; Goujon, A.] WU, VID OAW, Wittgenstein Ctr Demog & Global Human Capital IIA, Vienna, Austria; [Degomme, O.; Duysburgh, E.; Temmerman, M.] Univ Ghent, Dept Urogynaecol, Fac Med & Hlth Sci, Int Ctr Reprod Hlth, Ghent, Belgium; [Nassa, S.] Minist Sante, DGESS, Ouagadougou, Burkina Faso; [Kouanda, S.] African Inst Publ Hlth, Ouagadougou, Burkina Faso; [Temmerman, M.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Nairobi, Kenya								0	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22			1	SI	LBP.38	367	367						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FJ6VU	WOS:000412896900878					2019-04-02	
J	Solari, L; Soto, A; Van der Stuyft, P				Solari, Lely; Soto, Alonso; Van der Stuyft, Patrick			Performance of clinical prediction rules for diagnosis of pleural tuberculosis in a high-incidence setting	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						score; adenosine deaminase activity; pleural tuberculosis; Mycobacterium tuberculosis	ADENOSINE-DEAMINASE; ACTIVATION PRODUCTS; INTERFERON-GAMMA; MTB/RIF ASSAY; EFFUSIONS; METAANALYSIS; FLUID; THORACOSCOPY; ACCURACY; DISEASE	OBJECTIVES Diagnosis of pleural tuberculosis (PT) is still a challenge, particularly in resource-constrained settings. Alternative diagnostic tools are needed. We aimed at evaluating the utility of Clinical Prediction Rules (CPRs) for diagnosis of pleural tuberculosis in Peru. METHODS We identified CPRs for diagnosis of PT through a structured literature search. CPRs using high-complexity tests, as defined by the FDA, were excluded. We applied the identified CPRs to patients with pleural exudates attending two third-level hospitals in Lima, Peru, a setting with high incidence of tuberculosis. Besides pleural fluid analysis, patients underwent closed pleural biopsy for reaching a final diagnosis through combining microbiological and histopathological criteria. We evaluated the performance of the CPRs against this composite reference standard using classic indicators of diagnostic test validity. RESULTS We found 15 eligible CPRs, of which 12 could be validated. Most included ADA, age, lymphocyte proportion and protein in pleural fluid as predictive findings. A total of 259 patients were included for their validation, of which 176 (67%) had PT and 50 (19%) malignant pleural effusion. The overall accuracy of the CPRs varied from 41% to 86%. Two had a positive likelihood ratio (LR) above 10, but none a negative LR below 0.1. ADA alone at a cut-off of >= 40 IU attained 87% diagnostic accuracy and had a positive LR of 6.6 and a negative LR of 0.2. CONCLUSION Many CPRs for PT are available. In addition to ADA alone, none of them contributes significantly to diagnosis of PT.	[Solari, Lely; Van der Stuyft, Patrick] Inst Trop Med Antwerp, Unit Gen Epidemiol & Dis Control, Antwerp, Belgium; [Solari, Lely; Soto, Alonso] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru; [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, Ghent, Belgium	Soto, A (reprint author), Univ Peruana Ciencias Aplicadas, Prolongacio Primavera 2390, Lima, Peru.	alonso.soto@upc.edu.pe		Solari, Lely/0000-0002-8041-8807; Soto, Alonso/0000-0001-8648-8032	Damien Foundation; Belgian Directorate General for Development Cooperation	We thank Juan Agapito, Dante Vargas and Roberto Acinelli for their support in patient data collection. This work was supported by the Damien Foundation. LS received a PhD scholarship from the Belgian Directorate General for Development Cooperation.	Adams RF, 2001, CHEST, V120, P1798, DOI 10.1378/chest.120.6.1798; Aggarwal AN, 2015, J CLIN MICROBIOL, V53, P2451, DOI 10.1128/JCM.00823-15; Burgess LJ, 1996, CHEST, V109, P414, DOI 10.1378/chest.109.2.414; Carrion-Valero F, 2001, INT J TUBERC LUNG D, V5, P673; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Daniil ZD, 2007, EUR RESPIR J, V30, P957, DOI 10.1183/09031936.00126306; Demirer E, 2012, LUNG, V190, P239, DOI 10.1007/s00408-011-9342-z; DEOLIVEIRA HG, 1994, CYTOPATHOLOGY, V5, P27; Dheda K, 2009, EUR RESPIR J, V34, P1118, DOI 10.1183/09031936.00005309; Dixon G, 2015, J THORAC DIS, V7, P1041, DOI 10.3978/j.issn.2072-1439.2015.01.36; Ferreiro L, 2015, MED CLIN-BARCELONA, V145, P171, DOI 10.1016/j.medcli.2014.08.005; Ghanei Mostafa, 2004, Asian Cardiovasc Thorac Ann, V12, P23; Ingui BJ, 2001, J AM MED INFORM ASSN, V8, P391, DOI 10.1136/jamia.2001.0080391; Koegelenberg CFN, 2011, RESPIROLOGY, V16, P738, DOI 10.1111/j.1440-1843.2011.01973.x; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Li ZZ, 2015, GENET MOL RES, V14, P11672, DOI 10.4238/2015.September.28.19; Liang QL, 2008, RESP MED, V102, P744, DOI 10.1016/j.rmed.2007.12.007; Light RW, 1997, EUR RESPIR J, V10, P476, DOI 10.1183/09031936.97.10020476; Martinez L, 2013, AM J TROP MED HYG, V89, P507, DOI 10.4269/ajtmh.13-0005; Maskell N, 2010, THORAX, V65, P667, DOI 10.1136/thx.2010.140236; Melo FA, 2000, FOLHA MEDICA, V119, P9; Michot JM, 2016, DIAGN MICR INFEC DIS, V84, P215, DOI 10.1016/j.diagmicrobio.2015.11.007; Morisson Patrizio, 2008, J. bras. pneumol., V34, P217, DOI 10.1590/S1806-37132008000400006; Mowery NT, 2011, J TRAUMA, V70, P510, DOI 10.1097/TA.0b013e31820b5c31; Neves DD, 2007, BRAZ J INFECT DIS, V11, P83, DOI 10.1590/S1413-86702007000100019; Neves Denise Duprat, 2004, Braz J Infect Dis, V8, P311, DOI 10.1590/S1413-86702004000400007; Noppen M, 2010, SEMIN RESP CRIT CARE, V31, P751, DOI 10.1055/s-0030-1269835; Penz E, 2015, INT J TUBERC LUNG D, V19, P278, DOI 10.5588/ijtld.14.0262; Porcel JM, 2000, INT J TUBERC LUNG D, V4, P76; Porcel JM, 2008, RESP MED, V102, P1159, DOI 10.1016/j.rmed.2008.03.001; Porcel Jose Manuel, 2003, Med Sci Monit, V9, pCR175; Rufai SB, 2015, J CLIN MICROBIOL, V53, P3636, DOI 10.1128/JCM.02182-15; Sales RKB, 2009, RESPIROLOGY, V14, P1128, DOI 10.1111/j.1440-1843.2009.01621.x; Salomaa ER, 1998, CHEST, V114, P723, DOI 10.1378/chest.114.3.723; Samanta S, 2016, J CLIN DIAGN RES, V10, pBC14, DOI 10.7860/JCDR/2016/20652.8379; Sun Qin, 2011, Zhonghua Yi Xue Za Zhi, V91, P2392; Valdes L, 2010, RESP MED, V104, P1211, DOI 10.1016/j.rmed.2010.02.025; Yildiz PB, 2011, ASIAN PAC J CANCER P, V12, P419; Yu CJ, 2011, J PROTEOME RES, V10, P4671, DOI 10.1021/pr2004743	39	1	1	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22	10					1283	1292		10.1111/tmi.12932				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FI6PZ	WOS:000412120000007	28727272	Bronze, Green Published			2019-04-02	
J	Fikre, H; Mohammed, R; Atinafu, S; van Griensven, J; Diro, E				Fikre, Helina; Mohammed, Rezika; Atinafu, Saba; van Griensven, Johan; Diro, Ermias			Clinical features and treatment response of cutaneous leishmaniasis in North-West Ethiopia	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						cutaneous leishmaniasis; mucocutaneous leishmaniasis; diffuse cutaneous leishmaniasis; L. aethiopica	SODIUM STIBOGLUCONATE; AMPHOTERICIN-B; IMMUNOTHERAPY; AETHIOPICA; EFFICACY; WORLD	OBJECTIVE Cutaneous leishmaniasis (CL) receives far less attention than visceral leishmaniasis. Nevertheless, CL is predominantly caused by a unique species in Ethiopia (L. aethiopica), which is known to cause severe forms such as diffuse (DCL) and mucocutaneous leishmaniasis (MCL). We report on the number and type of CL cases diagnosed, the clinical features, the treatments and treatment outcomes in North-West Ethiopia. METHODS This is a retrospective chart record analysis of CL patients treated at the Leishmania Research and Treatment Center (LRTC) of the University of Gondar, Ethiopia. RESULTS From 178 CL patients seen between January 2014 and December 2015, a total of 154 chart records were retrieved. These included 80 localised CL (LCL), 7 DCL and 67 MCL. The median age was 23 years; 71.4% were male. Most (n = 121, 78.6%) of the lesions were on the face. The median time since onset was 12 months (6-24 months), and 28.6% presented after a trial of traditional medicine. The treatment of all forms of CL mainly consisted of 30 days of IM antimonial injections. Of these, 51/133 (38.3%) required treatment extension or change due to nonresponse. Three cases were treated with liposomal amphotericin B or miltefosine (two received the combination), of which two responded well. CONCLUSION CL was found to be complicated and difficult to treat. MCL was common, and patients presented after long delays. There is an urgent need to look for better treatment options for CL and improve access to care.	[Fikre, Helina; Mohammed, Rezika; Atinafu, Saba; Diro, Ermias] Univ Gondar, Leishmaniasis Res & Treatment Ctr, Gondar, Ethiopia; [Mohammed, Rezika; Diro, Ermias] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [van Griensven, Johan] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium	Diro, E (reprint author), Univ Gondar, Gondar, Ethiopia.	Ermi_diro@yahoo.com			Drugs for Neglected Diseases Initiative (DNDi)	The investigators would like to thank the team working at the Leishmaniasis Research and Treatment Center (LRTC) of University of Gondar (UoG) for taking care of the patients and retrieving the records. We also acknowledge the Drugs for Neglected Diseases Initiative (DNDi) for the continued support for the research and patient care at LRTC, UoG. We are also grateful for the patients who willingly consented to use their picture in this manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2011, P INT CONS M CUT LEI; BARNETSON RSC, 1978, T ROY SOC TROP MED H, V72, P516, DOI 10.1016/0035-9203(78)90173-6; Becker I, 1999, PARASITOL RES, V85, P165, DOI 10.1007/s004360050529; CONVIT J, 1989, J INFECT DIS, V160, P104, DOI 10.1093/infdis/160.1.104; Cunha MA, 2015, AM J TROP MED HYG, V93, P1214, DOI 10.4269/ajtmh.15-0033; El-On J, 2009, ISR MED ASSOC J, V11, P623; Ministry of Health E, 2013, GUID DIAGN TREATM PR; Morsy Tosson A., 1997, Journal of the Egyptian Society of Parasitology, V27, P205; Negera E, 2012, T ROY SOC TROP MED H, V106, P496, DOI 10.1016/j.trstmh.2012.02.006; Olliaro P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002130; Padovese V, 2009, T ROY SOC TROP MED H, V103, P707, DOI 10.1016/j.trstmh.2009.02.023; Reithinger R, 2007, LANCET INFECT DIS, V7, P581, DOI 10.1016/S1473-3099(07)70209-8; Seid A, 2014, GEOSPATIAL HEALTH, V8, P377, DOI 10.4081/gh.2014.27; Singh OP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00296; Utaile M, 2013, EXP PARASITOL, V134, P68, DOI 10.1016/j.exppara.2013.01.022; Valencia BM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002196; van Griensven J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004495	18	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2017	22	10					1293	1301		10.1111/tmi.12928				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FI6PZ	WOS:000412120000008	28712122				2019-04-02	
J	Becker, SL; Muller, I; Mertens, P; Herrmann, M; Zondie, L; Beyleveld, L; Gerber, M; du Randt, R; Puhse, U; Walter, C; Utzinger, J				Becker, Soren L.; Mueller, Ivan; Mertens, Pascal; Herrmann, Mathias; Zondie, Leyli; Beyleveld, Lindsey; Gerber, Markus; du Randt, Rosa; Puhse, Uwe; Walter, Cheryl; Utzinger, Jurg			PCR-based verification of positive rapid diagnostic tests for intestinal protozoa infections with variable test band intensity	ACTA TROPICA			English	Article						Cryptosporidium spp.; Giardia intestinalis; Intestinal protozoa; Multiplex PCR; Rapid diagnostic test; South Africa	ENTERIC PARASITE PANEL; GIARDIA-LAMBLIA; CRYPTOSPORIDIUM; METAANALYSIS; SENSITIVITY; DIARRHEA; DISEASE; SAMPLES; AFRICA; BURDEN	Stool-based rapid diagnostic tests (RDTs) for pathogenic intestinal protozoa (e.g. Cryptosporidium spp. and Giardia intestinalis) allow for prompt diagnosis and treatment in resource-constrained settings. Such RDTs can improve individual patient management and facilitate population-based screening programmes in areas without microbiological laboratories for confirmatory testing. However, RDTs are difficult to interpret in case of 'trace' results with faint test band intensities and little is known about whether such ambiguous results might indicate `true' infections. In a longitudinal study conducted in poor neighbourhoods of Port Elizabeth, South Africa, a total of 1428 stool samples from two cohorts of schoolchildren were examined on the spot for Cryptosporidium spp. and G. intestinalis using an RDT (Crypto/Giardia DuoStrip; Cods BioConcept). Overall, 121 samples were positive for G. intestinalis and the RDT suggested presence of cryptosporidiosis in 22 samples. After a storage period of 9-10 months in cohort 1 and 2-3 months in cohort 2, samples were subjected to multiplex PCR (BD Max (TM) Enteric Parasite Panel, Becton Dickinson). Ninety-three percent (112/121) of RDT-positive samples for G. intestinalis were confirmed by PCR, with a correlation between RDT test band intensity and quantitative pathogen load present in the sample. For Cryptosporidium spp., all positive RDTs had faintly visible lines and these were negative on PCR. The performance of the BD Max (TM) PCR was nearly identical in both cohorts, despite the prolonged storage at disrupted cold chain conditions in cohort 1. The Crypto/Giardia DuoStrip warrants further validation in communities with a high incidence of diarrhoea.	[Becker, Soren L.; Mueller, Ivan; Utzinger, Jurg] Swiss Trop & Publ Hlth Inst, CH-4002 Basel, Switzerland; [Becker, Soren L.; Mueller, Ivan; Utzinger, Jurg] Univ Basel, CH-4003 Basel, Switzerland; [Becker, Soren L.] Saarland Univ, Inst Med Microbiol & Hyg, Kirrberger Str,Bldg 43, D-66421 Homburg, Germany; [Mueller, Ivan; Gerber, Markus; Puhse, Uwe] Univ Basel, Dept Sport Exercise & Hlth, Birsstr 320B, CH-4056 Basel, Switzerland; [Mertens, Pascal] Coris BioConcept, Rue Jean Sonet 4A, B-5032 Gembloux, Belgium; [Herrmann, Mathias] Univ Munster, Med Fac, D-48149 Munster, Germany; [Zondie, Leyli; Beyleveld, Lindsey] Nelson Mandela Metropolitan Univ, Dept Med Lab Sci, POB 77000, ZA-6031 Port Elizabeth, South Africa; [du Randt, Rosa; Walter, Cheryl] Nelson Mandela Metropolitan Univ, Dept Human Movement Sci, POB 77000, ZA-6031 Port Elizabeth, South Africa	Becker, SL (reprint author), Saarland Univ, Inst Med Microbiol & Hyg, Kirrberger Str,Bldg 43, D-66421 Homburg, Germany.	soeren.becker@uks.eu	Herrmann, Mathias/B-6475-2013; Gerber, Markus/H-8654-2014	Muller, Ivan/0000-0002-6397-9979	Swiss National Science Foundation (SNSF) [IZLSZ3 149015]; National Research Foundation (NRF) of South Africa [87397]	This study was conducted within the scope of the Swiss-South African Joint Research Programme (SSAJRP), financially supported by the Swiss National Science Foundation (SNSF, project no. IZLSZ3 149015) and the National Research Foundation (NRF, project no. 87397) of South Africa. The reagents for the BD Max (TM) Enteric Parasite Panel were provided free of charge by the company Becton Dickinson Diagnostics (Heidelberg, Germany). The company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra R, 2016, EUR J CLIN MICROBIOL, V35, P1753, DOI 10.1007/s10096-016-2722-9; Becker S. L., 2015, Eurosurveillance, V20, P21151; Becker SL, 2014, KLIN PADIATR, V226, P301, DOI 10.1055/s-0034-1384526; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Becker SL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004818; Boelaert M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004853; Bouyou-Akotet M K, 2016, J Parasit Dis, V40, P1179, DOI 10.1007/s12639-015-0645-5; Coulibaly JT, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002109; Donowitz JR, 2016, CLIN INFECT DIS, V63, P792, DOI 10.1093/cid/ciw391; DuPont HL, 2016, JAMA-J AM MED ASSOC, V315, P2712, DOI 10.1001/jama.2016.7833; Gall S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005573; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Huang DB, 2006, GASTROENTEROL CLIN N, V35, P291, DOI 10.1016/j.gtc.2006.03.006; Ignatius R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001677; Johnston SP, 2003, J CLIN MICROBIOL, V41, P623, DOI 10.1128/JCM.41.2.623-626.2003; Laude A., 2016, CLIN MICROBIOL INFEC, V22, pe191, DOI [10.1016/j.cmi.2015.10.004, DOI 10.1016/J.CMI.2015.10.004]; Madison-Antenucci S, 2016, J CLIN MICROBIOL, V54, P2681, DOI 10.1128/JCM.00765-16; McHardy IH, 2014, J CLIN MICROBIOL, V52, P712, DOI 10.1128/JCM.02877-13; Molling P, 2016, J CLIN MICROBIOL, V54, P443, DOI 10.1128/JCM.02100-15; Muller I, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1761-5; Muhsen K, 2012, CLIN INFECT DIS, V55, pS271, DOI 10.1093/cid/cis762; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nguyen TKT, 2012, EUR J CLIN MICROBIOL, V31, P623, DOI 10.1007/s10096-011-1332-9; Oliveira-Arbex AP, 2016, EPIDEMIOL INFECT, V144, P1418, DOI 10.1017/S0950268815002514; Oster N, 2006, EUR J CLIN MICROBIOL, V25, P112, DOI 10.1007/s10096-006-0088-0; Santos CKS, 2012, T ROY SOC TROP MED H, V106, P473, DOI 10.1016/j.trstmh.2012.05.011; Shirley DAT, 2012, CURR OPIN INFECT DIS, V25, P555, DOI 10.1097/QCO.0b013e328357e569; Soares R, 2016, J MICROBIOL METH, V129, P98, DOI 10.1016/j.mimet.2016.08.017; Sow SO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004729; Speich B, 2016, LANCET INFECT DIS, V16, P87, DOI 10.1016/S1473-3099(15)00349-7; Squire SA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2111-y; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135; Utzinger J, 2015, CLIN MICROBIOL INFEC, V21, P529, DOI [10.1016/j.cmi.2015.03.014, 10.1016/j.cmi.2015.02.016]; Van den Bossche D, 2015, J MICROBIOL METH, V110, P78, DOI 10.1016/j.mimet.2015.01.016; Van der Palen M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-90; van Lieshout L, 2015, CLIN MICROBIOL INFEC, V21, P520, DOI 10.1016/j.cmi.2015.03.015; Verweij JJ, 2014, PARASITOLOGY, V141, P1863, DOI 10.1017/S0031182014000419; Weitzel T, 2006, CLIN MICROBIOL INFEC, V12, P656, DOI 10.1111/j.1469-0691.2006.01457.x; Yap P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2636-y	40	3	3	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	OCT	2017	174						49	55		10.1016/j.actatropica.2017.06.012				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FE6DD	WOS:000408299300008	28634143				2019-04-02	
J	Suter, T; Crespo, MM; de Oliveira, MF; de Oliveira, TSA; de Melo-Santos, MAV; de Oliveira, CMF; Ayres, CFJ; Barbosa, RMR; Araujo, AP; Regis, LN; Flacio, E; Engeler, L; Muller, P; Silva-Filha, MHNL				Suter, Tobias; Crespo, Monica Maria; de Oliveira, Mariana Francelino; de Oliveira, Thaynan Sama Alves; de Melo-Santos, Maria Alice Varjal; de Oliveira, Cludia Maria Fontes; Ayres, Constancia Flavia Junqueira; Barbosa, Rosangela Maria Rodrigues; Araujo, Ana Paula; Regis, Leda Narcisa; Flacio, Eleonora; Engeler, Lukas; Muller, Pie; Silva-Filha, Maria Helena Neves Lobo			Insecticide susceptibility of Aedes albopictus and Ae. aegypti from Brazil and the Swiss-Italian border region	PARASITES & VECTORS			English	Article						Vector control; Insecticide resistance; Biolarvicides; Insect growth regulator	THURINGIENSIS SUBSP ISRAELENSIS; QUINQUEFASCIATUS DIPTERA-CULICIDAE; BACILLUS-THURINGIENSIS; CATCH BASINS; SOUTHERN SWITZERLAND; FIELD POPULATIONS; MOSQUITO-CONTROL; DELTA-ENDOTOXIN; CULEX-PIPIENS; SAO-PAULO	Background: Aedes aegypti and Ae. albopictus are two highly invasive mosquito species, both vectors of several viruses, including dengue, chikungunya and Zika. While Ae. aegypti is the primary vector in the tropics and sub-tropics, Ae. albopictus is increasingly under the public health watch as it has been implicated in arbovirus-transmission in more temperate regions, including continental Europe. Vector control using insecticides is the pillar of most control programmes; hence development of insecticide resistance is of great concern. As part of a Brazilian-Swiss Joint Research Programme we set out to assess whether there are any signs of existing or incipient insecticide resistance primarily against the larvicide Bacillus thuringiensis svar. israelensis (Bti), but also against currently applied and potentially alternative insecticides in our areas, Recife (Brazil) and the Swiss-Italian border region. Methods: Following World Health Organization guidelines, dose-response curves for a range of insecticides were established for both colonized and field caught Ae. aegypti and Ae. albopictus. The larvicides included Bti, two of its toxins, Cry11Aa and Cry4Ba, Lysinibacillus sphaericus, Vectomax CG (R), a formulated combination of Bti and L. sphaericus, and diflubenzuron. In addition to the larvicides, the Swiss-Italian Ae. albopictus populations were also tested against five adulticides (bendiocarb, dichlorodiphenyltrichloroethane, malathion, permethrin and lambda-cyhalothrin). Results: Showing a similar dose-response, all mosquito populations were fully susceptible to the larvicides tested and, in particular, to Bti which is currently used both in Brazil and Switzerland. In addition, there were no signs of incipient resistance against Bti as larvae were equally susceptible to the individual toxins, Cry11Aa and Cry4Ba. The field-caught Swiss-Italian populations were susceptible to the adulticides tested but DDT mortality rates showed signs of reduced susceptibility. Conclusions: The insecticides currently used for mosquito control in Switzerland and Brazil are still effective against the target populations. The present study provides an important reference as relatively few insecticide susceptibility surveys have been carried out with Ae. albopictus.	[Suter, Tobias; Muller, Pie] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57,POB 4002, CH-4002 Basel, Switzerland; [Suter, Tobias; Muller, Pie] Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland; [Suter, Tobias] Avia GIS, Risschotlei 33, B-2980 Zoersel, Belgium; [Crespo, Monica Maria; de Oliveira, Mariana Francelino; de Oliveira, Thaynan Sama Alves; de Melo-Santos, Maria Alice Varjal; de Oliveira, Cludia Maria Fontes; Ayres, Constancia Flavia Junqueira; Barbosa, Rosangela Maria Rodrigues; Araujo, Ana Paula; Regis, Leda Narcisa; Silva-Filha, Maria Helena Neves Lobo] Fiocruz MS, Inst Aggeu Magalhaes, Dept Entomol, BR-50740465 Recife, PE, Brazil; [Flacio, Eleonora; Engeler, Lukas] Univ Appl Sci & Arts Southern Switzerland, Lab Appl Microbiol, Bellinzona, Switzerland	Muller, P (reprint author), Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Socinstr 57,POB 4002, CH-4002 Basel, Switzerland.; Muller, P (reprint author), Univ Basel, Peterspl 1, CH-4003 Basel, Switzerland.	pie.mueller@swisstph.ch	Muller, Pie/R-7275-2018	Muller, Pie/0000-0003-0181-5781	Brazilian-Swiss Joint Research Programme [BJRP 0112-08]; Guggenheim-Schnurr Stiftung (Basel, Switzerland); Conselho Nacional de Pesquisa [CNPq 590,154/2011-7, CNPq 472,491/2012-1]	This study received funds from the Brazilian-Swiss Joint Research Programme (Grant no. BJRP 0112-08), the Guggenheim-Schnurr Stiftung (Basel, Switzerland) and the Conselho Nacional de Pesquisa (CNPq 590,154/2011-7, CNPq 472,491/2012-1).	Anderson JF, 2011, J AM MOSQUITO CONTR, V27, P45, DOI 10.2987/10-6079.1; Angelini P., 2008, Parassitologia (Rome), V50, P97; [Anonymous], 2013, TEST PROC INREMO; Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Becker N, 1997, PARASITOL TODAY, V13, P485, DOI 10.1016/S0169-4758(97)01154-X; Becker Norbert, 1998, Israel Journal of Entomology, V32, P63; Bellinato DF, 2016, BIOMED RES INT, DOI 10.1155/2016/8603263; Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI [10.1128/AEM.68.10.5082-5095.2002, 10.1128/AEM.68.10.5082-5092.2002]; BERRY C, 1993, J BACTERIOL, V175, P510; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Boyer S, 2007, ENVIRON TOXICOL CHEM, V26, P157, DOI 10.1897/06-205R.1; Boyer S, 2012, BIOL CONTROL, V62, P75, DOI 10.1016/j.biocontrol.2012.02.001; Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113; Cadavid-Restrepo G, 2012, MEM I OSWALDO CRUZ, V107, P74, DOI 10.1590/S0074-02762012000100010; Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847; Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864; Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304; CRICKMORE N, 1995, FEMS MICROBIOL LETT, V131, P249; Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014; de Albuquerque CMR, 2000, REV SAUDE PUBL, V34, P314, DOI 10.1590/S0034-89102000000300017; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; DELECLUSE A, 1993, APPL ENVIRON MICROB, V59, P3922; Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108; Chalegre KDD, 2009, APPL ENVIRON MICROB, V75, P1044, DOI 10.1128/AEM.02032-08; dos Santos RLC, 2003, REV SAUDE PUBL, V37, P5; Dritz DA, 2011, J AM MOSQUITO CONTR, V27, P398, DOI 10.2987/11-6161.1; ECDC, 2017, VBORNET MOSQ MAPS; Eritja R, 2013, J AM MOSQUITO CONTR, V29, P280, DOI 10.2987/12-6308R.1; Fares RCG, 2015, BIOMED RES INT, DOI 10.1155/2015/321873; Flacio E, 2004, B SOC TICINESE SCI N, V92, P141; Flacio E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1577-3; Flacio E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0793-6; Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511; Georghiou GP, 1997, APPL ENVIRON MICROB, V63, P1095; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Gomez I, 2007, PEPTIDES, V28, P169, DOI 10.1016/j.peptides.2006.06.013; Guidi V, 2011, APPL ENVIRON MICROB, V77, P3663, DOI 10.1128/AEM.00132-11; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; Kawada H, 2010, JPN J INFECT DIS, V63, P19; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2; Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5; Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946; Loke SR, 2010, TROP BIOMED, V27, P493; Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020; Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992; Marten GG, 2007, J AM MOSQUITO CONTR, V23, P65, DOI 10.2987/8756-971X(2007)23[65:CC]2.0.CO;2; Martins AJ, 2008, PEST MANAG SCI, V64, P676, DOI 10.1002/ps.1547; MAZZARRI MB, 1995, J AM MOSQUITO CONTR, V11, P315; Moreira Beltrao HDB, 2007, FEMS MICROBIOL LETT, V266, P163, DOI 10.1111/j.1574-6968.2006.00527.x; Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5; Paris M, 2011, PEST MANAG SCI, V67, P122, DOI 10.1002/ps.2046; Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Pocquet N, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-299; R Development Core Team, 2011, R LANG ENV STAT COMP; Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008; REITER P, 1987, J AM MOSQUITO CONTR, V3, P494; ROBERTSON JL, 1995, J ECON ENTOMOL, V88, P1; Scholte Ernst-Jan, 2007, European Mosquito Bulletin, V22, P5; Secretaria de Vigilancia em Saude, 2009, 0152009CGPNCDDIGESSV; Secretaria de Vigilancia em Saude, 2014, 1232014GABSVSMS MIN; Secretaria de Vigilancia em Saude, 2008, RED NAC MONT RES AED; Secretaria de Vigilancia em Saude Ministerio da Saude, 2016, MON CAS DENG FEBR CH, V52; Sivan A, 2015, PARASITOL RES, V114, P4693, DOI 10.1007/s00436-015-4717-3; Somboon Pradya, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P87; Suter TT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004315; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; Tetreau G, 2013, MEM I OSWALDO CRUZ, V108, P894, DOI 10.1590/0074-0276130155; THIERY I, 1989, APPL MICROBIOL BIOT, V31, P577, DOI 10.1007/BF00270798; THOMAS WE, 1983, FEBS LETT, V154, P362, DOI 10.1016/0014-5793(83)80183-5; van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340; Vanlerberghe V, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1959; de Melo-Santos MAV, 2009, BIOL CONTROL, V49, P186, DOI 10.1016/j.biocontrol.2009.01.011; Vasquez MI, 2009, J MED ENTOMOL, V46, P881, DOI 10.1603/033.046.0421; WHO, 2006, GUID TEST MOSQ AD IN; WHO Pesticide Evaluation Scheme, 2016, DISCR CONC INS AD MO; WHO [World Health Organization], 2005, GUID LAB FIELD TEST; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Wirth MC, 2012, J MED ENTOMOL, V49, P886, DOI 10.1603/ME11192; Wirth MC, 2004, J MED ENTOMOL, V41, P935, DOI 10.1603/0022-2585-41.5.935; Wirth MC, 2010, OPEN TOXICOL J, V3, P126, DOI DOI 10.2174/1875414701003010126; WRAIGHT SP, 1987, J INVERTEBR PATHOL, V49, P291, DOI 10.1016/0022-2011(87)90061-9; Zhang HY, 2004, BIOCONTROL SCI TECHN, V14, P321, DOI 10.1080/09583150310001639187	87	2	3	1	16	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	SEP 19	2017	10								431	10.1186/s13071-017-2364-5				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FH8HM	WOS:000411434700005	28927441	DOAJ Gold, Green Published			2019-04-02	
J	Braae, UC; Devleesschauwer, B; Sithole, F; Wang, ZQ; Willingham, AL				Braae, Uffe Christian; Devleesschauwer, Brecht; Sithole, Fortune; Wang, Ziqi; Willingham, Arve Lee			Mapping occurrence of Taenia solium taeniosis/cysticercosis and areas at risk of porcine cysticercosis in Central America and the Caribbean basin	PARASITES & VECTORS			English	Article						Taenia solium taeniosis/cysticercosis; Distribution; Mapping; Tapeworm; Neglected tropical disease	RURAL GUATEMALAN COMMUNITIES; ALBENDAZOLE TREATMENT; UNITED-STATES; NEUROCYSTICERCOSIS; VENEZUELA; SEROPREVALENCE; PREVALENCE; HONDURAS; MEXICO; EPIDEMIOLOGY	Background: This study aimed to map the occurrence of Taenia solium taeniosis/cysticercosis at national level within Central America and the Caribbean basin, and to map the distribution of porcine cysticercosis at first-level administrative subdivision level (department level) and the porcine population at risk. This zoonotic parasite is believed to be widely endemic across most of Latin America. However, there is little information readily available for Central America and the Caribbean basin. Taenia solium has been ranked the most important foodborne parasitic hazard globally and within endemic areas is a common cause of preventable epilepsy. Methods: We conducted a structured literature search in PubMed, supplemented and crossed-referenced with relevant academic databases, grey literature, and active searches in identified literature, to identify all records of T. solium presence in Central America and the Caribbean basin between 1986 and April 2017. To retrieve grey literature, government entities, researchers and relevant institutions across the region were contacted in an attempt to cover all countries and territories. Identified records containing data on porcine cysticercosis were geo-referenced to identify department level distribution and compared to modelled distributions of pigs reared under extensive production systems. Results: We identified 51 records of T. solium at the national level, covering 13 countries and an additional three countries were included based on World Organisation for Animal Health (OIE) reports, giving a total of 16 countries out of 41 with evidence of the parasite's presence. Screening records for porcine cysticercosis data at the departmental level confirmed porcine cysticercosis presence in 11 departments across six countries (Colombia, Guatemala, Honduras, Mexico, Nicaragua and Venezuela). Conclusions: When comparing these results to areas where pigs were kept in extensive production systems and areas where no information on porcine cysticercosis exists, it is apparent that porcine cysticercosis is likely to be underreported, and that a substantial part of the regional pig population could be at risk of contracting porcine cysticercosis. More detailed information on the distribution of T. solium and accurate burden estimations are urgently needed to grasp the true extent of this zoonotic parasite and the public health and agricultural problems it potentially poses.	[Braae, Uffe Christian; Sithole, Fortune; Willingham, Arve Lee] Ross Univ, Sch Vet Med, Hlth Ctr Zoonoses & Trop Vet Med 1, Basseterre, West Indies, St Kitts & Nevi; [Devleesschauwer, Brecht] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Wang, Ziqi] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Wang, Ziqi] Univ Florida, Dept Anim Hlth, Gainesville, FL USA; [Wang, Ziqi] Univ Florida, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA	Braae, UC (reprint author), Ross Univ, Sch Vet Med, Hlth Ctr Zoonoses & Trop Vet Med 1, Basseterre, West Indies, St Kitts & Nevi.	UBraae@rossvet.edu.kn	Braae, Uffe/J-4720-2017; Devleesschauwer, Brecht/G-9895-2018	Braae, Uffe/0000-0002-2743-4584; Devleesschauwer, Brecht/0000-0002-2867-6892	CYSTINET: European Network on taeniosis/cysticercosis, COST ACTION [TD1302]	The work was carried out with support from CYSTINET (http://www.cystinet.org/): European Network on taeniosis/cysticercosis, COST ACTION TD1302. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna E R, 1988, Rev Med Panama, V13, P9; Acurero E, 2008, KASMERA, V36, P148; Agudelo Piedad, 2005, Biomedica, V25, P488; Agudelo-Florez P, 2003, REV NEUROLOGIA, V36, P706, DOI 10.33588/rn.3608.2002323; Agudelo-Florez P, 2009, REV SCI TECH OIE, V28, P1077; Agudelo-Flórez Piedad, 2009, Rev. salud pública, V11, P191; Allan JC, 1996, ANN TROP MED PARASIT, V90, P157, DOI 10.1080/00034983.1996.11813039; Allan JC, 1997, T ROY SOC TROP MED H, V91, P595, DOI 10.1016/S0035-9203(97)90042-0; Allan JC, 1996, AM J TROP MED HYG, V54, P352, DOI 10.4269/ajtmh.1996.54.352; Alviarez Y, 2007, ACTA CIENT VENEZ, V58, P463; [Anonymous], 2014, MULT BAS RANK RISK M; Badilla-Umana J, 2004, REV NEUROLOGIA, V39, P590, DOI 10.33588/rn.3906.2004047; Benitez JA, 2008, ANN NY ACAD SCI, V1149, P315, DOI 10.1196/annals.1428.051; Bhalla D, 2017, IJEP, V4, P65; Blaizot R, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2169-8; Blandon Roberto, 2002, Rev Med Panama, V27, P37; Boggio G, 2002, SEROPREVALENCIA CIST; BOTERO D, 1993, T ROY SOC TROP MED H, V87, P576, DOI 10.1016/0035-9203(93)90095-8; Braae UC, 2016, ANIM WELFARE, V25, P439, DOI 10.7120/09627286.25.4.439; Braae UC, 2015, VET PARASITOL, V214, P187, DOI 10.1016/j.vetpar.2015.08.009; Braae UC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0938-7; Bucardo F, 2005, ANN TROP MED PARASIT, V99, P41, DOI 10.1179/136485905X19856; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; Champetier de Ribes G, 2005, Bull Soc Pathol Exot, V98, P127; Coral-Almeida M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003919; Alcobedes MMC, 2010, TROP ANIM HEALTH PRO, V42, P531, DOI 10.1007/s11250-009-9456-y; DEKAMINSKY RG, 1991, T ROY SOC TROP MED H, V85, P531, DOI 10.1016/0035-9203(91)90245-T; DEKAMINSKY RG, 1991, T ROY SOC TROP MED H, V85, P648, DOI 10.1016/0035-9203(91)90378-C; Del Brutto OH, 2017, J NEUROL SCI, V372, P202, DOI 10.1016/j.jns.2016.11.045; Dixon HBF, 1961, SPECIAL REPORT SERIE, V299; Donadeu M, 2016, Wkly Epidemiol Rec, V91, P595; Ferrer E, 2005, T ROY SOC TROP MED H, V99, P568, DOI 10.1016/j.trstmh.2005.02.003; Ferrer E, 2003, T ROY SOC TROP MED H, V97, P522, DOI 10.1016/S0035-9203(03)80014-7; Ferrer E, 2002, AM J TROP MED HYG, V66, P170, DOI 10.4269/ajtmh.2002.66.170; Garcia-Noval J, 2001, ANN TROP MED PARASIT, V95, P167, DOI 10.1080/00034980120050260; GarciaNoval J, 1996, AM J TROP MED HYG, V55, P282, DOI 10.4269/ajtmh.1996.55.282; Gilbert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133381; GRACIA F, 1990, AM J TROP MED HYG, V42, P67, DOI 10.4269/ajtmh.1990.42.67; Gripper LB, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0245-y; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000300; Kanobana K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002202; Kappelgaard L, 2009, THESIS; Komba EVG, 2013, VET PARASITOL, V198, P284, DOI 10.1016/j.vetpar.2013.09.020; Kurup R, 2010, J VECTOR DIS, V47, P228; Maravilla P, 2003, MEM I OSWALDO CRUZ, V98, P1049, DOI 10.1590/S0074-02762003000800013; Maravilla P, 2003, J PARASITOL, V89, P1250, DOI 10.1645/GE-2786RN; Medina MT, 2011, EPILEPSIA, V52, P1177, DOI 10.1111/j.1528-1167.2010.02945.x; Medina MT, 2005, EPILEPSIA, V46, P124, DOI 10.1111/j.0013-9580.2005.11704.x; Meza NW, 2005, AM J TROP MED HYG, V73, P504, DOI 10.4269/ajtmh.2005.73.504; MSDS, 2001, DIR EP AN ESTR, P6; Nunez F. A., 1997, Cadernos de Saude Publica, V13, P67; O'Keefe KA, 2015, AM J TROP MED HYG, V92, P354, DOI 10.4269/ajtmh.14-0506; O'Neal SE, 2015, EMERG INFECT DIS, V21, P969, DOI 10.3201/eid2106.141324; O'Neal SE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001953; OIE, 2017, WORLD AN HLTH INF DA; Padilla J, 2004, CERDOS COMISADOS CIS, P138; Palacio LG, 1998, EPILEPSIA, V39, P1334, DOI 10.1111/j.1528-1157.1998.tb01333.x; Raccurt CP, 2009, J HELMINTHOL, V83, P113, DOI 10.1017/S0022149X09232330; Robinson T. P., 2011, GLOBAL LIVESTOCK PRO; Robinson TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096084; Rodriguez-Canul R, 1998, VET PARASITOL, V79, P165, DOI 10.1016/S0304-4017(98)00161-7; Rodriguez-Canul R, 1999, ANN TROP MED PARASIT, V93, P57; Roudier M, 2000, ANN PATHOL, V20, P238; Sakai H, 1998, VET PARASITOL, V78, P233, DOI 10.1016/S0304-4017(98)00144-7; Sanchez AL, 1997, ANN TROP MED PARASIT, V91, P163, DOI 10.1080/00034983.1997.11813126; Sanchez AL, 1999, ANN TROP MED PARASIT, V93, P247, DOI 10.1080/00034983.1999.11813420; Sanchez AL, 1998, ACTA TROP, V69, P141, DOI 10.1016/S0001-706X(97)00132-0; Sanchez Ana L., 1999, Parasitology International, V48, P81, DOI 10.1016/S1383-5769(99)00007-0; SARTIG E, 1992, VET PARASITOL, V41, P195, DOI 10.1016/0304-4017(92)90079-O; SCHANTZ PM, 1992, NEW ENGL J MED, V327, P692, DOI 10.1056/NEJM199209033271004; STEINMETZ RL, 1989, RETINA-J RET VIT DIS, V9, P276, DOI 10.1097/00006982-198909040-00007; Thomas LF, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-46; Torgerson PR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001920; van der Meer P, 2004, Ned Tijdschr Geneeskd, V148, P221; Villalobos-Perozo R, 2007, KASMERA, V35, P26; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Widdowson MA, 2000, T ROY SOC TROP MED H, V94, P620, DOI 10.1016/S0035-9203(00)90209-8	77	2	3	1	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	SEP 18	2017	10								424	10.1186/s13071-017-2362-7				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FH2VJ	WOS:000411000000002	28923090	DOAJ Gold, Green Published			2019-04-02	
J	Schuster, A; Thielecke, M; Raharimanga, V; Ramarokoto, CE; Rogier, C; Krantz, I; Feldmeier, H				Schuster, Angela; Thielecke, Marlene; Raharimanga, Vaomalala; Ramarokoto, Charles Emile; Rogier, Christophe; Krantz, Ingela; Feldmeier, Hermann			High-resolution infrared thermography: a new tool to assess tungiasis-associated inflammation of the skin	TROPICAL MEDICINE AND HEALTH			English	Article								Background: Tungiasis is highly prevalent in low-and middle-income countries but remains often under diagnosed and untreated eventually leading to chronic sequels. The objective of the study was to assess whether tungiasis-associated inflammation can be detected and quantified by high-resolution infrared thermography (HRIT) and whether after removal of the parasite inflammation resolves rapidly. Methods: Patients with tungiasis were identified through active case finding. Clinical examination, staging, and thermal imaging as well as conventional photography were performed. In exemplary cases, the embedded sandfly was extracted and regression of inflammation was assessed by thermal imaging 4 days after extraction. Results: The median perilesional temperature was significantly higher than the median temperature of the affected foot (rho = 0.480, p = 0.003). Median perilesional temperature measured by high-resolution infrared thermography was positively associated with the degree of pain (rho = 0.395, p < 0.017) and semi-quantitative scores for acute (rho = 0.380, p < 0.022) and chronic (rho = 0.337, p < 0.044) clinical pathology. Four days after surgical extraction, inflammation and hyperthermia of the affected area regressed significantly (rho = 0.457, p = 0.005). In single cases, when clinical examination was difficult, lesions were identified through HRIT. Conclusion: We proved that HRIT is a useful tool to assess tungiasis-associated morbidity as well as regression of clinical pathology after treatment. Additionally, HRIT might help to diagnose hidden and atypical manifestations of tungiasis. Our findings, although still preliminary, suggest that HRIT could be used for a range of infectious skin diseases prevalent in the tropics.	[Schuster, Angela; Thielecke, Marlene; Feldmeier, Hermann] Charite, Inst Microbiol & Hyg, Berlin, Germany; [Raharimanga, Vaomalala; Ramarokoto, Charles Emile; Rogier, Christophe] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Schuster, Angela] Inst Trop Med, Clin Sci Dept, Antwerp, Belgium; [Krantz, Ingela] Skaraborg Inst Res & Dev, Skovde, Sweden	Schuster, A (reprint author), Charite, Inst Microbiol & Hyg, Berlin, Germany.; Schuster, A (reprint author), Inst Trop Med, Clin Sci Dept, Antwerp, Belgium.	schuster_angela@gmx.de		Ramarokoto, Charles Emile/0000-0001-7831-7057	German Academic Exchange Service (DAAD), Bonn, Germany; German Doctors e.V., Frankfurt, Germany	This study was supported by German Doctors e.V., Frankfurt, Germany. MT received a travel grant from the German Academic Exchange Service (DAAD), Bonn, Germany. The HRIT camera was provided for research purposes by Winngold Messtechnik, Hamburg Germany; the company was not involved in the research development, evaluation and publication.		0	2	2	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1348-8945	1349-4147		TROP MED HEALTH	Trop. Med. Health	SEP 15	2017	45								23	10.1186/s41182-017-0062-9				13	Tropical Medicine	Tropical Medicine	FG8LH	WOS:000410682500001	28919835	DOAJ Gold, Green Published			2019-04-02	
J	Geurden, T; Six, R; Becskei, C; Maeder, S; Lloyd, A; Mahabir, S; Fourie, J; Liebenberg, J				Geurden, Thomas; Six, Robert; Becskei, Csilla; Maeder, Steven; Lloyd, Anne; Mahabir, Sean; Fourie, Josephus; Liebenberg, Julian			Evaluation of the efficacy of sarolaner (Simparica (R)) in the prevention of babesiosis in dogs	PARASITES & VECTORS			English	Article						Dogs; Dermacentor reticulatus; Babesia canis; Babesiosis; Transmission; Efficacy	DERMACENTOR-RETICULATUS TICKS; CANIS-CANIS; IXODES-RICINUS; TRANSMISSION; COMBINATION; PERMETHRIN; FIPRONIL; VECTOR; PREVALENCE; HUNGARY	Background: Canine babesiosis is a clinically significant emerging vector-borne disease caused among others by the protozoan Babesia canis. The efficacy of sarolaner (Simparica (R); Zoetis; at the minimum recommended label dose of 2.0 mg per kg bodyweight) in the prevention of babesiosis was evaluated in twenty-four dogs randomly allocated to either a placebo-treated group or one of two sarolaner-treated groups. At 21 or 28 days after treatment administration, dogs were infested with 50 +/- 4 Dermacentor reticulatus ticks of which 25% were confirmed to be infected with Babesia canis. Blood samples were collected from each dog prior to tick infestation and weekly thereafter until 49 days after infestation. The blood was assayed for B. canis antibodies using an indirect immunofluorescence test (IFAT) and for B. canis DNA by PCR assay. A dog was a priori defined as B. canis-positive if it tested positive by both IFAT and PCR at any time during the study. Results: No treatment-related adverse reactions were recorded during the study. All placebo-treated animals displayed clinical signs due to babesiosis and tested positive on both IFAT and PCR. None of the sarolaner-treated animals displayed any clinical symptoms or tested positive on both IFAT and PCR, resulting in a 100% efficacy in the prevention of canine babesiosis (P = 0.0002). Conclusion: When given 21 or 28 days before tick infestation, a single treatment with sarolaner at the minimum recommended label dose of 2.0 mg per kg body weight prevented the transmission of B. canis by D. reticulatus to dogs.	[Geurden, Thomas; Becskei, Csilla; Lloyd, Anne] Zoetis, Mercuriusstr 20, B-1930 Zaventem, Belgium; [Six, Robert; Maeder, Steven; Mahabir, Sean] Zoetis, 333 Portage St, Kalamazoo, MI 49007 USA; [Fourie, Josephus; Liebenberg, Julian] Clinvet Int, POB 11186,9321 Uitsig Rd, ZA-9338 Bloemfontein, South Africa	Geurden, T (reprint author), Zoetis, Mercuriusstr 20, B-1930 Zaventem, Belgium.	thomas.geurden@zoetis.com			Zoetis	The study reported here was funded by Zoetis.	Abdullah S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1673-4; Becskei C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1377-9; Beelitz P, 2012, BERL MUNCH TIERARZTL, V125, P168, DOI 10.2376/0005-9366-125-168; Beugnet F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-283; Beugnet F, 2009, VET PARASITOL, V163, P298, DOI 10.1016/j.vetpar.2009.03.028; Bullova E, 2009, VET PARASITOL, V165, P357, DOI 10.1016/j.vetpar.2009.07.023; Foldvari G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1599-x; Fourie JJ, 2013, VET PARASITOL, V192, P273, DOI 10.1016/j.vetpar.2012.10.017; Geurden T, 2016, VET PARASITOL, V222, P33, DOI 10.1016/j.vetpar.2016.03.024; Heile C, 2006, BERL MUNCH TIERARZTL, V119, P330; Honsberger NA, 2016, VET PARASITOL, V222, P67, DOI 10.1016/j.vetpar.2016.02.010; Irwin PJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S4; Jongejan F, 2012, PARASITE VECTOR, V8, P232; Jongejan F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1207-5; Jongejan F, 2011, VET PARASITOL, V179, P343, DOI 10.1016/j.vetpar.2011.03.047; Kiewra D, 2013, EXP APPL ACAROL, V59, P501, DOI 10.1007/s10493-012-9612-3; Kubelova M, 2011, VET PARASITOL, V180, P191, DOI 10.1016/j.vetpar.2011.03.033; Matjila TP, 2005, VET PARASITOL, V131, P23, DOI 10.1016/j.vetpar.2005.04.020; Navarro C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0645-4; Phipps LP, 2016, VET REC, V178, P243, DOI 10.1136/vr.i1265; Rubel F, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0477-7; Schetters TPM, 2009, VET PARASITOL, V162, P7, DOI 10.1016/j.vetpar.2009.02.012; Siroky P, 2011, VET PARASITOL, V183, P130, DOI 10.1016/j.vetpar.2011.07.006; Solano-Gallego L, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1596-0; Sreter T, 2005, VET PARASITOL, V128, P347, DOI 10.1016/j.vetpar.2004.11.025; Szell Z, 2006, VET PARASITOL, V141, P377, DOI 10.1016/j.vetpar.2006.06.008; Taenzler J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1481-x; Taenzler J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0923-1; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035	29	1	1	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	SEP 6	2017	10								415	10.1186/s13071-017-2358-3				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FG8NK	WOS:000410690000006	28877743	DOAJ Gold, Green Published			2019-04-02	
J	Alemayehu, E; Asale, A; Eba, K; Getahun, K; Tushune, K; Bryon, A; Morou, E; Vontas, J; Van Leeuwen, T; Duchateau, L; Yewhalaw, D				Alemayehu, Eba; Asale, Abebe; Eba, Kasahun; Getahun, Kefelegn; Tushune, Kora; Bryon, Astrid; Morou, Evangelia; Vontas, John; Van Leeuwen, Thomas; Duchateau, Luc; Yewhalaw, Delenasaw			Mapping insecticide resistance and characterization of resistance mechanisms in Anopheles arabiensis (Diptera: Culicidae) in Ethiopia	PARASITES & VECTORS			English	Article						Malaria; Insecticide resistance; Anopheles arabiensis; Resistance mechanisms; Vector control; Ethiopia	GLUTATHIONE S-TRANSFERASES; GATED SODIUM-CHANNEL; MOSQUITO VECTORS; MALARIA CONTROL; BURKINA-FASO; WEST-AFRICA; GAMBIAE; DDT; IDENTIFICATION; MUTATION	Background: The emergence and spread of insecticide resistance in the major African malaria vectors Anopheles gambiae (s.s.) and An. arabiensis may compromise the current vector control interventions and threatens the global malaria control and elimination efforts. Methods: Insecticide resistance was monitored in several study sites in Ethiopia from 2013 to 2015 using papers impregnated with discriminating concentrations of DDT, deltamethrin, bendiocarb, propoxur, malathion, fenitrothion and pirimiphos-methyl, following the WHO insecticide susceptibility test procedure. Mosquitoes sampled from different localities for WHO bioassay were morphologically identified as An. gambiae (s.l.) using standard taxonomic keys. Samples were identified to species using species-specific polymerase chain reaction (PCR) and screened for the presence of target site mutations L1014F, L1014S and N1575Y in the voltage gated sodium channel (VGSC) gene and G119S in the acethylcholinesterase (AChE) gene using allele-specific PCR. Biochemical assays were performed to assess elevated levels of acetylcholinesterases, carboxylcholinesterases, glutathione-S-transferases (GSTs) and cytochrome P450s monooxygenases in wild populations of An. arabiensis, compared to the fully susceptible Sekoru An. arabiensis laboratory strain. Results: Populations of An. arabiensis were resistant to DDT and deltamethrin but were susceptible to fenitrothion in all the study sites. Reduced susceptibility to malathion, pirimiphos-methyl, propoxur and bendiocarb was observed in some of the study sites. Knockdown resistance (kdr L1014F) was detected in all mosquito populations with allele frequency ranging from 42 to 91%. Elevated levels of glutathione-S-transferases (GSTs) were detected in some of the mosquito populations. However, no elevated levels of monooxygenases and esterases were detected in any of the populations assessed. Conclusions: Anopheles arabiensis populations from all surveyed sites in Ethiopia exhibited resistance against DDT and pyrethroids. Moreover, some mosquito populations exhibited resistance to propoxur and possible resistance to bendiocarb. Target site mutation kdr L1014F was detected in all mosquito populations while elevated levels of glutathione-S-transferases (GSTs) was detected in some mosquito populations. The reduced susceptibility of An. arabiensis to propoxur and bendiocarb, which are currently used for indoor residual spraying (IRS) in Ethiopia, calls for continuous resistance monitoring, in order to plan and implement evidence based insecticide resistance management.	[Alemayehu, Eba; Asale, Abebe] Jimma Univ, Coll Nat Sci, Dept Biol, Jimma, Ethiopia; [Alemayehu, Eba; Asale, Abebe; Eba, Kasahun; Yewhalaw, Delenasaw] Jimma Univ, Trop & Infect Dis Res Ctr, Jimma, Ethiopia; [Alemayehu, Eba; Duchateau, Luc] Univ Ghent, Dept Comparat Physiol & Biometr, Ghent, Belgium; [Getahun, Kefelegn] Jimma Univ, Dept Geog & Environm Studies, Jimma, Ethiopia; [Tushune, Kora] Jimma Univ, Coll Hlth Sci, Dept Hlth Serv Management, Jimma, Ethiopia; [Bryon, Astrid; Van Leeuwen, Thomas] Univ Ghent, Dept Crop Protect, Ghent, Belgium; [Morou, Evangelia] Univ Crete, Dept Biol, Iraklion, Greece; [Morou, Evangelia; Vontas, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Vontas, John] Agr Univ Athens, Pesticide Sci Lab, Dept Crop Sci, Athens, Greece; [Van Leeuwen, Thomas] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Yewhalaw, Delenasaw] Jimma Univ, Coll Hlth Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia	Yewhalaw, D (reprint author), Jimma Univ, Trop & Infect Dis Res Ctr, Jimma, Ethiopia.; Yewhalaw, D (reprint author), Jimma Univ, Coll Hlth Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	delenasawye@yahoo.com		asale, abebe/0000-0003-0143-5762; Vontas, John/0000-0002-8704-2574	Flemish Interuniversity Council (VLIR-IUC)	This study was financially supported by Flemish Interuniversity Council (VLIR-IUC).	Abdalla H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-213; Asale A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-131; Asghar U, 2015, ADV ENTOMOL, V3, P132; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bloomquist JR, 1996, ANNU REV ENTOMOL, V41, P163, DOI 10.1146/annurev.en.41.010196.001115; Brogdon WG, 1999, PESTIC BIOCHEM PHYS, V64, P101, DOI 10.1006/pest.1999.2415; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Chanda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024336; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; Dabire KR, 2009, TROP MED INT HEALTH, V14, P396, DOI 10.1111/j.1365-3156.2009.02243.x; Dabire KR, 2014, PLOS ONE, V9; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Djogbenou L, 2008, AM J TROP MED HYG, V78, P298, DOI 10.4269/ajtmh.2008.78.298; Djogbenou L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002172; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Fettene M, 2013, AFR ENTOMOL, V21, P89, DOI 10.4001/003.021.0109; Feyereisen R, 2015, PESTIC BIOCHEM PHYS, V121, P61, DOI 10.1016/j.pestbp.2015.01.004; FMoH, 2006, NAT 5 YEAR STRAT PLA; FMOH, 2012, NAT MAL GUID; FMoH, 2016, NAT MAL EL ROADM; GEBREMARIAM N., 1988, ECOLOGY HLTH DIS ETH, P136; Gerberg E. J, 1970, BULLETIN, V5; Gillies MT, 1987, JOHANNESBURG S AFR I, V55, P1; Gillies MT, 1968, PUBL S AFR I MED RES, V54, P1; Harbach RE, 1818, MOSQUITO TAXONOMIC I; HEMINGWAY J, 1991, PESTIC BIOCHEM PHYS, V39, P49, DOI 10.1016/0048-3575(91)90213-6; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Jones CM, 2012, P NATL ACAD SCI USA, V109, P6614, DOI 10.1073/pnas.1201475109; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Matowo J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-193; Meshesha B, 2010, PARASITE VECTOR, V3, P40; Morou E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000808; Mulamba C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110058; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Penilla RP, 1998, MED VET ENTOMOL, V12, P217; PRAPANTHADARA L, 1995, B ENTOMOL RES, V85, P267, DOI 10.1017/S0007485300034350; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Ranson H, 1997, BIOCHEM J, V15, P97; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Service Mike W., 2002, P59; Verhaeghen K, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-16; Vulule JM, 1999, MED VET ENTOMOL, V13, P239, DOI 10.1046/j.1365-2915.1999.00177.x; Weill M, 2004, INSECT MOL BIOL, V13, P1, DOI 10.1111/j.1365-2583.2004.00452.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2015, WORLD MALARIA REPORT; World Health Organisation, 2013, TEST PROC INS RES MO; World Health Organization, 1998, TECHN DET INS RES ME; Yewhalaw D, 2016, INSECTICIDES RESISTA, P199; Yewhalaw D, 2013, PATHOG GLOB HEALTH, V107, P437; Yewhalaw D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-159; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738	56	2	2	0	20	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	SEP 2	2017	10								407	10.1186/s13071-017-2342-y				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FF3ZT	WOS:000408865200001	28865490	DOAJ Gold, Green Published			2019-04-02	
J	Hasker, E; Baco, A; Younoussa, A; Mzembaba, A; Grillone, S; Demeulenaere, T; Groenen, G; Suffys, P; De Jong, BC				Hasker, Epco; Baco, Abdallah; Younoussa, Assoumani; Mzembaba, Aboubacar; Grillone, Saverio; Demeulenaere, Tine; Groenen, Guido; Suffys, Philip; De Jong, Bouke C.			Leprosy on Anjouan (Comoros): persistent hyper-endemicity despite decades of solid control efforts	LEPROSY REVIEW			English	Article								Introduction: Despite decades of solid leprosy control efforts, the disease remains highly endemic on the island of Anjouan, Comoros. Among a population of less than 400,000 over 300 new leprosy patients are diagnosed on average annually. Methods: We analysed routine data for the period of 2000-2015 for trends in epidemiological parameters and clustering in time and space. Results: Leprosy incidence remains high (7.4/10,000 per year, on average) with no indications of an imminent decrease. Increasing coverage of active case finding has led to increasing numbers of leprosy patients being detected over the past 8 years. The proportion of new patients presenting with visible deformities has consistently been low (2.4% on average). The proportion of children among new patients exceeds 30%, without any trend towards a decrease. At macro-level clusters in time and space were observed scattered across the island, without a clear pattern. Discussion: The leprosy epidemic on Anjouan continues unabated despite the activities of a well-organised control programme. There appears to be a need to further scale up case finding efforts and organise them in a more systematic manner. Use of modern technology, such as Geographic Information Systems, could help to improve targeting of case finding efforts. Prophylactic treatment of contacts should be considered. Studying markers of infection such as anti PGL-1, and DNA finger printing of leprosy bacteria could provide insights in the patterns of transmission and could be useful in identifying those at higher risk of developing leprosy for prophylactic treatment.	[Hasker, Epco; De Jong, Bouke C.] Inst Trop Med, Antwerp, Belgium; [Baco, Abdallah; Younoussa, Assoumani; Mzembaba, Aboubacar; Grillone, Saverio] Leprosy & TB Control Program, Moroni, Comoros; [Demeulenaere, Tine] Damien Fdn, Brussels, Belgium; [Groenen, Guido] BELTA TBnet, Brussels, Belgium; [Suffys, Philip] Oswaldo Cruz Inst, Lab Mol Biol Appl Mycobacteria, Rio De Janeiro, Brazil	Hasker, E (reprint author), Inst Trop Geneeskunde Antwerpen, Antwerp, Belgium.				European Research Council-INTERRUPTB starting grant [311725]; R2Stop	BdJ is supported by European Research Council-INTERRUPTB starting grant nr.311725. The present work was conducted in the context of preparation for a project funded by R2Stop.	[Anonymous], MAGN HUM RES THROUGH; Araujo S, 2016, CLIN INFECT DIS, V63, P1412, DOI 10.1093/cid/ciw570; Bakker MI, 2005, AM J TROP MED HYG, V72, P443, DOI 10.4269/ajtmh.2005.72.443; Blok DJ, 2015, ADV PARASIT, V87, P33, DOI 10.1016/bs.apar.2014.12.002; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; PATTYN SR, 1991, ANN SOC BELG MED TR, V71, P51; Penna MLF, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004703; Sakamuri RM, 2009, J CLIN MICROBIOL, V47, P2844, DOI 10.1128/JCM.02021-08; van Hooij A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34260; *WHO, 2000, LEPR EL MON LEM GUID; WHO, 2016, GLOB LEPR STRAT 2016; World Health Organization, 2008, WHO TECH REP SER, V2012, P968; World Health Organization, 2006, GLOB STRAT FURTH RED	13	0	0	0	0	LEPRA	COLCHESTER	28 MIDDLEBOROUGH, COLCHESTER CO1 1TG, ESSEX, ENGLAND	0305-7518	2162-8807		LEPROSY REV	Lepr. Rev.	SEP	2017	88	3					334	342						9	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	Dermatology; Infectious Diseases; Pathology; Tropical Medicine	FO5FD	WOS:000416878000005					2019-04-02	
J	Kuijpers, LMF; Phe, T; Veng, CH; Lim, K; leng, S; Kham, C; Fawal, N; Fabre, L; Le Hello, S; Vlieghe, E; Weill, FX; Jacobs, J; Peetermans, WE				Kuijpers, Laura M. F.; Phe, Thong; Veng, Chhun H.; Lim, Kruy; leng, Sovann; Kham, Chun; Fawal, Nizar; Fabre, Laetitia; Le Hello, Simon; Vlieghe, Erika; Weill, Francois-Xavier; Jacobs, Jan; Peetermans, Willy E.			The clinical and microbiological characteristics of enteric fever in Cambodia, 2008-2015	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TYPHOID-FEVER; PARATYPHOID FEVER; ANTIMICROBIAL RESISTANCE; SEROVAR TYPHI; SALMONELLA PARATYPHI; MULTIDRUG-RESISTANT; SEROTYPE TYPHI; UNITED-STATES; INDONESIA; SURVEILLANCE	Background Enteric fever remains a major public health problem in low resource settings and antibiotic resistance is increasing. In Asia, an increasing proportion of infections is caused by Salmonella enterica serovar Paratyphi A, which for a long time was assumed to cause a milder clinical syndrome compared to Salmonella enterica serovar Typhi. Methodology A retrospective chart review study was conducted of 254 unique cases of blood culture confirmed enteric fever who presented at a referral adult hospital in Phnom Penh, Cambodia between 2008 and 2015. Demographic, clinical and laboratory data were collected from clinical charts and antibiotic susceptibility testing was performed. Whole genome sequence analysis was performed on a subset of 121 isolates. Results One-hundred-and-ninety unique patients were diagnosed with Salmonella Paratyphi A and 64 with Salmonella Typhi. In the period 2008-2012, Salmonella Paratyphi A comprised 25.5% of 47 enteric fever cases compared to 86.0% of 207 cases during 2013-2015. Presenting symptoms were identical for both serovars but higher median leukocyte counts (6.8 x 10 (9) /L vs. 6.3 x 10 (9) /L; p = 0.035) and C-reactive protein (CRP) values (47.0 mg/L vs. 36 mg/L; p = 0.034) were observed for Salmonella Typhi infections. All but one of the Salmonella Typhi isolates belonged to haplotype H58 associated with multidrug resistance (MDR) (i. e. resistance to ampicillin, chloramphenicol and co-trimoxazole).; 42.9% actually displayed MDR compared to none of the Salmonella Paratyphi A isolates. Decreased ciprofloxacin susceptibility (DCS) was observed in 96.9% (62/64) of Salmonella Typhi isolates versus 11.5% (21/183) of Salmonella Paratyphi A isolates (all but one from 2015). All isolates were susceptible to azithromycin and ceftriaxone. Conclusions In Phnom Penh, Cambodia, Salmonella Paratyphi A now causes the majority of enteric fever cases and decreased susceptibility against ciprofloxacin is increasing. Overall, Salmonella Typhi was significantly more associated with MDR and DCS compared to Salmonella Paratyphi A.	[Kuijpers, Laura M. F.; Vlieghe, Erika; Jacobs, Jan] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Kuijpers, Laura M. F.; Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Phe, Thong; Veng, Chhun H.; Lim, Kruy; leng, Sovann; Kham, Chun] Sihanouk Hosp Ctr HOPE, Phnom Penh, Cambodia; [Fawal, Nizar; Fabre, Laetitia; Le Hello, Simon; Weill, Francois-Xavier] Ctr Natl Reference E Coli Shigella & Salmonella, Unite Bacteries Pathogenes Enter, Inst Pasteur, Paris, France; [Vlieghe, Erika] Univ Antwerp Hosp, Dept Gen Internal Med Infect Dis & Trop Med, Antwerp, Belgium; [Peetermans, Willy E.] Univ Hosp Leuven, Dept Internal Med, Leuven, Belgium	Kuijpers, LMF (reprint author), Inst Trop Med, Dept Clin Sci, Antwerp, Belgium.; Kuijpers, LMF (reprint author), Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium.	lkuijpers@itg.be	Le Hello, Simon/K-6584-2018	Le Hello, Simon/0000-0001-7993-4305; Kuijpers, Laura/0000-0002-4480-7872; Weill, Francois-Xavier/0000-0001-9941-5799	Belgian Directorate of Development Cooperation (DGD); Fund for Scientific Research Flanders (F.W.O.-Vlaanderen, Belgium) [K2.060.16N and K2.065.17N]	The surveillance of bloodstream infections at the Sihanouk Hospital Center of HOPE is supported by the Belgian Directorate of Development Cooperation (DGD) (https://diplomatie.belgium.be/en/policy/development_cooperation/who_we_are/our_organisation/dgd) through project 2.08 of the Third Framework Agreement between the Belgian DGD (Ministry of Development Cooperation) and the Institute of Tropical Medicine (ITM). This study was further supported by the Strategic Network Laboratory Quality Management (LQM) project (http://www.labquality.be/) (Belgian Development Cooperation), the Institut Pasteur and the French governments Investissement dAvenir programme, Laboratoire dExcellence Integrative Biology of Emerging Infectious Diseases (http://www.agence-nationale-recherche.fr/?ProjetIA=10-LABX-0062) (grant number ANR-10-LABX-62-IBEID). LMFK is supported by the Flemish Ministry of Sciences (EWI, SOFI project IDIS) (http://www.ewi-vlaanderen.be/en) and received additional travel grants (grant numbers K2.060.16N and K2.065.17N) from the Fund for Scientific Research Flanders (F.W.O.-Vlaanderen, Belgium) (http://www.fwo.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; Bhutta ZA, 1996, ARCH DIS CHILD, V75, P214, DOI 10.1136/adc.75.3.214; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Caumes E, 2001, J TRAVEL MED, V8, P293; Chiou CS, 2014, ANTIMICROB AGENTS CH, V58, P6501, DOI 10.1128/AAC.03608-14; CLSI, 2016, M100S26 CLSI; Cunha BA, 2004, INFECT DIS CLIN N AM, V18, P111, DOI 10.1016/S0891-5520(03)00094-1; Davis TME, 1999, CLIN INFECT DIS, V28, P582, DOI 10.1086/515143; Dobinson HC, 2017, CLIN INFECT DIS, V64, P1066, DOI 10.1093/cid/cix042; Thanh DP, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004785; Halim H Muong, 2017, PHNOM PENH POST; Hassing RJ, 2014, EMERG INFECT DIS, V20, P705, DOI 10.3201/eid2004.131536; Judd MC, 2015, EMERG INFECT DIS, V21, P1089, DOI 10.3201/eid2106.150088; Kalonji LM, 2015, CLIN INFECT DIS, V61, pS346, DOI 10.1093/cid/civ713; Karkey A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002391; Kuijpers LMF, 2016, GENOMIC ANAL SALMONE; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Medalla F, 2011, EMERG INFECT DIS, V17, P1095, DOI [10.3201/eid1706.100594, 10.3201/eid/1706.100594]; Meltzer E, 2005, J TRAVEL MED, V12, P275; Menezes GA, 2012, CLIN MICROBIOL INFEC, V18, P239, DOI 10.1111/j.1469-0691.2011.03546.x; Nair S, 2016, J ANTIMICROB CHEMOTH, V71, P3400, DOI 10.1093/jac/dkw318; Ochiai RL, 2005, EMERG INFECT DIS, V11, P1764, DOI 10.3201/eid1111.050168; Okoro CK, 2012, CLIN INFECT DIS, V54, P955, DOI 10.1093/cid/cir1032; Otegbayo J A, 2002, Trop Gastroenterol, V23, P9; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pokharel BM, 2006, INT J INFECT DIS, V10, P434, DOI 10.1016/j.ijid.2006.07.001; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Saitoh T, 2016, EPIDEMIOL INFECT, V144, P602, DOI 10.1017/S0950268815001648; Sar S, 2010, INT J ENV RURAL DEV, V1, P113; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shrestha KL, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0121-8; SIMANJUNTAK CH, 1991, LANCET, V338, P1055, DOI 10.1016/0140-6736(91)91910-M; Tourdjman M, 2013, EURO SURVEILL, V18; TVE Phe, 2016, 17 INT C INF DIS 201; Vlieghe E, 2011, EURO SURVEILL, V18; Vlieghe ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059775; Vlieghe ER, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001933; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; Vollaard AM, 2004, JAMA-J AM MED ASSOC, V291, P2607, DOI 10.1001/jama.291.21.2607; Wain J, 2004, T ROY SOC TROP MED H, V98, P423, DOI 10.1016/j.trstmh.2003.10.015; Wain J, 2001, J CLIN MICROBIOL, V39, P1571, DOI 10.1128/JCM.39.4.1571-1576.2001; Wong VK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12827; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281; World Health Organization, 2003, BACKGR DOC DIAGN TRE; Yeap C., 2012, PHNOM PENH POST 0425; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou ZM, 2014, P NATL ACAD SCI USA, V111, P12199, DOI 10.1073/pnas.1411012111	50	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2017	11	9							e0005964	10.1371/journal.pntd.0005964				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FI6YN	WOS:000412142800078	28931025	DOAJ Gold, Green Published			2019-04-02	
J	Pinto, J; Odongo, S; Lee, F; Gaspariunaite, V; Muyldermans, S; Magez, S; Sterckx, YGJ				Pinto, Joar; Odongo, Steven; Lee, Felicity; Gaspariunaite, Vaiva; Muyldermans, Serge; Magez, Stefan; Sterckx, Yann G. -J.			Structural basis for the high specificity of a Trypanosoma congolense immunoassay targeting glycosomal aldolase	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DIAGNOSTIC-TEST; MODEL; ANTIGENS; ELISA; OPTIMIZATION; TETRAMER; SYSTEM; VIVAX; SERUM	Background Animal African trypanosomosis (AAT) is a neglected tropical disease which imposes a heavy burden on the livestock industry in Sub-Saharan Africa. Its causative agents are Trypanosoma parasites, with T. congolense and T. vivax being responsible for the majority of the cases. Recently, we identified a Nanobody (Nb474) that was employed to develop a homologous sandwich ELISA targeting T. congolense fructose-1,6-bisphosphate aldolase (TcoALD). Despite the high sequence identity between trypanosomatid aldolases, the Nb474-based immunoassay is highly specific for T. congolense detection. The results presented in this paper yield insights into the molecular principles underlying the assay's high specificity. Methodology/Principal findings The structure of the Nb474-TcoALD complex was determined via X-ray crystallography. Together with analytical gel filtration, the structure reveals that a single TcoALD tetramer contains four binding sites for Nb474. Through a comparison with the crystal structures of two other trypanosomatid aldolases, TcoALD residues Ala77 and Leu106 were identified as hot spots for specificity. Via ELISA and surface plasmon resonance (SPR), we demonstrate that mutation of these residues does not abolish TcoALD recognition by Nb474, but does lead to a lack of detection in the Nb474-based homologous sandwich immunoassay. Conclusions/Significance The results show that the high specificity of the Nb474-based immunoassay is not determined by the initial recognition event between Nb474 and TcoALD, but rather by its homologous sandwich design. This (i) provides insights into the optimal set-up of the assay, (ii) may be of great significance for field applications as it could explain the potential detection escape of certain T. congolense strains, and (iii) may be of general interest to those developing similar assays.	[Pinto, Joar; Lee, Felicity; Gaspariunaite, Vaiva; Muyldermans, Serge; Magez, Stefan; Sterckx, Yann G. -J.] Vrije Univ Brussel, Res Unit Cellular & Mol Immunol CMIM, Brussels, Belgium; [Pinto, Joar; Magez, Stefan; Sterckx, Yann G. -J.] VIB, Struct Biol Res Ctr, Brussels, Belgium; [Odongo, Steven] Makerere Univ, Coll Vet Med Anim Resources & Biosecur COVAB, Dept Biotech & Diagnost Sci, Kampala, Uganda; [Magez, Stefan] Univ Ghent, Global Campus, Incheon, South Korea	Sterckx, YGJ (reprint author), Vrije Univ Brussel, Res Unit Cellular & Mol Immunol CMIM, Brussels, Belgium.; Sterckx, YGJ (reprint author), VIB, Struct Biol Res Ctr, Brussels, Belgium.	yann.sterckx@vub.be	Magez, Stefan/D-9497-2014; Sterckx, Yann/F-2269-2017	Magez, Stefan/0000-0003-3760-7968; Sterckx, Yann/0000-0002-7420-0983	VUB-SRP3 ("Nanobodies for Health" initiative); InterUniversity Attraction Pole (IUAP)	This work was supported by VUB-SRP3 ("Nanobodies for Health" initiative) and the InterUniversity Attraction Pole (IUAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alleman AR, 1996, J CLIN MICROBIOL, V34, P270; Anene BM, 2001, VET PARASITOL, V96, P83, DOI 10.1016/S0304-4017(00)00427-1; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BEERNINK PT, 1994, PROTEIN SCI, V3, P1383, DOI 10.1002/pro.5560030904; Beernink PT, 1996, P NATL ACAD SCI USA, V93, P5374, DOI 10.1073/pnas.93.11.5374; Bossard G, 2010, VET PARASITOL, V173, P39, DOI 10.1016/j.vetpar.2010.06.016; Boulange A, 2017, VET PARASITOL, V233, P32, DOI 10.1016/j.vetpar.2016.11.017; Buscher P, 2013, NEW ENGL J MED, V368, P1069, DOI 10.1056/NEJMc1210373; Chudzik DM, 2000, J MOL BIOL, V300, P697, DOI 10.1006/jmbi.2000.3910; Doerflinger SY, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00219-16; Dzakah EE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-199; Eisler MC, 1998, VET PARASITOL, V79, P187, DOI 10.1016/S0304-4017(98)00173-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESPINO AM, 1992, T ROY SOC TROP MED H, V86, P649, DOI 10.1016/0035-9203(92)90174-B; Fleming JR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004977; Grebaut P, 2009, INT J PARASITOL, V39, P1137, DOI 10.1016/j.ijpara.2009.02.018; GUOBADIA EE, 1995, VET PARASITOL, V58, P247, DOI 10.1016/0304-4017(94)00721-N; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; LAMBERT PH, 1981, J CLIN INVEST, V67, P77, DOI 10.1172/JCI110035; Magona JW, 2002, TROP ANIM HEALTH PRO, V34, P295, DOI 10.1023/A:1015630701923; MASIGA DK, 1992, INT J PARASITOL, V22, P909, DOI 10.1016/0020-7519(92)90047-O; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005247; Muller KM, 1998, ANAL BIOCHEM, V261, P149, DOI 10.1006/abio.1998.2725; Odongo S, 2016, PLOS NEGLECT TROP D, V10; OPPERDOES FR, 1977, FEBS LETT, V80, P360, DOI 10.1016/0014-5793(77)80476-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PETYOVKA N, 1995, J IMMUNOL METHODS, V186, P161, DOI 10.1016/0022-1759(95)00183-B; Rebeski DE, 1999, PARASITOL RES, V85, P550, DOI 10.1007/s004360050594; Reinhard L, 2013, ACTA CRYSTALLOGR F, V69, P209, DOI 10.1107/S1744309112051858; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; Simarro PP, 2011, PLOS NEGLECT TROP D, V5, pe1007, DOI DOI 10.1371/J0URNAL.PNTD.0001007; Swallow BM., 1999, IMPACTS TRYPANOSOMIA, P1; Szempruch AJ, 2016, CELL, V164, P246, DOI 10.1016/j.cell.2015.11.051; Tehseen S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1002-3; Tihon E, MOL ECOL; Tolan DR, 2003, BIOL CHEM, V384, P1463, DOI 10.1515/BC.2003.162; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	43	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2017	11	9							e0005932	10.1371/journal.pntd.0005932				23	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FI6YN	WOS:000412142800064	28915239	DOAJ Gold, Green Published			2019-04-02	
J	Sanoussi, CN; Affolabi, D; Rigouts, L; Anagonou, S; de Jong, B				Sanoussi, C. N'Dira; Affolabi, Dissou; Rigouts, Leen; Anagonou, Severin; de Jong, Bouke			Genotypic characterization directly applied to sputum improves the detection of Mycobacterium africanum West African 1, under-represented in positive cultures	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TUBERCULOSIS COMPLEX; PULMONARY TUBERCULOSIS; EPIDEMIOLOGY; DIAGNOSIS; CAMEROON; LINEAGE; STRAINS; DNA; TB	Background This study aimed to compare the prevalence of Mycobacterium tuberculosis complex (MTBc) lineages between direct genotyping (on sputum) and indirect genotyping (on culture), to characterize potential culture bias against difficult growers. Methodology/Principal findings Smear-positive sputa from consecutive new tuberculosis patients diagnosed in Cotonou, (Benin) were included, before patients had started treatment. An aliquot of decontaminated sputum was used for direct spoligotyping, and another aliquot was cultured on Lowenstein Jensen (LJ) medium (90 days), for indirect spoligotyping. After DNA extraction, spoligotyping was done according to the standard method for all specimens, and patterns obtained from sputa were compared versus those from the derived culture isolates. From 199 patient's sputa, 146 (73.4%) yielded a positive culture. In total, direct spoligotyping yielded a pattern in 98.5% (196/199) of the specimens, versus 73.4% (146/199) for indirect spoligotyping on cultures. There was good agreement between sputum-and isolate derived patterns: 94.4% (135/143) at spoligotype level and 96.5% (138/143) at (sub) lineage level. Two of the 8 pairs with discrepant pattern were suggestive of mixed infection in sputum. Ancestral lineages (Lineage 1, and M. africanum Lineages 5 and 6) were less likely to grow in culture (OR = 0.30, 95% CI (0.14 to 0.64), p = 0.0016); especially Lineage 5 (OR = 0.37 95% CI (0.17 to 0.79), p = 0.010). Among modern lineages, Lineage 4 was over-represented in positive-culture specimens (OR = 3.01, 95% CI (1.4 to 6.51), p = 0.005). Conclusions/Significance Ancestral lineages, especially M. africanum West African 1 (Lineage 5), are less likely to grow in culture relative to modern lineages, especially M. tuberculosis Euro-American (Lineage 4). Direct spoligotyping on smear positive sputum is effective and efficient compared to indirect spoligotyping of cultures. It allows for a more accurate unbiased determination of the population structure of the M. tuberculosis complex.	[Sanoussi, C. N'Dira; Rigouts, Leen; de Jong, Bouke] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Sanoussi, C. N'Dira; Affolabi, Dissou; Anagonou, Severin] Ctr Natl Hosp Univ Pneumophtisiol Cotonou, Natl TB Programme, Lab Reference Mycobacteries, Cotonou, Benin; [Sanoussi, C. N'Dira; Rigouts, Leen] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	Sanoussi, CN; de Jong, B (reprint author), Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium.; Sanoussi, CN (reprint author), Ctr Natl Hosp Univ Pneumophtisiol Cotonou, Natl TB Programme, Lab Reference Mycobacteries, Cotonou, Benin.; Sanoussi, CN (reprint author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	ndirasanoussi@gmail.com; bdejong@itg.be		de Jong, Bouke/0000-0002-1017-4675	European Research Council-INTERRUPTB starting grant [311725]; DGCD Belgium [FA3-III]; ITM, ITM-LRM [FA3-III]	BdJ and LR were supported by the European Research Council-INTERRUPTB starting grant (nr.311725). SA, DA and CNS were supported by the Third framework agreement programme between DGCD Belgium and ITM, ITM-LRM (FA3-III). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; Brosch R, 2002, P NATL ACAD SCI USA, V99, P3684, DOI 10.1073/pnas.052548299; Cafrune PI, 2009, CAN J MICROBIOL, V55, P895, DOI [10.1139/W09-033, 10.1139/w09-033]; Castets M, 1979, Med Trop (Mars), V39, P145; Chartier L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021212; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; de Jong BC, 2010, PLOS NEGL TROP DIS, V4; de Jong BC, 2010, FEMS IMMUNOL MED MIC, V58, P102, DOI 10.1111/j.1574-695X.2009.00628.x; Doughty EL, 2014, PEERJ, V2, DOI 10.7717/peerj.585; Drugeon HB, 1999, INACTIVATION MYCOBAC, V37, P2350; Firdessa R, 2013, EMERG INFECT DIS, V19, P460, DOI 10.3201/eid1903.120256; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gehre F, 2013, PLOS NEGL TROP DIS, V7; Gehre F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077000; Goyal M, 1999, J INFECTION, V38, P171, DOI 10.1016/S0163-4453(99)90246-3; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; Heyderman RS, 1998, THORAX, V53, P346, DOI 10.1136/thx.53.5.346; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907; Kato-Maeda M, 2011, FUTURE MICROBIOL, V6, P203, DOI 10.2217/FMB.10.165; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Kibiki GS, 2007, TROP MED INT HEALTH, V12, P1210, DOI 10.1111/j.1365-3156.2007.01907.x; Koro FK, 2013, J CLIN MICROBIOL, V51, P299, DOI 10.1128/JCM.01196-12; Manual T., COMPONENTS; Nguyen TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038209; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Ofori-Anyinam B, 2017, TUBERCULOSIS, V104, P58, DOI 10.1016/j.tube.2017.03.001; Organization WH, 2006, REC HIV PREV RES CON; Parwati I, 2003, J CLIN MICROBIOL, V41, P5350, DOI 10.1128/JCM.41.11.5350-5351.2003; RAVIGLIONE MC, 1995, JAMA-J AM MED ASSOC, V273, P220, DOI 10.1001/jama.273.3.220; Rieder H, 2007, TUBERCULOSIS; Shabbeer A, 2012, INFECT GENET EVOL, V12, P789, DOI 10.1016/j.meegid.2012.02.010; Stonebrink B., 1957, P TUBER RES COUNC R, V4467-74; Suresh N, 2007, J MICROBIOL METH, V68, P291, DOI 10.1016/j.mimet.2006.09.001; Tientcheu LD, 2015, GENES IMMUN, V16, P347, DOI 10.1038/gene.2015.21; vanSoolingen D, 2003, USE DNA EXTRACTS ZIE, V41, P1101; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2017	11	9							e0005900	10.1371/journal.pntd.0005900				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FI6YN	WOS:000412142800044	28863143	DOAJ Gold, Green Published			2019-04-02	
J	Vuylsteke, B; Sika, L; Semde, G; Anoma, C; Kacou, E; Laga, M				Vuylsteke, Bea; Sika, Lazare; Semde, Gisele; Anoma, Camille; Kacou, Elise; Laga, Marie			Estimating the number of female sex workers in Cote d'Ivoire: results and lessons learned	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						female sex workers; West Africa; methods; size estimation	MIDDLE-INCOME COUNTRIES; KEY POPULATIONS; SIZE ESTIMATION; HIV-INFECTION; CAPTURE-RECAPTURE; HIGHER RISK; MEN; PREVENTION; ABIDJAN; KENYA	ObjectiveTo report on the results of three size estimations of the populations of female sex workers (FSW) in five cities in Cote d'Ivoire and on operational lessons learned, which may be relevant for key population programmes in other parts of the world. MethodsWe applied three methods: mapping and census, capture-recapture and service multiplier. All were applied between 2008 and 2009 in Abidjan, San Pedro, Bouake, Yamoussoukro and Abengourou. ResultsAbidjan was the city with the highest number of FSW by far, with estimations between 7880 (census) and 13 714 (service multiplier). The estimations in San Pedro, Bouake and Yamoussoukro were very similar, with figures ranging from 1160 (Yamoussoukro, census) to 1916 (San Pedro, capture-recapture). Important operational lessons were learned, including strategies for mapping, the importance of involving peer sex workers for implementing the capture-recapture and the identification of the right question for the multiplier method. ConclusionsSuccessful application of three methods to estimate the population size of FSW in five cities in Cote d'Ivoire enabled us to make recommendations for size estimations of key population in low-income countries.	[Vuylsteke, Bea; Laga, Marie] Inst Trop Med, Nationalestr 155, B-2000 Antwerp, Belgium; [Sika, Lazare; Kacou, Elise] ENSEA, Abidjan, Cote Ivoire; [Semde, Gisele] Save Children, Abidjan, Cote Ivoire; [Anoma, Camille] Espace Confiance, Abidjan, Cote Ivoire	Vuylsteke, B (reprint author), Inst Trop Med, Nationalestr 155, B-2000 Antwerp, Belgium.	bvuylsteke@itg.be					Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Bernard HR, 2010, SEX TRANSM INFECT, V86, pI11, DOI 10.1136/sti.2010.044446; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Emmanuel F, 2010, AIDS, V24, pS77, DOI 10.1097/01.aids.0000386737.25296.c4; Ghys PD, 2002, AIDS, V16, P251, DOI 10.1097/00002030-200201250-00015; Johnston LG, 2013, SEX TRANSM DIS, V40, P304, DOI 10.1097/OLQ.0b013e31827fd650; Khalid FJ, 2014, AIDS BEHAV, V18, pS25, DOI 10.1007/s10461-013-0517-x; Kruse N, 2003, SEX TRANSM DIS, V30, P664, DOI 10.1097/01.OLQ.0000079523.04451.82; Maghsoudi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110917; NS (Institut National de la Statistique) and ICF International, 2013, ENQ DEM SANT IND MUL; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Okal J, 2013, SEX TRANSM INFECT, V89, P366, DOI 10.1136/sextrans-2013-051071; Quaye S, 2015, AIDS BEHAV, V19, pS16, DOI 10.1007/s10461-014-0943-4; Sabin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155150; UNAIDS/WHO, GUID EST SIZ POP MOS; Vadivoo S, 2008, AIDS, V22, pS137, DOI 10.1097/01.aids.0000343772.82647.2d; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vuylsteke B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032627; Vuylsteke B, 2012, SEX TRANSM INFECT, V88, P288, DOI 10.1136/sextrans-2011-050276; Vuylsteke B, 2010, TROP MED INT HEALTH, V15, P1537, DOI 10.1111/j.1365-3156.2010.02654.x; Vuylsteke B, 2009, HIV PREVENTION: A COMPREHENSIVE APPROACH, P376, DOI 10.1016/B978-0-12-374235-3.00014-5; Wohl DA, 2011, AIDS BEHAV, V15, P283, DOI 10.1007/s10461-010-9746-4; Yu DB, 2014, WEST PAC SURVEILL RE, V5, P43, DOI [10.5365/wpsar.2014.5.2.008, 10.5365/WPSAR.2014.5.2.008]	26	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	SEP	2017	22	9					1112	1118		10.1111/tmi.12911				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FF7LF	WOS:000409196800006	28627038				2019-04-02	
J	Rosas-Aguirre, A; Guzman-Guzman, M; Gamboa, D; Chuquiyauri, R; Ramirez, R; Manrique, P; Carrasco-Escobar, G; Puemape, C; Llanos-Cuentas, A; Vinetz, JM				Rosas-Aguirre, Angel; Guzman-Guzman, Mitchel; Gamboa, Dionicia; Chuquiyauri, Raul; Ramirez, Roberson; Manrique, Paulo; Carrasco-Escobar, Gabriel; Puemape, Carmen; Llanos-Cuentas, Alejandro; Vinetz, Joseph M.			Micro-heterogeneity of malaria transmission in the Peruvian Amazon: a baseline assessment underlying a population-based cohort study	MALARIA JOURNAL			English	Article						Malaria; Transmission; PCR; Heterogeneity; Hotspot; Peruvian Amazon	PLASMODIUM-VIVAX-MALARIA; FALCIPARUM-MALARIA; ANOPHELES-DARLINGI; RISK-FACTORS; REGION; IDENTIFICATION; EPIDEMIOLOGY; PARASITEMIA; COMMUNITIES; INFECTIONS	Background: Understanding the dynamics of malaria transmission in diverse endemic settings is key for designing and implementing locally adapted and sustainable control and elimination strategies. A parasitological and epidemiological survey was conducted in September-October 2012, as a baseline underlying a 3-year population-based longitudinal cohort study. The aim was to characterize malaria transmission patterns in two contrasting ecological rural sites in the Peruvian Amazon, Lupuna (LUP), a riverine environment, and Cahuide (CAH), associated with road-linked deforestation. Methods: After a full population census, 1941 individuals 3 years and older (829 in LUP, 1112 in CAH) were interviewed, clinically examined and had a blood sample taken for the detection of malaria parasites by microscopy and PCR. Species-specific parasite prevalence was estimated overall and by site. Multivariate logistic regression models assessed risk factors for parasite infection by PCR, while SaTScan detected spatial clusters of PCR-positive individuals within each site. In addition, data from routine malaria surveillance in the period 2009-2012 were obtained. Results: Parasite prevalence by PCR was higher in CAH than in LUP for Plasmodium vivax (6.2% vs. 3.9%) and for Plasmodium falciparum (2.6% vs. 1.2%). Among PCR-confirmed infections, asymptomatic (Asy) parasite carriers were always more common than symptomatic (Sy) infections for P. vivax (Asy/Sy ratio: 2/1 in LUP and 3.7/1 in CAH) and for P. falciparum (Asy/Sy ratio: 1.3/1 in LUP and 4/1 in CAH). Sub-patent (Spat) infections also predominated over patent (Pat) infections for both species: P. vivax (Spat/Pat ratio: 2.8/1 in LUP and 3.7/1 in CAH) and P. falciparum malaria (Spat/Pat ratio: 1.9/1 in LUP and 26/0 in CAH). For CAH, age, gender and living in a household without electricity were significantly associated with P. vivax infection, while only age and living in a household with electricity was associated with P. falciparum infection. For LUP, only household overcrowding was associated with P. falciparum infection. The spatial analysis only identified well-defined clusters of P. vivax and P. falciparum infected individuals in CAH. Reported malaria incidence indicated that malaria transmission has long occurred in LUP with primarily seasonal patterns, and confirmed a malaria outbreak in CAH since May 2012. Conclusions: This parasitological and epidemiological baseline assessment demonstrates that malaria transmission and parasite prevalence is heterogeneous in the Peruvian Amazon, and influenced by local socio-demographics and ecological contexts. Riverine and road construction/deforestation contexts must be taken into account in order to carry out effective anti-malaria control and elimination efforts.	[Rosas-Aguirre, Angel; Gamboa, Dionicia; Chuquiyauri, Raul; Llanos-Cuentas, Alejandro; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima 31, Peru; [Rosas-Aguirre, Angel] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, B-1200 Brussels, Belgium; [Guzman-Guzman, Mitchel; Gamboa, Dionicia; Ramirez, Roberson; Manrique, Paulo; Carrasco-Escobar, Gabriel; Puemape, Carmen; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Lab ICEMR Amazonia, Lab Invest & Desarrollo, Lima 31, Peru; [Gamboa, Dionicia; Vinetz, Joseph M.] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Dept Ciencias Celulares & Mol, Lima 31, Peru; [Carrasco-Escobar, Gabriel; Llanos-Cuentas, Alejandro] Univ Peruana Cayetano Heredia, Fac Salud Publ & Adm, Lima 31, Peru; [Chuquiyauri, Raul; Vinetz, Joseph M.] Univ Calif San Diego, Div Infect Dis, Dept Med, Sch Med, 9500 Gilman Dr,MC0760,Biomed Res Facil 2, La Jolla, CA 92093 USA	Vinetz, JM (reprint author), Univ Calif San Diego, Div Infect Dis, Dept Med, Sch Med, 9500 Gilman Dr,MC0760,Biomed Res Facil 2, La Jolla, CA 92093 USA.	jvinetz@ucsd.edu		Rosas Aguirre, Angel/0000-0002-3271-7028; Carrasco-Escobar, Gabriel/0000-0002-6945-0419; Gamboa, Dionicia/0000-0002-1420-7729	United States Public Health Service, NIH/NIAID [U19AI089681]; Amazonian International Center of Excellence in Malaria Research	We thank all residents and local authorities from the Loreto villages of Cahuide and Lupuna for their enthusiastic participation in the study, as well as all field workers for their dedication during the fieldwork. This study was funded by cooperative agreement U19AI089681 from the United States Public Health Service, NIH/NIAID, funded as the Amazonian International Center of Excellence in Malaria Research.	Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109; Bousema T, 2014, NAT REV MICROBIOL, V12, P833, DOI 10.1038/nrmicro3364; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Chuquiyauri R, 2012, ACTA TROP, V121, P292, DOI 10.1016/j.actatropica.2011.11.003; Clark EH, 2012, INFECT IMMUN, V80, P1583, DOI 10.1128/IAI.05961-11; Coura JR, 2006, MEM I OSWALDO CRUZ, V101, P229, DOI 10.1590/S0074-02762006000300001; Cueto Marcos, 1997, REGRESO EPIDEMIAS SA; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; del Peru Ministerio de Salud, 2015, B EPIDEMIOL, V24, P975; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Elissa N, 2003, ACTA TROP, V85, P355, DOI 10.1016/S0001-706X(02)00266-8; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; Flores W, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-379; Griffing SM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-303; Gryseels C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0689-0; Guarda JA, 1999, EMERG INFECT DIS, V5, P209; Kulldorff M, 2010, SATSCAN SOFTWARE SPA; Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/ERI.13.45, 10.1586/eri.13.45]; Maitland K, 1996, T ROY SOC TROP MED H, V90, P614, DOI 10.1016/S0035-9203(96)90406-X; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Ministerio de Salud del Peru, 2010, NORM TECN SAL CONTR; Moreno M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0804-2; Moss WJ, 2015, AM J TROP MED HYG, V93, P5, DOI 10.4269/ajtmh.15-0006; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Parekh FK, 2007, AM J TROP MED HYG, V77, P451, DOI 10.4269/ajtmh.2007.77.451; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Rao MR, 2015, AM J TROP MED HYG, V93, P1, DOI 10.4269/ajtmh.15-0407; Ricci F, 2012, MEDITERR J HEMATOL I, V4; Rosas-Aguirre A, 2016, AM J TROP MED HYG, V95, P133, DOI 10.4269/ajtmh.16-0268; Rosas-Aguirre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137458; Rosas-Aguirre A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0868-4; Rosas-Aguirre A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0670-y; Rosas-Aguirre Angel, 2011, Rev. perú. med. exp. salud publica, V28, P228, DOI 10.1590/s1726-46342011000200009; Rosas-Aguirre Ángel, 2010, Rev. perú. med. exp. salud publica, V27, P540, DOI 10.1590/s1726-46342010000400008; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Ruebush TK, 2004, J PUBLIC HEALTH POL, V25, P328, DOI 10.1057/palgrave.jphp.3190032; Seyoum D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1253-2; Soto-Calle V, 2017, SCI REP, V7, P40350; Teklehaimanot A, 2008, ANN NY ACAD SCI, V1136, P32, DOI 10.1196/annals.1425.037; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; Vinetz JM, 2002, AM J TROP MED HYG, V66, P639, DOI 10.4269/ajtmh.2002.66.639; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Williams HA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-85; Zwiebel LJ, 2004, INSECT BIOCHEM MOLEC, V34, P645, DOI 10.1016/j.ibmb.2004.03.017	48	4	4	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 4	2017	16								312	10.1186/s12936-017-1957-y				19	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FD9JK	WOS:000407838400001	28778210	DOAJ Gold, Green Published			2019-04-02	
J	Kamga, GR; Dissak-Delon, FN; Nana-Djeunga, HC; Biholong, BD; Ghogomu, SM; Souopgui, J; Kamgno, J; Robert, A				Kamga, Guy-Roger; Dissak-Delon, Fanny N.; Nana-Djeunga, Hugues C.; Biholong, Benjamin D.; Ghogomu, Stephen Mbigha; Souopgui, Jacob; Kamgno, Joseph; Robert, Annie			Important progress towards elimination of onchocerciasis in the West Region of Cameroon	PARASITES & VECTORS			English	Article						Onchocerciasis; Ivermectin; Persistence; Elimination; West Region; Cameroon	IVERMECTIN TREATMENT; AFRICAN PROGRAM; BLINDNESS; VOLVULUS; DISEASE; FUTURE; BURDEN	Background: After more than a decade of community-directed treatment with ivermectin (CDTI) in the West Region of Cameroon, epidemiological evaluation conducted in 2011 showed that onchocerciasis endemicity was still high in some communities. The conceptual framework for onchocerciasis elimination recommends in such case, to conduct additional phase 1A surveys at intervals of three to four years. Therefore, to assess the progress made towards the elimination of onchocerciasis in the West CDTI projects, we conducted a cross-sectional survey in May 2015 in 15 unevaluated communities where the highest baseline endemicity level were found in 1996. All volunteers living for at least five years in the community, aged five years or more, underwent clinical and parasitological examinations. Individual adherence to ivermectin treatment was also assessed. Analyses of data were weighted proportionally to age and gender distribution in the population. Results: The mean age was 28.4 +/- 22.2 years and there were 55% of women among the 2058 individuals examined. The weighted prevalences were 5.5%, 2.1% and 1.7% for microfilaridermia, nodule and cutaneous signs, respectively. The weighted microfilaridermia prevalences varied from 4.0 in 5-9 years old to 11.6% in 40-49 years old. In the 30 children under 10 years examined in Makouopsap, the weighted prevalences were 49.9% for microfilaridermia and 13.3% for nodule. In surveyed communities, the weighted prevalences varied from 0 to 41.6% for microfilaridermia, with 11 (73.3%) communities having <5%. Except Makouopsap which had 41.6%, all the surveyed communities were below 15% for microfilaridermia prevalence. The community microfilarial load (CMFL) expressed in microfilariae/skin snip (mf/ss), also significantly dropped by 98-100%, from 3.75-33.16 mf/ss in 1996 to 0-0.94 mf/ss in 2015. The weighted therapeutic coverage in 2014 was 69.4% and the 5 years' adherence was only 39.3% among participants. Conclusions: After more than 15 years of CDTI, there is an important progress towards the elimination of onchocerciasis in the communities surveyed. Innovative strategy like semi-annual ivermectin treatment plus vector control or the adjunction of a vector control strategy to the current annual treatment should be implemented in the bordering districts of the Centre and West Regions, as well as in other parts of the country with persistent high prevalences in the sight of onchocerciasis elimination.	[Kamga, Guy-Roger; Dissak-Delon, Fanny N.; Biholong, Benjamin D.] Minist Publ Hlth, 8 Rue 3038 Quartier Lac, Yaounde, Cameroon; [Kamga, Guy-Roger; Dissak-Delon, Fanny N.; Nana-Djeunga, Hugues C.; Kamgno, Joseph] Ctr Res Filariasis & Other Trop Dis CRFilMT, POB 5797, Yaounde, Cameroon; [Kamga, Guy-Roger; Robert, Annie] Catholic Univ Louvain, Fac Sante Publ, Inst Rech Expt & Clin, Clos Chapelle Aux Champs 30 Bte B1 30-13, B-1200 Brussels, Belgium; Univ Libre Bruxelles, Inst Biol & Mol Med, Rue Prof Jeener & Brachet 12, BE-6041 Gosselies, Belgium; [Nana-Djeunga, Hugues C.; Kamgno, Joseph] Univ Yaounde I, Fac Med & Biomed Sci, POB 1364, Yaounde, Cameroon; [Ghogomu, Stephen Mbigha] Univ Buea, Dept Biochem & Mol Biol, Mol & Cell Biol Lab, POB 63, Buea, Cameroon	Kamga, GR (reprint author), Minist Publ Hlth, 8 Rue 3038 Quartier Lac, Yaounde, Cameroon.; Kamga, GR (reprint author), Ctr Res Filariasis & Other Trop Dis CRFilMT, POB 5797, Yaounde, Cameroon.; Kamga, GR (reprint author), Catholic Univ Louvain, Fac Sante Publ, Inst Rech Expt & Clin, Clos Chapelle Aux Champs 30 Bte B1 30-13, B-1200 Brussels, Belgium.	guyrogerkgr@gmail.com			Belgian university cooperation	This study was funded by the Belgian university cooperation (www.ares-ac.be/fr/cooperation-au-developpement) through the PRD2013 collaborative project between Universite catholique de Louvain, Universite Libre de Bruxelles, the University of Buea, the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT) and the Ministry of Public Health of Cameroon.	Albiez E J, 1988, Trop Med Parasitol, V39 Suppl 4, P331; ALBIEZ EJ, 1985, TROPENMED PARASITOL, V36, P17; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P381; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P382; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P23; [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P577; APOC, 2010, CONC OP FRAM ONCH EL, P24; Baker RH, 1990, PHILOS T R SOC LON B, V328, P747; BAKER RHA, 1990, PHILOS T ROY SOC B, V328, P731, DOI 10.1098/rstb.1990.0141; Bottomley C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1605-3; Boussinesq M, 1992, B LIAS DOC OCEAC, V100, P27; Brieger WR, 2007, TROP MED INT HEALTH, V12, P260, DOI 10.1111/j.1365-3165.2006.01796.x; Brieger WR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-152; BUCREP, 2010, PROJ DEM TROIS REC G, V3, P3; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; DUKE BOL, 1993, TROP MED PARASITOL, V44, P61; Elimination of onchocerciasis in the WHO Region of the Americas, 2014, WKLY EPIDEMIOL REC, V89, P401; GTNO-Cameroun, 2015, RAPP TECHN ANN 2014; Hoerauf A, 2003, BRIT MED J, V326, P207, DOI 10.1136/bmj.326.7382.207; Kamga GR, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1868-8; Kamgno J, 1997, B SOC PATHOL EXOT, V90, P327; Katabarwa M, 2014, LANCET INFECT DIS, V14, P373, DOI 10.1016/S1473-3099(14)70732-7; Katabarwa MN, 2016, INT HEALTH, V8, P116, DOI 10.1093/inthealth/ihv038; Katabarwa Moses N, 2013, J Parasitol Res, V2013, P420928, DOI 10.1155/2013/420928; Katabarwa Moses N, 2012, J Parasitol Res, V2012, P748540, DOI 10.1155/2012/748540; Katabarwa MN, 2011, AM J TROP MED HYG, V85, P1041, DOI 10.4269/ajtmh.2011.11-0333; Murdoch ME, 2002, ANN TROP MED PARASIT, V96, P283, DOI 10.1179/000349802125000826; Murdoch ME, 2010, CURR OPIN INFECT DIS, V23, P124, DOI 10.1097/QCO.0b013e328336a256; NGOUMOU P, 1994, ANN TROP MED PARASIT, V88, P463, DOI 10.1080/00034983.1994.11812893; PLAISIER AP, 1991, ACTA TROP, V48, P271, DOI 10.1016/0001-706X(91)90015-C; Prost A., 1978, Medecine Tropicale, V38, P519; Remme JHF, 2006, DIS CONTROL PRIORITI; Report of Commission of Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ, P1; Resnikoff S, 2012, INDIAN J OPHTHALMOL, V60, P387, DOI 10.4103/0301-4738.100532; Stolk WA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1159-9; Tamarozzi F, 2011, CLIN MICROBIOL REV, V24, P459, DOI 10.1128/CMR.00057-10; Tekle AH, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0160-7; Walker M, 2017, EPIDEMICS-NETH, V18, P4, DOI 10.1016/j.epidem.2017.02.005; WANJI S, 2015, PARASITE VECTOR, V8; WHO, 2016, WKLY EPIDEMIOL REC, V91, P501; WHO, 2016, WKLY EPIDEMIOL REC, V91, P505; WHO, 2015, WKLY EPIDEMIOL REC, V90, P661; WHO, 2014, WKLY EPIDEMIOL REC, V89, P551; World Health Organization, 2016, GUID STOPP MASS DRUG; World Health Organization (WHO), 2003, INV MENT HLTH, P1; Zoure HGM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-326	46	4	4	1	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 3	2017	10								373	10.1186/s13071-017-2301-7				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FC7XP	WOS:000407056100001	28774318	DOAJ Gold, Green Published			2019-04-02	
J	Dissak-Delon, FN; Kamga, GR; Humblet, PC; Robert, A; Souopgui, J; Kamgno, J; Essi, MJ; Ghogomu, SM; Godin, I				Dissak-Delon, Fanny Nadia; Kamga, Guy-Roger; Humblet, Perrine Claire; Robert, Annie; Souopgui, Jacob; Kamgno, Joseph; Essi, Marie Jose; Ghogomu, Stephen Mbigha; Godin, Isabelle			Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs	PLOS NEGLECTED TROPICAL DISEASES			English	Article							AFRICAN PROGRAM; PREDICTORS; PROJECTS; NIGERIA	Background The fight against onchocerciasis in Africa has boomed thanks to the Community Directed Treatment with Ivermectin (CDTI) program. However, in Cameroon, after more than 15 years of mass treatment, onchocerciasis prevalence is still above the non- transmission threshold. This study aimed to explore a possible association between people's beliefs/perceptions of onchocerciasis and of CDTI program, and their adherence to ivermectin in three regions of Cameroon. Methodology/Principal findings A cross sectional survey was carried out in three health districts with persistent high onchocerciasis prevalence. Participants were randomly selected in 30 clusters per district. Adherence to ivermectin was comparable between Bafang and Bafia (55.0% and 48.8%, respectively, p>0.05) and lower in Yabassi (40.7%). Among all factors related to program perceptions and disease representations that were studied, perceptions of the program are the ones that were most determinant in adherence to ivermectin. People who had a - not positive opinion of ivermectin distribution campaigns were less compliant than those who had a positive opinion about the campaigns (40% vs 55% in Bafang, and 48% vs 62% in Bafia, p<0.01), as well as those who had a negative appreciation of community drug distributors' commitment (22% vs 53% in Bafang, 33% vs 59% in Bafia, 27% vs 47% in Yabassi; p<0.01). The most common misconception about onchocerciasis transmission was the lack of hygiene, especially in Bafia and Yabassi. In Bafang, high proportions of people believed that onchocerciasis was due to high consumption of sugar (31% vs less than 5% in Bafia and Yabassi, p<0.001). Conclusion/Significance There are still frequent misconceptions about onchocerciasis transmission in Cameroon. Perceptions of ivermectin distribution campaigns are more strongly associated to adherence. In addition to education/sensitisation on onchocerciasis during the implementation of the CDTI program, local health authorities should strive to better involve communities and more encourage community distributors' work.	[Dissak-Delon, Fanny Nadia; Kamga, Guy-Roger] Minist Publ Hlth, Yaounde, Cameroon; [Dissak-Delon, Fanny Nadia; Humblet, Perrine Claire; Souopgui, Jacob; Godin, Isabelle] Univ Libre Bruxelles, Brussels, Belgium; [Dissak-Delon, Fanny Nadia; Kamga, Guy-Roger; Ghogomu, Stephen Mbigha] Univ Buea, Buea, Cameroon; [Kamga, Guy-Roger; Robert, Annie] Catholic Univ Louvain, Inst Rech Expt & Clin, Epidemiol & Biostat Res Div, Brussels Campus, Brussels, Belgium; [Kamgno, Joseph] Ctr Res Filariasis & Other Trop Dis, Yaounde, Cameroon; [Kamgno, Joseph; Essi, Marie Jose] Univ Yaounde I, Yaounde, Cameroon	Dissak-Delon, FN (reprint author), Minist Publ Hlth, Yaounde, Cameroon.; Dissak-Delon, FN (reprint author), Univ Libre Bruxelles, Brussels, Belgium.; Dissak-Delon, FN (reprint author), Univ Buea, Buea, Cameroon.	fannynadia@gmail.com			Belgian Academie de Recherche et d'Enseignement Superieur (ARES-CCD) through the 2013 Research Project for development (PRD) in Cameroon	The study was funded by the Belgian Academie de Recherche et dEnseignement Superieur (ARES-CCD: www.ares-ac.be) through the 2013 Research Project for development (PRD) in Cameroon, named: PRD2013Cameroun-Souopgui- Strenghtening the Onchocerciasis Elimination Program in Cameroon. More information on: http://www.ares-ac.be/fr/cooperation-au-developpement/pays-projets/projets-dans-le-monde/item/54-prd-strengthening-the-onchocerciasis-elimination-program-in-cameroon. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi O, 2016, BR J MED MED RES, V13, P1; Akogun OB, 2000, SOC SCI MED, V50, P1451, DOI 10.1016/S0277-9536(99)00336-6; Amazigo U, 2007, SOC SCI MED, V64, P2070, DOI 10.1016/j.socscimed.2007.01.018; Aronson JK, 2007, BRIT J CLIN PHARMACO, V63, P383, DOI 10.1111/j.1365-2125.2007.02893.x; Bissonnette JM, 2008, J ADV NURS, V63, P634, DOI 10.1111/j.1365-2648.2008.04745.x; Boussinesq M, 1992, B LIAISON DOCUMENTAT, V100, P26; Brieger WR, 2012, TROP MED INT HEALTH, V17, P920, DOI 10.1111/j.1365-3156.2012.03007.x; Brieger WR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-152; Brieger WR, 2002, TROP MED INT HEALTH, V7, P11, DOI 10.1046/j.1365-3156.2002.00826.x; Diawara L, 2009, PLOS NEGL TROP DIS, V3; Endale A, 2015, PARASIT VECTORS, V8; Epee E, 2014, HLTH SCI DIS, V15; Kamga GR, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1868-8; Katabarwa MN, 2013, J PARASITOL RES, V2013; Lakwo T L, 2006, East Afr Med J, V83, P326; Meredith SEO, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-16; Mitchell C., ONCOCERCOSIS; Nana-Djeunga HC, 2015, PLOS NEGL TROP DIS, V9; Nuwaha F, 2005, TROP MED INT HEALTH, V10, P659, DOI 10.1111/j.1365-3156.2005.01436.x; PLAISIER AP, 1991, ACTA TROP, V48, P271, DOI 10.1016/0001-706X(91)90015-C; Programme Africain de Lutte contre l'Onchocercose (OMS/ APOC), 2010, CADR CONN OP EL ONCH; Programme Africain de Lutte contre l'Onchocercose (OMS/ APOC). Programme pour l'e A limination des maladies ne A glige A es en Afrique (PENDA), 2013, PROGR EL MAL NEGL AF; Remme JHF, 2010, B WORLD HEALTH ORGAN, V88, P509, DOI 10.2471/BLT.09.069203; RICHARDS F, 1991, SOC SCI MED, V32, P1275, DOI 10.1016/0277-9536(91)90043-C; Richards FO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004777; Senyonjo L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004905; Tekle AH, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0160-7; Wagbatsoma VA, 2004, AFR J CLIN EXP MICRO, V5, P235; Weldegebreal F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-98; WHO, ONCH DIS ITS IMP; World Health Organization, ADHERENCE LONG TERM; World Health Organization, ONCH; Yirga D, 2008, ETHIOP J HLTH SCI, V18, P66; Yirga D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-48; Zoure HGM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001210	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2017	11	8							e005849	10.1371/journal.pntd.0005849				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FH3SD	WOS:000411068800045	28806785	DOAJ Gold, Green Published			2019-04-02	
J	Walker, SL; Lebas, E; De Sario, V; Deyasso, Z; Doni, SN; Marks, M; Roberts, CH; Lambert, SM				Walker, Stephen L.; Lebas, Eglantine; De Sario, Valentina; Deyasso, Zeleke; Doni, Shimelis N.; Marks, Michael; Roberts, Chrissy H.; Lambert, Saba M.			The prevalence and association with health-related quality of life of tungiasis and scabies in schoolchildren in southern Ethiopia	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SCHOOL-CHILDREN; SKIN-DISEASE; INDEX CDLQI; DERMATOLOGY; EPIDEMIOLOGY; COMMUNITY; FOOT	Background The prevalence of skin disease in low and middle income countries is high and communicable skin diseases are a significant public health problem. Tungiasis is an ectoparasite infestation caused by the flea Tunga penetrans, which has a widespread geographical distribution. Tungiasis causes painful skin lesions and may affect activities of daily living. Objective We wished to determine the prevalence and impact of tungiasis and scabies in schoolchildren in southern Ethiopia. Methods A cross-sectional study was performed in which students were examined by dermatologists and the skin disorders recorded. Individuals with pyogenic skin infections, scabies and tungiasis were also invited to complete the Children's Dermatology Life Quality Index. Results There was a high burden of skin disease amongst this cohort with more than 40% having an ectodermal parasitic skin disease. The majority of these were due to tungiasis. Tungiasis was evident in more than a third of children and was associated with onychodystophy. There was a significant association between wearing "closed" footwear and a greater number of tungiasis lesions but not tungiasis per se. Dermatophyte infections, acne and plantar maceration secondary to occlusive footwear were also common. Scabies and tungiasis appeared to have a significant negative effect on quality of life. Conclusion Tungiasis is highly prevalent in schoolchildren in the part of Ethiopia where the study was conducted and is associated with a deleterious effect on quality of life. The role of footwear in both preventing and possibly exacerbating cutaneous ailments in this setting requires further study.	[Walker, Stephen L.; Marks, Michael; Roberts, Chrissy H.; Lambert, Saba M.] London Sch Hyg & Trop Med, London, England; [Lebas, Eglantine] Guys & St Thomas NHS Fdn Trust, St Johns Inst Dermatol, Dept Dermatopathol, London, England; [Lebas, Eglantine] Ctr Hosp Univ Liege, Dept Dermatol, Liege, Belgium; [De Sario, Valentina; Marks, Michael] Hosp Trop Dis, London, England; [Deyasso, Zeleke] Chito Hlth Ctr, Yirgacheffe, Ethiopia; [Doni, Shimelis N.] ALERT Ctr, Dept Dermatol, Addis Ababa, Ethiopia; [Lambert, Saba M.] Suisse Clin, Dept Family Med, Addis Ababa, Ethiopia	Walker, SL (reprint author), London Sch Hyg & Trop Med, London, England.	Steve.walker@lshtm.ac.uk		Roberts, Chrissy h./0000-0003-1064-5980; Marks, Michael/0000-0002-7585-4743; Walker, Stephen/0000-0002-2034-8376	Roger Harman African Travelling Fellowship of the British Association of Dermatologists; Hospital and Homes of St. Giles; Leprosy Research Initiative; Wellcome Trust [102807]; Wellcome Trust Institutional Support Fund [105609/Z/14/Z]	The study was funded by the Roger Harman African Travelling Fellowship of the British Association of Dermatologists. Stephen Walker is supported in part by the Hospital and Homes of St. Giles and the Leprosy Research Initiative. Michael Marks is supported by the Wellcome Trust (102807). Chrissy Roberts is supported by the Wellcome Trust Institutional Support Fund (105609/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENE FOI, 1984, PUBLIC HEALTH, V98, P282, DOI 10.1016/S0033-3506(84)80004-9; Ayode D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002199; Blaise G, 2008, INT J DERMATOL, V47, P884, DOI 10.1111/j.1365-4632.2008.03773.x; Caton EL, 2015, QJM-INT J MED, V108, P833, DOI 10.1093/qjmed/hcv076; DAGNEW MB, 1991, TROP GEOGR MED, V43, P152; Davis JS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002387; Deribe K, 2015, B WORLD HEALTH ORGAN, V93, P712, DOI 10.2471/BLT.14.150276; Feldmeier H, 2009, B WORLD HEALTH ORGAN, V87, P152, DOI 10.2471/BLT.07.047308; Figueroa JI, 1996, PEDIATR DERMATOL, V13, P378, DOI 10.1111/j.1525-1470.1996.tb00704.x; Figueroa JI, 1998, INT J DERMATOL, V37, P752, DOI 10.1046/j.1365-4362.1998.00425.x; Grupper M, 2012, TRAVEL MED INFECT DI, V10, P220, DOI 10.1016/j.tmaid.2012.09.002; Hay RJ, 2015, BRIT J DERMATOL, V172, P1469, DOI 10.1111/bjd.13854; Hay RJ, 2014, J INVEST DERMATOL, V134, P1527, DOI 10.1038/jid.2013.446; Heukelbach J, 2005, AM J TROP MED HYG, V72, P145, DOI 10.4269/ajtmh.2005.72.145; Heukelbach J, 2004, MEM I OSWALDO CRUZ, V99, P873, DOI 10.1590/S0074-02762004000800015; Heukelbach J, 2002, AM J TROP MED HYG, V67, P214, DOI 10.4269/ajtmh.2002.67.214; Karunamoorthi K, 2013, PARASITOL RES, V112, P3635, DOI 10.1007/s00436-013-3551-8; LEWISJONES MS, 1995, BRIT J DERMATOL, V132, P942; Marrone R, 2012, PEDIATR DERMATOL, V29, P442, DOI 10.1111/j.1525-1470.2011.01698.x; Mazigo HD, 2012, T ROY SOC TROP MED H, V106, P259, DOI 10.1016/j.trstmh.2011.12.001; Mitja O, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005136; Monsel G, 2016, ROOKS TXB DERMATOLOG, V1, P349; Mwangi JN, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003517; Mwangi JN, 2015, TROPICAL DIS TRAVEL, V1; R Core Team, 2013, R LANG ENV STAT COMP; Salek MS, 2013, BRIT J DERMATOL, V169, P734, DOI 10.1111/bjd.12437; Tomczyk S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003285; Ugbomoiko US, 2016, TROP DOCT; Wafula ST, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.77.8916; Watanabe E, 2014, J EPIDEMIOL GLOB HEA, V4, P323, DOI 10.1016/j.jegh.2014.06.001; WHITTLE HC, 1973, T ROY SOC TROP MED H, V67, P349, DOI 10.1016/0035-9203(73)90112-0; WILLIS I, 1973, J INVEST DERMATOL, V60, P166, DOI 10.1111/1523-1747.ep12682082	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2017	11	8							e0005808	10.1371/journal.pntd.0005808				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FH3SD	WOS:000411068800027	28771469	DOAJ Gold, Green Published			2019-04-02	
J	Awungafac, G; Delvaux, T; Vuylsteke, B				Awungafac, George; Delvaux, Therese; Vuylsteke, Bea			Systematic review of sex work interventions in sub-Saharan Africa: examining combination prevention approaches	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						sex work; sub-Saharan Africa; human immunodeficiency virus prevention; multicomponent Interventions; review	SEXUALLY-TRANSMITTED INFECTIONS; FAMILY-PLANNING-SERVICES; HIV PREVENTION; ALCOHOL-USE; CONDOM USE; STRUCTURAL INTERVENTION; HUMAN-PAPILLOMAVIRUS; CONTROLLED-TRIAL; HEALTH-SERVICES; RISK BEHAVIOR	OBJECTIVE The incidence of HIV and sexually transmitted infections is disproportionately high among sex workers (SW). We aimed to update the evidence on the effectiveness of SW interventions in sub-Saharan Africa and to provide more insights into combination prevention. METHODS The Systematic review followed PRISMA guidelines in a search of PUBMED and POPLINE for peer-reviewed literature published between 1 January 2000 and 22 July 2016 (registration number on PROSPERO: CRD42016042529). We considered cohort interventions, randomised controlled trials and cross-sectional surveys of SW programmes. A framework was used in the description and mapping of intervention to desired outcomes. RESULTS Twenty-six papers(reporting on 25 studies) were included. A strategy that empowered peer educator leaders to steer community activities showed a twofold increase in coverage of behaviour change communication and utilisation of health facility among SW. Brief alcohol harm reduction effort demonstrated a significant effect on sexual violence and engagement in sex trading. A risk reduction counselling intervention among drug-injecting SW showed an effect on alcohol, substance use and engagement in sex work. No study on a promising intervention like PrEP among SWs was found. We observed that interventions that combined some structural components, biomedical and behavioural strategies tend to accumulate more desired outcomes. CONCLUSION The evidence base that can be considered in intervention designs to prevent HIV in SW in SSA is vast. The health sector should consider interventions to reduce binge alcohol intake and intravenous drug use among sex workers. Programmes should staunchly consider multicomponent approaches that explore community-based structural approaches.	[Awungafac, George] African Soc Lab Med, Kebele 08, Addis Ababa, Ethiopia; [Awungafac, George] Minist Hlth, Yaounde, Cameroon; [Delvaux, Therese; Vuylsteke, Bea] Inst Trop Med, Antwerp, Belgium	Awungafac, G (reprint author), African Soc Lab Med, Kebele 08, Addis Ababa, Ethiopia.	awungafacg@yahoo.com			Belgian Development Cooperation Master in Public Health Scholarship	We thank the Flemish Government of the Kingdom of Belgium for providing the opportunities that enabled us to conduct this study, including access to the Library services of the Institute of Tropical Medicine. We thank the Librarians at ITM who assisted us in obtaining some articles during the manual search. The study was funded through a Belgian Development Cooperation Master in Public Health Scholarship of the first author.	Aho J, 2012, HIV MED, V13, P156, DOI 10.1111/j.1468-1293.2011.00951.x; Alary M, 2002, AIDS, V16, P463, DOI 10.1097/00002030-200202150-00019; Angelica M.D., 2008, ARTERIOSCL THROM VAS, V141, P520; Babor TF, 2001, BRIEF INTERVENTION H, P53; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Behanzin L, 2013, JAIDS-J ACQ IMM DEF, V63, P126, DOI 10.1097/QAI.0b013e318286b9d4; Bekker LG, 2015, LANCET, V385, P72, DOI 10.1016/S0140-6736(14)60974-0; Bengtson AM, 2014, AIDS CARE, V26, P1619, DOI 10.1080/09540121.2014.938013; Carney T, 2016, J PSYCHOACTIVE DRUGS, V48, P303, DOI 10.1080/02791072.2016.1208855; Chaney BH, 2016, ADDICT BEHAV, V60, P32, DOI 10.1016/j.addbeh.2016.03.035; Chersich MF, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-22; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Chow EPF, 2015, AIDS PATIENT CARE ST, V29, P454, DOI 10.1089/apc.2015.0043; Cornish F, 2006, J COMMUNITY APPL SOC, V16, P301, DOI 10.1002/casp.866; Cowan FM, 2008, SEX TRANSM INFECT, V84, P548, DOI 10.1136/sti.2008.031153; Dalhlgren G, 1991, POLICIES STRATEGIES; Dave B., 2003, TRAINING GUIDE HIV P; De Coninck Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115453; Dhana A, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-46; Dugas M, 2015, JAIDS-J ACQ IMM DEF, V68, pS198, DOI 10.1097/QAI.0000000000000463; Erausquin JT, 2012, J EPIDEMIOL COMMUN H, V66, pII49, DOI 10.1136/jech-2011-200511; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Gaikwad SS, 2012, J EPIDEMIOL COMMUN H, V66, pII69, DOI 10.1136/jech-2011-200514; Ghys PD, 2002, AIDS, V16, P251, DOI 10.1097/00002030-200201250-00015; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Grossman D, 2013, AIDS, V27, pS77, DOI 10.1097/QAD.0000000000000035; Gurnani V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-755; Izulla P, 2013, JAIDS-J ACQ IMM DEF, V62, P220, DOI 10.1097/QAI.0b013e318278ba1b; Jean K, 2014, J INFECT DIS, V209, P431, DOI 10.1093/infdis/jit470; Johnson LF, 2008, SEX TRANSM DIS, V35, P946, DOI 10.1097/OLQ.0b013e3181812d15; Johnson PS, 2016, ALCOHOL CLIN EXP RES, V40, P1339, DOI 10.1111/acer.13079; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, THE GAP REP; Jonas K, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0170-8; Kang DM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-717; Kaul R, 2004, JAMA-J AM MED ASSOC, V291, P2555, DOI 10.1001/jama.291.21.2555; Kimani J, 2008, AIDS, V22, P131, DOI 10.1097/QAD.0b013e3282f27035; Kurth Ann E, 2011, Curr HIV/AIDS Rep, V8, P62, DOI 10.1007/s11904-010-0063-3; L'Engle KL, 2014, JAIDS-J ACQ IMM DEF, V67, P446, DOI 10.1097/QAI.0000000000000335; Labbe AC, 2012, SEX TRANSM DIS, V39, P253, DOI 10.1097/OLQ.0b013e318244aaa0; Lam JUH, 2014, J MED SCREEN, V21, P38, DOI 10.1177/0969141314522454; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Low A, 2015, JAIDS-J ACQ IMM DEF, V68, pS180, DOI 10.1097/QAI.0000000000000441; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Malaju Marelign Tilahun, 2013, BMC Res Notes, V6, P96, DOI 10.1186/1756-0500-6-96; Marais D, 2006, VIRUS RES, V121, P220, DOI 10.1016/j.virusres.2006.04.009; Masese L, 2013, SEX TRANSM INFECT, V89, P217, DOI 10.1136/sextrans-2012-050564; Mbonye M, 2014, AJAR-AFR J AIDS RES, V13, P145, DOI 10.2989/16085906.2014.927779; McClelland RS, 2008, J INFECT DIS, V197, P1361, DOI 10.1086/587490; Metrik J, 2016, J STUD ALCOHOL DRUGS, V77, P104, DOI 10.15288/jsad.2016.77.104; Moore L, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-47; Morris CN, 2006, SEX TRANSM INFECT, V82, P368, DOI 10.1136/sti.2006.020933; Mulongo S, 2015, JAIDS-J ACQ IMM DEF, V68, pS248, DOI 10.1097/QAI.0000000000000449; Ngugi EN, 2007, JAIDS-J ACQ IMM DEF, V45, P588, DOI 10.1097/QAI.0b013e3180f616db; Odek WO, 2009, AIDS BEHAV, V13, P449, DOI 10.1007/s10461-008-9485-y; Parcesepe AM, 2016, DRUG ALCOHOL DEPEN, V161, P21, DOI 10.1016/j.drugalcdep.2015.12.037; Parimi P, 2012, J EPIDEMIOL COMMUN H, V66, pII62, DOI 10.1136/jech-2011-200832; Reza-Paul S, 2012, INDIAN J MED RES, V135, P98, DOI 10.4103/0971-5916.93431; Semahegn A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0072-1; Semini I, 2015, AIDS CARE, V2013, pS30; Shahmanesh M, 2008, TROP MED INT HEALTH, V13, P659, DOI 10.1111/j.1365-3156.2008.02040.x; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Steen R, 2000, SEX TRANSM DIS, V27, P1, DOI 10.1097/00007435-200001000-00001; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Thomsen SC, 2006, SEX TRANSM INFECT, V82, P397, DOI 10.1136/sti.2006.019992; Thyda L, 2015, JAIDS-J ACQ IMM DEF, V69, pE120, DOI 10.1097/QAI.0000000000000635; Traore IT, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20088; UNAIDS (Joint United Nations Programme on HIV/AIDS), 2010, COMB HIV PREV TAIL C; Vandepitte J, 2006, SEX TRANSM INFECT, V82, pIII18, DOI 10.1136/sti.2006.020081; Vuylsteke B, 2015, JAIDS-J ACQ IMM DEF, V68, pS99, DOI 10.1097/QAI.0000000000000442; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; Webel AR, 2010, AM J PUBLIC HEALTH, V100, P247, DOI 10.2105/AJPH.2008.149419; Wechsberg WM, 2006, AIDS BEHAV, V10, P131, DOI 10.1007/s10461-005-9036-8; Yadav G, 2005, JAIDS-J ACQ IMM DEF, V38, P329	74	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2017	22	8					971	993		10.1111/tmi.12890				23	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FC3YJ	WOS:000406775200005	28449198	Bronze			2019-04-02	
J	Kansal, S; Chakravarty, J; Kumar, A; Malaviya, P; Boelaert, M; Hasker, E; Ostyn, B; Sundar, S				Kansal, S.; Chakravarty, J.; Kumar, A.; Malaviya, P.; Boelaert, M.; Hasker, E.; Ostyn, B.; Sundar, S.			Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						visceral leishmaniasis; defaulter; primary health centre; India	KALA-AZAR	OBJECTIVE To assess the rate of default from treatment in the visceral leishmaniasis (VL) elimination programme and to identify risk factors and its underlying causes. METHODS Case-control study conducted between December 2009 and June 2012 in three primary health centres (PHCs) of Muzaffarpur district, India. Patients who defaulted from treatment from the PHCs were considered as 'cases' and those who completed their treatment as 'controls'. Two controls were included in the study for each case. Respondents' opinion and satisfaction with the services provided at the PHCs were also elicited. Logistic regression was performed to assess the contribution of sociodemographic variables on patient status, and a discriminant analysis was used (after decomposing the original data) to identify factors that can predict the patient status as defaulter or not, based on factor scores of the components as predictor variables. RESULTS During the study period, 16.3% (89/544) of patients defaulted; 87 cases and 188 controls were interviewed through a semistructured questionnaire. Women tended to be more at risk for default (OR, 1.6, 95% CI (0.9 -2.9). Treatment received was miltefosine in 55.6% and sodium stibogluconate (SSG) in 44.4%. Most (86%) defaulters completed their treatment at other healthcare facilities; 70% of them preferred non-governmental institutions. Most cited reasons for default were seeking a second opinion for VL treatment and preferring to be treated in specialised VL centres. Discriminant analysis showed only one significant predictor: dissatisfaction with the medical care received in PHCs. CONCLUSION Efforts are needed to enhance the quality of VL care at PHC level, which will be beneficial in increasing treatment completion rates.	[Kansal, S.; Chakravarty, J.; Kumar, A.; Malaviya, P.; Sundar, S.] Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India; [Boelaert, M.; Hasker, E.; Ostyn, B.] Inst Trop Med, Antwerp, Belgium	Sundar, S (reprint author), Banaras Hindu Univ, Inst Med Sci, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	Malaviya, Paritosh/B-1819-2012	Malaviya, Paritosh/0000-0002-7558-152X; Boelaert, Marleen/0000-0001-8051-6776	European Commission; DMID (Tropical Medicine Research Center Grant) [P50AI074321]	We gratefully acknowledge the European Commission for funding Kala Drug-R, the National Institute of Allergy and Infectious disease and DMID (Tropical Medicine Research Center Grant number P50AI074321).	Abdi H, 2010, COMPUTATIONAL STAT; Agarwal SP, 2017, TUBERCULOSIS CONTROL; [Anonymous], 2010, CONTROL LEISHMANIASE; Banjara MR, 2012, J TROP MED, DOI 10.1155/2012/126093; CERNY BA, 1977, MULTIVAR BEHAV RES, V12, P43, DOI 10.1207/s15327906mbr1201_3; Directorate of National Vector Borne Disease Control Programme (NVBDCP), 2014, DIR GEN HLTH SERV MI; Marshall GN, 1994, RAND CORPORATION; McLachlan G, 2004, DISCRIMINANT ANAL ST; Miller CM, 2010, TROP MED INT HEALTH, V15, P48, DOI 10.1111/j.1365-3156.2010.02514.x; Ostyn B, 2013, TROP MED INT HEALTH, V18, P725, DOI 10.1111/tmi.12092; Park CK, 2016, J KOREAN MED SCI, V31, P254, DOI 10.3346/jkms.2016.31.2.254; PefuraYone EW, 2011, BMJ OPEN, V1; Prasad S, 2013, ANN TROP MED PUBLIC, V6, P472, DOI 10.4103/1755-6783.127804; Singh SP, 2006, AM J TROP MED HYG, V75, P505, DOI 10.4269/ajtmh.2006.75.505; Snedecor G, 1989, STAT METHODS; Stevens J, 2002, APPL MULTIVARIATE ST; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2008, TROP MED INT HEALTH, V13, P2, DOI 10.1111/j.1365-3156.2007.01974.x; Yamey G, 2001, BRIT MED J, V322, P257	20	0	0	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2017	22	8					1037	1042		10.1111/tmi.12906				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FC3YJ	WOS:000406775200011	28594453	Bronze			2019-04-02	
J	Zein-Eddine, R; Djuikwo-Teukeng, FF; Dar, Y; Dreyfuss, G; Van den Broeck, F				Zein-Eddine, Rima; Djuikwo-Teukeng, Felicite F.; Dar, Yasser; Dreyfuss, Gilles; Van den Broeck, Frederik			Population genetics of the Schistosoma snail host Bulinus truncatus in Egypt	ACTA TROPICA			English	Article						Haplotype network; cox1; Microsatellites; F-statistics; Nile Delta; Upper Egypt; Baker's law	FRESH-WATER SNAIL; BIOMPHALARIA-PFEIFFERI; FORSKALII GASTROPODA; INTERMEDIATE HOST; MATING SYSTEM; LYMNAEA-TRUNCATULA; TEMPORAL VARIATION; SELFING RATE; PULMONATA; PLANORBIDAE	The tropical freshwater snail Bulinus truncatus serves as an important intermediate host of several human and cattle Schistosoma species in many African regions. Despite some ecological and malacological studies, there is no information on the genetic diversity of B. truncatus in Egypt. Here, we sampled 70-100 snails in ten localities in Upper Egypt and the Nile Delta. Per locality, we sequenced 10 snails at a partial fragment of the cytochrome c oxidase subunit 1 gene (coxl) and we genotyped 25-30 snails at six microsatellite markers. A total of nine mitochondrial haplotypes were detected, of which five were unique to the Nile Delta and three were unique to Upper Egypt, indicating that snail populations may have evolved independently in both regions. Bayesian clustering and hierarchical F-statistics using microsatellite markers further revealed strong population genetic structure at the level of locality. Observed heterozygosity was much lower compared to what is expected under random mating, which could be explained by high selfing rates, population size reductions and to a lesser extent by the Wahiund effect. Despite these observations, we found signatures of gene flow and cross-fertilization, even between snails from the Nile Delta and Upper Egypt, indicating that B. truncatus can travel across large distances in Egypt. These observations could have serious consequences for disease epidemiology, as it means that infected snails from one region could rapidly and unexpectedly spark a new epidemic in another distant region. This could be one of the factors explaining the rebound of human Schistosoma infections in the Nile Delta, despite decades of sustained schistosomiasis control.	[Zein-Eddine, Rima; Dreyfuss, Gilles] INSERM, UMR 1094, Inst Neuroepidemiol & Trop Parasitol, Fac Med, 2 Docteur Raymond Marcland St, F-87025 Limoges, France; [Zein-Eddine, Rima; Dreyfuss, Gilles] INSERM, UMR 1094, Inst Neuroepidemiol & Trop Parasitol, Fac Pharm, 2 Docteur Raymond Marcland St, F-87025 Limoges, France; [Djuikwo-Teukeng, Felicite F.] Univ Montagnes, Fac Hlth Sci, PB 208, Bangangte, Cameroon; [Dar, Yasser] Fac Sci, Dept Zool, Tanta, Egypt; [Van den Broeck, Frederik] Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium	Zein-Eddine, R (reprint author), INSERM, UMR 1094, Inst Neuroepidemiol & Trop Parasitol, Fac Med, 2 Docteur Raymond Marcland St, F-87025 Limoges, France.; Zein-Eddine, R (reprint author), INSERM, UMR 1094, Inst Neuroepidemiol & Trop Parasitol, Fac Pharm, 2 Docteur Raymond Marcland St, F-87025 Limoges, France.; Van den Broeck, F (reprint author), Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium.	rima_zn@hotmail.com; ffnouboue@yahoo.fr; yasser.dar@science.tanta.edu.eg; gilles.dreyfuss@unilim.fr; fvandenbroeck@gmail.com	Van den Broeck, Frederik/T-6182-2017	Van den Broeck, Frederik/0000-0003-2542-5585	Institute of Neuroepidemiology and Tropical Parasitology of Limoges [UMR-S 1094 INSERM]	This work was funded by the Institute of Neuroepidemiology and Tropical Parasitology of Limoges (UMR-S 1094 INSERM).	Abd El-Wakeil Khaleid F., 2013, Egyptian Journal of Aquatic Research, V39, P193; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], R LANG ENV STAT COMP, V1, P409; Arnon I., 1992, AGR DRY LANDS PRINCI; BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barakat RMR, 2013, J ADV RES, V4, P425, DOI 10.1016/j.jare.2012.07.003; Brown D. S., 1994, FRESHWATER SNAILS AF; Charbonnel N, 2005, OIKOS, V108, P283, DOI 10.1111/j.0030-1299.2005.13537.x; Charbonnel N, 2002, MOL ECOL, V11, P2213, DOI 10.1046/j.1365-294X.2002.01586.x; Charbonnel N., 2000, MOL ECOL, V35, P249; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Chlyeh G, 2003, PARASITOLOGY, V127, P243, DOI 10.1017/S0031182003003603; David P, 2007, MOL ECOL, V16, P2474, DOI 10.1111/j.1365-294X.2007.03330.x; DAZO BC, 1966, B WORLD HEALTH ORGAN, V35, P339; Diab M.R.M., 1993, BIOL STUDIES TREMATO; Djuikwo-Teukeng FF, 2011, INFECT GENET EVOL, V11, P17, DOI 10.1016/j.meegid.2010.10.018; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; El-Kady Gamal A., 2000, Egyptian Journal of Biology, V2, P42; Ellstrand NC, 2006, EUPHYTICA, V148, P35, DOI 10.1007/s10681-006-5939-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Goodall-Copestake WP, 2012, HEREDITY, V109, P50, DOI 10.1038/hdy.2012.12; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8278.2004.00828.x; Gow JL, 2005, J MOLLUS STUD, V71, P175, DOI 10.1093/mollus/eyi020; Gow JL, 2004, MOL ECOL, V13, P3561, DOI 10.1111/j.1365-294X.2004.02339.x; Gow JL, 2001, MOL ECOL NOTES, V1, P237, DOI 10.1046/j.1471-8278 .2001.00088.x; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hussein Mohamed A., 2011, Egyptian Academic Journal of Biological Sciences B Zoology, V3, P11; Jame P, 1995, GENET RES, V65, P193; Jame P., 1993, ANNU REV ECOL SYST, V24, P441; JARNE P, 1994, MOL ECOL, V3, P527, DOI 10.1111/j.1365-294X.1994.tb00132.x; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Keller SR, 2010, J EVOLUTION BIOL, V23, P1720, DOI 10.1111/j.1420-9101.2010.02037.x; KRISTENSEN TK, 1989, J MOLLUS STUD, V55, P103, DOI 10.1093/mollus/55.1.103; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lotfy Wael M., 2015, Folia Malacologica, V23, P18, DOI 10.12657/folmal.023.004; Mavarez J, 2002, HEREDITY, V89, P258, DOI 10.1038/sj.hdy.6800127; Meunier C, 2004, MOL ECOL, V13, P2535, DOI 10.1111/j.1365-294X.2004.02242.x; Meunier C, 2001, MOL ECOL, V10, P1333, DOI 10.1046/j.1365-294X.2001.01284.x; Mukaratirwa S, 1996, J HERED, V87, P288, DOI 10.1093/oxfordjournals.jhered.a023002; Nei M, 1987, MOL EVOLUTIONARY GEN; Oksanen J, 2013, PACKAGE VEGAN R PACK, V2, P1, DOI DOI 10.4135/9781412971874.N145; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Pannell JR, 2015, NEW PHYTOL, V208, P656, DOI 10.1111/nph.13539; Pfenninger M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-135; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pritchard JK, 2000, GENETICS, V155, P945; Rollinson D., 1987, BIOL SCHISTOSOMES GE; Rosenthal DM, 2008, MOL ECOL, V17, P4657, DOI 10.1111/j.1365-294X.2008.03844.x; Scott J., 1937, AM J HYG, V335, P724; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Trouve S, 2003, EVOLUTION, V57, P2303; Van den Broeck F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003998; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Viard F, 1996, GENETICS, V142, P1237; Viard F, 1997, GENETICS, V146, P973; Webster JP, 2001, ANN TROP MED PARASIT, V95, P203, DOI 10.1080/00034980120041062; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	60	2	2	2	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	AUG	2017	172						36	43		10.1016/j.actatropica.2017.04.002				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EY0GC	WOS:000403635200006	28408098				2019-04-02	
J	Samadoulougou, S; Pearcy, M; Ye, Y; Kirakoya-Samadoulougou, F				Samadoulougou, Sekou; Pearcy, Morgan; Ye, Yazoume; Kirakoya-Samadoulougou, Fati			Progress in coverage of bed net ownership and use in Burkina Faso 2003-2014: evidence from population-based surveys	MALARIA JOURNAL			English	Article						Bed net; LLIN ownership gap; LLIN use gap; LLIN access gap; Behavioural failure; Malaria	INSECTICIDE-TREATED NETS; CHILD HEALTH CAMPAIGN; PREVENTING MALARIA MORTALITY; PROTECTIVE EFFICACY; COST-EFFECTIVENESS; ENDEMIC AREAS; MOSQUITO NETS; TARGET GROUPS; INTERVENTIONS; BEDNETS	Background: Use of insecticide-treated bed nets (ITNs) is the cornerstone of malaria prevention. In 2010 and 2013, the Burkina Faso Government launched mass distribution campaigns of ITNs to increase coverage of ownership and use in the country. This study assessed the progress towards universal bed net coverage in Burkina Faso. Methods: The authors used data from the Burkina Faso 2003 and 2010 Demographic and Health Surveys (DHS), the 2006 Multiple Indicator Cluster Surveys (MICS) and the 2014 Malaria Indicator Survey (MIS). For each survey, the authors computed key malaria prevention indicators in line with recommendations from the Survey and Indicator Task Force of the Roll Back Malaria Monitoring and Evaluation Reference Group. The trends over a decade was assessed by calculating percentage point change between 2003 and 2014. Results: At national level, the proportion of households owning at least one ITN increased substantially from 5.6, 95% CI (4.7, 6.5%) in 2003 to 89.9% (88.5, 91.2%) in 2014, with low heterogeneity between regions. The proportion of households owning at least one ITN per two people increased significantly from 1.8% (1.4, 2.3%) in 2003 to 49.2% (47.3, 51.0%) in 2014. ITN use in the general population increased from 2.0% (1.6, 2.3%) in 2003, to 67.0% (65.3, 68.7%) in 2014. A similar trend was observed among children under the age of five years, increasing from 1.9% (1.5, 2.4%) in 2003 to 75.2% (73.2, 77.3%) in 2014, and among pregnant women, increasing from 3.0% (1.9, 4.2%) in 2003 to 77.1% (72.9, 81.3%) in 2014. The intra-household ownership gap was 67.0% (61.5, 72.4%) in 2003, but decreased significantly to 45.3% (43.6, 47.1%) in 2014. The behavioural gap, which was relatively low in 2013 with only 20.0% of people who had access to an ITN but were not using it, further decreased to 5.9% in 2014. Conclusion: Burkina Faso made considerable progress in coverage of ITN ownership, access and use between 2003 and 2014, as a result of the two free mass distribution campaigns in 2010 and 2013. However, ITN coverage remains below the national targets of 100% for ownership and 80% for use. The results of 90% of ownership and 67% of use confirm that free mass distribution campaigns of ITNs are effective; however, there is room for improvement to reach and maintain optimal coverage of ITN ownership and use.	[Samadoulougou, Sekou] UCL, IREC, B-1200 Brussels, Belgium; [Pearcy, Morgan] Univ Libre Bruxelles, Spatial Epidemiol Lab SpELL, Brussels, Belgium; [Ye, Yazoume] ICF, 530 Gaither Rd,Suite 500, Rockville, MD USA; [Kirakoya-Samadoulougou, Fati] Univ Libre Bruxelles, Plate Forme Biostatist, Brussels, Belgium	Samadoulougou, S (reprint author), UCL, IREC, B-1200 Brussels, Belgium.	sekou.samadoulougou@uclouvain.be					[Anonymous], 2013, MEAS EV HOUS SURV IN; Baume CA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-264; Birhanu Z, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2677-2; Eisele TP, 2010, INT J EPIDEMIOL, V39, P88, DOI 10.1093/ije/dyq026; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; Guyatt HL, 2002, TROP MED INT HEALTH, V7, P409, DOI 10.1046/j.1365-3156.2002.00879.x; Hanson K, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2434; Institut National de la Statistique et de la Demographie/ Burkina Faso, 2004, BRUK FAS ENQ DEM SAN; Institut National de la Statistique et de la Demographie/ Burkina Faso Programme National de Lutte contre le Paludisme/ Burkina Faso, 2015, ICF INT ENQ IND PAL; Institut National de la Statistique et de la Demographie (INSD) and ICF International, 2012, BURK FAS ENQ DEM SAN; Kilian A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-314; Kulkarni MA, 2010, AM J TROP MED HYG, V82, P420, DOI 10.4269/ajtmh.2010.09-0597; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Lugada E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012435; Marchant T, 2010, CAN MED ASSOC J, V182, P152, DOI 10.1503/cmaj.090268; Mueller DH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-73; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Paludisme Burkina Faso-PNLP, 2007, PLAN STRAT LUTT CONT; Skarbinski J, 2007, AM J TROP MED HYG, V76, P1100, DOI 10.4269/ajtmh.2007.76.1100; Steketee RW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-299; Taylor C, 2015, DHS ANAL STUDIES, V52; Terlouw DJ, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-199; Thwing J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S14; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021; White MT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-337; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2011, GUID MON DUR LONG LA	29	3	3	0	0	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JUL 28	2017	16								302	10.1186/s12936-017-1946-1				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FC2LR	WOS:000406669700001	28754113	DOAJ Gold, Green Published			2019-04-02	
J	Laranjo-Gonzalez, M; Devleesschauwer, B; Trevisan, C; Allepuz, A; Sotiraki, S; Abraham, A; Afonso, MB; Blocher, J; Cardoso, L; da Costa, JMC; Dorny, P; Gabriel, S; Gomes, J; Gomez-Morales, MA; Jokelainen, P; Kaminski, M; Krt, B; Magnussen, P; Robertson, LJ; Schmidt, V; Schmutzhard, E; Smit, GSA; Soba, B; Stensvold, CR; Staric, J; Troell, K; Rataj, AV; Vieira-Pinto, M; Vilhena, M; Wardrop, NA; Winkler, AS; Dermauw, V				Laranjo-Gonzalez, Minerva; Devleesschauwer, Brecht; Trevisan, Chiara; Allepuz, Alberto; Sotiraki, Smaragda; Abraham, Annette; Afonso, Mariana Boaventura; Blocher, Joachim; Cardoso, Luis; Correia da Costa, Jose Manuel; Dorny, Pierre; Gabriel, Sarah; Gomes, Jacinto; Gomez-Morales, Maria Angeles; Jokelainen, Pikka; Kaminski, Miriam; Krt, Brane; Magnussen, Pascal; Robertson, Lucy J.; Schmidt, Veronika; Schmutzhard, Erich; Smit, G. Suzanne A.; Soba, Barbara; Stensvold, Christen Rune; Staric, Joze; Troell, Karin; Rataj, Aleksandra Vergles; Vieira-Pinto, Madalena; Vilhena, Manuela; Wardrop, Nicola Ann; Winkler, Andrea S.; Dermauw, Veronique			Epidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe	PARASITES & VECTORS			English	Review						Taenia solium; Taenia saginata; Taeniasis; Neurocysticercosis; Porcine cysticercosis; Bovine cysticercosis	TAENIA-SAGINATA CYSTICERCOSIS; BOVINE CYSTICERCOSIS; MEAT INSPECTION; NEUROCYSTICERCOSIS; INFECTION; DISEASE; FIGATELLU; IMPACT; CATTLE	Background: Taenia solium and Taenia saginata are zoonotic parasites of public health importance. Data on their occurrence in humans and animals in western Europe are incomplete and fragmented. In this study, we aimed to update the current knowledge on the epidemiology of these parasites in this region. Methods: We conducted a systematic review of scientific and grey literature published from 1990 to 2015 on the epidemiology of T. saginata and T. solium in humans and animals. Additionally, data about disease occurrence were actively sought by contacting local experts in the different countries. Results: Taeniosis cases were found in twelve out of eighteen countries in western Europe. No cases were identified in Iceland, Ireland, Luxembourg, Norway, Sweden and Switzerland. For Denmark, Netherlands, Portugal, Slovenia, Spain and the UK, annual taeniosis cases were reported and the number of detected cases per year ranged between 1 and 114. Detected prevalences ranged from 0.05 to 0.27%, whereas estimated prevalences ranged from 0.02 to 0.67%. Most taeniosis cases were reported as Taenia spp. or T. saginata, although T. solium was reported in Denmark, France, Italy, Spain, Slovenia, Portugal and the UK. Human cysticercosis cases were reported in all western European countries except for Iceland, with the highest number originating from Portugal and Spain. Most human cysticercosis cases were suspected to have acquired the infection outside western Europe. Cases of T. solium in pigs were found in Austria and Portugal, but only the two cases from Portugal were confirmed with molecular methods. Germany, Spain and Slovenia reported porcine cysticercosis, but made no Taenia species distinction. Bovine cysticercosis was detected in all countries except for Iceland, with a prevalence based on meat inspection of 0.0002-7.82%. Conclusions: Detection and reporting of taeniosis in western Europe should be improved. The existence of T. solium tapeworm carriers, of suspected autochthonous cases of human cysticercosis and the lack of confirmation of porcine cysticercosis cases deserve further attention. Suspected cases of T. solium in pigs should be confirmed by molecular methods. Both taeniosis and human cysticercosis should be notifiable and surveillance in animals should be improved.	[Laranjo-Gonzalez, Minerva; Allepuz, Alberto] UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona 08193, Spain; [Devleesschauwer, Brecht] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Trevisan, Chiara] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet & Anim Sci, Frederiksberg C, Denmark; [Allepuz, Alberto] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain; HAO DEMETER, Vet Res Inst, Campus Thermi, Thessaloniki 57001, Greece; [Abraham, Annette; Schmidt, Veronika; Winkler, Andrea S.] Tech Univ Munich, Ctr Global Hlth, Dept Neurol, Ismaninger Str 22, D-81675 Munich, Germany; [Abraham, Annette; Schmidt, Veronika; Winkler, Andrea S.] Univ Oslo, Ctr Global Hlth, Dept Community Med & Global Hlth, Inst Hlth & Soc, Kirkeveien 166, N-0450 Oslo, Norway; [Afonso, Mariana Boaventura] Secretaria Reg Agr & Pescas, Div Protecao Vet & Pecuaria, Direcao Serv Alimentacao & Vet, Direcao Reg Agr, Ave Arriaga,21 Edificio Golden,3 Andar, P-9000690 Funchal, Portugal; [Blocher, Joachim] Acad Teaching Hosp Feldkirch, Inst Acute Neurol & Stroke, Feldkirch, Austria; [Cardoso, Luis; Vieira-Pinto, Madalena] Univ Tras Os Montes & Alto Douro, Dept Vet Sci, Sch Agr & Vet Sci, P-5000801 Vila Real, Portugal; [Correia da Costa, Jose Manuel] Natl Inst Hlth Dr Ricardo Jorge, Ctr Parasite Biol & Immunol, Rua Alexandre Herculano 321, P-4000055 Oporto, Portugal; [Correia da Costa, Jose Manuel] Univ Porto, Ctr Study Anim Sci CECA, Inst Agr & Agroalimentary Sci & Technol ICETA, Oporto, Portugal; [Dorny, Pierre; Smit, G. Suzanne A.] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Ghent, Belgium; [Dorny, Pierre; Smit, G. Suzanne A.; Dermauw, Veronique] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gabriel, Sarah] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Ghent, Belgium; [Gomes, Jacinto] Natl Inst Agr & Vet Res, Oeiras, Portugal; [Gomez-Morales, Maria Angeles] Ist Super Sanita, European Union Reference Lab Parasites, I-00161 Rome, Italy; [Jokelainen, Pikka] Univ Helsinki, Fac Vet Med, POB 66, FIN-00014 Helsinki, Finland; [Jokelainen, Pikka; Stensvold, Christen Rune] Statens Serum Inst, Lab Parasitol, Dept Bacteria Fungi & Parasites, Infect Dis Preparedness, Artillerivej 5, DK-2300 Copenhagen S, Denmark; [Jokelainen, Pikka] Estonian Univ Life Sci, Dept Basic Vet Sci & Populat Med, Inst Vet Med & Anim Sci, Kreutzwaldi 62, EE-51014 Tartu, Estonia; [Kaminski, Miriam] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Ismaninger Str 22, D-81675 Munich, Germany; [Krt, Brane; Rataj, Aleksandra Vergles] Univ Ljubljana, Inst Microbiol & Parasitol, Fac Vet, Gerbiceva 60, Ljubljana 1000, Slovenia; [Magnussen, Pascal] Univ Copenhagen, Ctr Med Parasitol, Dept Immunol & Microbiol, Copenhagen, Denmark; [Magnussen, Pascal] Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol & Aquat Dis, Dept Vet & Anim Sci, Copenhagen, Denmark; [Robertson, Lucy J.] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, Fac Vet Med, Adamstuen Campus, N-0033 Oslo, Norway; [Schmutzhard, Erich] NICU Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria; [Smit, G. Suzanne A.] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium; [Soba, Barbara] Univ Ljubljana, Inst Microbiol & Immunol, Fac Med, Ljubljana, Slovenia; [Staric, Joze] Univ Ljubljana, Fac Vet, Clin Reprod & Large Anim, Sect Ruminants, Ljubljana, Slovenia; [Troell, Karin] Natl Vet Inst, SE-75189 Uppsala, Sweden; [Vieira-Pinto, Madalena] UTAD, CECAV Anim & Vet Res Ctr, P-5000801 Quinta De Prados, Vila Real, Portugal; [Vilhena, Manuela] Univ Evora, ICAAM, Evora, Portugal; [Wardrop, Nicola Ann] Univ Southampton, Geog & Environm, Highfield Campus, Southampton SO17 1BJ, England	Laranjo-Gonzalez, M (reprint author), UAB, Ctr Recerca Sanitat Anim CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona 08193, Spain.	minervalaranjo@gmail.com	Devleesschauwer, Brecht/G-9895-2018; Cardoso, Luis/J-8310-2013	Devleesschauwer, Brecht/0000-0002-2867-6892; Cardoso, Luis/0000-0002-6145-7560; Vieira-Pinto, Madalena/0000-0002-8588-7071; Dermauw, Veronique/0000-0001-8745-5304; Trevisan, Chiara/0000-0002-4920-6750; Jokelainen, Pikka/0000-0002-3035-5094; Freire, Lina/0000-0003-2089-9191	Medical Research Council [MR/J012343/1]		Administration of the Republic of Slovenia for Food Safety Veterinary Sector and Plant Protection (UVHVVR), 2014, LETN POR ZOON POVZR; [Anonymous], 2004, OFFICIAL J EUROPEA L, VL139, P206; Antunes GJ., 2014, THESIS; BARBIER D, 1990, APPL ENVIRON MICROB, V56, P1420; Blagojevic B, 2017, FOOD CONTROL, V78, P64, DOI 10.1016/j.foodcont.2017.02.052; Bundeskanzleramt, 1998, VET 1998; Bundesministerium fur Gesundheit (BMG) and Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit GmbH (AGES), 2014, BER UB ZOON IHR ERR; Bundesministerium fur Gesundheit (BMG) and Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit GmbH (AGES), 2010, BER UB ZOON IHR ERR; Bundesministerium fur Gesundheit (BMG) and Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit GmbH (AGES), 2012, BER UB ZOON IHR ERR; Bundesministerium fur Gesundheit (BMG) and Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit GmbH (AGES), 2013, BER UB ZOON IHR ERR; Bundesministerium fur Gesundheit (BMG) and Osterreichische Agentur fur Gesundheit und Ernahrungssicherheit GmbH (AGES), 2011, BER UB ZOON IHR ERR; Bundesministerium fur Gesundheit und Frauen, 2002, VET 2002; Bundesministerium fur soziale Sicherheit und Generationen, 2000, VET 2000; Bundesministerium fur soziale Sicherheit und Generationen, 2001, VET 2001; Bundesministerium fur soziale Sicherheit und Generationen. Veterinarjahresbericht, 1999, VET 1999; Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152; cited in Food Safety Authority of Ireland (FSAI), 2008, MUN IND ORG MAT AGR; Del Brutto OH, 2012, ACTA NEUROL BELG, V112, P335, DOI 10.1007/s13760-012-0068-3; della Salute Ministero, 2011, DIPARTIMENTO QUALITA; Department for Environment Food and Rural Affairs (DEFRA), 2003, ZOON REP UK 2001; Devleesschauwer B, 2017, ACTA TROP, V165, P96, DOI 10.1016/j.actatropica.2015.08.006; Dorny P, 2007, VET PARASITOL, V149, P22, DOI 10.1016/j.vetpar.2007.07.004; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; Dorny P, 2010, EFSA SUPPORT PUBL, V7, P30; EFSA (European Food Safety Authority), 2011, EFSA J, V9, P2371, DOI DOI 10.2903/J.EFSA.2011.2371; Eichenberger RM, 2013, INT J PARASITOL, V43, P853, DOI 10.1016/j.ijpara.2013.05.011; Eichenberger RM, 2011, FOOD CONTROL, V22, P989, DOI 10.1016/j.foodcont.2010.11.033; Embaetti landlaeknis (Directorate of Health), 2015, FARS 2013 2014; Fabiani S, 2013, ACTA TROP, V128, P18, DOI 10.1016/j.actatropica.2013.06.020; Federal Ministry of Health and Women's Affairs (BMGF) and Austrian Agency for Health and Food Safety (AGES), 2016, REP ZOON ZOON AG AUS; Federal Ministry of Health (BMG) and Austrian Agency for Health and Food Safety (AGES), 2015, REP ZOON ZONN AG AUS; Fernandez-Aranda F, 2001, INT J EAT DISORDER, V30, P107, DOI 10.1002/eat.1060; Freire LMR, 2005, ACOMPANHAMENTO INSPE; Gabriel S, 2015, VET PARASITOL, V213, P38, DOI 10.1016/j.vetpar.2015.03.006; Galan-Puchades MT, 2014, CLIN RES HEPATOL GAS, V38, pE73, DOI 10.1016/j.clinre.2014.03.004; Garcia HH, 2005, LANCET NEUROL, V4, P653, DOI 10.1016/S1474-4422(05)70194-0; Garcia Vallejo TB, 1999, THESIS; Geerts S, 1990, Verh K Acad Geneeskd Belg, V52, P537; Geerts S., 1992, AGRICONTACT, P236; Geysen D, 2007, J FOOD PROTECT, V70, P236, DOI 10.4315/0362-028X-70.1.236; Gracey J. F., 1999, MEAT HYGIENE; Halfon P, 2014, CLIN RES HEPATOL GAS, V38, P241, DOI 10.1016/j.clinre.2013.10.006; Hill AA, 2014, FOOD CONTROL, V38, P96, DOI 10.1016/j.foodcont.2013.10.002; ILSOE B, 1990, ACTA VET SCAND, V31, P159; Institut de Veille Sanitaire (InVS), 2003, MORB MORT DUES MAL I; Kassar H, 2014, EUR J PUBLIC HEALTH, V24, P2, DOI 10.1093/eurpub/cku105; Landbrug & Fodevarer, 2010, 1 OV MUL HAZ, P74; Laranjo-Gonzalez M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1362-3; Lavikainen T, 2010, ACTA VET SCAND S1, V52, pS4; List C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000771; LORENZ J, 1992, Angewandte Parasitologie, V33, P23; McCarthy JS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001601; MOBIUS G, 1993, DEUT TIERARZTL WOCH, V100, P110; Moyano LM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005130; Murrell K.D., 2005, WHO FAO OIE GUIDELIN; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Nesbakken T, 2007, RISK BASED MEAT INSP; Norwegian Veterinary Institute (NVI), 2012, ARS 2011 VET; Norwegian Veterinary Institute (NVI) - Veterinaerinstituttet, 2012, FER GA BEND KFOTT; Pellegrino A, 2004, IOM MIGRATION RES SE, V16; Sheridan MK., 1982, THESIS; Siikamaki Heli, 2002, Duodecim, V118, P1235; Silva Claudio V., 2010, Infectious Disorders - Drug Targets, V10, P313; Sotelo J, 2000, ARCH MED RES, V31, P3, DOI 10.1016/S0188-4409(99)00073-9; Tamburrini A., 1995, Parassitologia (Rome), V37, P195; THARALDSEN J, 1992, Norsk Veterinaertidsskrift, V104, P15; Torgerson PR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001920; Torgerson PR, 2013, VET PARASITOL, V195, P223, DOI 10.1016/j.vetpar.2013.04.004; Vieira-Pinto M, 2015, P 3 CYSTINET WORK GR; Vilhena M, 2007, TROPICAL MED INT S1, V12, P147; Vilhena M, 2015, P 1 CYSTINET INT C T; WILSON M, 1991, J INFECT DIS, V164, P1007, DOI 10.1093/infdis/164.5.1007; Winkler AS, 2015, WHOHTMNTDNZD201505; World Health Organization, 2015, END TAEN SOL 2015; Zammarchi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069537	75	13	14	3	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUL 21	2017	10								349	10.1186/s13071-017-2280-8				14	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FC7VH	WOS:000407049900002	28732550	DOAJ Gold, Green Published			2019-04-02	
J	Essomba, NE; Ngaba, PG; Halle, MP; Afane-Voundi, Y; Coppieters, Y				Essomba, N. E.; Ngaba, P. G.; Halle, M. P.; Afane-Voundi, Y.; Coppieters, Y.			Risk factors for mortality in patients with tuberculosis and HIV in Douala (Cameroon)	MEDECINE ET SANTE TROPICALES			French	Article						Factors; coinfection; TB / HIV; mortality; Douala-Cameroon	ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; THAILAND; COHORT; HIV/AIDS; AFRICA; MALAWI; DEATH; AIDS	Introduction: Despite prevention efforts, and free treatment, TB-HIV co-infection still occurs in Cameroon. The objective of this work is to present the risk factors for mortality in patients co-infected with TB and HIV in Douala from 2009 to 2014. Methodology: This transversal, analytic, and retrospective study took place from November 2014 to May 2015 in the Laquintinie Hospital in Douala. A review of our records identified patients aged at least 15 years, with this co-infection who received TB treatment, with or without anti-retroviral agents. The bivariate analysis compared qualitative variables with Pearson's Chi2 test. In the multivariate analysis, we determined the risk factors for mortality by backward stepwise logistic regression. Model fit was tested with the Hosmer-Lemeshow test. Results: The study identified 394 patients, 213 (54.1%) of whom were women (sex ratio 0.84). The mean age was 39 +/- 10 years. All patients received drugs to treat tuberculosis drugs; 351 (89%) also received antiretroviral drugs, 78.2% of them including efavirenz; and 320 (81.2%) received cotrimoxazole prophylaxis. During the study period, 67.3% were cured of tuberculosis and 15.7% died. The multivariate regression results show that hepatitis B (P < 0.0009), absence of cotrimoxazole prophylaxis (P < 0.005), poor treatment adherence (P < 0.0001), and a CD4 count < 50 (P < 0.0001) were risk factors for mortality. Conclusion: The cure rate for patients co-infected with TB and HIV in Cameroon remains low, and their mortality high. Comorbidities and the presence of opportunistic diseases are risk factors for death. Appropriate measures to prevent this coinfection and the systematic use of cotrimoxazole should reduce this mortality rate.	[Essomba, N. E.; Ngaba, P. G.; Halle, M. P.; Afane-Voundi, Y.] Univ Douala, Douala 106, Cameroon; [Coppieters, Y.] Univ Libre Bruxelles, Ecole Sante, Brussels, Belgium	Essomba, NE (reprint author), Univ Douala, Douala 106, Cameroon.	noelesso@yahoo.fr		Coppieters, Yves/0000-0001-8899-9549			Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Ako A, 2014, PLOS ONE, V9; Alvarez-Uria G, 2013, BIOIMPACTS, V3, P123, DOI 10.5681/bi.2013.025; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cain KR, 2007, INT J TUBERC LUNG D, V11, P1008; Chow JY, 2015, AIDS CARE, V27, P844, DOI 10.1080/09540121.2015.1007114; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Essomba NE, 2015, PAN AFRICAN MED J, V20, P412; Friedland G, 2007, J INFECT DIS, V196, pS1, DOI 10.1086/1518667; Groupe technique de lutte contre le sida-littoral, 2014, RAPP TRIM DONN PRIS; Harries AD, 1998, T ROY SOC TROP MED H, V92, P343, DOI 10.1016/S0035-9203(98)91036-7; Harries AD, 2000, SCOT MED J, V45, P47, DOI 10.1177/00369330000450S122; Ifebunandu NA, 2012, TROP DOCT, V42, P74, DOI 10.1258/td.2011.110421; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Kantipong P, 2012, HIV AIDS-RES PALLIAT, V4, P159, DOI 10.2147/HIV.S33535; Karim SSA, 2011, NEW ENGL J MED, V365, P1492, DOI 10.1056/NEJMoa1014181; Kirenga BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090614; Lucejko Mariusz, 2013, Pneumonol Alergol Pol, V81, P502; Munene E, 2015, AIDS CARE, V27, P378, DOI 10.1080/09540121.2014.963020; Mungrue Kameel, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P170, DOI 10.1177/1545109709331471; Mwaungulu FBD, 2004, B WORLD HEALTH ORGAN, V82, P354; ONUSIDA, 2013, RAPP EP MOND SIDA; Organisation mondiale de la sante, 2011, CONTR GLOB TUB RAPP; Organisation mondiale de la Sante, 2013, RAPP GLOB TUB 2013; Programme national de lutte contre la Tuberculose, 20152019 PNLT; Sanguanwongse N, 2008, JAIDS-J ACQ IMM DEF, V48, P181, DOI 10.1097/QAI.0b013e318177594e; Semu M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2109-7; Shastri S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-838; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Sume G E, 2009, East Afr Med J, V86, P469; Thuy TT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000507; Walker NF, 2015, HIV AIDS-RES PALLIAT, V7, P49, DOI 10.2147/HIV.S42328; WHO, 2010, TREATM TUB GUID 4, V4; Yone EWP, 2012, REV PNEUMOL CLIN, V68, P338, DOI 10.1016/j.pneumo.2012.10.001; Yone EWP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-190; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3; 2012, GLOB TUB REP 2013, P1	37	1	1	0	8	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	JUL-SEP	2017	27	3					286	291		10.1684/mst.2017.0713				6	Tropical Medicine	Tropical Medicine	FI4JR	WOS:000411937900013	28947405				2019-04-02	
J	Dinh, NN; Stevenson, MA; Dorny, P; Gabriel, S; Vo, TV; Nguyen, VAT; Phan, TV; Hii, SF; Traub, RJ				Dinh Ng-Nguyen; Stevenson, Mark A.; Dorny, Pierre; Gabriel, Sarah; Tinh Van Vo; Van-Anh Thi Nguyen; Trong Van Phan; Hii, Sze Fui; Traub, Rebecca J.			Comparison of a new multiplex real-time PCR with the Kato Katz thick smear and copro-antigen ELISA for the detection and differentiation of Taenia spp. in human stools	PLOS NEGLECTED TROPICAL DISEASES			English	Article							LINKED-IMMUNOSORBENT-ASSAY; SOLIUM TAENIASIS; COPROANTIGEN ELISA; DIAGNOSIS; CYSTICERCOSIS; ASIATICA; NEUROCYSTICERCOSIS; PATHOGENESIS; FIELD	Background Taenia solium, the cause of neurocysticercosis (NCC), has significant socioeconomic impacts on communities in developing countries. This disease, along with taeniasis is estimated to infect 2.5 to 5 million people globally. Control of T. solium NCC necessitates accurate diagnosis and treatment of T. solium taeniasis carriers. In areas where all three species of Taenia tapeworms (T. solium, Taenia saginata and Taenia asiatica) occur sympatrically, conventional microscope-and copro-antigen based diagnostic methods are unable to distinguish between these three Taenia species. Molecular diagnostic tools have been developed to overcome this limitation; however, conventional PCR-based techniques remain unsuitable for large-scale deployment in community-based surveys. Moreover, a real-time PCR (qPCR) for the discrimination of all three species of Taenia in human stool does not exist. This study describes the development and validation of a new triplex Taq-Man probe-based qPCR for the detection and discrimination of all three Taenia human tapeworms in human stools collected from communities in the Central Highlands of Vietnam. The diagnostic characteristics of the test are compared with conventional Kato Katz (KK) thick smear and copro-antigen ELISA (cAgELISA) method utilizing fecal samples from a community based cross-sectional study. Using this new multiplex real-time PCR we provide an estimate of the true prevalence of taeniasis in the source population for the community based cross-sectional study. Methodology/Principal findings Primers and TaqMan probes for the specific amplification of T. solium, T. saginata and T. asiatica were designed and successfully optimized to target the internal transcribed spacer I (ITS-1) gene of T. solium and the cytochrome oxidase subunit I (COX-1) gene of T. saginata and T. asiatica. The newly designed triplex qPCR (T3qPCR) was compared to KK and cAgELISA for the detection of Taenia eggs in stool samples collected from 342 individuals in Dak Lak province, Central Highlands of Vietnam. The overall apparent prevalence of taeniasis in Dak Lak province was 6.72% (95% confidence interval (CI) [3.94-9.50]) in which T. solium accounted for 1.17% (95% CI [0.37-3.17]), according to the T3qPCR. There was sympatric presence of T. solium, T. saginata and T. asiatica. The T3qPCR proved superior to KK and cAgELISA for the detection and differentiation of Taenia species in human feces. Diagnostic sensitivities of 0.94 (95% credible interval (CrI) [0.88-0.98]), 0.82 (95% CrI [0.58-0.95]) and 0.52 (95% CrI [0.07-0.94]), and diagnostic specificities of 0.98 (95% CrI [0.94-1.00]), 0.91 (95% CrI [0.85-0.96]) and 0.99 (95% CrI [0.96-1.00]) were estimated for the diagnosis of taeniasis for the T3qPCR, cAgELISA and KK thick smear in this study, respectively. Conclusions T3qPCR is not only superior to the KK thick smear and cAgELISA in terms of diagnostic sensitivity and specificity, but it also has the advantage of discriminating between species of Taenia eggs in stools. Application of this newly developed T3qPCR has identified the existence of all three human Taenia tapeworms in Dak Lak province and proves for the first time, the existence of T. asiatica in the Central Highlands and the south of Vietnam.	[Dinh Ng-Nguyen; Stevenson, Mark A.; Traub, Rebecca J.] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Dinh Ng-Nguyen; Van-Anh Thi Nguyen; Trong Van Phan] Tay Nguyen Univ, Fac Anim Sci & Vet Med, Dak Lak, Vietnam; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gabriel, Sarah] Univ Ghent, Fac Vet Med, Merelbeke, Belgium; [Tinh Van Vo] Pham Ngoc Thach Univ Med, Dept Physiol Pathol & Immunol, Ho Chi Minh, Vietnam; [Hii, Sze Fui] Univ Hosp Geelong, Barwon Hlth, Victoria, Australia	Dinh, NN (reprint author), Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia.; Dinh, NN (reprint author), Tay Nguyen Univ, Fac Anim Sci & Vet Med, Dak Lak, Vietnam.	ngocn4@student.unimelb.edu.au	Traub, Rebecca/A-4273-2013	Traub, Rebecca/0000-0002-7484-7592			Ale A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-45; ALLAN JC, 1990, PARASITOLOGY, V101, P473, DOI 10.1017/S0031182000060686; Allan JC, 1996, AM J TROP MED HYG, V54, P352, DOI 10.4269/ajtmh.1996.54.352; Allan JC, 1992, PARASITOL; Asaava LL, 2009, PREV VET MED, V89, P197, DOI 10.1016/j.prevetmed.2009.02.010; Aung AK, 2016, AM J TROP MED HYG, V94, P947, DOI 10.4269/ajtmh.15-0684; Bhattarai R, 2015, TROP MED INT HEAL; Bouma A, 2001, J VET DIAGN INVEST, V13, P383, DOI 10.1177/104063870101300503; BOWLES J, 1994, AM J TROP MED HYG, V50, P33; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152; Casella G, 2006, SPRINGER TEXTS STAT; Choudhury AAK, 2013, ECOHEALTH, V10, P54, DOI 10.1007/s10393-013-0821-y; DEPLAZES P, 1991, T ROY SOC TROP MED H, V85, P391, DOI 10.1016/0035-9203(91)90302-F; Dorny P, 2003, ACTA TROP, V87, P79, DOI 10.1016/S0001-706X(03)00058-5; Eom Keeseon S., 1993, Korean Journal of Parasitology, V31, P1; Eom KS, 2009, KOREAN J PARASITOL, V47, pS115, DOI 10.3347/kjp.2009.47.S.S115; Gelman A., 1996, MARKOV CHAIN MONTE C, P131, DOI DOI 10.1007/978-1-4899-4485-6_8; Gonzales I, 2016, PARASITE IMMUNOL, V38, P136, DOI 10.1111/pim.12307; Gordon CA, 2015, INT J PARASITOL, V45, P477, DOI 10.1016/j.ijpara.2015.02.011; Guezala MC, 2009, AM J TROP MED HYG, V81, P433, DOI 10.4269/ajtmh.2009.81.433; Ito A, 2003, LANCET, V362, P1918, DOI 10.1016/S0140-6736(03)14965-3; Ito A, 2016, INFECT GENET EVOL, V40, P357, DOI 10.1016/j.meegid.2015.06.022; Jeon HK, 2009, KOREAN J PARASITOL, V47, P73, DOI 10.3347/kjp.2009.47.1.73; Jeon HK, 2009, EXP PARASITOL, V121, P151, DOI 10.1016/j.exppara.2008.10.014; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Lambert SB, 2008, PEDIATRICS, V122, pE615, DOI 10.1542/peds.2008-0691; Levine MZ, 2007, J PARASITOL, V93, P409, DOI 10.1645/GE-938R.1; Llewellyn S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004380; Mayta H, 2000, J CLIN MICROBIOL, V38, P133; Mayta H, 2008, J CLIN MICROBIOL, V46, P286, DOI 10.1128/JCM.01172-07; Murrell KD, 2005, WHO FAO OIE GUIDE LI; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, P1; Ng-Nguyen D, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2085-9; De NV, 2014, KOREAN J PARASITOL, V52, P125, DOI 10.3347/kjp.2014.52.2.125; Nkouawa A, 2009, J CLIN MICROBIOL, V47, P168, DOI 10.1128/JCM.01573-08; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; Praet N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000406; Price DL, 1994, PROCEDURE MANUAL DIA; Raftery A., 1992, STAT SCI, V7, P493, DOI DOI 10.1214/SS/1177011143; Raftery AL, 1992, BAYESIAN STATISTICS, V4, P763; Rajkotia Y, 2007, T ROY SOC TROP MED H, V101, P840, DOI 10.1016/j.trstmh.2007.03.008; Raoul F, 2013, PARASITOLOGY, V140, P1578, DOI 10.1017/S0031182013001303; Schantz P M, 1993, Bull Pan Am Health Organ, V27, P397; SLEIGH A, 1982, T ROY SOC TROP MED H, V76, P403, DOI 10.1016/0035-9203(82)90201-2; Somers R, 2007, T ROY SOC TROP MED H, V101, P275, DOI 10.1016/j.trstmh.2006.04.007; Team R Core, 2017, R LANG ENV STAT COMP; Teerasukjinda Ornusa, 2016, Hawaii J Med Public Health, V75, P187; TEESDALE CH, 1976, B WORLD HEALTH ORGAN, V54, P703; Thienpont D., 1986, DIAGNOSING HELMINTHI; Van Chuong N., 2005, STATUS HELMINTHIC IN; White AC, 2000, ANNU REV MED, V51, P187, DOI 10.1146/annurev.med.51.1.187; Wilkins PP, 1999, AM J TROP MED HYG, V60, P199, DOI 10.4269/ajtmh.1999.60.199; World Health Organization, 2005, ATL EP CAR WORLD; Yamasaki H, 2004, J CLIN MICROBIOL, V42, P548, DOI 10.1128/JCM.42.2.548-553.2004; Yu B, 1998, STAT COMPUT, V8, P275, DOI 10.1023/A:1008917713940	56	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2017	11	7							e0005743	10.1371/journal.pntd.0005743				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FE2PD	WOS:000408057300050		DOAJ Gold, Green Published			2019-04-02	
J	Levick, B; Laudisoit, A; Tepage, F; Ensoy-Musoro, C; Mandro, M; Osoro, CB; Suykerbuyk, P; Kashama, JM; Komba, M; Tagoto, A; Falay, D; Begon, M; Colebunders, R				Levick, Bethany; Laudisoit, Anne; Tepage, Floribert; Ensoy-Musoro, Chellafe; Mandro, Michel; Osoro, Caroline Bonareri; Suykerbuyk, Patrick; Kashama, Jean Marie; Komba, Michel; Tagoto, Alliance; Falay, Dadi; Begon, Michael; Colebunders, Robert			High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo	PLOS NEGLECTED TROPICAL DISEASES			English	Article								Background An increased prevalence of epilepsy has been reported in many onchocerciasis endemic areas. The objective of this study was to determine the prevalence of epilepsy in onchocerciasis endemic areas in the Democratic Republic of the Congo (DRC) and investigate whether a higher annual intake of Ivermectin was associated with a lower prevalence of epilepsy. Methodology/Principle findings Between July 2014 and February 2016, house-to-house epilepsy prevalence surveys were carried out in areas with a high level of onchocerciasis endemicity: 3 localities in the Bas-Uele, 24 in the Tshopo and 21 in the Ituri province. Ivermectin uptake was recorded for every household member. This database allowed a matched case-control pair subset to be created that enabled putative risk factors for epilepsy to be tested using univariate logistic regression models. Risk factors relating to onchocerciasis were tested using a multivariate random effects model. To identify presence of clusters of epilepsy cases, the Kulldorff's scan statistic was used. Of 12, 408 people examined in the different health areas 407 (3.3%) were found to have a history of epilepsy. A high prevalence of epilepsy was observed in health areas in the 3 provinces: 6.8-8.5% in Bas-Uele, 0.8-7.4% in Tshopo and 3.6-6.2% in Ituri. Median age of epilepsy onset was 9 years, and the modal age 12 years. The case control analysis demonstrated that before the appearance of epilepsy, compared to the same life period in controls, persons with epilepsy were around two times less likely (OR: 0.52; 95% CI: (0.28, 0.98)) to have taken Ivermectin than controls. After the appearance of epilepsy, there was no difference of Ivermectin intake between cases and controls. Only in Ituri, a significant cluster (p-value = 0.0001) was identified located around the Draju sample site area. Conclusions The prevalence of epilepsy in health areas in onchocerciasis endemic regions in the DRC was 2-10 times higher than in non-onchocerciasis endemic regions in Africa. Our data suggests that Ivermectin protects against epilepsy in an onchocerciasis endemic region. However, a prospective population based intervention study is needed to confirm this.	[Levick, Bethany; Laudisoit, Anne; Begon, Michael] Univ Liverpool, Sch Biol Sci, Inst Integrat Biol, Liverpool, Merseyside, England; [Laudisoit, Anne] CIFOR, Jalan Cifor, Bogor Bar, Jawa Barat, Indonesia; [Laudisoit, Anne; Suykerbuyk, Patrick; Colebunders, Robert] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Tepage, Floribert] Minist Hlth, Natl Onchocerciasis Control Program PNLO, Buta, DEM REP CONGO; [Ensoy-Musoro, Chellafe; Osoro, Caroline Bonareri] Univ Hasselt, Interuniv Inst Biostat & Stat Bioinformat, Hasselt, Belgium; [Mandro, Michel] Minist Hlth, Ituri Prov Hlth Div, Bunia, DEM REP CONGO; [Osoro, Caroline Bonareri] Nanyuki Teaching & Referral Hosp, Nanyuki, Kenya; [Kashama, Jean Marie] Univ Kinshasa, Neuropsychopathol Ctr Mont Amba CNPP, Kinshasa, DEM REP CONGO; [Komba, Michel] Univ Kisangani, Fac Sci, Biodivers Monitoring Ctr, Kisangani, DEM REP CONGO; [Tagoto, Alliance] Minist Hlth, Natl HIV program, Kisangani, DEM REP CONGO; [Falay, Dadi] Univ Kisangani, Dept Pediat, Kisangani, DEM REP CONGO	Colebunders, R (reprint author), Univ Antwerp, Global Hlth Inst, Antwerp, Belgium.	robert.colebunders@uantwerpen.be			European Research Council [671055]	RC received funding from the European Research Council grant No. 671055 (https://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, 91 YEAR         1028, p[91, 501]; Bof JCM, 2015, TROP MED INT HEALTH, V20, P48, DOI 10.1111/tmi.12397; Colebunders R, 2016, INT J INFECT DIS; Colebunders R, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam8532; Colebunders R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004478; Colebunders Robert, 2016, BMC Res Notes, V9, P182, DOI 10.1186/s13104-016-1993-7; Colebunders R, 2016, INT J INFECT DIS, V44, P61, DOI 10.1016/j.ijid.2016.01.016; Diagana M, 2006, Bull Soc Pathol Exot, V99, P103; Edwards T, 2008, LANCET NEUROL, V7, P50, DOI 10.1016/S1474-4422(07)70292-2; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Forsgren L, 2008, LANCET NEUROL, V7, P21, DOI 10.1016/S1474-4422(07)70295-8; Johnson TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6953; Kaiser C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002147; Kamuyu G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002908; Kariuki SM, 2015, CLIN NEUROPHYSIOL; KIPP W, 1992, LANCET, V340, P789, DOI 10.1016/0140-6736(92)92329-E; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Mealey KL, 2004, J VET PHARMACOL THER, V27, P257, DOI 10.1111/j.1365-2885.2004.00607.x; OVUGA E, 1992, E AFR MED J, V69, P554; Pinheiro J, 2017, PACKAGE NLME; Pion SDS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000461; Preux PM, 2005, LANCET NEUROL, V4, P21, DOI 10.1016/S1474-4422(04)00963-9; R Core Team, 2016, R LANG ENV STAT COMP; Sozmen V, 2011, EUR NEUROL, V65, P4, DOI 10.1159/000322125; Tekle AH, 2011, ACTA TROP, V120, pS81, DOI 10.1016/j.actatropica.2010.05.008; Wamala JF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003880; WHO, 2010, CARD CONC OP EL ONCH; World Health Organization/African Programme for Onchocerciasis Control (WHO/APOC), 2007, REV HLTH CAR DEL SUB	28	17	17	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2017	11	7							e0005732	10.1371/journal.pntd.0005732				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FE2PD	WOS:000408057300044	28708828	DOAJ Gold, Green Published			2019-04-02	
J	Rovira-Vallbona, E; Contreras-Mancilla, JJ; Ramirez, R; Guzman-Guzman, M; Carrasco-Escobar, G; Llanos-Cuentas, A; Vinetz, JM; Gamboa, D; Rosanas-Urgell, A				Rovira-Vallbona, Eduard; Jose Contreras-Mancilla, Juan; Ramirez, Roberson; Guzman-Guzman, Mitchel; Carrasco-Escobar, Gabriel; Llanos-Cuentas, Alejandro; Vinetz, Joseph M.; Gamboa, Dionicia; Rosanas-Urgell, Anna			Predominance of asymptomatic and sub-microscopic infections characterizes the Plasmodium gametocyte reservoir in the Peruvian Amazon	PLOS NEGLECTED TROPICAL DISEASES			English	Article							NEW-GUINEAN CHILDREN; REAL-TIME PCR; FALCIPARUM INFECTIONS; MALARIA TRANSMISSION; VIVAX GAMETOCYTES; RISK-FACTORS; CARRIAGE; EPIDEMIOLOGY; COMMUNITY; THAILAND	Malaria transmission requires that Anopheles mosquitoes ingest Plasmodium gametocyte stages circulating in the human bloodstream. In the context of malaria elimination, understanding the epidemiology of gametocytes relative to all Plasmodium infections and the contribution of asymptomatic and sub-microscopic parasite carriers to the gametocyte reservoir is necessary, especially in low endemic settings with predominance of P. vivax. A 13-month longitudinal study was conducted in two communities (n = 1935 individuals) of Loreto Department, Peru, with five active screenings for Plasmodium infections and gametocyte stages by quantitative real-time PCR (qPCR) and reverse transcription (RT)-qPCR, respectively. Parasite prevalence by qPCR was 7.2% for P. vivax (n = 520/7235; range by survey 6.0%-8.1%) and 3.2% for P. falciparum (n = 235/7235; range by survey 0.4%-7.7%). Submicroscopic infections accounted for 73.5% of P. vivax (range by survey 60%-89%) and almost the totality of P. falciparum cases. Gametocytes were found in 28.4% P. vivax infections (range by survey 18.7%-34.1%), with a peak of 61.5% in one community at the start of the transmission season. About 59.8% of all P. vivax gametocyte carriers were asymptomatic and 31.9% were sub-microscopic. Age patterns for gametocyte prevalence paralleled asexual stage infections and peaked among >15-25 year old individuals. Asexual parasite density was found to be the strongest predictor for P. vivax gametocyte presence in longitudinal multivariate analysis (odds ratio 2.33 [95% confidence interval 1.96, 2.78]; P<0.001). Despite significant differences in seasonality patterns and P. vivax prevalence found at the local scale, sub-microscopic and asymptomatic infections predominate and contribute significantly to the gametocyte reservoir in different communities of the Peruvian Amazon. Control and elimination campaigns need sensitive tools to detect all infections that escape routine malaria surveillance, which may contribute to maintain transmission in the region.	[Rovira-Vallbona, Eduard; Rosanas-Urgell, Anna] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Jose Contreras-Mancilla, Juan; Carrasco-Escobar, Gabriel; Llanos-Cuentas, Alejandro; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Ramirez, Roberson; Guzman-Guzman, Mitchel] Univ Peruana Cayetano Heredia, Lab Satelite Iquitos UPCH UCSD, Loreto, Peru; [Vinetz, Joseph M.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Dept Ciencias Celulares & Mol, Fac Ciencias & Filosofia, Lima, Peru	Rovira-Vallbona, E (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.	erovira@itg.be		Rovira-Vallbona, Eduard/0000-0002-4765-1076; Contreras Mancilla, Juan Jose/0000-0003-0447-0926; Gamboa, Dionicia/0000-0002-1420-7729; Carrasco-Escobar, Gabriel/0000-0002-6945-0419	Belgian Directorate-General for Development Cooperation (DGD) within DGD-ITM Framework Agreement 3-III; International Centers for Excellence in Malaria Research (ICEMR) program from National Institute of Allergy and Infectious Diseases (NIAID), United States of America; US Public Health Service [U19AI089681]	Funding was provided by the Belgian Directorate-General for Development Cooperation (DGD, http://diplomatie.belgium.be/en/policy/development_cooperation) within DGD-ITM Framework Agreement 3-III, by International Centers for Excellence in Malaria Research (ICEMR) program from National Institute of Allergy and Infectious Diseases (NIAID), United States of America (https://www.niaid.nih.gov/research/icemr-program-overview) and by US Public Health Service Grants U19AI089681 (Joseph M. Vinetz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; Alves FP, 2002, AM J TROP MED HYG, V66, P641, DOI 10.4269/ajtmh.2002.66.641; Barbosa S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003109; Bassat Q, 2016, AM J TROP MED HYG; Betuela I, 2012, J INFECT DIS, V206, P1771, DOI 10.1093/infdis/jis580; Bousema T, 2011, CLIN MICROBIOL REV, V24, P377, DOI 10.1128/CMR.00051-10; Branch O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-27; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Delgado-Ratto C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004376; Direccion General de Epidemiologia Ministerio de Salud Peru, 2013, AN SIT SALUD PER; Douglas NM, 2013, J INFECT DIS, V208, P801, DOI 10.1093/infdis/jit261; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Gouagna LC, 2010, NAT GENET, V42, P328, DOI 10.1038/ng.554; Grange L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123102; GRIFFITH DA, 1983, J REGIONAL SCI, V23, P377, DOI 10.1111/j.1467-9787.1983.tb00996.x; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Karl S, 2016, ACTA TROP, V160, P1, DOI 10.1016/j.actatropica.2016.04.002; Koepfli C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126747; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lawaly YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011358; Lima NF, 2012, EXP PARASITOL, V132, P348, DOI 10.1016/j.exppara.2012.08.010; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/ERI.13.45, 10.1586/eri.13.45]; Mangold KA, 2005, J CLIN MICROBIOL, V43, P2435, DOI 10.1128/JCM.43.5.2435-2440.2005; Mateo S., 2013, B EPIDEMIOL PERU MIN, V22, P1088; McKenzie FE, 2006, J PARASITOL, V92, P1281, DOI 10.1645/GE-911R.1; Moreno M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0804-2; Nacher M, 2004, AM J TROP MED HYG, V71, P693, DOI 10.4269/ajtmh.2004.71.693; Nacher M, 2004, ANN TROP MED PARASIT, V98, P115, DOI 10.1179/000349804225003145; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Ouedraogo AL, 2007, AM J TROP MED HYG, V76, P626, DOI 10.4269/ajtmh.2007.76.626; Ouedraogo AL, 2016, J INFECT DIS, V213, P90, DOI 10.1093/infdis/jiv370; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Pan-American Health Organization (PAHO), 2016, 68 SESS REG COMM WHO; Rosas-Aguirre A, 2016, AM J TROP MED HYG; Rosas-Aguirre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137458; Roshanravan B, 2003, AM J TROP MED HYG, V69, P45, DOI 10.4269/ajtmh.2003.69.45; Stone W, 2015, TRENDS PARASITOL, V31, P287, DOI 10.1016/j.pt.2015.04.004; VALLEJO AF, 2016, MALARIA J, V15; Waltmann A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003758; Wampfler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076316; WWARN gametocytes study group, 2016, BMC MED, V14; Zhou ZY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1482-4	42	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2017	11	7							e0005674	10.1371/journal.pntd.0005674				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FE2PD	WOS:000408057300017	28671944	DOAJ Gold, Green Published			2019-04-02	
J	Schneider-Crease, I; Griffin, RH; Gomery, MA; Dorny, P; Noh, JC; Handali, S; Chastain, HM; Wilkins, PP; Nunn, CL; Snyder-Mackler, N; Beehner, JC; Bergman, TJ				Schneider-Crease, India; Griffin, Randi H.; Gomery, Megan A.; Dorny, Pierre; Noh, John C.; Handali, Sukwan; Chastain, Holly M.; Wilkins, Patricia P.; Nunn, Charles L.; Snyder-Mackler, Noah; Beehner, Jacinta C.; Bergman, Thore J.			Identifying wildlife reservoirs of neglected taeniid tapeworms: Non-invasive diagnosis of endemic Taenia serialis infection in a wild primate population	PLOS NEGLECTED TROPICAL DISEASES			English	Article							URINE ANTIGEN-DETECTION; CEREBRAL COENUROSIS; PET RABBIT; MOLECULAR-IDENTIFICATION; SAGINATA CYSTICERCOSIS; THEROPITHECUS-GELADA; CAT; SOLIUM; ELISA; NEUROCYSTICERCOSIS	Despite the global distribution and public health consequences of Taenia tapeworms, the life cycles of taeniids infecting wildlife hosts remain largely undescribed. The larval stage of Taenia serialis commonly parasitizes rodents and lagomorphs, but has been reported in a wide range of hosts that includes geladas (Theropithecus gelada), primates endemic to Ethiopia. Geladas exhibit protuberant larval cysts indicative of advanced T. serialis infection that are associated with high mortality. However, non-protuberant larvae can develop in deep tissue or the abdominal cavity, leading to underestimates of prevalence based solely on observable cysts. We adapted a non-invasive monoclonal antibody-based enzyme-linked immunosorbent assay (ELISA) to detect circulating Taenia spp. antigen in dried gelada urine. Analysis revealed that this assay was highly accurate in detecting Taenia antigen, with 98.4% specificity, 98.5% sensitivity, and an area under the curve of 0.99. We used this assay to investigate the prevalence of T. serialis infection in a wild gelada population, finding that infection is substantially more widespread than the occurrence of visible T. serialis cysts (16.4% tested positive at least once, while only 6% of the same population exhibited cysts). We examined whether age or sex predicted T. serialis infection as indicated by external cysts and antigen presence. Contrary to the female-bias observed in many Taenia-host systems, we found no significant sex bias in either cyst presence or antigen presence. Age, on the other hand, predicted cyst presence (older individuals were more likely to show cysts) but not antigen presence. We interpret this finding to indicate that T. serialis may infect individuals early in life but only result in visible disease later in life. This is the first application of an antigen ELISA to the study of larval Taenia infection in wildlife, opening the doors to the identification and description of infection dynamics in reservoir populations.	[Schneider-Crease, India; Griffin, Randi H.; Nunn, Charles L.; Snyder-Mackler, Noah] Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA; [Gomery, Megan A.; Beehner, Jacinta C.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Dorny, Pierre] Prince Leopold Inst Trop Med, Dept Vet Med, Nationalestr 155, Antwerp, Belgium; [Dorny, Pierre] Fac Vet Med, Dept Parasitol, Salisburylaan 133, Merelbeke, Belgium; [Noh, John C.; Handali, Sukwan; Chastain, Holly M.; Wilkins, Patricia P.] Ctr Dis Control & Prevent, Dept Parasit Dis & Malaria, Atlanta, GA USA; [Nunn, Charles L.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Beehner, Jacinta C.; Bergman, Thore J.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA; [Bergman, Thore J.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Schneider-Crease, I (reprint author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC USA.	ias6@duke.edu	Bergman, Thore/B-8196-2008	Bergman, Thore/0000-0002-9615-5001; Snyder-Mackler, Noah/0000-0003-3026-6160	National Science Foundation [IOS-1255974, BCS-0715179]; Leakey Foundation; National Geographic Society [8989-11, 8100-06]	Long-term gelada research was supported by: the National Science Foundation (IOS-1255974, awarded to JCB, and BCS-0715179, awarded to TJB, [https://www.nsf.gov), the Leakey Foundation (https://leakeyfoundation.org, awarded to JCB), and the National Geographic Society (Gr. #8989-11, Gr. #8100-06, http://www.nationalgeographc.com, awarded to JCB). Support for project-specific fieldwork and laboratory analysis was provided by Primate Conservation, Inc. (http://www.primate.org, awarded to ISC), Conservation International (http:/www.conservation.org, awarded to ISC), the Nacey Maggioncalda Foundation (http://naceymagg.org, awarded to ISC), the Margot Marsh Biodiversity Foundation (awarded to ISC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 2011, INT ENCY STAT SCI, DOI [10.1007/9783-64204898-2_110, DOI 10.1007/978-3-642-04898-2_110]; Allepuz A, 2012, RES VET SCI, V92, P393, DOI 10.1016/j.rvsc.2011.03.027; Avcioglu H, 2011, VET PARASITOL, V176, P59, DOI 10.1016/j.vetpar.2010.10.033; Bates D, 2015, J STAT SOFTW, V67, P1; BECKER BJP, 1951, LANCET, V261, P1202; BECKER BJP, 1951, LANCET, V261, P198; Benifla M, 2007, J NEUROSURG, V107, P511, DOI 10.3171/PED-07/12/511; Bennett H, 2000, VET REC, V147, P428; Bertolino P., 1957, PROFILASSI, V30, P3; BERTRAND I, 1956, PRESSE MED, V64, P333; BONNAL G., 1933, Bulletin de la Societe de Pathologie Exotique, V26, P1060; BRACKEN FK, 1950, J AM VET MED ASSOC, V116, P440; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; Brumpt E, 1936, PRECIS PARASITOLOGIE; Brumpt E., 1913, PRECIS PARASITOLOGIE, P281; Brumpt E., 1936, PRECIS PARASITOLOGIE, VI, P738; BUCKLEY JJC, 1947, T R SOC TROP MED HYG, V41, P7; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Castillo Y, 2009, AM J TROP MED HYG, V80, P379, DOI 10.4269/ajtmh.2009.80.379; Cecchi G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0898-y; CLARK JD, 1969, J AM VET MED ASSOC, V155, P1258; CORREA FERNANDO M. A., 1962, REV INST MED TROP SAO PAULO, V4, P38; D'ANDREA F., 1964, ACTA NEUROL [NAPLES], V19, P245; Debonnet G., 2006, REACTIVE MONITORING; Department of Animal Health, 2007, HUM PORC BOV SER SAM; DOLLFUS ROBERT PH, 1947, ANN PARASITOL HUMAINE ET COMP, V22, P143; Dorny P, 2003, ACTA TROP, V87, P79, DOI 10.1016/S0001-706X(03)00058-5; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; DUNBAR RIM, 1980, J ANIM ECOL, V49, P485, DOI 10.2307/4259; DUNSMORE J D, 1968, Australian Journal of Science, V30, P465; Eckert J., 1991, P201; El-On Joseph, 2008, Vet Ital, V44, P621; ELEK STEPHEN R., 1939, ZOOLOGICA [NEW YORK], V24, P323; Fain A., 1956, Annales de la Societe Belge de Medecine Tropicale, V36, P673; Fountain K, 2000, VET REC, V147, P340; Gabriel S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001851; GEORGI JR, 1969, CORNELL VET, V59, P127; GOUDSWAARD MF, 1991, VET REC, V129, P295, DOI 10.1136/vr.129.13.295-b; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; HAMILTON AG, 1950, PARASITOLOGY, V40, P46, DOI 10.1017/S0031182000017844; HAYES MA, 1978, CAN VET J, V19, P341; Hoberg EP, 2002, MICROBES INFECT, V4, P859, DOI 10.1016/S1286-4579(02)01606-4; Holmberg BJ, 2007, VET OPHTHALMOL, V10, P53, DOI 10.1111/j.1463-5224.2007.00501.x; Hough I, 2000, AUST VET J, V78, P468, DOI 10.1111/j.1751-0813.2000.tb11860.x; HUSS BT, 1994, J AM VET MED ASSOC, V205, P69; Ing MB, 1998, CLIN INFECT DIS, V27, P519, DOI 10.1086/514716; Jeon HK, 2009, EXP PARASITOL, V121, P151, DOI 10.1016/j.exppara.2008.10.014; Jia WZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-447; Jull P, 2012, J FELINE MED SURG, V14, P646, DOI 10.1177/1098612X12458211; KINGSTON N, 1984, P HELM SOC WASH, V51, P309; Lacasse C, 2005, J ZOO WILDLIFE MED, V36, P95, DOI 10.1638/04-001; LANDELLS JW, 1949, J CLIN PATHOL, V2, P61, DOI 10.1136/jcp.2.1.61; Leiby P. D, 1971, P174; Lescano Andres G, 2013, Handb Clin Neurol, V114, P335, DOI 10.1016/B978-0-444-53490-3.00027-3; Loos-Frank B, 2000, SYST PARASITOL, V45, P155, DOI 10.1023/A:1006219625792; MALOMO A, 1990, TROP GEOGR MED, V42, P280; Marty AM, 2000, PATHOLOGY INFECT DIS, V1, P185; McManus DP, 2006, PARASITOL INT, V55, pS31, DOI 10.1016/j.parint.2005.11.004; Mertz GJ, 2016, CLIN INFECT DIS, V63, P148; MICHAL A, 1977, J NEUROL, V216, P265, DOI 10.1007/BF00314050; Morales-Montor J, 2005, PARASITOLOGY, V131, P287, DOI 10.1017/S0031182005007894; Morales-Montor J, 2004, J PARASITOL, V90, P531, DOI 10.1645/GE-113R3; Mwape KE, 2011, T ROY SOC TROP MED H, V105, P574, DOI 10.1016/j.trstmh.2011.05.010; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; NEWBERNE P M, 1951, Vet Med, V46, P156; Nguyen N, 2015, AM J PRIMATOL, V77, P579, DOI 10.1002/ajp.22379; Nguekam JP, 2003, TROP MED INT HEALTH, V8, P144, DOI 10.1046/j.1365-3156.2003.01000.x; O'Reilly A, 2002, VET OPHTHALMOL, V5, P227, DOI 10.1046/j.1463-5224.2002.00230.x; Padgett KA, 2005, J PARASITOL, V91, P1435, DOI 10.1645/GE-3461.1; PAU A, 1990, British Journal of Neurosurgery, V4, P39, DOI 10.3109/02688699009000680; PAU A, 1987, SURG NEUROL, V27, P548, DOI 10.1016/0090-3019(87)90153-4; R Core Team, 2016, LANG ENV STAT COMP; Ranque J., 1955, Annales de Parasitologie Humaine et Comparee, V30, P22; RAPER A. B., 1956, ANN TROP MED AND PARASITOL, V50, P121; Roberts EK, 2017, INT J PRIMATOL, V38, P1, DOI 10.1007/s10764-016-9939-4; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodhain J., 1954, Rivista di Parassitologia, V15, P613; Roger H, 1942, REV NEUROL, V74, P319; Sabattani S, 2004, J NEUROSURG, V100, P964, DOI 10.3171/jns.2004.100.5.0964; Sandground J. H., 1937, Journal of Parasitology Urbana, V23, P482, DOI 10.2307/3272395; Santamaria E, 2002, J PARASITOL, V88, P69, DOI 10.2307/3285392; Schmidt G. D., 1986, CRC HDB TAPEWORM IDE; Schneider-Crease IA, ETHIOPIA IN REVIEW; Schneider-Crease IA, 2013, VET PARASITOL, V198, P240, DOI 10.1016/j.vetpar.2013.08.015; Schwartz B, 1927, J AGRIC RES, V35, P0471; Schwartz B., 1926, J PARASITOL, V12, P159; Scott HH, 1926, P ZOOL SOC LOND, V1926, P231; SLOCOMBE RF, 1989, AUST VET J, V66, P92, DOI 10.1111/j.1751-0813.1989.tb09753.x; SMITH MC, 1988, J AM VET MED ASSOC, V192, P82; Tappe D, 2016, J CLIN MICROBIOL, V54, P172, DOI 10.1128/JCM.02171-15; TEMPLETON AC, 1968, T ROY SOC TROP MED H, V62, P251, DOI 10.1016/0035-9203(68)90165-X; Urbain A., 1935, Bulletin Acad Veter France, V8, P322; Van Kerckhoven I, 1998, VET PARASITOL, V76, P269, DOI 10.1016/S0304-4017(97)00226-4; Wardle RA, 1975, ADV ZOOLOGY TAPEWORM; WATSON KC, 1955, LANCET, V2, P1321; Wills L, 2001, VET REC, V148, P188; WILSON VCLC, 1972, T ROY SOC TROP MED H, V66, P611, DOI 10.1016/0035-9203(72)90307-0; Zhang L, 2007, MOL CELL PROBE, V21, P379, DOI 10.1016/j.mcp.2007.05.003	98	1	1	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2017	11	7							e0005709	10.1371/journal.pntd.0005709				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FE2PD	WOS:000408057300029	28704366	DOAJ Gold, Green Published			2019-04-02	
J	Tajebe, F; Getahun, M; Adem, E; Hailu, A; Lemma, M; Fikre, H; Raynes, J; Tamiru, A; Mulugeta, Z; Diro, E; Toulza, F; Shkedy, Z; Ayele, T; Modolell, M; Munder, M; Muller, I; Takele, Y; Kropf, P				Tajebe, Fitsumbrhan; Getahun, Mulusew; Adem, Emebet; Hailu, Asrat; Lemma, Mulualem; Fikre, Helina; Raynes, John; Tamiru, Aschalew; Mulugeta, Zemenay; Diro, Ermias; Toulza, Frederic; Shkedy, Ziv; Ayele, Tadesse; Modolell, Manuel; Munder, Markus; Mueller, Ingrid; Takele, Yegnasew; Kropf, Pascale			Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HELMINTH INFECTIONS; INTERFERON-GAMMA; ETHIOPIA; UNDERNUTRITION; INTERLEUKIN-10; ASCARIASIS; HOOKWORM; DONOVANI; THERAPY; IMPACT	Visceral leishmaniasis (VL) is a neglected tropical disease that affects the poorest communities and can cause substantial morbidity and mortality. Visceral leishmaniasis is characterized by the presence of Leishmania parasites in the spleen, liver and bone marrow, hepatosplenomegaly, pancytopenia, prolonged fever, systemic inflammation and low body mass index (BMI). The factors impacting on the severity of VL are poorly characterized. Here we performed a cross-sectional study to assess whether co-infection of VL patients with intestinal parasites influences disease severity, assessed with clinical and haematological data, inflammation, cytokine profiles and BMI. Data from VL patients was similar to VL patients co-infected with intestinal parasites, suggesting that co-infection of VL patients with intestinal parasites does not alter disease severity.	[Tajebe, Fitsumbrhan; Getahun, Mulusew] Univ Gondar, Dept Immunol & Mol Biol, Gondar, Ethiopia; [Adem, Emebet; Fikre, Helina; Tamiru, Aschalew; Mulugeta, Zemenay; Diro, Ermias; Takele, Yegnasew] Univ Gondar, Leishmaniasis Res & Treatment Ctr, Gondar, Ethiopia; [Hailu, Asrat] Univ Addis Ababa, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Lemma, Mulualem; Diro, Ermias] Univ Gondar, Dept Internal Med, Gondar, Ethiopia; [Raynes, John] London Sch Hyg & Trop Med, Dept Immunol & Infect, London, England; [Toulza, Frederic] Kings Coll London, Fac Life Sci, Dept Haematol Med, London, England; [Shkedy, Ziv; Ayele, Tadesse] Univ Hasselt, Dept Math & Stat, Hasselt, Belgium; [Modolell, Manuel] Max Planck Inst Immunobiol & Epigenet, Dept Cellular Immunol, Freiburg, Germany; [Munder, Markus] Univ Med Ctr Mainz, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany; [Mueller, Ingrid; Takele, Yegnasew; Kropf, Pascale] Imperial Coll London, Dept Med, London, England; [Getahun, Mulusew] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia	Kropf, P (reprint author), Imperial Coll London, Dept Med, London, England.	p.kropf@imperial.ac.uk	Munder, Markus/K-6737-2013		DNDi; Wellcome Trust [104027/B/14/Z]	The authors would like to thank DNDi for their in-kind support in funding the staff of Gondar University Leishmaniasis Research and Treatment Centre. YT is supported by a fellowship from The Wellcome Trust (104027/B/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002134; Adem E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004468; Aiken AM, 2015, INT J EPIDEMIOL, V44, P1572, DOI 10.1093/ije/dyv127; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ansari NA, 2006, CLIN IMMUNOL, V119, P339, DOI 10.1016/j.clim.2006.01.017; Azeredo-Coutinho RBG, 2016, ACTA TROP, V154, P42, DOI 10.1016/j.actatropica.2015.10.015; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; BRANCA F, 1993, EUR J CLIN NUTR, V47, P840; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; Degarege A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1490-2; den Boer M, 2011, CLIN MICROBIOL INFEC, V17, P1471, DOI 10.1111/j.1469-0691.2011.03635.x; Diro E, 2015, TROP MED INT HEALTH, V20, P8, DOI 10.1111/tmi.12407; ENDRIS M, 2013, ISRN PARASITOLOGY, V2013, P5; Faria MS, 2014, FASEB J, V28, P3050, DOI 10.1096/fj.13-245126; Global Atlas of Helminth Infections, ETH SOIL TRANSM HELM; Global Atlas of Helminth Infections, DISTR SCHIST SURV DA; Hailu A, 2005, CLIN IMMUNOL, V117, P182, DOI 10.1016/j.clim.2005.06.015; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Jardim-Botelho A, 2008, TROP MED INT HEALTH, V13, P458, DOI 10.1111/j.1365-3156.2008.02022.x; Jones Kelsey D, 2014, Food Nutr Bull, V35, pS64; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; Kropf P, 2005, FASEB J, V19, P1000, DOI 10.1096/fj.04-3416fje; KUMAR R, 2014, PLOS NEGLECT TROP D, V8, P94442; LOCKSLEY RM, 1987, AM J TROP MED HYG, V36, P541, DOI 10.4269/ajtmh.1987.36.541; Maizels RM, 2012, CURR OPIN IMMUNOL, V24, P459, DOI 10.1016/j.coi.2012.06.003; Mengesha Bewketu, 2014, BMC Res Notes, V7, P75, DOI 10.1186/1756-0500-7-75; Mollinedo F, 2010, J BIOL CHEM, V285, P34528, DOI 10.1074/jbc.M110.125302; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Nylen S, 2007, TRENDS IMMUNOL, V28, P378, DOI 10.1016/j.it.2007.07.004; Ritmeijer K, 2011, CLIN INFECT DIS, V53, pE152, DOI 10.1093/cid/cir674; Takele Y, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001977; Wasunna KM, 1995, T ROY SOC TROP MED H, V89, P678, DOI 10.1016/0035-9203(95)90442-5; WHO, CONTR LEISHM 2010 19; Yimer Mulat, 2015, BMC Res Notes, V8, P820, DOI 10.1186/s13104-015-1822-4; Yizengaw MG E, 2016, FRONT IMMUNOL, V7, P517; ZWINGENBERGER K, 1990, CLIN IMMUNOL IMMUNOP, V57, P242, DOI 10.1016/0090-1229(90)90038-R	37	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2017	11	7							e0005727	10.1371/journal.pntd.0005727				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FE2PD	WOS:000408057300039	28732017	DOAJ Gold, Green Published			2019-04-02	
J	Watson, CH; Baker, S; Lau, CL; Rawalai, K; Taufa, M; Coriakula, J; Thieu, NTV; Van, TT; Ngoc, DTT; Hens, N; Lowry, JH; de Alwis, R; Cano, J; Jenkins, K; Mulholland, EK; Nilles, EJ; Kama, M; Edmunds, WJ				Watson, Conall H.; Baker, Stephen; Lau, Colleen L.; Rawalai, Kitione; Taufa, Mere; Coriakula, Jerimaia; Nga Tran Vu Thieu; Tan Trinh Van; Dung Tran Thi Ngoc; Hens, Niel; Lowry, John H.; de Alwis, Ruklanthi; Cano, Jorge; Jenkins, Kylie; Mulholland, E. Kim; Nilles, Eric J.; Kama, Mike; Edmunds, W. John			A cross-sectional seroepidemiological survey of typhoid fever in Fiji	PLOS NEGLECTED TROPICAL DISEASES			English	Article							CAPSULAR POLYSACCHARIDE VACCINE; ENTERICA SEROVAR TYPHI; SALMONELLA-TYPHI; RISK-FACTORS; ANTIBODIES; CHILDREN; CARRIERS; EPIDEMIOLOGY; IMMUNIZATION; PROTECTION	Fiji, an upper-middle income state in the Pacific Ocean, has experienced an increase in confirmed case notifications of enteric fever caused by Salmonella enterica serovar Typhi (S. Typhi). To characterize the epidemiology of typhoid exposure, we conducted a cross-sectional sero-epidemiological survey measuring IgG against the Vi antigen of S. Typhi to estimate the effect of age, ethnicity, and other variables on seroprevalence. Epidemiologically relevant cut-off titres were established using a mixed model analysis of data from recovering culture-confirmed typhoid cases. We enrolled and assayed plasma of 1787 participants for anti-Vi IgG; 1,531 of these were resident in mainland areas that had not been previously vaccinated against S. Typhi (seropositivity 32.3% (95% CI 28.2 to 36.3%)), 256 were resident on Taveuni island, which had been previously vaccinated (seropositivity 71.5% (95% CI 62.1 to 80.9%)). The seroprevalence on the Fijian mainland is one to two orders of magnitude higher than expected from confirmed case surveillance incidence, suggesting substantial subclinical or otherwise unreported typhoid. We found no significant differences in seropositivity prevalences by ethnicity, which is in contrast to disease surveillance data in which the indigenous iTaukei Fijian population are disproportionately affected. Using multivariable logistic regression, seropositivity was associated with increased age (odds ratio 1.3 (95% CI 1.2 to 1.4) per 10 years), the presence of a pit latrine (OR 1.6, 95% CI 1.1 to 2.3) as opposed to a septic tank or piped sewer, and residence in settlements rather than residential housing or villages (OR 1.6, 95% CI 1.0 to 2.7). Increasing seropositivity with age is suggestive of low-level endemic transmission in Fiji. Improved sanitation where pit latrines are used and addressing potential transmission routes in settlements may reduce exposure to S. Typhi. Widespread unreported infection suggests there may be a role for typhoid vaccination in Fiji, in addition to public health management of cases and outbreaks.	[Watson, Conall H.; Mulholland, E. Kim; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Baker, Stephen; Nga Tran Vu Thieu; Tan Trinh Van; Dung Tran Thi Ngoc; de Alwis, Ruklanthi] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Baker, Stephen; de Alwis, Ruklanthi] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Lau, Colleen L.] Australian Natl Univ, Res Sch Populat Hlth, Dept Global Hlth, Canberra, ACT, Australia; [Rawalai, Kitione] Project Heaven, Suva, Fiji; [Taufa, Mere; Kama, Mike] Minist Hlth & Med Serv, Fiji Ctr Communicable Dis Control, Suva, Fiji; [Coriakula, Jerimaia] Fiji Natl Univ, Pacific Res Ctr Prevent Obes & Noncommunicable Di, Suva, Fiji; [Hens, Niel] UHasselt, I Biostat, Ctr Stat, Hasselt, Belgium; [Hens, Niel] Univ Antwerp, Vaccine & Infect Dis Inst, Ctr Hlth Econ Res & Modelling Infect Dis, Antwerp, Belgium; [Lowry, John H.] Univ South Pacific, Sch Geog Earth Sci & Environm, Suva, Fiji; [de Alwis, Ruklanthi; Cano, Jorge] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Jenkins, Kylie] Fiji Hlth Sect Support Programme, Suva, Fiji; [Jenkins, Kylie] Telethon Kids Inst, Perth, WA, Australia; [Mulholland, E. Kim] Murdoch Childrens Res Inst, Infect & Immun, Melbourne, Vic, Australia; [Nilles, Eric J.] World Hlth Org Western Pacific Reg, Emerging Dis Surveillance & Response, Suva, Fiji	Watson, CH (reprint author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	conall.watson@lshtm.ac.uk	Lau, Colleen/F-5974-2012; Cano, Jorge/E-2962-2016	Lau, Colleen/0000-0001-8288-4169; Cano, Jorge/0000-0001-9864-5058; Watson, Conall/0000-0002-2469-791X; Nilles, Eric/0000-0001-7044-5257	World Health Organization Western Pacific Region; Chadwick Trust; UK Medical Research Council [MR/J003999/1]; Wellcome Trust of Great Britain; Global Change Institute at The University of Queensland [607562]	Fieldwork was funded by the World Health Organization Western Pacific Region (www.wpro.who.int) and by the Chadwick Trust(ucl.ac.uk/srs/our-services/academic-services/chadwick-trust). CHW is supported by the UK Medical Research Council (grant MR/J003999/1, mrc.ac.uk). SB and RdA are funded by the Wellcome Trust of Great Britain (wellcome.ac.uk). CLL was supported by a research grant from the Global Change Institute (607562) at The University of Queensland (uq.edu.au). Other than contributions by EJN of the World Health Organization to conceptualization, funding acquisition, methodology, resources, writing review & editing, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antillon M, 2017, VACCINE, V35, P3506, DOI 10.1016/j.vaccine.2017.05.001; Anwar E, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001261.pub3; Baker S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-45; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4; BLACK RE, 1985, B WORLD HEALTH ORGAN, V63, P899; Bokkenheuser V, 1964, AM J PUBLIC HLTH; Castonguay-Vanier J, 2013, J CLIN MICROBIOL, V51, P142, DOI 10.1128/JCM.02360-12; CLEGG A, 1994, ACTA TROP, V57, P255, DOI 10.1016/0001-706X(94)90071-X; Crump JA, 2003, EMERG INFECT DIS, V9, P539, DOI 10.3201/eid0905.020428; DESA/UNSD, 2005, DESA UNSD SERIES F, V98; Dougan G, 2014, ANNU REV MICROBIOL, V68, P317, DOI 10.1146/annurev-micro-091313-103739; Dunn John, 2005, Pac Health Dialog, V12, P53; Dunstan SJ, 2014, NAT GENET, V46, P1333, DOI 10.1038/ng.3143; DUPONT HL, 1971, B WORLD HEALTH ORGAN, V44, P667; EDELMAN R, 1986, REV INFECT DIS, V8, P329; Fiji Bureau of Statistics, 2012, FIJ 2007 CENS POP HO; FOX J, 1992, J AM STAT ASSOC, V87, P178, DOI 10.2307/2290467; Fox J., 2010, R COMPANION APPL REG; Gasem MH, 2001, TROP MED INT HEALTH, V6, P484, DOI 10.1046/j.1365-3156.2001.00734.x; Greenwell J, 2012, W PACIFIC SURVEILL R, V3, P41, DOI DOI 10.5365/WPSAR.2012.3.4.006; Gupta A, 2006, INT J INFECT DIS, V10, P309, DOI 10.1016/j.ijid.2005.06.005; Harrell Jr F. E., 2015, REGRESSION MODELING; Hornick R B, 1967, Trans Am Clin Climatol Assoc, V78, P70; Hosoglu S, 2006, EPIDEMIOL INFECT, V134, P612, DOI 10.1017/S0950268805005583; House D, 2008, J INFECT DEV COUNTR, V2, P308; Jenkins AP, 2016, ECOHEALTH, P1; Karkey A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002391; Keddy KH, 1999, VACCINE, V17, P110, DOI 10.1016/S0264-410X(98)00160-1; Khan MI, 2012, EPIDEMIOL INFECT, V140, P665, DOI 10.1017/S0950268811000938; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Klugman KP, 1996, VACCINE, V14, P435, DOI 10.1016/0264-410X(95)00186-5; Kumar SA, 2012, FIJI J PUBLIC HEAL, V1, P31; LANATA CF, 1983, LANCET, V2, P441; Lau CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004405; Lauritsen J, 2005, EPIDATA COMPREHENSIV; Levine MM, 2013, VACCINES, P812; LOSONSKY GA, 1987, J CLIN MICROBIOL, V25, P2266; Luby SP, 1998, EPIDEMIOL INFECT, V120, P129, DOI 10.1017/S0950268897008558; Luxemburger C, 2001, T ROY SOC TROP MED H, V95, P19, DOI 10.1016/S0035-9203(01)90318-9; MARMION DE, 1953, J HYG-CAMBRIDGE, V51, P260, DOI 10.1017/S0022172400015680; Mermin JH, 1999, J INFECT DIS, V179, P1416, DOI 10.1086/314766; Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; MURPHY JR, 1987, J INFECT DIS, V156, P1005, DOI 10.1093/infdis/156.6.1005; NOLAN CM, 1981, LANCET, V1, P583; Parry CM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-73; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Passey Megan, 1995, Papua New Guinea Medical Journal, V38, P300; Pitzer VE, 2015, CLIN INFECT DIS, V61, pS251, DOI 10.1093/cid/civ710; Pitzer VE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002642; Prasad N., 2015, 9 INT C TYPH OTH INV; Pulickal AS, 2013, J TROP PEDIATRICS, V59, P317, DOI 10.1093/tropej/fmt024; Pulickal AS, 2009, CLIN VACCINE IMMUNOL, V16, P1413, DOI 10.1128/CVI.00245-09; R Core Team, 2016, R LANG ENV STAT COMP; Ram PK, 2007, EPIDEMIOL INFECT, V135, P458, DOI 10.1017/S0950268806007114; Rondini S, 2011, CLIN VACCINE IMMUNOL, V18, P460, DOI 10.1128/CVI.00387-10; SCHROEDER SA, 1968, J AMER MED ASSOC, V206, P839, DOI 10.1001/jama.206.4.839; Scobie HM, 2014, AM J TROP MED HYG, V90, P1031, DOI 10.4269/ajtmh.13-0728; Sears HJ, 1924, AM J PUBLIC HEALTH, V14, P848, DOI 10.2105/AJPH.14.10.848; Sharma PK, 2009, TROP MED INT HEALTH, V14, P696, DOI 10.1111/j.1365-3156.2009.02283.x; SHLOMOWITZ R, 1989, J INTERDISCIPL HIST, V19, P585, DOI 10.2307/203955; Shlomowitz R, 1990, J Aust Popul Assoc, V7, P116; Simonsen J, 2008, EPIDEMIOL INFECT, V136, P895, DOI 10.1017/S0950268807009314; Srikantiah P, 2007, TROP MED INT HEALTH, V12, P838, DOI 10.1111/j.1365-3156.2007.01853.x; Sutiono Agung Budi, 2010, BMC Res Notes, V3, P106, DOI 10.1186/1756-0500-3-106; Sztein MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00516; Szu SC, 2013, VACCINE, V31, P1970, DOI 10.1016/j.vaccine.2013.02.006; The Commonwealth, 2015, COMMONW YB; The World Bank, FIJ; Thompson CN, 2014, TROP MED INT HEALTH, V19, P1284, DOI 10.1111/tmi.12367; Tran HH, 2005, T ROY SOC TROP MED H, V99, P819, DOI 10.1016/j.trstmh.2005.05.007; UN Habitat, 2012, FIJ NAT URB PROF; Velema JP, 1997, TROP MED INT HEALTH, V2, P1088, DOI 10.1046/j.1365-3156.1997.d01-179.x; Watson CH, 2015, VACCINE, V33, pC42, DOI 10.1016/j.vaccine.2015.04.013; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281	76	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUL	2017	11	7							e0005786	10.1371/journal.pntd.0005786				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	FE2PD	WOS:000408057300080	28727726	DOAJ Gold, Green Published			2019-04-02	
J	Madinga, J; Polman, K; Kanobana, K; van Lieshout, L; Brienen, E; Praet, N; Kabwe, C; Gabriel, S; Dorny, P; Lutumba, P; Speybroeck, N				Madinga, Joule; Polman, Katja; Kanobana, Kirezi; van Lieshout, Lisette; Brienen, Eric; Praet, Nicolas; Kabwe, Constantin; Gabriel, Sarah; Dorny, Pierre; Lutumba, Pascal; Speybroeck, Niko			Epidemiology of polyparasitism with Taenia soliwn, schistosomes and soil-transmitted helminths in the co-endemic village of Malanga, Democratic Republic of Congo	ACTA TROPICA			English	Article						Polyparasitism; Co-infection; Helminths; Taenia solium; Schistosoma; Soil-transmitted helminths; Democratic Republic of Congo	REAL-TIME PCR; NEGLECTED TROPICAL DISEASES; PLASMODIUM-FALCIPARUM; PARASITE COINFECTION; HOOKWORM COINFECTION; INFECTIONS; AFRICA; CYSTICERCOSIS; PATTERNS; ANEMIA	Helminth co-infections are common in sub-Saharan Africa. However, little is known about the distribution and determinants of co-infections with Taenia solium taeniasis/cysticercosis. Building on a previous community based study on human cysticercosis in Malanga village, we investigated co-infections with Taenia solium, soil transmitted helminths (STHs) and Schistosoma spp and associated risk factors in a random subsample of 330 participants. Real time PCR assays were used to detect DNA of soil-transmitted helminths (STHs), 7'. solium and Schistosoma in stool samples and Schistosoma DNA in urine samples. Serum samples were tested for T. solium cysticercosis using the B158/B60 monoclonal antibody-based antigen ELISA. Bivariate analysis and logistic regression were applied to assess associations of single and co-infections with common risk factors (age, sex, area, hygiene) as well as pair wise associations between helminth species. Overall, 240 (72.7%) participants were infected with at least one helminth species; 128 (38.8%) harbored at least two helminth species (16.1% with STHs-Schistosoma, 14.5% with STHs-T. solium taeniasis/cysticercosis and 8.2% with Schistosoma-T. solium taeniasis/cysticercosis co-infections). No significant associations were found between Schistosoma-T. solium taeniasis/cysticercosis co-infection and any of the risk factors studied. Males (OR = 2 (95%CI = 1.1-5), p = 0.03) and open defecation behavior (OR = 3.8 (95%CI = 1.1-6.5), p = 0.04) were associated with higher odds of STHs-T. solium taeniasis/cysticercosis co-infection.. Village districts that were found at high risk of T. solium taeniasis/cysticercosis were also at high risk of co-infection with STHs and T. solium taeniasis/cysticercosis (OR = 3.2 (95%CI = 1.1-7.8), p = 0.03). Significant pair-wise associations were found between T. solium cysticerci and Necator americans (OR = 2.2 (95%CI = 1.2-3.8), p < 0.01) as well as Strongyloides stercoralis (OR = 2.7 (95%CI = 1.1-6.5), p = 0.02). These findings show that co-infections with T. solium are common in this polyparasitic community in DRC. Our results on risk factors of helminth co-infections and specific associations between helminths may contribute to a better integration of control within programmes that target more than one NTD.	[Madinga, Joule; Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc, Brussels, Belgium; [Madinga, Joule; Polman, Katja; Kanobana, Kirezi; Praet, Nicolas; Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [van Lieshout, Lisette; Brienen, Eric] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Kabwe, Constantin; Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO	Madinga, J (reprint author), Catholic Univ Louvain, Inst Hlth & Soc, Brussels, Belgium.; Madinga, J (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.	jmadinga@yahoo.fr; kpolman@itg.be; KIKA@iwt.be; E.A.van_Lieshout@lumc.nl; E.A.T.Brienen@lumc.nl; nicolas.x.praet@gsk.com; kako_kabwe@yahoo.fr; sgabriel@itg.be; pdorny@itg.be; pascal_lutumba@yahoo.fr; niko.speybroeck@uclouvain.be		GABRIEL, SARAH/0000-0002-2523-233X; Joule, Madinga/0000-0003-2661-234X	Belgian Development Cooperation; Fonds Wetenschappelijk Onderzoek Vlaanderen; Universite catholique de Louvain	The authors would like to thank the team of the health district of Kimpese for its contribution to the field; Bjorn Victor and Famke Janssen for their assistance with the Ag-ELISA, Daniel Bimmel and Rebecca van Grootveld for performing the PCR analysis. This work was funded by the Belgian Development Cooperation within the Framework Agreement Programme 3 between the Institute of Tropical Medicine, Antwerp and the Belgian Development Cooperation. A travel grant for Kirezi Kanobana was obtained from the Fonds Wetenschappelijk Onderzoek Vlaanderen. Joule Madinga is a PhD student supported by the developing cooperation scholarship of the Universite catholique de Louvain. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ash A., 2015, ACTA TROP; Bisanzio D, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002992; Braae UC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0938-7; Brooker S, 2009, PARASITOLOGY, V136, P1707, DOI 10.1017/S0031182009005940; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; Brooker S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-99; Brooker S, 2009, INT J PARASITOL, V39, P591, DOI 10.1016/j.ijpara.2008.10.014; Brooker SJ, 2012, J INFECT DIS, V205, P841, DOI 10.1093/infdis/jir844; Chavarria A, 2003, MICROBES INFECT, V5, P1109, DOI 10.1016/S1286-4579(03)00206-5; Coral-Almeida M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003919; Domy P., 2004, TRENDS PARASITOL, V20, P259; Ellis MK, 2007, INT J PARASITOL, V37, P1153, DOI 10.1016/j.ijpara.2007.02.008; Erhart A, 2002, T ROY SOC TROP MED H, V96, P270, DOI 10.1016/S0035-9203(02)90095-7; FLISSER A, 1993, LANCET, V342, P748, DOI 10.1016/0140-6736(93)91743-6; Friedman JF, 2005, TRENDS PARASITOL, V21, P386, DOI 10.1016/j.pt.2005.06.006; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Gordon CA, 2011, MOL CELL PROBE, V25, P143, DOI 10.1016/j.mcp.2011.05.002; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; HENRY MC, 1995, ANN SOC BELG MED TR, V75, P105; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104; Kanobana K, 2011, INT J PARASITOL, V41, P1015, DOI 10.1016/j.ijpara.2011.06.004; Klein SL, 2004, PARASITE IMMUNOL, V26, P247, DOI 10.1111/j.0141-9838.2004.00710.x; Lopez-Moreno HS, 2002, SALUD PUBLICA MEXICO, V44, P145, DOI [10.1590/S0036-36342002000200010, 10.1590/s0036-36342002000200010]; Loukas A, 2001, CLIN MICROBIOL REV, V14, P689, DOI 10.1128/CMR.14.4.689-703.2001; Macfarlane SBJ, 1997, TROP DOCT, V27, P14, DOI 10.1177/004947559702700108; Madinga J, 2017, ACTA TROP, V165, P100, DOI 10.1016/j.actatropica.2016.03.013; Naing C, 2013, T ROY SOC TROP MED H, V107, P672, DOI 10.1093/trstmh/trt086; Naing L., 2006, ARCH OROFAC SCI, P9; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Praet N, 2010, INT J PARASITOL, V40, P85, DOI 10.1016/j.ijpara.2009.07.007; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; PRINZ A, 1979, WIEN MED WOCHENSCHR, V129, P674; Pullan RL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000352; Raso G, 2006, P NATL ACAD SCI USA, V103, P6934, DOI 10.1073/pnas.0601559103; Republique Democratique du Congo MdSP, 2012, PLAN CADR LUTT INT M; Righetti AA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001889; Rimoin AW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002118; SOARES M, 2011, PLOS NEGL TROP DIS, V0005; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; ten Hove RJ, 2008, T ROY SOC TROP MED H, V102, P179, DOI 10.1016/j.trstmh.2007.10.011; Terrazas LI, 1999, PARASITOL RES, V85, P135, DOI 10.1007/s004360050522; Vaumourin E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1167-9; Verweij JJ, 2014, CLIN MICROBIOL REV, V27, P371, DOI 10.1128/CMR.00122-13; Viney ME, 2013, ADV PARASIT, V82, P321, DOI 10.1016/B978-0-12-407706-5.00005-8; WHO, 2012, REP WHO EXP CONS FOO; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; Woolhouse MEJ, 1998, PARASITOL TODAY, V14, P428, DOI 10.1016/S0169-4758(98)01318-0; Yajima A, 2011, T ROY SOC TROP MED H, V105, P68, DOI 10.1016/j.trstmh.2010.11.003; Zoli A, 2003, ACTA TROP, V87, P35, DOI 10.1016/S0001-706X(02)00289-9	56	4	4	2	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUL	2017	171						186	193		10.1016/j.actatropica.2017.03.019				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EZ5XH	WOS:000404792500029	28336269				2019-04-02	
J	Zeghir-Bouteldja, R; Polome, A; Bousbata, S; Touil-Boukoffa, C				Zeghir-Bouteldja, Razika; Polome, Andy; Bousbata, Sabrina; Touil-Boukoffa, Chafia			Comparative proteome profiling of hydatid fluid from Algerian patients reveals cyst location-related variation in Echinococcus granulosus	ACTA TROPICA			English	Article						Echinococcus granulosus; Hydatid fluid proteomics; Anatomical location; Fertility; Antigens	NITRIC-OXIDE NO; EXCRETORY/SECRETORY PRODUCTS; IN-VITRO; HOST; PROTEINS; INFECTION; MOLECULES; DIAGNOSIS; IMMUNITY; DISEASE	Human cystic echinococcosis, an endemic zoonosis in Algeria, is caused by larvae of the cestode Echinococcus granulosus. Parasitic modulation of the immune response allows E. granulosus to persist in intermediate hosts. Previous in vitro and in vivo immunological studies have shown differences in host immune responses according to the status and location of the hydatid cysts in the body. In this study, a proteomic analysis of human hydatid fluids was performed to identify the proteins in hydatid cyst fluids. Hydatid fluid was obtained after cystic surgical removal from three patients with these cysts. The study was conducted on fertile hydatid fluids from lungs, vertebra, and infertile paravertebral fluids. Comparisons of the protein compositions of these fluids revealed differences in their protein profiles. These differences are probably related to the cyst location and fertility status of the parasite. Notably, our analysis identified new proteins from the parasite and human host. The identification of host proteins in hydatid fluids indicates that the hydatid walls are permeable allowing a high protein exchange rate between the metacestode and the affected tissue. Interestingly, our study also revealed that parasite antigenic protein expression variations reflect the differences observed in host immunostimulation.	[Zeghir-Bouteldja, Razika; Touil-Boukoffa, Chafia] Univ Sci & Technol Houari Boumediene, Fac Biol Sci, Team Cytokines & NO Synthases, Lab Cellular & Mol Biol, PB 32 El Alia, Algiers 16111, Algeria; [Zeghir-Bouteldja, Razika] Akli Mohand Oulhadj Univ, Dept Biol Sci, Bouira, Algeria; [Polome, Andy; Bousbata, Sabrina] Univ Libre Bruxelles, Dept Mol Biol, Microbiol Lab, Prote Platform, Brussels, Belgium	Touil-Boukoffa, C (reprint author), Univ Sci & Technol Houari Boumediene, Fac Biol Sci, Team Cytokines & NO Synthases, Lab Cellular & Mol Biol, PB 32 El Alia, Algiers 16111, Algeria.	bouteldja_raz@yahoo.fr; andy.polome@ulb.ac.be; sabrina.bousbata@ulb.ac.be; touilboukoffa@yahoo.fr			Thematic Research Agency in Health Sciences [PNR43/ANDRS/2011]	This work was supported by Thematic Research Agency in Health Sciences (PNR43/ANDRS/2011).	Aissa S. A., 2006, Cellular and Molecular Biology, V52, P65; Andrade MA, 2004, NITRIC OXIDE-BIOL CH, V10, P150, DOI 10.1016/j.niox.2004.03.002; Areshkov PO, 2012, INT J BIOL SCI, V8, P39, DOI 10.7150/ijbs.8.39; Aziz A, 2011, J PROTEOMICS, V74, P1560, DOI 10.1016/j.jprot.2011.02.021; Baz A, 1998, PARASITE IMMUNOL, V20, P399, DOI 10.1046/j.1365-3024.1998.00147.x; Chemale G, 2003, PROTEOMICS, V3, P1633, DOI 10.1002/pmic.200300487; Choi EH, 2001, GENES IMMUN, V2, P248, DOI 10.1038/sj.gene.6363767; Cui SJ, 2013, J PROTEOMICS, V84, P158, DOI 10.1016/j.jprot.2013.04.013; DELGIUDICE G, 1994, EXPERIENTIA, V50, P1061; Diaz A, 2000, MOL BIOCHEM PARASIT, V110, P171, DOI 10.1016/S0166-6851(00)00256-5; Diaz A, 2011, TRENDS PARASITOL, V27, P204, DOI 10.1016/j.pt.2010.12.012; Dobbin CA, 2002, J IMMUNOL, V169, P958, DOI 10.4049/jimmunol.169.2.958; FARMER PM, 1990, ANN CLIN LAB SCI, V20, P385; He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Khabiri AR, 2006, PARASITE IMMUNOL, V28, P357, DOI 10.1111/j.1365-3024.2006.00837.x; Latif AA, 2013, J ANIM PLANT SCI, V23, P405; Li J, 2004, GENE, V326, P157, DOI 10.1016/j.gene.2003.10.027; LIGHTOWLERS MW, 1989, MOL BIOCHEM PARASIT, V37, P171, DOI 10.1016/0166-6851(89)90149-7; Lorenzatto KR, 2012, GENE, V506, P76, DOI 10.1016/j.gene.2012.06.046; Martinez J, 1999, FOLIA PARASIT, V46, P76; Mezioug D, 2009, PARASITE, V16, P57, DOI 10.1051/parasite/2009161057; Mezioug D, 2012, EUR CYTOKINE NETW, V23, P112, DOI 10.1684/ecn.2012.0314; Monteiro KM, 2010, PROTEOMICS, V10, P1985, DOI 10.1002/pmic.200900506; Nair MG, 2006, J IMMUNOL, V177, P1393, DOI 10.4049/jimmunol.177.3.1393; Ortona E, 2002, CLIN EXP IMMUNOL, V128, P124, DOI 10.1046/j.1365-2249.2002.01807.x; Ortona E, 2001, CLIN EXP IMMUNOL, V125, P110, DOI 10.1046/j.1365-2249.2001.01569.x; Parkinson J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001897; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Siles-Lucas M, 2008, EXP PARASITOL, V119, P516, DOI 10.1016/j.exppara.2008.01.009; SIRACUSANO A, 2009, INTERDISCIP PERSPECT, DOI DOI 10.1155/2009/4743681; Siracusano Alessandra, 2012, Endocrine Metabolic & Immune Disorders-Drug Targets, V12, P16; Siracusano A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/639362; Sutherland TE, 2014, NAT IMMUNOL, V15, P1116, DOI 10.1038/ni.3023; Touil-Boukoffa C, 1998, BIOCHIMIE, V80, P739, DOI 10.1016/S0300-9084(99)80027-3; TouilBoukoffa C, 1997, J INTERF CYTOK RES, V17, P211, DOI 10.1089/jir.1997.17.211; Virag L, 2003, TOXICOL LETT, V140, P113, DOI 10.1016/S0378-4274(02)00508-8; Virginio VG, 2012, MOL BIOCHEM PARASIT, V183, P15, DOI 10.1016/j.molbiopara.2012.01.001; Wang Y, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0423-8; Xu QB, 1997, J CLIN INVEST, V100, P1089, DOI 10.1172/JCI119619; Zeghir-Bouteldja R, 2013, PARASITOL RES, V112, P649, DOI 10.1007/s00436-012-3181-6; Zhang WB, 2003, CLIN MICROBIOL REV, V16, P18, DOI [10.1128/CMR.16.1.18-36.2003, 10.1128/CMR.16.1.1.18-36.2003]; Zhang WB, 2008, J IMMUNOL, V181, P6679, DOI 10.4049/jimmunol.181.10.6679	43	4	4	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUL	2017	171						199	206		10.1016/j.actatropica.2017.03.034				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EZ5XH	WOS:000404792500031	28412048				2019-04-02	
J	Geurden, T; Borowski, S; Wozniakiewicz, M; King, V; Fourie, J; Liebenberg, J				Geurden, Thomas; Borowski, Stasia; Wozniakiewicz, Magda; King, Vickie; Fourie, Josephus; Liebenberg, Julian			Comparative efficacy of a new spot-on combination product containing selamectin and sarolaner (Stronghold (R) Plus) versus fluralaner (Bravecto (R)) against induced infestations with Ixodes ricinus ticks on cats	PARASITES & VECTORS			English	Article						Ixodes ricinus; Cats; Efficacy; Persistent; Application; Sarolaner; Selamectin; Fluralaner	DOGS; EUROPE; FORMULATION; SAFETY	Background: Ticks are increasingly reported on cats worldwide, with Ixodes ricinus being a relevant species across Europe and in near by areas of North Africa and the Middle East. Yet there are few acaracidal products with proven efficacy approved for use in cats. The objective of this study was to compare the efficacy of a new spot-on formulation containing selamectin and sarolaner with a topical application of fluralaner (Bravecto (R)) against Ixodes ricinus ticks on cats. To that end, twenty-four (24) cats were randomly allocated to one of three treatment groups. The cats in the control group remained untreated. Cats in group 2 were treated with selamectin/sarolaner (Stronghold (R) Plus; Zoetis) at the minimum recommended dose of 1.0 mg/kg sarolaner and 6.0 mg/kg selamectin on Days 0, 30 and 60. The cats in group 3 received a fluralaner treatment (Bravecto (R) spot-on solution for cats, MSD) at the minimum recommended dose of 40.0 mg/kg on Day 0. Cats were infested with 50 (+/- 4) viable, adult, unfed I. ricinus ticks on Days 26, 54, 82 and 89 and ticks were removed for counting 48 h (+/- 2 h) later. Results: Three monthly treatments with selamectin/sarolaner provided high and consistent efficacy against I. ricinus for the entire duration of the study period. In contrast, the efficacy of fluralaner declined in the second month after treatment and was below the efficacy threshold of 90% on Days 56, 84 and 91. The percentage efficacy against I. ricinus was numerically higher in the selemectin/sarolaner treated group than in the fluralaner-treated group on Days 56, 84 and 91. Furthermore, greasiness and spiking of the hair, as well as white deposits were frequently observed in the fluralaner-treated cats. Conclusion: The results of the present study confirm the high and consistent efficacy of a new spot-on combination product containing selamectin and sarolaner against I. ricinus in cats, and indicate a decline in fluralaner efficacy during the 91 day period after treatment.	[Geurden, Thomas; Borowski, Stasia; Wozniakiewicz, Magda] Zoetis, Vet Med Res & Dev, Mercurius Str 20, B-1930 Zaventem, Belgium; [King, Vickie] Zoetis, Vet Med Res & Dev, Portage Rd 333, Kalamazoo, MI 49007 USA; [Fourie, Josephus; Liebenberg, Julian] Univ Bloemfontein, Clinvet, POB 11186, Bloemfontein 9321, South Africa	Geurden, T (reprint author), Zoetis, Vet Med Res & Dev, Mercurius Str 20, B-1930 Zaventem, Belgium.	thomas.geurden@zoetis.com			Zoetis	The study reported here was funded by Zoetis.	[Anonymous], 2016, EMA8430292015; Becskei C, 2017, VET PARASITOL, V238, pS8, DOI 10.1016/j.vetpar.2017.03.009; Beugnet F, 2009, VET PARASITOL, V163, P298, DOI 10.1016/j.vetpar.2009.03.028; Claerebout E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-183; Geurden T, 2017, VET PARASITOL, V238, pS12, DOI 10.1016/j.vetpar.2017.03.008; Geurden T, 2017, VET PARASITOL, V238, pS3, DOI 10.1016/j.vetpar.2017.02.028; Kilp S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1564-8; McTier TL, 2016, VET PARASITOL, V222, P3, DOI 10.1016/j.vetpar.2016.02.019; Ogden NH, 2000, MED VET ENTOMOL, V14, P332, DOI 10.1046/j.1365-2915.2000.00244.x; Stanneck D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-66	10	0	0	2	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JUN 29	2017	10								319	10.1186/s13071-017-2259-5				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	FB1JS	WOS:000405900300003	28662690	DOAJ Gold, Green Published			2019-04-02	
J	Araujo, S; Goulart, LR; Truman, RW; Goulart, IMB; Vissa, V; Li, W; Matsuoka, M; Suffys, P; Fontes, AB; Rosa, PS; Scollard, DM; Williams, DL				Araujo, Sergio; Goulart, Luiz Ricardo; Truman, Richard W.; Goulart, Isabela Maria B.; Vissa, Varalakshmi; Li, Wei; Matsuoka, Masanori; Suffys, Philip; Fontes, Amanda B.; Rosa, Patricia S.; Scollard, David M.; Williams, Diana L.			qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients	PLOS NEGLECTED TROPICAL DISEASES			English	Article							REAL-TIME PCR; RESISTANT LEPROSY; DIHYDROPTEROATE SYNTHASE; UNITED-STATES; MUTATIONS; INDIA	Background Real-Time PCR-High Resolution Melting (qPCR-HRM) analysis has been recently described for rapid drug susceptibility testing (DST) of Mycobacterium leprae. The purpose of the current study was to further evaluate the validity, reliability, and accuracy of this assay for M. leprae DST in clinical specimens. Methodology/Principal findings The specificity and sensitivity for determining the presence and susceptibility of M. leprae to dapsone based on the folP1 drug resistance determining region (DRDR), rifampin (rpoB DRDR) and ofloxacin (gyrA DRDR) was evaluated using 211 clinical specimens from leprosy patients, including 156 multibacillary (MB) and 55 paucibacillary (PB) cases. When comparing the results of qPCR-HRM DST and PCR/direct DNA sequencing, 100% concordance was obtained. The effects of in-house phenol/chloroform extraction versus column-based DNA purification protocols, and that of storage and fixation protocols of specimens for qPCR-HRM DST, were also evaluated. qPCR-HRM results for all DRDR gene assays (folP1, rpoB, and gyrA) were obtained from both MB (154/156; 98.7%) and PB (35/55; 63.3%) patients. All PCR negative specimens were from patients with low numbers of bacilli enumerated by an M. leprae-specific qPCR. We observed that frozen and formalin-fixed paraffin embedded (FFPE) tissues or archival Fite's stained slides were suitable for HRM analysis. Among 20 mycobacterial and other skin bacterial species tested, only M. lepromatosis, highly related to M. leprae, generated amplicons in the qPCR-HRM DST assay for folP1 and rpoB DRDR targets. Both DNA purification protocols tested were efficient in recovering DNA suitable for HRM analysis. However, 3% of clinical specimens purified using the phenol/chloroform DNA purification protocol gave false drug resistant data. DNA obtained from freshly frozen (n = 172), formalin-fixed paraffin embedded (FFPE) tissues (n = 36) or archival Fite's stained slides (n = 3) were suitable for qPCR-HRM DST analysis. The HRM-based assay was also able to identify mixed infections of susceptible and resistant M. leprae. However, to avoid false positives we recommend that clinical specimens be tested for the presence of the M. leprae using the qPCR-RLEP assay prior to being tested in the qPCR-HRM DST and that all specimens demonstrating drug resistant profiles in this assay be subjected to DNA sequencing. Conclusion/Significance Taken together these results further demonstrate the utility of qPCR-HRM DST as an inexpensive screening tool for large-scale drug resistance surveillance in leprosy.	[Araujo, Sergio; Goulart, Luiz Ricardo; Goulart, Isabela Maria B.] Univ Fed Uberlandia, Natl Reference Ctr Sanit Dermatol & Leprosy, Uberlandia, MG, Brazil; [Araujo, Sergio; Goulart, Luiz Ricardo; Goulart, Isabela Maria B.] Univ Fed Uberlandia, Sch Med, Postgrad Program Hlth Sci, Uberlandia, MG, Brazil; [Araujo, Sergio; Truman, Richard W.; Scollard, David M.; Williams, Diana L.] US Dept Hlth & Human Serv DHHS, Div Natl Hansens Dis Programs NHDP, HSB, HRSA, Baton Rouge, LA 70821 USA; [Goulart, Luiz Ricardo] Univ Fed Uberlandia, Inst Genet & Biochem, Uberlandia, MG, Brazil; [Vissa, Varalakshmi] Good Samaritan Soc, Ft Collins, CO USA; [Li, Wei] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Matsuoka, Masanori] Natl Inst Infect Dis, Leprosy Res Ctr, Tokyo, Japan; [Suffys, Philip; Fontes, Amanda B.] Fundacao Oswaldo Cruz, Lab Mol Biol Appl Mycobacteria, Rio De Janeiro, RJ, Brazil; [Suffys, Philip] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Rosa, Patricia S.] Inst Lauro Souza Lima, Dept Biol, Sao Paulo, Brazil	Araujo, S (reprint author), Univ Fed Uberlandia, Natl Reference Ctr Sanit Dermatol & Leprosy, Uberlandia, MG, Brazil.; Araujo, S (reprint author), Univ Fed Uberlandia, Sch Med, Postgrad Program Hlth Sci, Uberlandia, MG, Brazil.; Araujo, S; Williams, DL (reprint author), US Dept Hlth & Human Serv DHHS, Div Natl Hansens Dis Programs NHDP, HSB, HRSA, Baton Rouge, LA 70821 USA.	saraujo@gmx.com; dwilliams2@hrsa.gov			Foundation for Research Support of the State of Minas Gerais (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais FAPEMIG); Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq); Brazilian Coordinating Office for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES); National Fund for Health/Brazilian Ministry of Health; Damien Foundation; U.S. Department of Health and Human Services (DHHS); Health Resources and Services Administration (HRSA); Healthcare Systems Bureau (HSB); National Hansen's Disease Programs; CAPES; National Institutes of Health/NIAID [YI-M-2646]	This study was financially supported in Brazil with grants from: Foundation for Research Support of the State of Minas Gerais (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais FAPEMIG), Brazilian National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq), Brazilian Coordinating Office for the Improvement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - CAPES), and by the National Fund for Health/Brazilian Ministry of Health and the Damien Foundation. In the US the study was supported by the U.S. Department of Health and Human Services (DHHS), Health Resources and Services Administration (HRSA), Healthcare Systems Bureau (HSB), National Hansen's Disease Programs. SA received a PDSE fellowship from CAPES during the conduction of the experiments in the NHDP facilities, National Institutes of Health/NIAID YI-M-2646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Contreras MMC, 2014, J CLIN MICROBIOL, V52, P4359, DOI DOI 10.1128/JCM.01688-14; ELLARD GA, 1984, INT J LEPROSY, V52, P395; Kai M, 1999, FEMS MICROBIOL LETT, V177, P231, DOI 10.1016/S0378-1097(99)00313-4; Lavania M, 2015, CLIN MICROBIOL INFEC, V21, pE85, DOI 10.1016/j.cmi.2015.08.004; Lavania M, 2014, LEPROSY REV, V85, P177; Li W, 2012, J CLIN MICROBIOL, V50, P742, DOI 10.1128/JCM.05183-11; Martin A, 2010, TUBERCULOSIS, V90, P201, DOI 10.1016/j.tube.2010.03.012; Matsuoka M, 2007, LEPROSY REV, V78, P343; Matsuoka M, 2010, JPN J INFECT DIS, V63, P1; PEARSON JMH, 1975, LANCET, V2, P69; Reja AHH, 2015, INDIAN J DERMATOL VE, V81, P155, DOI 10.4103/0378-6323.152185; Rocha AD, 2012, J CLIN MICROBIOL, V50, P1912, DOI 10.1128/JCM.06561-11; Saunderson PR, 2016, CLIN DERMATOL, V34, P79, DOI 10.1016/j.clindermatol.2015.10.019; Singh P, 2015, P NATL ACAD SCI USA, V112, P4459, DOI 10.1073/pnas.1421504112; Truman RW, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000328; Truman RW, 2001, INT J LEPROSY, V69, P1; WHO, 2016, LEPR DIS; WHO, 2009, GUID SURV DRUG RES L; WHO, 1982, CHEM LEPR CONTR PROG, P1; WHO, 2009, WKLY EPIDEMIOL REC, P264; Williams DL, 2014, CLIN INFECT DIS, V58, P72, DOI 10.1093/cid/cit628; Williams DL, 2012, LEPROSY REV, V83, P269; Williams DL, 2013, EMERG INFECT DIS, V19, P179, DOI 10.3201/eid1901.120864; Williams DL, 2000, ANTIMICROB AGENTS CH, V44, P1530, DOI 10.1128/AAC.44.6.1530-1537.2000; World Health Organization, 2012, World Health Organ Tech Rep Ser, P1	25	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2017	11	6							e0005506	10.1371/journal.pntd.0005506				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EZ9WL	WOS:000405080700007	28570560	DOAJ Gold, Green Published			2019-04-02	
J	Deep, DK; Singh, R; Bhandari, V; Verma, A; Sharma, V; Wajid, S; Sundar, S; Ramesh, V; Dujardin, JC; Salotra, P				Deep, Deepak Kumar; Singh, Ruchi; Bhandari, Vasundhra; Verma, Aditya; Sharma, Vanila; Wajid, Saima; Sundar, Shyam; Ramesh, V.; Dujardin, Jean Claude; Salotra, Poonam			Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress	PLOS NEGLECTED TROPICAL DISEASES			English	Article							VISCERAL LEISHMANIASIS; DERMAL LEISHMANIASIS; REACTIVE OXYGEN; L. DONOVANI; PROMASTIGOTES; EXPRESSION; ANTIMONY; SUSCEPTIBILITY; IDENTIFICATION; TRANSLOCATION	Background Miltefosine (MIL) is an oral antileishmanial drug used for treatment of visceral leishmaniasis (VL) in the Indian subcontinent. Recent reports indicate a significant decline in its efficacy with a high rate of relapse in VL as well as post kala-azar dermal leishmaniasis (PKDL). We investigated the parasitic factors apparently involved in miltefosine unresponsiveness in clinical isolates of Leishmania donovani. Methodology L. donovani isolated from patients of VL and PKDL at pretreatment stage (LdPreTx, n = 9), patients that relapsed after MIL treatment (LdRelapse, n = 7) and parasites made experimentally resistant to MIL (LdM30) were included in this study. MIL uptake was estimated using liquid chromatography coupled mass spectrometry. Reactive oxygen species and intracellular thiol content were measured fluorometrically. Q-PCR was used to assess the differential expression of genes associated with MIL resistance. Results LdRelapse parasites exhibited higher IC50 both at promastigote level (7.92 +/- 1.30 mu M) and at intracellular amastigote level (11.35 +/- 6.48 mu M) when compared with LdPreTx parasites (3.27 +/- 1.52 mu M) and (3.85 +/- 3.11 mu M), respectively. The percent infectivity (72 hrs post infection) of LdRelapse parasites was significantly higher (80.71 +/- 5.67%, P<0.001) in comparison to LdPreTx (60.44 +/- 2.80%). MIL accumulation was significantly lower in LdRelapse parasites (1.7 fold, P<0.001) and in LdM30 parasites (2.4 fold, P<0.001) when compared with LdPreTx parasites. MIL induced ROS levels were significantly lower (p<0.05) in macrophages infected with LdRelapse while intracellular thiol content were significantly higher in LdRelapse compared to LdPreTx, indicating a better tolerance for oxidative stress in LdRelapse isolates. Genes associated with oxidative stress, metabolic processes and transporters showed modulated expression in LdRelapse and LdM30 parasites in comparison with LdPreTx parasites. Conclusion The present study highlights the parasitic factors and pathways responsible for miltefosine unresponsiveness in VL and PKDL.	[Deep, Deepak Kumar; Singh, Ruchi; Bhandari, Vasundhra; Verma, Aditya; Sharma, Vanila; Salotra, Poonam] Natl Inst Pathol ICMR, Safdarjung Hosp Campus, New Delhi, India; [Deep, Deepak Kumar; Wajid, Saima] Jamia Hamdard, Fac Sci, Dept Biotechnol, New Delhi, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Varanasi, Uttar Pradesh, India; [Ramesh, V.] Safdarjang Hosp, Dermatol Dept, New Delhi, India; [Ramesh, V.] VMMC, New Delhi, India; [Dujardin, Jean Claude] Inst Trop Med, Unit Mol Parasitol, Dept Parasitol, Antwerp, Belgium; [Bhandari, Vasundhra] Univ Hyderabad, Sch Life Sci, Hyderabad, Telangana, India	Salotra, P (reprint author), Natl Inst Pathol ICMR, Safdarjung Hosp Campus, New Delhi, India.	salotra@vsnl.com	Singh, Ruchi/C-8608-2011	Singh, Ruchi/0000-0001-8094-4703	Indian Council of Medical Research [EC-FP7-222895]; Council for Scientific and Industrial Research, India	This work was supported by EC-FP7-222895, https://ec.europa.eu/research/fp7, Indian Council of Medical Research, www.icimr.nic.in DKD is grateful to Council for Scientific and Industrial Research, India for providing research fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcolea PJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2672-8; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Bhandari V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001657; Canuto GAB, 2014, ANAL BIOANAL CHEM, V406, P3459, DOI 10.1007/s00216-014-7772-1; Carter KC, 2006, ANTIMICROB AGENTS CH, V50, P88, DOI 10.1128/AAC.50.1.88-95.2006; Carvalho L, 2009, ANTIMICROB AGENTS CH, V53, P305; Das M, 2013, FEBS J, V280, P4807, DOI 10.1111/febs.12449; Dorlo TPC, 2008, J CHROMATOGR B, V865, P55, DOI 10.1016/j.jchromb.2008.02.005; Filardy AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085715; Ghosh AK, 2015, FASEB J, V29, P2081, DOI 10.1096/fj.14-258624; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kulshrestha A, 2014, PARASITOL RES, V113, P1171, DOI 10.1007/s00436-014-3755-6; Kulshrestha A, 2013, PARASITOL RES, V112, P825, DOI 10.1007/s00436-012-3212-3; Kulshrestha A, 2011, ANTIMICROB AGENTS CH, V55, P2916, DOI 10.1128/AAC.00812-10; Kumar D, 2012, PARASITOL RES, V111, P223, DOI 10.1007/s00436-012-2823-z; Maarouf M, 1998, PARASITE, V5, P167, DOI 10.1051/parasite/1998052167; Mishra J, 2013, EXP PARASITOL, V135, P397, DOI 10.1016/j.exppara.2013.08.004; Mondal D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000832; Mondelaers A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154101; Moreira D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001469; Mukhopadhyay R, 2011, INT J PARASITOL, V41, P1311, DOI 10.1016/j.ijpara.2011.07.013; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Perez-Victoria FJ, 2006, J BIOL CHEM, V281, P23766, DOI 10.1074/jbc.M605214200; Perez-Victoria FJ, 2003, ANTIMICROB AGENTS CH, V47, P2397, DOI 10.1128/AAC.47.8.2397-2403.2003; Rai K, 2013, MBIO, V4, DOI 10.1128/mBio.00611-13; Ramesh V, 2015, PLoS Negl Trop Dis, V9, pe0004289, DOI 10.1371/journal.pntd.0004289; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; SACKS DL, 1985, J IMMUNOL, V135, P564; Seifert K, 2003, INT J ANTIMICROB AG, V22, P380, DOI 10.1016/S0924-8579(03)00125-0; Shakarian AM, 2010, MOL CELL BIOCHEM, V341, P17, DOI 10.1007/s11010-010-0433-6; Singh R, 2006, J INFECT DIS, V194, P302, DOI 10.1086/505079; Singh R, 2010, INT J ANTIMICROB AG, V36, P50, DOI 10.1016/j.ijantimicag.2010.03.012; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2012, CLIN INFECT DIS, V55, P543, DOI 10.1093/cid/cis474; Vacchina P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1904-8; Vacchina P, 2016, ANTIMICROB AGENTS CH, V60, P4089, DOI 10.1128/AAC.00478-16; Verma NK, 2004, ANTIMICROB AGENTS CH, V48, P3010, DOI 10.1128/AAC.48.8.3010-3015.2004; World Health Organization, 2010, M WHO EXP COMM CONTR	38	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2017	11	6							e0005641	10.1371/journal.pntd.0005641				16	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EZ9WL	WOS:000405080700031	28575060	DOAJ Gold, Green Published			2019-04-02	
J	Hendy, A; Sluydts, V; Tushar, T; De Witte, J; Odonga, P; Loum, D; Nyaraga, M; Lakwo, T; Dujardin, JC; Post, R; Kalinga, A; Echodu, R				Hendy, Adam; Sluydts, Vincent; Tushar, Taylor; De Witte, Jacobus; Odonga, Patrick; Loum, Denis; Nyaraga, Michael; Lakwo, Thomson; Dujardin, Jean-Claude; Post, Rory; Kalinga, Akili; Echodu, Richard			Esperanza Window Traps for the collection of anthropophilic blackflies (Diptera: Simuliidae) in Uganda and Tanzania	PLOS NEGLECTED TROPICAL DISEASES			English	Article							DAMNOSUM COMPLEX DIPTERA; ONCHOCERCIASIS TRANSMISSION; HEMATOPHAGOUS DIPTERA; OLFACTORY STIMULI; ANOPHELES-GAMBIAE; CARBON-DIOXIDE; NORTHERN GHANA; BITING FLIES; AFRICA; BEHAVIOR	There is an increasing need to evaluate the impact of chemotherapeutic and vector-based interventions as onchocerciasis affected countries work towards eliminating the disease. The Esperanza Window Trap (EWT) provides a possible alternative to human landing collections (HLCs) for the collection of anthropophilic blackflies, yet it is not known whether current designs will prove effective for onchocerciasis vectors throughout sub-Saharan Africa. EWTs were deployed for 41 days in northern Uganda and south eastern Tanzania where different Simulium damnosum sibling species are responsible for disease transmission. The relative efficacy of EWTs and HLCs was compared, and responses of host-seeking blackflies to odour baits, colours, and yeast-produced CO2 were investigated. Blue EWTs baited with CO2 and worn socks collected 42.3% (2,393) of the total S. damnosum s.l. catch in northern Uganda. Numbers were comparable with those collected by HLCs (32.1%, 1,817), and higher than those collected on traps baited with CO2 and BG-Lure (25.6%, 1,446), a synthetic human attractant. Traps performed less well for the collection of S. damnosum s.l. in Tanzania where HLCs (72.5%, 2,432) consistently outperformed both blue (16.8%, 563) and black (10.7%, 360) traps baited with CO2 and worn socks. HLCs (72.3%, 361) also outperformed sock-baited (6.4%, 32) and BG-Lure-baited (21.2%, 106) traps for the collection of anthropophilic Simulium bovis in northern Uganda. Contrasting blackfly distributions were observed on traps in Uganda and Tanzania, indicating differences in behaviour in each area. The success of EWT collections of S. damnosum s.l. in northern Uganda was not replicated in Tanzania, or for the collection of anthropophilic S. bovis. Further research to improve the understanding of behavioural responses of vector sibling species to traps and their attractants should be encouraged.	[Hendy, Adam; De Witte, Jacobus; Dujardin, Jean-Claude] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Sluydts, Vincent] Univ Antwerp, Dept Biol, Evolutionary Ecol Grp, Antwerp, Belgium; [Tushar, Taylor; Post, Rory] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Odonga, Patrick; Loum, Denis; Nyaraga, Michael; Lakwo, Thomson] Minist Hlth, Vector Control Div, Kampala, Uganda; [Post, Rory] Liverpool John Moores Univ, Sch Nat Sci & Psychol, Liverpool, Merseyside, England; [Kalinga, Akili] Tukuyu Res Ctr, Natl Inst Med Res, Tukuyu, Tanzania; [Echodu, Richard] Gulu Univ, Fac Sci, Gulu, Uganda	Hendy, A (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.	adam_hendy@hotmail.co.uk		Hendy, Adam/0000-0001-8082-6352	Department of Economy, Science and Innovation (EWI) of the Flemish government through a "Structural Research Funding" (SOFI) grant of the Institute of Tropical Medicine, Antwerp; Flemish Interuniversity Council South Initiative (VLIR-UOS)	Financial support was provided through the Department of Economy, Science and Innovation (EWI) of the Flemish government through a "Structural Research Funding" (SOFI) grant of the Institute of Tropical Medicine, Antwerp, and the Flemish Interuniversity Council South Initiative (VLIR-UOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achee NL, 2015, VECTOR-BORNE ZOONOT, V15, P89, DOI 10.1089/vbz.2014.1628; Adler P.H., 2004, BLACK FLIES SIMULIID; Adler PH, 2010, INFECT GENET EVOL, V10, P846, DOI 10.1016/j.meegid.2010.07.003; African Programme for Onchocerciasis Control, 2013, JAF195 AFR PROGR ONC; African Programme for Onchocerciasis Control. Programme for the Elimination of Neglected Diseases in Africa (PENDA), 2013, JAF198 AFR PROGR ONC; ALLAN SA, 1987, ANNU REV ENTOMOL, V32, P297, DOI 10.1146/annurev.en.32.010187.001501; BENNETT GF, 1972, CAN J ZOOLOG, V50, P793, DOI 10.1139/z72-108; Biogents, 2016, BG SENT RES MOSQ TRA; BRADBURY WC, 1974, CAN J ZOOL, V52, P1355, DOI 10.1139/z74-173; BRADBURY WC, 1974, CAN J ZOOL, V52, P251, DOI 10.1139/z74-030; BROWN AWA, 1962, B WORLD HEALTH ORGAN, V27, P511; BROWNE SM, 1980, J MED ENTOMOL, V17, P58, DOI 10.1093/jmedent/17.1.58; CHEKE RA, 1987, TROP MED PARASITOL, V38, P62; Colebunders R, 2015, TROP MED INT HEALTH, V20, P194, DOI 10.1111/tmi.12421; Crosskey R. W., 1957, Annals of Tropical Medicine and Parasitology, V51, P80; Crosskey RW, 1990, NATURAL HIST BLACKFL; DAVIES D. M., 1951, CANADIAN JOUR ZOOL, V29, P65, DOI 10.1139/z51-006; DAVIES D. M., 1961, PROC ENTOMOL SOC ONTARIO, V91, P267; Davies D.M., 1972, Proceedings of the Entomological Society of Ontario, V102, P124; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; DUKE B. O. L., 1958, ANN TROP MED AND PARASITOL, V52, P274; FALLIS AM, 1975, J MED ENTOMOL, V12, P349, DOI 10.1093/jmedent/12.3.349; FALLIS AM, 1964, CAN J ZOOLOG, V42, P723, DOI 10.1139/z64-069; Freeman P., 1953, SIMULIIDAE ETHIOPIAN; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; Habbema JD, 2003, FILARIA J, V2, P8, DOI DOI 10.1186/1475-2883-2-8; HAM PJ, 1986, TROP MED PARASITOL, V37, P80; Hausermann W, 1966, Acta Trop, V23, P365; Hausermann W., 1969, ACTA TROP, V26, P29; Jacob BG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002342; KALOOSTIAN G, 1961, J ECON ENTOMOL, V54, P1009, DOI 10.1093/jee/54.5.1009; Kamga GR, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1868-8; Krueger A, 2006, MED VET ENTOMOL, V20, P60, DOI 10.1111/j.1365-2915.2006.00606.x; Krueger A, 2006, MED VET ENTOMOL, V20, P76, DOI 10.1111/j.1365-2915.2006.00607.x; Kruger A, 2005, ANN TROP MED PARASIT, V99, P293, DOI 10.1179/136485905X28009; Lakwo TL, 2014, INT J OPHTHALMOLOGY, V2, P17; Lamberton PHL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1703-2; Lamberton PHL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003688; Lamberton PHL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0511-9; Lawrence J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003507; LEWIS D J, 1974, Revue de Zoologie Africaine, V88, P225; LEWIS DJ, 1953, B ENTOMOL RES, V43, P597, DOI 10.1017/S0007485300026705; Lovett J. C., 1993, ASSESSMENT CONDITION; MCMAHON JP, 1967, B WORLD HEALTH ORGAN, V37, P415; Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Post RJ, 2007, TROP MED INT HEALTH, V12, P1342, DOI 10.1111/j.1365-3156.2007.01921.x; R Core Team, 2016, R LANG ENV STAT COMP; RAYBOULD JN, 1979, TROPENMED PARASITOL, V30, P505; RENZ A, 1983, T ROY SOC TROP MED H, V77, P748, DOI 10.1016/0035-9203(83)90278-X; Renz A, 1989, ADULT SIMULIUM DAMNO; Rodriguez-Perez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076814; RYAN L, 1981, INSECT SCI APPL, V1, P349, DOI 10.1017/S1742758400000643; Service MW, 1979, ANN TROP MED PARASIT, V73, P487; Service MW, 1977, METH SAMPL AD SIM SP; Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292; SUTCLIFFE JF, 1986, CAN J ZOOL, V64, P1041, DOI 10.1139/z86-156; SUTCLIFFE JF, 1987, INSECT SCI APPL, V8, P611, DOI 10.1017/S1742758400022682; Sutcliffe JF, 2010, ECOLOGY CONTROL VECT, P438; Swanson DA, 2012, MED VET ENTOMOL, V26, P56, DOI 10.1111/j.1365-2915.2011.00963.x; Swanson DA, 2010, MED VET ENTOMOL, V24, P182, DOI 10.1111/j.1365-2915.2010.00862.x; Temmen GmbH, 2016, TEMMEN INS 2016; The Carter Center, 2013, EYE EAGLE, V14, P5; The Carter Center and Ministry of Health Uganda, 2014, P 7 SESS UG ONCH EL; THOMPSON BH, 1977, TROPENMED PARASITOL, V28, P83; THOMPSON BH, 1976, TROPENMED PARASITOL, V27, P455; Toe LD, 2014, ACTA TROP, V137, P39, DOI 10.1016/j.actatropica.2014.04.029; TORR SJ, 1989, PHYSIOL ENTOMOL, V14, P325, DOI 10.1111/j.1365-3032.1989.tb01100.x; Torr SJ, 2010, ECOLOGY CONTROL VECT, P438; Traore S, 1997, B SOC PATHOL EXOT, V90, P358; Uganda Bureau of Statistics, 2014, DISTR PROF ADM REC K; WAHL G, 1991, TROP MED PARASITOL, V42, P368; WALSH JF, 1980, TROPENMED PARASITOL, V31, P479; WALSH JF, 1978, TROPENMED PARASITOL, V29, P492; WALSH JF, 1978, T ROY SOC TROP MED H, V72, P675, DOI 10.1016/0035-9203(78)90039-1; *WHO, 2001, WHOCDSCPECEE2001; World Health Organization, 1966, WHO EXP COMM ONCH; World Health Organization, 2016, GUID STOPP MASS DRUG; World Health Organization, 2015, DIRPMAPOCREPTCC40 WH; Young RM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003450	80	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2017	11	6							e0005688	10.1371/journal.pntd.0005688				22	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EZ9WL	WOS:000405080700061	28628653	DOAJ Gold, Green Published			2019-04-02	
J	Perez, SC; Folkesson, E; Anglaret, X; Beavogui, AH; Berbain, E; Camara, AM; Depoortere, E; Lefevre, A; Maes, P; Malme, KN; Malvy, JMD; Ombelet, S; Poelaert, G; Sissoko, D; Tounkara, A; Trbovic, P; Piguet, P; Antierens, A				Perez, Sara Carazo; Folkesson, Elin; Anglaret, Xavier; Beavogui, Abdoul-Habib; Berbain, Emmanuel; Camara, Alseny-Modet; Depoortere, Evelyn; Lefevre, Annabelle; Maes, Piet; Malme, Kristian Nodtvedt; Malvy, Jean-Marie Denis; Ombelet, Sien; Poelaert, Geertrui; Sissoko, Daouda; Tounkara, Alexis; Trbovic, Pierre; Piguet, Pascal; Antierens, Annick			Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa	PLOS NEGLECTED TROPICAL DISEASES			English	Article							VIRUS-DISEASE; FAVIPIRAVIR T-705; HEMORRHAGIC-FEVER; OUTBREAK; INFECTION; MODEL; THERAPIES; CHILDREN	During the large Ebola outbreak that affected West Africa in 2014 and 2015, studies were launched to evaluate potential treatments for the disease. A clinical trial to evaluate the effectiveness of the antiviral drug favipiravir was conducted in Guinea. This paper describes the main challenges of the implementation of the trial in the Ebola treatment center of Gueckedou. Following the principles of the Good Clinical Research Practices, we explored the aspects of the community's communication and engagement, ethical conduct, trial protocol compliance, informed consent of participants, ongoing benefit/risk assessment, record keeping, confidentiality of patients and study data, and roles and responsibilities of the actors involved. We concluded that several challenges have to be addressed to successfully implement a clinical trial during an international medical emergency but that the potential for collaboration between research teams and humanitarian organizations needs to be highlighted.	[Perez, Sara Carazo; Folkesson, Elin; Berbain, Emmanuel; Depoortere, Evelyn; Lefevre, Annabelle; Malme, Kristian Nodtvedt; Ombelet, Sien; Poelaert, Geertrui; Trbovic, Pierre; Piguet, Pascal; Antierens, Annick] Med Sans Frontieres, Brussels, Belgium; [Perez, Sara Carazo] Laval Univ, Dept Prevent & Social Med, Quebec City, PQ, Canada; [Anglaret, Xavier; Malvy, Jean-Marie Denis; Sissoko, Daouda] Univ Bordeaux, INSERM, UMR 1219, Bordeaux, France; [Anglaret, Xavier] Programme PACCI, Abidjan, Cote Ivoire; [Beavogui, Abdoul-Habib] Ctr Format & Rech Sante Rurale Maferinyah, Conackry, Guinea; [Camara, Alseny-Modet; Tounkara, Alexis] Med Sans Frontieres, Conackry, Guinea; [Depoortere, Evelyn] Inst Trop Med, Antwerp, Belgium; [Maes, Piet] European Mobile Lab Project, Hamburg, Germany; [Maes, Piet] Katholieke Univ Leuven, Rega Inst Med Res, Leuven, Belgium; [Malvy, Jean-Marie Denis; Sissoko, Daouda] Pellegrin Hosp, Bordeaux, France	Perez, SC (reprint author), Med Sans Frontieres, Brussels, Belgium.; Perez, SC (reprint author), Laval Univ, Dept Prevent & Social Med, Quebec City, PQ, Canada.	sara.carazo@gmail.com; annick.antierens@geneva.msf.org	Anglaret, Xavier/F-7333-2013; Maes, Piet/P-7782-2017	Maes, Piet/0000-0002-4571-5232			Adebamowo C, 2014, LANCET, V384, P1423, DOI 10.1016/S0140-6736(14)61734-7; Agua-Agum J, 2015, NEW ENGL J MED, V372, P1274, DOI 10.1056/NEJMc1415318; Anoko J., 2015, COMMUNICATION REBELL; BARON RC, 1983, B WORLD HEALTH ORGAN, V61, P997; Bebell LM, 2015, OBSTET GYNECOL, V125, P1293, DOI 10.1097/AOG.0000000000000853; Black BO, 2015, OBSTET MED, V8, P108, DOI 10.1177/1753495X15597354; Bouazza N, 2015, LANCET, V385, P603, DOI 10.1016/S0140-6736(15)60232-X; Calain P., 2016, J MED ETHICS; Martin AIC, 2016, INT HEALTH, V8, P227, DOI 10.1093/inthealth/ihw018; Cenciarelli Orlando, 2015, Int J Microbiol, V2015, P769121, DOI 10.1155/2015/769121; Cox E, 2014, NEW ENGL J MED, V371, P2350, DOI 10.1056/NEJMp1414145; Dallatomasina S, 2015, TROP MED INT HEALTH, V20, P448, DOI 10.1111/tmi.12454; Dunning J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162199; Dunning J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001997; Fairhead James, 2015, UNDERSTANDING SOCIAL; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Gowen BB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002614; Joffe S, 2014, JAMA-J AM MED ASSOC, V312, P1299, DOI 10.1001/jama.2014.12867; Lane HC, 2016, CLIN TRIALS, V13, P92, DOI 10.1177/1740774515618198; Lanini S, 2015, LANCET INFECT DIS, V15, P738, DOI 10.1016/S1473-3099(15)70106-4; Mendenhall M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001342; Mupere E, 2001, Afr Health Sci, V1, P60; Nagata T, 2014, DISASTER MED PUBLIC, P1; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1976, THE BELM REP; Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Sayburn A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5161; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; Whitehead J, 2016, CLIN TRIALS, V13, P31, DOI 10.1177/1740774515617740; WHO, 2014, ETH ISS REL STUD DES; World Health Organization, 2002, HDB GOOD CLIN RES PR; World Medical Association, 2008, DECL HELS	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JUN	2017	11	6							e0005545	10.1371/journal.pntd.0005545				9	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EZ9WL	WOS:000405080700011		DOAJ Gold, Green Published			2019-04-02	
J	Dao, HTT; Dermauw, V; Gabriel, S; Suwannatrai, A; Tesana, S; Nguyen, GTT; Dorny, P				Ha Thanh Thi Dao; Dermauw, Veronique; Gabriel, Sarah; Suwannatrai, Apiporn; Tesana, Smarn; Giang Thanh Thi Nguyen; Dorny, Pierre			Opisthorchis viverrini infection in the snail and fish intermediate hosts in Central Vietnam	ACTA TROPICA			English	Article						Opisthorchis viverrini; Bithynia spp.; Cyprinidae; Vietnam	BITHYNIA-SIAMENSIS-GONIOMPHALOS; LIVER FLUKE; LAO PDR; HIGH PREVALENCE; DINH PROVINCE; THAILAND; METACERCARIAE; CERCARIAE; AREA	Opisthorchis viverrini, a carcinogenic fish borne fluke, requires freshwater snails and fish as intermediate hosts. Opisthorchiasis is endemic in parts of Southeast Asia, including Central and South Vietnam. In this region the transmission by intermediate hosts has received little attention. Therefore, freshwater snails and wild fish from Bau My Tho, an opisthorchiasis endemic area in Binh Dinh Province were collected for examination of O. viverrini cercariae and metacercariae, respectively. A total of 12,000 snails belonging to six families, of which 1616 Bithynia snails representing Bithynia siamensis goniomphalos and Bithynia funiculata; as well as 754 fish representing 12 species were examined. Shedding of O. viverrini cercariae was observed only in B.s. goniomphalos and B.funiculata, at infection rates of 0.86% and 0.14%, respectively. O. viverrini infection in Bithynia spp. was significantly associated with the habitat but not with the species and the shell size of Bithynia spp. O. viverrini metacercariae were found in 10 fish species representing both Cyprinidae and non-Cyprinidae families. The prevalence of O. viverrini infection in fish was significantly associated with species. Carassius auratus, a fish species commonly eaten raw, Rasbora aurotaenia and Pundits brevis had the highest prevalence of 74.0%, 55.8% and 31.6%, respectively. Sharing of the same snail and fish intermediate host species was found for O. viverrini and a O. viverrini duck-genotype that are sympatric in the study region. This study is the first to report on the intermediate host species of O. viverrini in Central Vietnam and indicates a high risk of acquiring opistorchiasis when eating raw fish dishes. (C) 2017 Elsevier B.V. All rights reserved.	[Ha Thanh Thi Dao] Natl Inst Vet Res, Hanoi, Vietnam; [Ha Thanh Thi Dao; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Ha Thanh Thi Dao; Dermauw, Veronique; Dorny, Pierre] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Gabriel, Sarah] Univ Ghent, Dept Vet Publ Hlth, Fac Vet Med, Merelbeke, Belgium; [Suwannatrai, Apiporn; Tesana, Smarn] Khon Kaen Univ, Dept Parasitol, Khon Kaen, Thailand; [Giang Thanh Thi Nguyen] Minist Hlth, Hanoi, Vietnam	Dorny, P (reprint author), Inst Trop Med, Dept Biomed Sci, Vet Helminthol Unit, Nationalestr 155, B-2000 Antwerp, Belgium.	pdorny@itg.be		Thinkhamrop Suwannatrai, Apiporn/0000-0002-3722-1427; GABRIEL, SARAH/0000-0002-2523-233X; Dermauw, Veronique/0000-0001-8745-5304	Directorate General for Development Cooperation (DGD) - PhD Programme, Belgium	This study was financially supported by the Directorate General for Development Cooperation (DGD) - PhD Programme, Belgium. The authors wish to thank B. Sripa of the TDR Laboratory in Khon Kaen University, Thailand for organising training on opisthorchiasis of the first author; J. Vercruysse of Ghent University, Belgium, and D. Rollinson and B. Webster of the Natural History Museum, London, England for assistance in snail identification. The authors also would like to thank the staffs of the Sub-Animal Health Department of Binh Dinh Province, Vietnam and of the Biomedical Science Department of ITM, Belgium for technical help.	Adam R., 1995, Applied Parasitology, V36, P136; Andrews RH, 2008, TRENDS PARASITOL, V24, P497, DOI 10.1016/j.pt.2008.08.011; Aunpromma S, 2012, PARASITOL INT, V61, P60, DOI 10.1016/j.parint.2011.08.004; Bui TD, 2010, ACTA TROP, V116, P15, DOI 10.1016/j.actatropica.2010.04.016; Chitramvong Y.P., 1992, Malacological Review, V25, P21; Dao TH, 2014, J HELMINTHOL, V88, P441, DOI 10.1017/S0022149X13000400; DITRICH O, 1990, Angewandte Parasitologie, V31, P3; Donthaisong C, 2015, ACTA TROP, V141, P253, DOI 10.1016/j.actatropica.2014.10.015; Dorny P, 2015, J HELMINTHOL, V89, P257, DOI 10.1017/S0022149X13000722; Eom KS, 2015, KOREAN J PARASITOL, V53, P447, DOI 10.3347/kjp.2015.53.4.447; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Henrich T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-33; Kaewkes S, 2003, ACTA TROP, V88, P177, DOI 10.1016/j.actatropica.2003.05.001; Kiatsopit N, 2016, J HELMINTHOL, V90, P312, DOI 10.1017/S0022149X15000292; Kiatsopit N, 2012, AM J TROP MED HYG, V86, P464, DOI 10.4269/ajtmh.2012.11-0217; Le TH, 2008, INT J PARASITOL, V38, P725, DOI 10.1016/j.ijpara.2007.10.003; Nguyen V.D, 2011, EXP PARASITOL, V129, P355; Nissen S, 2012, THESIS, P100; Phongsasakulchoti Phunthira, 2005, Southeast Asian J Trop Med Public Health, V36 Suppl 4, P189; Rainboth W.J., 1996, FISHES CAMBODIAN MEK, P265; Schell S.C., 1985, HDB TREMATODES N AM; Sithithaworn P, 2003, ACTA TROP, V88, P187, DOI 10.1016/j.actatropica.2003.02.001; Sithithaworn P, 2012, PARASITOL INT, V61, P10, DOI 10.1016/j.parint.2011.08.014; Sripa B, 2003, ACTA TROP, V88, P209, DOI 10.1016/j.actatropica.2003.08.002; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Sripa B, 2012, TRENDS PARASITOL, V28, P395, DOI 10.1016/j.pt.2012.07.006; Thaenkham U, 2007, ACTA TROP, V103, P26, DOI 10.1016/j.actatropical.2007.05.006; Dao TTH, 2016, ACTA TROP, V157, P151, DOI 10.1016/j.actatropica.2016.01.029; Touch S, 2009, ACTA TROP, V111, P108, DOI 10.1016/j.actatropica.2009.03.002; Tran D.D., 2013, FISHES MEKONG DELTA, P174; UPATHAM E S, 1983, Malacological Review, V16, P107; Webster BL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-50; WHO, 2011, IARC MONOGRAPHS EVAL, V100 B, P341; WHO, 2008, REV EP PROF HELM THE, P110; World Health Organization (WHO), 1995, WHO TECHN REP SER, V894	35	4	4	3	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JUN	2017	170						120	125		10.1016/j.actatropica.2017.02.028				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EV2QN	WOS:000401600300014	28242064				2019-04-02	
J	Kipruto, EK; Ochieng, AO; Anyona, DN; Mbalanya, M; Mutua, EN; Onguru, D; Nyamongo, IK; Estambale, BBA				Kipruto, Edwin K.; Ochieng, Alfred O.; Anyona, Douglas N.; Mbalanya, Macrae; Mutua, Edna N.; Onguru, Daniel; Nyamongo, Isaac K.; Estambale, Benson B. A.			Effect of climatic variability on malaria trends in Baringo County, Kenya	MALARIA JOURNAL			English	Article						Baringo County; Malaria transmission; Seasonal trends; Rainfall; Temperature; Kenya	TRANSMISSION; AFRICA; TEMPERATURE; RISK; HIGHLANDS; VARIABLES; DYNAMICS; PATTERNS; ETHIOPIA; VECTORS	Background: Malaria transmission in arid and semi-arid regions of Kenya such as Baringo County, is seasonal and often influenced by climatic factors. Unravelling the relationship between climate variables and malaria transmission dynamics is therefore instrumental in developing effective malaria control strategies. The main aim of this study was to describe the effects of variability of rainfall, maximum temperature and vegetation indices on seasonal trends of malaria in selected health facilities within Baringo County, Kenya. Methods: Climate variables sourced from the International Research Institute (IRI)/Lamont-Doherty Earth Observatory (LDEO) climate database and malaria cases reported in 10 health facilities spread across four ecological zones (riverine, lowland, mid-altitude and highland) between 2004 and 2014 were subjected to a time series analysis. A negative binomial regression model with lagged climate variables was used to model long-term monthly malaria cases. The seasonal Mann-Kendall trend test was then used to detect overall monotonic trends in malaria cases. Results: Malaria cases increased significantly in the highland and midland zones over the study period. Changes in malaria prevalence corresponded to variations in rainfall and maximum temperature. Rainfall at a time lag of 2 months resulted in an increase in malaria transmission across the four zones while an increase in temperature at time lags of 0 and 1 month resulted in an increase in malaria cases in the riverine and highland zones, respectively. Conclusion: Given the existence of a time lag between climatic variables more so rainfall and peak malaria transmission, appropriate control measures can be initiated at the onset of short and after long rains seasons.	[Kipruto, Edwin K.] Hasselt Univ, Martelarenlaan 42, B-3500 Hasselt, Belgium; [Kipruto, Edwin K.; Anyona, Douglas N.; Mbalanya, Macrae; Estambale, Benson B. A.] Jaramogi Oginga Odinga Univ Sci & Technol, Div Res Innovat & Outreach, POB 210, Bondo 40601, Kenya; [Mutua, Edna N.; Nyamongo, Isaac K.] Univ Nairobi, Inst Anthropol Gender & African Studies, POB 30197, Nairobi 00100, Kenya; [Ochieng, Alfred O.] Jaramogi Oginga Odinga Univ Sci & Technol, Sch Biol & Phys Sci, POB 210, Bondo 40601, Kenya; [Onguru, Daniel] Jaramogi Oginga Odinga Univ Sci & Technol, Sch Hlth Sci, POB 210, Bondo 40601, Kenya	Estambale, BBA (reprint author), Jaramogi Oginga Odinga Univ Sci & Technol, Div Res Innovat & Outreach, POB 210, Bondo 40601, Kenya.	bestambale@jooust.ac.ke		Mutua, Edna/0000-0002-7511-9116; Nyamongo, Isaac K./0000-0003-1796-9590	WHO's Special Programme Research and Training in Tropical Diseases (TDR); International Development Research Centre of Canada [106905-00]	This study received financial assistance from the WHO's Special Programme for Research and Training in Tropical Diseases (TDR) through a grant agreement with the International Development Research Centre of Canada (106905-00).	Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259; Beck-Johnson LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079276; Bi P, 2003, PUBLIC HEALTH REP, V118, P65, DOI 10.1093/phr/118.1.65; Briet OJT, 2008, GEOSPATIAL HEALTH, V2, P183, DOI 10.4081/gh.2008.242; Brooker S, 2007, AM J TROP MED HYG, V77, P88, DOI 10.4269/ajtmh.2007.77.88; BUUREN S, 2011, J STAT SOFTW, V45, P1, DOI DOI 10.18637/JSS.V045.I03; Chaves LF, 2012, J INFECT DIS, V205, P1885, DOI 10.1093/infdis/jis289; Chikodzi David, 2013, J GEOSCIENCES GEOMAT, V1, P8, DOI 10.12691/jgg-1-1-2; Confalonieri U., 2007, CLIMATE CHANGE 2007; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Division of malaria control, 2011, 2010 KEN MAL IND SUR; Evrendilek F, 2008, SENSORS-BASEL, V8, P5270, DOI 10.3390/s8095270; Fernando SD, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-366; Funk C. C., 2013, US GEOLOGICAL SURVEY, V832, P4, DOI [10.3133/ds832, DOI 10.3133/DS832]; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; Grothendieck G, 2017, DYN TIME SERIES REGR; Guthmann JP, 2002, TROP MED INT HEALTH, V7, P518, DOI 10.1046/j.1365-3156.2002.00883.x; Hardy AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081931; Huang F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-54; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; International Research Institute for Climate and Society, SOURCES IRI LDEO COL; KNBS, 2010, POP DISTR AG SEX ADM; Kumar Mohajan H., 2014, AM J PUBLIC HLTH RES, V2, P159; Mellor PS, 2000, REV SCI TECH OIE, V19, P41, DOI 10.20506/rst.19.1.1211; Midekisa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-165; Ministry of Health, 2001, NAT MAL STRAT 2041 2; Ministry of Health, 2014, MAL FREE KEN KEN REV; Ministry of Health, 2006, NAT GUID DIAGN TREAT; Molenberghs G, 2014, HDB MISSING DATA MET; Mordecai EA, 2013, ECOL LETT, V16, P22, DOI 10.1111/ele.12015; Ochieng Alfred O., 2016, Infection Ecology & Epidemiology, V6, P32322, DOI 10.3402/iee.v6.32322; Odada Eric O., 2006, Lakes & Reservoirs Research and Management, V11, P287, DOI 10.1111/j.1440-1770.2006.00309.x; Paaijmans KP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-196; Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256; Pascual M, 2008, P R SOC B, V275, P123, DOI 10.1098/rspb.2007.1068; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Patz JA, 1998, TROP MED INT HEALTH, V3, P818, DOI 10.1046/j.1365-3156.1998.00309.x; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Pohlert T., 2015, TREND NONPARAMETRIC; SCHULTZ PA, 1993, ADV SPACE RES, V13, P277, DOI 10.1016/0273-1177(93)90559-T; Small J, 2003, P NATL ACAD SCI USA, V100, P15341, DOI 10.1073/pnas.2236969100; Smith MW, 2013, EARTH-SCI REV, V116, P109, DOI 10.1016/j.earscirev.2012.11.004; Teklehaimanot HD, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-41; Tonui WK, 2013, INT J EDUC RES, V1, P8; Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002; Vink G, 2014, STAT NEERL, V68, P61, DOI 10.1111/stan.12023; Wayant NM, 2010, GEOSPATIAL HEALTH, V4, P179, DOI 10.4081/gh.2010.199; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Woube Mengistu, 1997, Indian Journal of Malariology, V34, P140; Wyse APP, 2007, ECOL MODEL, V206, P322, DOI 10.1016/j.ecolmodel.2007.03.038; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	51	4	4	1	9	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 25	2017	16								220	10.1186/s12936-017-1848-2				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EW0VW	WOS:000402210300002	28545590	DOAJ Gold, Green Published			2019-04-02	
J	Nambozi, M; Kabuya, JBB; Hachizovu, S; Mwakazanga, D; Mulenga, J; Kasongo, W; Buyze, J; Mulenga, M; Van Geertruyden, JP; D'Alessandro, U				Nambozi, Michael; Kabuya, Jean-Bertin Bukasa; Hachizovu, Sebastian; Mwakazanga, David; Mulenga, Joyce; Kasongo, Webster; Buyze, Jozefien; Mulenga, Modest; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria	MALARIA JOURNAL			English	Article						Zambia; Sub-Saharan; Africa; Artemisinin-combination therapy; Treatment failure	PLASMODIUM-FALCIPARUM MALARIA; ARTEMETHER-LUMEFANTRINE; NCHELENGE DISTRICT; TREATMENT FAILURE; TRANSMISSION; PARASITEMIA; PIPERAQUINE; PREDICTORS; THAILAND; IMMUNITY	Background: In Zambia, malaria is one of the leading causes of morbidity and mortality, especially among under five children and pregnant women. For the latter, the World Health Organization recommends the use of artemisinin-based combination therapy (ACT) in the second and third trimester of pregnancy. In a context of limited information on ACT, the safety and efficacy of three combinations, namely artemether-lumefantrine (AL), mefloquine-artesunate (MQAS) and dihydroartemisinin-piperaquine (DHAPQ) were assessed in pregnant women with malaria. Methods: The trial was carried out between July 2010 and August 2013 in Nchelenge district, Luapula Province, an area of high transmission, as part of a multi-centre trial. Women in the second or third trimester of pregnancy and with malaria were recruited and randomized to one of the three study arms. Women were actively followed up for 63 days, and then at delivery and 1 year post-delivery. Results: Nine hundred pregnant women were included, 300 per arm. PCR-adjusted treatment failure was 4.7% (12/258) (95% CI 2.7-8.0) for AL, 1.3% (3/235) (95% CI 0.4-3.7) for MQAS and 0.8% (2/236) (95% CI 0.2-3.0) for DHAPQ, with significant risk difference between AL and DHAPQ (p = 0.01) and between AL and MQAS (p = 0.03) treatments. Re-infections during follow up were more frequent in the AL (HR: 4.71; 95% CI 3.10-7.2; p < 0.01) and MQAS (HR: 1.59; 95% CI 1.02-2.46; p = 0.04) arms compared to the DHAPQ arm. PCR-adjusted treatment failure was significantly associated with women under 20 years [Hazard Ratio (HR) 5.35 (95% CI 1.07-26.73; p = 0.04)] and higher malaria parasite density [3.23 (95% CI 1.03-10.10; p = 0.04)], and still women under 20 years [1.78, (95% CI 1.26-2.52; p < 0.01)] had a significantly higher risk of re-infection. The three treatments were generally well tolerated. Dizziness, nausea, vomiting, headache and asthenia as adverse events (AEs) were more common in MQAS than in AL or DHAPQ (p < 0.001). Birth outcomes were not significantly different between treatment arms. Conclusion: As new infections can be prevented by a long acting partner drug to the artemisinins, DHAPQ should be preferred in places as Nchelenge district where transmission is intense while in areas of low transmission intensity AL or MQAS may be used.	[Nambozi, Michael; Kabuya, Jean-Bertin Bukasa; Hachizovu, Sebastian; Mwakazanga, David; Mulenga, Joyce; Kasongo, Webster; Mulenga, Modest] Trop Dis Res Ctr, Dept Clin Sci, POB 71769, Ndola, Zambia; [Van Geertruyden, Jean-Pierre] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Buyze, Jozefien; D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Serekunda, Gambia; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England	Nambozi, M (reprint author), Trop Dis Res Ctr, Dept Clin Sci, POB 71769, Ndola, Zambia.	michaelnambozi@yahoo.com	Buyze, Jozefien/B-8550-2014; Van geertruyden, Jean-Pierre/K-6425-2014	Buyze, Jozefien/0000-0001-6780-380X; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Nambozi, Michael/0000-0002-0369-0970	European and Developing Countries Clinical Trials Partnership; Malaria in Pregnancy Consortium; Bill and Melinda Gates Foundation; Directorate-General for Development Cooperation (DGDC)-Belgium; Netherlands-African Partnership for Capacity Development and Clinical interventions Against Poverty-related diseases (NACCAP)-Netherlands; Medical Research Council (MRC)-UK	European and Developing Countries Clinical Trials Partnership, Email: infor@edctp.orgWeb:http://www.edctp.org; and by the Malaria in Pregnancy Consortium, which is funded through a grant from the Bill and Melinda Gates Foundation to the Liverpool School of Tropical Medicine (LSHTM)-United Kingdom; Directorate-General for Development Cooperation (DGDC)-Belgium, Netherlands-African Partnership for Capacity Development and Clinical interventions Against Poverty-related diseases (NACCAP)-Netherlands, and Medical Research Council (MRC)-UK.	Adegnika AA, 2005, AM J TROP MED HYG, V73, P263, DOI 10.4269/ajtmh.2005.73.263; Angus BJ, 1997, BLOOD, V90, P2037; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Butt K, 2014, J OBSTET GYNAECOL CA, V36, P171, DOI 10.1016/S1701-2163(15)30664-2; Chan Y H, 2004, Singapore Med J, V45, P249; Das S, 2016, AM J TROP MED HYG, V94, P1234, DOI 10.4269/ajtmh.15-0735; Dorsey G, 2004, AM J TROP MED HYG, V71, P531, DOI 10.4269/ajtmh.2004.71.531; Douglas NM, 2010, LANCET INFECT DIS, V10, P405, DOI 10.1016/S1473-3099(10)70079-7; Fievet Nadine, 2002, Malar J, V1, P16, DOI 10.1186/1475-2875-1-16; FONTANET AL, 1993, AM J TROP MED HYG, V49, P465, DOI 10.4269/ajtmh.1993.49.465; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Hoglund RM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-398; Ittarat W, 2003, AM J TROP MED HYG, V68, P147, DOI 10.4269/ajtmh.2003.68.147; Khalil IF, 2005, ANN TROP MED PARASIT, V99, P441, DOI 10.1179/136485905X46441; Kloprogge F, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.59; Laufer MK, 2007, AM J TROP MED HYG, V77, P160, DOI 10.4269/ajtmh.2007.77.160; Luxemburger C, 1997, T ROY SOC TROP MED H, V91, P256, DOI 10.1016/S0035-9203(97)90066-3; Manyando C, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-141; Manyando C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-249; McGready R, 2008, PLOS MED, V5, P1699, DOI 10.1371/journal.pmed.0050253; Nambozi M, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-5; Nambozi M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-220; Nambozi M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-50; National Malaria Control Center, 2014, GUID DIAGN TREAT MAL; National Malaria Control Center, 2012, ZAMB MAL IND SURV; Nchelenge District Office, 2016, HLTH MAN INF SYST; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Nosten F, 2006, CURR DRUG SAF, V1, P1, DOI 10.2174/157488606775252584; Pekyi D, 2016, NEW ENGL J MED, V374, P913, DOI 10.1056/NEJMoa1508606; Pinchoff J, 2015, AM J TROP MED HYG, V93, P1260, DOI 10.4269/ajtmh.15-0283; Piola P, 2010, LANCET INFECT DIS, V10, P762, DOI 10.1016/S1473-3099(10)70202-4; Poespoprodjo JR, 2011, J INFECT DIS, V204, P1613, DOI 10.1093/infdis/jir558; Rogerson SJ, 2010, LANCET INFECT DIS, V10, P51, DOI 10.1016/S1473-3099(09)70322-6; Salomon LJ, 2013, ULTRASOUND OBST GYN, V41, P233, DOI 10.1002/uog.12407; Shekalaghe S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-69; Steketee RW, 1996, AM J TROP MED HYG, V55, P2, DOI 10.4269/ajtmh.1996.55.2; terKuile FO, 1995, T ROY SOC TROP MED H, V89, P660, DOI 10.1016/0035-9203(95)90435-2; The 4ABC Study Group, 2011, PLOS MED, DOI DOI 10.1371/J0URNAL.PMED.1001119; WHO, 2008, METH TECHN CLIN TRIA; WHO, 2015, GEN WORLD HLTH ORG; Wilby KJ, 2011, CLIN PHARMACOKINET, V50, P705, DOI 10.2165/11594550-000000000-00000; World Health Organization (WHO), 2009, METH SURV ANT DRUG E; WWARN, 2012, CLIN MOD WWARN 2012	43	4	6	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAY 16	2017	16								199	10.1186/s12936-017-1851-7				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EW0VN	WOS:000402209400002	28511713	DOAJ Gold, Green Published			2019-04-02	
J	Roeber, F; Morrison, A; Casaert, S; Smith, L; Claerebout, E; Skuce, P				Roeber, Florian; Morrison, Alison; Casaert, Stijn; Smith, Lee; Claerebout, Edwin; Skuce, Philip			Multiplexed-tandem PCR for the specific diagnosis of gastrointestinal nematode infections in sheep: an European validation study	PARASITES & VECTORS			English	Article						Small ruminants; Sheep; Parasites; Trichostrongylid nematodes; Molecular diagnosis; MT-PCR	ANTHELMINTIC RESISTANCE; PARASITIC NEMATODES; MOLECULAR TOOLS; LIVESTOCK; IDENTIFICATION; PREVALENCE; RUMINANTS; CULTURE; CATTLE; IMPACT	Background: Traditional methods of detecting and identifying gastrointestinal nematode infections in small ruminants, including sheep and goats, are time-consuming and lack in sensitivity and specificity. Recently, we developed an automated multiplexed-tandem (MT)-PCR platform for the diagnosis and identification patent infections with key genera/species of gastrointestinal nematodes of sheep and validated this approach in detailed experiments carried out in Australia. In the present study, we deployed this diagnostic platform in Scotland and Belgium to test samples from naturally infected sheep in these environments and to validate the MT-PCR platform relative to traditional diagnostic methods routinely used by local laboratories. Results: MT-PCR detected all microscopy positive samples and there was a significant agreement between the results of the different test methods in terms of the species detected and their relative proportion in a test sample, however, for some samples, there were discrepancies between the results of the different test methods. Selective sequencing of purified MT-PCR products demonstrated the results to be 100% specific. Conclusions: The MT-PCR platform is an advanced method for the species/genus-specific diagnosis of gastrointestinal nematode infections in small ruminants and has demonstrated utility when deployed in different countries and climatic zones. The platform is user-friendly due to the largely automated procedure and has high versatility in that it can achieve a specific diagnosis from different types of sample templates, including larval culture and faecal samples. With appropriate modifications of the primers used, the MT-PCR platform also provides potential for the diagnosis of a variety of other pathogens of veterinary or medical importance.	[Roeber, Florian; Smith, Lee] AusDiagnost Pty Ltd, Beaconsfield, NSW 2015, Australia; [Morrison, Alison; Skuce, Philip] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [Casaert, Stijn; Claerebout, Edwin] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Salisburylaan 133, B-9820 Merelbeke, Belgium	Roeber, F (reprint author), AusDiagnost Pty Ltd, Beaconsfield, NSW 2015, Australia.	florian.roeber@ausdx.com		Smith, Lee/0000-0002-8089-9671	Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS) Strategic Research Programme; Merial Animal Health	This study was funded through Merial Animal Health. The authors would like to acknowledge financial support from the Scottish Government's Rural and Environment Science and Analytical Services Division (RESAS) Strategic Research Programme.	BERRIE DA, 1988, J HELMINTHOL, V62, P110, DOI 10.1017/S0022149X00011330; Burgess CGS, 2012, VET PARASITOL, V189, P299, DOI 10.1016/j.vetpar.2012.04.009; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Charlier J, 2015, VET PARASITOL, V212, P62, DOI 10.1016/j.vetpar.2015.06.018; Charlier J, 2014, TRENDS PARASITOL, V30, P361, DOI 10.1016/j.pt.2014.04.009; CHRISTIE M, 1982, RES VET SCI, V32, P113, DOI 10.1016/S0034-5288(18)32448-2; Conraths FJ, 2006, VET PARASITOL, V136, P91, DOI 10.1016/j.vetpar.2005.12.004; DOBSON RJ, 1992, INT J PARASITOL, V22, P1005, DOI 10.1016/0020-7519(92)90060-X; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; Gasser RB, 2008, BIOTECHNOL ADV, V26, P325, DOI 10.1016/j.biotechadv.2008.03.003; Laing R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r88; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Ministry of Agriculture FaF, 1986, MAN VET PAR LAB TECH, P20; Nielsen MK, 2010, VET PARASITOL, V167, P55, DOI 10.1016/j.vetpar.2009.09.043; Papadopoulos E, 2012, VET PARASITOL, V189, P85, DOI 10.1016/j.vetpar.2012.03.036; Playford MC, 2014, AUST VET J, V92, P464, DOI 10.1111/avj.12271; Roeber F, 2014, VET PARASITOL, V205, P619, DOI 10.1016/j.vetpar.2014.08.005; Roeber F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-153; Roeber F, 2012, INT J PARASITOL, V42, P1151, DOI 10.1016/j.ijpara.2012.10.005; Roeber F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037327; Schwarz EM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r89; Stanley KK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni182; van Wyk JA, 2004, VET PARASITOL, V119, P277, DOI 10.1016/j.vetpar.2003.10.012	23	10	10	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAY 8	2017	10								226	10.1186/s13071-017-2165-x				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EU1PI	WOS:000400791900005	28482924	DOAJ Gold, Green Published			2019-04-02	
J	Masumbuku, JL; Kiswaya, ES; Mairiaux, P; Gillain, D; Petermans, J				Masumbuku, Jacques Lofandjola; Kiswaya, Ernest Sumaili; Mairiaux, Philippe; Gillain, Daniel; Petermans, Jean			Chronic illness needing palliative care in Kinshasa hospitals, Democratic Republic of the Congo (DRC)	TROPICAL MEDICINE AND HEALTH			English	Article								Background: Chronic illnesses are a major public health problem in low-income countries. In the Democratic Republic of the Congo (DRC), few data are available, especially in palliative care. In this context, the present study aimed at describing the patterns of diseases in Kinshasa hospitals as well as risk factors associated with patients' evolving status and length of hospital stay. Methods: A prospective study was conducted in ten hospitals of Kinshasa, over a 1-year period. A total of 2699 patients with a chronic condition (non-communicable diseases (NCD) and/or AIDS) were consecutively enrolled in the study between January and December, 2013. Results: Out of 2699 patients studied, 36.9% were suffering from cardiovascular diseases, 29.7% from comorbidity and 17.5% from AIDS. 27.5% of patients died while hospitalized, and 67.4% were lost to follow-up. The risk factors independently associated with death in hospitals were AIDS (adjusted OR = 2.2) and age over 65 years old (adjusted OR = 1.7). Peri-urban and rural areas were significantly associated with a mean adjusted hospital stay longer than 3 days. The length of stay (LOS) was shorter for women and patients living in urban areas. Patients survived for a median of 10 days (range 7-20 days). Conclusions: This study reveals the high proportion of patients suffering from advanced chronic diseases, including cardiovascular diseases, AIDS and comorbidity. It demonstrates the need for palliative care (PC) in medical practices in Kinshasa, the capital of the Democratic Republic of the Congo.	[Masumbuku, Jacques Lofandjola] Higher Inst Med Engn, Kinshasa, DEM REP CONGO; [Masumbuku, Jacques Lofandjola; Mairiaux, Philippe; Gillain, Daniel] Univ Liege, Fac Med, Sch Publ Hlth, Sart Tilman B23, B-4000 Liege, Belgium; [Kiswaya, Ernest Sumaili] Univ Kinshasa, Fac Med, Renal Unit, Kinshasa, DEM REP CONGO; [Petermans, Jean] Univ Liege, Fac Med, Dept Geriatr, Liege, Belgium	Masumbuku, JL (reprint author), Higher Inst Med Engn, Kinshasa, DEM REP CONGO.; Masumbuku, JL (reprint author), Univ Liege, Fac Med, Sch Publ Hlth, Sart Tilman B23, B-4000 Liege, Belgium.	jlofandjola@student.ulg.ac.be		Mairiaux, Philippe/0000-0003-1617-7890				0	0	0	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1348-8945	1349-4147		TROP MED HEALTH	Trop. Med. Health	MAY 5	2017	45								11	10.1186/s41182-017-0052-y				9	Tropical Medicine	Tropical Medicine	EX5LF	WOS:000403283000001	28484317	DOAJ Gold, Green Published			2019-04-02	
J	Hendrickx, S; Van den Kerkhof, M; Mabille, D; Cos, P; Delputte, P; Maes, L; Caljon, G				Hendrickx, Sarah; Van den Kerkhof, Magali; Mabille, Dorien; Cos, Paul; Delputte, Peter; Maes, Louis; Caljon, Guy			Combined treatment of miltefosine and paromomycin delays the onset of experimental drug resistance in Leishmania infantum	PLOS NEGLECTED TROPICAL DISEASES			English	Article							LIPOSOMAL AMPHOTERICIN-B; IN-VITRO SELECTION; VISCERAL LEISHMANIASIS; DONOVANI; SUSCEPTIBILITY; EFFICACY; INDIA; FAILURE; SAFETY; NEPAL	Background Since miltefosine monotherapy against visceral leishmaniasis (VL) caused by Leishmania donovani has been discontinued in the Indian subcontinent due to an increase in the number of treatment failures, single dose liposomal amphotericin B is now advocated as a treatment option of choice. Paromomycin-miltefosine combination therapy can be used as substitute first-line treatment in regions without cold-chain potential. Previous laboratory studies in the closely related species Leishmania infantum have demonstrated that paromomycin monotherapy fairly rapidly selects for resistance producing a phenotype with increased fitness. Given the possible clinical implications of these findings for the current field situation, the present study aimed to identify the potential hazards of paromomycin-miltefosine combination therapy. Principal findings Drug interaction studies using the fixed-ratio isobologram method revealed an indifferent interaction between paromomycin and miltefosine. In hamsters infected with L. infantum, the combination resulted in cumulative efficacy in reducing parasite burdens in the liver, spleen and bone marrow. Selected resistant lines against the single drugs did not display cross-resistance. When the intracellular amastigote stage was repeatedly exposed to the paromomycin-miltefosine combination, either in vitro or in vivo, no significant susceptibility decrease towards either drug was noted. Conclusions These results suggest that implementation of paromomycin-miltefosine combination therapy indeed could represent a safe and affordable treatment option for L. donovani VL as miltefosine appears to overrule the anticipated rapid development of PMM resistance.	[Hendrickx, Sarah; Van den Kerkhof, Magali; Mabille, Dorien; Cos, Paul; Delputte, Peter; Maes, Louis; Caljon, Guy] Univ Antwerp, LMPH, Antwerp, Belgium	Caljon, G (reprint author), Univ Antwerp, LMPH, Antwerp, Belgium.	guy.caljon@uantwerpen.be	Maes, Louis/A-2384-2017; Delputte, Peter/A-1062-2008; Cos, Paul/L-9717-2015; Caljon, Guy/E-1310-2017	Maes, Louis/0000-0002-2324-9509; Delputte, Peter/0000-0003-3972-616X; Cos, Paul/0000-0003-4361-8911; Caljon, Guy/0000-0002-4870-3202	Fonds Wetenschappelijk Onderzoek [G051812N, 12I0317N]; University of Antwerp [TT-ZAPBOF 33049]	This work was funded by the Fonds Wetenschappelijk Onderzoek (www.fow.be), grant numbers G051812N (LM) and 12I0317N (SH). The work was also supported by a research fund of the University of Antwerp (www.uantwerpen.be), grant number TT-ZAPBOF 33049 (GC). LMPH is a partner of the Antwerp Drug Discovery Network (ADDN, www.addn.be) and the Excellence Centre 'Infla-Med' (www.uantwerpen.be/infla-med). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhandari V, 2014, ANTIMICROB AGENTS CH, V58, P2580, DOI 10.1128/AAC.01574-13; Chakravarty J, 2010, J GLOB INFECT DIS, V2, P167, DOI 10.4103/0974-777X.62887; Coelho AC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002999; Cojean S, 2012, EMERG INFECT DIS, V18, P704, DOI 10.3201/eid1804.110841; de Morais-Teixeira E, 2011, MEM I OSWALDO CRUZ, V106, P475, DOI 10.1590/S0074-02762011000400015; Dhillon GP, 2008, J INDIAN MED ASSOC, V106, P666; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; Fernandez-Prada C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005171; Garcia-Hernandez R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001974; Hendrickx S, 2016, J ANTIMICROB CHEMOTH, V71, P1914, DOI 10.1093/jac/dkw096; Hendrickx S, 2015, ANTIMICROB AGENTS CH, V59, P4714, DOI 10.1128/AAC.00707-15; Hendrickx S, 2015, PARASITOL RES, V114, P2561, DOI 10.1007/s00436-015-4460-9; Hendrickx S, 2014, PARASITOL RES, V113, P1875, DOI 10.1007/s00436-014-3835-7; Hendrickx S, 2015, J ANTIMICROB CHEMOTH; Hendrickx S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001664; Jha RK, 2013, J NEPAL MED ASSOC, V52, P645; Fernandez OL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002871; Maarouf M, 1998, PARASITE, V5, P167, DOI 10.1051/parasite/1998052167; Maes L., 2013, DRUG RESISTANCE LEIS, P407; Mondal D, 2014, LANCET GLOB HEALTH, V2, pE51, DOI 10.1016/S2214-109X(13)70118-9; Monge-Maillo B, 2013, DRUGS, V73, P1863, DOI 10.1007/s40265-013-0133-0; Obonaga R, 2014, ANTIMICROB AGENTS CH, V58, P144, DOI 10.1128/AAC.01023-13; Purkait B, 2012, ANTIMICROB AGENTS CH, V56, P1031, DOI 10.1128/AAC.00030-11; Ready PD, 2014, CLIN EPIDEMIOL, V6, P147, DOI 10.2147/CLEP.S44267; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Sane SA, 2011, EXP PARASITOL, V127, P376, DOI 10.1016/j.exppara.2010.09.003; Seifert K, 2006, ANTIMICROB AGENTS CH, V50, P73, DOI 10.1128/AAC.50.1.73-79.2006; Srivastava S, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1969-z; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; Sundar S, 2011, LANCET, V377, P477, DOI 10.1016/S0140-6736(10)62050-8; Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627; Sundar Shyam, 2007, Ther Clin Risk Manag, V3, P733; Vermeersch M, 2009, ANTIMICROB AGENTS CH, V53, P3855, DOI 10.1128/AAC.00548-09; Yardley V, 2005, AM J TROP MED HYG, V73, P272, DOI 10.4269/ajtmh.2005.73.272	34	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAY	2017	11	5							e0005620	10.1371/journal.pntd.0005620				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EX0RA	WOS:000402927300060	28505185	DOAJ Gold, Green Published			2019-04-02	
J	Beyene, HB; Tadesse, M; Disassa, H; Beyene, MB				Beyene, Habtamu Bedimo; Tadesse, Mulualem; Disassa, Haimanot; Beyene, Melkamu B.			Concurrent Plasmodium infection, anemia and their correlates among newly diagnosed people living with HIV/AIDS in Northern Ethiopia	ACTA TROPICA			English	Article						Concurrent malaria; Anemia; Correlates; HIV/AIDS patients; Northern Ethiopia	IMMUNODEFICIENCY-VIRUS-INFECTION; MALARIA COINFECTION; HEMOGLOBIN LEVELS; HIV-INFECTION; FALCIPARUM-MALARIA; PREGNANT-WOMEN; RURAL MALAWI; SOUTH-AFRICA; PREVALENCE; ADULTS	The magnitude of concurrent malaria infection and the impact it has on hematological abnormalities, such as anemia in people living with HIV/AIDS, is not well studied in Ethiopian set up. In this cross sectional study, therefore, we assessed the prevalence of concurrent malaria infection and anemia among highly active anti-retroviral therapy (HAART) naive people living with HIV/AIDS between October, 2012 to May, 2013 in Northern Ethiopia. After obtaining consent, socio demographic, clinical, immunological and behavioural data was obtained. The overall prevalence of concomitant malaria infection was 17.4%. Rural residents and low to middle income class clients were more frequently co-infected with malaria (p < 0.0001). Utilization of insecticide treated nets (p = 0.0002) and co-trimoxazole intake (p = 0.006) were protective factors against Plasmodium infection. The overall prevalence of anemia was also high (43%), being significantly higher (91.3%) in malaria positive people living with HIV/AIDS compared to malaria free HIV patients (32.8%) (p < 0.0001). Female gender (p = 0.011), history of opportunistic infections (P = 0.0027) and late HIV stages (III and IV) (p = 0.0001) were also significantly associated with anemia in HIV patients. In conclusion, concurrent malaria represents a common condition and there was a significant difference in the odds of anemia between malaria positive and negative people living with HIV/AIDS in Northern Ethiopia indicating a need for routine screening of people living with HIV/AIDS living in malaria endemic-areas and close monitoring of co-infected patients. Indeed utilization of ITNs, malaria prophylaxis and early HIV diagnosis are highly encouraged in people living with HIV/AIDS. (C) 2017 Elsevier B.V. All rights reserved.	[Beyene, Habtamu Bedimo] Univ Addis Ababa, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, POB 9086, Addis Ababa, Ethiopia; [Tadesse, Mulualem] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Tadesse, Mulualem] Inst Trop Med, Antwerp, Belgium; [Disassa, Haimanot] Assosa Univ, Assosa, Ethiopia; [Beyene, Melkamu B.] Bahir Dar Univ, Dept Publ Hlth, Coll Hlth Sci, POB 75, Bahir, Ethiopia	Beyene, HB (reprint author), Univ Addis Ababa, Coll Hlth Sci, Dept Microbiol Immunol & Parasitol, POB 9086, Addis Ababa, Ethiopia.	habtish1976@gmail.com					Akinbo Frederick O., 2009, New Zealand Journal of Medical Laboratory Science, V63, P78; Alemayehu G, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1029-0; Algoe SB, 2008, EMOTION, V8, P425, DOI 10.1037/1528-3542.8.3.425; Assefa M., 2015, BMC HEMATOL, V16, P1; Ayele DG, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-195; Cohen C, 2005, CLIN INFECT DIS, V41, P1631, DOI 10.1086/498023; Davenport GC, 2010, AM J HEMATOL, V85, P227, DOI 10.1002/ajh.21653; Denue B.A., 2013, E MEDITERR HEALTH J, V19, P1; Enawgaw Bamlaku, 2015, BMC Hematol, V15, P12, DOI 10.1186/s12878-015-0032-6; Erhabor O, 2006, Niger J Med, V15, P52; Ferede G., 2013, BMC HEMATOL, V13, P1; Gedefaw L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072202; Goselle ON, 2009, J VECTOR DIS, V46, P205; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/01.aids.0000096909.73209.14; Hambleton J, 1996, Oncology (Williston Park), V10, P671; Iliyasu Z, 2013, ACTA TROP, V128, P630, DOI 10.1016/j.actatropica.2013.09.011; Kamya MR, 2006, J INFECT DIS, V193, P9, DOI 10.1086/498577; Kublin JG, 2004, LANCET, V365, P233; Kyeyune R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-496; Lau B, 2005, JAIDS-J ACQ IMM DEF, V39, P620; Manyanga VP, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-24; Mata-Marin Jose A, 2010, BMC Res Notes, V3, P230, DOI 10.1186/1756-0500-3-230; Mihiretie H, 2015, ANEMIA, DOI 10.1155/2015/479329; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 1999, CLIN INFECT DIS, V29, P44, DOI 10.1086/520178; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Nkhoma ET, 2012, AM J TROP MED HYG, V87, P29, DOI 10.4269/ajtmh.2012.11-0380; Nkuo-Akenji T, 2008, AJAR-AFR J AIDS RES, V7, P229, DOI 10.2989/AJAR.2008.7.2.8.525; Omoregie R, 2009, NIGERIA TANZAN J HLT, V11, P1; Orish VN, 2013, INT J GYNECOL OBSTET, V120, P236, DOI 10.1016/j.ijgo.2012.09.021; Patnaik P, 2005, J INFECT DIS, V192, P984, DOI 10.1086/432730; Samet JH, 2001, AIDS, V15, P77, DOI 10.1097/00002030-200101050-00012; Sanyaolu AO, 2013, AFR HEALTH SCI, V13, P295, DOI 10.4314/ahs.v13i2.14; Saracino A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-241; Semba RD, 2001, J INVEST MED, V49, P225, DOI 10.2310/6650.2001.33967; Shankarkumar U, 2011, J VECTOR DIS, V48, P155; Tagoe DNA, 2012, J INFECT DEV COUNTR, V6, P660, DOI 10.3855/jidc.2124; Tay SCK, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0064-6; Tchinda GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040553; USAID, 2013, PRESIDENTS MALARIA I, P1; Van Geertruyden JP, 2006, J INFECT DIS, V194, P917, DOI 10.1086/507310; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2015, UPDATE ETHIOPIA HIV; Wondimeneh Y, 2013, EUR J EXP BIOL, V3, P497; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization, 2011, HAEM CONC DIAGN AN A, P3; Yinzhong S., 2013, PLOS ONE, V8, P1	47	2	2	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	MAY	2017	169						8	13		10.1016/j.actatropica.2017.01.007				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EO8QE	WOS:000396954000002	28119046				2019-04-02	
J	Marien, J; Borremans, B; Gryseels, S; Soropogui, B; De Bruyn, L; Bongo, GN; Becker-Ziaja, B; de Bellocq, JG; Gunther, S; Magassouba, N; Leirs, H; Fichet-Calvet, E				Marien, Joachim; Borremans, Benny; Gryseels, Sophie; Soropogui, Barre; De Bruyn, Luc; Bongo, Gedeon Ngiala; Becker-Ziaja, Beate; de Bellocq, Joelle Gouy; Guenther, Stephan; Magassouba, N'Faly; Leirs, Herwig; Fichet-Calvet, Elisabeth			No measurable adverse effects of Lassa, Morogoro and Gairo arenaviruses on their rodent reservoir host in natural conditions	PARASITES & VECTORS			English	Article						Arenavirus; Lassa virus; Morogoro virus; Gairo virus; Mastomys natalensis; Rodent-borne disease; Host-pathogen interaction; Reservoir host	MASTOMYS-NATALENSIS RODENTIA; VIRUS-INFECTION; HANTAVIRUS INFECTION; BANK VOLES; WEST-AFRICA; PUUMALA HANTAVIRUS; CALOMYS-MUSCULINUS; MOPEIA VIRUS; SIERRA-LEONE; JUNIN VIRUS	Background: In order to optimize net transmission success, parasites are hypothesized to evolve towards causing minimal damage to their reservoir host while obtaining high shedding rates. For many parasite species however this paradigm has not been tested, and conflicting results have been found regarding the effect of arenaviruses on their rodent host species. The rodent Mastomys natalensis is the natural reservoir host of several arenaviruses, including Lassa virus that is known to cause Lassa haemorrhagic fever in humans. Here, we examined the effect of three arenaviruses (Gairo, Morogoro and Lassa virus) on four parameters of wild-caught Mastomys natalensis: body mass, head-body length, sexual maturity and fertility. After correcting for the effect of age, we compared these parameters between arenavirus-positive (arenavirus RNA or antibody) and negative animals using data from different field studies in Guinea (Lassa virus) and Tanzania (Morogoro and Gairo viruses). Results: Although the sample sizes of our studies (1297, 749 and 259 animals respectively) were large enough to statistically detect small differences in body conditions, we did not observe any adverse effects of these viruses on Mastomys natalensis. We did find that sexual maturity was significantly positively related with Lassa virus antibody presence until a certain age, and with Gairo virus antibody presence in general. Gairo virus antibody-positive animals were also significantly heavier and larger than antibody-free animals. Conclusion: Together, these results suggest that the pathogenicity of arenaviruses is not severe in M. natalensis, which is likely to be an adaptation of these viruses to optimize transmission success. They also suggest that sexual behaviour might increase the probability of M. natalensis to become infected with arenaviruses.	[Marien, Joachim; Borremans, Benny; Gryseels, Sophie; De Bruyn, Luc; Leirs, Herwig] Univ Antwerp, Evolutionary Ecol Grp, Antwerp, Belgium; [Soropogui, Barre; Magassouba, N'Faly] Hop Donka, Projet Fievre Hemorrag Guinee, Conakry, Guinea; [Bongo, Gedeon Ngiala; Becker-Ziaja, Beate; Guenther, Stephan; Fichet-Calvet, Elisabeth] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [de Bellocq, Joelle Gouy] Czech Acad Sci, Inst Vertebrate Biol, Res Facil Studenec, Brno, Czech Republic; [Borremans, Benny] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Gryseels, Sophie] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Bongo, Gedeon Ngiala] Univ Kinshasa, Dept Biol, POB 190, Kinshasa XI, DEM REP CONGO	Marien, J (reprint author), Univ Antwerp, Evolutionary Ecol Grp, Antwerp, Belgium.	Joachim.marien@uantwerpen.be	Borremans, Benny/D-2241-2009; Gouy de Bellocq, Joelle/J-4733-2013	Borremans, Benny/0000-0002-7779-4107; Gouy de Bellocq, Joelle/0000-0001-5831-6284; Gunther, Stephan/0000-0002-6562-0230	University of Antwerp; Antwerp study centre for disease (ASCID) [GOA BOF FFB3567]; INCO-DEV grant [ICA4-CT2002-10050]; Marie Curie fellowship [PIEF-GA-2009-235164]; German Research Foundation (Focus Programs 1596 from Deutsche Forschungsgemeinschaft) [FI 1781/1-1, GU 883/3-1, LE SPP]; BEBUC (Bourse d'Excellence Bringmann aux Universites Congolaises); Holger-Pohlmann Foundation (Germany)	This work was supported by the University of Antwerp and the Antwerp study centre for disease (ASCID) grant number GOA BOF FFB3567, the INCO-DEV grant ICA4-CT2002-10050, the Marie Curie fellowship to EFC (PIEF-GA-2009-235164), grants FI 1781/1-1, GU 883/3-1 and LE SPP from the German Research Foundation (Focus Programs 1596 from Deutsche Forschungsgemeinschaft), BEBUC (Bourse d'Excellence Bringmann aux Universites Congolaises) and Holger-Pohlmann Foundation (Germany). Joachim Marien is a research fellow of the Flemish Interuniversity Council (VLIR-UOS). Benny Borremans and Sophie Gryseels were research fellows of Research Foundation Flanders (FWO) during part of the study.	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Augusteyn RC, 2014, MOL VIS, V20, P410; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Bernshtein AD, 1999, ARCH VIROL, V144, P2415, DOI 10.1007/s007050050654; Borremans B, 2015, SCI REP-UK, V5, DOI 10.1038/srep10445; Borremans B, 2011, VECTOR-BORNE ZOONOT, V11, P1125, DOI 10.1089/vbz.2010.0010; Childs J.C., 1993, ARENAVIRIDAE, P331, DOI DOI 10.1007/978-1-4615-3028-2; DELATORRE JC, 1992, P NATL ACAD SCI USA, V89, P9939, DOI 10.1073/pnas.89.20.9939; DEMARTINI JC, 1975, B WORLD HEALTH ORGAN, V52, P651; Demby AH, 2001, VECTOR-BORNE ZOONOT, V1, P283, DOI 10.1089/15303660160025912; DWYER G, 1990, ECOL MONOGR, V60, P423, DOI 10.2307/1943014; Fichet-Calvet E, 2008, VECTOR-BORNE ZOONOT, V8, P41, DOI 10.1089/vbz.2007.0118; Fichet-Calvet E, 2007, VECTOR-BORNE ZOONOT, V7, P119, DOI 10.1089/vbz.2006.0520; Fichet-Calvet E, 2016, SCI REP-UK, V6, DOI 10.1038/srep21977; Fichet-Calvet E, 2014, VECTOR-BORNE ZOONOT, V14, P665, DOI 10.1089/vbz.2013.1484; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Goyens J, 2013, J THEOR BIOL, V317, P55, DOI 10.1016/j.jtbi.2012.09.039; Gryseels S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006073; Gryseels S, 2015, VIROLOGY, V476, P249, DOI 10.1016/j.virol.2014.12.011; Gunther S, 2009, EMERG INFECT DIS, V15, P2008, DOI 10.3201/eid1512.090864; Gunther S, 2004, CRIT REV CL LAB SCI, V41, P339, DOI 10.1080/10408360490497456; HOTCHIN JE, 1958, CAN J MICROBIOL, V4, P149, DOI 10.1139/m58-016; HUFERT FT, 1989, ARCH VIROL, V106, P201, DOI 10.1007/BF01313953; Ishii A, 2011, EMERG INFECT DIS, V17, P1921, DOI 10.3201/eid1710.10452; Janova E, 2007, FOLIA ZOOL, V56, P119; Kallio ER, 2007, ECOLOGY, V88, P1911, DOI 10.1890/06-1620.1; Kallio ER, 2006, P ROY SOC B-BIOL SCI, V273, P2771, DOI 10.1098/rspb.2006.3645; Kallio ER, 2015, J ANIM ECOL, V84, P1264, DOI 10.1111/1365-2656.12387; Kennis J, 2008, MAMMALIA, V72, P150, DOI 10.1515/MAMM.2008.025; Kerber R, 2011, J VIROL, V85, P12518, DOI 10.1128/JVI.05091-11; Knell RJ, 2004, P ROY SOC B-BIOL SCI, V271, pS174, DOI 10.1098/rsbl.2003.0131; Lalis A, 2015, INTEGR ZOOL, V10, P505, DOI 10.1111/1749-4877.12164; LEIRS H, 1990, AFR J ECOL, V28, P298, DOI 10.1111/j.1365-2028.1990.tb01164.x; Leirs H, 1995, POPULATION ECOLOGY M; Lord K. D., 1959, Journal of Wildlife Management, V23, P358; McCormick JB, 1999, EMERGENCE AND CONTROL OF RODENT-BORNE VIRAL DISEASES (HANTAVIRAL AND ARENAL DISEASES), P177; MIMS CA, 1970, ARCH GES VIRUSFORSCH, V30, P67, DOI 10.1007/BF01262584; MONATH TP, 1987, J INFECT DIS, V155, P433, DOI 10.1093/infdis/155.3.433; MONATH TP, 1974, SCIENCE, V185, P263, DOI 10.1126/science.185.4147.263; MORRIS P, 1972, Mammal Review, V2, P69, DOI 10.1111/j.1365-2907.1972.tb00160.x; Olschlager S, 2010, J CLIN MICROBIOL, V48, P2009, DOI 10.1128/JCM.02351-09; Olayemi A, 2016, EMERG INFECT DIS, V22, P694, DOI 10.3201/eid2204.150155; Oldstone M., 2002, CURR TOP MICROBIOL, P1; Oldstone M, 1982, SCIENCE, V218, P6; OLDSTONE MB, 1968, J IMMUNOL, V100, P355; OLDSTONE MBA, 1984, SCIENCE, V224, P1440, DOI 10.1126/science.6203172; R Core Team, 2016, R LANG ENV STAT COMP; Sauvage F, 2003, J ANIM ECOL, V72, P1, DOI 10.1046/j.1365-2656.2003.00675.x; Sluydts V, 2007, INTEGR ZOOL, V2, P220, DOI 10.1111/j.1749-4877.2007.00065.x; Tersago K, 2012, J WILDLIFE DIS, V48, P148, DOI 10.7589/0090-3558-48.1.148; VEENSTRA A. J. F., 1958, ANIMAL BEHAVIOUR, V6, P195, DOI 10.1016/0003-3472(58)90050-2; VERHAGEN R, 1986, ARCH VIROL, V91, P193, DOI 10.1007/BF01314280; Vieth S, 2007, T ROY SOC TROP MED H, V101, P1253, DOI 10.1016/j.trstmh.2005.03.018; Vitullo A, 1988, J GEN VIROL, V69; VITULLO AD, 1990, INTERVIROLOGY, V31, P339, DOI 10.1159/000150170; VITULLO AD, 1987, AM J TROP MED HYG, V37, P663, DOI 10.4269/ajtmh.1987.37.663; Voutilainen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21323; Voutilainen L, 2015, J GEN VIROL, V96, P1238, DOI 10.1099/vir.0.000076; WALKER DH, 1975, B WORLD HEALTH ORGAN, V52, P523; WALKER DH, 1987, CURR TOP MICROBIOL, V133, P89; WEBB PA, 1975, B WORLD HEALTH ORGAN, V52, P493; WULFF H, 1975, B WORLD HEALTH ORGAN, V52, P429; WULFF H, 1977, B WORLD HEALTH ORGAN, V55, P441	65	3	3	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 27	2017	10								210	10.1186/s13071-017-2146-0				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	ET5FZ	WOS:000400310900001	28449693	DOAJ Gold, Green Published			2019-04-02	
J	Khatat, SE; Daminet, S; Kachani, M; Leutenegger, CM; Duchateau, L; El Amri, H; Hing, M; Azrib, R; Sahibi, H				Khatat, Sarah Elhamiani; Daminet, Sylvie; Kachani, Malika; Leutenegger, Christian M.; Duchateau, Luc; El Amri, Hamid; Hing, Mony; Azrib, Rahma; Sahibi, Hamid			Anaplasma spp. in dogs and owners in north-western Morocco	PARASITES & VECTORS			English	Article						Anaplasma phagocytophilum; Anaplasma platys; PCR; Serology; Dogs; Humans; Rhipicephalussanguineus; Morocco	BURGDORFERI SENSU-LATO; HUMAN GRANULOCYTIC EHRLICHIOSIS; VECTOR-BORNE PATHOGENS; TICK-BORNE; BORRELIA-BURGDORFERI; MOLECULAR EVIDENCE; IXODES-RICINUS; DIROFILARIA-IMMITIS; PHAGOCYTOPHILUM; PLATYS	Background: Anaplasma phagocytophilum is an emerging tick-borne zoonotic pathogen of increased interest worldwide which has been detected in northern Africa. Anaplasma platys is also present in this region and could possibly have a zoonotic potential. However, only one recent article reports on the human esposure to A. phagocytophilum in Morocco and no data are available on canine exposure to both bacteria. Therefore, we conducted a cross-sectional epidemiological study aiming to assess both canine and human exposure to Anaplasma spp. in Morocco. A total of 425 dogs (95 urban, 160 rural and 175 working dogs) and 11 dog owners were sampled from four cities of Morocco. Canine blood samples were screened for Anaplasma spp. antibodies by an enzyme-linked immunosorbent assay (ELISA) and for A. phagocytophilum and A. platys DNA by a real-time polymerase chain reaction (RT-PCR) targeting the msp2 gene. Human sera were tested for specific A. phagocytophilum immunoglobulin G (IgG) using a commercial immunofluorescence assay (IFA) kit. Results: Anaplasma spp. antibodies and A. platys DNA were detected in 21.9 and 7.5% of the dogs, respectively. Anaplasma phagocytophilum DNA was not amplified. Anaplasma platys DNA was significantly more frequently amplified for working dogs. No statistically significant differences in the prevalence of Anaplasma spp. antibodies or A. platys DNA detection were observed between sexes, age classes or in relation to exposure to ticks. A total of 348 Rhipicephalus sanguineus (sensu lato) ticks were removed from 35 urban and working dogs. The majority of dog owners (7/10) were seroreactive to A. phagoyctophilum IgG (one sample was excluded because of hemolysis). Conclusions: This study demonstrates the occurrence of Anaplasma spp. exposure and A. platys infection in dogs, and A. phagocytophilum exposure in humans in Morocco.	[Khatat, Sarah Elhamiani; Azrib, Rahma; Sahibi, Hamid] Inst Agron & Vet Hassan II, Rabat, Morocco; [Khatat, Sarah Elhamiani; Daminet, Sylvie; Duchateau, Luc] Univ Ghent, Fac Vet Med, Ghent, Merelbeke, Belgium; [Kachani, Malika] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA USA; [Leutenegger, Christian M.] Mol Diagnost IDEXX Labs Inc, West Sacramento, CA 95605 USA; [El Amri, Hamid] Lab Royal Gendarmerie, Rabat, Morocco; [Hing, Mony] Queen Astrid Mil Hosp, Natl Reference Lab Anaplasma Phagocytophilum, Lab Clin Biol, Brussels, Belgium	Khatat, SE (reprint author), Inst Agron & Vet Hassan II, Rabat, Morocco.; Khatat, SE (reprint author), Univ Ghent, Fac Vet Med, Ghent, Merelbeke, Belgium.	elhamianis@yahoo.fr					Alho AM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1509-2; Allison RW, 2013, VET CLIN PATH, V42, P127, DOI 10.1111/vcp.12040; Anderson JF, 2008, INFECT DIS CLIN N AM, V22, P195, DOI 10.1016/j.idc.2007.12.006; Arraga-Alvarado C, 1996, Invest Clin, V37, P35; Arraga-Alvarado C, 1999, J MED MICROBIOL, V48, P991, DOI 10.1099/00222615-48-11-991; Arraga-Alvarado CM, 2014, AM J TROP MED HYG, V91, P1161, DOI 10.4269/ajtmh.14-0372; Azzag N, 2015, COMP IMMUNOL MICROB, V38, P1, DOI 10.1016/j.cimid.2015.01.001; Baneth G, 2014, INT J PARASITOL, V44, P591, DOI 10.1016/j.ijpara.2014.03.011; Ben Said M, 2014, Bull Soc Pathol Exot, V107, P1, DOI 10.1007/s13149-013-0323-8; BOOM R, 1990, J CLIN MICROBIOL, V28, P495; Bouza-Mora L, 2017, TICKS TICK-BORNE DIS, V8, P36, DOI 10.1016/j.ttbdis.2016.09.012; Breitschwerdt EB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-298; Carrade DD, 2009, J VET INTERN MED, V23, P1129, DOI 10.1111/j.1939-1676.2009.0384.x; Chastagner A, 2013, EMERG INFECT DIS, V19, P825, DOI 10.3201/eid1905.121003; Chochlakis D, 2009, VECTOR-BORNE ZOONOT, V9, P457, DOI 10.1089/vbz.2008.0019; Clarke LL, 2014, J S AFR VET ASSOC, V85, DOI 10.4102/jsava.v85i1.996; Cochez C, 2011, TICKS TICK-BORNE DIS, V2, P156, DOI 10.1016/j.ttbdis.2011.06.004; Dahmani M, 2015, TICKS TICK-BORNE DIS, V6, P198, DOI 10.1016/j.ttbdis.2014.12.007; Dantas-Torres F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-26; Davoust B, 2013, COMP IMMUNOL MICROB, V36, P613, DOI 10.1016/j.cimid.2013.08.002; Diniz PPVP, 2010, VECTOR-BORNE ZOONOT, V10, P117, DOI 10.1089/vbz.2008.0184; Djiba ML, 2013, TROP ANIM HEALTH PRO, V45, P1557, DOI 10.1007/s11250-013-0399-y; Dong J, 2008, J MOL DIAGN, V10, P185, DOI 10.2353/jmoldx.2008.070063; Dugat T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-439; Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145; Ebani VV, 2014, ANN AGR ENV MED, V21, P671, DOI 10.5604/12321966.1129912; Egenvall A, 1998, VET REC, V143, P412, DOI 10.1136/vr.143.15.412; Foley JE, 2003, COMP IMMUNOL MICROB, V26, P103, DOI 10.1016/S0147-9571(02)00023-1; Ghafar MW, 2012, J ADV RES, V3, P189, DOI 10.1016/j.jare.2011.08.002; Harvey JW, 2012, INFECT DIS DOG CAT, P241; Heyman P, 2003, J INFECTION, V47, P129, DOI 10.1016/S0163-4453(03)00056-2; Hornok S, 2013, VET MICROBIOL, V167, P700, DOI 10.1016/j.vetmic.2013.08.011; Keysary A, 2007, EMERG INFECT DIS, V13, P1411, DOI 10.3201/eid1309.070455; Khatat SE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160880; Lilliehook I, 1998, VET CLIN PATH, V27, P116, DOI 10.1111/j.1939-165X.1998.tb01030.x; Lim S, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-32; Lima MLF, 2010, BRAZ J MICROBIOL, V41, P381, DOI [10.1590/S1517-83822010000200019, 10.1590/S1517-838220100002000019]; Livak K, 1995, PE APPL BIOSYST RES; M'Ghirbi Y, 2009, PARASITOL RES, V104, P767, DOI 10.1007/s00436-008-1253-4; M'ghirbi Y, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-180; Maggi RG, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-103; Mircean V, 2012, VECTOR-BORNE ZOONOT, V12, P595, DOI 10.1089/vbz.2011.0915; National Association of State Public Health Veterinarians Inc, 2011, MMWR Recomm Rep, V60, P1; Otranto D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-328; Pennisi MG, 2012, TICKS TICK-BORNE DIS, V3, P314, DOI 10.1016/j.ttbdis.2012.10.026; Perez M, 2006, ANN NY ACAD SCI, V1078, P110, DOI 10.1196/annals.1374.016; Psaroulaki A, 2009, CLIN MICROBIOL INFEC, V15, P10, DOI 10.1111/j.1469-0691.2008.02646.x; Pusterla N, 1999, J CLIN MICROBIOL, V37, P4042; Qablan MA, 2012, PARASITOL RES, V111, P301, DOI 10.1007/s00436-012-2839-4; Qurollo AB, 2014, INFECT ECOL EPIDEMIO, V4, P24699; Salakij C., 2012, Comparative Clinical Pathology, V21, P345, DOI 10.1007/s00580-011-1378-1; SANTAREM V. A., 2005, C AGRARIAE, V1, P60, DOI DOI 10.5747/CA.2005.V01.N2.A015; Santos AS, 2009, VET REC, V164, P168, DOI 10.1136/vr.164.6.168; Santos HA, 2011, J VET DIAGN INVEST, V23, P770, DOI 10.1177/1040638711406974; Sarih M, 2003, VECTOR-BORNE ZOONOT, V3, P133, DOI 10.1089/153036603768395834; Sarih MH, 2005, J CLIN MICROBIOL, V43, P1127, DOI 10.1128/JCM.43.3.1127-1132.2005; Schorn S, 2011, TICKS TICK-BORNE DIS, V2, P196, DOI 10.1016/j.ttbdis.2011.09.009; Seng P, 2009, CLIN MICROBIOL INFEC, V15, P86, DOI 10.1111/j.1469-0691.2008.02251.x; Silaghi C, 2008, EMERG INFECT DIS, V14, P972, DOI 10.3201/eid1406.061513; Skerget M, 2003, EMERG INFECT DIS, V9, P1337; Stillman BA, 2014, JAVMA-J AM VET MED A, V245, P80, DOI 10.2460/javma.245.1.80; Stuen S, 2007, VET RES COMMUN, V31, P79, DOI 10.1007/s11259-007-0071-y; Torina A, 2007, ZOONOSES PUBLIC HLTH, V54, P8, DOI 10.1111/j.1863-2378.2007.00989.x; Walder G, 2003, EUR J CLIN MICROBIOL, V22, P543, DOI 10.1007/s10096-003-0986-3; Walker A. R, 2003, BIOSCIENCE REPORTS E; Zhang L, 2014, BIOMED RES INT, V2014, P313; Zobba R, 2014, APPL ENVIRON MICROB, V80, P271, DOI 10.1128/AEM.03129-13	67	1	1	0	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 24	2017	10								202	10.1186/s13071-017-2148-y				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	ET5FU	WOS:000400310400002		DOAJ Gold, Green Published			2019-04-02	
J	Bannister-Tyrrell, M; Verdonck, K; Hausmann-Muela, S; Gryseels, C; Ribera, JM; Grietens, KP				Bannister-Tyrrell, Melanie; Verdonck, Kristien; Hausmann-Muela, Susanna; Gryseels, Charlotte; Muela Ribera, Joan; Grietens, Koen Peeters			Defining micro-epidemiology for malaria elimination: systematic review and meta-analysis	MALARIA JOURNAL			English	Review						Micro-epidemiology; Malaria elimination; Hotspot; Fine-scale heterogeneity; Epidemiology methods	PLASMODIUM-FALCIPARUM MALARIA; RISK-FACTORS; SPATIAL-DISTRIBUTION; HOUSEHOLD LEVEL; WESTERN KENYA; SRI-LANKA; TRANSMISSION; POPULATION; CHILDREN; AREA	Background: Malaria risk can vary markedly between households in the same village, or between villages, but the determinants of this "micro-epidemiological"variation in malaria risk remain poorly understood. This study aimed to identify factors that explain fine-scale variation in malaria risk across settings and improve definitions and methods for malaria micro-epidemiology. Methods: A systematic review of studies that examined risk factors for variation in malaria infection between individuals, households, clusters, hotspots, or villages in any malaria-endemic setting was conducted. Four databases were searched for studies published up until 6th October 2015. Crude and adjusted effect estimates for risk factors for malaria infection were combined in random effects meta-analyses. Bias was assessed using the Newcastle-Ottawa Quality Assessment Scale. Results: From 743 retrieved records, 51 studies were selected, representing populations comprising over 160,000 individuals in 21 countries, in high-and low-endemicity settings. Sixty-five risk factors were identified and meta-analyses were conducted for 11 risk factors. Most studies focused on environmental factors, especially increasing distance from a breeding site (OR 0.89, 95% CI 0.86-0.92, 10 studies). Individual bed net use was protective (OR 0.63, 95% CI 0.52-0.77, 12 studies), but not household bed net ownership. Increasing household size (OR 1.08, 95% CI 1.01-1.15, 4 studies) and household crowding (OR 1.79, 95% CI 1.48-2.16, 4 studies) were associated with malaria infection. Health seeking behaviour, medical history and genetic traits were less frequently studied. Only six studies examined whether individual-level risk factors explained differences in malaria risk at village or hotspot level, and five studies reported different risk factors at different levels of analysis. The risk of bias varied from low to high in individual studies. Insufficient reporting and comparability of measurements limited the number of meta-analyses conducted. Conclusions: Several variables associated with individual-level malaria infection were identified, but there was limited evidence that these factors explain variation in malaria risk at village or hotspot level. Social, population and other factors may confound estimates of environmental risk factors, yet these variables are not included in many studies. A structured framework of malaria risk factors is proposed to improve study design and quality of evidence in future micro-epidemiological studies.	[Bannister-Tyrrell, Melanie; Verdonck, Kristien; Gryseels, Charlotte; Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium; [Hausmann-Muela, Susanna] Swiss Agcy Dev & Cooperat, Bern, Switzerland; [Muela Ribera, Joan] MARC Univ Rovira & Virgili, Tarragona, Spain	Bannister-Tyrrell, M (reprint author), Inst Trop Med, Antwerp, Belgium.	mbannister@itg.be		Gryseels, Charlotte/0000-0002-8963-4469; Peeters Grietens, Koen/0000-0001-6570-9887	Erasmus Mundus Joint Doctorate Program of the European Union	This study received no specific funding. The first author (MBT) is funded by the Erasmus Mundus Joint Doctorate Program of the European Union. This funding body had no role in the design of the study or the collection, analysis, interpretation of data or manuscript writing.	Alemu K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-223; [Anonymous], 2015, GLOB TECHN STRAT MAL; Atieli HE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-241; AUDIBERT M, 1990, AM J TROP MED HYG, V42, P550, DOI 10.4269/ajtmh.1990.42.550; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Barrera R, 1999, AM J TROP MED HYG, V61, P784, DOI 10.4269/ajtmh.1999.61.784; Barros FSM, 2015, AM J TROP MED HYG, V93, P939, DOI 10.4269/ajtmh.15-0042; Basurko C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-90; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001993; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; CATTANI JA, 1986, PAPUA NEW GUINEA MED, V29, P11; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Coulibaly D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-82; Cox J, 2014, MALARIA J, V13, P1; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P624, DOI 10.4269/ajtmh.2008.79.624; da Silva-Nunes M, 2012, ACTA TROP, V121, P281, DOI 10.1016/j.actatropica.2011.10.001; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; Florey LS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001723; GAMAGEMENDIS AC, 1991, AM J TROP MED HYG, V45, P77, DOI 10.4269/ajtmh.1991.45.77; Gaudart J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-286; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Grange L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123102; Greenland S, 2016, EUR J EPIDEMIOL, V31, P337, DOI 10.1007/s10654-016-0149-3; Greenwood B.M., 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene, V83, P25, DOI 10.1016/0035-9203(89)90599-3; Grillet ME, 2010, SPAT SPATIO-TEMPORAL, V1, P251, DOI 10.1016/j.sste.2010.09.007; Grillet ME, 2010, AM J TROP MED HYG, V82, P194, DOI 10.4269/ajtmh.2010.09-0040; Gryseels C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0689-0; Gunawardena DM, 1998, AM J TROP MED HYG, V58, P533, DOI 10.4269/ajtmh.1998.58.533; Hackett LW, 1937, MALARIA EUROPE ECOLO; Hague U, 2013, AM J TROP MED HYG, V88, P727, DOI 10.4269/ajtmh.12-0456; Haque U, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-367; Haque U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018908; Kreuels B, 2008, J INFECT DIS, V197, P85, DOI 10.1086/524066; Loha E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047354; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; MARCELO L, 1994, AM J TROP MED HYG, V51, P16, DOI 10.4269/ajtmh.1994.51.16; Midega JT, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1672; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; de Barros FSM, 2011, J VECTOR ECOL, V36, P159, DOI 10.1111/j.1948-7134.2011.00153.x; Mosha JF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-221; Mosha JF, 2014, TANZANIA MALAR J, V13, P445; Murhandarwati EE, 2014, INDONESIA MALAR J, V13, P130, DOI DOI 10.1186/1475-2875-13-130; Mwakalinga VM, 2016, MALARIA J, V15, P1; Ndiath M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-453; Nemes S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-56; Nixon CP, 2014, PATHOG GLOB HEALTH, V108, P369, DOI 10.1179/2047773214Y.0000000167; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Ostlund U, 2011, INT J NURS STUD, V48, P369, DOI 10.1016/j.ijnurstu.2010.10.005; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0712-5; Peterson I, 2009, AM J TROP MED HYG, V80, P103, DOI 10.4269/ajtmh.2009.80.103; Prakash A, 2000, INDIAN J MED RES, V111, P121; Pullan RL, 2011, J INFECT DIS, V203, P406, DOI 10.1093/infdis/jiq063; Pullan RL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-2; Rosas-Aguirre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137458; Rosas-Aguirre A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0670-y; Rulisa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069443; Schapira A, 2012, ADV PARASIT, V78, P97, DOI 10.1016/B978-0-12-394303-3.00001-3; Sissoko MS, 2015, AM J TROP MED HYG, V93, P790, DOI 10.4269/ajtmh.14-0765; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; van der Hoek W, 1998, T ROY SOC TROP MED H, V92, P265, DOI 10.1016/S0035-9203(98)91003-3; Wells G. A., 2000, NEWCASTLE OTTAWA SCA; Winskill P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-98; World Health Organization, 2016, WHO GLOB ACT PLAN AN, P28; Ye Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-46	68	12	12	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	APR 20	2017	16								164	10.1186/s12936-017-1792-1				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	ES8TB	WOS:000399828700007	28427389	DOAJ Gold, Green Published			2019-04-02	
J	Seyoum, D; Yewhalaw, D; Duchateau, L; Brandt, P; Rosas-Aguirre, A; Speybroeck, N				Seyoum, Dinberu; Yewhalaw, Delenasaw; Duchateau, Luc; Brandt, Patrick; Rosas-Aguirre, Angel; Speybroeck, Niko			Household level spatio-temporal analysis of Plasmodium falciparum and Plasmodium vivax malaria in Ethiopia	PARASITES & VECTORS			English	Article						Spatio-temporal analysis; SatScan; Plasmodium vivax; Plasmodium falciparum; Active case detection; Ethiopia	SOUTH-CENTRAL ETHIOPIA; TRANSMISSION; KNOWLEDGE; PATTERNS; CHILDREN; AREA; DAM; IDENTIFICATION; ELIMINATION; PREVALENCE	Background: The global decline of malaria burden and goals for elimination has led to an increased interest in the fine-scale epidemiology of malaria. Micro-geographic heterogeneity of malaria infection could have implications for designing targeted small-area interventions. Methods: Two-year longitudinal cohort study data were used to explore the spatial and spatio-temporal distribution of malaria episodes in 2040 children aged < 10 years in 16 villages near the Gilgel-Gibe hydropower dam in Southwest Ethiopia. All selected households (HHs) were geo-referenced, and children were followed up through weekly house-to-house visits for two consecutive years to identify febrile episodes of P. falciparum and P. vivax infections. After confirming the spatial dependence of malaria episodes with Ripley's K function, SatScan(TM) was used to identify purely spatial and space-time clusters (hotspots) of annual malaria incidence for 2 years follow-up: year 1 (July 2008-June 2009) and year 2 (July 2009-June 2010). Results: In total, 685 P. falciparum episodes (in 492 HHs) and 385 P. vivax episodes (in 290 HHs) were identified, representing respectively incidence rates of 14.6 (95% CI: 13.4-15.6) and 8.2 (95% CI: 7.3-9.1) per 1000 child-months at risk. In year 1, the most likely (128 HHs with 63 episodes, RR = 2.1) and secondary (15 HHs with 12 episodes, RR = 5.31) clusters of P. vivax incidence were found respectively in southern and north-western villages; while in year 2, the most likely cluster was located only in north-western villages (85 HHs with 16 episodes, RR = 4.4). Instead, most likely spatial clusters of P. falciparum incidence were consistently located in villages south of the dam in both years: year 1 (167 HHs with 81 episodes, RR = 1.8) and year 2 (133 HHs with 67 episodes, RR = 2.2). Space-time clusters in southern villages for P. vivax were found in August-November 2008 in year 1 and between November 2009 and February 2010 in year 2; while for P. falciparum, they were found in September-November 2008 in year 1 and October-November 2009 in year 2. Conclusion: Hotspots of P. falciparum incidence in children were more stable at the geographical level and over time compared to those of P. vivax incidence during the study period.	[Seyoum, Dinberu; Rosas-Aguirre, Angel; Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium; [Seyoum, Dinberu] Jimma Univ, Dept Stat, Nat Sci Coll, Jimma, Ethiopia; [Yewhalaw, Delenasaw] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Hlth Sci, Jimma, Ethiopia; [Yewhalaw, Delenasaw] Jimma Univ, Trop & Infect Dis Res Ctr, Jimma, Ethiopia; [Duchateau, Luc] Univ Ghent, Dept Comparat Physiol & Biometr, Fac Vet Med, Ghent, Belgium; [Brandt, Patrick] Univ Texas Dallas, Sch Econ Polit & Policy Sci, Dallas, TX USA; [Rosas-Aguirre, Angel] Univ Peruana Cayetano Heredia, Inst Trop Med Alexander von Humboldt, Lima, Peru	Rosas-Aguirre, A; Speybroeck, N (reprint author), Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium.	angelrosasa@gmail.com; niko.speybroeck@uclouvain.be		Rosas Aguirre, Angel/0000-0002-3271-7028	Institutional University Cooperation IUC-JU project in the framework of the Flemish Interuniversity Council (VLIR-UOS)	This study was funded by the Institutional University Cooperation IUC-JU project in the framework of the Flemish Interuniversity Council (VLIR-UOS).	Abate A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-312; Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; Alemu K, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-223; Alemu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079966; Baddeley A, 2005, J STAT SOFTW, V12, P1; Bejon P, 2014, ELIFE, V3, DOI 10.7554/eLife.02130; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Broothaerts N, 2012, CATENA, V97, P127, DOI 10.1016/j.catena.2012.05.011; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Degefa T, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0532-z; Dejenie T, 2011, ETHIOP J HEALTH SCI, V21, P57; Devi R, 2008, BIORESOURCE TECHNOL, V99, P975, DOI 10.1016/j.biortech.2007.03.013; Federal Democratic Republic of Ethiopia Ministry of Health, 2012, NAT MAL GUID; Federal Democratic Republic of Ethiopia Ministry of health, 2015, HSDP 4 ANN PERF REP; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Ghebreyesus TA, 2000, T ROY SOC TROP MED H, V94, P17, DOI 10.1016/S0035-9203(00)90424-3; Golassa L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-352; Kibret S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-360; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2011, SATSCAN US GUID VERS; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; QGIS developer team, 2014, QGIS US GUID REL 2 1; Rosas-Aguirre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137458; Rosas-Aguirre A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0868-4; Rosas-Aguirre A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-339; Santana-Morales MA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-199; Sena L, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0625-x; Sena LD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-406; Seyoum D, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1253-2; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; Woldearegay K, 2013, MOMONA ETHIOP J SCI, V5, P3; World Health Organization, 2015, WORLD MAL REP 2015; Woyessa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-84; Yewhalaw D, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-161; Yewhalaw D, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-47; Yimer F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0749-5	40	3	3	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 20	2017	10								196	10.1186/s13071-017-2124-6				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	ES8TH	WOS:000399829300004	28427451	DOAJ Gold, Green Published			2019-04-02	
J	Habtewold, T; Groom, Z; Christophides, GK				Habtewold, Tibebu; Groom, Zoe; Christophides, George K.			Immune resistance and tolerance strategies in malaria vector and non-vector mosquitoes	PARASITES & VECTORS			English	Article						Mosquito immunity; Pathogen tolerance/resistance; Plasmodium; Microbiota; Haemolymph antimicrobial activity	ANOPHELES-GAMBIAE MOSQUITOS; PLASMODIUM-FALCIPARUM; INFECTIOUS-DISEASES; INSECT IMMUNITY; INNATE IMMUNITY; BACTERIAL; PARASITE; CAPACITY; SUSCEPTIBILITY; MICROBIOTA	Background: The Anopheles gambiae complex consists of species that vary greatly in their capacity to transmit malaria. The mosquito immune system has been identified as a key factor that can influence whether Plasmodium infection establishes within the mosquito vector. This study was designed to investigate the immune responses of An. coluzzii, An. arabiensis and An. quadriannulatus mosquitoes. The first two mosquito species are major vectors of malaria in sub-Saharan Africa, while the third is thought to be a non-vector. Methods: All three mosquito species were reared in mixed cultures. Their capacity to eliminate P. berghei and regulate midgut bacteria was examined. Results: Our results revealed large differences in mosquito resistance to P. berghei. In all three mosquito species, immune reactions involving the complement system were triggered when the number of parasites that mosquitoes were challenged with exceeded a certain level, i. e. immune tolerance threshold. This threshold was markedly lower in An. quadriannulatus compared to An. coluzzii and An. arabiensis. We also demonstrated that the level of immune tolerance to P. berghei infection in the haemolymph is inversely correlated with the level of immune tolerance to microbiota observed in the midgut lumen after a blood meal. The malaria non-vector mosquito species, An. Conclusions: We propose a model whereby an increased tolerance to microbiota in the mosquito midgut results in lower tolerance to Plasmodium infection. In this model, malaria non-vector mosquito species are expected to have increased immune resistance in the haemocoel, possibly due to complement priming by microbiota elicitors. We propose that this strategy is employed by the malaria non-vector mosquito, An. quadriannulatus, while An. coluzzii has reduced tolerance to bacterial infection in themidgut and consequently reduced immune resistance to Plasmodium infection at the haemocoel level. An in-depth understanding of the molecular mechanisms regulating immune tolerance versus resistance in different mosquito vectors of malaria could guide the design of new vector and disease control strategies.	[Habtewold, Tibebu; Groom, Zoe; Christophides, George K.] Imperial Coll London, Dept Life Sci, London, England; [Habtewold, Tibebu] Univ Ghent, Dept Comparat Physiol & Biometr, Ghent, Belgium; [Groom, Zoe] Costello Med Consulting, Cambridge, England	Habtewold, T (reprint author), Imperial Coll London, Dept Life Sci, London, England.; Habtewold, T (reprint author), Univ Ghent, Dept Comparat Physiol & Biometr, Ghent, Belgium.	t.habtewold@imperial.ac.uk		Christophides, George/0000-0002-3323-1687	Wellcome Trust [WT093587MA]; BBSRC [BB/K009338/1]	The work was supported by grants from the Wellcome Trust, WT093587MA and the BBSRC Project BB/K009338/1.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Basanez MG, 1996, PARASITOLOGY, V113, P331, DOI 10.1017/S003118200006649X; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006; Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019; Gendrin M, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P525, DOI 10.5772/55107; Gendrin M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6921; Gneme A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-204; Habtewold T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000070; Harris C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030849; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; Kause A, 2012, G3-GENES GENOM GENET, V2, P527, DOI 10.1534/g3.112.002311; Kinnebrew MA, 2012, IMMUNOL REV, V245, P113, DOI 10.1111/j.1600-065X.2011.01081.x; Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008; Le BV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002958; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Li MWM, 2014, J BIOL CHEM, V289, P24885, DOI 10.1074/jbc.M114.554519; MEDLEY GF, 1993, PARASITOLOGY, V106, P441, DOI 10.1017/S0031182000076721; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meister S, 2005, P NATL ACAD SCI USA, V102, P11420, DOI 10.1073/pnas.0504950102; Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542; Mendes AM, 2011, INFECT IMMUN, V79, P4708, DOI 10.1128/IAI.05647-11; Milling A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015853; Molina-Cruz A, 2012, P NATL ACAD SCI USA, V109, pE1957, DOI 10.1073/pnas.1121183109; Muturi Ephantus J, 2006, Filaria J, V5, P8, DOI 10.1186/1475-2883-5-8; Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Raberg L, 2009, PHILOS T R SOC B, V364, P37, DOI 10.1098/rstb.2008.0184; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Rescigno Maria, 2009, F1000 Biol Rep, V1, P9, DOI 10.3410/B1-9; Rodrigues J, 2010, SCIENCE, V329, P1353, DOI 10.1126/science.1190689; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; Salvaudon L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-189; Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Silipo A, 2010, GLYCOBIOLOGY, V20, P406, DOI 10.1093/glycob/cwp201; Sinden RE, 2007, PLOS PATHOG, V3, P2005, DOI 10.1371/journal.ppat.0030195; Stathopoulos S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003897; Takken W, 1999, T ROY SOC TROP MED H, V93, P578, DOI 10.1016/S0035-9203(99)90054-8; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	49	6	6	1	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	APR 18	2017	10								186	10.1186/s13071-017-2109-5				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	ES3HA	WOS:000399419200001	28420446	DOAJ Gold, Green Published			2019-04-02	
J	Aksoy, S; Buscher, P; Lehane, M; Solano, P; van den Abbeele, J				Aksoy, Serap; Buscher, Phillipe; Lehane, Mike; Solano, Philippe; van den Abbeele, Jan			Human African trypanosomiasis control: Achievements and challenges	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SLEEPING SICKNESS; TSETSE-FLIES; GAMBIENSE TRYPANOSOMIASIS; POPULATION; TRANSMISSION; ELIMINATION; CONTRIBUTE; DIAGNOSIS	Sleeping sickness, also known as human African trypanosomiasis (HAT), is a neglected disease that impacts 70 million people living in 1.55 million km(2) in sub-Saharan Africa. Since the beginning of the 20th century, there have been multiple HAT epidemics in sub-Saharan Africa, with the most recent epidemic in the 1990s resulting in about half a million HAT cases reported between 1990 and 2015. Here we review the status of HAT disease at the current time and the toolbox available for its control. We also highlight future opportunities under development towards novel or improved interventions.	[Aksoy, Serap] Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA; [Buscher, Phillipe; van den Abbeele, Jan] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Lehane, Mike] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England; [Solano, Philippe] IRD, Montpellier, France	Aksoy, S (reprint author), Yale Univ, Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT 06520 USA.	Serap.Aksoy@yale.edu		Buscher, Philippe/0000-0002-1926-7472; Van Den Abbeele, Jan/0000-0002-4533-4480; Aksoy, Serap/0000-0001-9941-143X; solano, philippe/0000-0002-4351-3506			Aksoy E, 2016, P NATL ACAD SCI USA, V113, P6961, DOI 10.1073/pnas.1600304113; Aksoy S, 2003, ADV PARASIT, V53, P1, DOI 10.1016/S0065-308X(03)53002-0; Aksoy S, 2008, ADV EXP MED BIOL, V627, P35, DOI 10.1007/978-0-387-78225-6_3; Aksoy S, 2014, CURR OPIN INSECT SCI, V3, P43, DOI 10.1016/j.cois.2014.07.003; Aksoy S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002624; Aksoy S, 2013, TRENDS PARASITOL, V29, P394, DOI 10.1016/j.pt.2013.06.005; Alsan M., 2015, AM ECON REV, P382; Barrett MP, 1999, LANCET, V353, P1113, DOI 10.1016/S0140-6736(98)00416-4; Benoit JB, 2015, ANNU REV ENTOMOL, V60, P351, DOI 10.1146/annurev-ento-010814-020834; Buscher P, 2015, EXPERT REV MOL DIAGN, V15, P607, DOI 10.1586/14737159.2015.1027195; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Courtin F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003727; Cunningham LJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004441; De Vooght L, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0156-6; De Vooght L, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-23; Dyer NA, 2013, TRENDS PARASITOL, V29, P188, DOI 10.1016/j.pt.2013.02.003; Franco JR, 2014, PARASITOLOGY, V141, P748, DOI 10.1017/S0031182013002102; Headrick DR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002772; Ilboudo H, 2011, MICROBES INFECT, V13, P943, DOI 10.1016/j.micinf.2011.05.007; Jamonneau V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003480; Kabayo JP, 2002, TRENDS PARASITOL, V18, P473, DOI 10.1016/S1471-4922(02)02371-1; Koffi M, 2016, PARASITE, V23, DOI 10.1051/parasite/2016059; Lehane M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004437; Macharia R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004421; MAGNUS E, 1978, ANN SOC BELG MED TR, V58, P169; Mantilla BS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006158; Michalkova V, 2014, APPL ENVIRON MICROB, V80, P5844, DOI 10.1128/AEM.01150-14; Molyneux D H, 1973, Ann Soc Belg Med Trop, V53, P605; Molyneux D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000609; Ngoyi DM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002954; Obiero GFO, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002663; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Rock KS, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1131-8; Rogers DJ, 2002, TRENDS PARASITOL, V18, P534, DOI 10.1016/S1471-4922(02)02422-4; Shaw APM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003624; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Solano P, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00033; Solano P, 2010, TRENDS PARASITOL, V26, P255, DOI 10.1016/j.pt.2010.02.006; Van Den Abbeele J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000926; Watanabe J, 2014, SCIENCE, V344, P380, DOI 10.1126/science.1249656; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001	41	16	17	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	APR	2017	11	4							e0005454	10.1371/journal.pntd.0005454				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EW1NH	WOS:000402256700016	28426685	DOAJ Gold, Green Published			2019-04-02	
J	Carabin, H; Winkler, AS; Dorny, P				Carabin, Helene; Winkler, Andrea S.; Dorny, Pierre			Taenia solium cysticercosis and taeniosis: Achievements from the past 10 years and the way forward	PLOS NEGLECTED TROPICAL DISEASES			English	Article							NEUROCYSTICERCOSIS; ALBENDAZOLE; OUTCOMES		[Carabin, Helene] Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73019 USA; [Winkler, Andrea S.] Univ Oslo, Fac Med, Inst Hlth & Soc, Ctr Global Hlth, Oslo, Norway; [Winkler, Andrea S.] Tech Univ Munich, Dept Neurol, Munich, Germany; [Dorny, Pierre] Inst Trop Med Antwerp, Dept Biomed Sci, Unit Vet Helminthol, Antwerp, Belgium	Carabin, H (reprint author), Univ Oklahoma, Hlth Sci Ctr, Coll Publ Hlth, Dept Biostat & Epidemiol, Oklahoma City, OK 73019 USA.	helene-carabin@ouhsc.edu			National Institute of Neurological Disorders and Stroke; Fogarty International Center [R21NS055353, R01NS064901]; Fogarty International Center of the National Institutes of Health [R21TW008434]; National Institute of Neurological Diseases and Stroke in the U.S [R21NS077466]; Department of Biotechnology in India under U.S.-India Bilateral Brain Research Collaborative Partnerships (U.S. - India BRCP) [BT/MB/BRCP/06/2011]; German Research Foundation (Neurocysticercosis in sub-Saharan Africa - a neglected infectious disease and am emerging public health problem) [WI-3427]; Bill and Melinda Gates Foundation (Integrated Control of Taeniosis/Cysticercosis in Sub-Saharan Africa Global Health) [OPP1017886]; German Federal Ministry of Education and Research (CYSTINET-Africa: Cysticercosis and Taeniosis Network of SubSaharan Africa) under the framework of the Federal Government's Strategy for Internationa [01DG13024, 01KA1602]	This Overview paper used knowledge acquired in part during the conduct of the following research projects in the past 10 years: the National Institute of Neurological Disorders and Stroke and the Fogarty International Center (R21NS055353, R01NS064901) and the Fogarty International Center (R21TW008434) of the National Institutes of Health under the Brain Disorders in the Developing World: Research Across the Lifespan program as well as by the National Institute of Neurological Diseases and Stroke in the U.S. (R21NS077466) and by the Department of Biotechnology in India (BT/MB/BRCP/06/2011) under the U.S.-India Bilateral Brain Research Collaborative Partnerships (U.S. - India BRCP), as well as from The German Research Foundation (Neurocysticercosis in sub-Saharan Africa - a neglected infectious disease and am emerging public health problem - WI-3427) under German - African Cooperation Projects in Infectious Diseases, the Bill and Melinda Gates Foundation (Integrated Control of Taeniosis/Cysticercosis in Sub-Saharan Africa Global Health Grant Number OPP1017886), and the German Federal Ministry of Education and Research (CYSTINET-Africa: Cysticercosis and Taeniosis Network of SubSaharan Africa 01DG13024 and 01KA1602) under the framework of the Federal Government's Strategy for Internationalization of Science and Research within Research Networks for Health Innovations in Sub-Saharan Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird RA, 2013, NEUROLOGY, V80, P1424, DOI 10.1212/WNL.0b013e31828c2f3e; Carabin Helene, 2014, Curr Trop Med Rep, V1, P181; Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152; Chavan SS, 2017, COMPUT BIOL MED, V81, P64, DOI 10.1016/j.compbiomed.2016.12.006; Coral-Almeida M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003919; Del Brutto OH, 2012, ACTA NEUROL BELG, V112, P335, DOI 10.1007/s13760-012-0068-3; Fleury A, 2016, PARASITE IMMUNOL, V38, P147, DOI 10.1111/pim.12299; Fleury A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002096; Gabriel S, 2017, ACTA TROP, V165, P252, DOI 10.1016/j.actatropica.2016.04.010; Garcia HH, 2016, NEW ENGL J MED, V374, P2335, DOI 10.1056/NEJMoa1515520; Garcia HH, 2014, EPILEPSIA, V55, P1452, DOI 10.1111/epi.12739; Garcia HH, 2014, LANCET INFECT DIS, V14, P687, DOI 10.1016/S1473-3099(14)70779-0; John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033; Lightowlers MW, 2016, PARASITE IMMUNOL, V38, P158, DOI 10.1111/pim.12291; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Nunes DD, 2013, DIAGN MICR INFEC DIS, V76, P36, DOI 10.1016/j.diagmicrobio.2013.01.020; Rodriguez S, 2012, PATHOG GLOB HEALTH, V106, P286, DOI 10.1179/2047773212Y.0000000048; Romo ML, 2015, T ROY SOC TROP MED H, V109, P738, DOI 10.1093/trstmh/trv078; Torgerson PR, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001920; Winkler AS, 2015, WHOHTMNTDNZD201505	21	2	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	APR	2017	11	4							e0005478	10.1371/journal.pntd.0005478				5	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EW1NH	WOS:000402256700025	28426664	DOAJ Gold, Green Published			2019-04-02	
J	van den Boogaard, W; Zuniga, I; Manzi, M; van den Bergh, R; Lefevre, A; Nanan-N'zeth, K; Duchenne, B; Etienne, W; Juma, N; Ndelema, B; Zachariah, R; Reid, A				van den Boogaard, W.; Zuniga, I.; Manzi, M.; van den Bergh, R.; Lefevre, A.; Nanan-N'zeth, K.; Duchenne, B.; Etienne, W.; Juma, N.; Ndelema, B.; Zachariah, R.; Reid, A.			How do low-birthweight neonates fare 2 years after discharge from a low-technology neonatal care unit in a rural district hospital in Burundi?	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						low-birthweight neonates; developmental impairments; malnutrition; sub-Saharan Africa; operational research	PRETERM BIRTH; MATERNAL MORTALITY; INFANTS; RISK; DISABILITY; COUNTRIES; SETTINGS; AFRICA; AGE	objectives As neonatal care is being scaled up in economically poor settings, there is a need to know more on post-hospital discharge and longer-term outcomes. Of particular interest are mortality, prevalence of developmental impairments and malnutrition, all known to be worse in lowbirthweight neonates (LBW, < 2500 g). Getting a better handle on these parameters might justify and guide support interventions. Two years after hospital discharge, we thus assessed: mortality, developmental impairments and nutritional status of LBW children. methods Household survey of LBW neonates discharged from a neonatal special care unit in Rural Burundi between January and December 2012. results Of 146 LBW neonates, 23% could not be traced and 4% had died. Of the remaining 107 children (median age = 27 months), at least one developmental impairment was found in 27%, with 8% having at least five impairments. Main impairments included delays in motor development (17%) and in learning and speech (12%). Compared to LBW children (n = 100), very-low-birthweight (VLBW, < 1500 g, n=7) children had a significantly higher risk of impairments (intellectual P = 0.001), needing constant supervision and creating a household burden (P = 0.009). Of all children (n-107), 18% were acutely malnourished, with a 3 1/2 times higher risk in VLBWs (P = 0.02). conclusions Reassuringly, most children were thriving 2 years after discharge. However, malnutrition was prevalent and one in three manifested developmental impairments (particularly VLBWs) echoing the need for support programmes. A considerable proportion of children could not be traced, and this emphasises the need for follow-up systems post-discharge.	[van den Boogaard, W.; Manzi, M.; van den Bergh, R.; Zachariah, R.; Reid, A.] Brussels Operat Ctr, Operat Res Unit LuxOR, Luxembourg, Luxembourg; [Zuniga, I.; Lefevre, A.; Etienne, W.] Brussels Operat Ctr, Brussels, Belgium; [Juma, N.; Ndelema, B.] Minist Hlth, Bujumbura, Burundi	van den Boogaard, W (reprint author), 68 Rue Gasperich, L-1617 Luxembourg, Luxembourg.	vandenboogaardw@gmail.com		Van den Bergh, Rafael/0000-0001-6277-8713	MSF Brussels Operational Centre,LuxOR,Luxembourg; Ministry of Foreign Affairs,Luxembourg	We thank the community health workers, without whom we would not have been able to find the participants, and the research team. We thank in particular the mothers and fathers of the children who were willing to participate. This study was funded by MSF Brussels Operational Centre, LuxOR, Luxembourg, and the Ministry of Foreign Affairs, Luxembourg.	Ballot DE, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-11; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Blencowe H, 2013, PEDIATR RES, V74, P4, DOI 10.1038/pr.2013.203; Christian P, 2013, INT J EPIDEMIOL, V42, P1340, DOI 10.1093/ije/dyt109; Cooper PA, 1997, PEDIATRICS, V99, P537, DOI 10.1542/peds.99.4.537; Ferreira RC, 2014, J PEDIAT-BRAZIL, V90, P293, DOI 10.1016/j.jped.2013.09.006; Fischer VJ, 2014, J HEALTH POPUL NUTR, V32, P314; Gladstone M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001121; Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7; Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Lawn JE, 2010, BMC PREGNANCY CHILDB, V10, DOI [10.1186/1471-2393-10-S1-S1, 10.1186/1471-2393-S1-S1]; Manu A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008107; Milner KM, 2015, PAEDIATR INT CHILD H, V35, P227, DOI 10.1179/2046905515Y.0000000043; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Ndelema Brigitte, 2016, BMC Res Notes, V9, P28, DOI 10.1186/s13104-015-1666-y; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P993, DOI 10.1111/tmi.12121; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P166, DOI 10.1111/tmi.12022; The World Bank Group, 2014, MORT RAT NEON PER 10; Trani JF, 2009, LANCET, V374, P1806, DOI 10.1016/S0140-6736(09)61996-6; UNICEF, 2013, RIGHT INGR NEED INV; UNICEF, 2016, UNICEF DAT MON SIT C; WHO, 2016, NEWB RED MORT; WHO, 2016, GLOB DAT CHILD GROWT; Zuniga I, 2013, PUBLIC HEALTH ACTION, V3, P276, DOI 10.5588/pha.13.0050	26	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	APR	2017	22	4					423	430		10.1111/tmi.12845				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EQ4SP	WOS:000398069000007	28142216	Other Gold			2019-04-02	
J	Linsuke, S; Mpabanzi, L; Nundu, S; Mukunda, F; Lutumba, P; Polman, K				Linsuke, Sylvie; Mpabanzi, Liliane; Nundu, Sabin; Mukunda, Faustin; Lutumba, Pascal; Polman, Katja			The road towards sustainable control of schistosomiasis in the Democratic Republic of Congo: Pre-assessment of staff performance and material resources in endemic regions	ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE			English	Article								Objective: To improve knowledge and practice of health staff as well as the availability of material resources for diagnosis and management of schistosomiasis in two endemic provinces of DRC (Kinshasa and Bas-Congo). Methods: Structured interviews were performed using questionnaires with staff from 35 healthcare facilities in 9 health zones (HZ) of Kinshasa and 2 HZ in Bas-Congo. Results: Schistosomiasis was reported to be present in all the included HZ. Health staff knew the most important symptoms of schistosomiasis, but advanced symptoms were more accurately reported in Bas-Congo. Knowledge of symptoms related to schistosomiasis such as anemia (P = 0.0 115) and pollakiuria (P = 0.0 260) was statistically different in both two provinces. Kato-Katz technique and urine filtration were unavailable in both provinces. Parasitological diagnosis was mostly performed using the direct smear method. PZQ was available in 70% of the health facilities, all situated in Bas-Congo. Diagnosis and treatment mostly relied on symptoms and cost more in urban area than in rural. Conclusions: Though knowledge on schistosomiasis among health staff appears sufficient, substantial efforts still must be made to improve the availability of diagnostic tools and treatment in the health facilities in DRC.	[Linsuke, Sylvie; Nundu, Sabin; Lutumba, Pascal] Natl Inst Biomed Res INRB, Dept Epidemiol, Kinshasa, DEM REP CONGO; [Mpabanzi, Liliane; Polman, Katja] Inst Trop Med, Biomed Sci Dept, Antwerp, Belgium; [Mukunda, Faustin] Minist Hlth, Natl Control Program Schistosomiasis & Intestinal, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Fac Med, Kinshasa, DEM REP CONGO	Linsuke, S (reprint author), Natl Inst Biomed Res INRB, Dept Epidemiol, Kinshasa, DEM REP CONGO.	sylvie_lin2003@yahoo.fr			World Health Organization (WHO/TDR) [A61119]	This work was supported by the World Health Organization (WHO/TDR), project ID A61119.	Democratic Republic of Congo, 2006, GUID HLTH ZON DEM RE; Democratic Republic of Congo, 2012, FRAM PLAN INT CONTR; Democratic Republic of Congo. Ministry of Public Health, 2010, NAT PLAN DEV HLTH SE; Gryseels B, 2012, INFECT DIS CLIN N AM, V26, P383, DOI 10.1016/j.idc.2012.03.004; Kabatereine Narcis, 2014, BMC Res Notes, V7, P900, DOI 10.1186/1756-0500-7-900; Khonde Kumbu R, 2016, ADV MED, V2016; Landoure A, 2003, ANN TROP MED PARASIT, V97, P723, DOI 10.1179/000349803225001544; Lengeler C, 2000, ACTA TROP, V74, P77, DOI 10.1016/S0001-706X(99)00046-7; Madinga J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1206-6; Marivoet W, 2011, IOB DISCUSSION PAPER; Rimoin AW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002118; United Nations Development Programme (UNDP)-DRC, 2014, NAT REP HUM DEV 2014; van der Werf MJ, 2004, TROP MED INT HEALTH, V9, P149; van der Werf MJ, 2002, TROP MED INT HEALTH, V7, P70, DOI 10.1046/j.1365-3156.2002.00823.x; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; World Health Organization, 2013, ASS EFF ANTH DRUG SC; World Health Organization, 2016, WKLY EPIDEMIOL REC, V5, P53; World Health Organization, 2013, SCHIST PROGR REP 200	18	0	0	0	0	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2221-1691	2588-9222		ASIAN PAC J TROP BIO	Asian Pac. Trop. Biomed.	APR	2017	7	4					275	279		10.1016/j.apjtb.2017.01.026				5	Tropical Medicine	Tropical Medicine	EQ4UR	WOS:000398075100001		DOAJ Gold			2019-04-02	
J	Jahfari, S; Ruyts, SC; Frazer-Mendelewska, E; Jaarsma, R; Verheyen, K; Sprong, H				Jahfari, Setareh; Ruyts, Sanne C.; Frazer-Mendelewska, Ewa; Jaarsma, Ryanne; Verheyen, Kris; Sprong, Hein			Melting pot of tick-borne zoonoses: the European hedgehog contributes to the maintenance of various tick-borne diseases in natural cycles urban and suburban areas	PARASITES & VECTORS			English	Article						Anaplasma phagocytophilum; Borrelia burgdorferi (sensu lato); Borrelia miyamotoi; "Candidatus Neoehrlichia mikurensis"; Rickettsia helvetica; European hedgehog; Erinaceus europaeus; Lyme borreliosis; Ixodes hexagonus; Ixodes ricinus	BURGDORFERI SENSU-LATO; RELAPSING FEVER SPIROCHETE; GARINII OSPA SEROTYPE-4; IXODES-RICINUS TICKS; BORRELIA-BURGDORFERI; ERINACEUS-EUROPAEUS; LYME BORRELIOSIS; ANAPLASMA-PHAGOCYTOPHILUM; TRANSMISSION DYNAMICS; SPOTTED-FEVER	Background: European hedgehogs (Erinaceus europaeus) are urban dwellers and host both Ixodes ricinus and Ixodes hexagonus. These ticks transmit several zoonotic pathogens like Borrelia burgdorferi (sensu lato), Anaplasma phagocytophilum, Rickettsia helvetica, Borrelia miyamotoi and " Candidatus Neoehrlichia mikurensis". It is unclear to what extent hedgehogs in (sub) urban areas contribute to the presence of infected ticks in these areas, which subsequently pose a risk for acquiring a tick-borne disease. Therefore, it is important to investigate to what extent hedgehogs contribute to the enzootic cycle of these tick-borne pathogens, and to shed more light at the mechanisms of the transmission cycles involving hedgehogs and both ixodid tick species. Methods: Engorged ticks from hedgehogs were collected from (sub) urban areas via rehabilitating centres in Belgium. Ticks were screened individually for presence of Borrelia burgdorferi (sensu lato), Borrelia miyamotoi, Anaplasma phagocytophilum, Rickettsia helvetica and " Candidatus Neoehrlichia mikurensis" using PCR-based methods. Infection rates of the different pathogens in ticks were calculated and compared to infection rates in questing ticks. Results: Both Ixodes hexagonus (n = 1132) and Ixodes ricinus (n = 73) of all life stages were found on the 54 investigated hedgehogs. Only a few hedgehogs carried most of the ticks, with 6 of the 54 hedgehogs carrying more than half of all ticks (624/ 1205). Borrelia miyamotoi, A. phagocytophilum, R. helvetica and B. burgdorferi genospecies (Borrelia afzelii, Borrelia bavariensis and Borrelia spielmanii) were detected in both I. hexagonus and I. ricinus. Anaplasma phagocytophilum, R. helvetica, B. afzelii, B. bavariensis and B. spielmanii were found significantly more in engorged ticks in comparison to questing I. ricinus. Conclusions: European hedgehogs seem to contribute to the spread and transmission of tick-borne pathogens in urban areas. The relatively high prevalence of B. bavariensis, B. spielmanii, B. afzelii, A. phagocytophilum and R. helvetica in engorged ticks suggests that hedgehogs contribute to their enzootic cycles in (sub) urban areas. The extent to which hedgehogs can independently maintain these agents in natural cycles, and the role of other hosts (rodents and birds) remain to be investigated.	[Jahfari, Setareh; Frazer-Mendelewska, Ewa; Jaarsma, Ryanne; Sprong, Hein] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Antonie Leeuwenhoeklaan 9, NL-3720 BA Bilthoven, Netherlands; [Ruyts, Sanne C.; Verheyen, Kris] Univ Ghent, Dept Forest & Water Management, Forest & Nat Lab, Geraardsbergsesteenweg 267, Ghent, Belgium	Sprong, H (reprint author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Antonie Leeuwenhoeklaan 9, NL-3720 BA Bilthoven, Netherlands.	hein.sprong@rivm.nl			IWT-Flanders; Institute for the Promotion of Innovation through Science and technology in Flanders	This investigation received financial support from IWT-Flanders, the Institute for the Promotion of Innovation through Science and technology in Flanders ( to SR).	Arthur DR, 1963, BRITISH TICKS, P213; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burri C, 2014, TICKS TICK-BORNE DIS, V5, P245, DOI 10.1016/j.ttbdis.2013.11.007; Coipan EC, 2016, INFECT GENET EVOL, V42, P66, DOI 10.1016/j.meegid.2016.04.019; Coipan EC, 2013, INFECT GENET EVOL, V17, P216, DOI 10.1016/j.meegid.2013.04.009; Gern L, 2008, PARASITE, V15, P244, DOI 10.1051/parasite/2008153244; Gern L, 1997, FOLIA PARASIT, V44, P309; GERN L, 1991, MED VET ENTOMOL, V5, P431, DOI 10.1111/j.1365-2915.1991.tb00571.x; Gray JS, 1998, EXP APPL ACAROL, V22, P249, DOI 10.1023/A:1006070416135; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Heylen D, 2016, ENVIRON MICROBIOL, V18, P988, DOI 10.1111/1462-2920.13164; Heylen D, 2013, INT J PARASITOL, V43, P603, DOI 10.1016/j.ijpara.2013.02.007; Heylen D, 2013, ENVIRON MICROBIOL, V15, P663, DOI 10.1111/1462-2920.12059; Hofmeester TR, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/043001; Hovius JWR, 2013, LANCET, V382, P658, DOI 10.1016/S0140-6736(13)61644-X; Hu CM, 2001, J CLIN MICROBIOL, V39, P1169, DOI 10.1128/JCM.39.3.1169-1171.2001; Hubert P, 2011, LANDSCAPE URBAN PLAN, V103, P34, DOI 10.1016/j.landurbplan.2011.05.010; Huegli D, 2002, J CLIN MICROBIOL, V40, P4735, DOI 10.1128/JCM.40.12.4735-4737.2002; Huijser M. P., 1999, Lutra, V42, P39; Humair PF, 1999, PARASITOLOGY, V118, P33, DOI 10.1017/S0031182098003564; Jahfari S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005042; Jahfari S, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-365; Jahfari S, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-74; Koetsveld J, 2016, TICKS TICK-BORNE DIS, V7, P371, DOI 10.1016/j.ttbdis.2015.12.010; Krawczyk AI, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0814-5; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; Labuda M, 1999, ZBL BAKT-INT J MED M, V289, P513; Mannelli A, 2012, FEMS MICROBIOL REV, V36, P837, DOI 10.1111/j.1574-6976.2011.00312.x; Mulder S, 2013, VECTOR-BORNE ZOONOT, V13, P865, DOI 10.1089/vbz.2012.1194; Ogden NH, 2000, MED VET ENTOMOL, V14, P332, DOI 10.1046/j.1365-2915.2000.00244.x; Pfaffle M, 2011, EXP APPL ACAROL, V54, P151, DOI 10.1007/s10493-011-9432-x; Randolph SE, 2011, TICKS TICK-BORNE DIS, V2, P179, DOI 10.1016/j.ttbdis.2011.07.004; Randolph SE, 2004, INT J MED MICROBIOL, V293, P5, DOI 10.1016/S1433-1128(04)80004-4; Reeve N.J., 1994, HEDGEHOGS; Richter D, 2004, APPL ENVIRON MICROB, V70, P6414, DOI 10.1128/AEM.70.11.6414-6419.2004; Silaghi C, 2016, EXP APPL ACAROL, V68, P279, DOI 10.1007/s10493-015-9935-y; Silaghi C, 2012, TICKS TICK-BORNE DIS, V3, P49, DOI 10.1016/j.ttbdis.2011.11.005; Skuballa J, 2007, EMERG INFECT DIS, V13, P952, DOI 10.3201/eid1306.070224; Skuballa J, 2012, TICKS TICK-BORNE DIS, V3, P8, DOI 10.1016/j.ttbdis.2011.09.008; Skuballa J, 2010, VECTOR-BORNE ZOONOT, V10, P1055, DOI 10.1089/vbz.2009.0150; Socolovschi C, 2009, VET RES, V40, DOI 10.1051/vetres/2009017; Speck S, 2013, TICKS TICK-BORNE DIS, V4, P222, DOI 10.1016/j.ttbdis.2012.11.003; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Stenos J, 2005, AM J TROP MED HYG, V73, P1083, DOI 10.4269/ajtmh.2005.73.1083; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Team RC, 2016, R LANG ENV STAT COMP; TOUTOUNGI LN, 1993, EXP APPL ACAROL, V17, P581, DOI 10.1007/BF00053487; van Duijvendijk G, 2016, ECOLOGY PREVENTION L, P268; Voordouw MJ, 2015, PARASITOLOGY, V142, P290, DOI 10.1017/S0031182014001486; Wagemakers A, 2017, TICKS TICK-BORNE DIS, V8, P370, DOI 10.1016/j.ttbdis.2016.12.012; Wagemakers A, 2015, TRENDS PARASITOL, V31, P260, DOI 10.1016/j.pt.2015.03.008; Welinder-Olsson C, 2010, J CLIN MICROBIOL, V48, P1956, DOI 10.1128/JCM.02423-09; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wormser GP, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw085; Young RP, 2006, J ZOOL, V269, P349, DOI 10.1111/j.1469-7998.2006.00078.x	55	15	16	1	15	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	MAR 7	2017	10								134	10.1186/s13071-017-2065-0				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EO7VS	WOS:000396898800001	28270232	DOAJ Gold, Green Published			2019-04-02	
J	Heng, S; Durnez, L; Mao, S; Siv, S; Tho, S; Mean, V; Sluydts, V; Coosemans, M				Heng, Somony; Durnez, Lies; Mao, Sokny; Siv, Sovannaroth; Tho, Sochantha; Mean, Vanna; Sluydts, Vincent; Coosemans, Marc			Passive case detection of malaria in Ratanakiri Province (Cambodia) to detect villages at higher risk for malaria	MALARIA JOURNAL			English	Article						Malaria; Incidence; Spatial clustering; Passive case detection; Cambodia	RANDOMIZED CONTROLLED-TRIAL; PLASMODIUM-VIVAX MALARIA; HOT-SPOTS; LOW TRANSMISSION; IDENTIFICATION; SURVEILLANCE; INFECTIONS; FALCIPARUM; HOTSPOTS; HEALTH	Background: Cambodia reduced malaria incidence by more than 75% between 2000 and 2015, a target of the Millennium Development Goal 6. The Cambodian Government aims to eliminate all forms of malaria by 2025. The country's malaria incidence is highly variable at provincial level, but less is known at village level. This study used passive case detection (PCD) data at village level in Ratanakiri Province from 2010 to 2014 to describe incidence trends and identify high-risk areas of malaria to be primarily targeted towards malaria elimination. Methods: In 2010, the Cambodian malaria programme created a Malaria Information System (MIS) to capture malaria information at village level through PCD by village malaria workers and health facilities. The MIS data of Ratanakiri Province 2010-2014 were used to calculate annual incidence rates by Plasmodium species at province and commune levels. For estimating the trend at provincial level only villages reporting each year were selected. The communal incidences and the number of cases per village were visualized on a map per Plasmodium species and per year. Analysis of spatial clustering of village malaria cases by Plasmodium species was performed by year. Results: Overall, malaria annual incidence rates per 1000 inhabitants decreased from 86 (2010) to 30 (2014). Falciparum incidence decreased (by 79% in 2014 compared to 2010; CI 95% 76-82%) more rapidly than vivax incidence (by 19% in 2014 compared to 2010; CI 95% 5-32%). There were ten to 16 significant spatial clusters each year. Big clusters tended to extend along the Cambodian-Vietnamese border and along the Sesan River. Three clusters appeared throughout all years (2010-2014): one with 21 villages appeared each year, the second shrunk progressively from 2012 to 2014 and the third was split into two smaller clusters in 2013 and 2014. Conclusion: The decline of malaria burden can be attributed to intensive malaria control activities implemented in the areas: distribution of a long-lasting insecticidal net per person and early diagnosis and prompt treatment. Dihydro-artemisinin piperaquine was the only first-line treatment for all malaria cases. No radical treatment with primaquine was provided for Plasmodium vivax cases, which could explain the slow decrease of P. vivax due to relapses. To achieve malaria elimination by 2025, priority should be given to the control of stable malaria clusters appearing over time.	[Heng, Somony; Mao, Sokny; Siv, Sovannaroth; Tho, Sochantha; Mean, Vanna] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Heng, Somony; Durnez, Lies; Sluydts, Vincent; Coosemans, Marc] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Sluydts, Vincent] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Heng, Somony; Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	Heng, S (reprint author), Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.; Heng, S (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; Heng, S (reprint author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	hengsomony@gmail.com			Bill and Melinda Gates Foundation under the Global Health Grant [OPP1032354]	This paper is part of MalaResT project funded by the Bill and Melinda Gates Foundation under the Global Health Grant Number OPP1032354. This project aims to evaluate the effectiveness of topical repellents, in addition to longlasting insecticidal nets, on malaria prevalence and incidence.	Ahmed S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069713; Bejon P, 2014, ELIFE, V3, DOI 10.7554/eLife.02130; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bousema T, 2013, ECOL CONT VECTOR-BOR, V3, P197; Bousema T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-36; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; CNM, 2011, NAT STRAT PLAN EL MA; CNM, 2013, ANN MAL REP 2012 CAM; CNM, 2012, MAL SIT RAT; Cox J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-371; Dolgin E, 2010, NAT MED, V16, P1055, DOI 10.1038/nm1010-1055; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Gryseels C, 2015, AM J TROP MED HYG, V93, P810, DOI 10.4269/ajtmh.15-0259; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Hagenlocher M, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0036-2; Hasegawa A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-292; Heng S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0960-4; Kerkhof K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1558-1; KULLDORF M, 2005, SATSCAN USER GUIDE V; Kumar DS, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-14; Magalhaes RJS, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-385; Maltha J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-171; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; MCDC Malaria Capacity Development Consortium, 2011, CHAR MAL HOTSP MOD E; Mellor S., 2013, MOVING MALARIA ELIMI; Mosha JF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-53; Mosha JF, 2014, TANZANIA MALAR J, V13, P445; Nath MJ, 2013, PUBLIC HEALTH, V127, P572, DOI 10.1016/j.puhe.2013.02.007; National Institute of Statistics, 2013, CAMB INT POP SURV 20; Ndiath M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-453; Price RN, 2011, CURR OPIN INFECT DIS, V24, P578, DOI 10.1097/QCO.0b013e32834c61e3; Qayum A, 2015, MALARIA J, V14, P392; Rosas-Aguirre A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0670-y; Siv S, 2016, AM J TROP MED HYG, V95, P97, DOI 10.4269/ajtmh.16-0208; Sluydts V, 2016, LANCET INFECT DIS, V16, P1169, DOI 10.1016/S1473-3099(16)30148-7; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Srivastava A, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-30; Statistics Japan, 2010, POP PROJ CAMB 2008 2; Sturrock HJW, 2016, TRENDS PARASITOL, V32, P635, DOI 10.1016/j.pt.2016.05.001; The R Development Core Team, 2010, R LANG ENV STAT COMP, V1; UNICEF, 2015, BRIDG LANG DIV ETHN; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; WHO, 2007, MAL EL FIELD MAN LOW, P85; WHO, EL MAL; WHO, 2014, MAL RAP DIAGN TEST P; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organization, 2015, WORLD MAL REP 2015; Xia J, 2015, MALARIA J, V14, P145; Xiaodong Sun, 2013, Malar J, V12, P6, DOI 10.1186/1475-2875-12-6; Zhou GF, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0551-4	52	5	5	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	MAR 6	2017	16								104	10.1186/s12936-017-1758-3				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EN9CX	WOS:000396299400001	28264678	DOAJ Gold, Green Published			2019-04-02	
J	Aderie, EM; Diro, E; Zachariah, R; da Fonseca, MS; Abongomera, C; Dolamo, BL; Ritmeijer, K				Aderie, Endashaw M.; Diro, Ermias; Zachariah, Rony; da Fonseca, Marcio Silveira; Abongomera, Charles; Dolamo, Bethabile L.; Ritmeijer, Koert			Does timing of antiretroviral treatment influence treatment outcomes of visceral leishmaniasis in Northwest Ethiopia?	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Antiretroviral therapy timing; Ethiopia; HIV infection; Tri-dimensional screening; Visceral leishmaniasis	HUMAN-IMMUNODEFICIENCY-VIRUS; RECONSTITUTION INFLAMMATORY SYNDROME; LIPOSOMAL AMPHOTERICIN-B; INFECTED PATIENTS; HIGH PREVALENCE; HIV-INFECTION; TUBERCULOSIS; THERAPY; MANIFESTATIONS; MILTEFOSINE	Background: Visceral leishmaniasis (VL) patients with HIV co-infection should receive antiretroviral treatment (ART). However, the best timing for initiation of ART is not known. Among such individuals, we assessed the influence of ART timing on VL outcomes. Methods: A retrospective cohort study was conducted in Northwest Ethiopia among VL patients starting ART between 2008 and 2015. VL outcomes were assessed by the twelfth month of starting ART, within 4 weeks of VL diagnosis or thereafter. Results: Of 213 VL-HIV co-infected patients with ART initiation, 96 (45.1%) had moderate to severe malnutrition, 53 (24.9%) had active TB and 128 (60.1%) had hemoglobin levels under 9 g/dL. Eighty-nine (41.8%) were already on ART before VL diagnosis, 46 (21.6%) started ART within 4 weeks, and 78 (36.6%) thereafter. Definitive cure in those starting ART within 4 weeks 59% (95% CI 43-75%) and those starting thereafter 56% (95% CI 44-68%) was not significantly different. Those starting ART before primary VL had higher 12-months mortality compared to those starting later (RR 0.6; 95% CI 0.4-0.9; p=0.012). Conclusions: VL-HIV patients are severely ill and with serious additional comorbidities. Outcomes of HIV-VL management are unsatisfactory and early ART initiation was associated with higher mortality. Further research on the optimal timing of ART initiation, and ensuring earlier diagnosis of VL patients, with improved management of comorbidities are needed.	[Aderie, Endashaw M.; Abongomera, Charles] Med Sans Frontieres, Addis Ababa, Ethiopia; [Diro, Ermias] Univ Gondar, Gondar, Ethiopia; [Zachariah, Rony] Med Sans Frontieres, Operat Ctr Brussels LuxOR, Luxembourg, Luxembourg; [da Fonseca, Marcio Silveira; Ritmeijer, Koert] Med Sans Frontieres, Operat Ctr Amsterdam, Amsterdam, Netherlands; [Abongomera, Charles] Inst Trop Med, Antwerp, Belgium; [Dolamo, Bethabile L.] Univ South Africa, Pretoria, South Africa; [Aderie, Endashaw M.] POB 3338 Code 1250,K13-14, Addis Ababa, Ethiopia	Aderie, EM (reprint author), Med Sans Frontieres, Addis Ababa, Ethiopia.; Aderie, EM (reprint author), POB 3338 Code 1250,K13-14, Addis Ababa, Ethiopia.	emengistu88@gmail.com			United Kingdom's Department for International Development (DFID); The Union; MSF; Medecins sans Frontieres-Operational Center Amsterdam	The program was funded by the United Kingdom's Department for International Development (DFID), The Union, MSF and Medecins sans Frontieres-Operational Center Amsterdam. Medecins Sans Frontieres-Operational Center Amsterdam supported open access publication. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdool Karim SS, 2010, NEW ENGL J MED, V362, P697, DOI DOI 10.1056/NEJM0A0905848; Agarwal U, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-17; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Berhe N, 1999, AIDS, V13, P1921, DOI 10.1097/00002030-199910010-00015; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Cota GF, 2011, PLOS NEGL TROP DIS, V5; Cotarelo MJF, 2003, CLIN INFECT DIS, V37, P973, DOI 10.1086/377607; Diro E, 2015, LANCET INFECT DIS, V15, P122, DOI 10.1016/S1473-3099(14)70833-3; Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869; Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002875; Dorlo TPC, 2012, J ANTIMICROB CHEMOTH, V67, P2576, DOI 10.1093/jac/dks275; FMoH (Federal Ministry of Health), 2013, GUID DIAGN TREATM PR; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Havlir DV, 2011, NEW ENGL J MED, V365, P1482, DOI 10.1056/NEJMoa1013607; Jarvis JN, 2013, CURR OPIN INFECT DIS, V26, P1, DOI 10.1097/QCO.0b013e32835c2198; Lin JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-321; Lopez-Velez R, 2003, ANN TROP MED PARASIT, V97, P143, DOI 10.1179/000349803225002615; Marques Nuno, 2007, Acta Med Port, V20, P291; Ritmeijer K, 2006, CLIN INFECT DIS, V43, P357, DOI 10.1086/505217; Salih NA, 2014, TROP MED INT HEALTH, V19, P146, DOI 10.1111/tmi.12238; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; ter Horst R, 2009, AM J TROP MED HYG, V80, P929, DOI 10.4269/ajtmh.2009.80.929; United Nations, SUST DEV GOALS 17 GO; van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005; Wade RL, 2013, DIAGN MICR INFEC DIS, V76, P361, DOI 10.1016/j.diagmicrobio.2013.04.001; World Health Organization, 2013, CONS GUID US ANT DRU	28	1	1	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	MAR	2017	111	3					107	116		10.1093/trstmh/trx023				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EZ2TI	WOS:000404562900003	28633331	Green Published, Bronze			2019-04-02	
J	Lindahl-Rajala, E; Hoffman, T; Fretin, D; Godfroid, J; Sattorov, N; Boqvist, S; Lundkvist, A; Magnusson, U				Lindahl-Rajala, Elisabeth; Hoffman, Tove; Fretin, David; Godfroid, Jacques; Sattorov, Nosirjon; Boqvist, Sofia; Lundkvist, Ake; Magnusson, Ulf			Detection and characterization of Brucella spp. in bovine milk in small-scale urban and peri-urban farming in Tajikistan	PLOS NEGLECTED TROPICAL DISEASES			English	Article							REAL-TIME PCR; RISK-FACTORS; DIAGNOSIS; LIVESTOCK; IDENTIFICATION; SEROPOSITIVITY; SURVEILLANCE; MELITENSIS; COUNTRIES; TESTS	Brucellosis is one of the most common zoonoses globally, and Central Asia remains a Brucella hotspot. The World Health Organization classifies brucellosis as a neglected zoonotic disease that is rarely in the spotlight for research and mainly affects poor, marginalized people. Urban and peri-urban farming is a common practice in many low-income countries, and it increases the incomes of families that are often restrained by limited economic resources. However, there is a concern that the growing number of people and livestock living close together in these areas will increase the transmission of zoonotic pathogens such as Brucella. This study investigates the presence of Brucella DNA in bovine milk in the urban and peri-urban area of Dushanbe, Tajikistan. Brucella DNA was detected in 10.3% of 564 cow milk samples by IS711-based real-time PCR. This finding is concerning because consumption of unpasteurized dairy products is common in the region. Furthermore, Brucella DNA was detected in the milk of all seropositive cows, but 8.3% of the seronegative cows also showed the presence of Brucella DNA. In addition, sequence analysis of the rpoB gene suggests that one cow was infected with B. abortus and another cow was most likely infected with B. melitensis. The discrepancies between the serology and real-time PCR results highlight the need to further investigate whether there is a need for implementing complementary diagnostic strategies to detect false serological negative individuals in Brucella surveillance, control, and eradication programmes. Furthermore, vaccination of cattle with S19 in addition to vaccination of small ruminants with Rev 1 might be needed in order to control Brucella infections in the livestock population but further research focusing on the isolation of Brucella is required to obtain a comprehensive understanding of the Brucella spp. circulating among the livestock in this region.	[Lindahl-Rajala, Elisabeth; Magnusson, Ulf] Swedish Univ Agr Sci, Div Reprod, Dept Clin Sci, Uppsala, Sweden; [Hoffman, Tove; Lundkvist, Ake] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Hoffman, Tove; Lundkvist, Ake] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Fretin, David] Vet & Agrochem Res Ctr, Unit Bacterial Zoonoses Livestock, Operat Direct Bacterial Dis, Brussels, Belgium; [Godfroid, Jacques] Arctic Univ Norway, Univ Tromso, Fac Biosci Fisheries & Econ, Dept Arctic & Marine Biol, Tromso, Norway; [Sattorov, Nosirjon] Tajik Acad Agr Sci, Inst Biosafety Problems, Ctr Natl Collect Pathogen Microorganisms, Dushanbe, Tajikistan; [Boqvist, Sofia] Swedish Univ Agr Sci, Div Food Safety & Bacteriol, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Magnusson, U (reprint author), Swedish Univ Agr Sci, Div Reprod, Dept Clin Sci, Uppsala, Sweden.	ulf.magnusson@slu.se	Godfroid, Jacques/U-3524-2017	Godfroid, Jacques/0000-0002-0782-7858	Swedish Ministry of Foreign Affair's special investment in food security	This study was funded by the Swedish Ministry of Foreign Affairs special investment in food security. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk Sascha, 2003, Clin Lab, V49, P577; [Anonymous], 2016, OIE TERRESTIAL MANUA; Bounaadja L, 2009, VET MICROBIOL, V137, P156, DOI 10.1016/j.vetmic.2008.12.023; Corbel M, 2006, BRUCELLOSIS HUMANS A; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747; Dean A.S., 2012, PLOS NEGL TROP DIS, V6; EU, 2010, DIR PROT AN US SCI P; Flynn K, 1999, CITIES FEEDING PEOPL; Gardner IA, 2000, PREV VET MED, V45, P107, DOI 10.1016/S0167-5877(00)00119-7; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Godfroid J, 2002, VET MICROBIOL, V90, P461, DOI 10.1016/S0378-1135(02)00230-4; Godfroid J, 2013, COMP IMMUNOL MICROB, V36, P241, DOI 10.1016/j.cimid.2012.09.001; Godfroid J, 2010, CROAT MED J, V51, P296, DOI 10.3325/cmj.2010.51.296; Gwida M, 2016, IRISH VET J, V69, DOI 10.1186/s13620-016-0062-9; Hinic V, 2008, J MICROBIOL METH, V75, P375, DOI 10.1016/j.mimet.2008.07.002; Hinic V, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-22; Jackson R, 2007, VET REC, V161, P476, DOI 10.1136/vr.161.14.476; Kasymbekov J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002047; KIRK MD, 2015, PLOS MED, V12; Lindahl E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117318; Lindahl E, 2014, TROP ANIM HEALTH PRO, V46, P563, DOI 10.1007/s11250-013-0534-9; Mailles A., 2012, EURO SURVEILL, V17; Marianelli C, 2006, MICROBES INFECT, V8, P860, DOI 10.1016/j.micinf.2005.10.008; Matero P, 2011, CLIN MICROBIOL INFEC, V17, P34, DOI 10.1111/j.1469-0691.2010.03178.x; McDermott J, 2013, REV SCI TECH OIE, V32, P249; Munoz PM, 2005, CLIN DIAGN LAB IMMUN, V12, P141, DOI 10.1128/CDLI.12.1.141-151.2005; Pappas G, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/j.ijantimicag.2010.06.013; Rajala EL, 2016, TROP ANIM HEALTH PRO, V48, P553, DOI 10.1007/s11250-015-0992-3; Saegerman C, 2010, INFECT PARASITIC DIS, P971; Scholz HC, 2016, INT J SYST EVOL MICR, V66, P2090, DOI 10.1099/ijsem.0.000998; Schwarz N.G., 2015, ACTA TROP; Steinfeld H, 2004, VET PARASITOL, V125, P19, DOI 10.1016/j.vetpar.2004.05.003; United Nations Department of Economic and Social Affairs Population Division, 2014, STESASERA352 UN DEP; Whatmore AM, 2014, INT J SYST EVOL MICR, V64, P4120, DOI 10.1099/ijs.0.065482-0; Whatmore AM, 2009, INFECT GENET EVOL, V9, P1168, DOI 10.1016/j.meegid.2009.07.001; World Health Organisation/Department for International Development-Animal Health Program, 2006, JOINT WHO DFID AHP M	36	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2017	11	3							e0005367	10.1371/journal.pntd.0005367				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EW1LG	WOS:000402251300015	28296882	DOAJ Gold, Green Published			2019-04-02	
J	Rai, K; Bhattarai, NR; Vanaerschot, M; Imamura, H; Gebru, G; Khanal, B; Rijal, S; Boelaert, M; Pal, C; Karki, P; Dujardin, JC; Van der Auwera, G				Rai, Keshav; Bhattarai, Narayan Raj; Vanaerschot, Manu; Imamura, Hideo; Gebru, Gebreyohans; Khanal, Basudha; Rijal, Suman; Boelaert, Marleen; Pal, Chiranjib; Karki, Prahlad; Dujardin, Jean-Claude; Van der Auwera, Gert			Single locus genotyping to track Leishmania donovani in the Indian subcontinent: Application in Nepal	PLOS NEGLECTED TROPICAL DISEASES			English	Article							RESISTANCE; REVEALS; COMPLEX	Background We designed a straightforward method for discriminating circulating Leishmania populations in the Indian subcontinent (ISC). Research on transmission dynamics of visceral leishmaniasis (VL, or Kala-azar) was recently identified as one of the key research priorities for elimination of the disease in the ISC. VL in Bangladesh, India, and Nepal is caused by genetically homogeneous populations of Leishmania donovani parasites, transmitted by female sandflies. Classical methods to study diversity of these protozoa in other regions of the world, such as microsatellite typing, have proven of little use in the area, as they are not able to discriminate most genotypes. Recently, whole genome sequencing (WGS) so far identified 10 different populations termed ISC001-ISC010. Methodology/Principle findings As an alternative to WGS for epidemiological or clinical studies, we designed assays based on PCR amplification followed by dideoxynucleotide sequencing for identification of the nonrecombinant genotypes ISC001 up to ISC007. These assays were applied on 106 parasite isolates collected in Nepal between 2011 and 2014. Combined with data from WGS on strains collected in the period 2002-2011, we provide a proof-of-principle for the application of genotyping to study treatment outcome, and differential geographic distribution. Conclusions/Significance Our method can aid in epidemiological follow-up of visceral leishmaniasis in the Indian subcontinent, a necessity in the frame of the Kala-azar elimination initiative in the region.	[Rai, Keshav; Bhattarai, Narayan Raj; Khanal, Basudha] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Rai, Keshav; Pal, Chiranjib] West Bengal State Univ, Dept Zool, Barasat, W Bengal, India; [Vanaerschot, Manu] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA; [Imamura, Hideo; Dujardin, Jean-Claude; Van der Auwera, Gert] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gebru, Gebreyohans] Aksum Univ, Coll Agr, Dept Anim Sci, Aksum, Ethiopia; [Rijal, Suman; Karki, Prahlad] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Dujardin, Jean-Claude] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium	Dujardin, JC (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; Dujardin, JC (reprint author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	jcdujardin@itg.be; gvdauwera@itg.be	Rai, Keshav/Q-1350-2016; Vanaerschot, Manu/B-6812-2013	Rai, Keshav/0000-0002-9747-3431; Vanaerschot, Manu/0000-0002-9141-2347; Teklu, Gebreyohans Gebru/0000-0002-9835-2658; Boelaert, Marleen/0000-0001-8051-6776; Imamura, Hideo/0000-0002-3282-1319; Pal, Chiranjib/0000-0002-0724-5292	GEMINI project; Flemish Ministry of Economy, Science and Innovation; Institute of Tropical Medicine (Antwerp, Belgium); Belgian Directorate General for Development (DGD)	Whole genome sequencing was funded by the GEMINI project (see www.leishrisk.net) and the Flemish Ministry of Economy, Science and Innovation (EWI). The Kala-azar laboratory (B. P. Koirala Institute of Health Sciences, Nepal) and GVdA were financially supported by the third framework program between the Institute of Tropical Medicine (Antwerp, Belgium) and the Belgian Directorate General for Development (DGD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MZ, 2009, INFECT GENET EVOL, V9, P24, DOI 10.1016/j.meegid.2008.09.005; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bhattarai NR, 2010, PARASITOLOGY, V137, P947, DOI 10.1017/S0031182009991752; Boelaert M, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD009135.PUB2; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096; Fraga J, 2013, DIAGN MICR INFEC DIS, V77, P245, DOI 10.1016/j.diagmicrobio.2013.07.023; Gourbal B, 2004, J BIOL CHEM, V279, P31010, DOI 10.1074/jbc.M403959200; Imamura H, 2016, ELIFE, V5, DOI 10.7554/eLife.12613; Kuhls K, 2005, MICROBES INFECT, V7, P1224, DOI 10.1016/j.micinf.2005.04.009; Laurent T, 2007, INFECT GENET EVOL, V7, P206, DOI 10.1016/j.meegid.2006.08.005; Mauricio IL, 2006, INT J PARASITOL, V36, P757, DOI 10.1016/j.ijpara.2006.03.006; Montalvo AM, 2012, EUR J CLIN MICROBIOL, V31, P1453, DOI 10.1007/s10096-011-1463-z; Odiwuor S, 2011, INFECT GENET EVOL; Ostyn B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003966; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Core Team, 2014, R LANG ENV STAT COMP; Roh SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126257; Singh O. P., 2016, LANCET INFECT DIS; Singh S, 1995, J PARASITOL, V81, P1000, DOI 10.2307/3284056; Sudarshan M, 2015, J CLIN MICROBIOL; Tobie EJ, 2001, J PARASITOL, V87, P714, DOI 10.1645/0022-3395(2001)087[0714:CAPOOT]2.0.CO;2; Tyagi S, 1996, NAT BIOTECHNOL, V14, P303, DOI 10.1038/nbt0396-303; Verma S, 2013, TROP MED INT HEALTH, V18, P268, DOI 10.1111/tmi.12047; WHO, 2016, LEISHM FACT SHEET; World Health Organization, 2016, LEISHM HIGH BURD COU	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2017	11	3							e0005420	10.1371/journal.pntd.0005420				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EW1LG	WOS:000402251300026	28249021	DOAJ Gold, Green Published			2019-04-02	
J	Sunyoto, T; Potet, J; Boelaert, M				Sunyoto, Temmy; Potet, Julien; Boelaert, Marleen			Visceral leishmaniasis in Somalia: A review of epidemiology and access to care	PLOS NEGLECTED TROPICAL DISEASES			English	Review							WESTERN UPPER NILE; KALA-AZAR; RIFT-VALLEY; PHLEBOTOMUS-MARTINI; BARINGO DISTRICT; SOUTHERN SUDAN; EASTERN SUDAN; ENDEMIC AREA; OUTBREAK; HEALTH	Somalia, ravaged by conflict since 1991, has areas endemic for visceral leishmaniasis (VL), a deadly parasitic disease affecting the rural poor, internally displaced, and pastoralists. Very little is known about VL burden in Somalia, where the protracted crisis hampers access to health care. We reviewed evidence about VL epidemiology in Somalia and appraised control options within the context of this fragile state's health system. VL has been reported in Somalia since 1934 and has persisted ever since in foci in the southern parts of the country. The only feasible VL control option is early diagnosis and treatment, currently mostly provided by nonstate actors. The availability of VL care in Somalia is limited and insufficient at best, both in coverage and quality. Precarious security remains a major obstacle to reach VL patients in the endemic areas, and the true VL burden and its impact remain unknown. Locally adjusted, innovative approaches in VL care provision should be explored, without undermining ongoing health system development in Somalia. Ensuring VL care is accessible is a moral imperative, and the limitations of the current VL diagnostic and treatment tools in Somalia and other endemic settings affected by conflict should be overcome.	[Sunyoto, Temmy; Boelaert, Marleen] Inst Trop Med, Antwerp, Belgium; [Sunyoto, Temmy; Potet, Julien] Med Sans Frontieres Campaign Access Med, Geneva, Switzerland	Sunyoto, T (reprint author), Inst Trop Med, Antwerp, Belgium.; Sunyoto, T (reprint author), Med Sans Frontieres Campaign Access Med, Geneva, Switzerland.	tsunyoto@itg.be		Sunyoto, Temmy/0000-0003-0369-8830; Boelaert, Marleen/0000-0001-8051-6776	European Union's Horizon research and innovation programme under the Marie Sklodowska-Curie grant [642609]; Euroleish project	The project leading to this research has received funding from the European Union's Horizon2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement 642609. TS is the author receiving the grant under the Euroleish project (see www.euroleish.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002720; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P287; [Anonymous], 1990, WHO TECHNICAL REPORT, P9; Anyamba A, 2009, P NATL ACAD SCI USA, V106, P955, DOI 10.1073/pnas.0806490106; BARUFFA G, 1966, Rivista di Parassitologia, V27, P1; Beyrer C, 2007, LANCET, V370, P619, DOI 10.1016/S0140-6736(07)61301-4; Boussery G, 2001, EMERG INFECT DIS, V7, P603; Bruckner C, 2011, CONFL HLTH, V5, P1; Bucheton B, 2002, MICROBES INFECT, V4, P1449, DOI 10.1016/S1286-4579(02)00027-8; Buckley J, 2015, SOMALIA PRIVATE SECT; Burki T, 2009, LANCET, V374, P371, DOI 10.1016/S0140-6736(09)61401-X; Burki TK, 2013, LANCET, V382, P1237, DOI 10.1016/S0140-6736(13)62083-8; CAHILL KM, 1971, T ROY SOC TROP MED H, V65, P28, DOI 10.1016/0035-9203(71)90182-9; CAHILL KM, 1968, TROP GEOGR MED, V20, P109; Capobianco E, 2008, REV HLTH SECTOR AID; Collin SM, 2006, TROP MED INT HEALTH, V11, P509, DOI 10.1111/j.1365-3156.2006.01589.x; Dereure J, 2003, MICROBES INFECT, V5, P1103, DOI 10.1016/j.micinf.2003.07.003; Dhimal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129869; Elkheir N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004360; Elnaiem DEA, 2011, J VECTOR ECOL, V36, pS23, DOI 10.1111/j.1948-7134.2011.00109.x; Fuje MM, 2011, 7 EUR C TROP; Gebre-Michael T, 2004, ACTA TROP, V90, P73, DOI 10.1016/j.actatropica.2003.09.021; GebreMichael T, 1996, MED VET ENTOMOL, V10, P53, DOI 10.1111/j.1365-2915.1996.tb00082.x; Gerstl S, 2006, TROP MED INT HEALTH, V11, P167, DOI 10.1111/j.1365-3156.2005.01550.x; Guha-Sapir D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000108; Hailu A, 2016, NEGLECT TROP DIS, P87, DOI 10.1007/978-3-319-25471-5_5; Hammond L, 2012, HUMANITARIAN SPACE S, P1; HARITH AE, 1986, T ROY SOC TROP MED H, V80, P583, DOI 10.1016/0035-9203(86)90149-5; Helander B., 1990, NOMADIC PEOPLES, V25/27, P122; Heppner G, 1993, NEW ENGL J MED, V329, P2002; Hill Peter S, 2014, Confl Health, V8, P20, DOI 10.1186/1752-1505-8-20; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, P2; Ibrahim ME, 1999, AM J TROP MED HYG, V61, P941, DOI 10.4269/ajtmh.1999.61.941; IRIN, 2011, AL SHAB BAN AG THREA; Karunakara U, MED SANS; Kohler JC, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-34; Kolaczinski JH, 2007, EMERG INFECT DIS, V13, P507, DOI 10.3201/eid1303.060706; LAUGHLIN LW, 1993, AM J TROP MED HYG, V48, pR6; Leduc B, 2011, HUMANITARIAN NEGOTIA, P77; Liddle KF, 2013, T ROY SOC TROP MED H, V107, P690, DOI 10.1093/trstmh/trt090; Linard C, 2010, INT J HEALTH GEOGR, V9; Maalim A, 2014, INT HEALTH, V6, P70, DOI 10.1093/inthealth/iht035; Malaria Consortium, 2010, LEISHM CONTR E AFR P; Marlet MVL, 2003, T ROY SOC TROP MED H, V97, P667, DOI 10.1016/S0035-9203(03)80099-8; Marlet MVL, 2003, T ROY SOC TROP MED H, V97, P515, DOI 10.1016/S0035-9203(03)80012-3; Menkhaus K, 2006, INT SECURITY, V31, P74, DOI 10.1162/isec.2007.31.3.74; Ministry of Health Somalia Federal Government, 2013, SOM HLTH SECT STRAT; Moise R, 1955, ANN MED NAVALE TROPI, V68, P481; Pavignani E., 2012, SOMALI HEALTHCARE AR; Pavignani E, 2013, INT REV RED CROSS, V95, P41, DOI 10.1017/S1816383113000726; Penso G, 1934, B ATTI RICERCA ACCAD, V60, P292; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.04395, 10.7554/eLife.02851]; Postigo JAR, 2010, INT J ANTIMICROB AG, V36, pS62, DOI 10.1016/j.ijantimicag.2010.06.023; Quayad MG, 2007, BILD AN INT J SOMALI, V7, P190; Raguenaud ME, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000085; Reithinger R, 2007, T ROY SOC TROP MED H, V101, P1169, DOI 10.1016/j.trstmh.2007.06.001; SCHAEFER KU, 1994, AM J TROP MED HYG, V50, P78, DOI 10.4269/ajtmh.1994.50.78; SCHAEFER KU, 1995, T ROY SOC TROP MED H, V89, P471, DOI 10.1016/0035-9203(95)90070-5; SCHORSCHER JA, 1992, T ROY SOC TROP MED H, V86, P622, DOI 10.1016/0035-9203(92)90154-5; Seal Andrew, 2013, Confl Health, V7, P22, DOI 10.1186/1752-1505-7-22; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; SHIDDO SA, 1995, TROP GEOGR MED, V47, P68; SHIDDO SA, 1995, T ROY SOC TROP MED H, V89, P361, DOI 10.1016/0035-9203(95)90008-X; SHIDDO SA, 1995, T ROY SOC TROP MED H, V89, P21, DOI 10.1016/0035-9203(95)90640-1; Shiddo SA, 1996, IMMUNOL LETT, V50, P87, DOI 10.1016/0165-2478(96)02529-1; Somalia Health Advisory Board, 2014, PRIOR HLTH POL ACT S; Somalia Ministries of Health and Health Sector Partners, 2015, SOM HLTH SECT CALL L; Somalia Ministry of Health, 2014, HUM RES HLTH STRAT P; Svoboda E., 2015, ISLAMIC HUMANITARIAN; Unicef, 2008, HLTH CAR SEEK BEH SO, P1; Warsame A, 2016, INT HEALTH, V8, P204, DOI 10.1093/inthealth/ihv060; Warsame A, 2014, LANCET GLOB HEALTH, V2, pE197, DOI 10.1016/S2214-109X(14)70010-5; WHO, 2016, WHO IMPL ONL EP SURV; Woolhead A, 1995, ANN TROP MED PARASIT, V89, P687, DOI 10.1080/00034983.1995.11813003; World Health Organization, 2015, STRAT REV SOM HLTH S, P44; World Health Organization, 2012, CHILD HLTH SOM SIT A; World Health Organization, WHO GLOB HLTH OBS; World Health Organization, 2015, VISC LEISHM CONTR ST; Zachariah R, 2012, TROP MED INT HEALTH, V17, P1156, DOI 10.1111/j.1365-3156.2012.03047.x; Zijlstra EE, 2001, T ROY SOC TROP MED H, V95, pS27, DOI 10.1016/S0035-9203(01)90218-4	81	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	MAR	2017	11	3							e0005231	10.1371/journal.pntd.0005231				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EW1LG	WOS:000402251300002	28278151	DOAJ Gold, Green Published			2019-04-02	
J	Delamou, A; Camara, BS; Kolie, JP; Guemou, AD; Haba, NY; Marquez, S; Beavogui, AH; Delvaux, T; van Griensven, J				Delamou, Alexandre; Camara, Bienvenu Salim; Kolie, Jean Pe; Guemou, Achille Diona; Haba, Nyankoye Yves; Marquez, Shannon; Beavogui, Abdoul Habib; Delvaux, Therese; van Griensven, Johan			Profile and reintegration experience of Ebola survivors in Guinea: a cross-sectional study	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						Ebola virus disease; survivors; reintegration; Guinea; West Africa	VIRUS DISEASE; LESSONS; HEALTH; PLASMA	ObjectiveTo describe the experience of Guinean Ebola virus disease (EVD) survivors in Guinea, up to ten months after discharge from the Ebola treatment unit. MethodsCross-sectional study using a standardised semistructured questionnaire among survivors from Conakry and Coyah districts in 2015 in Guinea. We used proportions, mean (standard deviation) and median (interquartile range) to summarise the variables. The McNemar chi-square test was used to compare proportions. ResultsThe 121 EVD survivors interviewed had a median reintegration time from discharge of 18 weeks (IQR: 14-32 weeks). Most survivors were aged 15-44 years (87.6%) with secondary to higher level of education (68.6%), and 25.6% were healthcare workers. The majority reported a lower socio-economic status (90%), a less favourable work situation (79%) and psychological status (60%). About 31% reported physical health problems. Most survivors reported lower levels of reintegration with friends and at work place (72%) and lower acceptance by others in general (71%) in the period after the EVD as compared to the period before the EVD. Only 55 survivors (45.5%) were involved in one or more activities of the EVD response: participation in clinical studies on the EVD (44 survivors, 36.4%), community sensitisation (28 survivors, 23.1%) or work in Ebola treatment and/or transit centres (23 survivors, 21.7%). ConclusionThere is a need for a long-term follow-up of EVD survivors in Guinea and more efforts to support their social, professional and economic reintegration, especially in rural areas.	[Delamou, Alexandre] Gamal Univ Conakry, Dept Publ Hlth, Fac Med, POB 4099, Conakry, Guinea; [Delamou, Alexandre; Camara, Bienvenu Salim; Beavogui, Abdoul Habib] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, Alexandre; Delvaux, Therese; van Griensven, Johan] Inst Trop Med, Antwerp, Belgium; [Kolie, Jean Pe; Guemou, Achille Diona] Reseau Natl Assoc Survivants Ebola Guinee, Conakry, Guinea; [Haba, Nyankoye Yves] Ctr Natl Transfus Sanguine, Conakry, Guinea; [Marquez, Shannon] Drexel Univ, Dept Publ Hlth, Philadelphia, PA 19104 USA	Delamou, A (reprint author), Gamal Univ Conakry, Dept Publ Hlth, Fac Med, POB 4099, Conakry, Guinea.	alexdelamou@yahoo.fr			European Union	We would like to thank all the EVD survivors who promptly agreed to share their life experiences. Some study participants were enrolled in the Ebola-Tx project funded by the European Union's Horizon 2020 research and innovation programme. The funders of the study had no role in study design, data collection, data analysis, interpretation of the data or in the writing of the report.	[Anonymous], 2015, WORLD HLTH STAT; Arwady MA, 2014, MMWR-MORBID MORTAL W, V63, P1207; Coordination Nationale Ebola. Guinee and OMS, 2016, RAPP SIT EP MAL VIR; Davtyan M, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.26058; Deen GF, 2017, NEW ENGL J MED, V377, P1428, DOI 10.1056/NEJMoa1511410; Delamou A, 2015, LANCET, V385, P503, DOI 10.1016/S0140-6736(15)60193-3; Enserink M, 2015, SCIENCE, V348, P742, DOI 10.1126/science.348.6236.742; Institut de Veille Sanitaire (InVS), 2016, POINT EPID, V201; Institut National de la Statistique, 2014, REC GEN POP HAB; Institut National des Statistiques G, 2014, ENQ DEM SANT IND MUL; Lee-Kwan SH, 2014, MMWR-MORBID MORTAL W, V63, P1205; Mattia JG, 2016, LANCET INFECT DIS, V16, P331, DOI 10.1016/S1473-3099(15)00489-2; Mohammed A, 2015, BMC PUBLIC HEALTH, V15, P824; Mohammed A, 2015, LANCET PSYCHIAT, V2, P955, DOI 10.1016/S2215-0366(15)00451-4; Organisation Mondiale de la Sante (OMS), 2014, TOUT COMM GUIN EP CO; Qureshi AI, 2015, CLIN INFECT DIS, V61, P1035, DOI 10.1093/cid/civ453; Thiam AB, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.379.6070, 10.11694/pamj.supp.2015.22.1.6626]; Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; William MK Trochim, 2006, RES METHODS KNOWLEDG; World Health Organization, 2016, EB SIT REP; World Health Organization, 2015, WHO M SURV EB VIR DI	22	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	MAR	2017	22	3					254	260		10.1111/tmi.12825				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EM1NG	WOS:000395083700001	27935657	Bronze			2019-04-02	
J	Verschuere, J; Decroo, T; Lim, D; Kindermans, JM; Nguon, C; Huy, R; Alkourdi, Y; Grietens, KP; Gryseels, C				Verschuere, Jesse; Decroo, Tom; Lim, Dara; Kindermans, Jean-Marie; Nguon, Chea; Huy, Rekol; Alkourdi, Yasmine; Grietens, Koen Peeters; Gryseels, Charlotte			Local constraints to access appropriate malaria treatment in the context of parasite resistance in Cambodia: a qualitative study	MALARIA JOURNAL			English	Article							PLASMODIUM-FALCIPARUM MALARIA; ANTIMALARIAL-DRUG-RESISTANCE; ARTEMISININ RESISTANCE; COMBINATION THERAPY; SOUTHEAST-ASIA; ELIMINATION; HEALTH; EPIDEMIOLOGY; POPULATION; PREVALENCE	Background: Despite emerging drug resistance in Cambodia, artemisinin-based combination therapy (ACT) is still the most efficacious therapy. ACT is available free of charge in the Cambodian public sector and at a subsidized rate in the private sector. However, un- and mistreated cases in combination with population movements may lead to the further spread of resistant parasites, stressing the importance of understanding how the perceived aetiology of malaria and associated health-seeking behaviour may delay access to appropriate treatment. A qualitative study explored these factors after an epidemiological survey confirmed parasite resistance in Preah Vihear province. Results: In Cambodian cosmology, illnesses can be inflicted by supernatural beings or originate from 'natural' causes because of disorder in the social, domestic or outdoor environment. Initial treatment options consist of cheap and accessible home-based care (manual therapy, herbs and biomedical medication) targeting single symptoms. If there is no steady recovery or if the condition quickly aggravates, care will be sought from 'village doctors', public health facilities, private pharmacies or, in case of suspicion of a supernatural cause, from a specialized indigenous healer. The choice of provider is mostly based on the family's financial situation, access to and trust in the provider, and the congruence between the suspected aetiology of the illness and the treatment offered by the provider. Different treatment options are often combined during the same illness episode through a serial process of trial and error guided by the observable improvements in the patient's condition. Conclusions: Cambodian perceptions of illness that focus on single symptoms and their perceived severity may lead to the identification of one or multiple illnesses at the same time, rarely suspecting malaria from the start and implying different patterns of health seeking behaviour and treatment choice. However, decisions to self-diagnose and treat at home are also pragmatic and must be understood in the context of poverty, a major barrier to seeking prompt and appropriate care for malaria in an area characterized by parasite resistance.	[Verschuere, Jesse; Lim, Dara] Medecins Sans Frontieres, Operat Ctr Brussels, Phnom Penh, Cambodia; [Decroo, Tom; Kindermans, Jean-Marie; Alkourdi, Yasmine] Medecins Sans Frontieres, Operat Ctr Brussels, Dept Med, Brussels, Belgium; [Nguon, Chea; Huy, Rekol] Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Belgium; [Grietens, Koen Peeters; Gryseels, Charlotte] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium	Gryseels, C (reprint author), Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium.	cgryseels@itg.be		Gryseels, Charlotte/0000-0002-8963-4469; Decroo, Tom/0000-0002-1205-1484; Peeters Grietens, Koen/0000-0001-6570-9887	Medicins Sans Frontieres (MSF) Belgium	Medicins Sans Frontieres (MSF) Belgium funded the study. Researchers working for the MSF Operational Cell Brussels and Phnom Penh were involved in the design of the study, the data collection, and the writing of the manuscript.	Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Breman JG, 2012, LANCET INFECT DIS, V12, P820, DOI 10.1016/S1473-3099(12)70226-8; Canavati SE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1491-3; Canavati SE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1322-6; D'Alessandro U, 2001, TROP MED INT HEALTH, V6, P845, DOI 10.1046/j.1365-3156.2001.00819.x; Dondorp AM, 2004, TROP MED INT HEALTH, V9, P1241, DOI 10.1111/j.1365-3156.2004.01342.x; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Fairhurst RM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0013-2016; Grietens KP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16837; Gryseels C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080343; Guyant P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0773-5; Helman CG, 2007, CULTURE HLTH ILLNESS, P512; Kelly AH, 2011, BIOSOCIETIES, V6, P71, DOI 10.1057/biosoc.2010.42; Khun S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-262; Lemoine J, 1997, HOMME, V37, P69; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; Muela S Hausmann, 2012, MALAR REP, V2, P17; Noedl H, 2010, CLIN INFECT DIS, V51, pE82, DOI 10.1086/657120; Ovesen J., 2010, NIAS MONOGRAPHS; Packard R. M., 1998, Parassitologia (Rome), V40, P217; Packard Randall M., 2007, MAKING TROPICAL DIS; WHO, 2010, GLOB ANT DRUG EFF DR; Whyte S. R., 2002, SOCIAL LIVES MED; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization (WHO), 2011, GLOB PLAN ART RES CO; Yeung S, 2015, AM J TROP MED HYG, V92, P39, DOI 10.4269/ajtmh.14-0391; Yeung S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-96	30	5	5	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	FEB 17	2017	16								81	10.1186/s12936-017-1732-0				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EN8WN	WOS:000396280700002	28212641	DOAJ Gold, Green Published			2019-04-02	
J	Diallo, A; Sie, A; Sirima, S; Sylla, K; Ndiaye, M; Bountogo, M; Ouedraogo, E; Tine, R; Ndiaye, A; Coulibaly, B; Ouedraogo, A; Faye, B; Ba, EH; Compaore, G; Tiono, A; Sokhna, C; Ye, M; Diarra, A; Bahmanyar, ER; De Boer, M; Pircon, JY; Usuf, EA				Diallo, Aldiouma; Sie, Ali; Sirima, Sodiomon; Sylla, Khadime; Ndiaye, Mahmadou; Bountogo, Mamadou; Ouedraogo, Esperance; Tine, Roger; Ndiaye, Assane; Coulibaly, Boubacar; Ouedraogo, Alphonse; Faye, Babacar; Ba, El Hadji; Compaore, Guillaume; Tiono, Alfred; Sokhna, Cheikh; Ye, Maurice; Diarra, Amidou; Bahmanyar, Edith Roset; De Boer, Melanie; Pircon, Jean-Yves; Usuf, Effua Abigail			An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal	MALARIA JOURNAL			English	Article						Malaria; Burkina Faso; Senegal; Epidemiological study; Parasite prevalence; Risk factors; Preventive interventions	SEASONAL TRANSMISSION; RESISTANCE; INFECTION; HEALTH	Background: Malariometric information is needed to decide how to introduce malaria vaccines and evaluate their impact in sub-Saharan African countries. Methods: This cross-sectional study (NCT01954264) was conducted between October and November, 2013, corresponding to the high malaria transmission season, in four sites with Health and Demographic Surveillance Systems (DSS) [two sites with moderate-to-high malaria endemicity in Burkina Faso (Nouna and Sapone) and two sites with low malaria endemicity in Senegal (Keur Soce and Niakhar)]. Children (N = 2421) were randomly selected from the DSS lists of the study sites and were stratified into two age groups (6 months-4 years and 5-9 years). A blood sample was collected from each child to evaluate parasite prevalence of Plasmodium falciparum and other Plasmodium species and gametocyte density by microscopy, and rapid diagnosis test in the event of fever within 24 h. Case report forms were used to evaluate malaria control measures and other factors. Results: Plasmodium falciparum was identified in 707 (29.2%) children, with a higher prevalence in Burkina Faso than Senegal (57.5 vs 0.9% of children). In Burkina Faso, prevalence was 57.7% in Nouna and 41.9% in Sapone in the 6 months-4 years age group, and 75.4% in Nouna and 70.1% in Sapone in the 5-9 years age group. Infections with other Plasmodium species were rare and only detected in Burkina Faso. While mosquito nets were used by 88.6-97.0 and 64.7-80.2% of children in Burkina Faso and Senegal, other malaria control measures evaluated at individual level were uncommon. In Burkina Faso, exploratory analyses suggested that use of malaria treatment or any other medication within 14 days, and use of insecticide spray within 7 days decreased the prevalence of malaria infection; older age, rural residence, natural floor, grass/palm roof, and unavailability of electricity in the house were factors associated with increased malaria occurrence. Conclusions: Plasmodium falciparum infection prevalence in children younger than 10 years was 57.5% in Burkina Faso and 0.9% in Senegal, and variability was observed, among others, by age, study site and malaria control measures.	[Diallo, Aldiouma; Ndiaye, Mahmadou; Ndiaye, Assane; Ba, El Hadji; Sokhna, Cheikh] Inst Rech Dev, Ctr Rech Niakhar, Dakar, Senegal; [Sie, Ali; Bountogo, Mamadou; Coulibaly, Boubacar; Compaore, Guillaume; Ye, Maurice] Ctr Rech Sante Nouna, Nouna, Burkina Faso; [Sirima, Sodiomon; Ouedraogo, Esperance; Ouedraogo, Alphonse; Tiono, Alfred; Diarra, Amidou] CNRFP, Ouagadougou, Burkina Faso; [Sylla, Khadime; Tine, Roger; Faye, Babacar] Univ Cheikh Anta Diop, Fac Med, Ctr Rech Koer Soce, Serv Parasitol Med, Dakar, Senegal; [Bahmanyar, Edith Roset] Profa Fdn, Vaud, Switzerland; [De Boer, Melanie; Pircon, Jean-Yves; Usuf, Effua Abigail] GSK Vaccines, Wavre, Belgium	Usuf, EA (reprint author), GSK Vaccines, Wavre, Belgium.	Effua-abigail.x.usuf@gsk.com		Tine, Roger C/0000-0003-3024-1270; SIE, Ali/0000-0002-3959-2520	GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA was the funding source and was involved in all stages of the study conduct and analysis. GlaxoSmithKline Biologicals SA also funded all costs associated with the development and submission of this manuscript.	Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685; [Anonymous], 2016, Wkly Epidemiol Rec, V91, P33; Breman Joel G., 2009, Science Progress, V92, P1, DOI 10.3184/003685009X440290; Ceesay SJ, 2008, LANCET, V372, P1545, DOI 10.1016/S0140-6736(08)61654-2; Clinical S., 2015, LANCET, V386, P31; Diboulo E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0679-7; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Edith IS, 2010, J MED ENTOMOL, V47, P618; European Medicines Agency (EMA), EMACHMP4883482015; Geiger C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-27; Gneme A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-67; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Lindsay S, 2000, LANCET, V355, P1972, DOI 10.1016/S0140-6736(00)02334-5; Louis VR, 2015, B WORLD HEALTH ORGAN, V93, P750, DOI 10.2471/BLT.14.147702; Meeting of the Strategic Advisory Group of Experts on immunization October 2015, 2015, WKLY EPIDEMIOL REC, V90, P681; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Ndiath M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-453; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Ntonifor N N, 2006, East Afr Med J, V83, P553; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Ouedraogo A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050036; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Protopopoff N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-149; RTS, 2011, NEW ENGL J MED, V365, P1863, DOI DOI 10.1056/NEJM0A1102287; Sylla K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0789-x; Tine Roger C K, 2013, ISRN Parasitol, V2013, P272701, DOI 10.5402/2013/272701; Tiono AB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086936; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; Verhulst NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028991; WHO, 2013, WORLD MALARIA REPORT 2013, P1	30	3	3	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	FEB 6	2017	16								63	10.1186/s12936-017-1715-1				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EK8QL	WOS:000394188400001	28166794	DOAJ Gold, Green Published			2019-04-02	
J	de Gier, B; Suryapranata, FST; Croughs, M; van Genderen, PJJ; Keuter, M; Visser, LG; van Vugt, M; Sonder, GJB				de Gier, Brechje; Suryapranata, Franciska S. T.; Croughs, Mieke; van Genderen, Perry J. J.; Keuter, Monique; Visser, Leo G.; van Vugt, Michele; Sonder, Gerard J. B.			Increase in imported malaria in the Netherlands in asylum seekers and VFR travellers	MALARIA JOURNAL			English	Article						Epidemiology; Surveillance; Travel	PLASMODIUM-FALCIPARUM MALARIA; CHEMOPROPHYLAXIS; PREVENTION; KNOWLEDGE; ENDEMICITY; ATTITUDES; AREAS	Background: Malaria is a notifiable disease in the Netherlands, a non-endemic country. Imported malaria infections occur regularly among travellers, migrants and visitors. Surveillance data were analysed from 2008 to 2015. Trends in amounts of notifications among risk groups were analysed using Poisson regression. For asylum seekers, yearly incidence was calculated per region of origin, using national asylum request statistics as denominator data. For tourists, denominator data were used from travel statistics to estimate incidence per travel region up to 2012. Results: A modest increase in overall imported malaria notifications occurred in 2008-2015 (from 222 in 2008 to 344 in 2015). Notably, in 2014 and 2015 sharp increases were seen in malaria among travellers visiting friends and relatives (VFR), and in asylum seekers. Of all Plasmodium falciparum infections, most (1254/1337; 93.8%) were imported from Africa; 1037/1337 (77.6%) were imported from Central and West Africa. Malaria in VFR was mostly caused by P. falciparum infection after visiting Ghana (22%) or Nigeria (19%). Malaria in asylum seekers was mostly caused by Plasmodium vivax infection from the Horn of Africa. The large number of notifications in asylum seekers resulted from both an increase in number of asylum seekers and a striking increase of malaria incidence in this group. Incidence of malaria in asylum seekers from the Horn of Africa ranged between 0.02 and 0.3% in 2008-2013, but rose to 1.6% in 2014 and 1.3% in 2015. In 2008-2012, incidence in tourists visiting Central and West Africa dropped markedly. Conclusions: Imported malaria is on the rise again in the Netherlands, most notably since 2013. This is mostly due to immigration of asylum seekers from the Horn of Africa. The predominance of P. vivax infection among asylum seekers warrants vigilance in health workers when a migrant presents with fever, as relapses of this type of malaria can occur long after arrival in the Netherlands.	[de Gier, Brechje] Natl Inst Publ Hlth & Environm, Dept Early Warning & Surveillance, Ctr Epidemiol & Surveillance Infect Dis, Bilthoven, Netherlands; [Suryapranata, Franciska S. T.; Sonder, Gerard J. B.] Publ Hlth Serv GGD Amsterdam, Dept Infect Dis, Nieuwe Achtergracht 100,POB 2200, NL-1000 CE Amsterdam, Netherlands; [Suryapranata, Franciska S. T.; Sonder, Gerard J. B.] Natl Coordinat Ctr Travellers Hlth Advice LCR, Nieuwe Achtergracht 100,POB 1008, NL-1000 BA Amsterdam, Netherlands; [Croughs, Mieke] Publ Hlth Serv GGD Hart Voor Brabant, Dept Environm, Ringbaan West 227, NL-5037 PC Tilburg, Netherlands; [Croughs, Mieke] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [van Genderen, Perry J. J.] Harbour Hosp Rotterdam, Inst Trop Dis, Haringvliet 72, NL-3011 TG Rotterdam, Netherlands; [Keuter, Monique] Radboud Univ Nijmegen, Med Ctr, Nijmegen Inst Int Hlth, Nijmegen, Netherlands; [Visser, Leo G.] Leiden Univ, Dept Infect Dis, Med Ctr, C5P46,Albinusdreef 2, NL-2333 ZA Leiden, Netherlands; [van Vugt, Michele; Sonder, Gerard J. B.] Acad Med Ctr, Dept Internal Med, Div Infect Dis Trop Med & AIDS, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Suryapranata, FST (reprint author), Publ Hlth Serv GGD Amsterdam, Dept Infect Dis, Nieuwe Achtergracht 100,POB 2200, NL-1000 CE Amsterdam, Netherlands.; Suryapranata, FST (reprint author), Natl Coordinat Ctr Travellers Hlth Advice LCR, Nieuwe Achtergracht 100,POB 1008, NL-1000 BA Amsterdam, Netherlands.	fsuryapranata@ggd.amsterdam.nl					Arends JE, 2013, AM J TROP MED HYG, V89, P527, DOI 10.4269/ajtmh.13-0213; Behrens RH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-461; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Durand R, 2008, EMERG INFECT DIS, V14, P320, DOI 10.3201/eid1402.070945; Dutch Tourist Board and NIPO Research, 2008, CONT HOL SURV; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Hu Y, 2016, ACTA TROP, V157, P12, DOI 10.1016/j.actatropica.2016.01.022; Jelinek T, 2008, EUROSURVEILLANCE, V13, P51; Roggelin L, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1366-7; Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X; Schwartz E, 2003, NEW ENGL J MED, V349, P1510, DOI 10.1056/NEJMoa021592; Sonden K, 2014, EUROSURVEILLANCE, V19, P35; van Genderen PJJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-74; van Genderen PJJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-179; van Rijckevorsel GGC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-300; Vliegenthart-Jongbloed K, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-265; Voumard R, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0654-y; World Health Organization, 2015, WORLD MAL REP 2015; Zhou GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1298-2	20	7	7	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	FEB 2	2017	16								60	10.1186/s12936-017-1711-5				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EK0NX	WOS:000393624500002	28148300	DOAJ Gold, Green Published			2019-04-02	
J	Nguyen, THT; Guedj, J; Anglaret, X; Laouenan, C; Madelain, V; Taburet, AM; Baize, S; Sissoko, D; Pastorino, B; Rodallec, A; Piorkowski, G; Carazo, S; Conde, MN; Gala, JL; Bore, JA; Carbonnelle, C; Jacquot, F; Raoul, H; Malvy, D; de Lamballerie, X; Mentre, F				Thi Huyen Tram Nguyen; Guedj, Jeremie; Anglaret, Xavier; Laouenan, Cedric; Madelain, Vincent; Taburet, Anne-Marie; Baize, Sylvain; Sissoko, Daouda; Pastorino, Boris; Rodallec, Anne; Piorkowski, Geraldine; Carazo, Sara; Conde, Mamoudou N.; Gala, Jean-Luc; Bore, Joseph Akoi; Carbonnelle, Caroline; Jacquot, Frederic; Raoul, Herve; Malvy, Denis; de lamballerie, Xavier; Mentre, France		JIKI grp	Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted	PLOS NEGLECTED TROPICAL DISEASES			English	Article							VIRUS INFECTION; T-705 FAVIPIRAVIR; ALDEHYDE OXIDASE; MODEL; EFFICACY; DRUGS	Background In 2014-2015, we assessed favipiravir tolerance and efficacy in patients with Ebola virus (EBOV) disease (EVD) in Guinea (JIKI trial). Because the drug had never been used before for this indication and that high concentrations of the drugs were needed to achieve antiviral efficacy against EBOV, a pharmacokinetic model had been used to propose relevant dosing regimen. Here we report the favipiravir plasma concentrations that were achieved in participants in the JIKI trial and put them in perspective with the model-based targeted concentrations. Methods and findings Pre-dose drug concentrations were collected at Day-2 and Day-4 of treatment in 66 patients of the JIKI trial and compared to those predicted by the model taking into account patient's individual characteristics. At Day-2, the observed concentrations were slightly lower than the model predictions adjusted for patient's characteristics (median value of 46.1 versus 54.3 mu g/mL for observed and predicted concentrations, respectively, p = 0.012). However, the concentrations dropped at Day-4, which was not anticipated by the model (median values of 25.9 and 64.4 mu g/mL for observed and predicted concentrations, respectively, p<10(-6)). There was no significant relationship between favipiravir concentrations and EBOV viral kinetics or mortality. Conclusions Favipiravir plasma concentrations in the JIKI trial failed to achieve the target exposure defined before the trial. Furthermore, the drug concentration experienced an unanticipated drop between Day-2 and Day-4. The origin of this drop could be due to severe sepsis conditions and/or to intrinsic properties of favipiravir metabolism. Dose-ranging studies should be performed in healthy volunteers to assess the concentrations and the tolerance that could be achieved with high doses.	[Thi Huyen Tram Nguyen; Guedj, Jeremie; Laouenan, Cedric; Madelain, Vincent; Mentre, France] INSERM, IAME, UMR 1137, F-75018 Paris, France; [Thi Huyen Tram Nguyen; Guedj, Jeremie; Laouenan, Cedric; Madelain, Vincent; Mentre, France] Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cite, F-75018 Paris, France; [Anglaret, Xavier; Sissoko, Daouda; Malvy, Denis] Univ Bordeaux, UMR 1219, INSERM, Bordeaux, France; [Anglaret, Xavier] ANRS Cote Ivoire, Programme PACCI Site, Abidjan, Cote Ivoire; [Madelain, Vincent; Mentre, France] Hop Bichat Claude Bernard, AP HP, Paris, France; [Taburet, Anne-Marie] Hop Bicetre, AP HP, Paris, France; [Taburet, Anne-Marie] Univ Paris Sud, UMR1184, INSERM, Paris, France; [Baize, Sylvain] UBIVE, Inst Pasteur, Ctr Int Rech Infectiol, Lyon, France; [Sissoko, Daouda; Malvy, Denis] Ctr Hosp Univ Bordeaux, Bordeaux, France; [Pastorino, Boris; Rodallec, Anne; Piorkowski, Geraldine; de lamballerie, Xavier] Univ Aix Marseille, Inst Rech Dev, Ecole Hautes Etud Sante Publ, EPV, Marseille, France; [Carazo, Sara] Med Sans Frontieres Belgique, Brussels, Belgium; [Conde, Mamoudou N.] ALIMA, Dakar, Senegal; [Gala, Jean-Luc] Belgian First Aid & Support B FAST, Biol Light Fieldable Lab Emergencies B LiFE, Brussels, Belgium; [Gala, Jean-Luc] Clin Univ St Luc, Brussels, Belgium; [Gala, Jean-Luc] Catholic Univ Louvain, Louvain La Neuve, Belgium; [Gala, Jean-Luc] Belgian Minist Def, Brussels, Belgium; [Bore, Joseph Akoi] European Mobile Lab Project, Hamburg, Germany; [Bore, Joseph Akoi] Inst Natl Sante Publ, Conakry, Guinea; [Bore, Joseph Akoi] Univ Gamal Abdel Nasser Conakry, Lab Fievres Hemorrag Guinee, Conakry, Guinea; [Carbonnelle, Caroline; Jacquot, Frederic; Raoul, Herve] INSERM, Lab Jean Merieux P4, Lyon, France	Mentre, F (reprint author), INSERM, IAME, UMR 1137, F-75018 Paris, France.; Mentre, F (reprint author), Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cite, F-75018 Paris, France.; Mentre, F (reprint author), Hop Bichat Claude Bernard, AP HP, Paris, France.	france.mentre@inserm.fr	LAOUENAN, Cedric/E-1157-2019; Anglaret, Xavier/F-7333-2013; Guedj, Jeremie/A-6842-2017	LAOUENAN, Cedric/0000-0002-3681-6314; Guedj, Jeremie/0000-0002-5534-5482; CARAZO PEREZ, Sara/0000-0003-0711-6703	French National Agency for AIDS and viral hepatitis research (ANRS, Paris, France); French Institute for Health Research (Inserm, Paris, France); European Commission (EU) [666092 - REACTION]	The JIKI trial was supported by grants from the French National Agency for AIDS and viral hepatitis research (ANRS, Paris, France, http:// ww.anrs.fr/), the French Institute for Health Research (Inserm, Paris, France, http://www.inserm.fr/) and the European Commission (EU Horizon 2020 programme, grant No 666092 - REACTION, http://ec.europa.eu/programmes/horizon2020/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzoli C, 2010, CLIN PHARMACOKINET, V49, P17, DOI 10.2165/11318110-000000000-00000; Bouazza N, 2015, LANCET, V385, P603, DOI 10.1016/S0140-6736(15)60232-X; Boucher BA, 2006, CRIT CARE CLIN, V22, P255, DOI 10.1016/j.ccc.2006.02.011; Gordon AH, 1940, BIOCHEM J, V34, P764, DOI 10.1042/bj0340764; Gowen BB, 2015, ANTIVIR RES, V121, P132, DOI 10.1016/j.antiviral.2015.07.003; Hartmann T, 2012, DRUG METAB DISPOS, V40, P856, DOI 10.1124/dmd.111.043828; Lobo DN, 2001, CLIN SCI, V101, P173, DOI 10.1042/CS20000316; Madelain V, 2017, ANTIMICROB AGENTS CH, P61; Madelain V, 2016, CLIN PHARMACOKINET, V55, P907, DOI 10.1007/s40262-015-0364-1; Madelain V, 2015, ANTIVIR RES, V123, P70, DOI 10.1016/j.antiviral.2015.08.015; Marty AM, 2006, CLIN LAB MED, V26, P345, DOI 10.1016/j.cll.2006.05.001; Mentre F, 2015, LANCET INFECT DIS, V15, P150, DOI 10.1016/S1473-3099(14)71047-3; Oestereich L, 2014, ANTIVIR RES, V105, P17, DOI 10.1016/j.antiviral.2014.02.014; Pharmaceuticals and Medical Devices Agency (PMDA), 2014, REP DEL RES; Roberts DJ, 2013, EXPERT OPIN DRUG MET, V9, P1067, DOI 10.1517/17425255.2013.799137; Sissoko D, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001967; Smither SJ, 2014, ANTIVIR RES, V104, P153, DOI 10.1016/j.antiviral.2014.01.012; World Health Organization, EB SIT REP; World Health Organization, 2015, EB TREATM INT	19	21	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	FEB	2017	11	2							e0005389	10.1371/journal.pntd.0005389				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EO0RW	WOS:000396406600022	28231247	DOAJ Gold, Green Published			2019-04-02	
J	Harapan, H; Anwar, S; Bustamam, A; Radiansyah, A; Angraini, P; Fasli, R; Salwiyadi, S; Bastian, RA; Oktiviyari, A; Akmal, I; Iqbalamin, M; Adil, J; Henrizal, F; Darmayanti, D; Mahmuda, M; Mudatsir, M; Imrie, A; Sasmono, RT; Kuch, U; Shkedy, Z; Pramana, S				Harapan, Harapan; Anwar, Samsul; Bustamam, Aslam; Radiansyah, Arsil; Angraini, Pradiba; Fasli, Riny; Salwiyadi, Salwiyadi; Bastian, Reza Akbar; Oktiviyari, Ade; Akmal, Imaduddin; Iqbalamin, Muhammad; Adil, Jamalul; Henrizal, Fenni; Darmayanti, Darmayanti; Mahmuda, Mahmuda; Mudatsir, Mudatsir; Imrie, Allison; Sasmono, R. Tedjo; Kuch, Ulrich; Shkedy, Ziv; Pramana, Setia			Willingness to pay for a dengue vaccine and its associated determinants in Indonesia: A community-based, cross-sectional survey in Aceh	ACTA TROPICA			English	Article						Dengue fever; Dengue vaccine; Indonesia; Vaccine introduction; Vaccine demand; Willingness to pay	HYPOTHETICAL MALARIA VACCINES; ACCEPTANCE; BURDEN	Vaccination strategies are being considered as a part of dengue prevention programs in endemic countries. To accelerate the introduction of dengue vaccine into the public sector program and private markets, understanding the private economic benefits of a dengue vaccine is therefore essential. The aim of this study was to assess the willingness to pay (WTP) for a dengue vaccine among community members in Indonesia and its associated explanatory variables. A community-based, cross-sectional survey was conducted in nine regencies of Aceh province, Indonesia, from November 2014 to March 2015. A pretested validated questionnaire was used to facilitate the interviews. To assess the explanatory variables influencing participants' WTP for a dengue vaccine, a linear regression analysis was employed. We interviewed 677 healthy community members; 476 participants (87.5% of the total) were included in the final analysis. An average individual was willing to pay around US-$4 (mean: US-$4.04; median: US-$3.97) for a dengue vaccine. Our final multivariate model revealed that working as a civil servant, living in the city, and having good knowledge on dengue viruses, a good attitude towards dengue, and good preventive practice against dengue virus infection were associated with a higher WTP (P<0.05). Our model suggests that marketing efforts should be directed to community members who are working in the suburbs especially as farmers. In addition, the results of our study underscore the need for low-cost quality vaccines, public sector subsidies for vaccinations, and intensifying efforts to further educate and encourage households regarding other dengue preventive measures, using trusted individuals as facilitators. (C) 2016 Elsevier B.V. All rights reserved.	[Harapan, Harapan; Radiansyah, Arsil; Angraini, Pradiba; Fasli, Riny; Salwiyadi, Salwiyadi; Bastian, Reza Akbar; Oktiviyari, Ade; Akmal, Imaduddin; Iqbalamin, Muhammad; Adil, Jamalul; Henrizal, Fenni; Darmayanti, Darmayanti] Syiah Kuala Univ, Sch Med, Med Res Unit, Darussalam 23111, Banda Aceh, Indonesia; [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Trop Dis Ctr, Banda Aceh, Indonesia; [Harapan, Harapan; Mudatsir, Mudatsir] Syiah Kuala Univ, Sch Med, Dept Microbiol, Banda Aceh, Indonesia; [Harapan, Harapan; Imrie, Allison] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA, Australia; [Anwar, Samsul] Syiah Kuala Univ, Fac Math & Nat Sci, Dept Stat, Banda Aceh, Indonesia; [Bustamam, Aslam] Syiah Kuala Univ, Fac Teacher Training & Educ, Dept Biol, Banda Aceh, Indonesia; [Mahmuda, Mahmuda] Syiah Kuala Univ, Fac Math & Nat Sci, Dept Biol, Banda Aceh, Indonesia; [Sasmono, R. Tedjo] Eijkman Inst Mol Biol, Jakarta, Indonesia; [Kuch, Ulrich] Goethe Univ, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany; [Shkedy, Ziv] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium; [Pramana, Setia] Inst Stat, Jakarta, Indonesia	Harapan, H (reprint author), Syiah Kuala Univ, Sch Med, Med Res Unit, Darussalam 23111, Banda Aceh, Indonesia.	harapan@unsyiah.ac.id	Harapan, Harapan/I-8741-2016	Harapan, Harapan/0000-0001-7630-8413; Mudatsir, Mudatsir/0000-0002-5643-9384; Sasmono, R. Tedjo/0000-0003-0986-2590			Abdullah M, 2013, AM INT J CONT RES, V3, P69; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Birhane MG, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004486; Blomquist GC, 2009, ENVIRON RESOUR ECON, V43, P473, DOI 10.1007/s10640-008-9242-8; BPS, 2015, BAD PUS STAT PROV; BPS, 2016, PROD DOM REG BRUT KA; BREUSCH TS, 1978, AUST ECON PAP, V17, P334, DOI 10.1111/j.1467-8454.1978.tb00635.x; Depkes RI, 2012, PROFIL KESEHATAN PRO; Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028; Feng Changyong, 2014, Shanghai Arch Psychiatry, V26, P105, DOI 10.3969/j.issn.1002-0829.2014.02.009; Filmer D, 1999, POPUL DEV REV, V25, P85, DOI 10.1111/j.1728-4457.1999.00085.x; GLEJSER H, 1969, J AM STAT ASSOC, V64, P316, DOI 10.2307/2283741; Hadisoemarto PF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002427; Hansen KS, 2013, HEALTH POLICY PLANN, V28, P185, DOI 10.1093/heapol/czs048; Harapan H, 2016, KNOWLEDGE ATTI UNPUB; Harapan H, 2016, ASIAN PAC J TROP MED, V9, P1092, DOI 10.1016/j.apjtm.2016.07.036; Harapan H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159139; Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026; Hou ZY, 2014, VACCINE, V32, P4471, DOI 10.1016/j.vaccine.2014.06.047; Karyanti MR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-412; Kemenkes RI, 2015, PROFIL KESEHATAN IND; Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692; Lee JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003810; List JA, 2001, ENVIRON RESOUR ECON, V20, P241, DOI 10.1023/A:1012791822804; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Palanca-Tan R, 2008, VACCINE, V26, P914, DOI 10.1016/j.vaccine.2007.12.011; Provincial Health Office, 2015, PEM KAS BAR PEN MEN; Sauerborn R, 2005, SCAND J PUBLIC HEALT, V33, P146, DOI 10.1080/14034940510005743; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055; Slunge D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143875; Udezi WA, 2010, CLIN THER, V32, P1533, DOI 10.1016/j.clinthera.2010.07.018; Worasathit R, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0137-6; World Bank, 2016, GDP PER CAP CURR US; Yap BW, 2011, J STAT COMPUT SIM, V81, P2141, DOI 10.1080/00949655.2010.520163	34	14	14	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	FEB	2017	166						249	256		10.1016/j.actatropica.2016.11.035				8	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EI8PN	WOS:000392769900032	27908746				2019-04-02	
J	Kurth, F; Develoux, M; Mechain, M; Malvy, D; Clerinx, J; Antinori, S; Gjorup, IE; Gascon, J; Morch, K; Nicastri, E; Ramharter, M; Bartoloni, A; Visser, L; Rolling, T; Zanger, P; Calleri, G; Salas-Coronas, J; Nielsen, H; Just-Nubling, G; Neumayr, A; Hachfeld, A; Schmid, ML; Antonini, P; Lingscheid, T; Kern, P; Kapaun, A; da Cunha, JS; Pongratz, P; Soriano-Arandes, A; Schunk, M; Suttorp, N; Hatz, C; Zoller, T				Kurth, Florian; Develoux, Michel; Mechain, Matthieu; Malvy, Denis; Clerinx, Jan; Antinori, Spinello; Gjorup, Ida E.; Gascon, Joaquim; Morch, Kristine; Nicastri, Emanuele; Ramharter, Michael; Bartoloni, Alessandro; Visser, Leo; Rolling, Thierry; Zanger, Philipp; Calleri, Guido; Salas-Coronas, Joaquin; Nielsen, Henrik; Just-Nuebling, Gudrun; Neumayr, Andreas; Hachfeld, Anna; Schmid, Matthias L.; Antonini, Pietro; Lingscheid, Tilman; Kern, Peter; Kapaun, Annette; da Cunha, Jose Saraiva; Pongratz, Peter; Soriano-Arandes, Antoni; Schunk, Mirjam; Suttorp, Norbert; Hatz, Christoph; Zoller, Thomas			Severe malaria in Europe: an 8-year multi-centre observational study	MALARIA JOURNAL			English	Article						Malaria; Falciparum; Severe malaria; Artesunate; Quinine; Plasmodium; Europe; Clinical study	IMPORTED FALCIPARUM-MALARIA; BLOOD-CELL EXCHANGE; INTENSIVE-CARE-UNIT; INTRAVENOUS ARTESUNATE; DELAYED HEMOLYSIS; RETROSPECTIVE COHORT; PARASITE CLEARANCE; AFRICAN CHILDREN; RISK-FACTORS; QUININE	Background: Malaria remains one of the most serious infections for travellers to tropical countries. Due to the lack of harmonized guidelines a large variety of treatment regimens is used in Europe to treat severe malaria. Methods: The European Network for Tropical Medicine and Travel Health (TropNet) conducted an 8-year, multi-centre, observational study to analyse epidemiology, treatment practices and outcomes of severe malaria in its member sites across Europe. Physicians at participating TropNet centres were asked to report pseudonymized retrospective data from all patients treated at their centre for microscopically confirmed severe Plasmodium falciparum malaria according to the 2006 WHO criteria. Results: From 2006 to 2014 a total of 185 patients with severe malaria treated in 12 European countries were included. Three patients died, resulting in a 28-day survival rate of 98.4%. The majority of infections were acquired in West Africa (109/185, 59%). The proportion of patients treated with intravenous artesunate increased from 27% in 2006 to 60% in 2013. Altogether, 56 different combinations of intravenous and oral drugs were used across 28 study centres. The risk of acute renal failure (36 vs 17% p = 0.04) or cerebral malaria (54 vs 20%, p = 0.001) was significantly higher in patients = 60 years than in younger patients. Respiratory distress with the need for mechanical ventilation was significantly associated with the risk of death in the study population (13 vs 0%, p = 0.001). Post-artemisinin delayed haemolysis was reported in 19/70 (27%) patients treated with intravenous artesunate. Conclusion: The majority of patients with severe malaria in this study were tourists or migrants acquiring the infection in West Africa. Intravenous artesunate is increasingly used for treatment of severe malaria in many European treatment centres and can be given safely to European patients with severe malaria. Patients treated with intravenous artesunate should be followed up to detect and manage late haemolytic events.	[Kurth, Florian; Lingscheid, Tilman; Suttorp, Norbert; Zoller, Thomas] Charite, Med Klin Schwerpunkt Infektiol & Pneumol, Berlin, Germany; [Develoux, Michel] Hop St Antoine, Paris, France; [Mechain, Matthieu; Malvy, Denis] Univ Hosp Ctr, Div Infect & Trop Dis, Sect Trop Med & Clin Int Hlth, Dept Med, Bordeaux, France; [Clerinx, Jan] Inst Trop Med, Antwerp, Belgium; [Antinori, Spinello] Univ Milan, Dept Biomed & Clin Sci L Sacco, Milan, Italy; [Gjorup, Ida E.] Herlev Univ Hosp, Infect Dis Unit, Copenhagen, Denmark; [Gascon, Joaquim] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Morch, Kristine] Haukeland Hosp, Dept Med, Natl Ctr Trop Infect Dis, Bergen, Norway; [Morch, Kristine] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Nicastri, Emanuele] Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy; [Ramharter, Michael] Med Univ Vienna, Div Infect Dis & Trop Med, Dept Med 1, Vienna, Austria; [Ramharter, Michael; Zanger, Philipp] Univ Tubingen, Inst Tropenmed, Tubingen, Germany; [Bartoloni, Alessandro] Azienda Osped Univ Careggi, SOD Malattie Infett & Tropicali, Florence, Italy; [Visser, Leo] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Rolling, Thierry] Univ Med Ctr Hamburg Eppendorf, Sect Trop Med, Dept Internal Med 1, Hamburg, Germany; [Rolling, Thierry] Bernhard Nocht Inst Trop Med, Dept Clin Res, Hamburg, Germany; [Zanger, Philipp] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany; [Calleri, Guido] ASLTO2, Amedeo di Savoia Hosp, Dept Infect Dis, Travel Med Unit, Turin, Italy; [Salas-Coronas, Joaquin] Hosp Poniente, Trop Med Unit, El Ejido, Spain; [Nielsen, Henrik] Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark; [Just-Nuebling, Gudrun] Univ Hosp Frankfurt Main, Dept Internal Med 2, Sect Infect Dis & Trop Med, Frankfurt, Germany; [Neumayr, Andreas; Hatz, Christoph; Zoller, Thomas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Neumayr, Andreas; Hatz, Christoph; Zoller, Thomas] Univ Basel, Basel, Switzerland; [Hachfeld, Anna] Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland; [Hachfeld, Anna] Univ Bern, Bern, Switzerland; [Schmid, Matthias L.] Royal Victoria Infirm, Dept Infect & Trop Med, Newcastle Upon Tyne, Tyne & Wear, England; [Antonini, Pietro] Clin Luganese, Lugano, Switzerland; [Kern, Peter] Ulm Univ Hosp, Dept Internal Med 3, Comprehens Infect Dis Ctr, Ulm, Germany; [Kapaun, Annette] Univ Heidelberg Hosp, Sect Clin Trop Med, Dept Infect Dis, Heidelberg, Germany; [da Cunha, Jose Saraiva] Ctr Hosp & Univ Coimbra, Coimbra, Portugal; [Pongratz, Peter] Univ Rostock, Div Trop Med & Infect Dis, Ctr Internal Med 2, Rostock, Germany; [Soriano-Arandes, Antoni] Hosp Univ Joan XXIII, Tarragona, Spain; [Soriano-Arandes, Antoni] Hosp Univ Vall dHebron, Barcelona, Spain; [Schunk, Mirjam] Univ Munich LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany	Zoller, T (reprint author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	thomas.zoller@unibas.ch	nicastri, emanuele/K-7780-2016; Gascon, Joaquim/M-3598-2015; Zanger, Philipp/B-8033-2010; BARTOLONI, ALESSANDRO/K-3403-2018; Ucar, Abdullah/P-8329-2017	nicastri, emanuele/0000-0002-5606-8712; Gascon, Joaquim/0000-0002-5045-1585; BARTOLONI, ALESSANDRO/0000-0001-9758-1523; Ramharter, Michael/0000-0002-9259-1885; Rolling, Thierry/0000-0002-0277-5067	Charite clinical Scientist Programme - Charite Universitatsmedizin Berlin; Berlin Institute of Health	FK is supported by Charite clinical Scientist Programme, funded by Charite Universitatsmedizin Berlin and the Berlin Institute of Health.	[Anonymous], 2015, RAPP ANN ACT ANN EX; Auer-Hackenberg L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-158; Bartoloni A, 2010, AM J TROP MED HYG, V83, P274, DOI 10.4269/ajtmh.2010.10-0128; Behrens RH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-461; Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC; Bruneel F, 2016, INTENS CARE MED, V42, P1588, DOI 10.1007/s00134-016-4356-x; Bruneel F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013236; Calvo-Cano A, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1264-z; Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116; De Nardo P, 2013, INFECTION, V41, P863, DOI 10.1007/s15010-013-0451-x; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; European centre for disease prevention and control ECDC, 2014, ANN EP REP 2014 EM V; Faiz MA, 2005, LANCET, V366, P717; Itoda Ichiro, 2002, Kansenshogaku Zasshi, V76, P600; Jaureguiberry S, 2015, EMERG INFECT DIS, V21, P804, DOI 10.3201/eid2105.141171; Jaureguiberry S, 2014, BLOOD, V124, P167, DOI 10.1182/blood-2014-02-555953; Kreeftmeijer-Vegter AR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-115; Kreeftmeijer-Vegter AR, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-102; Kreeftmeijer-Vegter AR, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-150; Kurth F, 2016, CLIN INFECT DIS, V62, P271, DOI 10.1093/cid/civ827; Kurth F, 2015, CLIN INFECT DIS, V61, P1441, DOI 10.1093/cid/civ575; Legros F, 2007, EMERG INFECT DIS, V13, P883, DOI 10.3201/eid1305.060955; Mai NTH, 1996, LANCET, V348, P917, DOI 10.1016/S0140-6736(96)01409-2; Marks ME, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-118; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073360; Morch Kristine, 2012, Tidsskr Nor Laegeforen, V132, P664, DOI 10.4045/tidsskr.11.0589; Muhlberger N, 2003, CLIN INFECT DIS, V36, P990, DOI 10.1086/374224; Newton PN, 2001, T ROY SOC TROP MED H, V95, P519, DOI 10.1016/S0035-9203(01)90025-2; Rolling T, 2014, J INFECT DIS, V209, P1921, DOI 10.1093/infdis/jit841; Rolling T, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-241; Santos LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-96; Sinclair D, 2012, COCHRANE DB SYST REV, V6; Twomey PS, 2015, ANN INTERN MED, V163, P498, DOI 10.7326/M15-0910; van Genderen PJJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-179; WHO, 2010, GUID TREATM MAL; Wieten RW, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-360; World Health Organisation, 2015, GUID TREATM MAL; Zoller T, 2011, EMERG INFECT DIS, V17, P771, DOI 10.3201/eid1705.101229	38	13	13	0	6	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 31	2017	16								57	10.1186/s12936-016-1673-z				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EK0NV	WOS:000393624300005	28143519	DOAJ Gold, Green Published			2019-04-02	
J	Kabaria, CW; Gilbert, M; Noor, AM; Snow, RW; Linard, C				Kabaria, Caroline W.; Gilbert, Marius; Noor, Abdisalan M.; Snow, Robert W.; Linard, Catherine			The impact of urbanization and population density on childhood Plasmodium falciparum parasite prevalence rates in Africa	MALARIA JOURNAL			English	Article						Malaria; Urbanization; Population density; Boosted regression trees	MALARIA TRANSMISSION; ENVIRONMENTAL DATA; EAST-AFRICA; URBAN AREAS; GLOBAL DATA; RISK; RESOLUTION; HEALTH; ENDEMICITY; INTENSITY	Background: Although malaria has been traditionally regarded as less of a problem in urban areas compared to neighbouring rural areas, the risk of malaria infection continues to exist in densely populated, urban areas of Africa. Despite the recognition that urbanization influences the epidemiology of malaria, there is little consensus on urbanization relevant for malaria parasite mapping. Previous studies examining the relationship between urbanization and malaria transmission have used products defining urbanization at global/continental scales developed in the early 2000s, that overestimate actual urban extents while the population estimates are over 15 years old and estimated at administrative unit level. Methods and results: This study sought to discriminate an urbanization definition that is most relevant for malaria parasite mapping using individual level malaria infection data obtained from nationally representative household-based surveys. Boosted regression tree (BRT) modelling was used to determine the effect of urbanization on malaria transmission and if this effect varied with urbanization definition. In addition, the most recent high resolution population distribution data was used to determine whether population density had significant effect on malaria parasite prevalence and if so, could population density replace urban classifications in modelling malaria transmission patterns. The risk of malaria infection was shown to decline from rural areas through peri-urban settlements to urban central areas. Population density was found to be an important predictor of malaria risk. The final boosted regression trees (BRT) model with urbanization and population density gave the best model fit (Tukey test p value <0.05) compared to the models with urbanization only. Conclusion: Given the challenges in uniformly classifying urban areas across different countries, population density provides a reliable metric to adjust for the patterns of malaria risk in densely populated urban areas. Future malaria risk models can, therefore, be improved by including both population density and urbanization which have both been shown to have significant impact on malaria risk in this study.	[Kabaria, Caroline W.] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Kabaria, Caroline W.; Noor, Abdisalan M.; Snow, Robert W.] Kenya Govt Med Res Ctr, Spatial Hlth Metr Grp, Wellcome Trust Res Programme, Nairobi, Kenya; [Gilbert, Marius; Linard, Catherine] Univ Libre Bruxelles, Spatial Epidemiol Lab, CP160-12,Av FD Roosevelt 50, B-1050 Brussels, Belgium; [Gilbert, Marius] Fonds Natl Rech Sci FRS FNRS, Brussels, Belgium; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Oxford, England; [Linard, Catherine] Univ Namur, Dept Geog, Rue Bruxelles 61, B-5000 Namur, Belgium	Kabaria, CW (reprint author), African Populat & Hlth Res Ctr, Nairobi, Kenya.	ckabaria@aphrc.org		Kabaria, Caroline/0000-0002-5641-5243; Snow, Robert/0000-0003-3725-6088	Wellcome Trust, UK [095127, 079080, 103602]; Belgian Science Policy [SR/00/304]; Fonds National de la Recherche Scientifique; KEMRI-Wellcome Trust Overseas Programme Strategic Award [084538]	AM is supported by the Wellcome Trust, UK as an intermediate fellow (# 095127); RWS is supported by the Wellcome Trust as Principal Research Fellow (# 079080 and # 103602), that's also supported CWK. CL is supported by funding from the Belgian Science Policy (SR/00/304). MG is funded by the 'Fonds National de la Recherche Scientifique'. CWK is also grateful to the KEMRI-Wellcome Trust Overseas Programme Strategic Award (# 084538) for additional support during her Ph. D.	Adlaoui E, 2011, MALAR RES TREAT, V2011; [Anonymous], WORLDP POP DAT; [Anonymous], DEM HLTH SURV DHS; Balk D, 2004, POPUL SPACE PLACE, V10, P175, DOI DOI 10.1002/PSP.328; Balk D, 2004, DISTRIBUTION PEOPLE; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Cairns M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1879; Center for International Earth Science Information Network (CIESIN) (IFPRI) IFPRI Bank TW Centro International de Agricultura Tropical (CIAT), 2004, GLOB RUR URB MAPP PR; Dorelien A, 2013, POPUL DEV REV, V39, P413, DOI 10.1111/j.1728-4457.2013.00610.x; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elvidge CD, 1997, GLOB CHANGE BIOL, V3, P387, DOI 10.1046/j.1365-2486.1997.00115.x; Esch T, 2013, IEEE GEOSCI REMOTE S, V10, P1617, DOI 10.1109/LGRS.2013.2272953; Gamba P, 2013, IEEE J-STARS, V6, P2184, DOI 10.1109/JSTARS.2012.2235410; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Gething PW, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-92; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Grinand C, 2008, GEODERMA, V143, P180, DOI 10.1016/j.geoderma.2007.11.004; Guerra CA, 2006, ADV PARASIT, V62, P157, DOI 10.1016/S0065-308X(05)62005-2; Guerra CA, 2006, TRENDS PARASITOL, V22, P353, DOI 10.1016/j.pt.2006.06.006; Hay SI, 2006, ADV PARASIT, V62, P37, DOI 10.1016/S0065-308X(05)62002-7; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Hijmans R, WORLDCLIM GLOBAL CLI; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Linard C, 2013, APPL GEOGR, V44, P23, DOI 10.1016/j.apgeog.2013.07.009; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; Machault V, 2012, PLOS ONE, V7; Machault V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-252; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; NOAA Climate Prediction centre (CPC) USAID/Famine Early Systems Network (FEWS), RFE 2 0 RAINF EST; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Omumbo JA, 2005, TROP MED INT HEALTH, V10, P557, DOI 10.1111/j.1365-3156.2005.01424.x; Omumbo JA, 2005, ACTA TROP, V93, P11, DOI 10.1016/j.actatropica.2004.08.010; Oyewole I. O., 2006, Journal of Vector Borne Diseases, V43, P173; Potere D, 2007, GEOJOURNAL, V69, P55, DOI 10.1007/s10708-007-9102-z; Potere D, 2009, INT J REMOTE SENS, V30, P6531, DOI 10.1080/01431160903121134; Ridgeway G., 2009, R NEWS, P15; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Scharlemann JPW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001408; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Small C, 2005, REMOTE SENS ENVIRON, V96, P277, DOI 10.1016/j.rse.2005.02.002; Smith DL, 2007, PLOS BIOL, V5, P531, DOI 10.1371/journal.pbio.0050042; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stoler J, 2009, AM J TROP MED HYG, V80, P547, DOI 10.4269/ajtmh.2009.80.547; Tatem AJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-218; United Nations, 2012, WORLD URB PROSP 2011; Utzinger J, 2006, ANN TROP MED PARASIT, V100, P517, DOI 10.1179/136485906X97372; Van Boeckel TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049528; Warren M, 1999, 71 ENV HLTH PROJ; Xu  Sheng, 2008, INT ARCH PHOTOGRAMME, VXXXVII; DEMOGRAPHIC HLTH SUR	54	6	6	0	10	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 26	2017	16								49	10.1186/s12936-017-1694-2				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI8NB	WOS:000392762000003	28125996	DOAJ Gold, Green Published			2019-04-02	
J	Kostopoulou, D; Claerebout, E; Arvanitis, D; Ligda, P; Voutzourakis, N; Casaert, S; Sotiraki, S				Kostopoulou, Despoina; Claerebout, Edwin; Arvanitis, Dimitrios; Ligda, Panagiota; Voutzourakis, Nikolaos; Casaert, Stijn; Sotiraki, Smaragda			Abundance, zoonotic potential and risk factors of intestinal parasitism amongst dog and cat populations: The scenario of Crete, Greece	PARASITES & VECTORS			English	Article						Intestinal parasites; Companion animals; Zoonotic; Molecular analyses	GIARDIA-DUODENALIS; PUBLIC-HEALTH; MOLECULAR CHARACTERIZATION; INFECTIOUS-DISEASES; ASCARID INFECTIONS; FECAL SAMPLES; KENNELED DOGS; SHELTER DOGS; RURAL-AREAS; PET DOGS	Background: The objectives of this study were to evaluate the prevalence and infection intensity of intestinal parasites in different dog and cat populations in Crete, Greece, estimate the zoonotic risk and identify risk factors. Methods: Faecal samples from shelter, household and shepherd dogs and shelter and household cats were analyzed using sedimentation/flotation techniques. Giardia and Cryptosporidium were detected by a quantitative direct immunofluorescence assay (IFA). PCR and sequencing was performed to evaluate the zoonotic potential of Giardia and Cryptosporidium positive samples. Results: Totals of 879 dog and 264 cat faecal samples were examined. In dogs, the overall prevalence was 25.2% (CI: 22.4-28.1) for Giardia spp.; 9.2% (CI: 7.3-11.1) for Ancylostoma/Uncinaria spp.; 7.6% (CI: 5.9-9.4) for Toxocara spp.; 5.9% (CI: 4.4-7.5) for Cryptosporidium spp.; 4.6% (CI: 3.2-5.9) for Cystoisospora spp.; 2.7% (CI: 1.7-3.8) for Toxascaris leonina; 1.7% (CI: 0.9-2.6) for Capillaria spp.; 0.8% (CI: 0.2-1.4) for taeniid eggs; 0.2% (CI: 0-0.5) for Dipylidium caninum; and 0.1% (CI: 0-0.3) for Strongyloides stercoralis. In cats, the prevalence was 20.5% (CI: 15.6-25.3) for Giardia spp.; 9.5% (CI: 5.9-13.0) for Cystoisospora spp.; 8.3% (CI: 5.0-11.7) for Toxocara spp.; 7.6% (CI: 4.4-10.8) for Ancylostoma/Uncinaria spp.; 6.8% (CI: 3.8-9.9) for Cryptosporidium spp.; 4.2% (CI: 1.8-6.6) for Capillaria spp.; 0.8% (CI: 0-1.8) for taeniid eggs; and 0.4% (CI: 0-1.1) for Hammondia/Toxoplasma. Concerning the risk factors evaluated, there was a negative association between age and Giardia infection and between age and T. leonina infection intensity for dogs. Sequencing results revealed the presence of mainly animal-specific G. duodenalis assemblages C and D in dogs and assemblages F, C and BIV-like in cats, with only a limited number of (co-) infections with assemblage A. As for Cryptosporidium, the dog-specific C. canis and the pig-specific C. scrofarum were detected in dogs and the cat-specific C. felis was detected in cats. Conclusions: High levels of parasitism in both dogs and cats were recorded. Giardia was the most prevalent parasite in all dog and cat populations except for shepherd dogs. Genotyping results suggest a limited zoonotic risk of Giardia and Cryptosporidium infections from dogs and cats in Crete. Taeniid eggs were more prevalent in shepherd dogs suggesting access to carcasses and posing a threat for cystic echinococcosis transmission. Infection rates of Toxocara spp. in both dogs and cats show that companion animals could be a significant source of infection to humans.	[Kostopoulou, Despoina; Claerebout, Edwin; Ligda, Panagiota; Casaert, Stijn] Univ Ghent, Parasitol Lab, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium; [Kostopoulou, Despoina; Arvanitis, Dimitrios; Ligda, Panagiota; Voutzourakis, Nikolaos; Sotiraki, Smaragda] Hellen Agr Org Demeter, Vet Res Inst, Thessaloniki 57001, Greece	Kostopoulou, D (reprint author), Univ Ghent, Parasitol Lab, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.; Kostopoulou, D (reprint author), Hellen Agr Org Demeter, Vet Res Inst, Thessaloniki 57001, Greece.	nelly_kost@hotmail.gr			Greek State Scholarships Foundation	This work is a part of a PhD scholarship funded by the Greek State Scholarships Foundation.	Ballweber LR, 2010, TRENDS PARASITOL, V26, P180, DOI 10.1016/j.pt.2010.02.005; Barutzki D, 2007, PARASITOL RES, V101, pS153, DOI 10.1007/s00436-007-0628-7; Barutzki Dieter, 2011, Parasitol Res, V109 Suppl 1, pS45, DOI 10.1007/s00436-011-2402-8; Becker AC, 2012, PARASITOL RES, V111, P849, DOI 10.1007/s00436-012-2909-7; Berrilli F, 2004, VET PARASITOL, V122, P193, DOI 10.1016/j.vetpar.2004.04.008; Beugnet F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-291; Bowman DD, 2010, EXP PARASITOL, V124, P121, DOI 10.1016/j.exppara.2009.01.003; Caccio SM, 2008, INT J PARASITOL, V38, P1523, DOI 10.1016/j.ijpara.2008.04.008; Caccio SM, 2008, MOL BIOCHEM PARASIT, V160, P75, DOI 10.1016/j.molbiopara.2008.04.006; Capelli G, 2003, PARASITOL RES, V90, pS154, DOI 10.1007/s00436-003-0924-4; Chaligiannis I, 2015, ACTA TROP, V150, P64, DOI 10.1016/j.actatropica.2015.06.021; Chen J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-152; Claerebout E, 2009, VET PARASITOL, V161, P41, DOI 10.1016/j.vetpar.2008.11.024; DAKKAK A., 1992, GUIDELINES DIAGNOSIS; Deplazes P, 2011, VET PARASITOL, V182, P41, DOI 10.1016/j.vetpar.2011.07.014; Dubna S, 2007, VET PARASITOL, V145, P120, DOI 10.1016/j.vetpar.2006.11.006; Fahrion AS, 2011, VET PARASITOL, V177, P186, DOI 10.1016/j.vetpar.2010.11.028; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; Fok E, 2001, VET QUART, V23, P96, DOI 10.1080/01652176.2001.9695091; Gates MC, 2009, VET PARASITOL, V166, P153, DOI 10.1016/j.vetpar.2009.07.041; Geurden T, 2008, VET PARASITOL, V157, P14, DOI 10.1016/j.vetpar.2008.07.002; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Habluetzel A, 2003, VET PARASITOL, V113, P243, DOI 10.1016/S0304-4017(03)00082-7; Hackett T, 2003, J AM ANIM HOSP ASSOC, V39, P52, DOI 10.5326/0390052; Hamnes IS, 2007, ACTA VET SCAND, V49, DOI 10.1186/1751-0147-49-22; Haralambidis ST, 1993, ISSUES PARASITOLOGY, P41; Haralambidou S, 2005, Eur J Intern Med, V16, P601, DOI 10.1016/j.ejim.2005.04.008; Hill SL, 2000, J AM VET MED ASSOC, V216, P687, DOI 10.2460/javma.2000.216.687; Hopkins RM, 1997, J PARASITOL, V83, P44, DOI 10.2307/3284315; Ito Y, 2016, J FELINE MED SURG, V18, P834, DOI 10.1177/1098612X15597023; Itoh N, 2015, PARASITOL RES, V114, P1221, DOI 10.1007/s00436-015-4322-5; Jackman S., PSCL CLASSES METHODS; Jenkins DJ, 2006, AUST VET J, V84, P12, DOI 10.1111/j.1751-0813.2006.tb13116.x; Joffe D, 2011, CAN VET J, V52, P1323; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Katzoura V, 2013, PARASITOL INT, V62, P554; Kostopoulou D, 2015, VET PARASITOL, V211, P170, DOI 10.1016/j.vetpar.2015.04.018; Lalle M, 2005, INT J PARASITOL, V35, P207, DOI 10.1016/j.ijpara.2004.10.022; Lambert D, 1992, AM STAT ASS AM SOC Q, V34, P1, DOI DOI 10.2307/1269547; le Nobel WE, 2004, TIJDSCHR DIERGENEESK, V129, P40; Lee ACY, 2010, TRENDS PARASITOL, V26, P155, DOI 10.1016/j.pt.2010.01.002; Leonhard S, 2007, VET PARASITOL, V150, P33, DOI 10.1016/j.vetpar.2007.08.034; Lucio-Forster A, 2010, TRENDS PARASITOL, V26, P174, DOI 10.1016/j.pt.2010.01.004; Macpherson CNL, 2013, INT J PARASITOL, V43, P999, DOI 10.1016/j.ijpara.2013.07.004; MAFF, 1986, MAN VET PAR LAB TECH; Martinez-Carrasco C, 2007, ZOONOSES PUBLIC HLTH, V54, P195, DOI 10.1111/j.1863-2378.2007.01047.x; Martinez-Moreno FJ, 2007, VET PARASITOL, V143, P7, DOI 10.1016/j.vetpar.2006.08.004; Mateus TL, 2014, INT J ENV RES PUB HE, V11, P9050, DOI 10.3390/ijerph110909050; Matos M, 2015, PREV VET MED, V122, P174, DOI 10.1016/j.prevetmed.2015.09.006; Minetti C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1059-z; Morgan UM, 2001, INT J PARASITOL, V31, P289, DOI 10.1016/S0020-7519(00)00164-8; Nijsse R, 2016, PARASITOL RES, V115, P4519, DOI 10.1007/s00436-016-5242-8; Nijsse R, 2014, VET PARASITOL, V204, P304, DOI 10.1016/j.vetpar.2014.05.019; Nijsse R, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1009-9; Ortuno A, 2011, ISR J VET MED, V66, P103; Ortuno A, 2014, VET J, V199, P465, DOI 10.1016/j.tvjl.2013.11.022; Osman M, 2015, VET PARASITOL, V214, P167, DOI 10.1016/j.vetpar.2015.09.015; Otranto D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-41; Overgaauw PAM, 1997, CRIT REV MICROBIOL, V23, P215, DOI 10.3109/10408419709115137; Overgaauw PAM, 2009, VET PARASITOL, V163, P115, DOI 10.1016/j.vetpar.2009.03.044; Pallant L, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0615-2; Palmer CS, 2008, VET PARASITOL, V151, P181, DOI 10.1016/j.vetpar.2007.10.015; Papazahariadou A, 2007, VET PARASITOL, V148, P170, DOI 10.1016/j.vetpar.2007.05.013; PARSONS JC, 1987, VET CLIN N AM-SMALL, V17, P1307, DOI 10.1016/S0195-5616(87)50004-3; Pereira A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1533-2; Polak KC, 2014, VET J, V201, P189, DOI 10.1016/j.tvjl.2014.05.020; R Core Team, 2013, R LANG ENV STAT COMP; Read CM, 2004, INFECT GENET EVOL, V4, P125, DOI 10.1016/j.meegid.2004.02.001; Riggio F, 2013, VET PARASITOL, V193, P78, DOI 10.1016/j.vetpar.2012.11.026; Rinaldi L, 2011, VET PARASITOL, V177, P345, DOI 10.1016/j.vetpar.2010.12.010; Ryan U, 2014, PARASITOLOGY, V11, P1, DOI DOI 10.1017/S0031182014001085; Scaramozzino P, 2009, VET J, V182, P231, DOI 10.1016/j.tvjl.2008.07.003; Scorza AV, 2012, VET PARASITOL, V189, P182, DOI 10.1016/j.vetpar.2012.04.032; Simonato G, 2015, PARASITOL RES, V114, P1963, DOI 10.1007/s00436-015-4385-3; Smith H, 2006, TOXOCARA: THE ENIGMATIC PARASITE, P89; Sotiraki S, 2010, PARASITE, V17, P205, DOI 10.1051/parasite/2010173205; Souza SLP, 2007, VET PARASITOL, V149, P258, DOI 10.1016/j.vetpar.2007.08.019; Sulaiman IM, 2003, EMERG INFECT DIS, V9, P1444, DOI 10.3201/eid0911.030084; Sutherst RW, 2004, CLIN MICROBIOL REV, V17, P136, DOI 10.1128/CMR.17.1.136-173.2004; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Theodoridis I, 2001, INT J IMMUNOPATH PH, V14, P17, DOI 10.1177/039463200101400104; Thompson RCA, 2011, VET PARASITOL, V182, P70, DOI 10.1016/j.vetpar.2011.07.016; Thompson RCA, 2008, VET J, V177, P18, DOI 10.1016/j.tvjl.2007.09.022; Traversa D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-91; Villeneuve A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0870-x; Wang XT, 2016, PARASITOL RES, V115, P1355, DOI 10.1007/s00436-016-4908-6; Xiao LH, 2001, APPL ENVIRON MICROB, V67, P1097, DOI 10.1128/AEM.67.3.1097-1101.2001; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; Xiao LH, 2007, J CLIN MICROBIOL, V45, P2014, DOI 10.1128/JCM.00503-07; Xinou E, 2003, AM J NEURORADIOL, V24, P714; Zanzani SA, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/696508	91	11	13	2	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	JAN 25	2017	10								43	10.1186/s13071-017-1989-8				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EN9NE	WOS:000396326100001	28122583	DOAJ Gold, Green Published			2019-04-02	
J	Cisse, M; Awandare, GA; Soulama, A; Tinto, H; Hayette, MP; Guiguemde, RT				Cisse, Mamoudou; Awandare, Gordon A.; Soulama, Alamissa; Tinto, Halidou; Hayette, Marie-Pierre; Guiguemde, Robert T.			Recent uptake of intermittent preventive treatment during pregnancy with sulfadoxine-pyrimethamine is associated with increased prevalence of Pfdhfr mutations in Bobo-Dioulasso, Burkina Faso	MALARIA JOURNAL			English	Article						Malaria; Pregnancy; Sulfadoxine-pyrimethamine; Drug resistance; Burkina Faso	RESISTANT PLASMODIUM-FALCIPARUM; DIHYDROFOLATE-REDUCTASE; DIHYDROPTEROATE SYNTHASE; MOLECULAR MARKERS; MALARIA PARASITES; DRUG-RESISTANCE; WOMEN; SELECTION; ALLELES; SULFADOXINE/PYRIMETHAMINE	Background: The impact of sulfadoxine-pyrimethamine (SP) used as intermittent preventive treatment during pregnancy (IPTp-SP) on mutant parasite selection has been poorly documented in Burkina Faso. This study sought first to explore the relationship between IPTp-SP and the presence of mutant parasites. Second, to assess the relationship between the mutant parasites and adverse pregnancy outcomes. Methods: From September to December 2010, dried blood spots (DBS) were collected during antenatal care visits and at delivery from 109 pregnant women with microscopically confirmed falciparum malaria infection. DBS were analysed by PCR-restriction fragment length polymorphism (PCR-RFLP) for the polymorphisms at codons 51, 59, 108, and 164 of the Pfdhfr gene and codons 437 and 540 in the Pfdhps gene. Results: Both the Pfdhfr and Pfdhps genes were successfully genotyped in 92.7% (101/109) of the samples. The prevalence of Pfdhfr mutations N51I, C59R and S108N was 71.3, 42.6 and 64.4%, respectively. Overall, 80.2% (81/101) of samples carried the Pfdhps A437G mutation. None of the samples had the Pfdhfr I164L and the Pfdhps K540E mutations. The prevalence of the triple mutation N51I + C59R + S108N was 25.7% (26/101). The use of IPTp-SP was associated with a threefold increased odds of Pfdhfr C59R mutation [crude OR 3.29; 95% CI (1.44-7.50)]. Pregnant women with recent uptake of IPTp-SP were at higher odds of both the Pfdhfr C59R mutation [adjusted OR 4.26; 95% CI (1.64-11.07)] and the Pfdhfr intermediate-to-high resistance, i.e., >= 2 Pfdhfr mutations [adjusted OR 3.45; 95% CI (1.18-10.07)]. There was no statistically significant association between the presence of the Pfdhfr intermediate-tohigh resistance and parasite densities or both maternal haemoglobin level and anaemia. Conclusion: The data indicate that despite the possibility that IPTp-SP contributes to the selection of resistant parasites, it did not potentiate pregnancy-associated malaria morbidity, suggesting the continuation of SP use as IPTp in Burkina Faso.	[Cisse, Mamoudou; Soulama, Alamissa; Guiguemde, Robert T.] Ctr MURAZ, Lab Parasitol & Entomol, 01 BP 390, Bobo Dioulasso, Burkina Faso; [Awandare, Gordon A.] Univ Ghana, Coll Basic & Appl Sci, West African Ctr Cell Biol Infect Pathogens, Accra, Ghana; [Tinto, Halidou] Ctr MURAZ, Dept Clin Res, Bobo Dioulasso, Burkina Faso; [Hayette, Marie-Pierre] Univ Hosp Liege, Lab Clin Microbiol, Liege, Belgium	Cisse, M (reprint author), Ctr MURAZ, Lab Parasitol & Entomol, 01 BP 390, Bobo Dioulasso, Burkina Faso.	cisse_m@yahoo.fr		Tinto, Halidou/0000-0002-0472-3586; Awandare, Gordon/0000-0002-8793-3641	World Bank African Centres of Excellence grant [ACE02-WACCBIP: GAA]; Wellcome Trust DELTAS grant [107755/Z/15/Z: AGA]	Part of this work was supported by funds from a World Bank African Centres of Excellence grant (ACE02-WACCBIP: GAA) and a Wellcome Trust DELTAS grant (107755/Z/15/Z: AGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertin G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-196; Bouyou-Akotet MK, 2010, J ANTIMICROB CHEMOTH, V65, P438, DOI 10.1093/jac/dkp467; Chauvin P, 2015, J ANTIMICROB CHEMOTH, V70, P2566, DOI 10.1093/jac/dkv160; Cisse Mamoudou, 2016, Parasitology Open, V2, pe15, DOI 10.1017/pao.2016.12; Cisse M, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0631-z; Coulibaly SO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-41; Diallo DA, 2007, AM J TROP MED HYG, V76, P237, DOI 10.4269/ajtmh.2007.76.237; Diourte Y, 1999, AM J TROP MED HYG, V60, P475, DOI 10.4269/ajtmh.1999.60.475; Dokomajilar C, 2006, AM J TROP MED HYG, V75, P162, DOI 10.4269/ajtmh.2006.75.162; Geiger C, 2014, TROP MED INT HEALTH, V19, P690, DOI 10.1111/tmi.12305; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Hastings IA, 2005, DRUG RESIST UPDATE, V8, P43, DOI 10.1016/j.drup.2005.03.003; Iriemenam NC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-134; Iwalokun BA, 2015, MED PRIN PRACT, V24, P436, DOI 10.1159/000430987; Jonathan V, 2004, PROTOCOLS DETECTING; Maiga OM, 2011, CLIN INFECT DIS, V53, P215, DOI 10.1093/cid/cir374; Marks F, 2005, ANTIMICROB AGENTS CH, V49, P1101, DOI 10.1128/AAC.49.3.1101-1105.2005; Menendez C, 2011, CLIN INFECT DIS, V52, P41, DOI 10.1093/cid/ciq049; Mockenhaupt FP, 2001, AM J TROP MED HYG, V65, P21, DOI 10.4269/ajtmh.2001.65.21; Mockenhaupt FP, 2008, J INFECT DIS, V198, P1545, DOI 10.1086/592455; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P332, DOI 10.1128/AAC.00856-06; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; Siame MNP, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0676-5; Some AF, 2010, ANTIMICROB AGENTS CH, V54, P1949, DOI 10.1128/AAC.01413-09; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Tahita MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137440; Taylor SM, 2012, CLIN INFECT DIS, V55, P42, DOI 10.1093/cid/cis301; Tinto H, 2007, AM J TROP MED HYG, V76, P608, DOI 10.4269/ajtmh.2007.76.608; Tipke M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-95; Triglia T, 1997, P NATL ACAD SCI USA, V94, P13944, DOI 10.1073/pnas.94.25.13944; WHO, 2012, INT PERV TREATM MAL; WHO, 2004, STRAT FRAM MAL PREV	33	4	4	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 23	2017	16								38	10.1186/s12936-017-1695-1				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI8MX	WOS:000392761600001	28114990	DOAJ Gold, Green Published			2019-04-02	
J	Matangila, JR; Fraeyman, J; Kambulu, MLM; Mpanya, A; da Luz, RI; Lutumba, P; Van Geertruyden, JP; Bastiaens, H				Matangila, Junior R.; Fraeyman, Jessica; Kambulu, Marie-Louise Mbula; Mpanya, Alain; da Luz, Raquel Inoencio; Lutumba, Pascal; Van Geertruyden, Jean-Pierre; Bastiaens, Hilde			The perception of parents and teachers about intermittent preventive treatment for malaria in school children in a semi-rural area of Kinshasa, in the Democratic Republic of Congo	MALARIA JOURNAL			English	Article							CONTROLLED-TRIAL; DOUBLE-BLIND; SCHOOLCHILDREN; PREGNANCY; EFFICACY; SAFETY; HEALTH	Background: Intermittent preventive treatment (IPT) is likely to be the most promising therapeutic strategy to prevent malaria and its related adverse outcomes in schoolchildren. However, its successful implementation will depend on acceptability to key stakeholders such as parents and teachers. Methods: A qualitative research was conducted, following a clinical trial assessing the effectiveness of IPT in schoolchildren (IPTsc), to understand the perceptions and experiences of parents and teachers with IPTsc, in two schools of Mokali, in Kinshasa, Democratic Republic of the Congo. Eighty parents participated in 8 focus group discussions and 6 school staff were involved in 6 semi-structured interviews. Results: Parents experiences with IPTsc divided them into two groups (owning positive experiences and owning negative experiences with IPTsc). Three major themes emerged as key factors associated with reluctance of parents to IPT use in schoolchildren. These included wrong malaria-related knowledge, bad experience with IPTsc administered during the trial and misunderstanding of IPTsc. The school staff were generally willing to be trained to give medicine to schoolchildren within the scope of IPT. However, most parents were more comfortable with the use of health workers than teachers for drug administration. More importantly, all parents accepting IPT suggested to diagnose malaria infection before any administration of IPT, which is not in line with IPT principal. Conclusion: These results suggest that more efforts are needed to improve overall malaria-related knowledge in the community, specifically chemo-prevention strategies and the safety of the drugs used, to ensure the success of health interventions.	[Matangila, Junior R.; Kambulu, Marie-Louise Mbula; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Matangila, Junior R.; da Luz, Raquel Inoencio; Van Geertruyden, Jean-Pierre] Univ Antwerp, Epidemiol Global Hlth Inst, Campus Drie Eiken,Univ Pl 1, B-2610 Antwerp, Belgium; [Fraeyman, Jessica] Univ Antwerp, Res Grp Med Sociol & Hlth Policy, Antwerp, Belgium; [Mpanya, Alain] Minist Publ Hlth, Dept Dis Control, Kinshasa, DEM REP CONGO; [Bastiaens, Hilde] Univ Antwerp, Dept Primary & Interdisciplinary Care, Antwerp, Belgium	Matangila, JR (reprint author), Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO.	matangilaj@yahoo.fr	Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Inocencio da Luz, Raquel/0000-0002-2870-0311	Flemish Interuniversity Council (VLIR UOS project) [ZRDC2012 70447]; Research Foundation-Flanders (FWO) [G.0978.11N]	This study was financed by the Flemish Interuniversity Council (VLIR UOS project), Grant Number: ZRDC2012 70447 and the Research Foundation-Flanders (FWO), Grant Number: G.0978.11N.	[Anonymous], 1997, HLTH SAF ISS TEL EUR; Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; Bundy DAP, 2000, PARASITOL TODAY, V16, P181, DOI 10.1016/S0169-4758(00)01658-6; Bundy DAP, 2013, PUBLIC HEALTH NUTR, V16, P1012, DOI 10.1017/S1368980012004661; Clarke SE, 2004, AM J TROP MED HYG, V71, P732, DOI 10.4269/ajtmh.2004.71.732; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Doua JY, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-311; Fernando D, 2006, AM J TROP MED HYG, V74, P386, DOI 10.4269/ajtmh.2006.74.386; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Kantele A, 2011, CLIN INFECT DIS, V52, P1356, DOI 10.1093/cid/cir180; Launiala A, 2006, ACTA TROP, V98, P111, DOI 10.1016/j.actatropica.2005.12.008; Leech NL, 2009, QUAL QUANT, V43, P265, DOI 10.1007/s11135-007-9105-3; Matangila J, ONE YEAR EFFICACY SA; Matangila JR, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0988-5; Pell C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-432; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Pool R, 2006, TROP MED INT HEALTH, V11, P1670, DOI 10.1111/j.1365-3156.2006.01725.x; Sandelowski M, 2000, RES NURS HEALTH, V23, P246, DOI 10.1002/1098-240X(200006)23:3<246::AID-NUR9>3.0.CO;2-H; World Health Organization, 2015, WORLD MAL REP 2015	19	1	1	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	JAN 7	2017	16								19	10.1186/s12936-016-1670-2				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EH3BR	WOS:000391643500001	28061851	DOAJ Gold, Green Published			2019-04-02	
J	Colebunders, R; Tepage, F; Ensoy-Musoro, C; Mandro, M; Levick, B; Suykerbuyk, P; Osoro, CB; Tagoto, A; Laudisoit, A				Colebunders, Robert; Tepage, Floribert; Ensoy-Musoro, Chellafe; Mandro, Michel; Levick, Bethany; Suykerbuyk, Patrick; Osoro, Caroline Bonareri; Tagoto, Alliance; Laudisoit, Anne			IVERMECTIN PROTECTS AGAINST EPILEPSY IN ONCHOCERCIASIS ENDEMIC REGIONS IN THE DEMOCRATIC REPUBLIC OF THE CONGO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Colebunders, Robert; Suykerbuyk, Patrick; Laudisoit, Anne] Univ Antwerp, Antwerp, Belgium; [Tepage, Floribert] Minist Hlth, Bas Uele, DEM REP CONGO; [Ensoy-Musoro, Chellafe] Univ Hasselt, Diegem, Belgium; [Mandro, Michel] Minist Hlth, Bunia, DEM REP CONGO; [Levick, Bethany] Univ Liverpool, Liverpool, Merseyside, England; [Osoro, Caroline Bonareri] Nanyuki Teaching & Referral Hosp, Laikipia, Kenya; [Tagoto, Alliance] Minist Hlth, Kisangani, DEM REP CONGO								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		24	8	8						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215202024					2019-04-02	
J	Schallig, H; Ruizendaal, E; Traore, M; Lompo, P; Magloire, N; Bradley, J; Scott, S; Traore, O; Valea, I; Peeters, K; Pagnoni, F; d'Alessandro, U; Tinto, H; Mens, P				Schallig, Henk; Ruizendaal, Esmee; Traore, Maminata; Lompo, Palpigiun; Magloire, Natama; Bradley, John; Scott, Susanna; Traore, Osmane; Valea, Innocent; Peeters, Koen; Pagnoni, Franco; d'Alessandro, Umberto; Tinto, Halidou; Mens, Petra			SCREENING FOR MALARIA IN PREGNANCY WITH RDTS BY COMMUNITY HEALTH WORKERS IN NANORO, BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Schallig, Henk; Ruizendaal, Esmee; Mens, Petra] Acad Med Ctr, Amsterdam, Netherlands; [Traore, Maminata; Lompo, Palpigiun; Magloire, Natama; Traore, Osmane; Valea, Innocent; Tinto, Halidou] Clin Res Unit Nanoro, Nanoro, Burkina Faso; [Bradley, John] London Sch Hyg & Trop Med, London, England; [Scott, Susanna; d'Alessandro, Umberto] MRC, Banjul, Gambia; [Peeters, Koen] Inst Trop Med, Antwerp, Belgium; [Pagnoni, Franco] WHO, TDR, Geneva, Switzerland								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		301	93	93						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215202301					2019-04-02	
J	Kabaria, CW; Gilbert, M; Noor, AM; Snow, RW; Linard, C				Kabaria, Caroline W.; Gilbert, Marius; Noor, Abdisalan M.; Snow, Robert W.; Linard, Catherine			THE IMPACT OF URBANIZATION AND POPULATION DENSITY ON CHILDHOOD PLASMODIUM FALCIPARUM PARASITE PREVALENCE RATES IN AFRICA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Kabaria, Caroline W.] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Gilbert, Marius; Linard, Catherine] Univ Libre Bruxelles, Spatial Epidemiol Lab, Brussels, Belgium; [Noor, Abdisalan M.; Snow, Robert W.] Wellcome Trust Res Programme, Kenya Med Res Inst, Spatial Hlth Metr Grp, Nairobi, Kenya								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		331	102	102						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215202331					2019-04-02	
J	Barboza, JL; Moreno, D; Torres, A; Contreras-Mancilla, J; Gamboa, D; Rodriguez, H; Vinetz, J; Soares, IS; Speybroeck, N; Rosas-Aguirre, A				Luis Barboza, Jose; Moreno, Diamantina; Torres, Anthony; Contreras-Mancilla, Juan; Gamboa, Dionicia; Rodriguez, Hugo; Vinetz, Joseph; Soares, Irene S.; Speybroeck, Niko; Rosas-Aguirre, Angel			SEROLOGICALLY DEFINED HETEROGENEITY IN PLASMODIUM VIVAX MALARIA TRANSMISSION USING A NOVEL CHIMERIC RECOMBINANT PROTEIN IN RIVERINE VILLAGES OF THE PERUVIAN AMAZON	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Luis Barboza, Jose; Contreras-Mancilla, Juan; Gamboa, Dionicia; Rosas-Aguirre, Angel] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Luis Barboza, Jose; Moreno, Diamantina; Rodriguez, Hugo] Univ Nacl Amazonia Peruana, Loreto, Iquitos, Peru; [Moreno, Diamantina; Speybroeck, Niko; Rosas-Aguirre, Angel] Catholic Univ Louvain, Res Inst Hlth & Soc IRSS, Brussels, Belgium; [Torres, Anthony; Contreras-Mancilla, Juan; Gamboa, Dionicia] Univ Peruana Cayetano Heredia, Lab Invest & Desarrollo, Fac Ciencias & Filosofia, Lima, Peru; [Contreras-Mancilla, Juan] 4 Lab, Lima, Peru; [Vinetz, Joseph] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [Soares, Irene S.] Univ Sao Paulo, Dept Anal Clin & Toxicol, Fac Ciencias Farmaceut, Sao Paulo, Brazil								0	0	0	2	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		347	107	107						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215202347					2019-04-02	
J	Venkatraman, N; Bowyer, G; Collins, K; Angell-Manning, P; Powlson, J; Bliss, C; Brendish, N; Griffiths, O; Poulton, I; Moyle, S; Berrie, E; Green, N; Mukhopadhyay, E; Lievens, M; Morelle, D; Lawrie, A; Roberts, R; Faust, S; Ewer, K; Hill, AV				Venkatraman, Navin; Bowyer, Georgina; Collins, Katharine; Angell-Manning, Philip; Powlson, Jonathan; Bliss, Carly; Brendish, Nathan; Griffiths, Oliver; Poulton, Ian; Moyle, Sarah; Berrie, Eleanor; Green, Nicola; Mukhopadhyay, Ekta; Lievens, Marc; Morelle, Danielle; Lawrie, Alison; Roberts, Rachel; Faust, Saul; Ewer, Katie; Hill, Adrian V.			SAFETY, IMMUNOGENICITY AND DURABILITY OF A NOVEL MALARIA VACCINE CANDIDATE, R21 ADJUVANTED WITH AS01(B)	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Venkatraman, Navin; Bowyer, Georgina; Collins, Katharine; Angell-Manning, Philip; Powlson, Jonathan; Bliss, Carly; Griffiths, Oliver; Poulton, Ian; Moyle, Sarah; Berrie, Eleanor; Green, Nicola; Mukhopadhyay, Ekta; Lawrie, Alison; Roberts, Rachel; Ewer, Katie; Hill, Adrian V.] Univ Oxford, Oxford, England; [Brendish, Nathan; Faust, Saul] NIHR Wellcome Trust Southampton Clin Res Facil, Southampton, Hants, England; [Lievens, Marc; Morelle, Danielle] GlaxoSmithKline Vaccines, Rixensart, Belgium			Ewer, Katie/B-4328-2011	Ewer, Katie/0000-0001-9827-9836				0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		430	132	132						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215202429					2019-04-02	
J	Barreto, PMV; O'Neal, S; Gamboa-Moran, R; Muro-Ecca, C; Moyano, LM; Beam, M; Bustos, J; Gabriel, S; Dorny, P; Garcia, HH				Vilchez Barreto, Percy M.; O'Neal, Seth; Gamboa-Moran, Ricardo; Muro-Ecca, Claudio; Moyano, Luz-Maria; Beam, Michelle; Bustos, Javier; Gabriel, Sarah; Dorny, Pierre; Garcia, Hector H.		Cysticercosis Working Grp Peru	FIELD BASED SCREENING FOR CIRCULATING ANTIGEN IN URINE SAMPLES FOR THE DETECTION OF SEVERE FORMS OF NEUROCYSTICERCOSIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Vilchez Barreto, Percy M.; Gamboa-Moran, Ricardo; Muro-Ecca, Claudio] Ctr Salud Global Tumbes, Tumbes, Peru; [O'Neal, Seth; Beam, Michelle] Oregon Hlth & Sci Univ, Sch Publ Hlth, Portland, OR 97201 USA; [O'Neal, Seth; Beam, Michelle] Portland State Univ, Portland, OR 97207 USA; [Moyano, Luz-Maria] Hosp Reg JAMO II 2, Epidemiol Unit, Tumbes, Peru; [Bustos, Javier; Garcia, Hector H.] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru; [Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Antwerp, Belgium; [Cysticercosis Working Grp Peru] Univ Peruana Cayetano Heredia, Tumbes, Peru								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		488	151	151						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215202487					2019-04-02	
J	Colebunders, R; Mandro, M; Njamnshi, AK; Boussinesq, M; Kamgno, J; O'Neill, S; Hopkins, AD; Suykerbuyk, P; Basanez, MG; Idro, R				Colebunders, Robert; Mandro, Michel; Njamnshi, Alfred K.; Boussinesq, Michel; Kamgno, Joseph; O'Neill, Sarah; Hopkins, Adrian D.; Suykerbuyk, Patrick; Basanez, Maria-Gloria; Idro, Richard			REPORT OF THE FIRST INTERNATIONAL WORKSHOP ON ONCHOCERCIASIS-ASSOCIATED EPILEPSY: A CHALLENGE TO THE SCIENTIFIC AND MEDICAL COMMUNITIES AND A RESEARCH AGENDA GOING FORWARDS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Colebunders, Robert; Suykerbuyk, Patrick] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Mandro, Michel] Minist Hlth, Bunia, DEM REP CONGO; [Njamnshi, Alfred K.] Univ Yaounde I, Dept Neurol, Yaounde, Cameroon; [Boussinesq, Michel] Inst Rech Dev, Montpellier, France; [Kamgno, Joseph] Ctr Res Filariasis & Other Trop Dis, Yaounde, Cameroon; [O'Neill, Sarah] Inst Trop Dis, Antwerp, Belgium; [Hopkins, Adrian D.] Neglected & Disabling Dis Poverty Consultant, Gravesend, Kent, England; [Basanez, Maria-Gloria] Imperial Coll London, London, England; [Basanez, Maria-Gloria] LCNTDR, London, England; [Idro, Richard] Makerere Univ, Kampala, Uganda								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		525	163	163						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215202525					2019-04-02	
J	Espana, G; Hogea, C; Guignard, A; ten Bosch, Q; Morrison, A; Smith, D; Scott, T; Schmidt, A; Perkins, A				Espana, Guido; Hogea, Cosmina; Guignard, Adrienne; ten Bosch, Quirine; Morrison, Amy; Smith, David; Scott, Thomas; Schmidt, Alexander; Perkins, Alex			PHASE-III DENGUE VACCINE TRIAL SIMULATIONS QUANTIFY SENSITIVITIES OF VACCINE EFFICACY ESTIMATES TO UNMEASURED HETEROGENEITIES	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Espana, Guido; Perkins, Alex] Univ Notre Dame, Mishawaka, IN USA; [Hogea, Cosmina; Schmidt, Alexander] GlaxoSmithKline, King Of Prussia, PA USA; [Guignard, Adrienne] GlaxoSmithKline, Wavre, Belgium; [ten Bosch, Quirine] Inst Pasteur, Paris, France; [Morrison, Amy; Scott, Thomas] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Smith, David] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		796	249	249						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215203166					2019-04-02	
J	Huits, R; Jess, N; Dickson, D; Makee-Sookram, S; Eggermont, K; Michiels, J; Arien, K; Ramsewak, S; Van Esbroeck, M; Bottieau, E; Minto-Bain, C; Cnops, L				Huits, Ralph; Jess, Natalie; Dickson, Devon; Makee-Sookram, Sonja; Eggermont, Kaat; Michiels, Johan; Arien, Kevin; Ramsewak, Samuel; Van Esbroeck, Marjan; Bottieau, Emmanuel; Minto-Bain, Catherine; Cnops, Lieselotte			PERSISTENCE OF ZIKA VIRUS IN SEMEN OF MEN LIVING IN AN ENDEMIC AREA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Huits, Ralph; Eggermont, Kaat; Michiels, Johan; Arien, Kevin; Van Esbroeck, Marjan; Bottieau, Emmanuel; Cnops, Lieselotte] Inst Trop Med, Antwerp, Belgium; [Jess, Natalie; Dickson, Devon; Makee-Sookram, Sonja; Ramsewak, Samuel; Minto-Bain, Catherine] Trinidad IVF Fertil Ctr, Trinidad, West Indies, Trinid & Tobago								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		825	258	258						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215203195					2019-04-02	
J	Compaore, A; Dierickx, S; Jaiteh, F; Nahum, A; D'Alessandro, U; Tinto, H; Schallig, H; Grietens, KP				Compaore, Adelaide; Dierickx, Susan; Jaiteh, Fatou; Nahum, Alain; D'Alessandro, Umberto; Tinto, Halidou; Schallig, Henk; Grietens, Koen P.			HOW RUMORS OF PLACENTA SELLERS LED TO THE DECLINE OF A MALARIA IN PREGNANCY TRIAL IN BENIN: AN ETHNOGRAPHIC STUDY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Compaore, Adelaide; Tinto, Halidou] Inst Res Hlth Sci, Clin Res Unit Nanoro, Ouagadougou, Burkina Faso; [Dierickx, Susan] Vrije Univ, Res Ctr Gender Divers & Intersect RHEA, Brussels, Belgium; [Jaiteh, Fatou; D'Alessandro, Umberto] MRC Unit, Fajara, Gambia; [Nahum, Alain] Ctr Rech Entomol Cotonou, Cotonou, Benin; [Schallig, Henk] Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [Grietens, Koen P.] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		912	284	284						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215203282					2019-04-02	
J	Sawada, I; Bannister-Tyrell, M; Xa, NX; Muela, J; Hausmann-Muela, S; Thanh, PV; Hong, NV; Van, NV; Duong, TT; Gryseels, C; D'Alessandro, U; Erhart, A; Grietens, KP				Sawada, Ikumi; Bannister-Tyrell, Melanie; Xa, Nguyen Xuan; Muela, Joan; Hausmann-Muela, Susanna; Pham Vinh Thanh; Nguyen Van Hong; Nguyen Van Van; Tran Thanh Duong; Gryseels, Charlotte; D'Alessandro, Umberto; Erhart, Annette; Grietens, Koen Peeters			POVERTY CONSTRAINS BED NET USE AMONG ETHNIC MINORITIES IN CENTRAL VIETNAM	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Sawada, Ikumi] Nagasaki Univ, Inst Trop Med, Nagasaki, Japan; [Bannister-Tyrell, Melanie] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Xa, Nguyen Xuan; Pham Vinh Thanh; Nguyen Van Hong; Tran Thanh Duong] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Muela, Joan] Univ Ramon & Virgili, Tarragona, Spain; [Hausmann-Muela, Susanna] PASS Int, Partners Appl Social Sci, Tessenderlo, Belgium; [Nguyen Van Van] Prov Malaria Stn, Quang Nam, Vietnam; [Gryseels, Charlotte; Erhart, Annette; Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium; [D'Alessandro, Umberto] MRC Unit, Fajala, Gambia								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1090	339	339						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215203460					2019-04-02	
J	Sagara, I; Healy, SA; Kone, M; Assadou, MH; Katile, A; Sissoko, MS; Sidibe, B; Alhousseini, ML; Guindo, MA; Sanogo, S; Bamadio, A; Sangare, B; Doucoure, M; Konate, A; Ouologuem, B; Traore, S; Anderson, C; Rausch, K; Narum, DL; Scaria, P; MacDonald, N; Zhu, D; Muratova, O; Swihart, B; Gabriel, E; Dolo, A; Morelle, D; Lievens, M; Duffy, PE; Doumbo, O				Sagara, Issaka; Healy, Sara A.; Kone, Mamady; Assadou, Mahamadoun H.; Katile, Abdoulaye; Sissoko, Mahamadou S.; Sidibe, Bouran; Alhousseini, Mohamed Lamine; Guindo, Merepen A.; Sanogo, Sintry; Bamadio, Amadou; Sangare, Boubou; Doucoure, M'Bouye; Konate, Amadou; Ouologuem, Boucary; Traore, Souleymane; Anderson, Charles; Rausch, Kelly; Narum, David L.; Scaria, Puthupparampil; MacDonald, Nicholas; Zhu, Daming; Muratova, Olga; Swihart, Bruce; Gabriel, Erin; Dolo, Amagana; Morelle, Danielle; Lievens, Marc; Duffy, Patrick E.; Doumbo, Ogobara			SAFETY AND FUNCTIONAL IMMUNOGENICITY OF PFS25M-EPA/AS01 AND PFS230D1M-EPA/AS01 TRANSMISSION BLOCKING VACCINES AGAINST PLASMODIUM FALCIPARUM IN MALIAN ADULTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Sagara, Issaka; Kone, Mamady; Assadou, Mahamadoun H.; Katile, Abdoulaye; Sissoko, Mahamadou S.; Sidibe, Bouran; Alhousseini, Mohamed Lamine; Guindo, Merepen A.; Sanogo, Sintry; Bamadio, Amadou; Sangare, Boubou; Doucoure, M'Bouye; Konate, Amadou; Ouologuem, Boucary; Traore, Souleymane; Dolo, Amagana; Doumbo, Ogobara] Univ Sci Tech & Technol, MRTC, Bamako, Mali; [Anderson, Charles; Rausch, Kelly; Narum, David L.; Scaria, Puthupparampil; MacDonald, Nicholas; Zhu, Daming; Muratova, Olga; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, Rockville, MD USA; [Swihart, Bruce; Gabriel, Erin] NIAID, BRB, NIH, Rockville, MD USA; [Morelle, Danielle; Lievens, Marc] GlaxoSmithKline Vaccines, Rixensart, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1175	366	366						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215203543					2019-04-02	
J	Sanogo, M; Diarra, B; Toloba, Y; Konate, B; Togo, ACG; Berthe, G; Soumare, D; Baya, B; Goita, D; Sarro, YDS; Maiga, M; Belson, M; Orsega, S; Dao, S; Murphy, RL; Siddiqui, S; de Jong, B; Doumbia, S; Diallo, S				Sanogo, Moumine; Diarra, Bassirou; Toloba, Yacouba; Konate, Bakary; Togo, Antieme Combo Georges; Berthe, Gaoussou; Soumare, Diaguina; Baya, Bocar; Goita, Drissa; Sarro, Yeya Dit Sadio; Maiga, Mamoudou; Belson, Michael; Orsega, Susan; Dao, Sounkalo; Murphy, Robert L.; Siddiqui, Sophia; de Jong, Bouke; Doumbia, Seydou; Diallo, Souleymane			ACQUISITION OF PROPER TREATMENT FOR EXTENSIVELY DRUG RESISTANT TUBERCULOSIS PATIENTS IN MALI: WHERE IS THE ISSUE?	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Sanogo, Moumine; Togo, Antieme Combo Georges; Baya, Bocar; Goita, Drissa; Sarro, Yeya Dit Sadio; Dao, Sounkalo; Doumbia, Seydou; Diallo, Souleymane] USTTB, UCRC, SEREFO Lab, Bamako, Mali; [Diarra, Bassirou] USTTB, Inst Trop Med, SEREFO Lab, UCRC, Antwerp, Belgium; [Diarra, Bassirou] USTTB, Inst Trop Med, SEREFO Lab, UCRC, Bamako, Mali; [Toloba, Yacouba; Berthe, Gaoussou; Soumare, Diaguina] Ctr Hosp Univ Point G, Serv Pneumo Phtisiol, Bamako, Mali; [Konate, Bakary] Minist Sante & Hygiene Publ, Programme Natl Lutte Tuberculose PNLT, Bamako, Mali; [Maiga, Mamoudou; Murphy, Robert L.] Northwestern Univ, Global Hlth, Chicago, IL 60611 USA; [Belson, Michael; Orsega, Susan; Siddiqui, Sophia] NIAID, Collaborat Clin Res Branch, Div Clin Res, 9000 Rockville Pike, Bethesda, MD 20892 USA; [de Jong, Bouke] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1250	389	389						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215203617					2019-04-02	
J	Mwesigwa, J; Achan, J; Worwui, A; Van Geertruyden, JP; D'Alessandro, U				Mwesigwa, Julia; Achan, Jane; Worwui, Archibald; Van Geertruyden, Jean-Pierre; D'Alessandro, Umberto			IMPACT OF TWO ANNUAL CYCLES OF MASS DRUG ADMINISTRATION ON TEMPORAL TRENDS OF CLINICAL MALARIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Mwesigwa, Julia; Achan, Jane; Worwui, Archibald; D'Alessandro, Umberto] Med Res Council Unit Gambia, Banjul, Gambia; [Van Geertruyden, Jean-Pierre] Univ Antwerp, Antwerp, Belgium			Van geertruyden, Jean-Pierre/K-6425-2014	Van geertruyden, Jean-Pierre/0000-0001-5006-6364				0	1	1	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1322	411	411						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204038					2019-04-02	
J	Cools, P; van de Wijgert, JHV; Jespers, V; Crucitte, T; Sanders, E; Verstraelen, H; Vaneechoutte, M				Cools, Piet; van de Wijgert, Janneke H.; Jespers, Vicky; Crucitte, Tania; Sanders, Eduard; Verstraelen, Hans; Vaneechoutte, Mario			HIV-EXPOSED BUT UNINFECTED INFANTS ARE AT INCREASED RISK FOR NEONATAL GBS DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Cools, Piet; Vaneechoutte, Mario] Univ Ghent, Ghent, Belgium; [van de Wijgert, Janneke H.] Univ Liverpool, Liverpool, Merseyside, England; [Jespers, Vicky; Crucitte, Tania] Inst Trop Med, Antwerp, Belgium; [Sanders, Eduard] Univ Oxford, Oxford, England; [Verstraelen, Hans] Ghent Univ Hosp, Ghent, Belgium			Verstraelen, Hans/A-5602-2008					0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1369	426	426						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204085					2019-04-02	
J	Borges, MB; Carvalho-Pereira, R; Marchevsky, R; Mendes, YS; Mendes, LG; Diniz-Mendes, L; Freire, M; Homma, A; Lepine, E; Vaughn, D; Lorin, C; Malice, MP; Caride, E; Warter, L				Borges, Maria Beatriz; Carvalho-Pereira, Renata; Marchevsky, Renato; Mendes, Ygara S.; Mendes, Luiz Gustavo; Diniz-Mendes, Leonardo; Freire, Marcos; Homma, Akira; Lepine, Edith; Vaughn, David; Lorin, Clarisse; Malice, Marie-Pierre; Caride, Elena; Warter, Lucile			EFFICACY OF A DENGUE PURIFIED INACTIVATED VACCINE CANDIDATE IN MACAQUES REVEALS INSIGHTS ON ACCURATE CHARACTERIZATION OF POST-CHALLENGE VIRAL REPLICATION AND ON CORRELATES OF PROTECTION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Borges, Maria Beatriz; Carvalho-Pereira, Renata; Marchevsky, Renato; Mendes, Ygara S.; Mendes, Luiz Gustavo; Diniz-Mendes, Leonardo; Freire, Marcos; Homma, Akira; Caride, Elena] Fiocruz MS, Rio De Janeiro, Brazil; [Lepine, Edith; Lorin, Clarisse; Malice, Marie-Pierre; Warter, Lucile] GlaxoSmithKline Vaccines, Rixensart, Belgium; [Vaughn, David] GlaxoSmithKline Vaccines, Rockville, MD USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1385	431	431						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204101					2019-04-02	
J	McCracken, MK; Gromowski, GD; Garver, LS; Goupil, BA; Friberg, H; Currier, JR; Mores, CN; Vaughn, D; Lepine, E; Lorin, C; Malice, MP; Thomas, SJ; Jarman, RG; Putnak, JR; Warter, L				McCracken, Michael K.; Gromowski, Gregory D.; Garver, Lindsey S.; Goupil, Brad A.; Friberg, Heather; Currier, Jeffrey R.; Mores, Christopher N.; Vaughn, David; Lepine, Edith; Lorin, Clarisse; Malice, Marie-Pierre; Thomas, Stephen J.; Jarman, Richard G.; Putnak, J. Robert; Warter, Lucile			MOSQUITO-DELIVERY OF DENGUE VIRUS IN RHESUS MACAQUES DELAYED ONSET AND INCREASED PEAK VIREMIA COMPARED TO SUBCUTANEOUS INOCULATION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[McCracken, Michael K.; Gromowski, Gregory D.; Garver, Lindsey S.; Friberg, Heather; Currier, Jeffrey R.; Thomas, Stephen J.; Jarman, Richard G.; Putnak, J. Robert] Walter Reed Army Inst Res, Silver Spring, MD USA; [Goupil, Brad A.; Mores, Christopher N.] Louisiana State Univ, Baton Rouge, LA 70803 USA; [Vaughn, David; Lepine, Edith] GlaxoSmithKline Vaccines, Rockville, MD USA; [Lorin, Clarisse; Malice, Marie-Pierre; Warter, Lucile] GlaxoSmithKline Vaccines, Rixensart, Belgium								0	0	0	2	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1399	435	435						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204115					2019-04-02	
J	Guerrero, NAS; Sharma, S; Kaptein, SJ; Neyts, J				Guerrero, Nidya A. Segura; Sharma, Sapna; Kaptein, Suzanne J.; Neyts, Johan			POTENT ACTIVITY OF THE BROAD SPECTRUM INHIBITOR FAVIPIRAVIR ON IN VITRO USUTU VIRUS REPLICATION AND IN A MOUSE INFECTION MODEL	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Guerrero, Nidya A. Segura] Katholieke Univ Leuven, Univ Pedag & Tecnol Colombia, Leuven, Belgium; [Sharma, Sapna; Kaptein, Suzanne J.; Neyts, Johan] Katholieke Univ Leuven, Leuven, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1430	444	445						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204146					2019-04-02	
J	Diallo, S; Gies, S; Ki, A; Pagbelguem, JG; Ouedraogo, GA; Tinto, H				Diallo, Salou; Gies, Sabine; Ki, Arnaud; Pagbelguem, John G.; Ouedraogo, Georges A.; Tinto, Halidou			CROSS-SECTIONAL ANALYSIS IN YOUNG NON-PREGNANT AND PREGNANT WOMEN IN BURKINA FASO OF ASSOCIATIONS BETWEEN BIOMARKERS OF IRON STATUS AND EFFECT MODIFICATION BY INFLAMMATION AND PLASMODIUM FALCIPARUM INFECTION	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Diallo, Salou; Ki, Arnaud; Pagbelguem, John G.; Tinto, Halidou] Clin Res Unit Nanoro, Ouagadougou, Burkina Faso; [Gies, Sabine] Inst Trop Med, Antwerp, Belgium; [Ouedraogo, Georges A.] Univ Polytech Bobo Dioulasso, Bobo Dioulasso, Burkina Faso								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1583	491	491						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204298					2019-04-02	
J	Ramachandra, S; Visser, T; Pothin, E; Jacobs, J; Cunningham, J; Le Menach, A; Gatton, M; Souza, SD; Aidoo, M				Ramachandra, Sumedh; Visser, Theodoor; Pothin, Emilie; Jacobs, Jan; Cunningham, Jane; Le Menach, Arnaud; Gatton, Michelle; Souza, Samaly dos Santos; Aidoo, Michael			COMPARISON OF COMMERCIALLY AVAILABLE MOBILE MEDICAL APPLICATIONS (MMAS) FOR INTERPRETING MALARIA RAPID DIAGNOSTIC TEST (RDT) RESULTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Ramachandra, Sumedh; Visser, Theodoor; Le Menach, Arnaud] Clinton Hlth Access Initiat, Boston, MA USA; [Pothin, Emilie] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Jacobs, Jan] Inst Trop Med, Antwerp, Belgium; [Cunningham, Jane] WHO, Geneva, Switzerland; [Gatton, Michelle] Queensland Univ Technol, Brisbane, Qld, Australia; [Souza, Samaly dos Santos; Aidoo, Michael] Ctr Dis Control & Prevent, Atlanta, GA USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1586	492	492						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204301					2019-04-02	
J	Natama, MH; Rovira-Vallbona, E; Sorgho, H; Some, A; Coulibaly-Traore, M; Schallig, H; D'Alessandro, U; Kestens, L; Tinto, H; Rosanas-Urgell, A				Natama, Magloire H.; Rovira-Vallbona, Eduard; Sorgho, Hermann; Some, Athanase; Coulibaly-Traore, Maminata; Schallig, Henk; D'Alessandro, Umberto; Kestens, Luc; Tinto, Halidou; Rosanas-Urgell, Anna			COMMUNITY-BASED SCHEDULED SCREENING AND TREATMENT OF MALARIA DURING PREGNANCY PROVIDES ADDITIONAL PROTECTION AGAINST FEBRILE ILLNESSES DURING THE FIRST YEAR OF LIFE IN A BIRTH COHORT STUDY IN BURKINA FASO	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Natama, Magloire H.; Sorgho, Hermann; Some, Athanase; Coulibaly-Traore, Maminata; Tinto, Halidou] Clin Res Unit Nanoro, Ouagadougou, Burkina Faso; [Rovira-Vallbona, Eduard; Kestens, Luc; Rosanas-Urgell, Anna] Inst Trop Med, Antwerp, Belgium; [Schallig, Henk] Acad Med Ctr, Amsterdam, Netherlands; [D'Alessandro, Umberto] MRC, Fajara, Gambia								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1639	509	509						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204354					2019-04-02	
J	Nguyen, TT; Nguyen, XX; Tran, DT; Vu, DAK; Pham, KV; Erhart, A; Peeters, KG				Nguyen, Thuan T.; Xa Xuan Nguyen; Duong Thanh Tran; Dung Anh Khac Vu; Ky Van Pham; Erhart, Annette; Peeters, Koen Grietens			FACTORS LIMITING THE EFFECTIVENESS OF STANDARDIZED MALARIA CONTROL STRATEGIES IN FORESTED HIGHLANDS OF VIETNAM: A QUALITATIVE STUDY	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Nguyen, Thuan T.; Erhart, Annette] Inst Trop Med, Antwerp, Belgium; [Nguyen, Thuan T.; Xa Xuan Nguyen; Duong Thanh Tran; Dung Anh Khac Vu] Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam; [Ky Van Pham] Prov Ctr Malariol Parasitol & Entomol, Ninh Thuan, Vietnam; [Erhart, Annette] Med Res Council Gambia, Antwerp, Belgium; [Peeters, Koen Grietens] Inst Trop Med, Med Anthropol Unit, Antwerp, Belgium								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1691	525	525						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204407					2019-04-02	
J	Dierickx, S; O'Neill, S; Gryseels, C; Immaculate, EA; Bannister-Tyrell, M; Okebe, J; Mwesigwa, J; Jaiteh, F; Gerrets, R; Ravinetto, R; D'Alessandro, U; Grietens, KP				Dierickx, Susan; O'Neill, Sarah; Gryseels, Charlotte; Immaculate, Edna A.; Bannister-Tyrell, Melanie; Okebe, Joseph; Mwesigwa, Julia; Jaiteh, Fatou; Gerrets, Rene; Ravinetto, Raffaella; D'Alessandro, Umberto; Grietens, Koen Peeters			COMMUNITY SENSITIZATION AND DECISION-MAKING FOR TRIAL PARTICIPATION: A MIXED-METHODS STUDY FROM THE GAMBIA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Dierickx, Susan] Vrije Univ Brussel, Brussels, Belgium; [O'Neill, Sarah; Gryseels, Charlotte; Bannister-Tyrell, Melanie; Ravinetto, Raffaella; Grietens, Koen Peeters] Inst Trop Med, Antwerp, Belgium; [Immaculate, Edna A.; Okebe, Joseph; Mwesigwa, Julia; Jaiteh, Fatou; D'Alessandro, Umberto] Med Res Council Unit Gambia, Fajara, Gambia; [Gerrets, Rene] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands								0	0	0	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1772	551	551						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204488					2019-04-02	
J	Dana, D; Vlaminck, J; Ayana, M; Mekonnen, Z; Geldhof, P; Levecke, B				Dana, Daniel; Vlaminck, Johnny; Ayana, Mio; Mekonnen, Zeleke; Geldhof, Peter; Levecke, Bruno			DIAGNOSIS OF ASCARIS LUMBRICOIDES INFECTIONS IN ETHIOPIAN CHILDREN AND ADULTS BY THREE COPROLOGICAL TECHNIQUES AND TWO NOVEL SEROLOGICAL TESTS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Dana, Daniel; Ayana, Mio; Mekonnen, Zeleke] Jimma Univ, Jimma, Ethiopia; [Vlaminck, Johnny; Geldhof, Peter; Levecke, Bruno] Univ Ghent, Merelbeke, Belgium								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1823	567	567						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204539					2019-04-02	
J	Minassian, AM; Silk, SE; Poulton, ID; Mitton, CH; Jin, J; Miura, K; Diouf, A; Querol-Rubiera, A; Bisnauthsing, K; Ogrina, T; Payne, RO; Folegatti, P; Silman, D; Batra, R; Brendish, N; Taylor, IJ; Smith, R; Berrie, E; Morelle, D; Lievens, M; Noe, AR; Soisson, LA; Ashfield, R; Long, CA; Goodman, AL; Faust, SN; Nugent, FL; Lawrie, AM; Draper, SJ				Minassian, Angela M.; Silk, Sarah E.; Poulton, Ian D.; Mitton, Celia H.; Jin, Jing; Miura, Kazutoyo; Diouf, Ababacar; Querol-Rubiera, Antonio; Bisnauthsing, Karen; Ogrina, Tatiana; Payne, Ruth O.; Folegatti, Pedro; Silman, Daniel; Batra, Rahul; Brendish, Nathan; Taylor, Iona J.; Smith, Robert; Berrie, Eleanor; Morelle, Danielle; Lievens, Marc; Noe, Amy R.; Soisson, Lorraine A.; Ashfield, Rebecca; Long, Carole A.; Goodman, Anna L.; Faust, Saul N.; Nugent, Fay L.; Lawrie, Alison M.; Draper, Simon J.			SAFETY AND IMMUNOGENICITY OF THE NOVEL PLASMODIUM FALCIPARUM BLOOD-STAGE VACCINE RH5.1/AS01B IN A PHASE I/IIA CLINICAL TRIAL	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Minassian, Angela M.; Silk, Sarah E.; Poulton, Ian D.; Mitton, Celia H.; Jin, Jing; Payne, Ruth O.; Folegatti, Pedro; Silman, Daniel; Taylor, Iona J.; Ashfield, Rebecca; Nugent, Fay L.; Lawrie, Alison M.; Draper, Simon J.] Univ Oxford, Oxford, England; [Miura, Kazutoyo; Diouf, Ababacar; Long, Carole A.] NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Querol-Rubiera, Antonio; Bisnauthsing, Karen; Batra, Rahul] Guys & St Thomas Hosp NHS Trust, London, England; [Ogrina, Tatiana; Brendish, Nathan; Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, NIHR Wellcome Trust Clin Res Facil, Southampton, Hants, England; [Smith, Robert; Berrie, Eleanor] Clin Biomfg Facil, Oxford, England; [Morelle, Danielle; Lievens, Marc] GlaxoSmithKline Vaccines, Wavre, Belgium; [Noe, Amy R.] Leidos Life Sci, Frederick, MD USA; [Soisson, Lorraine A.] US Agcy Int Dev, Washington, DC 20523 USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1912	594	595						2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204628					2019-04-02	
J	Robinson, LJ; Ome-Kaius, M; Koepfli, C; Kattenberg, JH; Lautu-Ninda, D; Hofmann, NE; Rodriguez, D; Katusele, M; Keven, JB; Mantila, D; Kombut, B; Jally, S; Malau, E; Obadia, T; Walker, ED; Barry, A; Hetzel, M; Karl, S; King, CL; Felger, I; Laman, M; Kazura, J; Mueller, I				Robinson, Leanne J.; Ome-Kaius, Maria; Koepfli, Cristian; Kattenberg, Johanna H.; Lautu-Ninda, Dulcie; Hofmann, Natalie E.; Rodriguez, Daniela; Katusele, Michelle; Keven, John B.; Mantila, Daisy; Kombut, Benishar; Jally, Shadrach; Malau, Elisheba; Obadia, Thomas; Walker, Edward D.; Barry, Alyssa; Hetzel, Manuel; Karl, Stephan; King, Christopher L.; Felger, Ingrid; Laman, Moses; Kazura, James; Mueller, Ivo			UNDERSTANDING THE HIGHLY DYNAMIC NATURE OF DECLINING MALARIA TRANSMISSION IN PAPUA NEW GUINEA	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Robinson, Leanne J.] Burnet Inst, Melbourne, Vic, Australia; [Robinson, Leanne J.; Ome-Kaius, Maria] PNG Inst Med Res, Melbourne, Vic, Australia; [Robinson, Leanne J.; Ome-Kaius, Maria; Barry, Alyssa; Karl, Stephan; Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Koepfli, Cristian] Univ Calif Irvine, Irvine, CA USA; [Kattenberg, Johanna H.] Inst Trop Med, Antwerp, Belgium; [Lautu-Ninda, Dulcie; Katusele, Michelle; Mantila, Daisy; Kombut, Benishar; Jally, Shadrach; Laman, Moses] PNG Inst Med Res, Madang, Papua N Guinea; [Hofmann, Natalie E.; Rodriguez, Daniela; Hetzel, Manuel; Felger, Ingrid] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Keven, John B.; Walker, Edward D.] Michigan State Univ, Lansing, MI USA; [Malau, Elisheba] Federat Univ, Melbourne, Vic, Australia; [Obadia, Thomas] Inst Pasteur, Paris, France; [King, Christopher L.; Kazura, James] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Mueller, Ivo] Pasteur Inst, Melbourne, Vic, Australia								0	0	0	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1938	603	603						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204654					2019-04-02	
J	Mackenzie, G; Hill, P; Jeffries, D; Hossain, I; Ndiaye, M; Badji, H; Ikumapayi, U; Salaudeen, R; Jarju, S; Antonio, M; Ceesay, L; Sowe, D; Jasseh, M; Mulhollan, K; Knoll, M; Levine, O; Howie, S; Adegbola, R; Greenwood, B; Corrah, T				Mackenzie, Grant; Hill, Philip; Jeffries, David; Hossain, Ilias; Ndiaye, Malick; Badji, Henry; Ikumapayi, Usman; Salaudeen, Rasheed; Jarju, Sheikh; Antonio, Martin; Ceesay, Lamin; Sowe, Dawda; Jasseh, Momodou; Mulhollan, Kim; Knoll, Maria; Levine, Orin; Howie, Stephen; Adegbola, Richard; Greenwood, Brian; Corrah, Tumani			IMPACT OF PNEUMOCOCCAL CONJUGATE VACCINE ON INVASIVE PNEUMOCOCCAL DISEASE IN THE GAMBIA: POPULATION-BASED SURVEILLANCE OVER 9 YEARS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Mackenzie, Grant; Jeffries, David; Hossain, Ilias; Ndiaye, Malick; Badji, Henry; Ikumapayi, Usman; Salaudeen, Rasheed; Jarju, Sheikh; Antonio, Martin; Jasseh, Momodou; Corrah, Tumani] MRC Unit, Banjul, Gambia; [Hill, Philip] Univ Otago, Dunedin, New Zealand; [Ceesay, Lamin; Sowe, Dawda] Gambia Govt, Minist Hlth, Banjul, Gambia; [Mulhollan, Kim] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Knoll, Maria] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Levine, Orin] Bill & Melinda Gates Fdn, Seattle, WA USA; [Howie, Stephen] Univ Auckland, Auckland, New Zealand; [Adegbola, Richard] GlaxoSmithKline, Wavre, Belgium; [Greenwood, Brian] London Sch Hyg & Trop Med, London, England								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1953	608	608						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204669					2019-04-02	
J	Oliveira, RG; Easton, AV; Lamberton, PH; Vlaminck, J; Beaumier, CM; Kihara, JH; Njenga, SM; Mwandawiro, CS; Geldhof, P; Drakeley, C; Brooker, SJ; Anderson, RM				Oliveira, Rita G.; Easton, Alice V.; Lamberton, Poppy H.; Vlaminck, Johnny; Beaumier, Coreen M.; Kihara, Jimmy H.; Njenga, Sammy M.; Mwandawiro, Charles S.; Geldhof, Peter; Drakeley, Chris; Brooker, Simon J.; Anderson, Roy M.			ENZYME-LINKED IMMUNOSORBENT ASSAY AS AN ENDGAME DIAGNOSTIC METHOD FOR SOIL-TRANSMITTED HELMINTH INFECTIONS	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Meeting Abstract	66th Annual Meeting of the American-Society-of-Tropical-Medicine-and-Hygiene (ASTMH)	NOV 05-09, 2017	Baltimore, MD	Amer Soc Trop Med & Hyg					[Oliveira, Rita G.; Anderson, Roy M.] Imperial Coll London, London, England; [Easton, Alice V.] NIH, Washington, DC USA; [Lamberton, Poppy H.] Univ Glasgow, Glasgow, Lanark, Scotland; [Vlaminck, Johnny; Geldhof, Peter] Univ Ghent, Merelbeke, Belgium; [Beaumier, Coreen M.] Baylor Coll Med, Houston, TX 77030 USA; [Kihara, Jimmy H.; Njenga, Sammy M.; Mwandawiro, Charles S.] Kenya Med Res Ctr, Nairobi, Kenya; [Drakeley, Chris] London Sch Hyg & Trop Med, London, England; [Brooker, Simon J.] Bill & Melinda Gates Fdn, Seattle, WA USA								0	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5		S		1972	614	614						1	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5TD	WOS:000423215204688					2019-04-02	
J	Bahizire, E; Bahwere, P; Donnen, P; Tugirimana, PL; Balol'ebwami, S; Dramaix, M; Nfundiko, C; Chirimwami, R; Mubagwa, K				Bahizire, Esto; Bahwere, Paluku; Donnen, Philippe; Tugirimana, P. Lundimu; Balol'ebwami, Serge; Dramaix, Michele; Nfundiko, Chouchou; Chirimwami, Raphael; Mubagwa, Kanigula			High Prevalence of Anemia but Low Level of Iron Deficiency in Preschool Children during a Low Transmission Period of Malaria in Rural Kivu, Democratic Republic of the Congo	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							ASYMPTOMATIC MALARIA; INFECTION; PROTEIN; KENYA; POLYMORPHISM; HOMEOSTASIS; COUNTRIES; VITAMIN; INFANTS; RWANDA	Anemia is a worldwide public health concern especially in preschool children in developing countries and iron deficiency (ID) is generally assumed to cause at least 50% of the cases. However, data on this contribution are scarce. To close this gap, we determined in 2013 the contribution of ID in the etiology of anemia and measured others factors associated to noniron deficiency anemia (NIDA) in 900 preschool children randomly selected during a two-stage cluster nutritional survey in the Miti-Murhesa health zone, in eastern Democratic Republic of the Congo. In these children, we collected sociodemographic, clinical, and biological parameters and determined the nutritional status according to the World Health Organization 2006 standards. Anemia was defined as altitude-adjusted hemoglobin <110 g/L and ID was defined as serum ferritin <12 mu g/L or <30 mu g/L in the absence or presence of inflammation, respectively. Median (interquartile range) age was 29.4 (12-45) months. The prevalence of anemia was 46.6% (391/838) among whom only 16.5% (62/377) had ID. Among children without signs of inflammation, only 4.4%(11/251) met the ferritin-based (unadjusted) definition of ID. Logistic regression analysis identified ID, history of fever during the last 2 weeks andmid-upper arm circumference <125 mm as the only independent factors associated to anemia. In conclusion, anemia is a severe public health problem in the Miti-Murhesa health zone, but NIDA is mostly predominant and needs to be further studied. Control of infections and prevention of acute undernutrition (wasting) are some of appropriate interventions to reduce the burden anemia in this region.	[Bahizire, Esto] Ctr Rech Sci Nat Lwiro, 343 Av PE Lumumba, Bukavu, DEM REP CONGO; [Bahizire, Esto; Bahwere, Paluku; Donnen, Philippe; Dramaix, Michele] Univ Libre Bruxelles, Ctr Res Epidemiol Biostat & Clin Res, Route Lennik,808,CP594, B-1070 Brussels, Belgium; [Bahwere, Paluku] Valid Int, Oxford, England; [Tugirimana, P. Lundimu] Natl Univ Rwanda, Dept Biol Clin, Kigali, Rwanda; [Tugirimana, P. Lundimu] Univ Goma, Fac Med, Goma, DEM REP CONGO; [Balol'ebwami, Serge] Univ Catholique Bukavu, Dept Pediat, Bukavu, DEM REP CONGO; [Nfundiko, Chouchou] Div Prov Sante Sud Kivu, Natl Program Nutr, Bukavu, DEM REP CONGO; [Chirimwami, Raphael] Univ Catholique Bukavu, Dept Pathol, Bukavu, DEM REP CONGO; [Mubagwa, Kanigula] Katholieke Univ Leuven, Dept Cardiovasc Dis, Leuven, Belgium	Bahizire, E (reprint author), Ctr Rech Sci Nat Lwiro, 343 Av PE Lumumba, Bukavu, DEM REP CONGO.; Bahizire, E (reprint author), Univ Libre Bruxelles, Ctr Res Epidemiol Biostat & Clin Res, Route Lennik,808,CP594, B-1070 Brussels, Belgium.	esto.bahizire@gmail.com; paluku@validinternational.org; pdonnen@ulb.ac.be; pierrotlundimu@gmail.com; sergebalole@gmail.com; michele.dramaix@ulb.ac.be; cnfundiko@yahoo.fr; chirimwamibr@hotmail.com; kanigula.mubagwa@med.kuleuven.ac.be			VLIR-UOS Project [ZRDC2010MP068]; David and Alice Van Buuren foundation	This study was partially supported by the grant from the VLIR-UOS Project ZRDC2010MP068 and the David and Alice Van Buuren foundation.	Action Against Hunger, 2012, ENQ NUTR ANTHR ZON S; Alvarez-Uria G, 2014, ANEMIA, DOI 10.1155/2014/176182; Annan AR, 2014, MANAGEMENT MODERATE; Asobayire FS, 2001, AM J CLIN NUTR, V74, P776; Bahizire E., 2016, Medecine d'Afrique Noire, V63, P437; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Burte F, 2013, BLOOD, V121, P3016, DOI 10.1182/blood-2012-10-461418; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Cikomola JC, 2016, ACTA TROP, V163, P14, DOI 10.1016/j.actatropica.2016.07.011; Cogill B., 2003, ANTHROPOMETRIC INDIC; Cojulun AC, 2015, AM J TROP MED HYG, V93, P1099, DOI 10.4269/ajtmh.15-0353; Danquah I, 2014, TROP MED INT HEALTH, V19, P117, DOI 10.1111/tmi.12216; de Gier B, 2016, AM J TROP MED HYG, V95, P77, DOI 10.4269/ajtmh.15-0533; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Diouf S, 2015, ROLE IRON DEFICIENCY, V22, P1188; Donnen P, 1997, TROP MED INT HEALTH, V2, P38, DOI 10.1046/j.1365-3156.1997.d01-121.x; Elbadry MA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1051-2; Erhardt JG, 2004, J NUTR, V134, P3127; Ezzati M, 2004, COMP QUANTIFICATION, V1; FONDU P, 1978, AM J CLIN NUTR, V31, P46; Foote EM, 2013, AM J TROP MED HYG, V88, P757, DOI 10.4269/ajtmh.12-0560; Frosch AEP, 2014, AM J CLIN NUTR, V100, P968, DOI 10.3945/ajcn.114.087114; Gahutu JB, 2012, T ROY SOC TROP MED H, V106, P63, DOI 10.1016/j.trstmh.2011.09.002; Gahutu JB, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-134; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gorstein J, 2007, INDICATORS METHODS C; Harvey-Leeson S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020098; International MoPaM, 2008, DEM REP CONG DEM HLT; Kasvosve I, 2013, CLIN CHIM ACTA, V416, P20, DOI 10.1016/j.cca.2012.11.013; Kateera F, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0973-z; Levitt DG, 2016, INT J GEN MED, V9, P229, DOI 10.2147/IJGM.S102819; Lozoff B, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e51; McCuskee S, 2014, ANN GLOB HEALTH, V80, P458, DOI 10.1016/j.aogh.2015.01.003; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Ministry of Planning and Monitoring of the Implementation of the Revolution of Modernity (MPMIRM) Ministry of Public Health (MPH) and ICF International, 2014, DEM HLTH SURV DEM RE; Mitangala PN, 2013, REV EPIDEMIOL SANTE, V61, P111, DOI 10.1016/j.respe.2012.06.404; Ndeba PM, 2012, J CLIN EXP PATHOL S, VS3, P5, DOI DOI 10.4172/2161-0681.S3-005; Osawa M, 2002, BLOOD, V100, P2769, DOI 10.1182/blood-2002-01-0182; Parr JB, 2017, J INFECT DIS, V216, P36, DOI 10.1093/infdis/jiw538; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Prentice AM, 2012, ADV NUTR, V3, P583, DOI 10.3945/an.111.001230; Sanou D, 2012, ANEMIA; Shaw JG, 2011, ANEMIA, DOI 10.1155/2011/260380; Sherriff A, 2001, ARCH DIS CHILD, V84, P480, DOI 10.1136/adc.84.6.480; SMART, 2012, SAMPL METH SAMPL SIZ; Stoltzfus RJ, 1997, AM J CLIN NUTR, V65, P153; Taylor-Robinson DC, 2015, COCHRANE DB SYST REV, V3; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Tshilolo L, 2009, J CLIN PATHOL, V62, P35, DOI 10.1136/jcp.2008.058958; Veenemans J, 2008, J INFECT DIS, V198, P401, DOI 10.1086/589884; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; WHO, 2011, WHONMHNHDMNM111; WHO, 2013, GUID UPD MAN SEV AC; WHO/CDC, 2004, TECHN CONS ASS IR ST; WIERINGA FT, 2016, NUTRIENTS, V8; World Health Organization, 2005, WORLD HLTH REP 2005	56	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	2					489	496		10.4269/ajtmh.17-0030				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5MI	WOS:000423197200029		Bronze			2019-04-02	
J	Lingscheid, T; Kurth, F; Clerinx, J; Marocco, S; Trevino, B; Schunk, M; Munoz, J; Gjorup, IE; Jelinek, T; Develoux, M; Fry, G; Janisch, T; Schmid, ML; Bouchaud, O; Puente, S; Zammarchi, L; Morch, K; Bjorkman, A; Siikamaki, H; Neumayr, A; Nielsen, H; Hellgren, U; Paul, M; Calleri, G; Kosina, P; Myrvang, B; Ramos, JM; Just-Nubling, G; Beltrame, A; da Cunha, JS; Kern, P; Rochat, L; Stich, A; Pongratz, P; Grobusch, MP; Suttorp, N; Witzenrath, M; Hatz, C; Zoller, T				Lingscheid, Tilman; Kurth, Florian; Clerinx, Jan; Marocco, Stefania; Trevino, Begona; Schunk, Mirjam; Munoz, Jose; Gjorup, Ida E.; Jelinek, Tomas; Develoux, Michel; Fry, Graham; Jaenisch, Thomas; Schmid, Matthias L.; Bouchaud, Olivier; Puente, Sabino; Zammarchi, Lorenzo; Morch, Kristine; Bjorkman, Anders; Siikamaki, Heli; Neumayr, Andreas; Nielsen, Henrik; Hellgren, Urban; Paul, Malgorzata; Calleri, Guido; Kosina, Pavel; Myrvang, Bjorn; Ramos, Jose M.; Just-Nuebling, Gudrun; Beltrame, Anna; da Cunha, Jose Saraiva; Kern, Peter; Rochat, Laurence; Stich, August; Pongratz, Peter; Grobusch, Martin P.; Suttorp, Norbert; Witzenrath, Martin; Hatz, Christoph; Zoller, Thomas		TropNet Schistosomiasis	Schistosomiasis in European Travelers and Migrants: Analysis of 14 Years TropNet Surveillance Data	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							IMPORTED SCHISTOSOMIASIS; AFRICA; DIAGNOSIS; DISEASES; ILLNESS; NETWORK; COUNTRY; MALI	Schistosomiasis remains one of the most prevalent parasitic diseases worldwide and the infection is frequently found in travelers and migrants. The European Network for Tropical Medicine and Travel Health conducted a sentinel surveillance study on imported schistosomiasis between 1997 and 2010. This report summarizes epidemiological and clinical data from 1,465 cases of imported schistosomiasis. Direct pathogen detection and serology were the main diagnostic tools applied. Of these, 486 (33%) cases were identified among European travelers, 231 (16%) among long-term expatriates, and 748 (51%) among non-European immigrants. Overall, only 18.6% of travelers had received pretravel advice; 95% of infections were acquired in the African region. On species level, Schistosoma mansoni was identified in 570 (39%) and Schistosoma haematobium in 318 (22%) cases; 57.5% of patients were symptomatic. Acute symptoms were reported in 27% of patients leading to earlier presentation within 3 months. Praziquantel was used in all patients to treat schistosomiasis. Many infections were detected in asymptomatic patients. In 47.4% of asymptomatic patients infection was detected by microscopy and in 39% by serology or antigen testing. Schistosomiasis remains a frequent infection in travelers and migrants to Europe. Travelers should be made aware of the risk of schistosomiasis infection when traveling to sub-Saharan Africa. Posttravel consultations particularly for returning expatriates are useful given the high potential for detecting asymptomatic infections.	[Lingscheid, Tilman; Kurth, Florian; Suttorp, Norbert; Witzenrath, Martin; Zoller, Thomas] Charite Univ Med Berlin, Med Klin Schwerpunkt Infektiol & Pneumol, Berlin, Germany; [Clerinx, Jan] Inst Trop Med, Antwerp, Belgium; [Marocco, Stefania; Beltrame, Anna] Osped S Cuore, Ctr Malattie Trop, Verona, Italy; [Trevino, Begona] PROSICS Barcelona, Hosp Vall dHebron Drassanes, Trop Med & Int Hlth Unit, Barcelona, Spain; [Schunk, Mirjam] LMU, Med Ctr, Div Infect Dis & Trop Med, Munich, Germany; [Munoz, Jose] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Gjorup, Ida E.] Herlev Univ Hosp, Infect Dis Unit, Copenhagen, Denmark; [Jelinek, Tomas] Berlin Ctr Travel & Trop Med, Berlin, Germany; [Develoux, Michel] Hop St Antoine, Serv Parasitol, Paris, France; [Fry, Graham] Trop Med Bur, Dublin, Ireland; [Jaenisch, Thomas] Univ Hosp Heideberg, Dept Infect Dis, Heidelberg, Germany; [Schmid, Matthias L.] Royal Victoria Infirm, Dept Infect & Trop Med, Newcastle Upon Tyne, Tyne & Wear, England; [Bouchaud, Olivier] Hop Avicenne, Consultat Med Trop, Bobigny, France; [Puente, Sabino] Hosp Carlos III, Madrid, Spain; [Zammarchi, Lorenzo] Univ Florence, Dept Expt & Clin Med, Infect Dis Unit, Florence, Italy; [Morch, Kristine] Haukeland Hosp, Natl Ctr Trop Infect Dis, Dept Med, Bergen, Norway; [Bjorkman, Anders] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Siikamaki, Heli] Univ Helsinki, Clin Infect Dis, Inflammat Ctr, Helsinki, Finland; [Siikamaki, Heli] Helsinki Univ Hosp, Helsinki, Finland; [Neumayr, Andreas; Hatz, Christoph; Zoller, Thomas] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Neumayr, Andreas; Hatz, Christoph; Zoller, Thomas] Univ Basel, Basel, Switzerland; [Nielsen, Henrik] Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark; [Hellgren, Urban] Karolinska Inst, Dept Med Huddinge, Unit Infect Dis, Stockholm, Sweden; [Paul, Malgorzata] Poznan Univ Med Sci, Dept & Clin Trop & Parasit Dis, Poznan, Poland; [Calleri, Guido] Amedeo Savoia Hosp ASLTO2, Dept Infect Dis, Travel Med Unit, Turin, Italy; [Kosina, Pavel] Univ Hosp, Dept Infect Dis, Hradec Kralove, Czech Republic; [Myrvang, Bjorn] Oslo Univ Hosp, Ulleval, Norway; [Ramos, Jose M.] Hosp Gen Univ Elche, Infect Dis Unit, Alicante, Spain; [Just-Nuebling, Gudrun] Univ Hosp Frankfurt, Sect Infect Dis & Trop Med, Dept Internal Med 2, Mainz, Germany; [Beltrame, Anna] Univ Udine, Clin Infect Dis, Udine, Italy; [da Cunha, Jose Saraiva] Ctr Hosp & Univ Coimbra, Coimbra, Portugal; [Kern, Peter] Ulm Univ Hosp, Comprehens Infect Dis Ctr, Dept Internal Med 3, Ulm, Germany; [Rochat, Laurence] Univ Hosp, Travel Clin, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Stich, August] Missionsarztliche Klin, Abt Tropenmed, Wurzburg, Germany; [Pongratz, Peter] Rostock Univ, Med Ctr, Div Trop Med & Infect Dis, Rostock, Germany; [Grobusch, Martin P.] Univ Amsterdam, Acad Med Ctr, Ctr Trop Med & Travel Med, Amsterdam, Netherlands; [Hatz, Christoph] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland	Lingscheid, T (reprint author), Charite Univ Med Berlin, Dept Infect & Resp Med, Charitepl 1, D-10117 Berlin, Germany.	tilman.lingscheid@charite.de; florian.kurth@charite.de; jclerinx@itg.be; stefania.marocco@sacrocuore.it; btrevino.bcn.ics@gencat.cat; schunk@lrz.uni-muenchen.de; jose.munoz@isglobal.org; ida.elisabeth.gjoerup.skinhoej@regionh.dk; jelinek@bcrt.de; micheldeveloux@yahoo.fr; graham.fry@tmb.ie; thomas.jaenisch@urz.uni-heidelberg.de; matthias.schmid@nuth.nhs.uk; olivier.bouchaud@avc.aphp.fr; sabinopuente@gmail.com; lorezammarchi@gmail.com; kristine.morch@helse-bergen.no; anders.bjorkman@ki.se; heli.siikamaki@hus.fi; andreas.neumayr@unibas.ch; henrik.nielsen@rn.dk; urban.hellgren@karolinska.se; mpaul@ump.edu.pl; guido.calleri@aslto2.piemonte.it; kosinap@lfhk.cuni.cz; Uxbjmy@ous-hf.no; jramosrincon@yahoo.es; just-nuebling@em.uni-frankfurt.de; beltrame.anna@aoud.sanita.fvg.it; saraiva@huc.min-saude.pt; peter.kern@uni-ulm.de; laurence.rochat@hospvd.ch; august.stich@mail.uni-wuerzburg.de; ppongratz1@me.com; m.p.grobusch@amc.uva.nl; norbert.suttorp@charite.de; martin.witzenrath@charite.de; christoph.hatz@unibas.ch; thomas.zoller@charite.de	Ramos, Jose Manuel/B-6420-2018; Munoz Gutierrez, Jose/X-5917-2018	Ramos, Jose Manuel/0000-0002-6501-9867; Munoz Gutierrez, Jose/0000-0002-0945-1735; ZAMMARCHI, Lorenzo/0000-0003-0892-8404; Kosina, Pavel/0000-0001-6819-3193			Berry A, 2014, EMERG INFECT DIS, V20, P1595, DOI 10.3201/eid2009.140928; Bierman WFW, 2005, J TRAVEL MED, V12, P9; Cetron MS, 1996, LANCET, V348, P1274, DOI 10.1016/S0140-6736(96)01511-5; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Clerinx J, 2011, TRAVEL MED INFECT DI, V9, P6, DOI 10.1016/j.tmaid.2010.11.002; Cnops L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002413; Cnops L, 2012, TROP MED INT HEALTH, V17, P1208, DOI 10.1111/j.1365-3156.2012.03060.x; Colebunders R, 1995, J TRAVEL MED, V2, P235, DOI DOI 10.1111/j.1708-8305.1995.tb00667.x; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Coltart CEM, 2015, T ROY SOC TROP MED H, V109, P214, DOI 10.1093/trstmh/tru195; CORACHAN M, 1992, AM J TROP MED HYG, V47, P6, DOI 10.4269/ajtmh.1992.47.6; Gautret P, 2012, EUROSURVEILLANCE, V17, P16; Grobusch MP, 2003, J TRAVEL MED, V10, P164; Holtfreter MC, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.22.20821; Jelinek TEuropean Network on Imported Infectious Disease Surveillance, 2008, EURO SURVEILL, V13; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Meltzer E, 2006, EMERG INFECT DIS, V12, P1696, DOI 10.3201/eid1211.060340; Mendelson M, 2014, EMERG INFECT DIS, V20, P532, DOI 10.3201/eid2004.131128; Meurs L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003959; Nicolls DJ, 2008, AM J TROP MED HYG, V79, P729, DOI 10.4269/ajtmh.2008.79.729; Rapoport AB, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv003; Rochat L, 2015, J TRAVEL MED, V22, P168, DOI 10.1111/jtm.12187; Ross AG, 2007, LANCET INFECT DIS, V7, P218, DOI 10.1016/S1473-3099(07)70053-1; Utzinger J, 2015, CLIN MICROBIOL INFEC, V21, P529, DOI [10.1016/j.cmi.2015.03.014, 10.1016/j.cmi.2015.02.016]; VISSER LG, 1995, CLIN INFECT DIS, V20, P280, DOI 10.1093/clinids/20.2.280; Whitty CJM, 2000, T ROY SOC TROP MED H, V94, P531, DOI 10.1016/S0035-9203(00)90077-4; World Health Organization, 2015, 5 WHO, V90, P25; Zhang YB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1048-2	28	11	11	1	5	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	2					567	574		10.4269/ajtmh.17-0034				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5MI	WOS:000423197200039	28722637	Bronze			2019-04-02	
J	Asua, V; Tukwasibwe, S; Conrad, M; Walakira, A; Nankabirwa, JI; Mugenyi, L; Kamya, MR; Nsobya, SL; Rosenthal, PJ				Asua, Victor; Tukwasibwe, Stephen; Conrad, Melissa; Walakira, Andrew; Nankabirwa, Joaniter I.; Mugenyi, Levicatus; Kamya, Moses R.; Nsobya, Samuel L.; Rosenthal, Philip J.			Plasmodium Species Infecting Children Presenting with Malaria in Uganda	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							POLYMERASE CHAIN-REACTION; TRANSMISSION; FALCIPARUM; AREA; EPIDEMIOLOGY; POPULATION; PREVALENCE; CHALLENGES	Contributions of species other than Plasmodium falciparum to human malaria in sub-Saharan Africa are uncertain. We collected blood from children aged 6 months to 10 years diagnosed with malaria by Giemsa-stained blood smears (176 subjects) or histidine rich protein-2-based rapid diagnostic tests (323 subjects) in 2016; 50 samples from each of 10 sites across Uganda were studied to identify infecting species. Of 499 available samples, 474 demonstrated plasmodial infection by polymerase chain reaction amplification of 18S ribosomal RNA genes, including P. falciparum in 472, Plasmodium malariae in 22, Plasmodium ovale in 15, and Plasmodium vivax in four; 435 were pure P. falciparum, two did not contain P. falciparum, and the remainder were mixed infections including P. falciparum. The prevalence of nonfalciparum species varied geographically. Stratifying based on recent history of indoor residual spraying (IRS) of insecticides, nonfalciparum infections were seen in 27/189 (14.8%) samples from sites that received and 13/285 (4.6%) samples from sites that did not receive IRS since 2010 (P = 0.0013). Overall, 39/474 (8.2%) samples from individuals diagnosed with malaria included nonfalciparum infections. Thus, a substantial proportion of episodes of malaria in Uganda include infections with plasmodial species other than P. falciparum.	[Asua, Victor; Tukwasibwe, Stephen; Walakira, Andrew; Nankabirwa, Joaniter I.; Mugenyi, Levicatus; Kamya, Moses R.; Nsobya, Samuel L.] Infect Dis Res Collaborat, Kampala, Uganda; [Conrad, Melissa; Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, Box 0811, San Francisco, CA 94946 USA; [Nankabirwa, Joaniter I.; Kamya, Moses R.] Makerere Univ, Dept Med, Kampala, Uganda; [Nsobya, Samuel L.] Makerere Univ, Deparment Pathol, Kampala, Uganda; [Asua, Victor; Tukwasibwe, Stephen; Walakira, Andrew] Infect Dis Res Collab orat, Lab Unit, Kampala, Uganda; [Nankabirwa, Joaniter I.; Kamya, Moses R.] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Mugenyi, Levicatus] Univ Hasselt, Biostat 1, Diepenbeek, Belgium	Rosenthal, PJ (reprint author), Univ Calif San Francisco, Dept Med, Box 0811, San Francisco, CA 94946 USA.	victorasua@yahoo.co.uk; stephentukwasibwe@yahoo.com; melissa.conrad@ucsf.edu; w.andrew01@yahoo.com; jnankabirwa@yahoo.co.uk; lmugenyi005@gmail.com; mkamya@idrc-uganda.org; samnsobya@yahoo.co.uk; philip.rosenthal@ucsf.edu		Walakira, Andrew/0000-0002-3651-2679	National Institutes of Health [AI089674, AI075045, TW007375, TW010132]	We thank the staffs of the 10 study health centers and Michelle Roh for assistance with preparation of the figure. This study (AI089674 and AI075045) and trainees (TW007375 and TW010132) were supported by funding from the National Institutes of Health.	Amanfo SA, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1325-3; Barnish G, 1993, Parassitologia, V35 Suppl, P1; Betson M, 2014, PARASITOLOGY, V141, P1880, DOI 10.1017/S003118201400033X; Bonnet S, 2002, TROP MED INT HEALTH, V7, P249, DOI 10.1046/j.1365-3156.2002.00861.x; BOUDIN C, 1991, B WORLD HEALTH ORGAN, V69, P199; Browne ENL, 2000, ANN TROP MED PARASIT, V94, P15, DOI 10.1080/00034980057572; Calleri G, 2013, J ANTIMICROB CHEMOTH, V68, P1447, DOI 10.1093/jac/dkt005; Clark TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011759; Doderer-Lang C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-240; Howes RE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004222; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; Katureebe A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002167; Lo E, 2017, EMERG INFECT DIS, V23, P601, DOI 10.3201/eid2304.161245; Mouatcho JC, 2013, J MED MICROBIOL, V62, P1491, DOI 10.1099/jmm.0.052506-0; Mueller I, 2007, TRENDS PARASITOL, V23, P278, DOI 10.1016/j.pt.2007.04.009; Nsobya SL, 2004, J INFECT DIS, V189, P2220, DOI 10.1086/421281; PLOWE CV, 1995, AM J TROP MED HYG, V52, P565, DOI 10.4269/ajtmh.1995.52.565; Poirier P, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1620-z; Raouf S, 2017, CLIN INFECT DIS, V65, P453, DOI 10.1093/cid/cix251; Rogier E, 2017, AM J TROP MED HYG, V96, P312, DOI 10.4269/ajtmh.16-0476; Roh ME, 2016, EMERG INFECT DIS, V22, P1494, DOI 10.3201/eid2208.160619; Sitali L, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0935-7; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; White NJ, 2014, LANCET, V383, P723, DOI 10.1016/S0140-6736(13)60024-0; World Health Organisation, 2015, GUID TREATM MAL; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004	27	4	4	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	3					753	757		10.4269/ajtmh.17-0345				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5OM	WOS:000423202900025	28990911	Bronze			2019-04-02	
J	Mukendi, D; Kalo, JRL; Mpanya, A; Minikulu, L; Kayembe, T; Lutumba, P; Barbe, B; Gillet, P; Jacobs, J; Van Loen, H; Yansouni, CP; Chappuis, F; Ravinetto, R; Verdonck, K; Boelaert, M; Winkler, AS; Bottieau, E				Mukendi, Deby; Kalo, Jean-Roger Lilo; Mpanya, Alain; Minikulu, Luigi; Kayembe, Tharcisse; Lutumba, Pascal; Barbe, Barbara; Gillet, Philippe; Jacobs, Jan; Van Loen, Harry; Yansouni, Cedric P.; Chappuis, Francois; Ravinetto, Raffaella; Verdonck, Kristien; Boelaert, Marleen; Winkler, Andrea S.; Bottieau, Emmanuel			Clinical Spectrum, Etiology, and Outcome of Neurological Disorders in the Rural Hospital of Mosango, the Democratic Republic of Congo	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; DISEASE; BURDEN; ENCEPHALITIS; INFECTIONS; PREVALENCE; REGIONS; PATTERN	There is little published information on the epidemiology of neurological disorders in rural Central Africa, burden is considered to be substantial. This study aimed to investigate the pattern, etiology, and outcome of neurological disorders in children > 5 years and adults admitted to the rural hospital of Mosango, province of Kwilu, Democratic Republic of Congo, with a focus on severe and treatable infections of the central nervous system (CNS). From September 2012 to January 2015, 351 consecutive patients hospitalized for recent and/or ongoing neurological disorder were prospectively evaluated by a neurologist, subjected to a set of reference diagnostic tests in blood or cerebrospinal fluid, and followed-up for 3-6 months after discharge. No neuroimaging was available. Severe headache (199, 56.7%), gait/walking disorders (97, 27.6%), epileptic seizure (87, 24.8%), and focal neurological deficit (86, 24.5%) were the predominant presentations, often in combination. Infections of the CNS were documented in 63 (17.9%) patients and mainly included bacterial meningitis and unspecified meningoencephalitis (33, 9.4%), second-stage human African trypanosomiasis (10, 2.8%), and human immunodeficiency virus (HIV)-related neurological disorders (10, 2.8%). Other focal/systemic infections with neurological manifestations were diagnosed in an additional 60 (17.1%) cases. The leading noncommunicable conditions were epilepsy (61, 17.3%), psychiatric disorders (56, 16.0%), and cerebrovascular accident (23, 6.6%). Overall fatality rate was 8.2% (29/351), but up to 23.8% for CNS infections. Sequelae were observed in 76 (21.6%) patients. Clinical presentations and etiologies of neurological disorders were very diverse in this rural Central African setting and caused considerable mortality and morbidity.	[Mukendi, Deby; Kalo, Jean-Roger Lilo; Mpanya, Alain; Minikulu, Luigi; Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Mukendi, Deby; Kayembe, Tharcisse; Lutumba, Pascal] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Barbe, Barbara; Gillet, Philippe; Jacobs, Jan; Van Loen, Harry; Bottieau, Emmanuel] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Yansouni, Cedric P.] McGill Univ, Hlth Ctr, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada; [Chappuis, Francois] Geneva Univ Hosp, Div Trop & Humanitarian Med, Geneva, Switzerland; [Chappuis, Francois] Univ Geneva, Geneva, Switzerland; [Ravinetto, Raffaella; Verdonck, Kristien; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Winkler, Andrea S.] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkler, Andrea S.] Univ Oslo, Ctr Global Hlth, Oslo, Norway	Bottieau, E (reprint author), Inst Trop Med, 155 Natl Str, B-2000 Antwerp, Belgium.	debymukendi@yahoo.fr; lilo.kalo@yahoo.fr; mpanya_alain@yahoo.fr; luigiminikulu@yahoo.fr; tharkayembe@gmail.com; pascal_lutumba@yahoo.fr; bbarbe@itg.be; philippegillet@proximus.be; jjacobs@itg.be; hvanloen@itg.be; cedric.yansouni@mail.mcgill.ca; Francois.Chappuis@hcuge.ch; rravinetto@itg.be; kverdonck@itg.be; mboelaert@itg.be; andrea.winkler@tum.de; ebottieau@itg.be		gillet, philippe/0000-0001-5878-6446; Boelaert, Marleen/0000-0001-8051-6776	European Union's Seventh Framework Programme for research, technological development, and demonstration [260260]; Fonds de recherche du Quebec - Sante (FRQS)	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. CPY holds a "Chercheur-boursier clinicien" career award from the Fonds de recherche du Quebec - Sante (FRQS).	Bennett DA, 2015, EUR J EPIDEMIOL, V30, P569, DOI 10.1007/s10654-015-0034-5; Birbeck GL, 2001, TROP DOCT, V31, P82, DOI 10.1177/004947550103100209; Boelaert M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004853; Bower JH, 2007, NEUROLOGY, V68, P338, DOI 10.1212/01.wnl.0000252801.61190.e8; Cohen DB, 2010, TROP MED INT HEALTH, V15, P910, DOI 10.1111/j.1365-3156.2010.02565.x; Drake RE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7086; Ekenze O S, 2010, Niger J Med, V19, P419; Franco JR, 2014, CLIN EPIDEMIOL, V6, P257, DOI 10.2147/CLEP.S39728; Glaser CA, 2003, CLIN INFECT DIS, V36, P731, DOI 10.1086/367841; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Hasker E, 2011, TROP MED INT HEALTH, V16, P869, DOI 10.1111/j.1365-3156.2011.02772.x; Howlett W, 2012, NEUROLOGY, V83, P654; Kinoshita-Moleka R, 2008, EPIDEMIOL INFECT, V136, P1290, DOI [10.1017/S0950268807009818, 10.1017/S095026S807009818]; KWASA TOO, 1992, E AFR MED J, V69, P236; Mpanya A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110167; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Mwape KE, 2015, PLOS NEGLECT TROP D, V9; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ojini F, 2003, NIGER J CLIN PRACT, V5, P38; OSUNTOKUN BO, 1971, J NEUROL SCI, V12, P417, DOI 10.1016/0022-510X(71)90110-9; Philip-Ephraim EE, 2013, CAN J NEUROL SCI, V40, P576, DOI 10.1017/S0317167100014694; Praet N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000817; Ravinetto R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004654; Robertson K, 2010, J NEUROVIROL, V16, P189, DOI 10.3109/13550284.2010.489597; Siddiqi OK, 2010, J NEUROL SCI, V290, P1, DOI 10.1016/j.jns.2009.12.022; Winkler AS, 2011, J NEUROL SCI, V300, P47, DOI 10.1016/j.jns.2010.10.004; Winkler AS, 2009, TROP DOCT, V39, P102, DOI 10.1258/td.2008.080144; World Health Organization, 2004, ATL COUNTR RES NEUR; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5	30	4	4	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5					1454	1460		10.4269/ajtmh.17-0375				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5VW	WOS:000423222300028	28820708	Green Published, Other Gold			2019-04-02	
J	Bahizire, E; Tugirimana, PL; Dramaix, M; Zozo, D; Bahati, M; Mwale, A; Meuris, S; Donnen, P				Bahizire, Esto; Tugirimana, P. Lundimu; Dramaix, Michele; Zozo, Deogratias; Bahati, Mugisho; Mwale, Andrew; Meuris, Sylvain; Donnen, Philippe			Malaria Is More Prevalent Than Iron Deficiency among Anemic Pregnant Women at the First Antenatal Visit in Rural South Kivu	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; RISK-FACTORS; MICRONUTRIENT STATUS; MATERNAL ANEMIA; CHILDBEARING AGE; PLASMA FERRITIN; INFLAMMATION; CHILDREN; INFECTION; PROTEIN	Anemia is common during pregnancy and is associated with poor outcomes. Objectives were not only 1) to determine the prevalence of anemia and iron deficiency (ID) but also 2) to identify other factors associated with anemia in pregnant women from South Kivu province, in the eastern Democratic Republic of Congo. Between December 2013 and March 2014, 531 women attending the first antenatal visit in their second trimester of pregnancy were recruited. Sociode-mographic, clinical, and biological data were collected. Hemoglobin (Hb) was determined by a portable photometer (Hemocue (R) Hb201+), and anemiawas defined as altitude-adjusted Hb < 110 g/L. ID was defined as serumferritin < 15 mu g/L adjusted for inflammation status (C-reactive protein [CRP] > 5 mg/L and/or alpha-1-acid glycoprotein > 1 g/L) whereas hypoalbuminemia was defined as serum albumin < 35 g/L. A Giemsa-stained blood smear was used to diagnose malaria. The median age (interquartile range) was 25.5 (21.1-31.3) years, with anemia in17.6% and ID in 8%. Malaria was present in 7.5% and hypoalbuminemia among 44%. Soluble transferrin receptor concentration was higher in the presence of inflammation and/or malaria. In the final logistic regression model, factors independently associated with anemia were malaria (adjusted odds ratio[aOR]: 11.24 (4.98-25.37) P<0.001), hypoalbuminemia [aOR: 2.14(1.27-3.59); P= 0.004] andelevatedCRP[aOR: 1.94(1.10-3.45); P= 0.022]. IDwas not highlyprevalent andnot associated with a nemia in our population. Effective control of anemia during pregnancy in this region should consider fighting malaria and other infectious diseases in combination with measures to improve women's nutrition, both before and during pregnancy.	[Bahizire, Esto; Zozo, Deogratias] Ctr Rech Sci Naturelles Lwiro, 343 Av PE, Bukavu, DEM REP CONGO; [Bahizire, Esto; Dramaix, Michele] Univ Libre Bruxelles, Ctr Res Epidemiol Biostat & Clin Res, Brussels, Belgium; [Bahizire, Esto; Mwale, Andrew] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Tugirimana, P. Lundimu] Natl Univ Rwanda, Dept Clin Biol, Kigali, Rwanda; [Tugirimana, P. Lundimu] Univ Goma, Fac Med, Goma, DEM REP CONGO; [Bahati, Mugisho] Div Provinciale Sante Sud Kivu, Bukavu, DEM REP CONGO; [Meuris, Sylvain] Univ Libre Bruxelles, Lab Expt Hormonol, Brussels, Belgium; [Donnen, Philippe] Univ Libre Bruxelles, Ctr Res Hlth Policy & Syst Int Hlth, Brussels, Belgium	Bahizire, E (reprint author), Ctr Rech Sci Naturelles Lwiro, 343 Av PE, Bukavu, DEM REP CONGO.	esto.bahizire@gmail.com; pltugirimana@gmail.com; miwilmet@ulb.ac.be; dezozo@hotmail.com; livmugisho@yahoo.fr; kuchimwale@gmail.com; meuris.sylvain@ulb.ac.be; pdonnen@ulb.ac.be			Belgian "Commission Universitaire pour le Developpement" (CUD)	We thank the pregnant women who agreed to participate in this study. We also appreciate the commitment of the team that was involved in the study activities especially nurses and midwives of the Miti-Murhesa general referral hospital. We thank Balume Mulanga, Alfonsine Mashukano, Alves Namunesha, Ghislain Materanya, Jean-Marie Mpongo, and Nicolai Petry for their contribution in the collection, processing, storage, and shipment of blood samples. We are also thankful to Juergen Erhardt for blood analysis. This study was supported by a grant from the Belgian "Commission Universitaire pour le Developpement" (CUD).	Ayoya MA, 2012, PUBLIC HEALTH NUTR, V15, P916, DOI 10.1017/S1368980011002424; Bahizire E., 2016, Medecine d'Afrique Noire, V63, P437; Baingana RK, 2015, PUBLIC HEALTH NUTR, V18, P1423, DOI 10.1017/S1368980014001888; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Beguin Y, 2003, CLIN CHIM ACTA, V329, P9, DOI 10.1016/S0009-8981(03)00005-6; Cikomola JC, 2016, ACTA TROP, V163, P14, DOI 10.1016/j.actatropica.2016.07.011; Cogill B., 2003, ANTHROPOMETRIC INDIC; Cohee LM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-274; David NG, 2015, SCI SIGNAL, V8, pfs9; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Engle-Stone R, 2013, J NUTR, V143, P369, DOI 10.3945/jn.112.167775; Erhardt JG, 2004, J NUTR, V134, P3127; Ezzati M., 2004, COMP QUANTIFICATION; Ferro-Luzzi A, 2007, BR J NUTR, V75, P3; Frosch AEP, 2014, AM J CLIN NUTR, V100, P968, DOI 10.3945/ajcn.114.087114; Gahutu JB, 2012, T ROY SOC TROP MED H, V106, P63, DOI 10.1016/j.trstmh.2011.09.002; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Geller SE, 2006, INT J GYNECOL OBSTET, V92, P202, DOI 10.1016/j.ijgo.2005.12.009; Guimaraes JS, 2015, EUR J HAEMATOL, V94, P511, DOI 10.1111/ejh.12464; Haas JD, 2001, J NUTR, V131, p676S, DOI 10.1093/jn/131.2.676S; HAIDER M, 1984, CLIN CHEM, V30, P1286; Harvey-Leeson S, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020098; International MoPaM, 2008, DEM REP CONG DEM HLT; Karakochuk CD, 2015, J WATER HEALTH, V13, P575, DOI 10.2166/wh.2014.297; Kasvosve I, 2013, CLIN CHIM ACTA, V416, P20, DOI 10.1016/j.cca.2012.11.013; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Kuvibidila S, 1996, AM J CLIN NUTR, V63, P596; KUVIBIDILA S, 1994, AM J CLIN NUTR, V60, P603; MacLeod J, 1998, TROP MED INT HEALTH, V3, P130, DOI 10.1046/j.1365-3156.1998.00174.x; Mayor A, 2012, CLIN INFECT DIS, V54, P1561, DOI 10.1093/cid/cis236; Mayor A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-9; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Menendez C, 2001, AM J TROP MED HYG, V65, P138, DOI 10.4269/ajtmh.2001.65.138; Ministry of Planning and Monitoring of the Implementation of the Revolution of Modernity (MPMIRM) MoPHMaII, 2014, DEM HLTH SURV DEM RE; Nsibu CN, 2016, OBSTET GYNECOL INT, DOI 10.1155/2016/5423413; Ononge Sam, 2014, BMC Res Notes, V7, P712, DOI 10.1186/1756-0500-7-712; Osawa M, 2002, BLOOD, V100, P2769, DOI 10.1182/blood-2002-01-0182; Ouedraogo S, 2012, AM J TROP MED HYG, V87, P418, DOI 10.4269/ajtmh.2012.11-0706; Prasad AS, 2009, CURR OPIN CLIN NUTR, V12, P646, DOI 10.1097/MCO.0b013e3283312956; Price EA, 2010, ADV HEMATOL, V2010; Rahman S, 2016, PUBLIC HEALTH NUTR, V19, P1862, DOI 10.1017/S1368980015003651; Righetti AA, 2013, J INFECT DIS, V207, P1604, DOI 10.1093/infdis/jit066; Shaw JG, 2011, ANEMIA, DOI 10.1155/2011/260380; Shindano TA, 2017, AM J TROP MED HYG, V96, P400, DOI [10.4269/ajtmh.16-0287, 10.4269/ajtmh.17-0030]; Speeckaert MM, 2010, CRIT REV CL LAB SCI, V47, P213, DOI 10.3109/10408363.2010.550461; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Suchdev PS, 2016, ADV NUTR, V7, P349, DOI 10.3945/an.115.010215; Tandu-Umba B, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0623-z; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Tomkins A, 2003, J NUTR, V133, p1649S, DOI 10.1093/jn/133.5.1649S; Tshilolo L, 2009, J CLIN PATHOL, V62, P35, DOI 10.1136/jcp.2008.058958; van den Broek NR, 2000, AM J CLIN NUTR, V72, p247S, DOI 10.1093/ajcn/72.1.247S; WHO, 2005, WORLD HLTH REP; WHO UNICEF UNFPA World Bank Group and the United Nations Population Division, 2015, TRENDS MAT MORT 1990; Wieringa FT, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060348; World Health Organization, 2016, WHO REC ANT CAR POS; World Health Organization, 2011, HAEM CONC DIAGN AN A; World Health Organization, 2015, GLOB PREV AN 2011	61	2	2	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	5					1551	1560		10.4269/ajtmh.17-0267				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5VW	WOS:000423222300042	29016317	Bronze			2019-04-02	
J	Muro, C; Gomez-Puerta, LA; Flecker, RH; Gamboa, R; Barreto, PV; Dorny, P; Tsang, VCW; Gilman, RH; Gonzalez, AE; Garcia, HH; O'Neal, SE				Muro, Claudio; Gomez-Puerta, Luis A.; Flecker, Robert H.; Gamboa, Ricardo; Vilchez Barreto, Percy; Dorny, Pierre; Tsang, Victor C. W.; Gilman, Robert H.; Gonzalez, Armando E.; Garcia, Hector H.; O'Neal, Seth E.		Cysticercosis Working Grp Peru	Porcine Cysticercosis: Possible Cross-Reactivity of Taenia hydatigena to GP50 Antigen in the Enzyme-Linked Immunoelectrotransfer Blot Assay	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SOLIUM; PIGS; PREVALENCE; PERU	The lentil lectin glycoprotein enzyme-linked immunoelectrotransfer blot (LLGP EITB, reported sensitivity 99% and specificity 100%) is used as a serologic marker of exposure to Taenia solium in pigs. However, only a limited number of parasites have been evaluated for cross reactivity. Pigs may host other related cestode infections, including Taenia hydatigena, which have not been formally evaluated for cross-reactions. We investigated a corral in Tumbes, Peru, a region where a cysticercosis elimination demonstration project was completed in 2012. In this corral, 14/19 (73.7%) 6-8-week-old piglets were reactive to GP50 on LLGP EITB, and all had circulating Taenia sp. antigens. From eight necropsied piglets; four were infected with T. hydatigena metacestodes whereas none had evidence of T. solium infection. Two resident dogs were subsequently confirmed to have T. hydatigena taeniasis. These results suggest GP50 cross-reactivity in T. hydatigena-infected pigs, although controlled experimental infection is needed to confirm this hypothesis.	[Muro, Claudio; Gamboa, Ricardo; Vilchez Barreto, Percy; Garcia, Hector H.; O'Neal, Seth E.] Univ Peruana Cayetano Heredia, Ctr Global Hlth Tumbes, Tumbes, Peru; [Gomez-Puerta, Luis A.; Gonzalez, Armando E.] Univ Nacl Mayor San Marcos, Sch Vet Med, Lima, Peru; [Flecker, Robert H.; O'Neal, Seth E.] Oregon Hlth & Sci Univ, Sch Publ Hlth, CSB658, Portland, OR 97225 USA; [Flecker, Robert H.; O'Neal, Seth E.] Portland State Univ, CSB658, Portland, OR 97225 USA; [Dorny, Pierre] Inst Trop Med, Antwerp, Belgium; [Tsang, Victor C. W.] Georgia State Univ, Atlanta, GA 30303 USA; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Garcia, Hector H.] Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru; [Gomez-Puerta, Luis A.] Univ Nacl Mayor San Marcos, Fac Med Vet, Lima, Peru; [Vilchez Barreto, Percy] UPCH, Ctr Salud Global, Tumbes, Peru; [Gilman, Robert H.] Johns Hopkins Univ, Dept Int Hlth, Baltimore, MD USA; [Garcia, Hector H.] Univ Peruana Cayetano Heredia, Sch Sci, Dept Microbiol, Lima, Peru	O'Neal, SE (reprint author), Oregon Hlth & Sci Univ, Sch Publ Hlth, CSB658, Portland, OR 97225 USA.; O'Neal, SE (reprint author), Portland State Univ, CSB658, Portland, OR 97225 USA.	claudio.muro@peruresearch.org; lucho92@yahoo.com; flecker@ohsu.edu; rgamboa@peruresearch.org; pvilchez@peruresearch.org; pdorny@itg.be; vct123@gmail.com; gilmanbob@gmail.com; agonza41@jhu.edu; hgarcia1@jhu.edu; oneals@ohsu.edu			Fogarty International Center (FIC); National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) [R21AI119438]; Fogarty International Center [TW001140]	This research was made possible with support from the Fogarty International Center (FIC) and the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) grant number R21AI119438. Partial support from Training grant TW001140 from the Fogarty International Center in training of study team members is also acknowledged.	BOWLES J, 1994, AM J TROP MED HYG, V50, P33; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; CHENG RWK, 1991, VET PARASITOL, V39, P161, DOI 10.1016/0304-4017(91)90071-3; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Garcia HH, 2016, NEW ENGL J MED, V374, P2335, DOI 10.1056/NEJMoa1515520; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Gavidia CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002192; GEMMELL MA, 1973, B WORLD HEALTH ORGAN, V48, P649; GONZALEZ AE, 1994, AM J TROP MED HYG, V51, P847, DOI 10.4269/ajtmh.1994.51.847; Guezala MC, 2009, AM J TROP MED HYG, V81, P433, DOI 10.4269/ajtmh.2009.81.433; Liu GH, 2011, MOL BIOL REP, V38, P2249, DOI 10.1007/s11033-010-0355-0; Nguyen MTT, 2016, VET PARASITOL, V226, P97, DOI 10.1016/j.vetpar.2016.06.034; Mohan VR, 2013, T ROY SOC TROP MED H, V107, P62, DOI 10.1093/trstmh/trs003; Nguekam A, 2003, VET PARASITOL, V111, P323, DOI 10.1016/S0304-4017(02)00391-6; O'Neal SE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003125; Sikasunge CS, 2008, VET J, V176, P240, DOI 10.1016/j.tvjl.2007.02.030; TSANG VCW, 1991, VET IMMUNOL IMMUNOP, V29, P69, DOI 10.1016/0165-2427(91)90053-F; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50; Zhang GT, 2014, J PARASITOL, V100, P542, DOI 10.1645/13-224.1	19	5	5	1	4	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	6					1830	1832		10.4269/ajtmh.17-0378				3	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5ZI	WOS:000423231800038	29016332	Bronze			2019-04-02	
J	Silber, SA; Diro, E; Workneh, N; Mekonnen, Z; Levecke, B; Steinmann, P; Umulisa, I; Alemu, H; Baeten, B; Engelen, M; Hu, P; Friedman, A; Baseman, A; Mrus, J				Silber, Steven A.; Diro, Ermias; Workneh, Netsanet; Mekonnen, Zeleke; Levecke, Bruno; Steinmann, Peter; Umulisa, Irenee; Alemu, Hailemaryam; Baeten, Benny; Engelen, Marc; Hu, Peter; Friedman, Andrew; Baseman, Alan; Mrus, Joseph			Efficacy and Safety of a Single-Dose Mebendazole 500 mg Chewable, Rapidly-Disintegrating Tablet for Ascaris lumbricoides and Trichuris trichiura Infection Treatment in Pediatric Patients: A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							TRANSMITTED HELMINTH INFECTIONS; INTENSITY; CHILDREN; AGE	This randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of a new chewable, rapidly-disintegrating mebendazole (MBZ) 500 mg tablet for Ascaris lumbricoides and Trichuris trichiura infection treatment. Pediatric patients (1-15 years; N = 295; from Ethiopia and Rwanda) excreting A. lumbricoides and/or T. trichiura eggs were enrolled. The study had a screening phase (3 days), a double-blind treatment phase (DBP, 19 days), and an open-label phase (OLP, 7 days). Patients received MBZ or placebo on day 1 of DBP and open-label MBZ on day 19 +/- 2 after stool sample collection. Cure rates (primary endpoint), defined as species-specific egg count of 0 at the end of DBP, were significantly higher in the MBZ group than placebo for A. lumbricoides (83.7% [72/86; 95% CI: 74.2%; 90.8%] versus 11.1% [9/81; 95% CI: 5.2%; 20.1%], P < 0.001) and for T. trichiura (33.9% [42/124; 95% CI: 25.6%; 42.9%] versus 7.6% [9/119; 95% CI: 3.5%; 13.9%], P < 0.001). Egg reduction rates (secondary endpoint) were significantly higher in the MBZ group than placebo for A. lumbricoides (97.9% [95% CI: 94.4; 99.9] versus 19.2% [95% CI: -5.9; 41.5]; P < 0.001) and T. trichiura (59.7% [95% CI: 33.9; 78.8] versus 10.5% [95% CI: -16.8; 32.9]; P = 0.003). Treatment-emergent adverse events (TEAEs) in MBZ group occurred in 6.3% (9/144) of patients during DBP and 2.5% (7/278) during OLP. No deaths, serious TEAEs, or TEAEs leading to discontinuations were reported. A 500 mg chewable MBZ tablet was more efficacious than placebo for the treatment of A. lumbricoides and T. trichiura infections in pediatric patients, and no safety concerns were identified.	[Silber, Steven A.; Hu, Peter; Friedman, Andrew; Baseman, Alan; Mrus, Joseph] Janssen Res & Dev LLC, Raritan, NJ 08869 USA; [Diro, Ermias; Alemu, Hailemaryam] Univ Gondar, Gondar, Ethiopia; [Workneh, Netsanet] Jimma Univ, Dept Pediat, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Mekonnen, Zeleke] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Levecke, Bruno] Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Steinmann, Peter] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Steinmann, Peter] Univ Basel, Basel, Switzerland; [Umulisa, Irenee] Rwanda Biomed Ctr, Kigali, Rwanda; [Baeten, Benny; Engelen, Marc] Janssen Pharmaceut NV, Beerse, Belgium; [Mrus, Joseph] Vii V Healthcare, Res Triangle Pk, NC USA	Silber, SA (reprint author), Janssen Res & Dev LLC, Raritan, NJ 08869 USA.	ssilber@its.jnj.com; ermidiro3@gmail.com; konetsanet@gmail.com; zeleke.mekonnen@ju.edu.et; bruno.levecke@ugent.be; peter.steinmann@unibas.ch; umulisa5@gmail.com; hailataaa@gmail.com; bbaeten@its.jnj.com; mengelen@its.jnj.com; phu2@its.jnj.com; afriedm3@its.jnj.com; abaseman@its.jnj.com; joemrus@hotmail.com		Levecke, Bruno/0000-0001-8912-5595	Janssen Research & Development, LLC	Supported by funding from Janssen Research & Development, LLC.	Albonico M, 2003, B WORLD HEALTH ORGAN, V81, P343; [Anonymous], 2006, PREV CHEM HUM HELM C; Brooker S, 2006, ADV PARASIT, V62, P221, DOI 10.1016/S0065-308X(05)62007-6; Brooker S, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-42; Dana D, 2015, T ROY SOC TROP MED H, V109, P225, DOI 10.1093/trstmh/tru178; FRIEDMAN AJ, 2012, J TROPICAL MED, V2012; GBD 2015 DALYs and HALE Collaborators, 2016, LANCET, V388, P11603, DOI DOI 10.1016/S0140-6736(16)31460-X; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002865; Joseph SA, 2016, AM J TROP MED HYG, V95, P83, DOI 10.4269/ajtmh.15-0816; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Kure A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1101-1; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Mrus J, 2017, J HELMINTHOL, V18, P1; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Tchuente LAT, 2011, ACTA TROP, V120, pS4, DOI 10.1016/j.actatropica.2010.07.001; van der Werff SD, 2014, TROP MED INT HEALTH, V19, P706, DOI 10.1111/tmi.12290; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, pe948, DOI DOI 10.1371/J0URNAL.PNTD.0000948; *WHO, 2007, ACT WORMS; World Health Organization, 2013, ASS EFF ANTH DRUGS S; World Health Organization Immunization and Vaccine related Implementa- tion Research Advisory Committee (IVIR-AC), 2015, WKLY EPIDEMIOLOG REP, V90, P1; World Health Organization (WHO), 2012, EL SOIL TRANSM HELM	24	2	2	1	5	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	6					1851	1856		10.4269/ajtmh.17-0108				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5ZI	WOS:000423231800043	29016336	Green Published, Other Gold			2019-04-02	
J	Ikumapayi, UN; Boisen, N; Hossain, MJ; Betts, M; Lamin, M; Saha, D; Kwambana-Adams, B; Dione, M; Adegbola, RA; Roca, A; Nataro, JP; Antonio, M				Ikumapayi, Usman N.; Boisen, Nadia; Hossain, Mohammad J.; Betts, Modupeh; Lamin, Modou; Saha, Debasish; Kwambana-Adams, Brenda; Dione, Michel; Adegbola, Richard A.; Roca, Anna; Nataro, James P.; Antonio, Martin			Identification of Subsets of Enteroaggregative Escherichia coli Associated with Diarrheal Disease among Under 5 Years of Age Children from Rural Gambia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							GLOBAL ENTERIC MULTICENTER; HEAT-STABLE ENTEROTOXIN-1; HEMOLYTIC-UREMIC SYNDROME; AGGREGATIVE ADHERENCE; VIRULENCE CHARACTERISTICS; MOLECULAR EPIDEMIOLOGY; EPITHELIAL-CELLS; DEVELOPING-COUNTRIES; TRAVELERS DIARRHEA; SHIGELLA-FLEXNERI	Enteroaggregative Escherichia coli (EAEC) cause acute and persistent diarrhea, mostly in children worldwide. Outbreaks of diarrhea caused by EAEC have been described, including a large outbreak caused by a Shiga toxin expressing strain. This study investigated the association of EAEC virulence factors with diarrhea in children less than 5 years. We characterized 428 EAEC strains isolated from stool samples obtained from moderate-to-severe diarrhea cases (157) and healthy controls (217) children aged 0-59 months recruited over 3 years as part of the Global Enteric Multicenter Study (GEMS) in The Gambia. Four sets of multiplex polymerase chain reaction were applied to detect 21 EAEC-virulence genes from confirmed EAEC strains that target pCVD432 (aatA) and AAIC (aaiC). In addition, Kirby-Bauer disc diffusion antimicrobial susceptibility testing was performed on 88 EAEC strains following Clinical Laboratory Standard Institute guidelines. We observed that the plasmid-encoded enterotoxin [odds ratio (OR): 6.9, 95% confidence interval (CI): 2.06-29.20, P <0.001], aggregative adherence fimbriae/I fimbriae (aggA) [OR: 2.2, 95% CI: 1.16-4.29, P = 0.008], and hexosyltransferase (capU) [OR: 1.9, 95% CI 1.02-3.51, P = 0.028] were associated with moderate-to-severe diarrhea among children <12 months old but not in the older age strata (> 12 months). Our data suggest that some EAEC-virulent factors have age-specific associations with moderate-to-severe diarrhea in infants. Furthermore, our study showed that 85% and 72% of EAEC strains tested were resistant to sulphamethoxazole-trimethoprim and ampicillin, respectively. Sulphamethoxazole-trimethoprim and ampicillin are among the first-line antibiotics used for the treatment of diarrhea in The Gambia.	[Ikumapayi, Usman N.; Betts, Modupeh; Saha, Debasish; Kwambana-Adams, Brenda; Dione, Michel; Adegbola, Richard A.; Antonio, Martin] Med Res Council Unit Gambia, Vaccines & Immun Theme, Atlantic Rd, Banjul, Gambia; [Ikumapayi, Usman N.; Hossain, Mohammad J.; Lamin, Modou; Roca, Anna] Med Res Council Unit Gambia, Dis Control & Eliminat Theme, Banjul, Gambia; [Boisen, Nadia] Statens Serum Inst, Dept Microbiol Surveillance & Res, Copenhagen, Denmark; [Roca, Anna] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Nataro, James P.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Nataro, James P.] Univ Virginia, Sch Med, Dept Pediat, Charlottesville, VA 22908 USA; [Antonio, Martin] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England; [Antonio, Martin] Univ Warwick, Microbiol & Infect Unit, Warwick Med Sch, Coventry, W Midlands, England; [Ikumapayi, Usman N.; Hossain, Mohammad J.; Betts, Modupeh; Lamin, Modou; Kwambana-Adams, Brenda; Dione, Michel; Roca, Anna; Antonio, Martin] MRC Unit, Banjul, Gambia; [Saha, Debasish; Adegbola, Richard A.] GlaxoSmithKline Vaccines, Wavre, Belgium	Antonio, M (reprint author), Med Res Council Unit Gambia, Vaccines & Immun Theme, Atlantic Rd, Banjul, Gambia.	uikumapayi@mrc.gm; nboboisen@gmail.com; jhossain@mrc.gm; mbetts@mrc.gm; mlamin@mc.gm; debasish.x.saha@gsk.com; bkwambana@mrc.gm; richard.a.adegbola@gsk.com; jpn2r@hscmail.mcc.virginia.edu; mantonio@mrc.gm	; Kwambana, Brenda/U-5786-2017	Betts, Modupeh/0000-0003-0083-7487; Kwambana, Brenda/0000-0002-1202-8540; Dione, Michel/0000-0001-7812-5776	Medical Research Council (United Kingdom); Bill & Melinda Gates Foundation	The financial support for this study was from The Medical Research Council, (United Kingdom), and the Bill & Melinda Gates Foundation via Professor James P. Nataro who was previously at CVD-University of Maryland, Baltimore, now at the University of Virginia, Virginia.	Adachi JA, 2001, CLIN INFECT DIS, V32, P1706, DOI 10.1086/320756; Aslani MM, 2011, INT J INFECT DIS, V15, pE136, DOI 10.1016/j.ijid.2010.10.002; Bafandeh S, 2015, J MED MICROBIOL, V64, P519, DOI 10.1099/jmm.0.000055; BENJELLOUNTOUIMI Z, 1995, MOL MICROBIOL, V17, P123, DOI 10.1111/j.1365-2958.1995.mmi_17010123.x; BHAN MK, 1989, J INFECT DIS, V159, P1061, DOI 10.1093/infdis/159.6.1061; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Boisen N, 2012, J INFECT DIS, V205, P431, DOI 10.1093/infdis/jir757; Boisen N, 2009, AM J TROP MED HYG, V80, P294, DOI 10.4269/ajtmh.2009.80.294; Cennimo D, 2009, J MED MICROBIOL, V58, P403, DOI 10.1099/jmm.0.005793-0; Cobeljic M, 1996, EPIDEMIOL INFECT, V117, P11; Cohen MB, 2005, J PEDIATR-US, V146, P54, DOI 10.1016/j.jpeds.2004.08.059; Czeczulin JR, 1997, INFECT IMMUN, V65, P4135; de Sousa CP, 2001, INT J MED MICROBIOL, V291, P15, DOI 10.1078/1438-4221-00097; Dutta PR, 2002, INFECT IMMUN, V70, P7105, DOI 10.1128/IAI.70.12.7105-7113.2002; Eslava C, 1998, INFECT IMMUN, V66, P3155; Eslava C. V. J., 1993, 93 GEN M AM SOC MICR, P44; Farag TH, 2012, CLIN INFECT DIS, V55, pS225, DOI 10.1093/cid/cis787; Harrington SM, 2006, FEMS MICROBIOL LETT, V254, P12, DOI 10.1111/j.1574-6968.2005.00005.x; Harrington SM, 2005, CELL MICROBIOL, V7, P1565, DOI 10.1111/j.1462-5822.2005.00588.x; Henderson IR, 1999, INFECT IMMUN, V67, P5587; Ikumapayi UN, 2007, J MED MICROBIOL, V56, P1479, DOI 10.1099/jmm.0.47416-0; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546; Januszkiewicz A, 2012, J MED MICROBIOL, V61, P552, DOI 10.1099/jmm.0.039289-0; Jonsson R, 2015, INFECT IMMUN, V83, P1396, DOI 10.1128/IAI.02820-14; Kahali S, 2004, J CLIN MICROBIOL, V42, P4111, DOI 10.1128/JCM.42.9.4111-4120.2004; Knutton S, 2001, J PEDIATR GASTR NUTR, V33, P32, DOI 10.1097/00005176-200107000-00006; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Kotloff KL, 2012, CLIN INFECT DIS, V55, pS232, DOI 10.1093/cid/cis753; Menard LP, 2002, CRIT REV MICROBIOL, V28, P43, DOI 10.1080/1040-840291046687; Arancibia EM, 2009, J ANTIMICROB CHEMOTH, V64, P343, DOI 10.1093/jac/dkp178; Moyo SJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/147-2334/7/92; NATARO JP, 1994, J BACTERIOL, V176, P4691; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142; Nataro JP, 1998, METH MOLEC MED, V15, P387, DOI 10.1385/0-89603-498-4:387; Nataro JP, 1998, EMERG INFECT DIS, V4, P251, DOI 10.3201/eid0402.980212; Navarro-Garcia F, 2001, INFECT IMMUN, V69, P1053, DOI 10.1128/IAI.69.2.1053-1060.2001; Navarro-Garcia F, 1999, INFECT IMMUN, V67, P2184; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Opintan JA, 2010, T ROY SOC TROP MED H, V104, P504, DOI 10.1016/j.trstmh.2010.02.011; Pai M, 1997, INDIAN J MED RES, V106, P7; Panchalingam S, 2012, CLIN INFECT DIS, V55, pS294, DOI 10.1093/cid/cis754; PAUL M, 1994, FEMS MICROBIOL LETT, V117, P319, DOI 10.1016/0378-1097(94)90578-9; Presterl E, 1999, EUR J CLIN MICROBIOL, V18, P209, DOI 10.1007/s100960050261; Raju B, 2009, SCAND J INFECT DIS, V41, P105, DOI 10.1080/00365540802641856; Samie A, 2007, AM J TROP MED HYG, V77, P142, DOI 10.4269/ajtmh.2007.77.142; SAVARINO SJ, 1991, J CLIN INVEST, V87, P1450, DOI 10.1172/JCI115151; Scheutz F, 2011, EUROSURVEILLANCE, V16, P5; Smith HR, 1997, LANCET, V350, P814, DOI 10.1016/S0140-6736(05)62611-6; Steiner TS, 2000, J CLIN INVEST, V105, P1769, DOI 10.1172/JCI8892; Toshima H, 2004, J FOOD PROTECT, V67, P2117, DOI 10.4315/0362-028X-67.10.2117; Veilleux S, 2008, COMP IMMUNOL MICROB, V31, P567, DOI 10.1016/j.cimid.2007.10.003; Vila J, 1998, J MED MICROBIOL, V47, P889, DOI 10.1099/00222615-47-10-889; Villaseca JM, 2000, INFECT IMMUN, V68, P5920, DOI 10.1128/IAI.68.10.5920-5927.2000; Zhou Z, 2002, EPIDEMIOL INFECT, V128, P363, DOI 10.1017/S0950268802006994	54	1	1	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	4					997	1004		10.4269/ajtmh.16-0705				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5QM	WOS:000423208300005	28820687	Other Gold, Green Published			2019-04-02	
J	Mendo-Lopez, R; Jasso, L; Guevara, X; Astocondor, AL; Alejos, S; Bardossy, AC; Prentiss, T; Zervos, MJ; Jacobs, J; Garcia, C				Mendo-Lopez, Rafael; Jasso, Luis; Guevara, Ximena; Lizeth Astocondor, Aurora; Alejos, Saul; Bardossy, Ana C.; Prentiss, Tyler; Zervos, Marcus J.; Jacobs, Jan; Garcia, Coralith			Multidrug-Resistant Microorganisms Colonizing Lower Extremity Wounds in Patients in a Tertiary Care Hospital, Lima, Peru	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SPECTRUM BETA-LACTAMASE; UNIT ADMISSION; COLONIZATION; BACTERIA; RESIDENTS	Multidrug-resistant organism (MDRO) infections cause high morbidity and mortality, and high costs to patients and hospitals. The study aims were to determine the frequency of MDRO colonization and associated factors in patients with lower-extremity wounds with colonization. A cross-sectional study was designed during November 2015 to July 2016 in a tertiary care hospital in Lima, Peru. A wound swab was obtained for culture and susceptibility testing. MDRO colonization was defined if the culture grew with methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and/or extended spectrum beta-lactamase (ESBL) microorganisms. The frequency of MDRO wound colonization was 26.8% among the 97 patients enrolled. The most frequent MDRO obtained was ESBL-producing Escherichia coli, which was significantly more frequent in chronic wounds versus acute wounds (17.2% versus 0%, P < 0.05). Infection control measures should be implemented when patients with chronic lower-extremity wounds are admitted.	[Mendo-Lopez, Rafael; Lizeth Astocondor, Aurora; Alejos, Saul; Garcia, Coralith] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Ave Honorio Delgado 430, Lima, Peru; [Jasso, Luis; Guevara, Ximena; Garcia, Coralith] Hosp Cayetano Heredia, Lima, Peru; [Bardossy, Ana C.; Prentiss, Tyler; Zervos, Marcus J.] Henry Ford Hlth Syst, Infect Dis Div, Detroit, MI USA; [Jacobs, Jan] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Jasso, Luis; Guevara, Ximena] Hosp Nacl Cayetano Heredia, Dept Endocrinol, Lima, Peru; [Prentiss, Tyler; Jacobs, Jan] Henry Ford Hlth Serv, Global Hlth Initiat, Detroit, MI USA; [Garcia, Coralith] Hosp Nacl Cayetano Heredia, Div Infect Dis, Lima, Peru	Garcia, C (reprint author), Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Ave Honorio Delgado 430, Lima, Peru.	rafael.mendo@upch.pe; ljasso18@yahoo.es; ximenaguevara@yahoo.com; lizeth1226@hotmail.com; savaf@hotmail.com; cbardos1@hfhs.org; tprenti1@hfhs.org; mzervos1@hfhs.org; jjacobs@itg.be; coralith.garcia@upch.pe		Guevara, Ximena/0000-0003-4858-7798	Directorate General for Development Cooperation (DGCD) of the Belgian Government [95502]; Henry Ford Health System	This study was sponsored by the Directorate General for Development Cooperation (DGCD) of the Belgian Government (framework agreement 3, project 95502) and Henry Ford Health System.	Agarwala Sanjay, 2016, J Clin Orthop Trauma, V7, P12, DOI 10.1016/j.jcot.2015.08.004; Azim A, 2010, J MED MICROBIOL, V59, P955, DOI 10.1099/jmm.0.018085-0; Beezhold DW, 1996, CLIN INFECT DIS, V1997, P704; Clinical and Laboratory Standards Institute, 2016, PERFORMANCE STANDARD; Cohen CC, 2015, J HOSP INFECT, V90, P275, DOI 10.1016/j.jhin.2015.05.003; Del Rosario-Quintana Cristobal, 2015, Rev Esp Geriatr Gerontol, V50, P232, DOI 10.1016/j.regg.2014.11.006; Flores-Paredes Wilfredo, 2010, Rev Med Hered, V21, P128; Garcia C, 2016, AM J TROP MED HYG, V94, P285, DOI 10.4269/ajtmh.15-0373; Guzman-Blanco M, 2014, BRAZ J INFECT DIS, V18, P421, DOI 10.1016/j.bjid.2013.10.005; Harris AD, 2007, EMERG INFECT DIS, V13, P1144, DOI 10.3201/eid1308.070071; Hernandez DR, 2016, J CLIN MICROBIOL, V54, P305, DOI 10.1128/JCM.02410-15; Lipke V, 2016, PUBLIC HEALTH ACTION, V6, P160, DOI 10.5588/pha.16.0027; Low DE, 2001, CLIN INFECT DIS, V32, pS133, DOI 10.1086/320185; March A, 2010, CLIN MICROBIOL INFEC, V16, P934, DOI 10.1111/j.1469-0691.2009.03024.x; Ponessa A, 2006, ACTA BIOQUIM CLIN L, V40, P499; Reyes J, 2009, CLIN INFECT DIS, V49, P1861, DOI 10.1086/648426; Ruscher C, 2014, INT J MED MICROBIOL, V304, P1123, DOI 10.1016/j.ijmm.2014.08.006; Talavera G, 2011, PEDIATRIA-ASUNCION, V38, P123	18	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	4					1045	1048		10.4269/ajtmh.17-0235				4	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5QM	WOS:000423208300011	28722595	Bronze			2019-04-02	
J	Ruizendaal, E; Schallig, HDFH; Scott, S; Traore-Coulibaly, M; Bradley, J; Lompo, P; Natama, HM; Traore, O; Valea, I; Dierickx, S; Drabo, KM; Pagnoni, F; d' Alessandro, U; Tinto, H; Mens, PF				Ruizendaal, Esmee; Schallig, Henk D. F. H.; Scott, Susana; Traore-Coulibaly, Maminata; Bradley, John; Lompo, Palpouguini; Natama, Hamtandi M.; Traore, Ousmane; Valea, Innocent; Dierickx, Susan; Drabo, Koine M.; Pagnoni, Franco; d' Alessandro, Umberto; Tinto, Halidou; Mens, Petra F.			Evaluation of Malaria Screening during Pregnancy with Rapid Diagnostic Tests Performed by Community Health Workers in Burkina Faso	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							INTERMITTENT PREVENTIVE TREATMENT; SULFADOXINE-PYRIMETHAMINE RESISTANCE; LOW-BIRTH-WEIGHT; DRUG-RESISTANCE; INFECTIONS; METAANALYSIS; WOMEN; PARASITES; AFRICA; IMPACT	One of the current strategies to prevent malaria in pregnancy is intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP). However, in order for pregnant women to receive an adequate number of SP doses, they should attend a health facility on a regular basis. In addition, SP resistance may decrease IPTp-SP efficacy. New or additional interventions for preventing malaria during pregnancy are therefore warranted. Because it is known that community health workers (CHWs) can diagnose and treat malaria in children, in this study screening and treatment of malaria in pregnancy by CHWs was evaluated as an addition to the regular IPTp-SP program. CHWs used rapid diagnostic tests (RDTs) for screening and artemether-lumefantrine was given in case of a positive RDT. Overall, CHWs were able to conduct RDTs with a sensitivity of 81.5% (95% confidence interval [CI] 67.9-90.2) and high specificity of 92.1% (95% CI 89.9-93.9) compared with microscopy. After a positive RDT, 79.1% of women received artemether-lumefantrine. When treatment was not given, this was largely due to the woman being already under treatment. Almost all treated women finished the full course of artemether-lumefantrine (96.4%). In conclusion, CHWs are capable of performing RDTs with high specificity and acceptable sensitivity, the latter being dependent on the limit of detection of RDTs. Furthermore, CHWs showed excellent adherence to test results and treatment guidelines, suggesting they can be deployed for screen and treat approaches of malaria in pregnancy.	[Ruizendaal, Esmee; Schallig, Henk D. F. H.; Mens, Petra F.] Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Scott, Susana] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Scott, Susana; d' Alessandro, Umberto] MRC Unit, Dis Control & Eliminat, Fajara, Gambia; [Traore-Coulibaly, Maminata; Lompo, Palpouguini; Natama, Hamtandi M.; Traore, Ousmane; Valea, Innocent; Tinto, Halidou] IRSS, URCN, Nanoro, Burkina Faso; [Bradley, John] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London, England; [Dierickx, Susan] Inst Trop Med, Dept Publ Hlth, Med Anthropol Unit, Antwerp, Belgium; [Dierickx, Susan] Amsterdam Inst Social Sci Res, Amsterdam, Netherlands; [Drabo, Koine M.] IRSS, Ouagadougou, Burkina Faso; [Pagnoni, Franco] Chemin Petite Boissiere 44, Geneva, Switzerland; [d' Alessandro, Umberto] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London, England	Ruizendaal, E (reprint author), Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands.	esmee.ruizendaal@gmail.com; h.d.schallig@amc.uva.nl; sscott@mrc.gm; traore_maminata@yahoo.fr; john.bradley@lshtm.ac.uk; palponet@yahoo.fr; natamagloire@yahoo.fr; ousmane_tra@yahoo.fr; innocentvalea@yahoo.fr; susan.dierickx@vub.ac.be; m_drabok@yahoo.fr; fpagnoni47@gmail.com; udalessandro@mrc.gm; halidoutinto@gmail.com; p.f.mens@amc.uva.nl		Tinto, Halidou/0000-0002-0472-3586; Traore, Ousmane/0000-0003-1873-6473	European Community [305662]	This study was funded by European Community's Seventh Framework Programme under grant agreement no. 305662 (Project: Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health: a cluster-randomized trial "COSMIC").	Braun V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0909-7; Chico RM, 2015, TROP MED INT HEALTH, V20, P1621, DOI 10.1111/tmi.12595; Cottrell G, 2015, CLIN INFECT DIS, V60, P1481, DOI 10.1093/cid/civ122; da Silva IM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111774; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Desai M, 2016, CLIN INFECT DIS, V62, P323, DOI 10.1093/cid/civ881; Eisele TP, 2012, LANCET INFECT DIS, V12, P942, DOI 10.1016/S1473-3099(12)70222-0; Fernandes S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1539-4; Geiger C, 2014, TROP MED INT HEALTH, V19, P690, DOI 10.1111/tmi.12305; Grietens KP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012013; Harrington WE, 2011, CLIN INFECT DIS, V53, P224, DOI 10.1093/cid/cir376; Hermsen CC, 2001, MOL BIOCHEM PARASIT, V118, P247, DOI 10.1016/S0166-6851(01)00379-6; Jarra W, 1998, INFECT IMMUN, V66, P3783; Joanny F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-234; Kattenberg JH, 2012, TROP MED INT HEALTH, V17, P550, DOI 10.1111/j.1365-3156.2012.02975.x; Kattenberg JH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-321; Kyabayinze DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156954; Mockenhaupt FP, 2008, J INFECT DIS, V198, P1545, DOI 10.1086/592455; Naidoo I, 2013, TRENDS PARASITOL, V29, P505, DOI 10.1016/j.pt.2013.08.002; Naidoo I, 2011, PARASITOLOGY, V138, P1469, DOI 10.1017/S0031182011000746; Ruizendaal E, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-229; Scott S, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-340; Thiam S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-353; van Eijk AM, 2013, LANCET INFECT DIS, V13, P1029, DOI 10.1016/S1473-3099(13)70199-3; Williams JE, 2016, CLIN INFECT DIS, V62, P837, DOI 10.1093/cid/civ1198; World Health Organization, 2005, ROLL BACK MAL STRAT; World Health Organization, 2016, WHO REC ANT CAR POS; World Health Organization, 2012, MAL RAP DIAGN TEST P, V4	28	4	4	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	97	4					1190	1197		10.4269/ajtmh.17-0138				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FT5QM	WOS:000423208300035	28722627	Bronze			2019-04-02	
J	Berthe, A; Somda, MAS; Berthe-Sanou, L; Konate, B; Hien, H; Bayala, E; Tou, F; Drabo, M; Badini-Kinda, F; Macq, J				Berthe, A.; Somda, M. A. S.; Berthe-Sanou, L.; Konate, B.; Hien, H.; Bayala, E.; Tou, F.; Drabo, M.; Badini-Kinda, F.; Macq, J.			Advantages and disadvantages of using the PRISMA7 to determine the elderly subjects for whom the SMAF is useful for assessing functional status in Bobo-Dioulasso (Burkina Faso)	MEDECINE ET SANTE TROPICALES			French	Article						Aged; disability evaluation; disabled persons; health policy; health priorities; sub-Saharan Africa	AUTONOMY MEASUREMENT SYSTEM; SUB-SAHARAN AFRICA; OLDER-PEOPLE; DISABILITY; POPULATION; PREVALENCE; HEALTH; CARE; HOME	Introduction: One of the difficulties faced by African actors working with the elderly is the lack of appropriate tools for the identification and/ or diagnosis of functional disabilities among older people in this limited-resource (material, human, and financial) setting. This study sought to assess the advantages and disadvantages of the combined use of two tools, PRISMA7 (for identifying older individuals at risk of functional disabilities and loss of autonomy) and SMAF (to evaluate the functional status of the elderly) in Bobo-Dioulasso (Burkina Faso). Methods: PRISMA7 and SMAF were administered to a representative sample of elderly people who lived at home. Data analysis was performed with Stata. Results: The results show that the combination of PRISMA7 and SMAF made it possible to avoid unncessary administration of the SMAF to all subjects, reducing the number of questionnaires to photocopy by 48 % and the working time by 45 %. The prevalence of moderate to severe functional disabilities was 32 % according to the SMAF alone and 25 % when PRISMA7 was administered first and determined whether the SMAF would be used. The 7 % rate of loss to follow-up shows a need for monitoring or help, generally in instrumental activities. Conclusion: In a limited-resource setting, this combination is a good strategy for identifying and evaluating functional disabilities in the elderly. This strategy allows the development of work plans tailored to individual functional needs.	[Berthe, A.; Somda, M. A. S.; Berthe-Sanou, L.; Konate, B.; Hien, H.; Tou, F.] Ctr Muraz, Bobo Dioulasso 01, Burkina Faso; [Berthe, A.; Berthe-Sanou, L.; Konate, B.; Hien, H.; Bayala, E.] ABSP, Bobo Dioulasso, Burkina Faso; [Drabo, M.] Inst Rech Sci Sante, Bobo Dioulasso, Burkina Faso; [Badini-Kinda, F.] Univ Ouagadougou, Ouagadougou, Burkina Faso; [Berthe, A.; Macq, J.] Catholic Univ Louvain, Brussels, Belgium	Berthe, A (reprint author), Ctr Muraz, Bobo Dioulasso 01, Burkina Faso.; Berthe, A (reprint author), ABSP, Bobo Dioulasso, Burkina Faso.; Berthe, A (reprint author), Catholic Univ Louvain, Brussels, Belgium.	aberthe56@yahoo.fr					Allain TJ, 1997, AGE AGEING, V26, P115, DOI 10.1093/ageing/26.2.115; Benaim C., 2005, Annales de Readaptation et de Medecine Physique, V48, P336, DOI 10.1016/j.annrmp.2005.04.005; Berthe A, 2013, REV EPIDEMIOL SANTE, V61, P531, DOI 10.1016/j.respe.2013.07.682; Berthe A, 2000, RISQUES SANITAIRES C; Berthe A, 2013, REV GERIATRIE, V38, P249; Berthe A., 2013, THESIS; Berthe A, 2015, GERIATR PSYCHOL NEUR, V13, P381, DOI 10.1684/pnv.2015.0569; Berthe A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-689; Berthe A, 2013, SANTE PUBLIQUE, V25, P367, DOI 10.3917/spub.253.0367; Berthe A, 2012, SANTE PUBLIQUE, V24, P439, DOI 10.3917/spub.125.0439; Berthe-Sanou L, 2013, SANTE PUBLIQUE, V25, P517, DOI 10.3917/spub.134.0517; Bureau central du recensement MdlEedFBF, 2009, REC GEN POP HAB 2006; de Jong Willemijn, 2005, AGEING INSECURITY CA; Domenach H., 2008, MONDES DEV, V2, P97; Dubuc N, 2006, ARCH GERONTOL GERIAT, V42, P191, DOI 10.1016/j.archger.2005.07.001; Dubuc N, 2004, DEV IMPLANTATION PRO, P177; Godin C., LA FIN DE LHUMANITE; Gureje O, 2008, Afr J Med Med Sci, V37, P239; Gureje O, 2006, J AM GERIATR SOC, V54, P1784, DOI 10.1111/j.1532-5415.2006.00944.x; Harwood RH, 2004, B WORLD HEALTH ORGAN, V82, P251; Hebert R, INTEGRATION SERVICES; Hebert R, 2003, REV GERIATRIE, V28, P323; Institut National de la Statistique et de la Demographie (INSD) MdlEedF Burkina Faso), 2009, REC GEN POP HAB RGPH; Kuate-Defo B, 2005, CAH QUE DEMOGR, V34, P1, DOI 10.7202/012515ar; Nordberg E, 1997, E AFR MED J, V74, P629; Ouakam JF., 2004, THESIS; Pinsonnault E, 2003, ARCH GERONTOL GERIAT, V37, P223, DOI 10.1016/S0167-4943(03)00049-9; Pison G., 2009, POPULATION SOC, P457; Rai GS, 1996, ARCH GERONTOL GERIAT, V22, P81, DOI 10.1016/0167-4943(95)00680-X; Raiche M, 2007, REV GERIATRIE, V32, P209; Sanou-Berthe L., 2012, EVALUATION PERTINENC; Uwakwe R, 2007, Niger J Clin Pract, V10, P58; Uwakwe R, 2009, J AM GERIATR SOC, V57, P1620, DOI 10.1111/j.1532-5415.2009.02397.x; World Health Organization, INT CLASS FUNCT DIS; 2011, WORLD REP DIS 2011, P1	35	0	0	0	0	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	JAN-MAR	2017	27	1					71	76		10.1684/mst.2017.0658				6	Tropical Medicine	Tropical Medicine	FI4JA	WOS:000411936000020	28406421				2019-04-02	
J	Mayaki, Z; Seydou, M; Moutschen, M; Albert, A; Dardenne, N; Sondag, D; Gossens, D; Gerard, C				Mayaki, Z.; Seydou, M.; Moutschen, M.; Albert, A.; Dardenne, N.; Sondag, D.; Gossens, D.; Gerard, C.			Rapid tests and transfusion safety in Niamey, Niger	MEDECINE ET SANTE TROPICALES			French	Article						blood donation; rapid tests; false negative; transfusion safety; Niger	HEPATITIS-C VIRUS; SUB-SAHARAN AFRICA; BLOOD-DONORS; INFECTION; CONTINENT; SETTINGS; ANTIBODY; VIREMIA; MARKERS; RISK	Aim of the study: To evaluate the virological safety of blood components provided by the Niamey blood transfusion center after undergoing rapid tests. Methods/Materials: Samples found negative with rapid tests (n = 222) were screened by the Abbott Prism assay. Positive samples were confirmed by appropriate methods. Results: Of 222 samples, nine (4.1%) were reactive for all markers. After confirmation, seven samples were positive (i.e., 3.2% false-negative results) : five (2.3%) for the surface antigen of hepatitis B (HBsAg) and two (0.9%) for the antibody directed against the hepatitis C virus (HCV-Ab). No false negative results were observed for HIV-Ab (antibody directed against the Human Immunodeficiency Virus). Conclusion: The performance of the rapid tests used in Niamey to screen for transfusion-transmissible infections is not satisfactory, especially for hepatitis B and C. The use of more sensitive tests should be considered to minimize the risk of contaminating patients receiving blood components.	[Mayaki, Z.; Seydou, M.] Ctr Natl Transfus Sanguine, BP 2399, Niamey, Niger; [Moutschen, M.] CHU Sart Tilman, Serv Malad Infect & Med Interne Gen, B35, B-4000 Liege, Belgium; [Albert, A.] Univ Liege, CHU Sart Tilman, Fac Med, Dept Sci Sante Publ, B23, B-4000 Liege, Belgium; [Dardenne, N.] Univ Liege, CHU Sart Tilman, Unite Soutien Methodol Epidemiol & Biostat, B23, B-4000 Liege, Belgium; [Sondag, D.; Gossens, D.] Croix Rouge Belgique, Serv Francophone Sang, 8 Rue Fond du Marechal, B-5020 Suarlee, Belgium; [Gerard, C.] CHU Sart Tilman, Serv Immunohematol Transfus, B35, B-4000 Liege, Belgium; [Gerard, C.] CHU Sart Tilman, Lab Reference Sida, B35, B-4000 Liege, Belgium	Mayaki, Z (reprint author), Ctr Natl Transfus Sanguine, BP 2399, Niamey, Niger.	mzoubeida@yahoo.fr					Allain JP, 2006, ISBT SCI SER, V1, P89, DOI 10.1111/j.1751-2824.2006.00019.x; Allain JP, 2005, EXPERT REV MOL DIAGN, V5, P31, DOI 10.1586/14737159.5.1.31; Allain JP, 2003, BLOOD, V101, P2419, DOI 10.1181/blood-2002-04-1084; Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Chiu YHC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018294; Contreras AM, 2010, TRANSFUSION, V50, P1335, DOI 10.1111/j.1537-2995.2009.02571.x; Dessie Azene, 2008, Ethiop Med J, V46, P1; Grijalva M, 2005, J CLIN VIROL, V34, P47; Hillaire S., 2006, HEPATO GASTRO, V13, P87; Jayaraman S, 2010, TRANSFUSION, V50, P433, DOI 10.1111/j.1537-2995.2009.002402.x; Laperche S, 2013, TRANSFUSION, V53, P816, DOI 10.1111/j.1537-2995.2012.03797.x; Laperche S, 2009, TRANSFUSION, V49, P1600, DOI 10.1111/j.1537-2995.2009.02239.x; Lee CH, 2013, CLIN MOL HEPATOL, V19, P376, DOI 10.3350/cmh.2013.19.4.376; Lefrere JJ, 1998, VIROLOGIE, V2, P227; Makuwa M, 2002, J VIROL METHODS, V103, P183, DOI 10.1016/S0166-0934(02)00026-5; Mayaki Z, 2013, REV EPIDEMIOL SANTE, V61, P233, DOI 10.1016/j.respe.2012.12.018; O'Connell RJ, 2013, TRANSFUSION, V53, P505, DOI 10.1111/j.1537-2995.2012.03770.x; Organisation Mondiale de la Sante e?? (OMS), 2010, DEP ITT DONS SANG RE; Organisation Mondiale de la Sante (OMS), FAITS CHIFFR TRANSF; Orkuma JA, 2013, NIGER J MED, V23, P192; Owusu-Ofori S, 2005, TRANSFUSION, V45, P133, DOI 10.1111/j.1537-2995.2004.04279.x; Page K, 2013, CLIN INFECT DIS, V56, P405, DOI 10.1093/cid/cis921; Pereira FM, 2014, REV SOC BRAS MED TRO, V47, P12, DOI 10.1590/0037-8682-0222-2013; Republique du Niger, ENQ DEM SANT IND MUL; Rezza G, 1998, J ACQ IMMUN DEF SYND, V17, pS13, DOI 10.1097/00042560-199801001-00005; Scheiblauer H, 2006, TRANSFUSION, V46, P708, DOI 10.1111/j.1537-2995.2006.00789.x; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73; World Health Organisation, 2004, GLOB DAT BLOOD SAF S; World Health Organization Regional Office for Africa Centers for Disease Control and Prevention and Association of Public Health Laboratories, GUID APPR EV HIV TES	30	0	0	1	1	JOHN LIBBEY EUROTEXT LTD	MONTROUGE	127 AVE DE LA REPUBLIQUE, 92120 MONTROUGE, FRANCE	2261-3684	2261-2211		MED SANTE TROP	Med. Sante Trop.	JAN-MAR	2017	27	1					95	100		10.1684/mst.2017.0663				6	Tropical Medicine	Tropical Medicine	FI4JA	WOS:000411936000024	28406424				2019-04-02	
J	Schmidt, AC; Lin, L; Martinez, LJ; Ruck, RC; Eckels, KH; Collard, A; De La Barrera, R; Paolino, KM; Toussaint, JF; Lepine, E; Innis, BL; Jarman, RG; Thomas, SJ				Schmidt, Alexander C.; Lin, Leyi; Martinez, Luis J.; Ruck, Richard C.; Eckels, Kenneth H.; Collard, Alix; De La Barrera, Rafael; Paolino, Kristopher M.; Toussaint, Jean-Francois; Lepine, Edith; Innis, Bruce L.; Jarman, Richard G.; Thomas, Stephen J.			Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							FLAVIVIRUS-NAIVE ADULTS; CLINICAL-TRIAL; VIRUS-VACCINE; LATIN-AMERICA; IMMUNOGENICITY; SAFETY; CANDIDATE; FORMULATIONS; RESPONSES; EFFICACY	The safety and immunogenicity of four formulations of an investigational tetravalent dengue purified inactivated vaccine (DPIV), formulated at 1 or 4 mu g with aluminum hydroxide (alum) or at 1 mu g with an adjuvant system (AS01(E) or AS03(B)), were evaluated in a first-time-in-human, placebo-controlled, randomized, observer-blind, phase 1 trial in the continental United States. Two doses of vaccine or placebo were administered intramuscularly 4 weeks apart to 100 healthy adults 18-39 years of age, randomized 1: 1: 1: 1: 1 to receive one of four DPIV formulations or saline placebo. The response to a third dose was evaluated in a subset of nine participants remote from primary vaccination. Humoral immunogenicity was assessed using a 50% microneutralization assay. All DPIV formulations were well tolerated. No vaccine-related serious adverse events were observed through 12 months after the second vaccine dose. In all DPIV groups, geometric mean antibody titers peaked at Day 56, waned through 6 months after the second vaccine dose, and then stabilized. In the nine subjects where boosting was evaluated, a strong anamnestic response was observed. These results support continuation of the clinical development of this dengue vaccine candidate (clinicaltrials.gov: NCT01666652).	[Schmidt, Alexander C.; Collard, Alix; Toussaint, Jean-Francois] GSK Vaccines, Rixensart, Belgium; [Lin, Leyi; Martinez, Luis J.; Ruck, Richard C.; Eckels, Kenneth H.; De La Barrera, Rafael; Paolino, Kristopher M.; Jarman, Richard G.; Thomas, Stephen J.] Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA; [Lepine, Edith; Innis, Bruce L.] GSK Vaccines, King Of Prussia, PA USA	Thomas, SJ (reprint author), Walter Reed Army Inst Res, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	thomstep@upstate.edu		Toussaint, Jean-Francois/0000-0003-1964-5039	U.S. Army Medical Research and Materiel Command; Military Infectious Diseases Research Program; GlaxoSmithKline Biologicals SA	This study was cofunded by the U.S. Army Medical Research and Materiel Command, Military Infectious Diseases Research Program and GlaxoSmithKline Biologicals SA. Manuscript development was funded by GlaxoSmithKline Biologicals SA.	[Anonymous], 2009, DENG GUID DIAGN TREA; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; Dayan GH, 2014, HUM VACC IMMUNOTHER, V10, P2853, DOI 10.4161/21645515.2014.972131; Diaz C, 2015, J NANOMATER, DOI 10.1155/2015/105157; Dorigatti I, 2015, VACCINE, V33, P3746, DOI 10.1016/j.vaccine.2015.05.059; Eder S, 2011, VACCINE, V29, P2607, DOI 10.1016/j.vaccine.2011.01.058; Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268; Fernandez S, 2011, CLIN VACCINE IMMUNOL, V18, P523, DOI 10.1128/CVI.00016-11; George SL, 2015, J INFECT DIS, V212, P1032, DOI 10.1093/infdis/jiv179; International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), 2012, MED DICT REG ACT MED; Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040; Leroux-Roels I, 2013, VACCINE, V31, P2196, DOI 10.1016/j.vaccine.2012.05.035; Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Plentz A, 2009, VACCINE, V27, P853, DOI 10.1016/j.vaccine.2008.11.082; Roman F, 2010, VACCINE, V28, P1740, DOI 10.1016/j.vaccine.2009.12.014; Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7; Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916; Simasathien S, 2008, AM J TROP MED HYG, V78, P426, DOI 10.4269/ajtmh.2008.78.426; Simmons M, 2010, VIROLOGY, V396, P280, DOI 10.1016/j.virol.2009.10.023; Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361; Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037; Yauch LE, 2014, ADV VIRUS RES, V88, P315, DOI 10.1016/B978-0-12-800098-4.00007-6	24	7	7	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	96	6					1325	1337		10.4269/ajtmh.16-0634				13	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	FA7WW	WOS:000405659100011	28719287	Green Published, Other Gold			2019-04-02	
J	Diro, E; Yansouni, CP; Takele, Y; Mengesha, B; Lynen, L; Hailu, A; van Griensven, J; Boelaert, M; Bucher, P				Diro, Ermias; Yansouni, Cedric P.; Takele, Yegnasew; Mengesha, Bewketu; Lynen, Lutgarde; Hailu, Asrat; van Griensven, Johan; Boelaert, Marleen; Buscher, Philippe			Diagnosis of Visceral Leishmaniasis Using Peripheral Blood Microscopy in Ethiopia: A Prospective Phase-III Study of the Diagnostic Performance of Different Concentration Techniques Compared to Tissue Aspiration	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							DISCREPANT ANALYSIS; KALA-AZAR; DEFENSE; TESTS	Visceral leishmaniasis (VL) is a fatal parasitic disease. Unfortunately, diagnosis of VL in east Africa currently relies on aspiration of tissue from the spleen or bone marrow, which is painful and potentially dangerous. We sought to determine whether peripheral blood could be used instead of invasive tissue aspirates to diagnose VL, using three parasite concentration techniques. Three hundred and one consecutive people suspected of having VL were recruited. Compared with microscopy of tissue aspirates, the diagnostic accuracy of peripheral blood microscopy was as follows: whole blood thin smear sensitivity 1.5% (95% confidence interval [CI] 0.0-8.3) and specificity 100% (95% CI 76.8-100); buffy-coat smear sensitivity 19.5% (95% CI 14.3-25.6) and specificity 98.9% (95% CI 94.1-100); peripheral blood mononuclear cell (PBMC) smear sensitivity 33.7% (95% CI 27.3-40.5) and specificity 95.7% (95% CI 89.6-98.6). Sensitivity of PBMC smears was significantly higher in human immunodeficiency virus (HIV)-coinfected patients (N = 48/301); two-sample test of proportions, P = 0.0097; sensitivity 55.9% (95% CI 37.972.8) and specificity 92.9% (95% CI 66.1-99.8), and correlated with the degree of parasite load in the tissue. Combining the results from smears of both PBMC and buffy coat yielded a sensitivity and specificity of 67.6% (95% CI 49.1-82.6) and 92.9% (95% CI 66.1-99.8), respectively, in HIV-coinfected patients. In this setting, VL could be ruled-in with peripheral blood microscopy in a substantial number of VL suspects and may reduce the number of tissue aspirations performed, particularly in HIV-coinfected patients. More sensitive and logistically feasible methods than light microscopy are needed to detect Leishmania donovani parasites present in blood.	[Diro, Ermias; Takele, Yegnasew; Mengesha, Bewketu] Univ Gondar, Gondar, Ethiopia; [Yansouni, Cedric P.] McGill Univ, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada; [Diro, Ermias; Lynen, Lutgarde; van Griensven, Johan; Boelaert, Marleen; Buscher, Philippe] lnst of Trop Med, Antwerp, Belgium; [Hailu, Asrat] Univ Addis Ababa, Coll Hlth Sci, Sch Med, Addis Ababa, Ethiopia	Yansouni, CP (reprint author), McGill Univ, Div Infectious Dis, Dept Microbiol, JD MacLean Ctr Trop Dis,McGill Univ Hlth Ctr, 1001 Decarie Blvd,Room EM3-3242, Montreal, PQ H4A 3J1, Canada.	cedric.yansouni@mcgill.ca	Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Boelaert, Marleen/0000-0001-8051-6776; Buscher, Philippe/0000-0002-1926-7472	AIDS Mecenaat at Institute of Tropical Medicine (ITM); Belgian Directorate General for Development Cooperation under the ITM-DGDC; European Union [305178]; Fonds de recherche du Quebec-Sante (FRQS)	This study was supported by a grant from AIDS Mecenaat at Institute of Tropical Medicine (ITM). Ermias Diro has received a PhD scholarship granted from the Belgian Directorate General for Development Cooperation under the ITM-DGDC framework agreement FA-III and from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 305178 via AfriCoLeish project. Cedric Yansouni holds a "Chercheur-boursier clinicien" career award from the Fonds de recherche du Quebec-Sante (FRQS).	Alvar J, 2007, AM J TROP MED HYG, V77, P275; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Bern C, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000313; Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72; Boelaert M, 1999, TROP MED INT HEALTH, V4, P395, DOI 10.1046/j.1365-3156.1999.00421.x; Boelaert M, 2014, COCHRANE DB SYST REV, V6, DOI DOI 10.1002/14651858.CD009135.PUB2; Boelart M, 2007, NATURE REV MICROBIOL, V1, pS30, DOI DOI 10.1038/NRMICRO1766; Chemli J, 2006, MED MALADIES INFECT, V36, P390, DOI 10.1016/j.medmal.2006.02.003; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; Deniau M, 2003, ANN TROP MED PARASIT, V97, P115, DOI 10.1179/000349803225002598; Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869; Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002875; Gidwani K, 2011, CLIN VACCINE IMMUNOL, V18, P346, DOI 10.1128/CVI.00473-10; Green TA, 2001, J CLIN EPIDEMIOL, V54, P210, DOI 10.1016/S0895-4356(00)00288-2; IZRI MA, 1993, PRESSE MED, V22, P1010; Izri MA, 1996, B WORLD HEALTH ORGAN, V74, P91; Lipman HB, 1998, CLIN CHEM, V44, P108; Medrano FJ, 1998, AM J TROP MED HYG, V59, P155, DOI 10.4269/ajtmh.1998.59.155; Petithory JC, 1997, AM J TROP MED HYG, V57, P637, DOI 10.4269/ajtmh.1997.57.637; Schachter J, 2001, J CLIN EPIDEMIOL, V54, P211, DOI 10.1016/S0895-4356(00)00289-4; ter Horst R, 2008, CLIN INFECT DIS, V46, P1702, DOI 10.1086/587899; van Griensven J, 2012, INFECT DIS CLIN N AM, V26, P309, DOI 10.1016/j.idc.2012.03.005; WHO, 2010, WHO TECH REP SER, V949, P1	23	4	4	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	JAN	2017	96	1					190	196		10.4269/ajtmh.16-0362				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EQ1IH	WOS:000397822900034	27799651	Green Published, Bronze			2019-04-02	
J	Ravinetto, R				Ravinetto, Raffaella			Noma: Time to Address a Collective Moral Failure	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Editorial Material									[Ravinetto, Raffaella] Inst Trop Med, Dept Publ Hlth, Natl Str 155, B-2000 Antwerp, Belgium	Ravinetto, R (reprint author), Inst Trop Med, Dept Publ Hlth, Natl Str 155, B-2000 Antwerp, Belgium.	rravinetto@itg.be					Ashok Nipun, 2015, Glob J Health Sci, V8, P53, DOI 10.5539/gjhs.v8n4p53; Beyrer C, 2007, LANCET, V370, P619, DOI 10.1016/S0140-6736(07)61301-4; Burki T, 2016, LANCET INFECT DIS, V16, P1231, DOI 10.1016/S1473-3099(16)30420-0; Dias M, 2016, MYCETOMA NEGLECT TRO; Garcia-Moro M, 2015, REV ESP QUIM, V28, P225; Marck KW, 2013, LANCET GLOB HEALTH, V1, pE58, DOI 10.1016/S2214-109X(13)70035-4; Office of the High Commissioner for Human Rights, 2000, CESCR GEN COMM NO 14; Srour ML, 2017, AM J TROP MED HYG, V96, P268, DOI 10.4269/ajtmh.16-0718; Srour ML, 2015, INT HEALTH, V7, P149, DOI 10.1093/inthealth/ihv001; Summers LH, 2015, LANCET, V386, P2112; The World Health Organization Strategic and Technical Advisory Group for Neglected Tropical Diseases (WHO STAG), 2016, REC AD ADD DIS NEGL; Wali IM, 2016, J ELECT TEST, P1	12	0	0	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	96	2					263	264		10.4269/ajtmh.16-0997				2	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EV4XP	WOS:000401767400002	28115663	Other Gold, Green Published			2019-04-02	
J	Shindano, TA; Bahizire, E; Fiasse, R; Horsmans, Y				Shindano, Tony Akilimali; Bahizire, Esto; Fiasse, Rene; Horsmans, Yves			Knowledge, Attitudes, and Practices of Health-Care Workers about Viral Hepatitis B and C in South Kivu	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							NEEDLESTICK INJURIES; RISK; PROFESSIONALS; INFECTION; EXPOSURE; BLOOD	Health-care workers (HCWs) are at risk of infections associated with accidental exposure to blood, including viral hepatitis B (HBV) and C (HCV). A survey using a questionnaire was conducted on 250 HCW in Bukavu, an eastern town of the Democratic Republic of Congo, to analyze their attitude and knowledge about these two viruses. A response rate of 86.8% (217/250) was obtained. The mean age of the respondents was 39.6 +/- 9.8 years, in majority from paramedical staff (66.4%) and with more than 5 years of professional experience (60.8%). The mean proportion of adequate answers on HBV and HCV was 33.2% (+/- 11%) and 30.6% (+/- 7%), respectively. Ninety-three HCW (42.8%) reported recent experience of blood exposure accident, more frequently among the paramedical staff (50%) than physicians (28.8%; P = 0.002). This was mainly related to inadequate protection resources (76.9%). Among all participants, only 24.4% had a history of at least one injection of HBV vaccine; this was more frequently found among physicians than among paramedical staff (49.3% versus 11.8%; P < 0.001). Moreover, only 3.8% of vaccinated HCW received the complete vaccination schedule of three vaccine doses. The efficiency of this vaccine is not well recognized by HCW, and the majority of them seemed to be more worried about the risk of infection by human immunodeficiency virus than by viral hepatitis. Our study reveals that the level of knowledge about HBV and HCV is rather low among HCW in Bukavu.	[Shindano, Tony Akilimali] Univ Catholique Bukavu, Dept Internal Med, Bukavu, DEM REP CONGO; [Shindano, Tony Akilimali; Fiasse, Rene; Horsmans, Yves] UCL, Clin Univ St Luc, Dept Hepatogastroenterol, Ave Hippocrate10, B-1200 Brussels, Belgium; [Bahizire, Esto] Ctr Rech Sci Nat Lwiro, Bukavu, DEM REP CONGO; [Bahizire, Esto] Univ Nairobi, Dept Microbiol, Nairobi, Kenya	Horsmans, Y (reprint author), UCL, Clin Univ St Luc, Dept Hepatogastroenterol, Ave Hippocrate10, B-1200 Brussels, Belgium.	yves.horsmans@uclouvain.be					Alam M, 2002, ANN SAUDI MED, V22, P396, DOI 10.5144/0256-4947.2002.396; Askarian M, 2011, INT J OCCUP ENV MED, V2, P191; Askarian M, 2007, ANN EPIDEMIOL, V17, P988, DOI 10.1016/j.annepidem.2007.07.106; Bagny A, 2013, MED SANTE TROP, V23, P300, DOI 10.1684/mst.2013.0227; Benie J, 2008, SANTE PUBLIQUE, V7, P7; De Carli G, 2014, BIOCHEM MEDICA, V24, P45, DOI 10.11613/BM.2014.007; De Schryver A, 2011, EUR J PUBLIC HEALTH, V21, P338, DOI 10.1093/eurpub/ckq122; Doebbeling BN, 2003, CLIN INFECT DIS, V37, P1006, DOI 10.1086/377535; HEALD AE, 1990, J GEN INTERN MED, V5, P389, DOI 10.1007/BF02599422; Joukar F, 2012, WORLD J GASTROENTERO, V18, P2238, DOI 10.3748/wjg.v18.i18.2238; Kabinda J. M., 2014, Open Journal of Preventive Medicine, V4, P672, DOI 10.4236/ojpm.2014.48076; Kabir A, 2010, HEPAT MON, V10, P176; Kateera F, 2015, T ROY SOC TROP MED H, V109, P203, DOI 10.1093/trstmh/trv004; Laraqui O, 2009, SANTE PUBLIQUE, V21, P271, DOI 10.3917/spub.093.0271; ONEILL TM, 1992, ARCH INTERN MED, V152, P1451, DOI 10.1001/archinte.152.7.1451; Pol S, 2012, CONTRIB NEPHROL, V176, P1, DOI 10.1159/000332374; Puro V, 2005, Euro Surveill, V10, P260; Richmond JA, 2007, J VIRAL HEPATITIS, V14, P624, DOI 10.1111/j.1365-2893.2007.00849.x; Sagoe-Moses C, 2001, NEW ENGL J MED, V345, P538, DOI 10.1056/NEJM200108163450711; Saleh DA, 2009, J EGYPT PUBLIC HEAL, V84, P423; Vos D, 2006, AM J INFECT CONTROL, V34, P610, DOI 10.1016/j.ajic.2006.02.004; WHO, 2015, HEP B; Wilburn SQ, 2004, INT J OCCUP ENV HEAL, V10, P451, DOI 10.1179/oeh.2004.10.4.451; World Health Organization, 2015, HEP FACT SHEET; Ziraba AK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-191	25	9	9	1	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	96	2					400	404		10.4269/ajtmh.16-0287				5	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EV4XP	WOS:000401767400026	27920392	Green Published, Bronze			2019-04-02	
J	Conteh, S; Anderson, C; Lambert, L; Orr-Gonzalez, S; Herrod, J; Robbins, YL; Carter, D; Karhemere, SBS; Pyana, P; Buscher, P; Duffy, PE				Conteh, Solomon; Anderson, Charles; Lambert, Lynn; Orr-Gonzalez, Sachy; Herrod, Jessica; Robbins, Yvette L.; Carter, Dariyen; Karhemere, Stomy Bin Shamamba; Pyana, Pati; Buscher, Philippe; Duffy, Patrick E.			Grammomys surdaster, the Natural Host for Plasmodium berghei Parasites, as a Model to Study Whole-Organism Vaccines against Malaria	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							THAMNOMYS-SURDASTER; FALCIPARUM SPOROZOITES; TREE-RAT; IMMUNIZATION; PROTECTION; PHYLOGENY; INFECTION; RADIATION; SUSCEPTIBILITY; VIRULENCE	Inbred mice are commonly used to test candidate malaria vaccines, but have been unreliable for predicting efficacy in humans. To establish a more rigorous animal model, we acquired African woodland thicket rats of the genus Grammomys, the natural hosts for Plasmodium berghei. Thicket rats were acquired and identified as Grammomys surdaster by skull and teeth measurements and mitochondrial DNA genotyping. Herein, we demonstrate that thicket rats are highly susceptible to infection by P. berghei, and moderately susceptible to Plasmodium yoelii and Plasmodium chabaudi: 1-2 infected mosquito bites or 25-100 sporozoites administered by intravenous injection consistently resulted in patent parasitemia with P. berghei, and resulted in patent parasitemia with P. yoelii and P. chabaudi strains for at least 50% of animals. We then assessed efficacy of whole-organism vaccines to induce sterile immunity, and compared the thicket rat model to conventional mouse models. Using P. berghei ANKA radiation-attenuated sporozoites, and P. berghei ANKA and P. yoelii chemoprophylaxis vaccination approaches, we found that standard doses of vaccine sufficient to protect laboratory mice for a long duration against malaria challenge, are insufficient to protect thicket rats, which require higher doses of vaccine to achieve even short-term sterile immunity. Thicket rats may offer a more stringent and pertinent model for evaluating whole-organism vaccines.	[Conteh, Solomon; Anderson, Charles; Lambert, Lynn; Orr-Gonzalez, Sachy; Herrod, Jessica; Robbins, Yvette L.; Carter, Dariyen; Duffy, Patrick E.] NIAID, Lab Malaria Immunol & Vaccinol, NIH, 5640 Fishers Lane,TWB1-1111, Rockville, MD 20852 USA; [Karhemere, Stomy Bin Shamamba; Pyana, Pati] INRB, Dept Parasitol, Kinshasa, DEM REP CONGO; [Buscher, Philippe] Inst Trop Med, Unit Parasite Diagnost, Dept Biomed Sci, Antwerp, Belgium	Duffy, PE (reprint author), NIAID, Lab Malaria Immunol & Vaccinol, NIH, 5640 Fishers Lane,TWB1-1111, Rockville, MD 20852 USA.	patrick.duffy@nih.gov		Buscher, Philippe/0000-0002-1926-7472	Intramural Research Program of the National Institute for Allergy and Infectious Disease of the National Institutes of Health	This research was supported and funded by the Intramural Research Program of the National Institute for Allergy and Infectious Disease of the National Institutes of Health.	BRAY RS, 1976, T ROY SOC TROP MED H, V70, P258, DOI 10.1016/0035-9203(76)90054-7; Buscher P, 2005, TROP MED INT HEALTH, V10, P850, DOI 10.1111/j.1365-3156.2005.01468.x; Center LUM, PLASM BERGH LIF HIST; Chatterjee S, 2006, J POSTGRAD MED, V52, P321; Chatterjee S, 2001, Afr J Med Med Sci, V30 Suppl, P25; Chattopadhyay R, 2009, VACCINE, V27, P3675, DOI 10.1016/j.vaccine.2008.11.073; De Niz M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11659; EDELMAN R, 1993, J INFECT DIS, V168, P1066, DOI 10.1093/infdis/168.4.1066; Happold DCD, 2013, GRAMMOMYS DOLICHURUS, V3, P410; HERRINGTON D, 1991, AM J TROP MED HYG, V45, P539, DOI 10.4269/ajtmh.1991.45.539; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; JAFFE RI, 1990, AM J TROP MED HYG, V42, P309, DOI 10.4269/ajtmh.1990.42.309; KILLICKKENDRICK R, 1974, PARASITOLOGY, V69, P225, DOI 10.1017/S0031182000048071; Larremore DB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9368; Lecompte E, 2002, CR BIOL, V325, P827, DOI 10.1016/S1631-0691(02)01488-9; Matuschewski K, 2011, HUM VACCINES, V7, P16, DOI 10.4161/hv.7.0.14557; Musser G. G., 2005, MAMMAL SPECIES WORLD, P894; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.2307/3285540; Perkins SL, 2007, INFECT GENET EVOL, V7, P74, DOI 10.1016/j.meegid.2006.04.005; Perkins SL, 2008, MITOCHONDR DNA, V19, P471, DOI 10.1080/19401730802570926; Schwan TG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001924; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Siu E, 2015, ANN NY ACAD SCI, V1342, P29, DOI 10.1111/nyas.12618; Waters H, 2011, BETTER ANIMAL MODELS; YOELI M, 1963, SCIENCE, V142, P1585, DOI 10.1126/science.142.3599.1585; YOELI M, 1964, AM J TROP MED HYG, V13, P659, DOI 10.4269/ajtmh.1964.13.659; YOELI M, 1974, T ROY SOC TROP MED H, V68, P302, DOI 10.1016/0035-9203(74)90037-6	27	1	1	1	8	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.		2017	96	4					835	841		10.4269/ajtmh.16-0745				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EV4WA	WOS:000401763000015	28115674	Bronze, Green Published			2019-04-02	
J	Camara, BS; Delamou, A; Diro, E; Beavogui, AH; El Ayadi, AM; Sidibe, S; Grovogui, FM; Takarinda, KC; Bouedouno, P; Sandouno, SD; Okumura, J; Balde, MD; Van Griensven, J; Zachariah, R				Camara, Bienvenu S.; Delamou, Alexandre; Diro, Ermias; Beavogui, Abdoul H.; El Ayadi, Alison M.; Sidibe, Sidikiba; Grovogui, Fassou M.; Takarinda, Kudakwashe C.; Bouedouno, Patrice; Sandouno, Sah D.; Okumura, Junko; Balde, Mamadou D.; Van Griensven, Johan; Zachariah, Rony			Effect of the 2014/2015 Ebola outbreak on reproductive health services in a rural district of Guinea: an ecological study	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Ebola; Guinea; Health service utilization; Health systems; Operational research; Sustainable Development Goals	AFRICA; EPIDEMIOLOGY; CARE	Background: The 2014/2015 Ebola outbreak was the most sustained in history. In Guinea, we compared trends in family planning, antenatal care, and institutional deliveries over the period before, during and after the outbreak. Methods: We carried out an ecological study involving all the health facilities during pre-Ebola (1 March 2013 to 28 February 2014), intra-Ebola (1 March 2014 to 28 February 2015) and post-Ebola (1 March to 31 July 2016) periods in Macenta district. Results: Utilization of family planning declined from a monthly average of 531 visits during the pre-Ebola period to 242 visits in the peak month of the Ebola outbreak (51% decline) but recovered in the post-Ebola period. From a monthly average of 2053 visits pre-Ebola, antenatal care visits declined by 41% during Ebola and then recovered to only 63% of the pre-Ebola level (recovery gap of 37%, p < 0.001). From a monthly average of 1223 deliveries pre-Ebola, institutional deliveries also declined during Ebola and then recovered to only 66% of the pre-Ebola level (p < 0.001). Conclusions: All services assessed were affected by Ebola. Family planning recovered post-Ebola; however, shortfalls were observed in recovery of antenatal care and institutional deliveries. We call for stronger political will, international support and generous funding to change the current state of affairs.	[Camara, Bienvenu S.; Delamou, Alexandre; Sidibe, Sidikiba; Sandouno, Sah D.; Balde, Mamadou D.] Gamal Univ Conakry, Dept Publ Hlth, Conakry, Guinea; [Delamou, Alexandre] Inst Trop Med, Woman & Child Hlth Res Ctr, Antwerp, Belgium; [Diro, Ermias] Univ Gondar, Gondar, Ethiopia; [Beavogui, Abdoul H.; Grovogui, Fassou M.; Bouedouno, Patrice] Ctr Natl Format & Rech Sante Rurale Maferinya, Forecariah, Guinea; [El Ayadi, Alison M.] Univ Calif San Francisco, Bixby Ctr Global Reprod Hlth, San Francisco, CA USA; [Takarinda, Kudakwashe C.] Int Union TB & Lung Dis, Paris, France; [Okumura, Junko] Nagasaki Univ, Inst Trop Med, Nagasaki, Japan; [Van Griensven, Johan] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Zachariah, Rony] Brussels Operat Ctr LuxOR, Meds Sans Frontisres, Luxembourg, Luxembourg	Camara, BS (reprint author), Gamal Univ Conakry, Dept Publ Hlth, Conakry, Guinea.	bienvenusalimcamara@gmail.com			United Kingdom's Department for International Development (DFID),; The Union, MSF; La Fondation Veuve Emile Metz-Tesch (Luxembourg)	The program was funded by the United Kingdom's Department for International Development (DFID), The Union, MSF and La Fondation Veuve Emile Metz-Tesch (Luxembourg). La Fondation Veuve Emile MetzTesch supported open access publications costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Black BO, 2015, OBSTET MED, V8, P108, DOI 10.1177/1753495X15597354; Bolkan HA, 2014, PLOS CURR, V6; Coordination Nationale Ebola en Guinee et OMS, 2015, 319 COORD NAT EB GUI; Dallatomasina S, 2015, TROP MED INT HEALTH, V20, P448, DOI 10.1111/tmi.12454; Delamou A, 2017, LANCET GLOB HLTH; Delamou A, 2017, BMJ GLOB HLTH; Delamou A, 2015, LANCET, V385, P503, DOI 10.1016/S0140-6736(15)60193-3; Delamou A, 2014, LANCET, V384, P2105, DOI 10.1016/S0140-6736(14)62364-3; Elston JW, 2015, J PUBLIC HLTH, V27; Evans DK, 2015, 7344 WPS WORLD BANK, P17; Gostin LO, 2014, JAMA-J AM MED ASSOC, V312, P1095, DOI 10.1001/jama.2014.11176; Leuenberger D, 2015, AIDS, V29, P1883, DOI 10.1097/QAD.0000000000000784; Ministere de la Sante et de lHygiene Publique de Guinee, 2015, ANN STAT SAN NAT 201; Plucinski MM, 2015, LANCET INFECT DIS, V15, P1017, DOI 10.1016/S1473-3099(15)00061-4; Ribacke KJB, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00222; Tayler-Smith K, 2013, TROP MED INT HEALTH, V18, P166, DOI 10.1111/tmi.12022; The DHS Program, GUIN DHA 2012 FIN RE; Thiam AB, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.379.6070, 10.11694/pamj.supp.2015.22.1.6626]; United Nations, 2008, ACH MILL DEV GOALS A; United Nations (UN), 2015, SUST DEV GOALS 17 GO; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO, 2016, WHO GUID MAT REPR WO; WHO, 2016, LAT UPD EB OUTBR; WHO UNFPA UNICEF and AMDD, 2009, MON EM OBST CAR HDB; World Bank, 2016, OP DAT PHYS PER 1000; World Health Organization, 2016, EB RESP ROADM SIT RE; World Health Organization, 2015, WORLD HLTH STAT 2015; Zachariah R, 2015, INT J TUBERC LUNG D, V19, P1271, DOI 10.5588/ijtld.15.0355; Zachariah R, 2011, T ROY SOC TROP MED H, V105, P301, DOI 10.1016/j.trstmh.2011.03.002	29	2	2	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	JAN	2017	111	1					22	29		10.1093/trstmh/trx009				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EQ9GO	WOS:000398393100005	28340207	Bronze, Green Published			2019-04-02	
J	Lagatie, O; Van Dorst, B; Stuyver, LJ				Lagatie, Ole; Van Dorst, Bieke; Stuyver, Lieven J.			Identification of three immunodominant motifs with atypical isotype profile scattered over the Onchocerca volvulus proteome	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SOIL-TRANSMITTED HELMINTHIASIS; ERYTHROCYTE-MEMBRANE PROTEIN-1; NEGLECTED TROPICAL DISEASES; LINKED-IMMUNOSORBENT-ASSAY; JC POLYOMAVIRUS INFECTION; SOUTH-WEST CAMEROON; PLASMODIUM-FALCIPARUM; IMMUNE MODULATION; RIVER-BLINDNESS; MECHANISMS	Understanding the immune response upon infection with the filarial nematode Onchocerca volvulus and the mechanisms that evolved in this parasite to evade immune mediated elimination is essential to expand the toolbox available for diagnostics, therapeutics and vaccines development. Using high-density peptide microarrays we scanned the proteome-wide linear epitope repertoire in Cameroonian onchocerciasis patients and healthy controls from Southern Africa which led to the identification of 249 immunodominant antigenic peptides. Motif analysis learned that 3 immunodominant motifs, encompassing 3 linear epitopes, are present in 70, 43, and 31 of these peptides, respectively and appear to be scattered over the entire proteome in seemingly non-related proteins. These linear epitopes are shown to have an atypical isotype profile dominated by IgG1, IgG3, IgE and IgM, in contrast to the commonly observed IgG4 response in chronic active helminth infections. The identification of these linear epitope motifs may lead to novel diagnostic development but further evaluation of cross-reactivity against common co-infecting human nematode infections will be needed.	[Lagatie, Ole; Van Dorst, Bieke; Stuyver, Lieven J.] Janssen Pharmaceut NV, Janssen Diagnost, Beerse, Belgium	Lagatie, O (reprint author), Janssen Pharmaceut NV, Janssen Diagnost, Beerse, Belgium.	olagatie@its.jnj.com		Lagatie, Ole/0000-0002-0638-1313			Adjobimey T, 2010, ANN TROP MED PARASIT, V104, P455, DOI 10.1179/136485910X12786389891407; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Borup LH, 2003, CUTIS, V72, P297; CABRERA Z, 1989, TROP MED PARASITOL, V40, P454; Carmona SJ, 2015, MOL CELL PROTEOMICS, V14, P1871, DOI 10.1074/mcp.M114.045906; Carmona SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050748; Carvalho L, 2009, IMMUNOLOGY, V126, P28, DOI 10.1111/j.1365-2567.2008.03008.x; Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103; DAFAALLA TH, 1992, CLIN EXP IMMUNOL, V88, P258; Danilowicz-Luebert E, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/821578; Dubois ME, 2012, VECTOR-BORNE ZOONOT, V12, P400, DOI 10.1089/vbz.2011.0779; Enk CD, 2006, CLIN DERMATOL, V24, P176, DOI 10.1016/j.clindermatol.2005.11.008; Gbakima AA, 1996, CLIN DIAGN LAB IMMUN, V3, P98; Golden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069231; Hewitson JP, 2009, MOL BIOCHEM PARASIT, V167, P1, DOI 10.1016/j.molbiopara.2009.04.008; Holmes P, 2014, LANCET, V383, P1803, DOI 10.1016/S0140-6736(14)60875-8; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Jackson JA, 2009, IMMUNOLOGY, V126, P18, DOI 10.1111/j.1365-2567.2008.03010.x; Joergensen L, 2007, J IMMUNOL, V178, P428, DOI 10.4049/jimmunol.178.1.428; KAUR P, 1990, INT J PEPT PROT RES, V36, P515; KOLLO B, 1995, AM J TROP MED HYG, V53, P243, DOI 10.4269/ajtmh.1995.53.243; Lagatie O, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-174; Lagatie O, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-158; Lagatie O, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-41; Liang FT, 1999, J CLIN MICROBIOL, V37, P3990; Lipner EM, 2006, J INFECT DIS, V194, P216, DOI 10.1086/505081; LUCIUS R, 1992, TROP MED PARASITOL, V43, P139; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Maizels RM, 2016, J ALLERGY CLIN IMMUN; Melnyk O, 2002, BIOCONJUGATE CHEM, V13, P713, DOI 10.1021/bc015584o; Mpagi JL, 2000, PARASITE IMMUNOL, V22, P455, DOI 10.1046/j.1365-3024.2000.00325.x; Nana-Djeunga HC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004001; Pellois JP, 2002, NAT BIOTECHNOL, V20, P922, DOI 10.1038/nbt723; Pion SDS, 2006, PARASITOLOGY, V132, P843, DOI 10.1017/S003118200600984X; PORSTMANN T, 1993, J IMMUNOL METHODS, V158, P95, DOI 10.1016/0022-1759(93)90262-6; Renard BY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-324; Satoguina J, 2002, MICROBES INFECT, V4, P1291, DOI 10.1016/S1286-4579(02)00014-X; Senczuk AM, 2001, BLOOD, V98, P3132, DOI 10.1182/blood.V98.10.3132; Shin SY, 1997, BIOCHEM MOL BIOL INT, V43, P713; Smyth GK, 2004, STAT APPL GENET MOL, V3, P1, DOI DOI 10.2202/1544-6115.1027; STAHL HD, 1985, P NATL ACAD SCI USA, V82, P543, DOI 10.1073/pnas.82.2.543; STAHL HD, 1987, MOL BIOL MED, V4, P199; Steel C, 2015, CLIN VACCINE IMMUNOL, V22, P896, DOI 10.1128/CVI.00227-15; Stuyver LJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-192; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; TAYLOR HR, 1989, AM J TROP MED HYG, V41, P467, DOI 10.4269/ajtmh.1989.41.467; Tchuente LAT, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-602; Tchuente LAT, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001553; Thomson MC, 2004, FILARIA J, V3, P7, DOI DOI 10.1186/1475-2883-3-7; TSANG VCW, 1991, J IMMUNOL, V146, P3993; Van Loy T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070950; van Riet E, 2007, IMMUNOBIOLOGY, V212, P475, DOI 10.1016/j.imbio.2007.03.009; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wanji S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1595-1; Wanji S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0817-2; Weil GJ, 2000, J INFECT DIS, V182, P1796, DOI 10.1086/317629; Winthrop KL, 2006, AM J TROP MED HYG, V75, P1058	60	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2017	11	1							e0005330	10.1371/journal.pntd.0005330				21	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EK8CR	WOS:000394152000080	28125577	DOAJ Gold, Green Published			2019-04-02	
J	Maleki-Ravasan, N; Solhjouy-Fard, S; Beaucournu, JC; Laudisoit, A; Mostafavi, E				Maleki-Ravasan, Naseh; Solhjouy-Fard, Samaneh; Beaucournu, Jean-Claude; Laudisoit, Anne; Mostafavi, Ehsan			The Fleas (Siphonaptera) in Iran: Diversity, Host Range, and Medical Importance	PLOS NEGLECTED TROPICAL DISEASES			English	Article							CUTANEOUS LEISHMANIASIS; ECTOPARASITE INFESTATIONS; RICKETTSIA-FELIS; BORNE DISEASES; WESTERN IRAN; VECTOR; PLAGUE; FAUNA; DOGS; PROVINCE	Background Flea-borne diseases have a wide distribution in the world. Studies on the identity, abundance, distribution and seasonality of the potential vectors of pathogenic agents (e.g. Yersinia pestis, Francisella tularensis, and Rickettsia felis) are necessary tools for controlling and preventing such diseases outbreaks. The improvements of diagnostic tools are partly responsible for an easier detection of otherwise unnoticed agents in the ectoparasitic fauna and as such a good taxonomical knowledge of the potential vectors is crucial. The aims of this study were to make an exhaustive inventory of the literature on the fleas (Siphonaptera) and range of associated hosts in Iran, present their known distribution, and discuss their medical importance. Methodology/Principal Findings The data were obtained by an extensive literature review related to medically significant fleas in Iran published before 31st August 2016. The flea-host specificity was then determined using a family and subfamily-oriented criteria to further realize and quantify the shared and exclusive vertebrate hosts of fleas among Iran fleas. The locations sampled and reported in the literature were primarily from human habitation, livestock farms, poultry, and rodents' burrows of the 31 provinces of the country. The flea fauna were dominated by seven families, namely the Ceratophyllidae, Leptopsyllidae, Pulicidae, Ctenophthalmidae, Coptopsyllidae, Ischnopsyllidae and Vermipsyllidae. The hosts associated with Iran fleas ranged from the small and large mammals to the birds. Pulicidae were associated with 73% (56/77) of identified host species. Flea-host association analysis indicates that rodents are the common hosts of 5 flea families but some sampling bias results in the reduced number of bird host sampled. Analyses of flea-host relationships at the subfamily level showed that most vertebrates hosted fleas belgonging to 3 subfamilies namely Xenopsyllinae (n = 43), Ctenophthalminae (n = 20) and Amphipsyllinae (n = 17). Meriones persicus was infested by 11 flea subfamilies in the arid, rocky, mountainous regions and Xenopsyllinae were hosted by at least 43 mammal species. These findings place the Persian jird (M. persicus) and the Xenopsyllinae as the major vertebrate and vector hosts of flea-borne diseases in Iran including Yersinia pestis, the etiological agent of plague. We found records of at least seven vector-borne pathogenic agents that can potentially be transmitted by the 117 flea species (or subspecies) of Iran. Conclusions/Significance Herein, we performed a thorough inventary of the flea species and their associated hosts, their medical importance and geographic distribution throughout Iran. This exercise allowed assessing the diversity of flea species with the potential flea-borne agents transmission risk in the country by arranging published data on flea-host associations. This information is a first step for issuing public health policies and rodent-flea control campaigns in Iran as well as those interested in the ecology/epidemiology of flea-borne disease.	[Maleki-Ravasan, Naseh] Pasteur Inst Iran, Malaria & Vector Res Grp, Biotechnol Res Ctr, Tehran, Iran; [Solhjouy-Fard, Samaneh; Mostafavi, Ehsan] Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Kabudar Ahang, Hamadan, Iran; [Solhjouy-Fard, Samaneh; Mostafavi, Ehsan] Pasteur Inst Iran, Dept Epidemiol & Biostat, Tehran, Iran; [Beaucournu, Jean-Claude] Univ Rennes, France Fac Med, Rennes, France; [Beaucournu, Jean-Claude] Univ Rennes, Western Insitute Parasitol, Rennes, France; [Laudisoit, Anne] Univ Antwerp, Evolutionary Biol Grp, Antwerp, Belgium; [Laudisoit, Anne] Univ Liverpool, Sch Biol Sci, Liverpool, Merseyside, England; [Laudisoit, Anne] CIFOR, Jalan Cifor, Bogor Bar, Jawa Barat, Indonesia	Mostafavi, E (reprint author), Pasteur Inst Iran, Res Ctr Emerging & Reemerging Infect Dis, Kabudar Ahang, Hamadan, Iran.; Mostafavi, E (reprint author), Pasteur Inst Iran, Dept Epidemiol & Biostat, Tehran, Iran.	mostafaviehsan@gmail.com	Mostafavi, Ehsan/A-7627-2011	Mostafavi, Ehsan/0000-0002-1997-517X			Adams NE, 1995, AN ANNOTATED CATALOG; [Anonymous], 2012, PULICIDAE IN THE MIC; [Anonymous], 1999, REGIONAL DISEASE VEC; ARATA A, 1973, B WORLD HEALTH ORGAN, V49, P597; AZAD AF, 1987, J MED ENTOMOL, V24, P689, DOI 10.1093/jmedent/24.6.689; Bahrami A. M., 2012, World Applied Sciences Journal, V18, P884; BALTAZARD M, 1952, Bull World Health Organ, V5, P441; BALTAZARD M., 1963, BULL SOC PATHOL EXOTIQUE, V56, P1230; Baltazard M., 1960, Bulletin of the World Health Organization, V23, P141; BALTAZARD M, 1960, Bull World Health Organ, V23, P157; BALTAZARD M, 1960, Bull World Health Organ, V23, P169; BALTAZARD M, 1960, Bull World Health Organ, V23, P217; Baltazard M, 1951, BULLETIN OF THE WORL, V5, P441; BEAUCOURNU J C, 1975, Revista Iberica de Parasitologia, V35, P139; Beaucournu J-C, 2014, ANN SOC ENTOMOL FR; Beaucournu Jean-Claude, 2011, Bulletin de la Societe Entomologique de France, V116, P57; Ben Ari T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002160; Benda Petr, 2012, Acta Societatis Zoologicae Bohemicae, V76, P163; Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x; Bitam I, 2010, INT J INFECT DIS, V14, pE667, DOI 10.1016/j.ijid.2009.11.011; Blyummer A. G., 2004, Parazitologiya (St. Petersburg), V38, P261; Brouqui P, 2006, ANN NY ACAD SCI, V1078, P223, DOI 10.1196/annals.1374.041; Chen H. T., 1934, Zeitschrift fuer Parasitenkunde, V6, P603, DOI 10.1007/BF02123768; Comer JA, 2001, VECTOR-BORNE ZOONOT, V1, P91, DOI 10.1089/153036601316977714; Cook GC, 1996, MANSONS TROPICAL DIS; Crosskey RW, 1993, MEDICAL INSECTS AND; Darvishi Mohammad Mehdi, 2014, Asian Pacific Journal of Tropical Disease, V4, P85; Dehghani R., 2013, FEYZ, V17, P203; Dianat M, 2016, J ZOOLOG SYST EVOL R, P1; EDRISSIAN GH, 1975, T ROY SOC TROP MED H, V69, P517, DOI 10.1016/0035-9203(75)90113-3; Eisen RJ, 2012, ANNU REV ENTOMOL, V57, P61, DOI 10.1146/annurev-ento-120710-100717; Emami MM, 2009, T ROY SOC TROP MED H, V103, P1257, DOI 10.1016/j.trstmh.2009.04.020; Esamaeili S, 2013, EMERG INFECT DIS, V19, P1549, DOI 10.3201/eid1909.121829; Esmaeili S, 2014, INT J INFECT DIS, V18, P27, DOI 10.1016/j.ijid.2013.08.013; Fallah E., 2006, Archives of Razi Institute, V61, P27; Farhang-Azad A., 1969, Bull. Soc. Path. exot., V62, P750; FARHANG-AZAD A, 1972, Bulletin de la Societe de Pathologie Exotique, V65, P322; FARHANG-AZAD A, 1969, Bulletin de la Societe de Pathologie Exotique, V62, P151; Farhang-Azad A., 1972, PARAZITOLOGIYA, V6, P513; Farhang-Azad A., 1966, JOURNAL OF NATURAL H, V9, P337; Farhang-Azad A., 1966, JOURNAL OF NATURAL H, V9, P347; FARHANGA.A, 1966, ANN MAG NAT HIST, V9, P343; FARHANGA.A, 1973, J MED ENTOMOL, V10, P273, DOI 10.1093/jmedent/10.3.273; FARHANGA.A, 1972, J MED ENTOMOL, V9, P205, DOI 10.1093/jmedent/9.3.205; Faulde MK, VECTOR BORNE INFECTI; Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136; GOLVAN Y J, 1963, Bull Soc Pathol Exot Filiales, V56, P1145; Gomez-Diaz E, 2010, TRENDS PARASITOL, V26, P470, DOI 10.1016/j.pt.2010.06.007; GUZMAN RF, 1984, NEW ZEAL VET J, V32, P71, DOI 10.1080/00480169.1984.35067; Hanafi-Bojd A. A., 2007, Iranian Journal of Environmental Health Science & Engineering, V4, P173; HUNTER KW, 1979, J MED ENTOMOL, V16, P547, DOI 10.1093/jmedent/16.6.547; Iakuba V N, 1977, Parazitologiia, V11, P268; Jamshidi S, 2012, REV BRAS PARASITOL V, V21, P326, DOI 10.1590/S1984-29612012000300030; KARIMI Y, 1980, B SOC PATHOL EXOT, V73, P28; Kassiri H., 2011, Advanced Studies in Biology, V3, P247; Khoobdel M., 2012, Journal of School of Public Health & Institute of Public Health Research, V9, P63; Kia E, 2009, IRAN J ARTHROPOD BOR, V3; Kia EB, 2010, IRAN J PARASITOL, V5, P15; Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9; KLEIN J. -M, 1964, BULL SOC ENTOMOL FRANCE, V69, P174; KLEIN J. M., 1963, BULL SOC PATHOL EXOTIQUE, V56, P533; KLEIN J. M., 1967, Cahiers ORSTOM., V4, P31; KLEIN J. M., 1964, Bulletin de la Societe de Pathologie Exotique, V56, P1202; KLEIN J M, 1975, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V13, P29; KLEIN J M, 1975, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V13, P13; KLEIN J. M., 1962, BULL SOC PATHOL EXOT, V55, P900; KLEIN J. M., 1963, BULL SOC PATHOL EXOT, V56, P251; Kolenati FA, 1862, BEITRAGE ZUR KENNTNI; Kramer F, 2001, FLEA BIOLOGY AND CON; Krasnov BR, 2008, FUNCTIONAL AND EVOLU; LEWIS RE, 1993, J MED ENTOMOL, V30, P239, DOI 10.1093/jmedent/30.1.239; Lewis RE, 1998, J MED ENTOMOL, V35, P377, DOI 10.1093/jmedent/35.4.377; Lewis RE, 1973, SIPHONAPTERA COLLECT; Mohebali M, 2004, East Mediterr Health J, V10, P591; Mollaret H, 1962, B SOC PATHOL EXOT, V56, P1186; MOLLARET HH, 1968, CR ACAD SCI D NAT, V267, P972; Mosallanejad B, 2012, J ARTHROPOD-BORNE DI, V6, P70; Nateghpour M, 2013, TROP BIOMED, V30, P72; Oliveira RP, 2002, EMERG INFECT DIS, V8, P317, DOI 10.3201/eid0803.010301; Orf EC, 2004, INFECTIONS IN HUMANS; Oshaghi MA, 2009, J VECTOR DIS, V46, P247; Oskouizadeh K, 2010, IRAN J MICROBIOL, V2, P80; Parola P, 2011, CLIN MICROBIOL INFEC, V17, P996, DOI 10.1111/j.1469-0691.2011.03516.x; Peus F., 1976, FLOHE AUS ANATOLIEN; Poland JD, 1999, PLAGUE MANUAL EPIDEM, P55; Rahbari S, 2008, IRAN J PARASITOL, V3, P43; Rassi Y, 2001, IRAN J PUBLIC HEALTH, V30, P143; Razmjoo Mostafa, 2013, Global Veterinaria, V10, P626; SCHWAN TG, 1985, AM J TROP MED HYG, V34, P372, DOI 10.4269/ajtmh.1985.34.372; Seyf A, 1989, Stud Islam, P151, DOI 10.2307/1596071; Shoorijeh SJ, 2008, TURK J VET ANIM SCI, V32, P309; Smit F. G. A. M., 1960, Bulletin of the British Museum (Natural History) Entomology, V8, P337; Studies CfN, 2003, ANTI PLAGUE SERVICE; Telmadarraiy Z, 2007, IRAN J ARTHROPOD-BOR, V1, P58; Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942; Traub R, 1978, Trop Dis Bull, V75, P237; Triplehorn CA, 2005, BORROR AND DELONG S; Whiting MF, 2008, CLADISTICS, V24, P677, DOI 10.1111/j.1096-0031.2008.00211.x; Xhaxhiu D, 2009, PARASITOL RES, V105, P1577, DOI 10.1007/s00436-009-1591-x; Yaghoobi-Ershadi MR, 2001, ACTA TROP, V79, P115, DOI 10.1016/S0001-706X(01)00085-7; Yakhchali Mohammad, 2006, Veterinarski Arhiv, V76, P431; Yavar R, 2011, ASIAN PAC J TROP MED, V4, P97, DOI 10.1016/S1995-7645(11)60045-X; Yousefi Ali, 2015, Asian Pacific Journal of Tropical Disease, V5, P606; Zentko DC, 2011, CTENOCEPHALIDES FELI, P1; Zimba M, 2011, VECTOR-BORNE ZOONOT, V11, P1187, DOI 10.1089/vbz.2010.0095	105	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2017	11	1							e0005260	10.1371/journal.pntd.0005260				24	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EK8CR	WOS:000394152000039	28068343	DOAJ Gold, Green Published			2019-04-02	
J	Meurs, L; Polderman, AM; Melchers, NVSV; Brienen, EAT; Verweij, JJ; Groosjohan, B; Mendes, F; Mechendura, M; Hepp, DH; Langenberg, MCC; Edelenbosch, R; Polman, K; van Lieshout, L				Meurs, Lynn; Polderman, Anton M.; Melchers, Natalie V. S. Vinkeles; Brienen, Eric A. T.; Verweij, Jaco J.; Groosjohan, Bernhard; Mendes, Felisberto; Mechendura, Manito; Hepp, Dagmar H.; Langenberg, Marijke C. C.; Edelenbosch, Rosanne; Polman, Katja; van Lieshout, Lisette			Diagnosing Polyparasitism in a High-Prevalence Setting in Beira, Mozambique: Detection of Intestinal Parasites in Fecal Samples by Microscopy and Real-Time PCR	PLOS NEGLECTED TROPICAL DISEASES			English	Article							POLYMERASE-CHAIN-REACTION; NEGLECTED TROPICAL DISEASES; SOIL-TRANSMITTED HELMINTHS; PERSISTENT DIGESTIVE DISORDERS; SCHISTOSOMA-MANSONI DNA; KATO-KATZ TECHNIQUE; STRONGYLOIDES-STERCORALIS; GASTROINTESTINAL PARASITES; OESOPHAGOSTOMUM-BIFURCUM; ANCYLOSTOMA-DUODENALE	Background Many different intestinal parasite species can co-occur in the same population. However, classic diagnostic tools can only frame a particular group of intestinal parasite species. Hence, one or two tests do not suffice to provide a complete picture of infecting parasite species in a given population. The present study investigated intestinal parasitic infections in Beira, Mozambique, i.e. in the informal settlement of Inhamudima. Diagnostic accuracy of five classical microscopy techniques and real-time PCR for the detection of a broad spectrum of parasites was compared. Methodology/Principal Findings A cross-sectional population-based survey was performed. One stool sample per participant (n = 303) was examined by direct smear, formal-ether concentration (FEC), Kato smear, Baermann method, coproculture and real-time PCR. We found that virtually all people (96%) harbored at least one helminth, and that almost half (49%) harbored three helminths or more. Remarkably, Strongyloides stercoralis infections were widespread with a prevalence of 48%, and Ancylostoma spp. prevalence was higher than that of Necator americanus (25% versus 15%), the hookworm species that is often assumed to prevail in East-Africa. Among the microscopic techniques, FEC was able to detect the broadest spectrum of parasite species. However, FEC also missed a considerable number of infections, notablyS. stercoralis, Schistosoma mansoni and G. intestinalis. PCR outperformed microscopy in terms of sensitivity and range of parasite species detected. Conclusions/Significance We showed intestinal parasites D especially helminths D to be omnipresent in Inhamudima, Beira. However, it is a challenge to achieve high diagnostic sensitivity for all species. Classical techniques such as FEC are useful for the detection of some intestinal helminth species, but they lack sensitivity for other parasite species. PCR can detect intestinal parasites more accurately but is generally not feasible in resource- poor settings, at least not in peripheral labs. Hence, there is a need for a more field- friendly, sensitive approach for on- the- spot diagnosis of parasitic infections.	[Meurs, Lynn; Polderman, Anton M.; Melchers, Natalie V. S. Vinkeles; Brienen, Eric A. T.; Verweij, Jaco J.; Hepp, Dagmar H.; Langenberg, Marijke C. C.; Edelenbosch, Rosanne; van Lieshout, Lisette] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands; [Meurs, Lynn; Polman, Katja] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Groosjohan, Bernhard; Mendes, Felisberto; Mechendura, Manito] Catholic Univ Mozambique, Fac Hlth Sci, Beira, Mozambique; [Melchers, Natalie V. S. Vinkeles] Univ Med Ctr Rotterdam ErasmusMC, Dept Publ Hlth, Rotterdam, Netherlands; [Verweij, Jaco J.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Hepp, Dagmar H.] Vrije Univ Amsterdam, Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Edelenbosch, Rosanne] Rathenau Inst, The Hague, Netherlands	van Lieshout, L (reprint author), Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands.	E.A.van_Lieshout@lumc.nl		Meurs, Lynn/0000-0002-6973-1237	Leiden University Fund (LUF); Jo Keur Fund; LUSTRA scholarship; Prof. Dr. P.C. Flu-Foundation	Leiden University Fund (LUF; www.luf.nl/en), the Jo Keur Fund (https://www.lumc.nl/sub/9500/att/131107035332416.pdf) and the LUSTRA scholarship (http://hum.leiden.edu/internationalisation/outgoing-students/outgoing-exchange-students/news/lustra-scholarship-applications.html) were awarded to MCCL, DHH and RE. The PCR analyses at Leiden University Medical Center were partly supported by the Prof. Dr. P.C. Flu-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam AF, 2009, TROP MED INT HEALTH, V14, P316, DOI 10.1111/j.1365-3156.2009.02225.x; Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Arndt MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081915; Augusto G, 2009, AM J TROP MED HYG, V81, P799, DOI 10.4269/ajtmh.2009.08-0344; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Booth M, 2003, PARASITOLOGY, V127, P525, DOI 10.1017/S0031182003004128; Polanco LC, 2014, REV ESP SALUD PUBLIC, V88, P581, DOI 10.4321/S1135-57272014000500004; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Clark CG, 2006, INT J SYST EVOL MICR, V56, P2235, DOI 10.1099/ijs.0.64208; Clark CG, 2013, ADV PARASIT, V82, P1, DOI 10.1016/B978-0-12-407706-5.00001-0; Clavero AO, 1999, ACTA TROP, V72, P25, DOI 10.1016/S0001-706X(98)00079-5; Colley DG, 2014, LANCET; CROMPTON DWT, 1993, B WORLD HEALTH ORGAN, V71, P1; de Carvalho GC, 2012, MEM I OSWALDO CRUZ, V107, P899, DOI 10.1590/S0074-02762012000700010; Easton AV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1314-y; Efunshile MA, 2015, AM J TROP MED HYG, V93, P257, DOI 10.4269/ajtmh.14-0781; Frickmann H, 2015, INFECT DIS-NOR, V47, P491, DOI 10.3109/23744235.2015.1022212; Garcia LS, 2007, DIAGNOSTIC MED PARAS; Garcia LS, 2016, J CLIN MICROBIOL, V54, P2243, DOI 10.1128/JCM.00400-16; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Goldsmid J. M., 1991, Parasitic helminths and zoonoses in Africa., P101; Gomes LI, 2009, MEM I OSWALDO CRUZ, V104, P1194, DOI 10.1590/S0074-02762009000800021; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Jonker FAM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001555; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Knopp S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000331; Knopp S, 2014, AM J TROP MED HYG, V90, P535, DOI 10.4269/ajtmh.13-0268; Lane S, 2002, CRIT REV MICROBIOL, V28, P123, DOI 10.1080/10408410490435133; Levecke B, 2015, EMERG INFECT DIS, V21, P1871, DOI 10.3201/eid2110.141456; Mandomando IM, 2007, AM J TROP MED HYG, V76, P522, DOI 10.4269/ajtmh.2007.76.522; Mejia R, 2013, AM J TROP MED HYG, V88, P1041, DOI 10.4269/ajtmh.12-0726; Melchers NVSV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002807; Meurs L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003959; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Niesters HGM, 2002, J CLIN VIROL, V25, pS3; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Obeng BB, 2008, ANN TROP MED PARASIT, V102, P625, DOI 10.1179/136485908X337490; Palmer P. E. S., 2001, IMAGING TROPICAL DIS, V2, P51; Parija Subhash Chandra, 2014, Trop Parasitol, V4, P90, DOI 10.4103/2229-5070.138535; Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072; Pierce KK, 2009, CURR OPIN GASTROEN, V25, P12, DOI 10.1097/MOG.0b013e32831da7dd; Pillay P, 2014, AM J TROP MED HYG, V90, P546, DOI 10.4269/ajtmh.13-0406; Polderman AM, 2010, ADV PARASIT, V71, P93, DOI 10.1016/S0065-308X(10)71002-2; POLDERMAN AM, 1985, ANN SOC BELG MED TR, V65, P243; Polman K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1074-x; Pontes LA, 2003, AM J TROP MED HYG, V68, P652, DOI 10.4269/ajtmh.2003.68.652; Pontes LA, 2002, AM J TROP MED HYG, V66, P157, DOI 10.4269/ajtmh.2002.66.157; Schar F, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002288; Stanley SL, 2003, LANCET, V361, P1025, DOI 10.1016/S0140-6736(03)12830-9; Stark D, 2009, CLIN MICROBIOL REV, V22, P634, DOI 10.1128/CMR.00017-09; Turkeltaub JA, 2015, CURR OPIN GASTROEN, V31, P38, DOI 10.1097/MOG.0000000000000135; van Coppenraet LESB, 2009, CLIN MICROBIOL INFEC, V15, P869, DOI 10.1111/j.1469-0691.2009.02894.x; van den Bijllaardt W, 2014, CLIN MICROBIOL INFEC, V20, pO972, DOI 10.1111/1469-0691.12626; van Lieshout L, 2015, CLIN MICROBIOL INFEC; van Lieshout L, 2013, LANCET INFECT DIS, V13, P469, DOI [10.1016/S1473-3099(13)70094-X, 10.1016/s1473-3099(13)70094-X]; van Mens SP, 2013, T ROY SOC TROP MED H, V107, P269, DOI 10.1093/trstmh/trs094; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; Verweij JJ, 2007, DIAGN MICR INFEC DIS, V57, P163, DOI 10.1016/j.diagmicrobio.2006.08.009; Verweij JJ, 2014, CLIN MICROBIOL REV, V27, P371, DOI 10.1128/CMR.00122-13; Verweij JJ, 2009, T ROY SOC TROP MED H, V103, P342, DOI 10.1016/j.trstmh.2008.12.001; Verweij JJ, 2000, INT J PARASITOL, V30, P137, DOI 10.1016/S0020-7519(99)00175-7; Verweij JJ, 2003, TROP MED INT HEALTH, V8, P1153, DOI 10.1046/j.1360-2276.2003.01145.x; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; World Health Organization, 2016, HLTH STAT INF SYST E; World Health Organization (WHO), 1991, BAS LAB METH MED PAR	69	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2017	11	1							e0005310	10.1371/journal.pntd.0005310				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EK8CR	WOS:000394152000070	28114314	DOAJ Gold, Green Published			2019-04-02	
J	Mofid, LS; Casapia, M; Aguilar, E; Silva, H; Montresor, A; Rahme, E; Fraser, WD; Marquis, GS; Vercruysse, J; Allen, LH; Blouin, B; Razuri, H; Pezo, L; Gyorkos, TW				Mofid, Layla S.; Casapia, Martin; Aguilar, Eder; Silva, Hermann; Montresor, Antonio; Rahme, Elham; Fraser, William D.; Marquis, Grace S.; Vercruysse, Jozef; Allen, Lindsay H.; Blouin, Brittany; Razuri, Hugo; Pezo, Lidsky; Gyorkos, Theresa W.			A Double-Blind Randomized Controlled Trial of Maternal Postpartum Deworming to Improve Infant Weight Gain in the Peruvian Amazon	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SOIL-TRANSMITTED HELMINTHS; CHILD UNDERNUTRITION; DEVELOPING-COUNTRIES; TRICHURIS-TRICHIURA; DIAGNOSTIC-TESTS; GOLD STANDARD; RISK-FACTORS; HOOKWORM; HEALTH; INFECTIONS	Background Nutritional interventions targeting the critical growth and development period before two years of age can have the greatest impact on health trajectories over the life course. Compelling evidence has demonstrated that interventions investing in maternal health in the first 1000 days of life are beneficial for both mothers and their children. One such potential intervention is deworming integrated into maternal postpartum care in areas where soil-transmitted helminth (STH) infections are endemic. Methodology/Principal Findings From February to August 2014, 1010 mother-infant pairs were recruited into a trial aimed at assessing the effectiveness of maternal postpartum deworming on infant and maternal health outcomes. Following delivery, mothers were randomly assigned to receive either single-dose 400 mg albendazole or placebo. Participants were followed-up at 1 and 6 months postpartum. There was no statistically significant difference in mean weight gain between infants in the experimental and control groups (mean difference: -0.02; 95% CI: -0.1, 0.08) at 6 months of age. Further, deworming had no effect on measured infant morbidity indicators. However, ad hoc analyses restricted to mothers who tested positive for STHs at baseline suggest that infants of mothers in the experimental group had greater mean length gain in cm (mean difference: 0.8; 95% CI: 0.1, 1.4) and length-for-age z-score (mean difference: 0.5; 95% CI: 0.2, 0.8) at 6 months of age. Conclusions/Significance In a study population composed of both STH-infected and uninfected mothers, maternal postpartum deworming was insufficient to impact infant growth and morbidity indicators up to 6 months postpartum. Among STH-infected mothers, however, important improvements in infant length gain and length-for-age were observed. The benefits of maternal postpartum deworming should be further investigated in study populations having higher overall prevalences and intensities of STH infections and, in particular, where whipworm and hookworm infections are of public health concern.	[Mofid, Layla S.; Blouin, Brittany; Gyorkos, Theresa W.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Mofid, Layla S.; Rahme, Elham; Blouin, Brittany; Razuri, Hugo; Gyorkos, Theresa W.] McGill Univ, Ctr Hlth, Res Inst, Div Clin Epidemiol, Montreal, PQ, Canada; [Casapia, Martin; Pezo, Lidsky] Asociac Civil Selva Amazon, Iquitos, Peru; [Aguilar, Eder; Silva, Hermann] Hosp Iquitos Cesar Garayar Garcia, Iquitos, Peru; [Montresor, Antonio] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland; [Rahme, Elham] McGill Univ, Dept Med, Montreal, PQ, Canada; [Fraser, William D.] Univ Sherbrooke, Ctr Rech, Sherbrooke, PQ, Canada; [Fraser, William D.] Univ Sherbrooke, Dept Obstet & Gynecol, Sherbrooke, PQ, Canada; [Marquis, Grace S.] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada; [Vercruysse, Jozef] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Allen, Lindsay H.] Univ Calif Davis, USDA, ARS, Western Human Nutr Res Ctr, Davis, CA 95616 USA	Gyorkos, TW (reprint author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.; Gyorkos, TW (reprint author), McGill Univ, Ctr Hlth, Res Inst, Div Clin Epidemiol, Montreal, PQ, Canada.	theresa.gyorkos@mcgill.ca			Bill and Melinda Gates Foundation [OPP1066903]; Fonds de Recherche du Quebec Sante; Canadian Institutes of Health Research; International Development Research Centre	This study was supported by grants from the Bill and Melinda Gates Foundation (OPP1066903 (http://www.gatesfoundation.org/) (Principal Investigator: TWG; Co-investigators: LSM, MC, AM, ER, WDF, GSM, JV, LHA). TWG's research is funded, in part, by a grant to the Research Institute of the McGill University Health Centre from the Fonds de Recherche du Quebec Sante (www.frqs.gouv.qc.ca/en). LSM also received personal and project support from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) (Frederick Banting and Charles Best Canada Graduate Scholarship; Michael Smith Foreign Study Supplement) and the International Development Research Centre (https://www.idrc.ca/) (Doctoral Research Award). The funders provided feedback on the study design prior to trial commencement, but had no role in the data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Allen Henrietta E., 2002, Trends in Parasitology, V18, P381, DOI 10.1016/S1471-4922(02)02386-3; [Anonymous], 2006, PREV CHEM HUM HELM C; Barda B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003698; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Bryce J, 2008, LANCET, V371, P510, DOI 10.1016/S0140-6736(07)61694-8; Casapia M, 2006, INT J PARASITOL, V36, P741, DOI 10.1016/j.ijpara.2006.03.004; Casey BM, 2001, NEW ENGL J MED, V344, P467, DOI 10.1056/NEJM200102153440701; Chammartin F, 2013, LANCET INFECT DIS, V13, P507, DOI 10.1016/S1473-3099(13)70071-9; Crompton DWT, 2002, ANNU REV NUTR, V22, P35, DOI 10.1146/annurev.nutr.22.120501.134539; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Glinz D, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000754; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Gyorkos Theresa W, 2013, PLoS Negl Trop Dis, V7, pe2397, DOI 10.1371/journal.pntd.0002397; Gyorkos TW, 2011, T ROY SOC TROP MED H, V105, P204, DOI 10.1016/j.trstmh.2010.12.003; Hemming K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h391; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Imhoff-Kunsch B, 2012, PAEDIATR PERINAT EP, V26, P223, DOI 10.1111/j.1365-3016.2012.01280.x; JOSEPH L, 1995, AM J EPIDEMIOL, V141, P263, DOI 10.1093/oxfordjournals.aje.a117428; Joseph SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004020; Joseph SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003369; Knopp S, 2012, INFECT DIS CLIN N AM, V26, P341, DOI 10.1016/j.idc.2012.02.006; Larocque R, 2006, TROP MED INT HEALTH, V11, P1485, DOI 10.1111/j.1365-3156.2006.01706.x; Larocque R, 2006, CAN J PUBLIC HEALTH, V97, P222; Mofid LS, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008560; Montresor A, 1998, GUIDELINES EVALUATIO; Montresor A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004165; Montresor A, 2015, T ROY SOC TROP MED H, V109, P262, DOI 10.1093/trstmh/tru180; Ndibazza J, 2010, CLIN INFECT DIS, V50, P531, DOI 10.1086/649924; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Pullan R.L, 2014, PARASITE VECTOR, V7, P37, DOI DOI 10.1186/1756-3305-7-37; ROBERTSON LJ, 1992, T ROY SOC TROP MED H, V86, P654, DOI 10.1016/0035-9203(92)90176-D; Salam R.A, 2015, COCHRANE DB SYST REV, V6; Salam RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005547.pub3; Stephenson LS, 2000, PARASITOLOGY, V121, pS73, DOI 10.1017/S0031182000006867; Tarafder MR, 2010, INT J PARASITOL, V40, P399, DOI 10.1016/j.ijpara.2009.09.003; Taylor-Robinson DC, 2015, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD000371.PUB6; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2014, INT MAN CHILDH ILLN; WHO, 2002, PREV CONTR SCHIST SO; Wrottesley SV, 2016, J DEV ORIG HLTH DIS, V7, P144, DOI 10.1017/S2040174415001439; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	46	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	JAN	2017	11	1							e0005098	10.1371/journal.pntd.0005098				22	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EK8CR	WOS:000394152000001	28056024	DOAJ Gold, Green Published			2019-04-02	
J	Johansen, MV; Welburn, SC; Dorny, P; Brattig, NW				Johansen, Maria Vang; Welburn, Susan Christina; Dorny, Pierre; Brattig, Norbert W.			Control of neglected zoonotic diseases	ACTA TROPICA			English	Editorial Material									[Johansen, Maria Vang] Univ Copenhagen, Copenhagen, Denmark; [Welburn, Susan Christina] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Dorny, Pierre] Inst Trop Med, Antwerp, Belgium; [Brattig, Norbert W.] Bernhard Nocht Inst Trop Med, Hamburg, Germany	Johansen, MV (reprint author), Univ Copenhagen, Copenhagen, Denmark.							0	0	0	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JAN	2017	165				SI		1	2		10.1016/j.actatropica.2016.11.036				2	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EG3VS	WOS:000390973400001	27964807				2019-04-02	
J	Devleesschauwer, B; Allepuz, A; Dermauw, V; Johansen, MV; Laranjo-Gonzalez, M; Smit, GSA; Sotiraki, S; Trevisan, C; Wardrop, NA; Dorny, P; Gabriel, S				Devleesschauwer, Brecht; Allepuz, Alberto; Dermauw, Veronique; Johansen, Maria V.; Laranjo-Gonzalez, Minerva; Smit, G. Suzanne A.; Sotiraki, Smaragda; Trevisan, Chiara; Wardrop, Nicola A.; Dorny, Pierre; Gabriel, Sarah			Taenia solium in Europe: Still endemic?	ACTA TROPICA			English	Article						Cysticercosis; Epidemiology; Europe; Neurocysticercosis; Taenia solium; Taeniasis	NEUROCYSTICERCOSIS; HEALTH; CATTLE; PIGS	The pork tapeworm, Taenia solium, causes an important economic and health burden, mainly in rural or marginalized communities of sub-Saharan Africa, Asia, and Latin-America. Although improved pig rearing conditions seem to have eliminated the parasite in most Western European countries, little is known about the true endemicity status of T. solium throughout Europe. Three recent reviews indicate that autochthonous human T. solium taeniasis/cysticercosis may be possible in Europe, but that current peer reviewed literature is biased towards Western Europe. Officially reported data on porcine cysticercosis are highly insufficient. Favourable conditions for local T. solium transmission still exist in eastern parts of Europe, although the ongoing integration of the European Union is speeding up modernisation and intensification of the pig sector. Further evidence is urgently needed to fill the gaps on the European T. solium endemicity map. We urge to make human cysticercosis notifiable and to improve the reporting of porcine cysticercosis. (C) 2015 Elsevier B.V. All rights reserved.	[Devleesschauwer, Brecht; Smit, G. Suzanne A.; Dorny, Pierre] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Allepuz, Alberto; Laranjo-Gonzalez, Minerva] UAB IRTA, Ctr Recerca Sanitat Anim CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Allepuz, Alberto] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Spain; [Dermauw, Veronique; Dorny, Pierre; Gabriel, Sarah] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Johansen, Maria V.; Trevisan, Chiara] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Smit, G. Suzanne A.] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium; [Sotiraki, Smaragda] Hellen Agr Org Demeter, Vet Res Inst, Thessaloniki, Greece; [Wardrop, Nicola A.] Univ Southampton, Geog & Environm, Southampton, Hants, England	Devleesschauwer, B (reprint author), Univ Florida, Shealy Dr 2055, Gainesville, FL 32611 USA.	brechtdv@gmail.com	Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892; GABRIEL, SARAH/0000-0002-2523-233X; Dermauw, Veronique/0000-0001-8745-5304; Laranjo Gonzalez, Minerva/0000-0001-7417-807X	Medical Research Council [MR/J012343/1]		Ahlberg T., 2015, SCAND BALT SOC M UPP; BIOHAZ/AHAW, 2007, EFSA J, V600, P1; Del Brutto OH, 2012, ACTA NEUROL BELG, V112, P335, DOI 10.1007/s13760-012-0068-3; Dorny P, 2009, VET PARASITOL, V163, P196, DOI 10.1016/j.vetpar.2009.05.026; Dorny P., 2010, DEV HARMONISED SCHEM; EC, 2013, FACTS FIG ORG AGR EU; EFSA,, 2012, EU SUMM REP ZOON ZOO; *EFSA, 2008, COMM SUMM REP TRENDS; Fabiani S, 2013, ACTA TROP, V128, P18, DOI 10.1016/j.actatropica.2013.06.020; FAO/WHO FAO of the UNHO, 2014, MICR RISK ASS SER, V23; Gabriel S., 2015, VET PARASIT IN PRESS; Gonzalez LM, 2006, VET PARASITOL, V142, P95, DOI 10.1016/j.vetpar.2006.06.009; Khomenko S, 2013, EMPRES WATCH, V28, P1, DOI DOI 10.1016/J.MEATSCI.2007.06.018; Kozlowska-Loj Jolanta, 2014, Annals of Parasitiology, V60, P309; Kozlowska-Loj Jolanta, 2011, Wiad Parazytol, V57, P193; Marquer P, 2014, PIG FARMING EUROPEAN; Mestrovic T, 2012, J HELMINTHOL, V86, P259, DOI 10.1017/S0022149X11000253; Papatsiros VG, 2012, J HELL VET MED SOC, V63, P37; Schantz Peter M., 2002, P63, DOI 10.1079/9780851996288.0063; Soba B, 2014, PARASITOLOGY, V141, P547, DOI 10.1017/S0031182013001947; Wellbrock W., 2010, P 9 EUR IFSA S 4 7 J, P1036; World Health Organisation, 2015, INV OV GLOB IMP NEGL; Zammarchi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069537	23	19	19	2	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JAN	2017	165				SI		96	99		10.1016/j.actatropica.2015.08.006				4	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EG3VS	WOS:000390973400012	26276698				2019-04-02	
J	Madinga, J; Kanobana, I; Lukanu, P; Abatih, E; Baloji, S; Linsuke, S; Praet, N; Kapinga, S; Polman, K; Lutumba, P; Speybroeck, N; Dorny, P; Harrison, W; Gabriel, S				Madinga, Joule; Kanobana, Iirezi; Lukanu, Philippe; Abatih, Emmanuel; Baloji, Sylvain; Linsuke, Sylvie; Praet, Nicolas; Kapinga, Serge; Polman, Katja; Lutumba, Pascal; Speybroeck, Niko; Dorny, Pierre; Harrison, Wendy; Gabriel, Sarah			Geospatial and age-related patterns of Taenia solium taeniasis in the rural health zone of Kimpese, Democratic Republic of Congo	ACTA TROPICA			English	Article						Taeniasis; Porcine cysticercosis; Epidemiology; Spatial clustering; Democratic republic of Congo	PORCINE CYSTICERCOSIS; TAPEWORM CARRIERS; RISK-FACTORS; GUATEMALAN COMMUNITIES; NORTHERN TANZANIA; EASTERN ZAMBIA; PREVALENCE; PIGS; EPIDEMIOLOGY; INFECTIONS	Background: Taenia solium infections are mostly endemic in less developed countries where poor hygiene conditions and free-range pig management favor their transmission. Knowledge on patterns of infections in both human and pig is crucial to design effective control strategies. The aim of this study was to assess the prevalence, risk factors and spatial distribution of taeniasis in a rural area of the Democratic Republic of Congo (DRC), in the prospect of upcoming control activities. Methods: A cross-sectional study was conducted in 24 villages of the health zone of Kimpese, Bas Congo Province. Individual and household characteristics, including geographical coordinates were recorded. Stool samples were collected from willing participants and analyzed using the copro-antigen enzyme linked immunosorbent assay (copro-Ag ELISA) for the detection of taeniasis. Blood samples were collected from pigs and analyzed using the B158/660 monoclonal antibody-based antigen ELISA (sero-Ag ELISA) to detect porcine cysticercosis. Logistic regression and multilevel analysis were applied to identify risk factors. Global clustering and spatial correlation of taeniasis and porcine cysticercosis were assessed using K functions. Local clusters of both infections were identified using the Kulldorff s scan statistic. Results: A total of 4751 participants above 5 years of age (median: 23 years; IQR: 11-41) were included. The overall proportion of taeniasis positivity was 23.4% (95% CI: 22.2-24.6), ranging from 1 to 60% between villages, with a significant between-household variance of 2.43 (SE = 0.29, p < 0.05). Taeniasis was significantly associated with age (p < 0.05) and the highest positivity was found in the 5-10 years age group (27.0% (95% CI: 24.4-29.7)). Overall, 45.6% (95% CI: 40.2-51) of sampled pigs were sero-positive. The K functions revealed a significant overall clustering of human and pig infections but no spatial dependence between them. Two significant clusters of taeniasis (p<0.001; n = 276 and n = 9) and one cluster of porcine cysticercosis (p<0.001; n = 24) were found. Conclusion: This study confirms high endemicity and geographical dispersal of taeniasis in the study area. The role of age in taeniasis patterns and significant spatial clusters of both taeniasis and porcine cysticercosis were evidenced, though no spatial correlation was found between human and pig infections. Urgent control activities are needed for this endemic area. (C) 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license.	[Madinga, Joule; Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc, Brussels, Belgium; [Madinga, Joule; Kanobana, Iirezi; Abatih, Emmanuel; Praet, Nicolas; Polman, Katja; Dorny, Pierre; Gabriel, Sarah] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Madinga, Joule; Linsuke, Sylvie; Kapinga, Serge; Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lukanu, Philippe] Zone Sante Rurale Kimpese, Kinshasa, DEM REP CONGO; [Baloji, Sylvain] Programme Natl Lutte Trypanosomiase Humaine Afric, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Harrison, Wendy] Imperial Coll, Dept Infect Dis & Epidemiol, London, England	Madinga, J (reprint author), Catholic Univ Louvain, Inst Hlth & Soc, Brussels, Belgium.; Madinga, J (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; Madinga, J (reprint author), Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO.	jmadinga@yahoo.fr		GABRIEL, SARAH/0000-0002-2523-233X; Joule, Madinga/0000-0003-2661-234X	Bill and Melinda Gates foundation; Universite catholique de Louvain	We are very grateful to inhabitants of the rural health zone of Kimpese who kindly participated in the study. We are also most appreciative of the local health team that collaborated with us in carrying out the fieldwork. The study was financially supported by the Bill and Melinda Gates foundation through the project "Integrated control of taeniasis and cysticercosis" coordinated by Imperial College, London. Joule Madinga is a PhD student supported by the "developing cooperation" scholarship of the Universite catholique de Louvain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ale A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-45; Allan JC, 1996, ANN TROP MED PARASIT, V90, P157, DOI 10.1080/00034983.1996.11813039; ALLAN JC, 1990, PARASITOLOGY, V101, P473, DOI 10.1017/S0031182000060686; Allan JC, 1997, T ROY SOC TROP MED H, V91, P595, DOI 10.1016/S0035-9203(97)90042-0; Allan JC, 2003, ACTA TROP, V87, P87, DOI 10.1016/S0001-706X(03)00059-7; BESAG J, 1977, J ROY STAT SOC B MET, V39, P73; Braae U.C., 2015, TROP ANIM HLTH PROD; BRANDT JRA, 1992, INT J PARASITOL, V22, P471, DOI 10.1016/0020-7519(92)90148-E; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; CHARTIER C, 1990, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V43, P491; Copado F, 2004, APPL ANIM BEHAV SCI, V88, P243, DOI 10.1016/j.applanim.2004.03.013; DIAZ F, 1992, AM J EPIDEMIOL, V135, P875, DOI 10.1093/oxfordjournals.aje.a116383; Dixon P, 2002, ENCY ENV, P1796; Dorny P, 2004, TRENDS PARASITOL, V20, P259, DOI 10.1016/j.pt.2004.04.001; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; FABIYI JP, 1979, J HELMINTHOL, V53, P65, DOI 10.1017/S0022149X00005757; Fan Ping-Chin, 1997, Kaohsiung Journal of Medical Sciences, V13, P647; Garcia HH, 2007, J NEUROL SCI, V262, P153, DOI 10.1016/j.jns.2007.06.039; Garcia HH, 1999, NEUROLOGY, V53, P1582, DOI 10.1212/WNL.53.7.1582; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; GarciaNoval J, 1996, AM J TROP MED HYG, V55, P282, DOI 10.4269/ajtmh.1996.55.282; Gilman RH, 2000, NEUROLOGY, V55, P1062, DOI 10.1212/WNL.55.7.1062; Gonzalez AE, 2001, AM J TROP MED HYG, V65, P15, DOI 10.4269/ajtmh.2001.65.15; Horak I.G, 1980, THESIS U NATAL S AFR, P201; Kanobana K, 2011, INT J PARASITOL, V41, P1015, DOI 10.1016/j.ijpara.2011.06.004; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2010, SATSCAN USER GUIDE V; Kulldorff M, 2007, STAT MED, V26, P1824, DOI 10.1002/sim.2818; Lescano AG, 2007, AM J TROP MED HYG, V76, P376, DOI 10.4269/ajtmh.2007.76.376; Morales J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000284; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Ngowi HA, 2004, TROP ANIM HEALTH PRO, V36, P335, DOI 10.1023/B:TROP.0000026663.07862.2a; Ngowi HA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000652; O'Neal SE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001953; Pawlowski ZS, 2006, PARASITOL INT, V55, pS105, DOI 10.1016/j.parint.2005.11.017; Permin A, 1999, VET PARASITOL, V87, P63, DOI 10.1016/S0304-4017(99)00159-4; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; Praet N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000817; Praet N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000406; Raghava MV, 2010, T ROY SOC TROP MED H, V104, P601, DOI 10.1016/j.trstmh.2010.06.002; Rimoin AW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002118; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Rodriguez-Canul R, 1999, ANN TROP MED PARASIT, V93, P57; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; Sarti E, 2000, T ROY SOC TROP MED H, V94, P85, DOI 10.1016/S0035-9203(00)90451-6; Sciutto E, 2000, MICROBES INFECT, V2, P1875, DOI 10.1016/S1286-4579(00)01336-8; Thomas LF, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-46; WHO, 2012, REP WHO EXP CONS FOO; WHO, 2004, TECH REP SER, P912; Widdowson MA, 2000, T ROY SOC TROP MED H, V94, P620, DOI 10.1016/S0035-9203(00)90209-8; Zimi Gutu Kia, 2014, ETUDE EC DEV REGION	55	5	5	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JAN	2017	165				SI		100	109		10.1016/j.actatropica.2016.03.013				10	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EG3VS	WOS:000390973400013	26996821	Green Published, Other Gold			2019-04-02	
J	Trevisan, C; Devleesschauwer, B; Schmidt, V; Winkler, AS; Harrison, W; Johansen, MV				Trevisan, Chiara; Devleesschauwer, Brecht; Schmidt, Veronika; Winkler, Andrea Sylvia; Harrison, Wendy; Johansen, Maria Vang			The societal cost of Taenia solium cysticercosis in Tanzania	ACTA TROPICA			English	Article						Taenia solium taeniosis/cysticercosis; Epilepsy; Parasitic zoonoses; Societal cost; Disability-adjusted life years; Tanzania	DOOR-TO-DOOR; ACTIVE CONVULSIVE EPILEPSY; DAR-ES-SALAAM; RISK-FACTORS; PORCINE CYSTICERCOSIS; MBEYA REGION; CLINICAL CHARACTERISTICS; SOUTHERN HIGHLANDS; RURAL TANZANIA; MBULU DISTRICT	Taenia solium is a zoonotic parasite prevalent in many low income countries throughout Latin America, Asia and sub-Saharan Africa, including Tanzania. The parasite is recognized as a public health threat; however the burden it poses on populations of Tanzania is unknown. The aim of this study was to estimate the societal cost of T. solium cysticercosis in Tanzania, by assessing both the health and economic burden. The societal cost of T. solium cysticercosis was assessed in humans and pigs based on data obtained by a systematic review. Experts' opinion was sought in cases where data were not retrievable. The health burden was assessed in terms of annual number of neurocysticercosis (NCC) associated epilepsy incident cases, deaths and disability-adjusted life years (DALYs), while the economic burden was assessed in terms of direct and indirect costs imposed by NCC-associated epilepsy and potential losses due to porcine cysticercosis. Based on data retrieved from the systematic review and burden assessments, T. solium cysticercosis contributed to a significant societal cost for the population. The annual number of NCC-associated epilepsy incident cases and deaths were 17,853 (95% Uncertainty Interval (UI), 5666-36,227) and 212 (95% UI, 37-612), respectively. More than 11% (95% UI, 6.3-17) of the pig population was infected with the parasite when using tongue examination as diagnostic method. For the year 2012 the number of DALY5 per thousand person-years for NCC-associated epilepsy was 0.7 (95% UI, 0.2-1.6). Around 5 million USD (95% UI, 797,535-16,933,477) were spent due to NCC-associated epilepsy and nearly 3 million USD (95% UI, 1,095,960-5,366,038) were potentially lost due to porcine cysticercosis. Our results show that T. solium imposes a serious public health, agricultural and economic threat for Tanzania. We urge that a One Health approach, which involves the joint collaboration and effort of veterinarians, medical doctors, agricultural extension officers, researchers and relevant governmental agencies, is taken to find sustainable solutions for prevention, control and elimination of T. solium. (C) 2016 Elsevier B.V. All rights reserved.	[Trevisan, Chiara; Johansen, Maria Vang] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark; [Devleesschauwer, Brecht] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Schmidt, Veronika; Winkler, Andrea Sylvia] Tech Univ Munich, Dept Neurol, Munich, Germany; [Harrison, Wendy] Imperial Coll London, Sch Publ Hlth, Fac Med, London, England	Trevisan, C (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg C, Denmark.; Trevisan, C (reprint author), Dyrlaegevej 100, DK-1870 Frederiksberg C, Denmark.	chiara@sund.ku.dk	Devleesschauwer, Brecht/G-9895-2018	Devleesschauwer, Brecht/0000-0002-2867-6892; Trevisan, Chiara/0000-0002-4920-6750	Bill and Melinda Gates foundation; Danish International Development Agency (DANIDA); project: SLIPP-project (Securing rural Livelihoods through Improved smallholder Pig Production in Mozambique and Tanzania) [09-007LIFE]	The study was conducted under the ICTC-project (Integrated Control of Taeniosis/Cysticercosis in sub-Saharan Africa) funded by Bill and Melinda Gates foundation and further supported by the Danish International Development Agency (DANIDA) with its project: SLIPP-project (Securing rural Livelihoods through Improved smallholder Pig Production in Mozambique and Tanzania), file no. 09-007LIFE. The study was done in collaboration within the framework of CYSTINET, the European Network on taeniosis/cysticercosis, COST ACTION TD1302. The authors would like to acknowledge Professor W. Matuja and Dr. H. Ngowi for providing their expert opinion and Dr. F. Gianoli for assisting the authors with the creation of Fig. 1.	Arriola CS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003247; Bhattarai R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001521; Blocher J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001185; Boa ME, 2006, VET PARASITOL, V139, P249, DOI 10.1016/j.vetpar.2006.02.012; BOA ME, 1995, J HELMINTHOL, V69, P113, DOI 10.1017/S0022149X00013997; Braae UC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0574-7; Burton KJ, 2012, EPILEPSIA, V53, P752, DOI 10.1111/j.1528-1167.2011.03395.x; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152; Carod FJ, 1998, REV NEUROLOGIA, V26, P1064, DOI 10.33588/rn.26154.98049; Chacha M., 2014, Health, V6, P2894, DOI 10.4236/health.2014.621328; Coleman PG, 2004, EMERG INFECT DIS, V10, P140, DOI 10.3201/eid1001.020744; Dent W, 2005, EPILEPSIA, V46, P1963, DOI 10.1111/j.1528-1167.2005.00338.x; Dent W, 2004, CEPHALALGIA, V24, P960, DOI 10.1111/j.1468-2982.2004.00775.x; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P565, DOI 10.1007/s00038-014-0552-z; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P571, DOI 10.1007/s00038-014-0553-y; Devleesschauwer B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002634; Dewhurst F, 2013, ACTA NEUROL SCAND, V127, P198, DOI 10.1111/j.1600-0404.2012.01709.x; Essink-Bot ML, 2002, B WORLD HEALTH ORGAN, V80, P644; Fabiani S, 2013, ACTA TROP, V128, P18, DOI 10.1016/j.actatropica.2013.06.020; FAO/WHO FAO of the UNHO, 2014, MICR RISK ASS SER, V23; GONZALEZ AE, 1993, B WORLD HEALTH ORGAN, V71, P223; Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029; Hunter E, 2012, SEIZURE-EUR J EPILEP, V21, P691, DOI 10.1016/j.seizure.2012.07.009; IHME, 2014, GBD DAT; Johansen MV, 2014, TRENDS PARASITOL, V30, P372, DOI 10.1016/j.pt.2014.06.003; Kalage R.E., 2008, LAY PEOPLES KNOWLEDG, P88; Kamuyu G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002908; Kavishe M.D.B., 2009, THESIS; Komba EVG, 2013, VET PARASITOL, V198, P284, DOI 10.1016/j.vetpar.2013.09.020; Lightowlers MW, 2013, PARASITOLOGY, V140, P1566, DOI 10.1017/S0031182013001005; Maridadi A. F., 2011, International Journal of Animal and Veterinary Advances, V3, P196; Matemba LE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000868; MATUJA WBP, 1995, HEADACHE, V35, P273, DOI 10.1111/j.1526-4610.1995.hed3505273.x; Mayer M., 2005, THESIS; Mellau BL, 2011, TROP ANIM HEALTH PRO, V43, P857, DOI 10.1007/s11250-010-9773-1; Mkupasi EM, 2014, J HELMINTHOL, V6, P1, DOI DOI 10.1017/50022149X14000418; Mkupasi EM, 2011, TROP ANIM HEALTH PRO, V43, P417, DOI 10.1007/s11250-010-9708-x; Mkupasi EM, 2013, ACTA TROP, V128, P48, DOI 10.1016/j.actatropica.2013.06.010; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Mosser P, 2007, J NEUROL SCI, V258, P33, DOI 10.1016/j.jns.2007.02.015; Murray C.J.L., 1996, GLOBAL BURDEN DIS CO, P1022; Mushi D, 2012, EPILEPSY BEHAV, V23, P224, DOI 10.1016/j.yebeh.2011.12.003; Mwang'onde B. J., 2012, ADV INFECT DIS, V2, P62, DOI [10.4236/aid.2012.23009, DOI 10.4236/AID.2012.23009]; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; NBS National Bureau of Statistics, 2015, STAT DEV; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Ngugi AK, 2013, LANCET NEUROL, V12, P253, DOI 10.1016/S1474-4422(13)70003-6; Nsengwa G.R.M., 1995, TANZANIA VET J, V15, P9; Phiri IK, 2003, ACTA TROP, V87, P13, DOI [10.1016/S0001-706X(03)00051-2, 10.1016/S0001-706X(03)00202-X]; Polinder S, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-21; Praet N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000406; R Core Team, 2014, R LANG ENV STAT COMP; RWIZA HT, 1992, EPILEPSIA, V33, P1051, DOI 10.1111/j.1528-1157.1992.tb01758.x; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Schaffert M.B., 2005, THESIS; SENANAYAKE N, 1993, B WORLD HEALTH ORGAN, V71, P247; The United Republic of Tanzania, 2012, NAT SAMPL CENS AGR S; The United Republic of Tanzania, 2013, 2012 POP HOUS CENS N, P264; United Nations, 2015, WORLD POP 2012; Wilson T.R., 2015, WHITE MEAT VALUE CHA, P138; Winkler AS, 2010, CEPHALALGIA, V30, P582, DOI 10.1111/j.1468-2982.2009.01994.x; Winkler AS, 2009, EPILEPSIA, V50, P2310, DOI 10.1111/j.1528-1167.2009.02184.x; Winkler AS, 2010, EPILEPSY BEHAV, V19, P596, DOI 10.1016/j.yebeh.2010.09.023; Winkler AS, 2009, EPILEPSIA, V50, P987, DOI 10.1111/j.1528-1167.2008.01867.x; Yohana C., 2013, International Journal of Animal and Veterinary Advances, V5, P251	67	11	13	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JAN	2017	165				SI		141	154		10.1016/j.actatropica.2015.12.021				14	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EG3VS	WOS:000390973400018	26756713				2019-04-02	
J	Gabriel, S; Dorny, P; Mwape, KE; Trevisan, C; Braae, UC; Magnussen, P; Thys, S; Bulaya, C; Phiri, IK; Sikasunge, CS; Makungu, C; Afonso, S; Nicolau, Q; Johansen, MV				Gabriel, S.; Dorny, P.; Mwape, K. E.; Trevisan, C.; Braae, U. C.; Magnussen, P.; Thys, S.; Bulaya, C.; Phiri, I. K.; Sikasunge, C. S.; Makungu, C.; Afonso, S.; Nicolau, Q.; Johansen, M. V.			Control of Taenia solium taeniasis/cysticercosis: The best way forward for sub-Saharan Africa?	ACTA TROPICA			English	Article						Taenia solium; Control; Sub-Saharan africa; One health	HEALTH-EDUCATION INTERVENTION; RESOURCE-POOR COMMUNITIES; SYNTHETIC PEPTIDE VACCINE; PORCINE CYSTICERCOSIS; GLOBAL BURDEN; MBEYA REGION; PIGS; OXFENDAZOLE; INFECTIONS; NEUROCYSTICERCOSIS	Taeniasolium taeniasis/cysticercosis is a neglected parasitic zoonosis with significant economic and public health impacts. Control measures can be broadly grouped into community health education, improvements in hygiene and sanitary conditions, proper meat handling at household and community level, improved standards of meat inspection, pig management, treatment of individual patients and possibly human populations, and treatment and/or vaccination of porcine populations. This manuscript looks critically into currently existing control options and provides suggestions on which (combination of) tools would be most effective in the control of T. solium taeniasis/cysticercosis in sub-Saharan Africa. Field data and disease transmission simulations suggest that implementation of a single intervention control strategy will not lead to a satisfactory reduction of disease morbidity or transmission. A feasible strategy to combat T. solium taeniasis/cysticercosis would include a combination of approaches focussing on both human (health education and treatment) and animal host (management, treatment and vaccination), which can vary for different communities and different geographical locations. Selection of the specific strategy depends on cost-effectiveness analyses based on solid field data, currently unavailable, though urgently needed; as well as on health priorities and resources of the country. A One Health approach involving medical, veterinary, environmental and social sectors is essential for T. solium to be controlled and eventually eliminated. Finally the success of any intervention is largely dependent on the level of societal and political acceptance, commitment and engagement. (C) 2016 Elsevier B.V. All rights reserved.	[Gabriel, S.; Dorny, P.; Thys, S.] Inst Trop Med, Antwerp, Belgium; [Dorny, P.] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Mwape, K. E.; Bulaya, C.; Phiri, I. K.; Sikasunge, C. S.; Makungu, C.] Univ Zambia, Sch Vet Med, Lusaka, Zambia; [Trevisan, C.; Braae, U. C.; Magnussen, P.; Johansen, M. V.] Univ Copenhagen, Dept Vet Dis Biol, Fac Hlth & Med Sci, Frederiksberg C, Denmark; [Afonso, S.; Nicolau, Q.] Eduardo Mondlane Univ, Fac Vet Med, Maputo, Mozambique	Gabriel, S (reprint author), Natl Str 155, B-2000 Antwerp, Belgium.	sgabriel@itg.be	Braae, Uffe/J-4720-2017	Braae, Uffe/0000-0002-2743-4584; Trevisan, Chiara/0000-0002-4920-6750; GABRIEL, SARAH/0000-0002-2523-233X; Magnussen, Pascal/0000-0001-7372-0250	European Union's Seventh Framework Programme (FP7) [221948]; Danish International Development Agency [09-007LIFE]	The work was supported by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 221948Integrated Control of Neglected Zoonoses (ICONZ) and by the Danish International Development Agency, file no.09-007LIFE through the project SLIPP (Securing rural Livelihoods through Improved smallholder Pig Production in Mozambique and Tanzania). The work was done in collaboration within the framework of CYSTINET, the European Network on taeniosis/cysticercosis, COST ACTION TD1302.	Alexander AM, 2012, INT HEALTH, V4, P164, DOI 10.1016/j.inhe.2012.04.003; Allan JC, 1997, T ROY SOC TROP MED H, V91, P595, DOI 10.1016/S0035-9203(97)90042-0; [Anonymous], 2006, CONTR NEGL ZOON DIS; [Anonymous], 2007, GLOB PLAN COMB NEGL; Ash A., 2015, ACTA TROP, V19; Assana E, 2010, J HELMINTHOL, V84, P441, DOI 10.1017/S0022149X10000167; Avvannavar SM, 2008, SCI TOTAL ENVIRON, V390, P1, DOI 10.1016/j.scitotenv.2007.09.018; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Boa M, 2003, ACTA TROP, V87, P7, DOI [10.1016/S0001-706X(03)00068-8, 10.1016/S0001-706X(02)00215-2]; Braae U.C., 2015, ACTA TROP; Braae UC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0938-7; Braae UC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0574-7; Bulaya C, 2015, VET PARASITOL, V207, P241, DOI 10.1016/j.vetpar.2014.12.030; Burniston S, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/2049-9957-4-11; Bustos JA, 2012, CLIN VACCINE IMMUNOL, V19, P570, DOI 10.1128/CVI.05428-11; Carabin H, 2006, TROP MED INT HEALTH, V11, P906, DOI 10.1111/j.1365-3156.2006.01627.x; Carabin H, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001152; Coral-Almeida M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003919; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Engels D, 2003, ACTA TROP, V87, P177, DOI [10.1016/S0001-706X(03)00064-0, 10.1016/j.actatropica.2003.05.001]; Ertel R. L., 2015, ACTA TROP; Esrey SA, 1996, AM J EPIDEMIOL, V143, P608; [FAO] Food and Agriculture Organization of the United Nations [WHO] World Health Organization, 2014, MICR RISK ASS SER, V23; FLISSER A, 1993, LANCET, V342, P748, DOI 10.1016/0140-6736(93)91743-6; Gabriel S, 2015, VET PARASITOL, V213, P38, DOI 10.1016/j.vetpar.2015.03.006; Garcia HH, 2002, CLIN MICROBIOL REV, V15, P747, DOI 10.1128/CMR.15.4.747-756.2002; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Gilman R.H., 1999, TAENIA SOLIUM TAENIA, P313; Gonzalez AE, 1997, VET REC, V141, P420, DOI 10.1136/vr.141.16.420; Gonzalez AE, 1998, AM J TROP MED HYG, V59, P832, DOI 10.4269/ajtmh.1998.59.832; GONZALEZ AE, 1993, B WORLD HEALTH ORGAN, V71, P223; Gonzalez AE, 2001, AM J TROP MED HYG, V65, P15, DOI 10.4269/ajtmh.2001.65.15; Gule C.A., 2008, THESIS; Huerta M, 2001, VACCINE, V20, P262, DOI 10.1016/S0264-410X(01)00249-3; Hunt PG, 2001, WATER SCI TECHNOL, V44, P19; Jayashi CM, 2012, VET PARASITOL, V188, P261, DOI 10.1016/j.vetpar.2012.03.055; Jeri C, 2004, LANCET, V363, P949, DOI 10.1016/S0140-6736(04)15791-7; Johansen MV, 2014, TRENDS PARASITOL, V30, P372, DOI 10.1016/j.pt.2014.06.003; Joshi DD, 2003, ACTA TROP, V87, P119, DOI 10.1016/S0001-706X(02)00230-9; Kar K., 2010, WORKSH COMM LED TOT; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; Lekule FP, 2003, ACTA TROP, V87, P111, DOI 10.1016/S0001-706X(03)00026-3; Lightowlers MW, 2013, PARASITOLOGY, V140, P1566, DOI 10.1017/S0031182013001005; Madinga J., GEOSPATIAL AGE UNPUB; Makungu C., 2015, BMC PUBLIC HLTH; Martinez-Ocana J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-3; Mkupasi EM, 2013, ACTA TROP, V128, P48, DOI 10.1016/j.actatropica.2013.06.010; Mkupasi EM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002200; Moreno L, 2012, FOOD CHEM TOXICOL, V50, P3819, DOI 10.1016/j.fct.2012.07.023; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murrell K.D., 2005, WHO FAO OIE GUIDELIN; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwape K.E., 2014, CURR TROP MED REP; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Mwidunda SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118541; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi HA, 2009, INT J HEALTH PROMOT, V47, P24, DOI 10.1080/14635240.2009.10708154; Pawlowski Z, 2005, INT J PARASITOL, V35, P1221, DOI 10.1016/j.ijpara.2005.07.015; Phaswana-Mafuya Nancy, 2005, Afr Health Sci, V5, P21; Phiri IK, 2003, ACTA TROP, V87, P13, DOI [10.1016/S0001-706X(03)00051-2, 10.1016/S0001-706X(03)00202-X]; Pondja A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001651; Pondja A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000594; Praet N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000817; Praet N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000406; Pruss-Ustun A, 2014, TROP MED INT HEALTH, V19, P894, DOI 10.1111/tmi.12329; Rajshekhar V, 2004, LANCET, V363, P912, DOI 10.1016/S0140-6736(04)15820-0; Sanchez AL, 2003, ACTA TROP, V87, P165, DOI [10.1016/S0001-706X(03)00040-8, 10.1016/S0001-706X(02)00225-5]; Sarti E, 2003, ACTA TROP, V87, P137, DOI [10.1016/S0001-706X(03)00034-2, 10.1016/S0001-706X(03)00197-9]; Sarti E, 1997, AM J TROP MED HYG, V56, P127, DOI 10.4269/ajtmh.1997.56.127; Sarti E, 2000, T ROY SOC TROP MED H, V94, P85, DOI 10.1016/S0035-9203(00)90451-6; Schantz PM, 2006, PARASITOL INT, V55, pS7, DOI 10.1016/j.parint.2005.11.050; Sciutto E, 2007, PARASITOLOGY, V134, P129, DOI 10.1017/S0031182006001132; Sciutto E, 2007, VACCINE, V25, P1368, DOI 10.1016/j.vaccine.2006.10.018; Sikasunge CS, 2008, VET PARASITOL, V158, P57, DOI 10.1016/j.vetpar.2008.08.014; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Thys S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003570; Torgerson PR, 2014, TRENDS PARASITOL, V30, P20, DOI 10.1016/j.pt.2013.11.002; Wandra T, 2000, T ROY SOC TROP MED H, V94, P46, DOI 10.1016/S0035-9203(00)90433-4; Wardrop NA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004223; WHO World Health Organization, 2015, ASS FRAM INT CONTR T; Winkler AS, 2009, WIEN KLIN WOCHENSCHR, V121, P3, DOI 10.1007/s00508-009-1242-3; World Bank, 2013, SAN OV; Zylberman V, 2004, J BIOL CHEM, V279, P8093, DOI 10.1074/jbc.M312035200	85	15	16	0	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JAN	2017	165				SI		252	260		10.1016/j.actatropica.2016.04.010				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EG3VS	WOS:000390973400029	27140860				2019-04-02	
J	Okello, AL; Thomas, L; Inthavong, P; Ash, A; Khamlome, B; Keokamphet, C; Newberry, K; Gauci, CG; Gabriel, S; Dorny, P; Thompson, RCA; Lightowlers, MW; Allen, J				Okello, Anna L.; Thomas, Lian; Inthavong, Phouth; Ash, Amanda; Khamlome, Boualam; Keokamphet, Chattouphone; Newberry, Kim; Gauci, Charles G.; Gabriel, Sarah; Dorny, Pierre; Thompson, R. C. Andrew; Lightowlers, Marshall W.; Allen, John			Reprint of "Assessing the impact of a joint human-porcine intervention package for Taenia solium control: Results of a pilot study from northern Lao PDR"	ACTA TROPICA			English	Article							SOUTHEAST-ASIA; CYSTICERCOSIS; PREVALENCE; ZOONOSES; EPILEPSY; PEOPLE; HEALTH; FOCUS; PCR	Following confirmation that a remote village of approximately 300 inhabitants in northern Lao PDR was hyperendemic for the Neglected Tropical Disease Taenia solium, a pilot human-porcine therapeutic control intervention was implemented between October 2013 and November 2014. Mass drug administration with a three day albendazole 400 mg protocol was offered to all eligible humans in October 2013 and March 2014. At these times, and again in October 2014, eligible village pigs received the anti-cysticercosis TSOL18 vaccination and an oral dose of oxfendazole anthelmintic at 30 mg/kg, both repeated one month later. Community and individual human taeniasis prevalences were estimated via copro-antigen ELISA of volunteered human faecal samples prior to October 2013, and again in January 2015, in order to examine the short term impact of the intervention. (C) 2016 The Author(s). Published by Elsevier B.V.	[Okello, Anna L.; Newberry, Kim; Allen, John] CSIRO, Australian Anim Hlth Lab AAHL Reg Programme, Geelong, Vic, Australia; [Okello, Anna L.] Univ Edinburgh, Div Pathway Med, Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Okello, Anna L.] Univ Edinburgh, Ctr Infect Dis, Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland; [Inthavong, Phouth; Keokamphet, Chattouphone] Minist Agr, Natl Anim Hlth Lab, Dept Livestock & Fisheries, Viangchan, Laos; [Ash, Amanda; Thompson, R. C. Andrew] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia; [Khamlome, Boualam] Minist Hlth, Dept Hyg & Prevent, Vientiane Capital, Laos; [Gauci, Charles G.; Lightowlers, Marshall W.] Univ Melbourne, Fac Vet & Agr Sci, 250 Princes Highway, Werribee, Vic 3030, Australia; [Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Natl Str 155, B-2000 Antwerp, Belgium	Okello, AL (reprint author), CSIRO, Australian Anim Hlth Lab AAHL Reg Programme, Geelong, Vic, Australia.; Okello, AL (reprint author), Univ Edinburgh, Div Pathway Med, Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.; Okello, AL (reprint author), Univ Edinburgh, Ctr Infect Dis, Sch Biomed Sci, Coll Med & Vet Med, Chancellors Bldg,49 Little France Crescent, Edinburgh EH16 4SB, Midlothian, Scotland.	anna.okello1@gmail.com		Thomas, Lian/0000-0001-8447-1210	Australian Centre for International Agricultural Research (ACIAR) Animal Health Programm [AH2009/001-019]; Australian National Health and Medical Research Council [1003546, 1043327]	The SPSP human and animal health component wish to thank their project counterparts from the Centre for International Agriculture in the Tropics (CIAT) and the Lao PDR National Agricultural and Forestry Research Institute (NAFRI) for their assistance during the pig interventions. The team also wish to thank the Lao PDR national WHO office for their overall support, as well as the Lao PDR Department for Communicable Disease Control (DCDC) for their facilitation and assistance in the human MDA interventions. In particular, the project team would like to thank the staff from the provincial and district Ministry of Health offices for their care and support in building community rapport during the project lifetime, and finally the community themselves for their hospitality, cooperation and trust. This research was funded by the Australian Centre for International Agricultural Research (ACIAR) Animal Health Programme, grant number AH2009/001-019. Funding support is also acknowledged from the Australian National Health and Medical Research Council, grants 1003546 and 1043327 (MWL).	Allan JC, 2006, PARASITOL INT, V55, pS75, DOI 10.1016/j.parint.2005.11.010; Ash A., 2015, ACTA TROP; Bardosh K, 2014, SOC SCI MED, V120, P215, DOI 10.1016/j.socscimed.2014.09.030; Carabin H., 2014, CURR TROP MED REP, P1; Conlan J, 2008, PARASITOL INT, V57, P252, DOI 10.1016/j.parint.2008.04.002; Conlan JV, 2011, VET PARASITOL, V182, P22, DOI 10.1016/j.vetpar.2011.07.013; Deckers N, 2010, TRENDS PARASITOL, V26, P137, DOI 10.1016/j.pt.2009.12.008; Del Brutto OH, 2012, SCI WORLD J, DOI 10.1100/2012/159821; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Dorny P, 2004, SE ASIAN J TROP MED, V35, P223; FAO, 2014, TOP 10 LIST FOOD BOR; Gabriel S, 2015, VET PARASITOL, V213, P38, DOI 10.1016/j.vetpar.2015.03.006; Garcia HH, 2006, AM J TROP MED HYG, V74, P850, DOI 10.4269/ajtmh.2006.74.850; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; Lightowlers MW, 2013, PARASITOLOGY, V140, P1566, DOI 10.1017/S0031182013001005; Maurice J, 2014, LANCET, V384, P571, DOI 10.1016/S0140-6736(14)61353-2; Moreno L, 2012, FOOD CHEM TOXICOL, V50, P3819, DOI 10.1016/j.fct.2012.07.023; Ndimubanzi PC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000870; Okello A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-134; Okello AL, 2015, AM J TROP MED HYG, V92, P1059, DOI 10.4269/ajtmh.14-0551; Praet N, 2013, TROP MED INT HEALTH, V18, P608, DOI 10.1111/tmi.12089; R Development Core Team, 2005, R LANG ENV STAT COMP; Steinmann P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025003; Stevenson M., 2013, EPIR R PACKAGE ANAL, P9; Trachsel D, 2007, PARASITOLOGY, V134, P911, DOI 10.1017/S0031182007002235; Tran Duc Si, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P537; WHO, 2015, LANDSC AN MAN NEUR E; WHO, 2015, 4 INT M CONTR NEGL Z; WHO, 2006, MAN HLTH PROF PROGR; Willingham AL, 2010, ADV PARASIT, V72, P235, DOI 10.1016/S0065-308X(10)72009-1; Wolak ME, 2012, METHODS ECOL EVOL, V3, P129, DOI 10.1111/j.2041-210X.2011.00125.x; World Health Organization, 2012, ACC WORK OV GLOB IMP	32	2	2	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	JAN	2017	165				SI		261	267		10.1016/j.actatropica.2016.11.010				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EG3VS	WOS:000390973400030	27887694	Green Published, Other Gold			2019-04-02	
J	Coulibaly, YI; Coulibaly, SY; Dolo, H; Konate, S; Diallo, AA; Doumbia, SS; Soumaoro, L; Coulibaly, ME; Dicko, I; Sangare, MB; Dembele, B; Sangare, M; Dembele, M; Toure, YT; Kelly-Hope, L; Polman, K; Kyelem, D; Traore, SF; Bockarie, M; Klion, AD; Nutman, TB				Coulibaly, Yaya I.; Coulibaly, Siaka Y.; Dolo, Housseini; Konate, Siaka; Diallo, Abdallah A.; Doumbia, Salif S.; Soumaoro, Lamine; Coulibaly, Michel E.; Dicko, Ilo; Sangare, Moussa B.; Dembele, Benoit; Sangare, Modibo; Dembele, Massitan; Toure, Yeya T.; Kelly-Hope, Louise; Polman, Katja; Kyelem, Dominique; Traore, Sekou F.; Bockarie, Moses; Klion, Amy D.; Nutman, Thomas B.			Dynamics of antigenemia and transmission intensity of Wuchereria bancrofti following cessation of mass drug administration in a formerly highly endemic region of Mali	PARASITES & VECTORS			English	Article						Wuchereria bancrofti; Transmission assessment survey; Anopheles gambiae complex; Mass drug administration; Post-MDA surveillance	LYMPHATIC FILARIASIS TRANSMISSION; INFECTION; MOSQUITOS; PROGRAMS; SURVEILLANCE; ELIMINATION; IMPACT; TOOLS; RATES; FOCUS	Background: After seven annual rounds of mass drug administration (MDA) in six Malian villages highly endemic for Wuchereria bancrofti (overall prevalence rate of 42.7%), treatment was discontinued in 2008. Surveillance was performed over the ensuing 5 years to detect recrudescence. Methods: Circulating filarial antigen (CFA) was measured using immunochromatographic card tests (ICT) and Og4C3 ELISA in 6-7 year-olds. Antibody to the W. bancrofti infective larval stage (L3) antigen, Wb123, was tested in the same population in 2012. Microfilaraemia was assessed in ICT-positive subjects. Anopheles gambiae complex specimens were collected monthly using human landing catch (HLC) and pyrethrum spray catch (PSC). Anopheles gambiae complex infection with W. bancrofti was determined by dissection and reverse transcriptase polymerase chain reaction (RT-PCR) of mosquito pools. Results: Annual CFA prevalence rates using ICT in children increased over time from 0% (0/289) in 2009 to 2. 7% (8/301) in 2011, 3.9% (11/285) in 2012 and 4.5% (14/309) in 2013 (trend chi(2) = 11.85, df = 3, P = 0.0006). Wb123 antibody positivity rates in 2013 were similar to the CFA prevalence by ELISA (5/285). Although two W. bancrofti-infected Anopheles were observed by dissection among 12,951 mosquitoes collected by HLC, none had L3 larvae when tested by L3-specific RT-PCR. No positive pools were detected among the mosquitoes collected by pyrethrum spray catch. Whereas ICT in 6-7 year-olds was the major surveillance tool, ICT positivity was also assessed in older children and adults (8-65 years old). CFA prevalence decreased in this group from 4.9% (39/800) to 3.5% (28/795) and 2.8% (50/1,812) in 2009, 2011 and 2012, respectively (trend.2 = 7.361, df = 2, P = 0.0067). Some ICT-positive individuals were microfilaraemic in 2009 [2.6% (1/39)] and 2011 [8.3% (3/36)], but none were positive in 2012 or 2013. Conclusion: Although ICT rates in children increased over the 5-year surveillance period, the decrease in ICT prevalence in the older group suggests a reduction in transmission intensity. This was consistent with the failure to detect infective mosquitoes or microfilaraemia. The threshold of ICT positivity in children may need to be re-assessed and other adjunct surveillance tools considered.	[Coulibaly, Yaya I.; Coulibaly, Siaka Y.; Dolo, Housseini; Konate, Siaka; Diallo, Abdallah A.; Doumbia, Salif S.; Soumaoro, Lamine; Coulibaly, Michel E.; Dicko, Ilo; Sangare, Moussa B.; Dembele, Benoit; Sangare, Modibo; Traore, Sekou F.] Fac Med & Odontostomatol, Int Ctr Excellence Res, Filariasis Unit, Bamako, Mali; [Dembele, Massitan] Natl Lymphat Filariasis Eliminat Program, Bamako, Mali; [Toure, Yeya T.] Fac Med & Odontostomatol Bamako, Bamako, Mali; [Coulibaly, Yaya I.; Kelly-Hope, Louise] Univ Liverpool Liverpool Sch Trop Med, Filarial Program, Support Unit, Liverpool, Merseyside, England; [Polman, Katja] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Kyelem, Dominique] Task Force Global Hlth, Neglected Trop Dis Support Ctr, Decatur, GA USA; [Bockarie, Moses] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Klion, Amy D.; Nutman, Thomas B.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD USA	Coulibaly, YI (reprint author), Fac Med & Odontostomatol, Int Ctr Excellence Res, Filariasis Unit, Bamako, Mali.; Coulibaly, YI (reprint author), Univ Liverpool Liverpool Sch Trop Med, Filarial Program, Support Unit, Liverpool, Merseyside, England.	yicoulibaly@icermali.org			WHO/UNDP/World Bank Special Program for Tropical Diseases grant [A00583]; Task Force for Global Health; Division of Intramural Research, NIAID, NIH	This study was funded by the WHO/UNDP/World Bank Special Program for Tropical Diseases grant (ID A00583) to SFT and the Task Force for Global Health. This study was funded in part by the Division of Intramural Research, NIAID, NIH. The funding bodies did not play any role in the study design, data collection, analysis and interpretation, nor the decision to write the manuscript.	Amuzu H, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-85; Bakajika DK, 2014, AM J TROP MED HYG, V91, P1142, DOI 10.4269/ajtmh.14-0358; BRENGUES J, 1968, B WORLD HEALTH ORGAN, V38, P595; Coulibaly Y I, 2006, Mali Med, V21, P12; Coulibaly YI, 2015, AM J TROP MED HYG, V93, P356, DOI 10.4269/ajtmh.14-0516; Coulibaly YI, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-247; Dembele M, 2012, PLOS NEGLECT TROP D, DOI [10.1371/journal.pntd.0001574, DOI 10.1371/JOURNAL.PNTD.0001574.]; DETINOVA T. S., 1964, BULL WORLD HEALTH ORGAN, V30, P23; Dorkenoo A M, 2015, Bull Soc Pathol Exot, V108, P181, DOI 10.1007/s13149-014-0408-z; Golden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069231; Goodman DS, 2003, FILARIA J, V2, P11, DOI [10.1186/1475-2883-2-11, DOI 10.1186/1475-2883-2-11]; Govella N, 2010, AM J TROP MED HYG, V83, P596, DOI 10.4269/ajtmh.2010.09-0682; Harnett W, 1998, PARASITOLOGY, V117, pS59; Keiser PB, 2003, AM J TROP MED HYG, V69, P331, DOI 10.4269/ajtmh.2003.69.331; Kia EB, 2014, IRAN J PARASITOL, V9, P145; Kubofcik J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001930; Lamberton PHL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0511-9; Laney SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000602; Lovato R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002821; Ngom EHM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0711-0; Ramaiah KD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003319; Ramaiah KD, 2013, T ROY SOC TROP MED H, V107, P293, DOI 10.1093/trstmh/trt011; Richards FO, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001346; SOUTHGATE BA, 1992, T ROY SOC TROP MED H, V86, P523, DOI 10.1016/0035-9203(92)90096-U; Steel C, 2013, CLIN VACCINE IMMUNOL, V20, P1155, DOI 10.1128/CVI.00252-13; Talla C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114047; WALSH JF, 1978, T ROY SOC TROP MED H, V72, P675, DOI 10.1016/0035-9203(78)90039-1; Wanji S, 2015, PLOS NEGLECT TROP D, V9, P1; Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001; WHO, 2011, LYMPH FIL MON ED ASS; WHO, 2014, WKLY EPIDEMIOL REC, V89, P409; World Health Organization, 2013, GLOB PROGR EL LYMPH	32	4	4	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 3	2016	9								628	10.1186/s13071-016-1911-9				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EI3DS	WOS:000392370500004	27912789	DOAJ Gold, Green Published			2019-04-02	
J	Collantes, J; Solari, FB; Rigouts, L				Collantes, Jimena; Barletta Solari, Francesca; Rigouts, Leen			Rapid Detection of Mycobacterium tuberculosis Strains Resistant to Isoniazid and/or Rifampicin: Standardization of Multiplex Polymerase Chain Reaction Analysis	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							GENOTYPE MTBDRPLUS ASSAY; REAL-TIME PCR; RPOB MUTATIONS; NONTUBERCULOUS MYCOBACTERIA; CLINICAL SPECIMENS; COMPLEX; INHA; KATG; ELECTROPHORESIS; IDENTIFICATION	Drug susceptibility testing using molecular techniques can enhance the identification of drug-resistant Mycobacterium tuberculosis. Two multiplex real-time polymerase chain reaction (qPCR) assays were developed to detect the most common resistance-associated mutations to isoniazid (katGS315T, inhA-15C -> T), and rifampicin (rpoBH526Y and rpoBS531L). To assess the species specificity of the qPCR, we selected 31 nontuberculous mycobacteria (NTM) reference strains belonging to 17 species from the public collection of mycobacterial cultures (BCCM/ITM). Additionally, we tested 17 isoniazid and/or rifampicin-resistant strains with other mutations in the target genes to assess mutation specificity. The limit of detection for all the targeted mutations was 20 bacilli/reaction. Multiplex 1 showed 90%, 95%, and 100% efficiency for wild type (WT), Mut katGS315T, and Mut rpoBS531L, respectively; whereas Multiplex 2 showed 97%, 94%, and 90% efficiency for WT, Mut inhA-15, and Mut rpoBH526Y, respectively. Three of 17 strains that presented other mutations in the target genes were identified as rifampicin resistant and only 3/31 NTM showed a similar melting temperature to rpoBL531 and/or katG11.315 mutants. Thus, our proposed cascade of specific tuberculosis detection followed by drug resistance testing showed sensitivities for katGS315T, rpoBS531L, rpoBH526Y, and inhA-15 detection of 100%, 100%, 100%, and 96%, respectively; and specificities of 98%, 95%, 100%, and 100, respectively.	[Collantes, Jimena; Barletta Solari, Francesca] Inst Med Trop Alexander von Humboldt, Lima, Peru; [Collantes, Jimena; Barletta Solari, Francesca] Univ Peruana Cayetano Heredia, Lima, Peru; [Rigouts, Leen] Inst Trop Med, Antwerp, Belgium; [Rigouts, Leen] Univ Antwerp, Antwerp, Belgium; [Rigouts, Leen] Inst Trop Med, Microbiol, Antwerp, Belgium	Collantes, J (reprint author), Inst Med Trop Alexander von Humboldt, Mol Epidemiol Unit TB, Ave Honorio Delgado 430, Lima, Peru.	jimena_collantes@hotmail.com			Belgian Directorate General for Development Cooperation (DGDC)	This study was funded by the Belgian Directorate General for Development Cooperation (DGDC) through an institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium, and the Institute de Medicina Tropical Alexander von Humboldt in Lima, Peru.	Ahmad S, 2012, INDIAN J MED RES, V135, P756; Ahmad S, 2009, RESP MED, V103, P1777, DOI 10.1016/j.rmed.2009.07.010; Asencios Luis, 2012, Rev Peru Med Exp Salud Publica, V29, P92; Barletta F, 2014, AM J TROP MED HYG, V91, P709, DOI 10.4269/ajtmh.13-0603; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21; Cavusoglu C, 2004, CLIN MICROBIOL INFEC, V10, P662, DOI 10.1111/j.1469-0691.2004.00917.x; Caws M, 2006, J CLIN MICROBIOL, V44, P2333, DOI 10.1128/JCM.00330-06; de Freitas FAD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104100; Grange JM, GUIDELINES SPECIATIO; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hoefsloot W, 2013, EUR RESPIR J, V42, P1604, DOI 10.1183/09031936.00149212; Isfahani BN, 2006, MEM I OSWALDO CRUZ, V101, P597, DOI 10.1590/S0074-02762006000600004; Jacobson KR, 2011, CLIN INFECT DIS, V53, P369, DOI 10.1093/cid/cir406; Jenkins HE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022927; Kaiser M, 2009, ENVIRON MICROBIOL, V75, P414; Kremer K, 1999, J CLIN MICROBIOL, V37, P2607; Lacoma A, 2008, J CLIN MICROBIOL, V46, P3660, DOI 10.1128/JCM.00618-08; Leung ETY, 2006, ANTIMICROB AGENTS CH, V50, P1075, DOI 10.1128/AAC.50.3.1075-1078.2006; Marras TK, 2007, THORAX, V62, P661, DOI 10.1136/thx.2006.070797; Marras TK, 2002, CLIN CHEST MED, V23, P553, DOI 10.1016/S0272-5231(02)00019-9; Martin-Casabona N, 2004, INT J TUBERC LUNG D, V8, P1186; Maschmann RD, 2013, J CLIN MICROBIOL, V51, P1606, DOI 10.1128/JCM.00364-13; Mayta H, 2003, J CLIN MICROBIOL, V41, P5774, DOI 10.1128/JCM.41.12.5774-5777.2003; McCammon MT, 2005, ANTIMICROB AGENTS CH, V49, P2200, DOI 10.1128/AAC.49.6.2200-2209.2005; Menzies D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000150; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; Montenegro SH, 2003, CLIN INFECT DIS, V36, P16, DOI 10.1086/344900; Moure R, 2011, J CLIN MICROBIOL, V49, P1137, DOI 10.1128/JCM.01831-10; Munayco CV, 2008, REV SAUDE PUBL, V42, P146, DOI [10.1590/S0034-89102008000100020, 10.1590/s0034-89102008000100020]; Murphy KM, 2003, EXPERT REV MOL DIAGN, V3, P811, DOI 10.1586/14737159.3.6.811; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Nikolayevsky V, 2004, J CLIN MICROBIOL, V42, P4498, DOI 10.1128/JCM.42.10.4498-4502.2004; Perez-Osorio AC, 2012, J CLIN MICROBIOL, V50, P326, DOI 10.1128/JCM.05570-11; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Richter E, 2004, J CLIN MICROBIOL, V42, P4303, DOI 10.1128/JCM.42.9.4303-4306.2004; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Scarpellini P., 2003, New Microbiologica, V26, P345; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Sheng J, 2008, J APPL MICROBIOL, V105, P904, DOI 10.1111/j.1365-2672.2008.03815.x; Shi RR, 2007, MICROBES INFECT, V9, P1538, DOI 10.1016/j.micinf.2007.08.009; Silva MSN, 2003, J CLIN MICROBIOL, V41, P4471, DOI 10.1128/JCM.41.9.4471-4474.2003; Somoskovi A, 2001, RESPIR RES, V2, P164, DOI 10.1186/rr54; Sougakoff W, 2004, CLIN MICROBIOL INFEC, V10, P289, DOI 10.1111/j.1198-743X.2004.889.x; Steingart KR, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009593.PUB3; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Thacker TC, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-100; Ugarte-Gil César, 2008, Acta méd. peruana, V25, P171; Valim ARM, 2000, J CLIN MICROBIOL, V38, P3119; Van Deun A, 2013, INT J TUBERC LUNG D; van Doorn HR, 2006, CLIN MICROBIOL INFEC, V12, P769, DOI 10.1111/j.1469-0691.2006.01495.x; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406; Vilcheze C, 2006, NAT MED, V12, P1027, DOI 10.1038/nm1466; WHO, 2014, GLOB TUB REP 2014; Wittwer CT, 2009, HUM MUTAT, V30, P857, DOI 10.1002/humu.20951; World Health Organization, 2013, TOP 10 CAUS DEATH; Zhao P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099659	59	0	0	1	6	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2016	95	6					1257	1264		10.4269/ajtmh.16-0120				8	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3VF	WOS:000400206900007	27928076	Bronze, Green Published			2019-04-02	
J	Manabe, YC; Worodria, W; van Leth, F; Mayanja-Kizza, H; Traore, AN; Ferro, J; Pakker, N; Frank, M; Grobusch, MP; Colebunders, R; Cobelens, F				Manabe, Yukari C.; Worodria, William; van Leth, Frank; Mayanja-Kizza, Harriet; Traore, Afsatou Ndama; Ferro, Josef; Pakker, Nadine; Frank, Matthias; Grobusch, Martin P.; Colebunders, Robert; Cobelens, Frank			Prevention of Early Mortality by Presumptive Tuberculosis Therapy Study: An Open Label, Randomized Controlled Trial	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SUB-SAHARAN AFRICA; INITIATING ANTIRETROVIRAL THERAPY; HIGH-INCOME COUNTRIES; DIAGNOSTIC-ACCURACY; TREATMENT PROGRAMS; RURAL DISTRICT; SCALING-UP; HIV; ADULTS; OUTCOMES	Early mortality after initiation of antiretroviral therapy (ART) occurs in 9-39% of patients in sub-Saharan Africa. A significant proportion of deaths are attributable to tuberculosis (TB). Low baseline CD4 T-cell count and low body mass index (BMI) are strongly associated with early mortality. We hypothesized that initiation of ART concurrent with presumptive anti-TB chemotherapy in high-risk patients would reduce mortality within the first 6 months by treating unrecognized TB. From October 2011 to December 2012, ART-naive, smear-negative participants with a CD4 T-cell count < 50 cells/mu L and BMI < 18 kg/m(2) were randomly assigned to undergo either empiric four-drug anti-TB treatment followed 2 weeks later by efavirenz-based ART (N = 23) (ART + TB) or ART only (N = 20). This open-label, 1:1 randomized, controlled trial took place in Uganda, Mozambique, and Gabon and was stopped prematurely by the sponsor for slow recruitment. Overall, the 43 participants had a median CD4 of 22 (interquartile range [IQR]: 9-35) cells/mu L and a median BMI of 17.5 (IQR: 16.6-18.0) kg/m(2). The mortality was 14% (95% confidence interval [CI]: 5.3-27.9); two (10.0%) participants (ART-only group), and four (17.4%; ART + TB group). The associated hazard ratio (HR) for all-cause mortality was 1.6 (95% CI: 0.30-8.90). Despite limited enrollment, the study did not suggest that empiric TB treatment in severely immunosuppressed patients with low BMI decreased mortality and, had an HR in the opposite direction than expected. Notably, two participants in the ART + TB group died with autopsy-confirmed drug-induced hepatotoxicity. Improved TB diagnostics sensitive in immunosuppressed patients presenting late to care are urgently needed for more targeted interventions.	[Manabe, Yukari C.; Worodria, William; Mayanja-Kizza, Harriet] Makerere Univ, Coll Hlth Sci, Infect Dis Inst, POB 22418,Mulago Hosp Complex, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [van Leth, Frank; Pakker, Nadine; Cobelens, Frank] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [van Leth, Frank; Pakker, Nadine; Cobelens, Frank] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Mayanja-Kizza, Harriet] Makerere Univ, Dept Med, Coll Hlth Sci, Kampala, Uganda; [Traore, Afsatou Ndama; Frank, Matthias; Grobusch, Martin P.] Albert Schweitzer Hosp, Ctr Rech Med Lambarene CERMEL, Lambarene, Gabon; [Traore, Afsatou Ndama] Univ Venda, Dept Microbiol, Thohoyandou, South Africa; [Ferro, Josef] Catholic Univ Mozambique, Beira, Mozambique; [Frank, Matthias; Grobusch, Martin P.] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Grobusch, Martin P.] Univ Amsterdam, Div Internal Med, Dept Infect Dis, Ctr Trop Med & Travel Med, Amsterdam, Netherlands; [Colebunders, Robert] Inst Trop Med, Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, Global Hlth Inst, Antwerp, Belgium; [Cobelens, Frank] KNCV TB Fdn, The Hague, Netherlands; [Manabe, Yukari C.] Johns Hopkins Univ, Med, Baltimore, MD USA; [Worodria, William] Mulago Hosp, Dept Med, Kampala, Uganda; [Ferro, Josef] Catholic Univ Mozambique, Dept Med, Beira, Mozambique; [Pakker, Nadine] Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Amsterdam, Netherlands; [Colebunders, Robert] Prince Leopold Inst Trop Med, Clin Sci, Antwerp, Belgium	Manabe, YC (reprint author), Makerere Univ, Coll Hlth Sci, Infect Dis Inst, POB 22418,Mulago Hosp Complex, Kampala, Uganda.	ymanabe@jhmi.edu		Mayanja-Kizza, Harriet/0000-0002-9297-6208; van Leth, Frank/0000-0002-5490-8968	European Developing Countries Trials Program (EDCTP) [IP.2009.33011.007]; National Institutes of Health Fogarty International Center [D43TW009771]	This clinical trial was funded by European Developing Countries Trials Program (EDCTP) (grant no. IP.2009.33011.007). Funding was withdrawn when EDCTP decided against trial continuation. Additional support for Yukari C. Manabe and William Worodria was provided from the National Institutes of Health Fogarty International Center (D43TW009771).	Alland D, 2015, C RETR OPP INF OR; Avila D, 2014, JAIDS-J ACQ IMM DEF, V65, pE8, DOI 10.1097/QAI.0b013e3182a39979; BASSETT ICS, 2009, INTENSIVE TB SCREENI; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Braitstein P, 2006, LANCET, V367, P817; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Grant A, 2016, EMPIRICAL TB TREATME; Gupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022730; Hosseinipour MC, 2016, LANCET, V387, P1198, DOI 10.1016/S0140-6736(16)00546-8; Johannessen A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-52; Katagira W, 2016, JAIDS-J ACQ IMM DEF, V72, P297, DOI 10.1097/QAI.0000000000000970; Lahuerta M, 2014, CLIN INFECT DIS, V58, P432, DOI 10.1093/cid/cit724; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P1354, DOI 10.5588/ijtld.12.0174; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2006, AIDS, V20, P1605, DOI 10.1097/01.aids.0000238406.93249.cd; Lawn SD, 2012, AIDS, V26, P2121, DOI 10.1097/QAD.0b013e3283565dd1; Lawn SD, 2012, AIDS, V26, P1635, DOI 10.1097/QAD.0b013e3283553685; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Moore D, 2007, AIDS, V21, P713, DOI 10.1097/QAD.0b013e328013f632; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8; Nakiyingi L, 2014, JAIDS-J ACQ IMM DEF, V66, P270, DOI 10.1097/QAI.0000000000000151; Pac L, 2015, JAIDS-J ACQ IMM DEF, V68, pE69, DOI 10.1097/QAI.0000000000000527; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2; Russell EC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-433; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; UNAIDS, 2014, THE GAP REP 2014; Wong EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047542; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization (WHO), 2007, IMPR DIAGN TREATM SM; Zachariah R, 2006, AIDS, V20, P2355, DOI 10.1097/QAD.0b013e32801086b0	38	2	2	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	DEC	2016	95	6					1265	1271		10.4269/ajtmh.16-0239				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3VF	WOS:000400206900008	27928077	Bronze, Green Published			2019-04-02	
J	Lagatie, O; Merino, M; Debrah, LB; Debrah, AY; Stuyver, LJ				Lagatie, Ole; Merino, Michelle; Debrah, Linda Batsa; Debrah, Alexander Y.; Stuyver, Lieven J.			An isothermal DNA amplification method for detection of Onchocerca volvulus infection in skin biopsies	PARASITES & VECTORS			English	Article						Onchocerca volvulus; River blindness; Onchocerciasis; Skin biopsy; DNA; cox1; LAMP; Isothermal; Diagnostic	POLYMERASE-CHAIN-REACTION; RIVER-BLINDNESS; BLACK FLIES; WUCHERERIA-BANCROFTI; ELIMINATION PROGRAMS; IVERMECTIN TREATMENT; FILARIAL INFECTIONS; DIAGNOSTIC METHODS; EXTRACTION METHODS; LOA-LOA	Background: Diagnostic procedures for the diagnosis of infection with the nematode parasite Onchocerca volvulus are currently based on the microscopic detection of microfilariae in skin biopsies. Alternative approaches based on amplification of parasitic DNA in these skin biopsies are currently being explored. Mostly this is based on the detection of the O-150 repeat sequence using PCR based techniques. Methods: An isothermal, loop-mediated amplification method has been designed using the mitochondrial O. volvulus cox1 gene as a target. Results: Analysis of dilution series of synthetic DNA containing the targeted sequence show a non-linear dose-response curve, as is usually the case for isothermal amplification methods. Evaluation of cross-reactivity with the heterologous sequence from the closely related parasites Wuchereria bancrofti, Loa loa and Brugia malayi demonstrated strong specificity, as none of these sequences was amplified. The assay however amplified both O. volvulus and O. ochengi DNA, but with a different melting point that can be used to discriminate between the species. Evaluation of this assay in a set of skin snip biopsies collected in an endemic area in Ghana showed a high correlation with O-150 qPCR and also demonstrated a similar sensitivity. Compared to qPCR, LAMP had a sensitivity of 88.2% and a specificity of 99.2%. Conclusions: We have developed a sensitive and specific loop-mediated amplification method for detection of O. volvulus DNA in skin biopsies that is capable of providing results within 30 min.	[Lagatie, Ole; Merino, Michelle; Stuyver, Lieven J.] Janssen Diagnost, Janssen R&D, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Debrah, Linda Batsa] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Debrah, Alexander Y.] Kwame Nkrumah Univ Sci & Technol, Fac Allied Hlth Sci, Kumasi, Ghana	Lagatie, O (reprint author), Janssen Diagnost, Janssen R&D, Turnhoutseweg 30, B-2340 Beerse, Belgium.	olagatie@its.jnj.com					Alhassan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108927; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], 2010, WHOHTMNTD20101; Boatin BA, 2002, PARASITOLOGY, V125, P545, DOI 10.1017/S0031182002002494; Borup LH, 2003, CUTIS, V72, P297; Bottomley C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1605-3; BOUSSINESQ M, 1993, ANN SOC BELG MED TR, V73, P189; BWANGAMOI O, 1969, Bulletin of Epizootic Diseases of Africa, V17, P321; Chandrashekar R, 1996, TROP MED INT HEALTH, V1, P575; Creecy A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130260; Debrah AY, 2015, CLIN INFECT DIS, V61, P517, DOI 10.1093/cid/civ363; Denery JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000834; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; Drame PM, 2014, J CLIN MICROBIOL, V52, P2071, DOI 10.1128/JCM.00525-14; Enk CD, 2006, CLIN DERMATOL, V24, P176, DOI 10.1016/j.clindermatol.2005.11.008; Fernandez-Soto P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094664; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; Fink DL, 2011, J CLIN MICROBIOL, V49, P42, DOI 10.1128/JCM.01697-10; Globisch D, 2013, P NATL ACAD SCI USA, V110, P4218, DOI 10.1073/pnas.1221969110; Golden A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1623-1; Golden A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069231; Gopal H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001712; Guevara AG, 2003, AM J TROP MED HYG, V68, P222, DOI 10.4269/ajtmh.2003.68.222; KATHOLI CR, 1995, J INFECT DIS, V172, P1414, DOI 10.1093/infdis/172.5.1414; Lagatie O, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1582-6; LAVEBRATT C, 1994, T ROY SOC TROP MED H, V88, P303, DOI 10.1016/0035-9203(94)90090-6; Lefoulon E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004233; Lipner EM, 2006, J INFECT DIS, V194, P216, DOI 10.1086/505081; Liu ZY, 2016, MITOCHONDRIAL DNA A, V27, P2318, DOI 10.3109/19401736.2015.1022762; Lloyd MM, 2015, ACTA TROP, V146, P114, DOI 10.1016/j.actatropica.2015.03.019; Nagai S, 2012, MAR GENOM, V7, P51, DOI 10.1016/j.margen.2012.03.002; Notomi T, 2015, J MICROBIOL, V53, P1, DOI 10.1007/s12275-015-4656-9; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Poole CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139286; Poole CB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001948; Quintana JF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0656-1; Rejili M, 2016, B ENTOMOL RES, V106, P695, DOI 10.1017/S000748531600050X; ROBIN ED, 1988, J CELL PHYSIOL, V136, P507, DOI 10.1002/jcp.1041360316; Rodriguez-Perez MA, 2006, AM J TROP MED HYG, V74, P1026, DOI 10.4269/ajtmh.2006.74.1026; Rodriguez-Perez MA, 2013, PARASITOL RES, V112, P3925, DOI 10.1007/s00436-013-3583-0; Seyrig G, 2015, J MICROBIOL METH, V119, P223, DOI 10.1016/j.mimet.2015.11.004; Steel C, 2015, CLIN VACCINE IMMUNOL, V22, P896, DOI 10.1128/CVI.00227-15; Sun Y, 2014, J VIROL METHODS, V204, P49, DOI 10.1016/j.jviromet.2014.04.006; Takagi H, 2011, PARASITOL INT, V60, P493, DOI 10.1016/j.parint.2011.08.018; TAYLOR HR, 1989, AM J TROP MED HYG, V41, P467, DOI 10.4269/ajtmh.1989.41.467; Toe L, 1998, J INFECT DIS, V178, P282, DOI 10.1086/517454; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; Tritten L, 2014, MOL BIOCHEM PARASIT, V198, P14, DOI 10.1016/j.molbiopara.2014.11.001; Tritten L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002971; Vlaminck J, 2015, TRENDS PARASITOL, V31, P571, DOI 10.1016/j.pt.2015.06.007; Weil GJ, 2000, J INFECT DIS, V182, P1796, DOI 10.1086/317629; WHO, 2015, WKLY EPIDEMIOL REC, V90, P661; Zhang XZ, 2014, BIOSENS BIOELECTRON, V61, P491, DOI 10.1016/j.bios.2014.05.039; Zhao YX, 2015, CHEM REV, V115, P12491, DOI 10.1021/acs.chemrev.5b00428	54	6	6	1	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	DEC 1	2016	9								624	10.1186/s13071-016-1913-7				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EI3DQ	WOS:000392370300004	27906100	DOAJ Gold, Green Published			2019-04-02	
J	Braae, UC; Devleesschauwer, B; Gabriel, S; Dorny, P; Speybroeck, N; Magnussen, P; Torgerson, P; Johansen, MV				Braae, Uffe Christian; Devleesschauwer, Brecht; Gabriel, Sarah; Dorny, Pierre; Speybroeck, Niko; Magnussen, Pascal; Torgerson, Paul; Johansen, Maria Vang			CystiSim - An Agent-Based Model for Taenia solium Transmission and Control	PLOS NEGLECTED TROPICAL DISEASES			English	Article							HEALTH-EDUCATION INTERVENTION; PORCINE CYSTICERCOSIS; MASS CHEMOTHERAPY; MBEYA REGION; RISK-FACTORS; FIELD TRIAL; PIGS; OXFENDAZOLE; PREVALENCE; INFECTION	Taenia solium taeniosis/cysticercosis was declared eradicable by the International Task Force for Disease Eradication in 1993, but remains a neglected zoonosis. To assist in the attempt to regionally eliminate this parasite, we developed cystiSim, an agent-based model for T. solium transmission and control. The model was developed in R and available as an R package (http://cran.r-project.org/package=cystiSim). cystiSim was adapted to an observed setting using field data from Tanzania, but adaptable to other settings if necessary. The model description adheres to the Overview, Design concepts, and Details (ODD) protocol and consists of two entities D pigs and humans. Pigs acquire cysticercosis through the environment or by direct contact with a tapeworm carrier's faeces. Humans acquire taeniosis from slaughtered pigs proportional to their infection intensity. The model allows for evaluation of three interventions measures or combinations hereof: treatment of humans, treatment of pigs, and pig vaccination, and allows for customary coverage and efficacy settings. cystiSim is the first agent-based transmission model for T. solium and suggests that control using a strategy consisting of an intervention only targeting the porcine host is possible, but that coverage and efficacy must be high if elimination is the ultimate goal. Good coverage of the intervention is important, but can be compensated for by including an additional intervention targeting the human host. cystiSim shows that the scenarios combining interventions in both hosts, mass drug administration to humans, and vaccination and treatment of pigs, have a high probability of success if coverage of 75% can be maintained over at least a four year period. In comparison with an existing mathematical model for T. solium transmission, cystiSim also includes parasite maturation, host immunity, and environmental contamination. Adding these biological parameters to the model resulted in new insights in the potential effect of intervention measures.	[Braae, Uffe Christian; Magnussen, Pascal; Johansen, Maria Vang] Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol & Aquat Dis, Dept Vet Dis Biol, Frederiksberg, Denmark; [Devleesschauwer, Brecht] Sci Inst Publ Hlth WIV ISP, Dept Publ Hlth & Surveillance, Brussels, Belgium; [Gabriel, Sarah; Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Gabriel, Sarah] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Merelbeke, Belgium; [Dorny, Pierre] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Merelbeke, Belgium; [Speybroeck, Niko] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium; [Magnussen, Pascal] Univ Copenhagen, Fac Hlth & Med Sci, Ctr Med Parasitol, Copenhagen, Denmark; [Torgerson, Paul] Univ Zurich, Vetsuisse Fac, Epidemiol Sect, Zurich, Switzerland	Braae, UC (reprint author), Univ Copenhagen, Fac Hlth & Med Sci, Sect Parasitol & Aquat Dis, Dept Vet Dis Biol, Frederiksberg, Denmark.	braae@sund.ku.dk	Braae, Uffe/J-4720-2017; Devleesschauwer, Brecht/G-9895-2018; Torgerson, Paul/M-4447-2013	Braae, Uffe/0000-0002-2743-4584; Devleesschauwer, Brecht/0000-0002-2867-6892; Torgerson, Paul/0000-0003-4277-9983; Magnussen, Pascal/0000-0001-7372-0250	CYSTINET: European Network on taeniosis/cysticercosis, COST ACTION [TD1302]	The work was carried out with support from CYSTINET (http://www.cystinet.org/): European Network on taeniosis/cysticercosis, COST ACTION TD1302. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AM, 2012, INT HEALTH, V4, P164, DOI 10.1016/j.inhe.2012.04.003; Allan JC, 1997, T ROY SOC TROP MED H, V91, P595, DOI 10.1016/S0035-9203(97)90042-0; Arriola CS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003247; Assana E, 2010, INT J PARASITOL, V40, P515, DOI 10.1016/j.ijpara.2010.01.006; Bonnell TR, 2010, ECOL MODEL, V221, P2491, DOI 10.1016/j.ecolmodel.2010.07.020; Braae U.C., 2015, ACTA TROP; Braae Uffe Christian, 2016, Parasite Epidemiol Control, V1, P245; Braae UC, 2015, VET PARASITOL, V214, P187, DOI 10.1016/j.vetpar.2015.08.009; Braae UC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0938-7; Braae UC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0574-7; CAMACHO SPD, 1991, AM J TROP MED HYG, V45, P522, DOI 10.4269/ajtmh.1991.45.522; CRUZ M, 1989, B WORLD HEALTH ORGAN, V67, P401; Devleesschauwer B, 2016, CYSTISIM AGENT BASED; Flisser A, 1994, Prog Clin Parasitol, V4, P77; Garcia HH, 2006, AM J TROP MED HYG, V74, P850, DOI 10.4269/ajtmh.2006.74.850; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Gomez-Puerta LA, 2014, REV BRAS PARASITOL V, V23, P94, DOI 10.1590/S1984-29612014014; Gonzalez AE, 2005, AM J TROP MED HYG, V72, P837, DOI 10.4269/ajtmh.2005.72.837; Gonzalez AE, 1998, AM J TROP MED HYG, V59, P832, DOI 10.4269/ajtmh.1998.59.832; Gonzalez AE, 2001, AM J TROP MED HYG, V65, P15, DOI 10.4269/ajtmh.2001.65.15; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Haagsma JA, 2013, INT J FOOD MICROBIOL, V166, P34, DOI 10.1016/j.ijfoodmicro.2013.05.029; ILSOE B, 1990, ACTA VET SCAND, V31, P153; Jayashi CM, 2012, VET PARASITOL, V188, P261, DOI 10.1016/j.vetpar.2012.03.055; Jiang W, 2012, J THEOR BIOL, V293, P15, DOI 10.1016/j.jtbi.2011.10.006; Johansen MV, 2016, PARASITOLOGY, P1; KEILBACH N M, 1989, Acta Leidensia, V57, P181; Komba EVG, 2013, VET PARASITOL, V198, P284, DOI 10.1016/j.vetpar.2013.09.020; Krentel A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002447; Kyvsgaard NC, 2007, INT J PARASITOL, V37, P547, DOI 10.1016/j.ijpara.2006.11.018; LAWSON JR, 1990, PARASITOLOGY, V100, P143, DOI 10.1017/S0031182000060224; Lightowlers MW, 2013, PARASITOLOGY, V140, P1566, DOI 10.1017/S0031182013001005; Mkupasi EM, 2013, ACTA TROP, V128, P48, DOI 10.1016/j.actatropica.2013.06.010; Molinari JL, 1997, VET PARASITOL, V69, P55, DOI 10.1016/S0304-4017(96)01102-8; Ngowi HA, 2008, PREV VET MED, V85, P52, DOI 10.1016/j.prevetmed.2007.12.014; Ngowi HA, 2010, PLOS NEGL TROP DIS, V4; Okello AL, 2016, ACTA TROP, V159, P185, DOI 10.1016/j.actatropica.2016.03.012; Pawlowski Zbigniew S., 2002, P1, DOI 10.1079/9780851996288.0001; Pondja A, 2012, PLOS NEGL TROP DIS, V6; Rajshekhar V, 2003, ACTA TROP, V87, P53, DOI 10.1016/S0001-706X(03)00055-X; Rose H, 2015, ECOL MODEL, V297, P232, DOI 10.1016/j.ecolmodel.2014.11.033; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; Sarti E, 1997, AM J TROP MED HYG, V56, P127, DOI 10.4269/ajtmh.1997.56.127; Sarti E, 2000, T ROY SOC TROP MED H, V94, P85, DOI 10.1016/S0035-9203(00)90451-6; Sikasunge CS, 2008, VET PARASITOL, V158, P57, DOI 10.1016/j.vetpar.2008.08.014; URT, 2013, POP HOUS CENS 2012 P, P1; URT URoT, 2012, NAT SAMPL CENS AGR 2; Verastegui M, 2000, VET PARASITOL, V94, P33, DOI 10.1016/S0304-4017(00)00369-1; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1	50	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2016	10	12							e0005184	10.1371/journal.pntd.0005184				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0IX	WOS:000392158100053	27984581	DOAJ Gold, Green Published			2019-04-02	
J	De Muylder, G; Vanhollebeke, B; Caljon, G; Wolfe, AR; McKerrow, J; Dujardin, JC				De Muylder, Geraldine; Vanhollebeke, Benoit; Caljon, Guy; Wolfe, Alan R.; McKerrow, James; Dujardin, Jean-Claude			Naloxonazine, an Amastigote-Specific Compound, Affects Leishmania Parasites through Modulation of Host-Encoded Functions	PLOS NEGLECTED TROPICAL DISEASES			English	Article							LARGE GENE LISTS; TUBERCULOSIS; DONOVANI; INHIBITOR; TARGETS; POTENT	Host-directed therapies (HDTs) constitute promising alternatives to traditional therapy that directly targets the pathogen but is often hampered by pathogen resistance. HDT could represent a new treatment strategy for leishmaniasis, a neglected tropical disease caused by the obligate intracellular parasite Leishmania. This protozoan develops exclusively within phagocytic cells, where infection relies on a complex molecular interplay potentially exploitable for drug targets. We previously identified naloxonazine, a compound specifically active against intracellular but not axenic Leishmania donovani. We evaluated here whether this compound could present a host cell-dependent mechanism of action. Microarray profiling of THP-1 macrophages treated with naloxonazine showed upregulation of vATPases, which was further linked to an increased volume of intracellular acidic vacuoles. Treatment of Leishmania-infected macrophages with the vATPase inhibitor concanamycin A abolished naloxonazine effects, functionally demonstrating that naloxonazine affects Leishmania amastigotes indirectly, through host cell vacuolar remodeling. These results validate amastigote-specific screening approaches as a powerful way to identify alternative host-encoded targets. Although the therapeutic value of naloxonazine itself is unproven, our results further demonstrate the importance of intracellular acidic compartments for host defense against Leishmania, highlighting the possibility of targeting this host cell compartment for anti-leishmanial therapy.	[De Muylder, Geraldine; Caljon, Guy; Dujardin, Jean-Claude] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [De Muylder, Geraldine; Wolfe, Alan R.; McKerrow, James] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Vanhollebeke, Benoit] Univ Libre Bruxelles, Mol Parasitol Lab, IBMM, Gosselies, Belgium; [Dujardin, Jean-Claude] Univ Antwerp, Dept Biomed Sci, Fac Pharmaceut Biomed & Vet Sci, Antwerp, Belgium; [Caljon, Guy] Univ Antwerp, LMPH, Antwerp, Belgium; [McKerrow, James] Univ Calif San Diego, Skaggs Sch Pharm, San Diego, CA 92103 USA	De Muylder, G (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; De Muylder, G (reprint author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	gdemuylder@itg.be	Wolfe, Alan/A-6853-2009; Caljon, Guy/E-1310-2017	Wolfe, Alan/0000-0002-0932-4146; Caljon, Guy/0000-0002-4870-3202; Vanhollebeke, Benoit/0000-0002-0353-365X	Belgian Science Policy Office [TRIT P7/41]; Back-to-Belgium Return grant; Flemish Fund for Scientific Research [12Q8115N]; Center for Discovery and Innovation in Parasitic Diseases; EU/FP7 ERC starting grant [282312]	This work was supported by the Belgian Science Policy Office (TRIT P7/41 (BV, JCD) and Back-to-Belgium Return grant (GDM)) https.//www.belspo.be/belspo/index_fr.stm; the Flemish Fund for Scientific Research (12Q8115N (GDM)) www.fwo.be; and the Center for Discovery and Innovation in Parasitic Diseases. GC was supported by the EU/FP7 ERC starting grant (No.282312). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruns H, 2012, J IMMUNOL, V189, P4069, DOI 10.4049/jimmunol.1201538; CHANG KP, 1978, J EXP MED, V147, P515, DOI 10.1084/jem.147.2.515; Croft SL, 2011, CLIN MICROBIOL INFEC, V17, P1478, DOI 10.1111/j.1469-0691.2011.03630.x; De Muylder G, 2011, PLOS NEGL TROP DIS, V5; Desjardins M, 1997, J EXP MED, V185, P2061, DOI 10.1084/jem.185.12.2061; Fernandez MM, 2011, ANTIMICROB AGENTS CH, V55, P86, DOI 10.1128/AAC.00506-10; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; Goyard S, 2003, MOL BIOCHEM PARASIT, V130, P31, DOI 10.1016/S0166-6851(03)00142-7; HAHN EF, 1982, LIFE SCI, V31, P1385, DOI 10.1016/0024-3205(82)90387-3; Haldar Arun Kumar, 2011, Mol Biol Int, V2011, P571242, DOI 10.4061/2011/571242; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Jayaswal S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000839; Napier RJ, 2011, CELL HOST MICROBE, V10, P475, DOI 10.1016/j.chom.2011.09.010; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; Pena I, 2015, SCI REP-UK, V5, DOI 10.1038/srep08771; Prussia A, 2011, INT J MOL SCI, V12, P4027, DOI 10.3390/ijms12064027; Roatt BM, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00272; Luque-Ortega JR, 2007, ANTIMICROB AGENTS CH, V51, P1327, DOI 10.1128/AAC.01415-06; Saunders EC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003888; Schwegmann A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.129re8; Singh N, 2012, ASIAN PAC J TROP MED, V5, P485, DOI 10.1016/S1995-7645(12)60084-4; Singh OP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00296; Spath GF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000381; Vanaerschot M, 2014, EXPERT REV ANTI-INFE, V12, P937, DOI 10.1586/14787210.2014.916614; Vanaerschot M, 2013, CRIT REV MICROBIOL, V39, P384, DOI 10.3109/1040841X.2012.716818; Vinet AF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000628; Wallis RS, 2015, NAT REV IMMUNOL, V15, P255, DOI 10.1038/nri3813; Zumla A, 2015, CLIN INFECT DIS, V61, P1432, DOI 10.1093/cid/civ631	30	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2016	10	12							e0005234	10.1371/journal.pntd.0005234				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0IX	WOS:000392158100077	28036391	DOAJ Gold, Green Published			2019-04-02	
J	Vlaminck, J; Masure, D; Wang, T; Nejsum, P; Hokke, CH; Geldhof, P				Vlaminck, Johnny; Masure, Dries; Wang, Tao; Nejsum, Peter; Hokke, Cornelis H.; Geldhof, Peter			A Phosphorylcholine-Containing Glycolipid-like Antigen Present on the Surface of Infective Stage Larvae of Ascaris spp. Is a Major Antibody Target in Infected Pigs and Humans	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRANSMITTED HELMINTH INFECTIONS; SUUM INFECTIONS; TRICHOSTRONGYLUS-COLUBRIFORMIS; INTESTINAL IMMUNITY; SERODIAGNOSIS; LUMBRICOIDES; GLYCOSPHINGOLIPIDS; SEROPOSITIVITY; EXPRESSION; RESISTANCE	Background The pig parasite Ascaris suum plays and important role in veterinary medicine and represents a suitable model for A. lumbricoides, which infects over 800 million people. In pigs, continued exposure to Ascaris induces immunity at the level of the gut, protecting the host against migrating larvae. The objective of this study was to identify and characterize parasite antigens targeted by this local immune response that may be crucial for parasite invasion and establishment and to evaluate their protective and diagnostic potential. Methodology/Principal Findings Pigs were immunized by trickle infection for 30 weeks, challenged with 2,000 eggs at week 32 and euthanized two weeks after challenge. At necropsy, there was a 100% reduction in worms recovered from the intestine and a 97.2% reduction in liver white spots in comparison with challenged non-immune control animals. Antibodies purified from the intestinal mucus or from the supernatant of cultured antibody secreting cells from mesenteric lymph nodes of immune pigs were used to probe L3 extracts to identify antibody targets. This resulted in the recognition of a 12kDa antigen (As12) that is actively shed from infective Ascaris L3. As12 was characterized as a phosphorylcholine-containing glycolipid-like antigen that is highly resistant to different enzymatic and chemical treatments. Vaccinating pigs with an As12 fraction did not induce protective immunity to challenge infection. However, serological analysis using sera or plasma from experimentally infected pigs or naturally infected humans demonstrated that the As12 ELISA was able to detect long-term exposure to Ascaris with a high diagnostic sensitivity (98.4% and 92%, respectively) and specificity (95.5% and 90.0%) in pigs and humans, respectively. Conclusions/Significance These findings show the presence of a highly stage specific, glycolipid-like component (As12) that is actively secreted by infectious Ascaris larvae and which acts as a major antibody target in infected humans and pigs.	[Vlaminck, Johnny; Masure, Dries; Wang, Tao; Geldhof, Peter] Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium; [Nejsum, Peter] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Copenhagen, Denmark; [Hokke, Cornelis H.] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands	Vlaminck, J (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium.	Vlaminck.johnny@gmail.com		Wang, Tao/0000-0003-1359-8913; Nejsum, Peter/0000-0002-6673-8505	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT)	The Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT) funded the work of JV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo Z, 2015, REV INST MED TROP SP, V57, P47, DOI 10.1590/S0036-46652015000100007; Arizono N, 2010, JPN J INFECT DIS, V63, P447; Bendall RP, 2011, EMERG INFECT DIS, V17, P1964, DOI 10.3201/eid1710.101826; Bhattacharyya T, 2001, J CLIN MICROBIOL, V39, P2991, DOI 10.1128/JCM.39.8.2991-2994.2001; BLAXTER ML, 1992, PARASITOL TODAY, V8, P243, DOI 10.1016/0169-4758(92)90126-M; Chatterjee BP, 1996, TROP MED INT HEALTH, V1, P633; Deehan MR, 2002, PARASITE IMMUNOL, V24, P463, DOI 10.1046/j.1365-3024.2002.00489.x; Dell A, 1999, BBA-MOL BASIS DIS, V1455, P353, DOI 10.1016/S0925-4439(99)00064-2; EDWARDS MK, 1990, TROP MED PARASITOL, V41, P174; ERIKSEN L, 1992, VET PARASITOL, V41, P137, DOI 10.1016/0304-4017(92)90017-4; Harrison GBL, 2003, PARASITE IMMUNOL, V25, P79, DOI 10.1046/j.1365-3024.2003.00606.x; Harrison GBL, 2003, PARASITE IMMUNOL, V25, P45, DOI 10.1046/j.1365-3024.2003.00602.x; Hewitson JP, 2016, INT J PARASITOL, V46, P157, DOI 10.1016/j.ijpara.2015.10.004; Kean DE, 2006, PARASITE IMMUNOL, V28, P69, DOI 10.1111/j.1365-3024.2005.00801.x; Lamberton Poppy H L, 2015, Curr Trop Med Rep, V2, P189; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; Liu GH, 2012, GENE, V492, P110, DOI 10.1016/j.gene.2011.10.043; LYNCH NR, 1993, PARASITOL RES, V79, P547, DOI 10.1007/BF00932238; Maizels RM, 2013, VET PARASITOL, V193, P365, DOI 10.1016/j.vetpar.2012.12.032; Masure D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002138; Mekonnen Z, 2013, PATHOG GLOB HEALTH, V107, P207, DOI 10.1179/2047773213Y.0000000092; Miller LA, 2015, EMERG INFECT DIS, V21, P332, DOI 10.3201/eid2102.140048; Nejsum P, 2009, PARASITOLOGY, V136, P193, DOI 10.1017/S0031182008005349; Nejsum P, 2005, J CLIN MICROBIOL, V43, P1142, DOI 10.1128/JCM.43.3.1142-1148.2005; Nejsum P, 2012, J HELMINTHOL, V86, P148, DOI 10.1017/S0022149X12000193; Nikolay B, 2014, INT J PARASITOL, V44, P765, DOI 10.1016/j.ijpara.2014.05.009; Pullan R.L, 2014, PARASITE VECTOR, V7, P37, DOI DOI 10.1186/1756-3305-7-37; Reis A, 2013, J LIPID RES, V54, P1812, DOI 10.1194/jlr.M034330; Roepstorff A, 1998, PARASITOL RES, V84, P537, DOI 10.1007/s004360050444; Santra A, 2001, T ROY SOC TROP MED H, V95, P289, DOI 10.1016/S0035-9203(01)90236-6; Slotved HC, 1996, J PARASITOL, V82, P612, DOI 10.2307/3283786; Smit CH, 2015, MOL CELL PROTEOMICS, V14, P1750, DOI 10.1074/mcp.M115.048280; SMITH HV, 1981, MOL BIOCHEM PARASIT, V4, P183, DOI 10.1016/0166-6851(81)90017-7; Supali T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002586; URBAN JF, 1981, P HELM SOC WASH, V48, P241; URBAN JF, 1988, EXP PARASITOL, V66, P66, DOI 10.1016/0014-4894(88)90051-3; Van Riet E, 2006, PARASITE IMMUNOL, V28, P363, DOI 10.1111/j.1365-3024.2006.00844.x; Vercruysse J, 2007, REV SCI TECH OIE, V26, P105, DOI 10.20506/rst.26.1.1728; Vlaminck J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004532; Vlaminck J, 2014, PARASITOLOGY, V141, P1904, DOI 10.1017/S0031182014000328; Vlaminck J, 2012, VET PARASITOL, V189, P267, DOI 10.1016/j.vetpar.2012.04.024; Vlaminck J, 2010, J PARASITOL, V96, P643, DOI 10.1645/GE-2276.1	42	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	DEC	2016	10	12							e0005166	10.1371/journal.pntd.0005166				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0IX	WOS:000392158100036	27906979	DOAJ Gold, Green Published			2019-04-02	
J	Ravinetto, R; De Weggheleire, A; Dorlo, TPC; Francque, S; Sokkab, A; Pouget, C; Meessen, B; Tabernero, P; Newton, PN; Lynen, L				Ravinetto, Raffaella; De Weggheleire, Anja; Dorlo, Thomas P. C.; Francque, Sven; Sokkab, An; Pouget, Corinne; Meessen, Bruno; Tabernero, Patricia; Newton, Paul N.; Lynen, Lut			Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpoint	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Editorial Material							SUBSTANDARD MEDICINES; DRUG; RESISTANCE		[Ravinetto, Raffaella; De Weggheleire, Anja; Lynen, Lut] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Ravinetto, Raffaella] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium; [Dorlo, Thomas P. C.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Dorlo, Thomas P. C.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Francque, Sven] Univ Antwerp, Antwerp, Belgium; [Sokkab, An] Sihanouk Hosp Ctr Hope, Phnom Penh, Cambodia; [Pouget, Corinne] Inst Trop Med, QUAMED, Antwerp, Belgium; [Meessen, Bruno] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Tabernero, Patricia] INSERM, U1058, Montpellier, France; [Newton, Paul N.] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos; [Newton, Paul N.] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England; [Newton, Paul N.] Univ Oxford, Churchill Hosp, Worldwide Antimalarial Resistance Network, Oxford, England; [Newton, Paul N.] London Sch Hyg & Trop Med, London, England	Ravinetto, R (reprint author), Inst Trop Med, Natl Str 155, B-2000 Antwerp, Belgium.	rravinetto@itg.be	Tabernero, Patricia/O-8340-2017; De Weggheleire, Anja/C-7345-2018; Lynen, Lutgarde/A-1212-2014; Dorlo, Thomas/F-1339-2011	Tabernero, Patricia/0000-0002-1015-6207; De Weggheleire, Anja/0000-0001-9377-4766; Lynen, Lutgarde/0000-0001-7183-4895; Meessen, Bruno/0000-0002-0359-8621; Dorlo, Thomas/0000-0003-3076-8435			African Medicines Regulatory Harmonization Initiative (AMRHI), 2008, WHO DRUG INFORM, V22, P182; Andrieux-Meyer I, 2015, LANCET GLOB HEALTH, V3, pE676, DOI 10.1016/S2214-109X(15)00156-4; [Anonymous], 2015, NATION; [Anonymous], 2016, SOVALDI COUNTERFEITS; [Anonymous], 2015, FACTORY PRODUCING CO; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Consumers Protection Agency, 2016, WARN COUNT HEP C SOV; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorlo TPC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001544; Edlin Brian R, 2016, Lancet Infect Dis, V16, pe196, DOI 10.1016/S1473-3099(16)30005-6; Edwards DJ, 2015, B WORLD HEALTH ORGAN, V93, P799, DOI 10.2471/BLT.15.157784; Freeman J, 2016, EASL INT LIV C 2016, DOI LB03; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Gray AL, 2015, LANCET, V386, P1601, DOI 10.1016/S0140-6736(15)00514-0; Hawkes N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5554; Hepatitis C, 2015, LANCET, V386, P1917; Hill A, 2016, J VIRUS ERAD, V2, P28; Hill A, 2014, CLIN INFECT DIS, V58, P928, DOI 10.1093/cid/ciu012; Holmes JA, 2015, HEPATIC MED-EVID RES, V7, P51, DOI 10.2147/HMER.S55864; Jensen DM, 2016, LIVER INT, V36, P925, DOI 10.1111/liv.13120; Kamal-Yanni M, 2015, LANCET GLOB HEALTH, V3, pE73, DOI 10.1016/S2214-109X(14)70365-1; Lam BP, 2015, THER ADV GASTROENTER, V8, P298, DOI 10.1177/1756283X15587481; Maponga C, 2003, QUALITY ANTIMALARIAL; Medecins du Monde (MDM), 2014, NEW TREATM HEP C VIR; Minghetti P, 2010, J PHARM HEALTH SERV, V1, P107, DOI 10.1111/j.1759-8893.2010.00018.x; Newton PN, 2010, TRENDS PHARMACOL SCI, V31, P99, DOI 10.1016/j.tips.2009.11.005; Nishtar S, 2012, LANCET, V379, P1084, DOI 10.1016/S0140-6736(12)60277-3; Otte WM, 2015, LANCET NEUROL, V14, P1075, DOI 10.1016/S1474-4422(15)00255-0; Ravinetto R, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4524; Siederdissen CHZ, 2016, CLIN INFECT DIS, V62, P561, DOI 10.1093/cid/civ973; 't Hoen E, 2015, J PUBLIC HEALTH POL, V36, P384, DOI 10.1057/jphp.2015.22; 't Hoen EFM, 2014, J PUBLIC HEALTH POL, V35, P137, DOI 10.1057/jphp.2013.53; Tabernero P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-139; Ward JW, 2015, NEW ENGL J MED, V3, pe676; White NJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-253; WHO, 2010, WOR HEALT REP, P1; WHO, 2015, 19 WHO MOD LIST ESS; World Health Organization, DEF SSFFC MED PROD; World Health Organization (WHO), PREQ MED PROGR UN PR; World Health Organization (WHO), 2014, PREQ PROGR 12 INV MA	40	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	DEC	2016	21	12					1490	1495		10.1111/tmi.12784				6	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EE1KZ	WOS:000389341700001	27671365	Green Published			2019-04-02	
J	Kamga, GR; Dissak-Delon, FN; Nana-Djeunga, HC; Biholong, BD; Mbigha-Ghogomu, S; Souopgui, J; Zoure, HGM; Boussinesq, M; Kamgno, J; Robert, A				Kamga, Guy-Roger; Dissak-Delon, Fanny N.; Nana-Djeunga, Hugues C.; Biholong, Benjamin D.; Mbigha-Ghogomu, Stephen; Souopgui, Jacob; Zoure, Honorat G. M.; Boussinesq, Michel; Kamgno, Joseph; Robert, Annie			Still mesoendemic onchocerciasis in two Cameroonian community-directed treatment with ivermectin projects despite more than 15 years of mass treatment	PARASITES & VECTORS			English	Article						Onchocerciasis; Ivermectin; Persistence; Elimination; Bafia; Yabassi; Cameroon	AFRICAN PROGRAM; CLINICAL-MANIFESTATIONS; PARTICIPATING COUNTRIES; TREATED POPULATION; 1ST EVIDENCE; VOLVULUS; ELIMINATION; ENDEMICITY; TRANSMISSION; FEASIBILITY	Background: After more than a decade of community-directed treatment with ivermectin (CDTI) in Centre and Littoral Regions of Cameroon, onchocerciasis endemicity was still high in some communities according to the 2011 epidemiological evaluations. Some corrective measures were undertaken to improve the CDTI process and therefore reduce the burden of the disease. The objective of the present study was to assess the progress made towards the elimination of onchocerciasis in the Centre 1 and Littoral 2 CDTI projects where the worst performances were found in 2011. To this end, a cross-sectional survey was conducted in April 2015 in eight communities in two health districts (HD), Bafia in Centre 1 and Yabassi in Littoral 2, chosen because assessed at baseline and in 2011. All volunteers living for at least five years in the community, aged five years or more, underwent clinical and parasitological examinations. Individual compliance to ivermectin treatment was also assessed. Analyses of data were weighted proportionally to age and gender distribution in the population. Results: In the Bafia and Yabassi HD, 514 and 242 individuals were examined with a mean age of 35.1 (standard deviation, SD: 20.7) and 44.6 (SD: 16.3) years, respectively. In the Bafia HD, the weighted prevalences varied from 24.4 to 57.0 % for microfilaridermia and from 3.6 to 37.4 % for nodule presence across the surveyed communities. The community microfilarial load (CMFL), expressed in microfilariae/skin snip (mf/ss), significantly dropped from 20.84-114. 50 mf/ss in 1991 to 0.31-1.62 mf/ss in 2015 in all the surveyed communities. In the Yabassi HD, the weighted prevalences varied from 12.3 to 59.3 % for microfilaridermia and from 1.5 to 3.7 % for nodule presence across the surveyed communities, while a significant drop was observed in CMFL, from 20.40-28.50 mf/ss in 1999 to 0.48-1.74 mf/ss in 2015. The 2014 weighted therapeutic coverage of participants varied from 65.8 % (95 % CI: 58.4-73.2) in Yabassi HD, to 68.0 % (95 % CI: 63.3-72.7) in Bafia HD, with important variations among communities. Conclusions: After more than 15 years of CDTI, onchocerciasis is still mesoendemic in the surveyed communities. Further studies targeting therapeutic coverage, socio-anthropological considerations of CDTI implementation and entomological studies would bring more insights to the persistence of the disease as observed in the present study.	[Kamga, Guy-Roger; Dissak-Delon, Fanny N.; Biholong, Benjamin D.] Minist Publ Hlth, 8 Rue 3038 Quartier Lac, Yaounde, Cameroon; [Kamga, Guy-Roger; Dissak-Delon, Fanny N.; Nana-Djeunga, Hugues C.; Kamgno, Joseph] Ctr Res Filariasis & Other Trop Dis CRFilMT, POB 5797, Yaounde, Cameroon; [Kamga, Guy-Roger; Robert, Annie] Catholic Univ Louvain, Fac Sante Publ, Inst Rech Expt & Clin, Clos Chapelle Aux Champs 30 Bte B1-30-13, BE-1200 Brussels, Belgium; [Dissak-Delon, Fanny N.; Souopgui, Jacob] Univ Libre Bruxelles, Inst Biol Mol Med, Rue Prof Jeener & Brachet 12, BE-6041 Brussels, Belgium; [Nana-Djeunga, Hugues C.; Kamgno, Joseph] Univ Yaounde I, Fac Med & Biomed Sci, POB 1364, Yaounde, Cameroon; [Mbigha-Ghogomu, Stephen] Univ Buea, Dept Biochem & Mol Biol, Mol & Cell Biol Lab, POB 63, Buea, Cameroon; [Zoure, Honorat G. M.] WHO, APOC, 01 POB 549, Ouagadougou 01, Burkina Faso; [Boussinesq, Michel] Univ Montpellier, INSERM U1175, IRD UMI TransVIHMI 233, IRD, 911 Ave Agropolis,POB 64501, F-34394 Montpellier 5, France	Kamga, GR (reprint author), Minist Publ Hlth, 8 Rue 3038 Quartier Lac, Yaounde, Cameroon.; Kamga, GR (reprint author), Ctr Res Filariasis & Other Trop Dis CRFilMT, POB 5797, Yaounde, Cameroon.; Kamga, GR (reprint author), Catholic Univ Louvain, Fac Sante Publ, Inst Rech Expt & Clin, Clos Chapelle Aux Champs 30 Bte B1-30-13, BE-1200 Brussels, Belgium.	guyrogerkgr@gmail.com			Belgian university cooperation; University of Buea; Centre for Research on Filariasis and other Tropical Diseases (CRFilMT); Ministry of Public Health of Cameroon; Universite catholique de Louvain; Universite Libre de Bruxelles	This study was funded by the Belgian university cooperation (http://www.ares-ac.be/fr/cooperation-au-developpement) through the PRD2013 collaborative project between Universite catholique de Louvain, Universite Libre de Bruxelles, the University of Buea, the Centre for Research on Filariasis and other Tropical Diseases (CRFilMT) and the Ministry of Public Health of Cameroon.	Albiez E J, 1988, Trop Med Parasitol, V39 Suppl 4, P331; ALBIEZ EJ, 1985, TROPENMED PARASITOL, V36, P17; Ameh GI, 2008, JOS J MED, V3, P33; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P381; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P382; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P23; [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P577; APOC, 2010, CONC OP FRAM ONCH EL, P24; Boussinesq M, 1992, B LIAISON DOCUMENTAT, V100, P26; Brieger WR, 2007, TROP MED INT HEALTH, V12, P260, DOI 10.1111/j.1365-3165.2006.01796.x; Brieger WR, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-152; BUCREP, 2010, PROJ DEM TROIS REC G, P91; CDC, 2013, MMWR-MORBID MORTAL W, V62, P405; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; DUKE BOL, 1993, TROP MED PARASITOL, V44, P61; Elimination of onchocerciasis in the WHO Region of the Americas, 2014, WKLY EPIDEMIOL REC, V89, P401; EVANS TG, 1995, B WORLD HEALTH ORGAN, V73, P495; Gardon J, 2002, LANCET, V360, P203, DOI 10.1016/S0140-6736(02)09456-4; GTNO, 2015, RAPP TECHN ANN 2014, P70; Hoerauf A, 2003, BRIT MED J, V326, P207, DOI 10.1136/bmj.326.7382.207; Hopkins A, 2011, WATER SANITATION REL, V1, P133; Kamgno J, 2004, T ROY SOC TROP MED H, V98, P496, DOI 10.1016/j.trstmh.2003.10.018; Katabarwa M, 1999, E AFR MED J, V76, P440; Katabarwa M, 2014, LANCET INFECT DIS, V14, P373, DOI 10.1016/S1473-3099(14)70732-7; Katabarwa MN, 2011, AM J TROP MED HYG, V85, P1041, DOI 10.4269/ajtmh.2011.11-0333; Murdoch ME, 2002, ANN TROP MED PARASIT, V96, P283, DOI 10.1179/000349802125000826; Murdoch ME, 2010, CURR OPIN INFECT DIS, V23, P124, DOI 10.1097/QCO.0b013e328336a256; Nana-Djeunga HC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002824; Newell ED, 1997, B SOC PATHOL EXOT, V90, P107; Newell ED, 1997, TROP MED INT HEALTH, V2, P218, DOI 10.1046/j.1365-3156.1997.d01-263.x; NGOUMOU P, 1994, ANN TROP MED PARASIT, V88, P463, DOI 10.1080/00034983.1994.11812893; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pion SDS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002084; PLAISIER AP, 1991, ACTA TROP, V48, P271, DOI 10.1016/0001-706X(91)90015-C; PROST A, 1979, B WORLD HEALTH ORGAN, V57, P655; Prost A., 1978, Medecine Tropicale, V38, P519; Remme JHF, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P433; Report of Commission of Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ, P1; Resnikoff S, 2012, INDIAN J OPHTHALMOL, V60, P387, DOI 10.4103/0301-4738.100532; Rodriguez-Perez MA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003922; Stolk WA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1159-9; Tchounkeu YFL, 2012, T ROY SOC TROP MED H, V106, P340, DOI 10.1016/j.trstmh.2012.02.009; Tekle AH, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0160-7; Tekle AH, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-28; Traore MO, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001825; Wanji S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1283-6; WHO, 2014, WKLY EPIDEMIOL REC, V89, P551; World Health Organization (WHO), 2003, INV MENT HLTH, P1; Zoure HGM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-326	49	14	14	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	NOV 14	2016	9								581	10.1186/s13071-016-1868-8				12	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	EC5AN	WOS:000388145600005	27842567	DOAJ Gold, Green Published			2019-04-02	
J	Faway, E; Musset, L; Pelleau, S; Volney, B; Casteras, J; Caro, V; Menard, D; Briolant, S; Legrand, E				Faway, Emilie; Musset, Lise; Pelleau, Stephane; Volney, Beatrice; Casteras, Jessica; Caro, Valerie; Menard, Didier; Briolant, Sebastien; Legrand, Eric			Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana	MALARIA JOURNAL			English	Article							RESISTANT PLASMODIUM-VIVAX; WESTERN BRAZILIAN AMAZON; MALARIA-ENDEMIC AREA; DRUG-RESISTANCE; CHLOROQUINE RESISTANCE; PVCRT-O; MULTIDRUG-RESISTANCE; FALCIPARUM; PVMDR1; AMPLIFICATION	Background: Plasmodium vivax malaria is a major public health problem in French Guiana. Some cases of resistance to chloroquine, the first-line treatment used against P. vivax malaria, have been described in the Brazilian Amazon region. The aim of this study is to investigate a possible dispersion of chloroquine-resistant P. vivax isolates in French Guiana. The genotype, polymorphism and copy number variation, of the P. vivax multidrug resistance gene-1 (pvmdr1) have been previously associated with modification of the susceptibility to chloroquine. Methods: The pvmdr1 gene polymorphism was evaluated by sequencing and copy number variation was assessed by real-time PCR, in P. vivax isolates obtained from 591 symptomatic patients from 1997 to 2013. Results: The results reveal that 1.0% [95% CI 0.4-2.2] of French Guiana isolates carry the mutations Y976F and F1076L, and that the proportion of isolates with multiple copies of pvmdr1 has significantly decreased over time, from 71.3% (OR = 6.2 [95% CI 62.9-78.7], p < 0.0001) in 1997-2004 to 12.8% (OR = 0.03 [95% CI 9.4-16.9], p < 0.0001) in 2009-2013. A statistically significant relationship was found between Guf-A (harboring the single mutation T958M) and Sal-1 (wild type) alleles and pvmdr1 copy number. Conclusions: Few P. vivax isolates harboring chloroquine-resistant mutations in the pvmdr1 gene are circulating in French Guiana. However, the decrease in the prevalence of isolates carrying multiple copies of pvmdr1 might indicate that the P. vivax population in French Guiana is evolving towards a decreased susceptibility to chloroquine.	[Faway, Emilie; Musset, Lise; Pelleau, Stephane; Volney, Beatrice; Casteras, Jessica; Briolant, Sebastien; Legrand, Eric] Inst Pasteur, Lab Parasitol, Cayenne, French Guiana; [Faway, Emilie] Univ Namur, URPhyM NARILIS, Namur, Belgium; [Musset, Lise; Pelleau, Stephane; Volney, Beatrice; Casteras, Jessica; Legrand, Eric] Inst Pasteur, Natl Reference Ctr Malaria, Cayenne, French Guiana; [Musset, Lise; Pelleau, Stephane; Volney, Beatrice; Legrand, Eric] Inst Pasteur, World Hlth Org, Collaborating Ctr Surveillance Antimalarial Drug, Cayenne, French Guiana; [Caro, Valerie] Inst Pasteur, Environm & Infect Risks Unit, Genotyping Pathogens Pole, Paris, France; [Menard, Didier] Inst Pasteur Cambodia, Malaria Mol Epidemiol Unit, Phnom Penh, Cambodia; [Menard, Didier] Inst Pasteur Cambodia, Malaria Translat Res Unit, Phnom Penh, Cambodia; [Briolant, Sebastien] Direct Interarmees Serv Sante, Cayenne, French Guiana; [Briolant, Sebastien] Inst Rech Biomed Armees, Bretigny Sur Orge, France; [Legrand, Eric] Inst Pasteur, Malaria Translat Res Unit, Paris, France; [Legrand, Eric] Inst Pasteur, Genet & Genom Insect Vectors Unit, Paris, France	Legrand, E (reprint author), Inst Pasteur, Genet & Genom Insect Vectors Unit, Paris, France.	eric.legrand@pasteur.fr	Menard, Didier/O-3294-2013	Menard, Didier/0000-0003-1357-4495; Legrand, Eric/0000-0003-4725-0712	Institut de Veille Sanitaire (French Ministry of Health); French Army [LR607e]; European grant [REGPOT-CT-2011-285837-STRONGER]; European Union (Lifelong Learning Programme)	This work benefited from funding from the Institut de Veille Sanitaire (French Ministry of Health) and the French Army (Grant LR607e). SP was financed by European grant managed by the European Commission (REGPOT-CT-2011-285837-STRONGER). EF was financed by the European Union (Lifelong Learning Programme).	ARIAS AE, 1989, TROP MED PARASITOL, V40, P21; Baird JK, 2009, CLIN MICROBIOL REV, V22, P508, DOI 10.1128/CMR.00008-09; Barnadas C, 2008, ANTIMICROB AGENTS CH, V52, P4233, DOI 10.1128/AAC.00578-08; Chehuan YF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-226; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; de Santi VP, 2016, EMERG INFECT DIS, V22, P903, DOI 10.3201/eid2205.151957; de Santi VP, 2016, EMERG INFECT DIS, V22, P344, DOI 10.3201/eid2202.151292; del Carmen R, 2012, AM J TROP MED HYG, V87, P813, DOI 10.4269/ajtmh.2012.12-0094; Dua VK, 1996, TROP MED INT HEALTH, V1, P816; Fernandez-Becerra C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-55; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Gama BE, 2011, MEM I OSWALDO CRUZ, V106, P159, DOI 10.1590/S0074-02762011000900020; Gama BE, 2009, MEM I OSWALDO CRUZ, V104, P1009, DOI 10.1590/S0074-02762009000700012; GARAVELLI PL, 1992, T ROY SOC TROP MED H, V86, P128, DOI 10.1016/0035-9203(92)90535-K; Gomes LR, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1141-9; Graf Paul C F, 2012, Malar Res Treat, V2012, P936067, DOI 10.1155/2012/936067; Guthmann JP, 2008, TROP MED INT HEALTH, V13, P91, DOI 10.1111/j.1365-3156.2007.01978.x; Hupalo DN, 2016, NAT GENET, V48, P953, DOI 10.1038/ng.3588; Imwong M, 2008, ANTIMICROB AGENTS CH, V52, P2657, DOI 10.1128/AAC.01459-07; Jovel IT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-376; Ketema T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-177; Khatoon L, 2009, AM J TROP MED HYG, V81, P525, DOI 10.4269/ajtmh.2009.81.525; Khim N, 2014, EMERG INFECT DIS, V20, P1637, DOI 10.3201/eid2010.140411; Kim YK, 2011, AM J TROP MED HYG, V84, P532, DOI 10.4269/ajtmh.2011.10-0486; Kurcer MA, 2006, ANN TROP MED PARASIT, V100, P109, DOI 10.1179/136485906X86284; Legrand E, 2008, ANTIMICROB AGENTS CH, V52, P288, DOI 10.1128/AAC.00263-07; Legrand E, 2012, ANTIMICROB AGENTS CH, V56, P1382, DOI 10.1128/AAC.05280-11; Lekweiry KM, 2012, J ANTIMICROB CHEMOTH, V67, P367, DOI 10.1093/jac/dkr464; Lu F, 2011, ACTA TROP, V117, P69, DOI 10.1016/j.actatropica.2010.08.011; Marques MM, 2014, ANTIMICROB AGENTS CH, V58, P342, DOI 10.1128/AAC.02279-12; Melo GC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105922; Musset L, 2014, MEM I OSWALDO CRUZ, V109, P525, DOI 10.1590/0074-0276140031; National Reference Centre for Malaria, 2015, NAT REF CTR MAL 2014; Orjuela-Sanchez P, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-65; Orjuela-Sanchez P, 2009, ANTIMICROB AGENTS CH, V53, P3561, DOI 10.1128/AAC.00004-09; Pearson RD, 2016, NAT GENET, V48, P959, DOI 10.1038/ng.3599; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phan GT, 2002, TROP MED INT HEALTH, V7, P858, DOI 10.1046/j.1365-3156.2002.00948.x; Phillips EJ, 1996, CLIN INFECT DIS, V23, P1171, DOI 10.1093/clinids/23.5.1171; Price RN, 2004, LANCET, V364, P438, DOI 10.1016/S0140-6736(04)16767-6; RIECKMANN KH, 1989, LANCET, V2, P1183; Rungsihirunrat K, 2015, KOREAN J PARASITOL, V53, P43, DOI 10.3347/kjp.2015.53.1.43; Schousboe ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004196; Soto J, 2001, AM J TROP MED HYG, V65, P90, DOI 10.4269/ajtmh.2001.65.90; Suwanarusk R, 2008, J INFECT DIS, V198, P1558, DOI 10.1086/592451; Suwanarusk R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001089; WHO, 2016, WORLD MALARIA REPORT, DOI DOI 10.1017/CBO9781107415324.004	48	5	6	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 8	2016	15								540	10.1186/s12936-016-1595-9				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EC5AA	WOS:000388144300005	27825387	DOAJ Gold, Green Published			2019-04-02	
J	Radin, K; Clement, F; Jongert, E; Sterckx, YGJ; Ockenhouse, C; Regules, J; Lemiale, F; Leroux-Roels, G				Radin, Kristina; Clement, Frederic; Jongert, Erik; Sterckx, Yann G. J.; Ockenhouse, Christian; Regules, Jason; Lemiale, Franck; Leroux-Roels, Geert			A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum	MALARIA JOURNAL			English	Article						Malaria; Competition ELISA; Enzyme-linked immunosorbent assay; Immunoassay; Circumsporozoite protein	CANDIDATE MALARIA VACCINE; DOUBLE-BLIND; IMMUNE-RESPONSE; NAIVE ADULTS; EFFICACY; SAFETY; TRIAL; IMMUNOGENICITY; IMMUNIZATION; INFECTION	Background: The malaria vaccine candidate RTS, S/AS01 (GSK Vaccines) induces high IgG concentration against the circumsporozoite protein (CSP) of Plasmodium falciparum. In human vaccine recipients circulating anti-CSP antibody concentrations are associated with protection against infection but appear not to be the correlate of protection. However, in a humanized mouse model of malaria infection prophylactic administration of a human monoclonal antibody (MAL1C), derived from a RTS, S/AS01-immunized volunteer, directed against the CSP repeat region, conveyed full protection in a dose-dependent manner suggesting that antibodies alone are able to prevent P. falciparum infection when present in sufficiently high concentrations. A competition ELISA was developed to measure the presence of MAL1C-like antibodies in polyclonal sera from RTS, S/AS01 vaccine recipients and study their possible contribution to protection against infection. Results: MAL1C-like antibodies present in polyclonal vaccine-induced sera were evaluated for their ability to compete with biotinylated monoclonal antibody MAL1C for binding sites on the capture antigen consisting of the recombinant protein encompassing 32 NANP repeats of CSP (R32LR). Serum samples were taken at different time points from participants in two RTS, S/AS01 vaccine studies (NCT01366534 and NCT01857869). Vaccine-induced protection status of the study participants was determined based on the outcome of experimental challenge with infected mosquito bites after vaccination. Optimal conditions were established to reliably detect MAL1C-like antibodies in polyclonal sera. Polyclonal anti-CSP antibodies and MAL1C-like antibody content were measured in 276 serum samples from RTS, S/AS01 vaccine recipients using the standard ELISA and MAL-1C competition ELISA, respectively. A strong correlation was observed between the results from these assays. However, no correlation was found between the results of either assay and protection against infection. Conclusions: The competition ELISA to measure MAL1C-like antibodies in polyclonal sera from RTS, S/AS01 vaccine recipients was robust and reliable but did not reveal the elusive correlate of protection.	[Radin, Kristina; Clement, Frederic; Leroux-Roels, Geert] Univ Ghent, Ctr Vaccinol CEVAC, Ghent, Belgium; [Jongert, Erik] GSK Vaccines, Rue Inst 89, B-1330 Rixensart, Belgium; [Sterckx, Yann G. J.] VIB, SBRC, Pl Laan 2, B-1050 Brussels, Belgium; [Sterckx, Yann G. J.] VUB, Res Unit Cellular & Mol Immunol CMIM, Pl Laan 2, B-1050 Brussels, Belgium; [Ockenhouse, Christian; Lemiale, Franck] PATH Malaria Vaccine Initiat MVI, 455 Massachusetts Ave NW, Washington, DC 20001 USA; [Regules, Jason] WRAIR, 503 Robert Grant Ave, Silver Spring, MD 20910 USA	Leroux-Roels, G (reprint author), Univ Ghent, Ctr Vaccinol CEVAC, Ghent, Belgium.	geert.lerouxroels@ugent.be	Sterckx, Yann/F-2269-2017; Clement, Frederic/B-2204-2009	Sterckx, Yann/0000-0002-7420-0983; Clement, Frederic/0000-0002-2720-3655	CEVAC; GlaxoSmithKline Biologicals SA	Funding for this work was provided by CEVAC and GlaxoSmithKline Biologicals SA. Experiments were reviewed and approved by the joint GSK-MVI RTS,S Immune Correlates of Protection Task Force.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Asante KP, 2011, LANCET INFECT DIS, V11, P741, DOI 10.1016/S1473-3099(11)70100-1; Ballou RW, 2009, MALARIA J, V8, P312; Behet MC, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-136; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Birkett AJ, 2013, VACCINE, V31, pB233, DOI 10.1016/j.vaccine.2013.02.040; Clement F, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-384; Clinical S., 2015, LANCET, V386, P31; Cohen J, 2010, HUM VACCINES, V6, P90, DOI 10.4161/hv.6.1.9677; Depraetere S, 2001, J IMMUNOL, V166, P2929, DOI 10.4049/jimmunol.166.5.2929; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; FOLENAWASSERMAN G, 1987, J CHROMATOGR, V411, P345, DOI 10.1016/S0021-9673(00)93985-2; Foquet L, 2014, J CLIN INVEST, V124, P140, DOI 10.1172/JCI70349; GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Leroux-Roels G, 2014, HUM VACC IMMUNOTHER, V10, P2211, DOI 10.4161/hv.29375; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; Ockenhouse CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131571; Olotu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115126; Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564; Olotu A, 2011, LANCET INFECT DIS, V11, P102, DOI 10.1016/51473-3099(10)70262-0; Ramasamy R, 1998, BBA-MOL BASIS DIS, V1406, P10, DOI 10.1016/S0925-4439(97)00078-1; Reeder JC, 1996, IMMUNOL CELL BIOL, V74, P546, DOI 10.1038/icb.1996.88; Regules JA, 2016, J INFECT DIS, V214, P762, DOI 10.1093/infdis/jiw237; Riley EM, 2013, NAT MED, V19, P168, DOI 10.1038/nm.3083; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; The RTS S Clinical Trials Partnership, 2012, NEW ENGL J MED, V367, P2284, DOI DOI 10.1056/NEJM0A1208394; World Health Organization, WORLD MAL REP 2015	35	3	3	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 8	2016	15								543	10.1186/s12936-016-1596-8				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EC5AA	WOS:000388144300008	27825382	DOAJ Gold, Green Published			2019-04-02	
J	Lebbe, EKM; Tytgat, J				Lebbe, Eline K. M.; Tytgat, Jan			In the picture: disulfide-poor conopeptides, a class of pharmacologically interesting compounds	JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES			English	Review						Cone snail; Conopressin; Contryphan; Conantokin; Contulakin; Conorfamid; Conophan; Conomap; Conomarphin; Conolysin; ConoGAY; ConoCAP; Cono-NPY	ACID-CONTAINING CONTRYPHAN; NMDA RECEPTOR ANTAGONIST; CONTAINING CONUS PEPTIDE; D-ASPARTATE RECEPTORS; LYS-CONOPRESSIN-G; D-AMINO-ACID; GAMMA-CARBOXYGLUTAMATE; CONANTOKIN-G; D-TRYPTOPHAN; STRUCTURAL-CHARACTERIZATION	During evolution, nature has embraced different strategies for species to survive. One strategy, applied by predators as diverse as snakes, scorpions, sea anemones and cone snails, is using venom to immobilize or kill a prey. This venom offers a unique and extensive source of chemical diversity as it is driven by the evolutionary pressure to improve prey capture and/or to protect their species. Cone snail venom is an example of the remarkable diversity in pharmacologically active small peptides that venoms can consist of. These venom peptides, called conopeptides, are classified into two main groups based on the number of cysteine residues, namely disulfide-rich and disulfide-poor conopeptides. Since disulfide-poor conotoxins are minor components of this venom cocktail, the number of identified peptides and the characterization of these peptides is far outclassed by its cysteine-rich equivalents. This review provides an overview of 12 families of disulfide-poor peptides identified to date as well as the state of affairs.	[Lebbe, Eline K. M.; Tytgat, Jan] Katholieke Univ Leuven, Toxicol & Pharmacol, O&N2,Box 922,Herestr 49, B-3000 Leuven, Belgium	Tytgat, J (reprint author), Katholieke Univ Leuven, Toxicol & Pharmacol, O&N2,Box 922,Herestr 49, B-3000 Leuven, Belgium.	jan.tytgat@kuleuven.be			F.W.O. Vlaanderen [G.0433.12, GOE3414N]; EU-FP7-MAREX (Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy) [IUAP 7/10]; KU Leuven [OT/12/081]	This work was supported by the following grants: G.0433.12, GOE3414N (F.W.O. Vlaanderen), EU-FP7-MAREX, IUAP 7/10 (Inter-University Attraction Poles Program, Belgian State, Belgian Science Policy) and OT/12/081 (KU Leuven).	Aguilar MB, 2008, PEPTIDES, V29, P186, DOI 10.1016/j.peptides.2007.09.022; Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; [Anonymous], PYMOL MOL GRAPHICS S; Banerjee P, 2017, GEN COMP ENDOCR, V241, P4, DOI 10.1016/j.ygcen.2016.04.025; Benarroch EE, 2009, NEUROLOGY, V72, P1016, DOI 10.1212/01.wnl.0000345258.18071.54; Bialer M, 2002, EPILEPSY RES, V51, P31, DOI 10.1016/S0920-1211(02)00106-7; Biggs JS, 2007, BIOCHEMISTRY-US, V46, P12586, DOI 10.1021/bi700775p; Brain SD, 2006, BRIT J PHARMACOL, V147, pS202, DOI 10.1038/sj.bjp.0706461; Chartrel N, 2011, FRONT NEUROENDOCRIN, V32, P387, DOI 10.1016/j.yfrne.2011.04.001; Clark RJ, 2010, ANGEW CHEM INT EDIT, V49, P6545, DOI 10.1002/anie.201000620; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; Craik DJ, 2007, ACS CHEM BIOL, V2, P457, DOI 10.1021/cb700091j; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; Davis J, 2009, PEPTIDES, V30, P1222, DOI 10.1016/j.peptides.2009.03.019; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dockray GJ, 2004, EXP PHYSIOL, V89, P229, DOI 10.1113/expphysiol.2004.027169; Donevan SD, 2000, MOL PHARMACOL, V58, P614; Dutertre S, 2008, J BIOL CHEM, V283, P7100, DOI 10.1074/jbc.M706477200; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; Elphick MR, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00093; Findeisen M, 2011, CHEMMEDCHEM, V6, P1081, DOI 10.1002/cmdc.201100089; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; Gowd KH, 2008, TOXICON, V52, P203, DOI 10.1016/j.toxicon.2008.04.178; Grant MA, 2004, J BIOL CHEM, V279, P32464, DOI 10.1074/jbc.M313826200; HAACK JA, 1990, J BIOL CHEM, V265, P6025; Han TS, 2008, CURR PHARM DESIGN, V14, P2462, DOI 10.2174/138161208785777469; Han YH, 2008, FEBS J, V275, P1976, DOI 10.1111/j.1742-4658.2008.06352.x; Hansson K, 2004, J BIOL CHEM, V279, P32453, DOI 10.1074/jbc.M313825200; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; Hokfelt T, 2008, NUTRITION, V24, P860, DOI 10.1016/j.nut.2008.06.010; Huang FJ, 2009, TOXICON, V54, P153, DOI 10.1016/j.toxicon.2009.03.033; Jacobsen R, 1998, J PEPT RES, V51, P173; Jacobsen RB, 1999, J PEPT RES, V54, P93, DOI 10.1034/j.1399-3011.1999.00093.x; Jimenez EC, 1997, BIOCHEMISTRY-US, V36, P989, DOI 10.1021/bi962840p; Jimenez EC, 1996, J BIOL CHEM, V271, P28002, DOI 10.1074/jbc.271.45.28002; Jimenez EC, 2002, EPILEPSY RES, V51, P73, DOI 10.1016/S0920-1211(02)00101-8; Jimenez EC, 2001, TOXICON, V39, P803, DOI 10.1016/S0041-0101(00)00210-5; Kern SE, 2007, ANESTH ANALG, V104, P1514, DOI 10.1213/01.ane.0000262038.58546.e6; Layer RT, 2006, MAR DRUGS, V4, P119; Layer RT, 2004, CURR MED CHEM, V11, P3073, DOI 10.2174/0929867043363901; Lebbe EKM, 2016, DRUGS, V14, P199, DOI [10.3390/md14110199, DOI 10.3390/MD14110199]; Lee HK, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00011; Lewis RJ, 2012, PHARMACOL REV, V64, P259, DOI 10.1124/pr.111.005322; LI KW, 1993, BIOCHEM BIOPH RES CO, V197, P1056, DOI 10.1006/bbrc.1993.2585; Maillo M, 2002, TOXICON, V40, P401, DOI 10.1016/S0041-0101(01)00176-3; Martinez-Mir I, 2002, INFLAMM RES, V51, P587, DOI 10.1007/PL00012433; Massilia GR, 2003, BIOCHEM BIOPH RES CO, V303, P238, DOI 10.1016/S0006-291X(03)00331-0; Massilia GR, 2001, BIOCHEM BIOPH RES CO, V288, P908, DOI 10.1006/bbrc.2001.5833; McCormick SD, 2006, GEN COMP ENDOCR, V147, P3, DOI 10.1016/j.ygcen.2005.12.009; MCINTOSH JM, 1984, J BIOL CHEM, V259, P4343; MCMASTER D, 1992, PEPTIDES, V13, P413, DOI 10.1016/0196-9781(92)90069-F; MENA EE, 1990, NEUROSCI LETT, V118, P241, DOI 10.1016/0304-3940(90)90637-O; Moller C, 2007, BIOCHEM J, V404, P413, DOI 10.1042/BJ20061480; Moller C, 2010, J BIOL CHEM, V285, P40673, DOI 10.1074/jbc.M110.171397; MUIR KW, 1994, BRIT J CLIN PHARMACO, V38, P33, DOI 10.1111/j.1365-2125.1994.tb04318.x; Nepravishta R, 2014, AMINO ACIDS, V46, P2841, DOI 10.1007/s00726-014-1841-9; NIELSEN DB, 1994, TOXICON, V32, P845, DOI 10.1016/0041-0101(94)90009-4; Norton RS, 2006, TOXICON, V48, P780, DOI 10.1016/j.toxicon.2006.07.022; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Pallaghy PK, 1999, BIOCHEMISTRY-US, V38, P11553, DOI 10.1021/bi990685j; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; Puillandre N, 2012, J MOL EVOL, V74, P297, DOI 10.1007/s00239-012-9507-2; Rajesh RP, 2015, J PEPT SCI, V21, P29, DOI 10.1002/psc.2715; RIVIER J, 1987, BIOCHEMISTRY-US, V26, P8508, DOI 10.1021/bi00400a002; Robinson SD, 2017, GEN COMP ENDOCR, V244, P11, DOI 10.1016/j.ygcen.2015.07.012; Robinson SD, 2015, J PROTEOMICS, V114, P38, DOI 10.1016/j.jprot.2014.11.003; Sabareesh V, 2006, PEPTIDES, V27, P2647, DOI 10.1016/j.peptides.2006.07.009; SALZET M, 1993, EUR J BIOCHEM, V217, P897, DOI 10.1111/j.1432-1033.1993.tb18319.x; Skjaerbaek N, 1997, J BIOL CHEM, V272, P2291; SVEINBJORNSDOTTIR S, 1993, EPILEPSY RES, V16, P165, DOI 10.1016/0920-1211(93)90031-2; Teichert RW, 2007, J BIOL CHEM, V282, P36905, DOI 10.1074/jbc.M706611200; Thakur SS, 2007, RAPID COMMUN MASS SP, V21, P3420, DOI 10.1002/rcm.3225; Twede VD, 2009, BIOCHEMISTRY-US, V48, P4063, DOI 10.1021/bi802259a; Ueberheide BM, 2009, P NATL ACAD SCI USA, V106, P6910, DOI 10.1073/pnas.0900745106; Ukena K, 1997, CELL TISSUE RES, V288, P567, DOI 10.1007/s004410050842; van Kesteren RE, P NATL ACAD SCI US; VANKESTEREN RE, 1995, J NEUROSCI, V15, P5989; Veenema AH, 2006, EUR J NEUROSCI, V24, P1711, DOI 10.1111/j.1460-9568.2006.05045.x; White HS, 2000, J PHARMACOL EXP THER, V292, P425; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu XC, 2010, ACTA BIOCH BIOPH SIN, V42, P502, DOI 10.1093/abbs/gmq042; Zhang L, 2010, PEPTIDES, V31, P177, DOI 10.1016/j.peptides.2009.10.017; Zhou LM, 1996, J NEUROCHEM, V66, P620	84	11	11	0	7	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1678-9199			J VENOM ANIM TOXINS	J. Venom. Anim. Toxins Trop. Dis.	NOV 7	2016	22								30	10.1186/s40409-016-0083-6				15	Toxicology; Tropical Medicine; Zoology	Toxicology; Tropical Medicine; Zoology	EB8EB	WOS:000387622700001	27826319	DOAJ Gold, Green Published			2019-04-02	
J	Kerkhof, K; Sluydts, V; Willen, L; Kim, S; Canier, L; Heng, S; Tsuboi, T; Sochantha, T; Sovannaroth, S; Menard, D; Coosemans, M; Durnez, L				Kerkhof, Karen; Sluydts, Vincent; Willen, Laura; Kim, Saorin; Canier, Lydie; Heng, Somony; Tsuboi, Takafumi; Sochantha, Tho; Sovannaroth, Siv; Menard, Didier; Coosemans, Marc; Durnez, Lies			Serological markers to measure recent changes in malaria at population level in Cambodia	MALARIA JOURNAL			English	Article						Malaria; Serological markers; Malaria transmission; Half life	PLASMODIUM-FALCIPARUM TRANSMISSION; MASS-SPECTROMETRY DATA; MULTIPLEX ASSAY; ANTIBODY-RESPONSES; ERYTHROCYTE INVASION; QUANTILE REGRESSION; CLINICAL MALARIA; RISK-FACTORS; VIVAX; ANTIGENS	Background: Serological markers for exposure to different Plasmodium species have recently been used in multiplex immunoassays based on the Luminex technology. However, interpretation of the assay results requires consideration of the half-life of specific antibodies against these markers. Therefore, the aim of the present study was to document the half-life of malaria specific serological makers, as well as assessing the sensitivity of these markers to pick up recent changes in malaria exposure. Methods: A recently developed multiplex immunoassay was used to measure the intensity of antibody (Ab) responses against 19 different Plasmodium specific antigens, covering different human malaria parasites and two vector saliva antigens. Therefore, 8439 blood samples from five cross-sectional surveys in Ratanakiri, Cambodia, were analysed. These involve a random selection from two selected surveys, and an additional set of blood samples of individuals that were randomly re-sampled three, four or five times. A generalized estimating equation model and linear regression models were fitted on log transformed antibody intensity data. Results: Results showed that most (17/21) Ab-responses are higher in PCR positive than PCR negative individuals. Furthermore, these antibody-responses follow the same upward trend within each age group. Estimation of the half-lives showed differences between serological markers that reflect short-(seasonal) and long-term (year round) transmission trends. Ab levels declined significantly together with a decrease of PCR prevalence in a group of malaria endemic villages. Conclusion: For Plasmodium falciparum, antibodies against LSA3. RE, GLURP and Pf.GLURP.R2 are most likely to be a reflexion of recent (range from 6 to 8 months) exposure in the Mekong Subregion. PvEBP is the only Plasmodium vivax Ag responding reasonably well, in spite of an estimated Ab half-life of more than 1 year. The use of Ab intensity data rather dichotomizing the continuous Ab-titre data (positive vs negative) will lead to an improved approach for serological surveillance.	[Kerkhof, Karen; Sluydts, Vincent; Willen, Laura; Coosemans, Marc; Durnez, Lies] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Kerkhof, Karen; Willen, Laura; Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Sluydts, Vincent] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Kim, Saorin; Canier, Lydie; Menard, Didier] Inst Pasteur Cambodge, Mol Epidemiol Unit, Phnom Penh, Cambodia; [Heng, Somony; Sochantha, Tho; Sovannaroth, Siv] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Tsuboi, Takafumi] Ehime Univ, Div Malaria Res, Proteosci Ctr, Matsuyama, Ehime, Japan	Kerkhof, K; Durnez, L (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.; Kerkhof, K (reprint author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.	kkerkhof@itg.be; ldurnez@itg.be	Willen, Laura/B-2977-2018; Menard, Didier/O-3294-2013	Willen, Laura/0000-0002-8027-8621; Kerkhof, Karen/0000-0002-2208-9902; Menard, Didier/0000-0003-1357-4495	Bill & Melinda Gates Foundation [OPP1032354]; association of Les Amis des Instituts Pasteur a Bruxelles	This work is part of a larger project "MalaResT" funded by the Bill & Melinda Gates Foundation under the Global Health Grant number OPP1032354. This project aims to evaluate the effectiveness of topical repellents, in addition to long-lasting insecticidal nets, on malaria prevalence and incidence. Next, this work fits within the large-scale research project for the SOFI research program "MalaSpot" entitled 'Eco-epidemiology of asymptomatic malaria hotspots, a prerequisite for malaria elimination?'. Furthermore, KK was supported by the association of Les Amis des Instituts Pasteur a Bruxelles.	Ambrosino E, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-317; Andraud M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002418; Arnold BF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093684; Badu K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-50; Bates D, 2015, J STAT SOFTW, V67, P1; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bretscher MT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-21; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Cham GKK, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-108; Cheng Y, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-323; Cho HJ, OUTLIERD OUTLIER DET; Cho HJ, 2008, BIOINFORMATICS, V24, P882, DOI 10.1093/bioinformatics/btn012; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Cook J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-169; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; de Souza JB, 2002, INFECT IMMUN, V70, P5045, DOI 10.1128/IAI.70.9.5045-5051.2002; Drakeley C, 2009, ADV PARASIT, V69, P299, DOI 10.1016/S0065-308X(09)69005-9; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Elliott Salenna R, 2014, F1000Prime Rep, V6, P100, DOI 10.12703/P6-100; Eo Soo-Heang, 2012, BMC Res Notes, V5, P236, DOI 10.1186/1756-0500-5-236; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; FIDOCK DA, 1994, J IMMUNOL, V153, P190; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Fowkes FJI, 2012, J INFECT DIS, V206, P1612, DOI 10.1093/infdis/jis566; Frank Jr E. H., 2015, HMISC HARRELL MISCEL; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Halekoh U, 2006, J STAT SOFTW, V15, P1; Helb DA, 2015, P NATL ACAD SCI USA, V112, pE4438, DOI 10.1073/pnas.1501705112; Henry-Halldin CN, 2011, INFECT GENET EVOL, V11, P391, DOI 10.1016/j.meegid.2010.11.010; Hens N, 2012, STAT BIOL HLTH, V63, P316; Hester J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002569; Hu FB, 1998, AM J EPIDEMIOL, V147, P694; Hviid L, 2015, TRENDS PARASITOL, V31, P89, DOI 10.1016/j.pt.2014.12.009; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Kerkhof K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0868-z; Khaireh BA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-395; Khim N, 2011, EMERG INFECT DIS, V17, P1900, DOI 10.3201/eid1710.110355; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Koffi D, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1043-2; Kusi KA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-103; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Ministry of Health, 2010, MIN HLTH STRAT MAST; Ondigo BN, 2014, J INFECT DIS, V210, P1123, DOI 10.1093/infdis/jiu225; Ondigo BN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-427; Orlandi-Pradines E, 2006, AM J TROP MED HYG, V74, P979; Poinsignon A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002472; R Core Team, 2015, R LANG ENV STAT COMP; Rogier E, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0955-1; Sarr JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-212; Scholzen A, 2013, TRENDS PARASITOL, V29, P252, DOI 10.1016/j.pt.2013.03.002; Sluydts V, 2016, LANCET INFECT DIS, V16, P1169, DOI 10.1016/S1473-3099(16)30148-7; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Smith C, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-377; Stanisic DI, 2015, INFECT IMMUN, V83, P646, DOI 10.1128/IAI.02398-14; Stewart L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006083; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Sutherland CJ, 2009, MOL BIOCHEM PARASIT, V166, P93, DOI 10.1016/j.molbiopara.2009.03.007; Tangpukdee N, 2009, KOREAN J PARASITOL, V47, P93, DOI 10.3347/kjp.2009.47.2.93; Theisen M, 2000, VACCINE, V19, P204, DOI 10.1016/S0264-410X(00)00181-X; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x; van den Hoogen LL, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0939-1; Vigan-Womas I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016544; von Fricken ME, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-361; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; White MT, 2014, J INFECT DIS, V210, P1115, DOI 10.1093/infdis/jiu219; WHO, 2015, STRAT MAL EL GREAT M; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Wong J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-451; World Health Organization, 2015, WORLD MAL REP 2015; Yan J, 2004, STAT MED, V23, P859, DOI 10.1002/sim.1650; Yan J., 2002, R NEWS, V2/3, P12; Yman V, 2016, SCI REP-UK, V6, DOI 10.1038/srep19472; Zenonos ZA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-93; Zeyrek FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028126	82	8	8	0	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	NOV 4	2016	15								529	10.1186/s12936-016-1576-z				18	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EC4ZY	WOS:000388144100003	27809852	DOAJ Gold, Green Published			2019-04-02	
J	Dieye, B; Affara, M; Sangare, L; Joof, F; Ndiaye, YD; Gomis, JF; Ndiaye, M; Mbaye, A; Diakite, M; Sy, N; Mbengue, B; Deme, AB; Daniels, R; Ahouidi, AD; Dieye, T; Abdullahi, A; Doumbia, S; Ndiaye, JL; Diarra, A; Ismaela, A; Coulibaly, M; Welty, C; Ngwa, AA; Shaffer, J; D'Alessandro, U; Volkman, SK; Wirth, DF; Krogstad, DJ; Koita, O; Nwakanma, D; Ndiayel, D				Dieye, Baba; Affara, Muna; Sangare, Lassana; Joof, Fatou; Ndiaye, Yaye D.; Gomis, Jules F.; Ndiaye, Mouhamadou; Mbaye, Aminata; Diakite, Mouhamadou; Sy, Ngayo; Mbengue, Babacar; Deme, Awa B.; Daniels, Rachel; Ahouidi, Ambroise D.; Dieye, Tandakha; Abdullahi, Ahmad; Doumbia, Seydou; Ndiaye, Jean L.; Diarra, Ayouba; Ismaela, Abubakar; Coulibaly, Mamadou; Welty, Clint; Ngwa, Alfred Amambua; Shaffer, Jeftley; D'Alessandro, Umberto; Volkman, Sarah K.; Wirth, Dyann F.; Krogstad, Donald J.; Koita, Ousmane; Nwakanma, Davis; Ndiayel, Daouda			West Africa International Centers of Excellence for Malaria Research: Drug Resistance Patterns to Artemether-Lumefantrine in Senegal, Mali, and The Gambia	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; DIHYDROARTEMISININ-PIPERAQUINE; CHLOROQUINE SUSCEPTIBILITY; ARTEMISININ RESISTANCE; INCREASED SENSITIVITY; COMBINATION THERAPY; UGANDAN CHILDREN; RANDOMIZED-TRIAL; PFMDR1 GENE; TRANSMISSION	In 2006, artemether lumefantrine (AL) became the first-line treatment of uncomplicated malaria in Senegal, Mali, and the Gambia. To monitor its efficacy, between August 2011 and November 2014, children with uncomplicated Plasmodium falciparum malaria were treated with AL and followed up for 42 days. A total of 463 subjects were enrolled in three sites (246 in Senegal, 97 in Mali, and 120 in Gambia). No early treatment failure was observed and malaria infection cleared in all patients by day 3. Polymerase chain reaction (PCR)-adjusted adequate clinical and parasitological response (ACPR) was 100% in Mali, and the Gambia, and 98.8% in Senegal. However, without PCR adjustment, ACPR was 89.4% overall; 91.5% in Mali, 98.8% in Senegal, and 64.3% in the Gambia (the lower value in the Gambia attributed to poor compliance of the full antimalarial course). However, pfmdrl mutations were prevalent in Senegal and a decrease in parasite sensitivity to artesunate and lumefantrine (as measured by ex vivo drug assay) was observed at all sites. Recrudescent parasites did not show Kelch 13 (K13) mutations and AL remains highly efficacious in these west African sites.	[Dieye, Baba; Ndiaye, Yaye D.; Gomis, Jules F.; Ndiaye, Mouhamadou; Mbaye, Aminata; Sy, Ngayo; Mbengue, Babacar; Deme, Awa B.; Ahouidi, Ambroise D.; Dieye, Tandakha; Ndiaye, Jean L.; Ndiayel, Daouda] Cheikh Anta Diop Univ, Dakar, Fann, Senegal; [Welty, Clint; Shaffer, Jeftley; Krogstad, Donald J.] Tulane Univ, New Orleans, LA 70118 USA; [Sangare, Lassana; Diakite, Mouhamadou; Doumbia, Seydou; Diarra, Ayouba; Coulibaly, Mamadou; Koita, Ousmane] Univ Bamako, BP 1805, Bamako, Mali; [Affara, Muna; Joof, Fatou; Abdullahi, Ahmad; Ismaela, Abubakar; Ngwa, Alfred Amambua; D'Alessandro, Umberto; Nwakanma, Davis] MRC, Serekunda, Gambia; [Daniels, Rachel; Volkman, Sarah K.; Wirth, Dyann F.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Volkman, Sarah K.; Wirth, Dyann F.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Volkman, Sarah K.] Simmons Coll, Sch Nursing & Hlth Sci, Boston, MA 02115 USA; [D'Alessandro, Umberto] London Sch Hyg & Trop Med, London, England; [D'Alessandro, Umberto] Inst Trop Med, Antwerp, Belgium; MRC Unit, Atlantic Blvd, Banjul, Gambia	Ndiayel, D (reprint author), Ave Cheikh Anta Diop Univ,POB 5005, Dakar, Senegal.	dieyebaba2004@yahoo.fr; maffara@mrc.gm; lansana.sangare@gmail.com; fajoof@mrc.gm; ydndiaye@gmail.com; jules.gomis@gmail.com; mouhamadou.ndiaye@ucad.edu.sn; natou5002@yahoo.fr; mdiakite@icermali.org; ngayosy50@hotmail.com; b.mbengue@yahoo.fr; deme.awa@gmail.com; rdaniels@broadinstitute.org; aahouidi@gmail.com; tandakha.dieye@ucad.edu.sn; angwa@mrc.gm; sdoumbi@gmail.com; jeanloab.ndiaye@ucad.edu.sn; adiarra@icemrwaf.org; udalessandro@mrc.gm; doudou@icermali.org; cwelty@icemrwaf.org; dnwakanma@mrc.gm; jshaffer@tulane.edu; svolkman@hsph.harvard.edu; dfwirth@hsph.harvard.edu; donkrogstad@gmail.com; okoita@icermali.org; dndiaye@hsph.harvard.edu		Nwakanma, Davis/0000-0002-6706-6069; Ndiaye, Jean/0000-0003-0450-5551	NIH/ICEMR, International Centre of Excellence for Malaria Research, west Africa [U19AI089696]; Medical Research Council [MC_UP_A900_1119, MC_EX_MR/K02440X/1]	The work was supported by the NIH/ICEMR, International Centre of Excellence for Malaria Research, west Africa (U19AI089696).	Adjuik M, 2004, LANCET, V363, P9; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Ashley EA, 2007, TROP MED INT HEALTH, V12, P195, DOI 10.1111/j.1365-3165.2006.01784.x; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Daniels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060780; Daniels R, 2012, ANTIMICROB AGENTS CH, V56, P2976, DOI 10.1128/AAC.05737-11; Daniels R, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-223; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dorkenoo MA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-338; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Dunyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017371; Duraisingh MT, 2000, MOL MICROBIOL, V36, P955, DOI 10.1046/j.1365-2958.2000.01914.x; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Faye B, 2011, MALARIA J, V10, P237; Faye B, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-80; Getnet G, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0775-3; Howie SRC, 2011, B WORLD HEALTH ORGAN, V89, P46, DOI 10.2471/BLT.10.080010; Ly O, 2012, PARASITOL RES, V111, P1541, DOI 10.1007/s00436-012-2994-7; Mens PF, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-237; Mwai L, 2009, ANTIMICROB AGENTS CH, V53, P5069, DOI 10.1128/AAC.00638-09; Mwesigwa J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0829-6; Ndiaye M, 2012, AM J TROP MED HYG, V87, P640, DOI 10.4269/ajtmh.2012.11-0709; Niang M, 2008, J ANTIMICROB CHEMOTH, V62, P921, DOI 10.1093/jac/dkn299; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; PAYNE D, 1987, PARASITOL TODAY, V3, P241, DOI 10.1016/0169-4758(87)90147-5; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Sagara I, 2012, AM J TROP MED HYG, V87, P50, DOI 10.4269/ajtmh.2012.11-0649; Sibley CH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-48; Sogoba N, 2007, ACTA TROP, V101, P232, DOI 10.1016/j.actatropica.2007.02.005; Talundzic E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004789; Thomas SM, 2002, AM J TROP MED HYG, V66, P474, DOI 10.4269/ajtmh.2002.66.474; Toure OA, 2011, TROP MED INT HEALTH, V16, P290, DOI 10.1111/j.1365-3156.2010.02701.x; TRAPE JF, 1992, AM J TROP MED HYG, V47, P181, DOI 10.4269/ajtmh.1992.47.181; Tumwebaze P, 2015, ANTIMICROB AGENTS CH, V59, P3018, DOI 10.1128/AAC.05141-14; Veiga MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020212; Vestergaard LS, 2007, AM J TROP MED HYG, V77, P153, DOI 10.4269/ajtmh.2007.77.153; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI 10.1172/JCI200421682; *WHO, 2005, WORLD MAL REP; Wilson PE, 2005, TRENDS PARASITOL, V21, P278, DOI 10.1016/j.pt.2005.04.007; World Health Organization, 2009, MAL MICR QUAL ASS MA; World Health Organization (WHO), 2009, METH SURV ANT DRUG E; Zongo I, 2007, CLIN INFECT DIS, V45, P1453, DOI 10.1086/522985	45	2	3	0	0	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA		1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	NOV	2016	95	5					1054	1060		10.4269/ajtmh.16-0053				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3VC	WOS:000400206600020	27549635	Bronze, Green Published			2019-04-02	
J	George, S; Geldhof, P; Albonico, M; Ame, SM; Bethony, JM; Engels, D; Mekonnen, Z; Montresor, A; Hem, S; Tchuem-Tchuente, LA; Huong, NT; Kang, G; Vercruysse, J; Levecke, B				George, Santosh; Geldhof, Peter; Albonico, Marco; Ame, Shaali M.; Bethony, Jeffrey M.; Engels, Dirk; Mekonnen, Zeleke; Montresor, Antonio; Hem, Sopheak; Tchuem-Tchuente, Louis-Albert; Nguyen Thu Huong; Kang, Gagandeep; Vercruysse, Jozef; Levecke, Bruno			The molecular speciation of soil-transmitted helminth eggs collected from school children across six endemic countries	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Ascaris lumbricoides; Trichiuris trichiura; Trichuris vulpis; Necator americanus; Ancylostoma duodenale; Zoonosis	ANCYLOSTOMA-CEYLANICUM; TRICHURIS-TRICHIURA; HOOKWORM INFECTION; RURAL-COMMUNITY; ASCARIS-SUUM; PCR-RFLP; HUMANS; TRANSMISSION; DOGS; IDENTIFICATION	Background: The diagnosis of soil-transmitted helminths (STHs; Ascaris, Trichuris and hookworms) is traditionally based on the demonstration of eggs in stool using microscopic techniques. While molecular techniques are more appropriate to speciate STH species they are seldom applied. In this study we speciated STH eggs from stool using molecular techniques to gain insights into the distribution of both human and animal STH species in the human host. Methods: We speciated 207 STH egg isolates from stool collected during the baseline survey of six drug efficacy trials conducted in Brazil, Cambodia, Cameroon, Ethiopia, Tanzania and Vietnam applying a PCR -restriction fragment length polymorphisms based approach. Results: DNA of Ascaris was detected in 71 (34.3%) samples, of which all were identified as the human roundworm Ascaris lumbricoides. In 87 (42.0%) samples, DNA of Trichuris spp. was found and further speciation demonstrated the presence of the human Trichuris trichiura (100%) and the canine Trichuris vulpis (n=7; 8.0%; in Cameroon only). Hookworms were identified in 104 (50.2%) samples, with Necator americanus (n=73; 70.2%) being the predominant species followed by Ancylostoma duodenale (n=40; 38.5%). Conclusions: Our study indicates that STH infections in humans are predominantly caused by human STH species. They also suggest that zoonotic transmission occurs on a local scale.	[George, Santosh; Geldhof, Peter; Vercruysse, Jozef; Levecke, Bruno] Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium; [George, Santosh; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [Albonico, Marco] Sacro Cuore Hosp, Ctr Trop Dis, WHO Collaborating Ctr Strongyloidiasis & Other In, Negrar, Italy; [Albonico, Marco] Univ Turin, Turin, Italy; [Ame, Shaali M.] Ivo Carneri, Publ Hlth Lab, Chake Chake, Zanzibar, Tanzania; [Bethony, Jeffrey M.] George Washington Univ, Med Ctr, Microbiol Immunol & Trop Med, Washington, DC 20037 USA; [Engels, Dirk; Montresor, Antonio] WHO, Dept Control Neglected Trop Dis, Geneva, Switzerland; [Mekonnen, Zeleke] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Hem, Sopheak] Pasteur Inst Cambodia, Clin Lab, Phnom Penh, Cambodia; [Tchuem-Tchuente, Louis-Albert] Univ Yaounde I, Ctr Schistosomiasis & Parasitol, Fac Sci, Yaounde, Cameroon; [Nguyen Thu Huong] Natl Inst Malariol Parasitol & Entomol, Dept Parasitol, Hanoi, Vietnam	Levecke, B (reprint author), Univ Ghent, Dept Virol Parasitol & Immunol, Fac Vet Med, Salisburylaan 133, B-9820 Merelbeke, Belgium.	bruno.levecke@ugent.be		Levecke, Bruno/0000-0001-8912-5595; ALBONICO, Marco/0000-0002-7805-2391	Special Research Fund of Ghent University; World Health Organization [APW200432311]; Coordination Action Plan of FWO; Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India	This work was supported by a Special Research Fund of Ghent University (https://www.ugent.be/nl/onderzoek/financiering/bof). The multicentric drug efficacy trial was financially supported by World Health Organization ([grant no APW200432311]; http://apps.who.int/whocc/Detail.aspx?cc_ref=BEL-42&cc_code=bel). The coordination of the trial was supported by a Coordination Action Plan of FWO (www.fwo.be). SG is supported by the Special Research Fund of Ghent University and the Division of Gastrointestinal Sciences, Christian Medical College, Vellore, India (www.cmcwtrl.in). BL is a postdoctoral fellow of FWO (Ref No. 0505 1.2.853.13; www.fwo.be).	ANDERSON TJC, 1995, PARASITOLOGY, V110, P215, DOI 10.1017/S0031182000063988; Areekul P, 2010, ASIAN BIOMED, V4, P49, DOI 10.2478/abm-2010-0006; Arizono N, 2010, JPN J INFECT DIS, V63, P447; Bendall RP, 2011, EMERG INFECT DIS, V17, P1964, DOI 10.3201/eid1710.101826; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Betson M, 2014, J INFECT DIS, V210, P932, DOI 10.1093/infdis/jiu193; Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1; Conlan JV, 2012, AM J TROP MED HYG, V86, P624, DOI 10.4269/ajtmh.2012.11-0413; CROESE J, 1994, ANN INTERN MED, V120, P369, DOI 10.7326/0003-4819-120-5-199403010-00003; Ng-Nguyen D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1015-y; George S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004891; George S, 2015, T ROY SOC TROP MED H, V109, P283, DOI 10.1093/trstmh/trv001; Inpankaew T, 2014, EMERG INFECT DIS, V20, P976, DOI 10.3201/eid2006.131770; Jiraanankul V, 2011, AM J TROP MED HYG, V84, P594, DOI 10.4269/ajtmh.2011.10-0189; Kaliappan SP, 2013, TROP MED INT HEALTH, V18, P1452, DOI 10.1111/tmi.12205; Landmann JK, 2003, MED J AUSTRALIA, V178, P69; Leles D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-42; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; McCarthy JS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001601; Ministry of Agriculture Fisheries and Food, 1986, MAN VET PAR LAB TECH, V418; Nejsum P, 2005, J CLIN MICROBIOL, V43, P1142, DOI 10.1128/JCM.43.3.1142-1148.2005; Nejsum P, 2012, J HELMINTHOL, V86, P148, DOI 10.1017/S0022149X12000193; Ngui R, 2012, AM J TROP MED HYG, V86, P837, DOI 10.4269/ajtmh.2012.11-0446; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001522; Nissen S, 2012, VET PARASITOL, V188, P68, DOI 10.1016/j.vetpar.2012.03.004; Pullan R.L, 2014, PARASITE VECTOR, V7, P37, DOI DOI 10.1186/1756-3305-7-37; Sparks AM, 2015, J HELMINTHOL, V89, P512, DOI 10.1017/S0022149X14000431; Steinmann P, 2015, ACTA TROP, V141, P184, DOI 10.1016/j.actatropica.2014.08.018; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Traub RJ, 2008, VET PARASITOL, V155, P67, DOI 10.1016/j.vetpar.2008.05.001; Traub RJ, 2013, INT J PARASITOL, V43, P1009, DOI 10.1016/j.ijpara.2013.07.006; Traub RJ, 2004, VET PARASITOL, V123, P245, DOI 10.1016/j.vetpar.2004.05.026; Traversa D, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-32; WHO, 2011, HELMINTH CONTROL IN SCHOOL-AGE CHILDREN: A GUIDE FOR MANAGERS OF CONTROL PROGRAMMES, SECOND EDITION, P1; World Health Organization, 2012, SOIL TRANSM HELM EL; YOSHIKAWA H, 1989, PARASITOL RES, V75, P649, DOI 10.1007/BF00930964; Zhou CH, 2012, INFECT GENET EVOL, V12, P1172, DOI 10.1016/j.meegid.2012.04.016; Zhu XQ, 1999, INT J PARASITOL, V29, P469, DOI 10.1016/S0020-7519(98)00226-4	38	5	5	4	10	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	NOV	2016	110	11					657	663		10.1093/trstmh/trw078				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EQ9FU	WOS:000398390800005	28100811	Green Accepted			2019-04-02	
J	Alirol, E; Horie, NS; Barbe, B; Lejon, V; Verdonck, K; Gillet, P; Jacobs, J; Buscher, P; Kanal, B; Bhattarai, NR; El Safi, S; Phe, T; Lim, K; Leng, L; Lutumba, P; Mukendi, D; Bottieau, E; Boelaert, M; Rijal, S; Chappuis, F				Alirol, Emilie; Horie, Ninon Seiko; Barbe, Barbara; Lejon, Veerle; Verdonck, Kristien; Gillet, Philippe; Jacobs, Jan; Buscher, Philippe; Kanal, Basudha; Bhattarai, Narayan Raj; El Safi, Sayda; Phe, Thong; Lim, Kruy; Leng, Long; Lutumba, Pascal; Mukendi, Deby; Bottieau, Emmanuel; Boelaert, Marleen; Rijal, Suman; Chappuis, Francois			Diagnosis of Persistent Fever in the Tropics: Set of Standard Operating Procedures Used in the NIDIAG Febrile Syndrome Study	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SCALE COLLABORATIVE PROJECT; ORIENTED RESEARCH CORE; TRAUMA PATIENT; CLINICAL CARE; MALARIA; INFLAMMATION; GUIDELINES; ILLNESS; INJURY	In resource-limited settings, the scarcity of skilled personnel and adequate laboratory facilities makes the differential diagnosis of fevers complex [1-5]. Febrile illnesses are diagnosed clinically in most rural centers, and both Rapid Diagnostic Tests (RDTs) and clinical algorithms can be valuable aids to health workers and facilitate therapeutic decisions [6,7]. The persistent fever syndrome targeted by NIDIAG is defined as presence of fever for at least one week. The NIDIAG clinical research consortium focused on potentially severe and treatable infections and therefore targeted the following conditions as differential diagnosis of persistent fever: visceral leishmaniasis (VL), human African trypanosomiasis (HAT), enteric (typhoid and paratyphoid) fever, brucellosis, melioidosis, leptospirosis, malaria, tuberculosis, amoebic liver abscess, relapsing fever, HIV/AIDS, rickettsiosis, and other infectious diseases (e.g., pneumonia). From January 2013 to October 2014, a prospective clinical phase III diagnostic accuracy study was conducted in one site in Cambodia, two sites in Nepal, two sites in Democratic Republic of the Congo (DRC), and one site in Sudan (clinicaltrials.gov no. NCT01766830). The study objectives were to (1) determine the prevalence of the target diseases in patients presenting with persistent fever, (2) assess the predictive value of clinical and first-line laboratory features, and (3) assess the diagnostic accuracy of several RDTs for the diagnosis of the different target conditions. In order to ensure consistency across study sites and compliance with Good Clinical (Laboratory) Practices (GC[L]P) and other applicable regulatory requirements, a robust quality assurance system was developed and implemented prior to recruitment start. This symposium describes the different components of the quality assurance system, introduces the set of standard operating procedures (SOPs) specifically developed for the NIDIAG persistent fever syndrome study, and identifies key challenges encountered by study sites in conducting the study in compliance with this quality framework.	[Alirol, Emilie; Horie, Ninon Seiko] Univ Hosp Geneva, Clin Res Ctr, Geneva, Switzerland; [Horie, Ninon Seiko; Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Barbe, Barbara; Verdonck, Kristien; Gillet, Philippe; Jacobs, Jan; Buscher, Philippe; Bottieau, Emmanuel; Boelaert, Marleen] Inst Trop Med, Antwerp, Belgium; [Lejon, Veerle] IRD, Unite Mixte Rech IRD CIRAD 177, Montpellier, France; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Kanal, Basudha; Bhattarai, Narayan Raj; Rijal, Suman] BP Koirala Inst Hlth Sci, Dharan, Nepal; [El Safi, Sayda] Univ Khartoum, Fac Med, Khartoum, Sudan; [Phe, Thong; Lim, Kruy; Leng, Long] HOPE, Sihanouk Hosp Ctr, Phnom Penh, Cambodia; [Lutumba, Pascal; Mukendi, Deby] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, Pascal; Mukendi, Deby] Univ Kinshasa, Dept Med Trop, Kinshasa, DEM REP CONGO	Alirol, E (reprint author), Univ Hosp Geneva, Clin Res Ctr, Geneva, Switzerland.	emilie.alirol@hcuge.ch		gillet, philippe/0000-0001-5878-6446; Buscher, Philippe/0000-0002-1926-7472; Boelaert, Marleen/0000-0001-8051-6776; Alirol, Emilie/0000-0001-8691-3991	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project) supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, 89 TRIALS MEET ENROL; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; Joshi R, 2008, AM J TROP MED HYG, V78, P393, DOI 10.4269/ajtmh.2008.78.393; Kleppinger CF, 2010, CLIN INFECT DIS, V51, pS111, DOI 10.1086/653058; Minei JP, 2006, J TRAUMA, V60, P1106, DOI 10.1097/01.ta.0000220424.34835.f1; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Nathens AB, 2005, J TRAUMA, V59, P764, DOI 10.1097/01.ta.0000177759.17704.35; Reyburn H, 2004, BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Shao AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132316; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Ye Y, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-160	12	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004749	10.1371/journal.pntd.0004749				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400004	27812090	DOAJ Gold, Green Published			2019-04-02	
J	Barbe, B; Verdonck, K; El-Safi, S; Khanal, B; Teav, S; Kalo, JRL; Ravinetto, R; Chappuis, F; Boelaert, M; Jacobs, J				Barbe, Barbara; Verdonck, Kristien; El-Safi, Sayda; Khanal, Basudha; Teav, Syna; Kalo, Jean-Roger Lilo; Ravinetto, Raffaella; Chappuis, Francois; Boelaert, Marleen; Jacobs, Jan			Rapid Diagnostic Tests for Neglected Infectious Diseases: Case Study Highlights Need for Customer Awareness and Postmarket Surveillance	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MEDICAL DEVICES; ACCURACY; QUALITY; AFRICA		[Barbe, Barbara; Verdonck, Kristien; Ravinetto, Raffaella; Boelaert, Marleen; Jacobs, Jan] Inst Trop Med, Antwerp, Belgium; [El-Safi, Sayda] Univ Khartoum, Fac Med, Khartoum, Sudan; [Khanal, Basudha] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Teav, Syna] HOPE, Sihanouk Hosp Ctr, Dept Infect Dis, Phnom Penh, Cambodia; [Kalo, Jean-Roger Lilo] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Ravinetto, Raffaella] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium; [Chappuis, Francois] Univ Hosp Geneva, Geneva, Switzerland; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Verdonck, K (reprint author), Inst Trop Med, Antwerp, Belgium.	tverdonck@itg.be		Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project) supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, 210 ISOTC; [Anonymous], 2012, 212 ISOTC; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-39; Hopkins H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-30; Jacobs J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-505; Mori M, 2011, TROP MED INT HEALTH, V16, P1439, DOI 10.1111/j.1365-3156.2011.02852.x; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Rugera SP, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0524-2; World Health Organization, 2014, WHO PROC CHANG WHO P; World Health Organization, 2015, WHO POSTM SURV IN VI; World Health Organization, 2014, OV PREQ IN VITR DIAG; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5	13	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004655	10.1371/journal.pntd.0004655				8	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400002	27812099	DOAJ Gold, Green Published			2019-04-02	
J	Barbe, B; Verdonck, K; Mukendi, D; Lejon, V; Kalo, JRL; Alirol, E; Gillet, P; Horie, N; Ravinetto, R; Bottieau, E; Yansouni, C; Winkler, AS; van Loen, H; Boelaert, M; Lutumba, P; Jacobs, J				Barbe, Barbara; Verdonck, Kristien; Mukendi, Deby; Lejon, Veerle; Kalo, Jean-Roger Lilo; Alirol, Emilie; Gillet, Philippe; Horie, Ninon; Ravinetto, Raffaella; Bottieau, Emmanuel; Yansouni, Cedric; Winkler, Andrea S.; van Loen, Harry; Boelaert, Marleen; Lutumba, Pascal; Jacobs, Jan			The Art of Writing and Implementing Standard Operating Procedures (SOPs) for Laboratories in Low-Resource Settings: Review of Guidelines and Best Practices	PLOS NEGLECTED TROPICAL DISEASES			English	Article							RAPID DIAGNOSTIC-TESTS; INSTRUCTIONS; TRANSLATE		[Barbe, Barbara; Verdonck, Kristien; Lejon, Veerle; Gillet, Philippe; Ravinetto, Raffaella; Bottieau, Emmanuel; van Loen, Harry; Boelaert, Marleen; Jacobs, Jan] Inst Trop Med, Antwerp, Belgium; [Mukendi, Deby; Kalo, Jean-Roger Lilo; Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lejon, Veerle] Inst Rech Dev, Montpellier, France; [Alirol, Emilie; Horie, Ninon] Univ Hosp Geneva, Geneva, Switzerland; [Ravinetto, Raffaella] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Yansouni, Cedric] McGill Univ, Ctr Hlth, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada; [Winkler, Andrea S.] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkler, Andrea S.] Univ Oslo, Ctr Global Hlth, Oslo, Norway; [Lutumba, Pascal] Univ Kinshasa, Kinshasa, DEM REP CONGO; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium	Barbe, B (reprint author), Inst Trop Med, Antwerp, Belgium.	bbarbe@itg.be		gillet, philippe/0000-0001-5878-6446; Alirol, Emilie/0000-0001-8691-3991; Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project) supported by the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro C, 2008, VALUE HEALTH, V11, P509, DOI 10.1111/j.1524-4733.2007.00292.x; Center for Medicare and Medicaid Services (US), 2011, CLIN LAB IMPR AM CLI; Clinical and laboratory Standards Institute (CLSI), 2013, QMS02A6 CLSI, V33; Clinical and laboratory Standards Institute (CLSI), 2011, QMS01A4 CLSI, V31; Cowgill J, 2003, JRC DESIGN SYMBOL US; Datema TAM, 2012, AFR J LAB MED, V1, DOI 10.4102/ajlm.v1i1.3; Emanuel EJ, 2004, J INFECT DIS, V189, P930, DOI 10.1086/381709; European Commission, 2009, ENTRF2SFJR2009D869 E; Hanrahan D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133394; Hermans V., 2011, MALARIA J, V10, P10; International Organization for Standardization, 2012, 15189 ISO; International Organization for Standardization, 2005, 17025 ISO; Jacobs J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-505; Joint Commission International, 2010, ACCR STAND CLIN LAB; Luman ET, 2014, AFR J LAB MED, V3, DOI 10.4102/ajlm.v3i2.265; Nielsen J., 2015, READABILITY COMPREHE; Patel Ilesh, 2007, Community Eye Health, V20, P40; Patil S, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7392; PETTERSSON R, 1982, ECTJ-EDUC COMMUN TEC, V30, P43; Rennie W, 2007, T ROY SOC TROP MED H, V101, P9, DOI 10.1016/j.trstmh.2006.03.011; Seidahmed OME, 2008, TROP MED INT HEALTH, V13, P406, DOI 10.1111/j.1365-3156.2008.02015.x; Tavrow P, 2000, OPERATIONS RES RESUL, V1; U.S. Food and Drug Administration (FDA), 1993, WRIT IT RIGHT REC DE; U.S. Food and Drug Administration (FDA), 2001, GUID MED DEV PAT LAB; UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases, 2009, GOOD CLIN LAB PRACT; Wallace LS, 2008, BLOOD PRESS MONIT, V13, P219, DOI 10.1097/MBP.0b013e3283057b0a; Wallace LS, 2006, J ASTHMA, V43, P375, DOI 10.1080/02770900600709856; WHO, 2015, HARM RAP DIAGN TESTS; World Health Organization, 2008, PAT SAF WORKSH LEARN; World Health Organization Regional Office for Africa (WHO-AFRO) US Centers for Disease Control and Prevention (CDC) American Society for Clinical Pathology (ASCP) Clinton Foundation, 2009, STRENGTH LAB MAN ACC; World Health Organization (WHO), 2011, LAB QUAL MAN SYST HD	31	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0005053	10.1371/journal.pntd.0005053				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400016	27812100	DOAJ Gold, Green Published			2019-04-02	
J	Becker, SL; Yap, P; Horie, NS; Alirol, E; Barbe, B; Bhatta, NK; Bhattarai, NR; Bottieau, E; Chatigre, JK; Coulibaly, JT; Fofana, HKM; Jacobs, J; Karki, P; Khanal, B; Knopp, S; Koirala, K; Mahendradhata, Y; Mertens, P; Meyanti, F; Murhandarwati, EH; N'Goran, EK; Peeling, RW; Pradhan, B; Ravinetto, R; Rijal, S; Sacko, M; Saye, R; Schneeberger, PHH; Schurmans, C; Silue, KD; Steinmann, P; van Loen, H; Verdonck, K; van Lieshout, L; von Muller, L; Yao, JA; Boelaert, M; Chappuis, F; Polman, K; Utzinger, J				Becker, Soren L.; Yap, Peiling; Horie, Ninon S.; Alirol, Emilie; Barbe, Barbara; Bhatta, Nisha K.; Bhattarai, Narayan R.; Bottieau, Emmanuel; Chatigre, Justin K.; Coulibaly, Jean T.; Fofana, Hassan K. M.; Jacobs, Jan; Karki, Prahlad; Khanal, Basudha; Knopp, Stefanie; Koirala, Kanika; Mahendradhata, Yodi; Mertens, Pascal; Meyanti, Fransiska; Murhandarwati, Elsa H.; N'Goran, Eliezer K.; Peeling, Rosanna W.; Pradhan, Bickram; Ravinetto, Raffaella; Rijal, Suman; Sacko, Moussa; Saye, Renion; Schneeberger, Pierre H. H.; Schurmans, Celine; Silue, Kigbafori D.; Steinmann, Peter; van Loen, Harry; Verdonck, Kristien; van Lieshout, Lisette; von Muller, Lutz; Yao, Joel A.; Boelaert, Marleen; Chappuis, Francois; Polman, Katja; Utzinger, Jurg			Experiences and Lessons from a Multicountry NIDIAG Study on Persistent Digestive Disorders in the Tropics	PLOS NEGLECTED TROPICAL DISEASES			English	Article							NEED ASYMPTOMATIC CONTROLS; MIDDLE-INCOME COUNTRIES; RAPID DIAGNOSTIC-TESTS; MAL-ED COHORT; PATIENT RECRUITMENT; INFECTIOUS DIARRHEA; GUIDELINES; CHILDREN; ILLNESS; MANAGEMENT		[Becker, Soren L.; Yap, Peiling; Coulibaly, Jean T.; Knopp, Stefanie; Schneeberger, Pierre H. H.; Steinmann, Peter; Utzinger, Jurg] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Becker, Soren L.; Yap, Peiling; Coulibaly, Jean T.; Knopp, Stefanie; Schneeberger, Pierre H. H.; Steinmann, Peter; Utzinger, Jurg] Univ Basel, Basel, Switzerland; [Becker, Soren L.; von Muller, Lutz] Univ Saarland, Inst Med Microbiol & Hyg, Homburg, Germany; [Horie, Ninon S.; Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Alirol, Emilie] Univ Hosp Geneva, Clin Res Ctr, Geneva, Switzerland; [Barbe, Barbara; Bottieau, Emmanuel; Jacobs, Jan; Ravinetto, Raffaella; Schurmans, Celine; van Loen, Harry] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Bhatta, Nisha K.] BP Koirala Inst Hlth Sci, Dept Paediat & Adolescent Med, Dharan, Nepal; [Bhattarai, Narayan R.; Khanal, Basudha] BP Koirala Inst Hlth Sci, Dept Microbiol, Dharan, Nepal; [Chatigre, Justin K.] Hop Methodiste Dabou, Dabou, Cote Ivoire; [Coulibaly, Jean T.; N'Goran, Eliezer K.; Silue, Kigbafori D.; Yao, Joel A.] Univ Felix Houphouet Boigny, Unite Format & Rech Biosci, Abidjan, Cote Ivoire; [Coulibaly, Jean T.; N'Goran, Eliezer K.; Silue, Kigbafori D.; Yao, Joel A.] Ctr Suisse Rech Sci Cote Ivoire, Dept Environm & Sante, Abidjan, Cote Ivoire; [Fofana, Hassan K. M.; Sacko, Moussa; Saye, Renion] Inst Natl Rech Sante Publ, Bamako, Mali; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Karki, Prahlad; Koirala, Kanika; Pradhan, Bickram; Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Knopp, Stefanie] Nat Hist Museum, Dept Life Sci, Wolfson Wellcome Biomed Labs, London, England; [Mahendradhata, Yodi; Meyanti, Fransiska; Murhandarwati, Elsa H.] Gadjah Mada Univ, Ctr Trop Med, Fac Med, Yogyakarta, Indonesia; [Mertens, Pascal] Coris BioConcept, Gembloux, Belgium; [Peeling, Rosanna W.] London Sch Hyg & Trop Med, London, England; [Ravinetto, Raffaella] Katholieke Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium; [Schneeberger, Pierre H. H.] Agroscope Changins Wadenswil, Dept Epidemiol & Mol Diagnost, Wadenswil, Switzerland; [Schneeberger, Pierre H. H.] Spiez Lab, Dept Virol, Fed Off Civil Protect, Spiez, Switzerland; [Verdonck, Kristien; Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [van Lieshout, Lisette] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Polman, Katja] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium	Utzinger, J (reprint author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Utzinger, J (reprint author), Univ Basel, Basel, Switzerland.	juerg.utzinger@unibas.ch		Alirol, Emilie/0000-0001-8691-3991; von Muller, Lutz/0000-0001-9013-4245; Knopp, Stefanie/0000-0001-5707-7963; Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-88; Adams M, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/1478-4505-13-8; ALAM N, 1989, INT J EPIDEMIOL, V18, P697, DOI 10.1093/ije/18.3.697; Becker SL, 2015, CLIN MICROBIOL INFEC, V21, pE53, DOI 10.1016/j.cmi.2015.04.024; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Bell-Syer SEM, 2011, EVID-BASED COMPL ALT, P1, DOI 10.1093/ecam/nen044; Blackwelder WC, 2012, CLIN INFECT DIS, V55, pS246, DOI 10.1093/cid/cis788; Dixon J R Jr, 1998, Qual Assur, V6, P65; Dubourg G, 2015, CLIN MICROBIOL INFEC, V21, pE51, DOI 10.1016/j.cmi.2015.04.020; Ekwochi U, 2014, J TROP PEDIATRICS, V60, P249, DOI 10.1093/tropej/fmt111; Ezzelle J, 2008, J PHARMACEUT BIOMED, V46, P18, DOI 10.1016/j.jpba.2007.10.010; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; KEMPER JT, 1978, B MATH BIOL, V40, P707, DOI 10.1007/BF02460601; Mukonzo JK, 2013, J MULTIDISCIP HEALTH, V6, P303, DOI 10.2147/JMDH.S49075; Murray-Kolb LE, 2014, CLIN INFECT DIS, V59, pS261, DOI 10.1093/cid/ciu437; Pawlowski SW, 2009, GASTROENTEROLOGY, V136, P1874, DOI 10.1053/j.gastro.2009.02.072; Platts-Mills JA, 2013, MUCOSAL IMMUNOL, V6, P876, DOI 10.1038/mi.2013.50; Platts-Mills JA, 2014, CLIN INFECT DIS, V59, pS233, DOI 10.1093/cid/ciu408; Polman K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1074-x; Raoult D, 2016, CLIN INFECT DIS, V62, P809, DOI 10.1093/cid/civ985; Ross AGP, 2013, NEW ENGL J MED, V368, P1817, DOI 10.1056/NEJMra1207777; Thoma A, 2010, CAN J SURG, V53, P205; Thomas PD, 2003, GUT, V52, P1; Utzinger J, 2015, CLIN MICROBIOL INFEC, V21, P529, DOI [10.1016/j.cmi.2015.03.014, 10.1016/j.cmi.2015.02.016]; Webair HH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-581; WEISS MG, 1988, SOC SCI MED, V27, P5, DOI 10.1016/0277-9536(88)90159-1; World Health Organization, 2009, DIARRH DIS FACT SHEE; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5; Yansouni CP, 2012, CLIN INFECT DIS, V55, P610, DOI 10.1093/cid/cis466	29	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004818	10.1371/journal.pntd.0004818				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400005	27812101	DOAJ Gold, Green Published			2019-04-02	
J	Boelaert, M				Boelaert, Marleen		The NIDIAG Consortium	Clinical Research on Neglected Tropical Diseases: Challenges and Solutions	PLOS NEGLECTED TROPICAL DISEASES			English	Editorial Material							RAPID DIAGNOSTIC-TESTS; PERSISTENT DIGESTIVE DISORDERS; NEED ASYMPTOMATIC CONTROLS; MALARIAL FEBRILE ILLNESS; AFRICA; FEVER; GOVERNANCE; SETTINGS; CHILDREN; TANZANIA		[Boelaert, Marleen; The NIDIAG Consortium] Inst Trop Med, Antwerp, Belgium	Boelaert, M (reprint author), Inst Trop Med, Antwerp, Belgium.	mboelaert@itg.be		von Muller, Lutz/0000-0001-9013-4245; Vounatsou, Penelope/0000-0002-4904-5352; Lestari, Trisasi/0000-0002-4799-5338; Boelaert, Marleen/0000-0001-8051-6776; Surendra, Henry/0000-0002-6029-0623	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044269; Alirol E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004749; Barbe B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004655; Barbe B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005053; Becker SL, 2015, CLIN MICROBIOL INFEC, V21, pE53, DOI 10.1016/j.cmi.2015.04.024; Becker SL, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-37; Becker SL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004818; Bosu WK, 1999, TROP MED INT HEALTH, V4, P114, DOI 10.1046/j.1365-3156.1999.00360.x; Chappuis F, 2013, CLIN MICROBIOL INFEC, V19, P422, DOI 10.1111/1469-0691.12154; CIOMS, 2002, INT ETH GUID BIOM RE; Clements ACA, 2010, TROP MED INT HEALTH, V15, P198, DOI 10.1111/j.1365-3156.2009.02440.x; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Dubourg G, 2015, CLIN MICROBIOL INFEC, V21, pE51, DOI 10.1016/j.cmi.2015.04.020; Nguyen DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055750; El-Safi S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004736; Hildenwall H, 2016, TROP MED INT HEALTH, V21, P149, DOI 10.1111/tmi.12635; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Kiemde F, 2016, TROP MED IN IN PRESS; Laman M, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-29; Liese B, 2010, LANCET, V375, P67, DOI 10.1016/S0140-6736(09)61749-9; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Mukadi P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146450; Murphy SC, 2013, AM J TROP MED HYG, V89, P824, DOI 10.4269/ajtmh.12-0675; Polman K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1074-x; Prasad N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127962; Pratt B, 2016, AM J BIOETHICS, V16, P29, DOI 10.1080/15265161.2016.1214304; Ravinetto R, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004654; Rosenberg M, 2016, PLOS NEGLECT TROP D, V10; ROUGEMONT A, 1991, LANCET, V338, P1292, DOI 10.1016/0140-6736(91)92592-P; Staunton C, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-35; Supali T, 2010, INT J PARASITOL, V40, P1171, DOI 10.1016/j.ijpara.2010.05.003; Tinto H, 2013, AM J TROP MED HYG, V88, P608, DOI 10.4269/ajtmh.12-0330; Utzinger J, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13727; van den Bogaart E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001617; Walter ND, 2009, B WORLD HEALTH ORGAN, V87, P99, DOI 10.2471/BLT.08.050740; World Health Organization, 2008, PAT SAF WORKSH LEARN; Yansouni CP, 2013, LANCET INFECT DIS, V13, P546, DOI 10.1016/S1473-3099(13)70004-5; Yansouni CP, 2012, CLIN INFECT DIS, V55, P610, DOI 10.1093/cid/cis466	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004853	10.1371/journal.pntd.0004853				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400006	27812095	DOAJ Gold, Green Published			2019-04-02	
J	Carneiro, MW; Fukutani, KF; Andrade, BB; Curvelo, RP; Cristal, JR; Carvalho, AM; Barral, A; Van Weyenbergh, J; Barral-Netto, M; de Oliveira, CI				Carneiro, Marcia W.; Fukutani, Kiyoshi F.; Andrade, Bruno B.; Curvelo, Rebecca P.; Cristal, Juqueline R.; Carvalho, Augusto M.; Barral, Aldina; Van Weyenbergh, Johan; Barral-Netto, Manoel; de Oliveira, Camila I.			Gene Expression Profile of High IFN-gamma Producers Stimulated with Leishmania braziliensis Identifies Genes Associated with Cutaneous Leishmaniasis	PLOS NEGLECTED TROPICAL DISEASES			English	Article							MUCOSAL LEISHMANIASIS; IMMUNE-RESPONSE; TEGUMENTARY LEISHMANIASIS; DIFFERENTIAL REGULATION; T-CELLS; INFECTION; ALPHA; AMAZONENSIS; NEUTROPHILS; INHIBITION	Background The initial response to Leishmania parasites is essential in determining disease development or resistance. In vitro, a divergent response to Leishmania, characterized by high or low IFN-gamma production has been described as a potential tool to predict both vaccine response and disease susceptibility in vivo. Methods and findings We identified uninfected and healthy individuals that were shown to be either high-or low IFN-gamma producers (HPs and LPs, respectively) following stimulation of peripheral blood cells with Leishmania braziliensis. Following stimulation, RNA was processed for gene expression analysis using immune gene arrays. Both HPs and LPs were shown to upregulate the expression of CXCL10, IFI27, IL6 and LTA. Genes expressed in HPs only (CCL7, IL8, IFI44L and IL1B) were associated with pathways related to IL17 and TREM 1 signaling. In LPs, uniquely expressed genes (for example IL9, IFI44, IFIT1 and IL2RA) were associated with pathways related to pattern recognition receptors and interferon signaling. We then investigated whether the unique gene expression profiles described here could be recapitulated in vivo, in individuals with active Cutaneous Leishmaniasis or with subclinical infection. Indeed, using a set of six genes (TLR2, JAK2, IFI27, IFIT1, IRF1 and IL6) modulated in HPs and LPs, we could successfully discriminate these two clinical groups. Finally, we demonstrate that these six genes are significantly overexpressed in CL lesions. Conclusion Upon interrogation of the peripheral response of naive individuals with diverging IFN-gamma production to L. braziliensis, we identified differences in the innate response to the parasite that are recapitulated in vivo and that discriminate CL patients from individuals presenting a subclinical infection.	[Carneiro, Marcia W.; Fukutani, Kiyoshi F.; Andrade, Bruno B.; Curvelo, Rebecca P.; Cristal, Juqueline R.; Carvalho, Augusto M.; Barral, Aldina; Barral-Netto, Manoel; de Oliveira, Camila I.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Goncalo Moniz, Salvador, BA, Brazil; [Andrade, Bruno B.] Fundacao Jose Silveira, Multinat Org Network Sponsoring Translat & Epidem, Salvador, BA, Brazil; [Van Weyenbergh, Johan] Katholieke Univ Leuven, Rega Inst Med Res, Dept Microbiol & Immunol, Leuven, Belgium; [Barral, Aldina; Barral-Netto, Manoel] Univ Fed Bahia, Sch Med, Salvador, BA, Brazil; [Carneiro, Marcia W.] Univ Catolica Salvador, Salvador, BA, Brazil	de Oliveira, CI (reprint author), Fundacao Oswaldo Cruz FIOCRUZ, Inst Goncalo Moniz, Salvador, BA, Brazil.	camila@bahia.fiocruz.br	Van Weyenbergh, Johan/B-4187-2009	Van Weyenbergh, Johan/0000-0003-3234-8426; Barral Netto, Manoel/0000-0002-5823-7903; Fukutani, Kiyoshi/0000-0003-2223-0918	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302464/2009-3]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB); Coordenacao de Apoio a Pesquisa e Ensino Superior (CAPES)	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant 302464/2009-3 to M.BN and fellowship to MWC and KFF), Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) (fellowship to KFF) and Coordenacao de Apoio a Pesquisa e Ensino Superior (CAPES) (fellowship to JRC). AB, MBN, and MO are senior researchers at CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli LRV, 2005, IMMUNOL LETT, V101, P226, DOI 10.1016/j.imlet.2005.06.004; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Bacellar O, 2009, J INFECT DIS, V200, P75, DOI 10.1086/599380; Boaventura VS, 2010, EUR J IMMUNOL, V40, P2830, DOI 10.1002/eji.200940115; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Campanelli AP, 2010, HUM IMMUNOL, V71, P1220, DOI 10.1016/j.humimm.2010.09.002; Carneiro MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052296; CARVALHO EM, 1985, J IMMUNOL, V135, P4144; Carvalho LP, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00301; Castellucci L, 2006, J INFECT DIS, V194, P519, DOI 10.1086/505504; Castes M, 1993, Biol Res, V26, P233; Coelho ZCB, 2010, BRAZ J INFECT DIS, V14, P476, DOI 10.1590/S1413-86702010000500009; DaCruz AM, 1996, MEM I OSWALDO CRUZ, V91, P225, DOI 10.1590/S0074-02761996000200019; DAVIES CR, 1995, EPIDEMIOL INFECT, V114, P297, DOI 10.1017/S0950268800057964; de Oliveira CI, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00145; Diehl S, 2002, J EXP MED, V196, P39, DOI 10.1084/jem.20020026; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Follador I, 2002, CLIN INFECT DIS, V34, pE54, DOI 10.1086/340261; Franca-Costa J, 2016, J INFECT DIS, V213, P1143, DOI 10.1093/infdis/jiv548; GESSNER A, 1993, IMMUNOBIOLOGY, V189, P419, DOI 10.1016/S0171-2985(11)80414-6; Hardaker EL, 2004, FASEB J, V18, P191, DOI 10.1096/fj.03-0170fje; Huang L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003546; Khouri R, 2014, J INFECT DIS, V210, P306, DOI 10.1093/infdis/jiu087; Khouri R, 2009, J IMMUNOL, V182, P2525, DOI 10.4049/jimmunol.0802860; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martensen PM, 2001, EUR J BIOCHEM, V268, P5947, DOI 10.1046/j.0014-2956.2001.02545.x; Matikainen S, 2001, EUR J IMMUNOL, V31, P2236, DOI 10.1002/1521-4141(200107)31:7<2236::AID-IMMU2236>3.3.CO;2-7; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Murray HW, 2008, INFECT IMMUN, V76, P4088, DOI 10.1128/IAI.00490-08; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; NANDAN D, 1995, INFECT IMMUN, V63, P4495; Netea MG, 2006, J LEUKOCYTE BIOL, V80, P1454, DOI 10.1189/jlb.1205758; Novais FO, 2014, J INVEST DERMATOL; Oliveira PRS, 2015, J IMMUNOL, V194, P2664, DOI 10.4049/jimmunol.1402047; Pompeu MML, 2001, INFECT IMMUN, V69, P7453, DOI 10.1128/IAI.69.12.7453-7460.2001; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; Rogers KA, 2004, AM J TROP MED HYG, V71, P568, DOI 10.4269/ajtmh.2004.71.568; Romagnani P, 2001, BLOOD, V97, P601, DOI 10.1182/blood.V97.3.601; Schnorr D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001947; Temann UA, 2002, J CLIN INVEST, V109, P29, DOI 10.1172/JCI200213696; Weber B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003900	41	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							0005116	10.1371/journal.pntd.0005116				17	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400038	27870860	DOAJ Gold, Green Published			2019-04-02	
J	El-Safi, S; Chappuis, F; Boelaert, M				El-Safi, Sayda; Chappuis, Francois; Boelaert, Marleen			The Challenges of Conducting Clinical Research on Neglected Tropical Diseases in Remote Endemic Areas in Sudan	PLOS NEGLECTED TROPICAL DISEASES			English	Article							FEVER		[El-Safi, Sayda] Univ Khartoum, Khartoum, Sudan; [Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium	El-Safi, S (reprint author), Univ Khartoum, Khartoum, Sudan.	shelsafi@yahoo.com		Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alirol E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004749; [Anonymous], 2008, J ONCOL PRACT, V4, P233, DOI 10.1200/JOP.0854601; Ax J., 2014, REUTERS; Barbe B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004655; D'Acremont V, 2014, NEW ENGL J MED, V370, P809, DOI 10.1056/NEJMoa1214482; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; Mayxay M, 2013, LANCET GLOB HEALTH, V1, pE46, DOI 10.1016/S2214-109X(13)70008-1; Mendelson M, 2015, LANCET	8	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004736	10.1371/journal.pntd.0004736				10	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400003	27812094	DOAJ Gold, Green Published			2019-04-02	
J	Ravinetto, R; Alirol, E; Mahendradhata, Y; Rijal, S; Lutumba, P; Sacko, M; El-Safi, S; Lim, K; van Loen, H; Jacobs, J; Peeling, RW; Chappuis, F; Boelaert, M				Ravinetto, Raffaella; Alirol, Emilie; Mahendradhata, Yodi; Rijal, Suman; Lutumba, Pascal; Sacko, Moussa; El-Safi, Sayda; Lim, Kruy; van Loen, Harry; Jacobs, Jan; Peeling, Rosanna W.; Chappuis, Francois; Boelaert, Marleen			Clinical Research in Neglected Tropical Diseases: The Challenge of Implementing Good Clinical (Laboratory) Practices	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRIALS; PARTICIPANTS; CONSENT; AFRICA		[Ravinetto, Raffaella; van Loen, Harry; Jacobs, Jan] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium; [Ravinetto, Raffaella] Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium; [Alirol, Emilie] Medecins Sans Frontieres United Kingdom, London, England; [Alirol, Emilie] Hop Univ Geneve, Ctr Rech Clin, Geneva, Switzerland; [Mahendradhata, Yodi] Gadjah Mada Univ, Dept Publ Hlth, Fac Med, Yogyakarta, Indonesia; [Rijal, Suman] BP Koirala Inst Hlth Sci, Dept Internal Med, Dharan, Nepal; [Lutumba, Pascal] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Sacko, Moussa] Inst Natl Rech Sante Publ, Bamako, Mali; [El-Safi, Sayda] Univ Khartoum, Khartoum, Sudan; [Lim, Kruy] Sihanouk Hosp Ctr Hope, Phnom Penh, Cambodia; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Peeling, Rosanna W.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Chappuis, Francois] Univ Hosp Geneva, Div Trop & Humanitarian Med, Geneva, Switzerland; [Boelaert, Marleen] Inst Trop Med Antwerp, Dept Publ Hlth, Antwerp, Belgium	Ravinetto, R (reprint author), Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium.; Ravinetto, R (reprint author), Katholieke Univ Leuven, Clin Pharmacol & Pharmacotherapy, Leuven, Belgium.	rravinetto@itg.be		Alirol, Emilie/0000-0001-8691-3991; Boelaert, Marleen/0000-0001-8051-6776	European Union [260260]	This work is part of the NIDIAG European research network (Collaborative Project), supported by the European Union's Seventh Framework Programme for research, technological development, and demonstration under grant agreement no. 260260. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi MO, 2014, TROP MED INT HEALTH, V19, P625, DOI 10.1111/tmi.12288; Afolabi MO, 2015, B WORLD HEALTH ORGAN, V93, P320, DOI 10.2471/BLT.14.146159; [Anonymous], 2009, GOOD CLIN LAB PRACT; [Anonymous], 2015, B WORLD HEALTH ORGAN, V93, P70, DOI [10.2471/BLT.15.020215, DOI 10.2471/BLT.15.020215]; Chen H, 2015, B WORLD HEALTH ORGAN, V93, P113, DOI 10.2471/BLT.14.138420; Chilengi R, 2010, WEBMEDCENTRAL CLIN T, V1; CIOMS, 2002, INT ETH GUID BIOM RE; Guindo MA, 2012, AM J TROP MED HYG, V86, P573, DOI 10.4269/ajtmh.2012.11-0691; Idoko OT, 2013, AM J TROP MED HYG, V88, P414, DOI 10.4269/ajtmh.12-0576; International Conference of Harmonization (ICH), 1996, ICH TRIP GUID GOOD C; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Mavoko HM, 2015, TROP MED INT HEALTH, V20, P163; Newton PN, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h602; Tam NT, 2015, B WORLD HEALTH ORGAN, V93, P186, DOI 10.2471/BLT.14.141390; PEDRIQUE B, 2000, LANCET GLOB HEALTH, V1, P371, DOI DOI 10.1016/S2214-109X(13)70078-0; PLOS Medicine Editors, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1001949, DOI 10.1371/JOURNAL.PMED.1001949]; Ravinetto R, BMC INT HLT IN PRESS; Ravinetto RM, 2013, TROP MED INT HEALTH, V18, P237, DOI 10.1111/tmi.12036; Singh Jerome Amir, 2009, Acta Trop, V112 Suppl 1, pS71, DOI 10.1016/j.actatropica.2009.07.032; Stevens W, 2003, Qual Assur, V10, P83; Thupasi T, 2016, B WORLD HEALTH ORGAN, V94, P147, DOI [10.2471/BLT.15.154997, DOI 10.2471/BLT.15.154997]; Tinto H, 2013, AM J TROP MED HYG, V88, P608, DOI 10.4269/ajtmh.12-0330; WHO, 1995, WHO TECHN REP SER, V850; World Health Organization-Special Programme for Research and Training in Tropical Diseases (WHO-TDR), 2007, ETH CHALL STUD DES I	24	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	NOV	2016	10	11							e0004654	10.1371/journal.pntd.0004654				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EI0HR	WOS:000392154400001	27812089	DOAJ Gold, Green Published			2019-04-02	
J	Delamou, A; Utz, B; Delvaux, T; Beavogui, AH; Shahabuddin, A; Koivogui, A; Leveque, A; Zhang, WH; De Brouwere, V				Delamou, Alexandre; Utz, Bettina; Delvaux, Therese; Beavogui, Abdoul Habib; Shahabuddin, Asm; Koivogui, Akoi; Leveque, Alain; Zhang, Wei-Hong; De Brouwere, Vincent			Pregnancy and childbirth after repair of obstetric fistula in sub-Saharan Africa: Scoping Review	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						pregnancy; childbirth; post-repair; obstetric fistula; sub-Saharan Africa	FEMALE GENITAL FISTULA; FOLLOW-UP; WOMEN; OUTCOMES; PREVALENCE; FERTILITY; COUNTRIES; PROGRAM; HEALTH; IMPACT	OBJECTIVE To synthesise the evidence on pregnancy and childbirth after repair of obstetric fistula in sub-Saharan Africa and to identify the existing knowledge gaps. METHODS A scoping review of studies reporting on pregnancy and childbirth in women who underwent repair for obstetric fistula in sub-Saharan Africa was conducted. We searched relevant articles published between 1 January 1970 and 31 March 2016, without methodological or language restrictions, in electronic databases, general Internet sources and grey literature. RESULTS A total of 16 studies were included in the narrative synthesis. The findings indicate that many women in sub-Saharan Africa still desire to become pregnant after the repair of their obstetric fistula. The overall proportion of pregnancies after repair estimated in 11 studies was 17.4% (ranging from 2.5% to 40%). Among the 459 deliveries for which the mode of delivery was reported, 208 women (45.3%) delivered by elective caesarean section (CS), 176 women (38.4%) by emergency CS and 75 women (16.3%) by vaginal delivery. Recurrence of fistula was a common maternal complication in included studies while abortions/miscarriage, stillbirths and neonatal deaths were frequent foetal consequences. Vaginal delivery and emergency C-section were associated with increased risk of stillbirth, recurrence of the fistula or even maternal death. CONCLUSION Women who get pregnant after repair of obstetric fistula carry a high risk for pregnancy complications. However, the current evidence does not provide precise estimates of the incidence of pregnancy and pregnancy outcomes post-repair. Therefore, studies clearly assessing these outcomes with the appropriate study designs are needed.	[Delamou, Alexandre; Leveque, Alain; Zhang, Wei-Hong] Univ Libre Bruxelles, Ecole Sante Publ, Brussels, Belgium; [Delamou, Alexandre; Beavogui, Abdoul Habib] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, Alexandre; Utz, Bettina; Delvaux, Therese; Shahabuddin, Asm; De Brouwere, Vincent] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Koivogui, Akoi] Assoc Depistage Organise Canc, Dept Saone & Loire, Charnay Les Macon, France	Delamou, A (reprint author), Ctr Natl Format & Rech Sante Rurale Maferinyah, POB 4099, Conakry, Guinea.	adelamou@gmail.com		Zhang, Wei-Hong/0000-0003-0380-770X; Utz, Bettina/0000-0002-7263-3320; KOIVOGUI, AKOI/0000-0001-9097-3006			Adler AJ, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-246; AIMAKHU VE, 1974, FERTIL STERIL, V25, P586; Andreucci CB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0742-6; Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616; Barone MA, 2012, OBSTET GYNECOL, V120, P524, DOI 10.1097/AOG.0b013e31826579e8; Benfield N, 2011, INT J GYNECOL OBSTET, V114, P265, DOI 10.1016/j.ijgo.2011.02.024; Browning A, 2008, BJOG-INT J OBSTET GY, V115, P1564, DOI 10.1111/j.1471-0528.2008.01900.x; Browning A, 2009, BJOG-INT J OBSTET GY, V116, P1265, DOI 10.1111/j.1471-0528.2009.02182.x; de Bernis L, 2007, INT J GYNECOL OBSTET, V99, pS117, DOI 10.1016/j.ijgo.2007.06.032; Delamou A, 2015, TROP MED INT HEALTH, V20, P1454, DOI 10.1111/tmi.12584; Delamou A, 2015, TROP MED INT HEALTH, V20, P813, DOI 10.1111/tmi.12489; Docquier J, 1988, Acta Urol Belg, V56, P535; Donnay F, 2006, INT J GYNECOL OBSTET, V94, P254, DOI 10.1016/j.ijgo.2006.04.005; Donnelly K, 2015, CULT HEALTH SEX, V17, P150, DOI 10.1080/13691058.2014.964320; Drew LB, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0755-1; EMEMBOLU J, 1992, INT J GYNECOL OBSTET, V39, P205, DOI 10.1016/0020-7292(92)90658-6; EVOH NJ, 1978, ANN CLIN RES, V10, P303; Fistula C., 2013, PROJECT REPORT OCT 1; Ford CCM, 2013, BJOG-INT J OBSTET GY, V120, P332; Frajzyngier V, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.02.006; Genadry RR, 2007, INT J GYNECOL OBSTET, V99, pS51, DOI 10.1016/j.ijgo.2007.06.026; Gottvall K, 2002, BJOG-INT J OBSTET GY, V109, P254, DOI 10.1016/S1470-0328(02)01200-4; Gupta NP, 2012, UROL INT, V88, P259, DOI 10.1159/000331503; Hawkins L, 2013, INT J GYNECOL OBSTET, V120, P178, DOI 10.1016/j.ijgo.2012.08.014; Khisa W, 2017, BJOG-INT J OBSTET GY, V124, P503, DOI 10.1111/1471-0528.13902; Landry E, 2013, GLOB PUBLIC HEALTH, V8, P926, DOI 10.1080/17441692.2013.824018; Lawani LO, 2015, INT J GYNECOL OBSTET, V129, P256, DOI 10.1016/j.ijgo.2014.11.028; Lombard L, 2015, TROP MED INT HEALTH, V20, P554, DOI 10.1111/tmi.12469; MacDonald P, 2007, INT J GYNECOL OBSTET, V99, pS112, DOI 10.1016/j.ijgo.2007.06.031; Maheu-Giroux M, 2015, LANCET GLOB HEALTH, V3, pE271, DOI 10.1016/S2214-109X(14)70348-1; Maulet N, 2013, TROP MED INT HEALTH, V18, P524, DOI 10.1111/tmi.12086; Maulet NBE, 2012, INT J GYNECOL OBSTET, V119, pS841; Miller S, 2005, J MIDWIFERY WOM HEAL, V50, P286, DOI 10.1016/j.jmwh.2005.03.009; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Muleta M, 2010, ACTA OBSTET GYN SCAN, V89, P945, DOI 10.3109/00016341003801698; Muleta M, 2008, J OBSTET GYNAECOL CA, V30, P44, DOI 10.1016/S1701-2163(16)32712-8; Nielsen HS, 2009, BJOG-INT J OBSTET GY, V116, P1258, DOI 10.1111/j.1471-0528.2009.02200.x; Osotimehin B., 2016, COMMUNICATION; Osotimehin B, 2013, LANCET, V381, P1702, DOI 10.1016/S0140-6736(13)61001-6; OTUBU JA, 1982, INT J GYNECOL OBSTET, V20, P163, DOI 10.1016/0020-7292(82)90032-7; Peters MDJ, 2015, INT J EVID-BASED HEA, V13, P141, DOI 10.1097/XEB.0000000000000050; Ruminjo JK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-220; Siddle K, 2013, INT UROGYNECOL J, V24, P1215, DOI 10.1007/s00192-012-1994-6; Tayler-Smith K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-164; Tembely A, 2014, Prog Urol, V24, P876, DOI 10.1016/j.purol.2014.08.202; Turan Janet Molzan, 2007, Glob Public Health, V2, P64, DOI 10.1080/17441690600648728; Wilson AL, 2011, INT J GYNECOL OBSTET, V113, P196, DOI 10.1016/j.ijgo.2011.01.006	47	3	3	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	NOV	2016	21	11					1348	1365		10.1111/tmi.12771				18	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EC6YZ	WOS:000388283900002	27596732	Bronze			2019-04-02	
J	Cikomola, JC; Vandepoele, K; Katchunga, PB; Kishabongo, AS; Padalko, EY; Speeckaert, MM; Delanghe, JR				Cikomola, Justin C.; Vandepoele, Karl; Katchunga, Philippe B.; Kishabongo, Antoine S.; Padalko, Elizaveta Y.; Speeckaert, Marijn M.; Delanghe, Joris R.			The association between fructosamine-3 kinase 900C/G polymorphism, transferrin polymorphism and human herpesvirus-8 infection in diabetics living in South Kivu	ACTA TROPICA			English	Article						Diabetes meliitus; Ferroportin Q248H mutation; Fructosamine-3 kinase 900C/G polymorphism; Human herpes virus-8; TF polymorphism	FERROPORTIN Q248H POLYMORPHISM; KAPOSIS-SARCOMA; AFRICAN-AMERICANS; SERUM FERRITIN; IRON HOMEOSTASIS; HEPCIDIN; MUTATION; GENE; HEMOCHROMATOSIS; VARIABILITY	Prevalences of human herpesvirus-8 (HHV-8) infection and diabetes mellitus are very common in certain parts of Africa, containing iron-rich soils. We hypothesized that some genetic factors could have a link with susceptibility to HHV-8 infection. We focused on ferroportin Q248H mutation (rs11568350), transferrin (TF) polymorphism and fructosamine-3 kinase (FN3K) 900C/G polymorphism (rs1056534). The study population consisted of 210 type 2 diabetic adults and 125 healthy controls recruited in Bukavu (South Kivu). In the whole study population (diabetics + healthy controls), ferroportin Q248H mutation was detected in 47 subjects (14.0%) with 43 heterozygotes and 4 homozygotes. TF phenotype frequencies were 88.1% (CC), 10.4% (CD) and 1.5% (BC). Genotype frequencies of FN3K 900C/G polymorphism were respectively 9,3% (CC), 43.3% (GC) and 47.4% (GG). Prevalence of HHV8-infection in the study population was 77.3%. HHV-8 infection rate and HHV-8 IgG antibody titer were significantly higher in diabetics then in controls (p < 0.0001). Significant differences were observed in HHV-8 infection rate and in HHV-8 IgG antibody titer according to FN3K rs1056534 (p < 0.05 and p < 0.05, respectively) and TF polymorphism (p < 0.05 and p = 0.005, respectively). No significant differences in HHV-8 infection rate and in HHV-8 IgG antibody titer were observed in the ferroportin Q248H mutation carriers (rs11568350) in comparison with ferroportin wild type. In a multiple regression analysis, FN3K rs1056534, TF polymorphism and presence of diabetes mellitus were predictors for HHV-8 infection. In contrast to these findings, ferroportin Q248H mutation (rs11568350) did not influence the susceptibility for an HHV-8 infection in sub-Saharan Africans. (C) 2016 Elsevier B.V. All rights reserved.	[Cikomola, Justin C.; Katchunga, Philippe B.] Catholic Univ Bukavu, Dept Internal Med, Bukavu, Zaire; [Cikomola, Justin C.; Delanghe, Joris R.] Ghent Univ Hosp, Dept Clin Chem, De Pintelaan 185, B-9000 Ghent, Belgium; [Vandepoele, Karl] Ghent Univ Hosp, Lab Mol Diagnost & Hematol, Ghent, Belgium; [Kishabongo, Antoine S.] Catholic Univ Bukavu, Dept Lab Med, Bukavu, Zaire; [Padalko, Elizaveta Y.] Ghent Univ Hosp, Dept Virol, Ghent, Belgium; [Speeckaert, Marijn M.] Ghent Univ Hosp, Dept Nephrol, Ghent, Belgium	Delanghe, JR (reprint author), Ghent Univ Hosp, Dept Clin Chem, De Pintelaan 185, B-9000 Ghent, Belgium.	Joris.Delanghe@ugent.be	Vandepoele, Karl/C-1197-2009	Vandepoele, Karl/0000-0002-0025-5594; Speeckaert, Marijn/0000-0001-9183-4390; Delanghe, Joris/0000-0002-5702-6792			Albuquerque D, 2011, ANN HUM BIOL, V38, P378, DOI 10.3109/03014460.2010.541496; American, 2012, DIABETES CARE S1, V35, pS64, DOI DOI 10.2337/DC12-S064; Buysschaert M, 1997, DIABETES METAB, V23, P308; Caselli E, 2014, J MED VIROL, V86, P1745, DOI 10.1002/jmv.23771; Cavalli-Sforza L, 1994, HIST GEOGRAPHY HUMAN, P188; Collard FO, 2003, DIABETES, V52, P2888, DOI 10.2337/diabetes.52.12.2888; Dedicoat M, 2003, BRIT J CANCER, V88, P1, DOI 10.1038/sj.bjc.660745; Defrere S, 2011, HISTOL HISTOPATHOL, V26, P1083, DOI 10.14670/HH-26.1083; Delpierre G, 2006, DIABETES METAB, V32, P31, DOI 10.1016/S1262-3636(07)70244-6; DMOCHOWSKI K, 1993, J CLIN ENDOCR METAB, V77, P478, DOI 10.1210/jc.77.2.478; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; GIBLETT ER, 1959, NATURE, V183, P1589, DOI 10.1038/1831589a0; Gordeuk VR, 2008, ALCOHOL CLIN EXP RES, V32, P1947, DOI 10.1111/j.1530-0277.2008.00782.x; Gordeuk VR, 2003, BLOOD CELL MOL DIS, V31, P299, DOI 10.1016/S1079-9796(03)00164-5; Hang H., 2015, DIABETES-METAB RES, V31, P127; Ingianni A, 2007, AM J INFECT DIS, V3, P123, DOI 10.3844/ajidsp.2007.123.127; Ingianni A, 2013, NEW MICROBIOL, V36, P257; Johnson EE, 2010, INFECT IMMUN, V78, P5099, DOI 10.1128/IAI.00498-10; KAMBOH MI, 1987, HUM HERED, V37, P65, DOI 10.1159/000153680; Kasvosve I, 2000, CLIN CHEM, V46, P1535; Kasvosve I, 2005, AM J CLIN NUTR, V82, P1102; Kasvosve I, 2002, AM J CLIN NUTR, V75, P321; Kasvosve I, 2015, CLIN CHIM ACTA, V444, P257, DOI 10.1016/j.cca.2015.02.037; Kasvosve I, 2013, CLIN CHIM ACTA, V416, P20, DOI 10.1016/j.cca.2012.11.013; Kasvosve I, 2010, CLIN CHIM ACTA, V411, P1248, DOI 10.1016/j.cca.2010.04.031; Katchunga PB, 2013, DIABETES METAB SYND, V7, P112, DOI 10.1016/j.dsx.2013.02.017; Masaisa F, 2012, ANN HEMATOL, V91, P911, DOI 10.1007/s00277-011-1400-3; Mayr R, 2010, J HEPATOL, V53, P941, DOI 10.1016/j.jhep.2010.05.016; Mohas M, 2010, EXP CLIN ENDOCR DIAB, V118, P209, DOI 10.1055/s-0029-1238319; Monnier Vincent M, 2006, Biochem J, V399, pe11; Mosca L, 2011, CLIN CHEM LAB MED, V49, P803, DOI 10.1515/CCLM.2011.133; Nekhai S, 2013, HAEMATOLOGICA, V98, P455, DOI 10.3324/haematol.2012.066530; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003; Rajpathak SN, 2009, BBA-GEN SUBJECTS, V1790, P671, DOI 10.1016/j.bbagen.2008.04.005; River CA, 2007, BLOOD CELL MOL DIS, V38, P247, DOI 10.1016/j.bcmd.2006.12.002; Rose PP, 2007, ONCOGENE, V26, P1995, DOI 10.1038/sj.onc.1210006; Schulz TF, 2000, J ANTIMICROB CHEMOTH, V45, P15, DOI 10.1093/jac/45.suppl_4.15; Schwager J., 2015, MOL NUTR FOOD RES, P1; Simonart T, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-1; SMITHIES O, 1957, NATURE, V180, P1482, DOI 10.1038/1801482a0; Smithies O., 1959, GENETIC CONTROL TRAN; Sobngwi E, 2008, JAMA-J AM MED ASSOC, V299, P2770, DOI 10.1001/jama.299.23.2770; Sun QM, 2003, J BIOL CHEM, V278, P52437, DOI 10.1074/jbc.M304199200; Szwergold BS, 2001, DIABETES, V50, P2139, DOI 10.2337/diabetes.50.9.2139; Weissmann A, 2000, J EUR ACAD DERMATOL, V14, P91, DOI 10.1046/j.1468-3083.2000.00022.x; ZIEGLER JL, 1993, LANCET, V342, P1348, DOI 10.1016/0140-6736(93)92252-O	50	3	3	0	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0001-706X	1873-6254		ACTA TROP	Acta Trop.	NOV	2016	163						14	19		10.1016/j.actatropica.2016.07.011				6	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DW3FO	WOS:000383527700004	27461879				2019-04-02	
J	Kerkhof, K; Sluydts, V; Heng, S; Kim, S; Pareyn, M; Willen, L; Canier, L; Sovannaroth, S; Menard, D; Sochantha, T; Coosemans, M; Durnez, L				Kerkhof, Karen; Sluydts, Vincent; Heng, Somony; Kim, Saorin; Pareyn, Myrthe; Willen, Laura; Canier, Lydie; Sovannaroth, Siv; Menard, Didier; Sochantha, Tho; Coosemans, Marc; Durnez, Lies			Geographical patterns of malaria transmission based on serological markers for falciparum and vivax malaria in Ratanakiri, Cambodia	MALARIA JOURNAL			English	Article						Malaria; Serological markers; Geographical patterns; Malaria pockets; Heterogeneous transmission; Cambodia	RANDOMIZED CONTROLLED-TRIAL; THAILAND-MYANMAR BORDER; PLASMODIUM-FALCIPARUM; RISK-FACTORS; CLINICAL MALARIA; EPIDEMIOLOGY; ELIMINATION; INFECTIONS; AREAS; HOTSPOTS	Background: Malaria transmission is highly heterogeneous, especially in low endemic countries, such as Cambodia. This results in geographical clusters of residual transmission in the dry, low transmission season, which can fuel the transmission to wider areas or populations during the wet season. A better understanding of spatial clustering of malaria can lead to a more efficient, targeted strategy to reduce malaria transmission. This study aims to evaluate the potential of the use of serological markers to define spatial patterns in malaria exposure. Methods: Blood samples collected in a community-based randomized trial performed in 98 high endemic communities in Ratanakiri province, north-eastern Cambodia, were screened with a multiplex serological assay for five serological markers (three Plasmodium falciparum and two Plasmodium vivax). The antibody half-lives range from approximately six months until more than two years. Geographical heterogeneity in malaria transmission was examined using a spatial scan statistic on serology, PCR prevalence and malaria incidence rate data. Furthermore, to identify behavioural patterns or intrinsic factors associated with malaria exposure (antibody levels), risk factor analyses were performed by using multivariable random effect logistic regression models. The serological outcomes were then compared to PCR prevalence and malaria incidence data. Results: A total of 6502 samples from two surveys were screened in an area where the average parasite prevalence estimated by PCR among the selected villages is 3.4 %. High-risk malaria pockets were observed adjacent to the 'Tonle San River' and neighbouring Vietnam for all three sets of data (serology, PCR prevalence and malaria incidence rates). The main risk factors for all P. falciparum antigens and P. vivax MSP1.19 are age, ethnicity and staying overnight at the plot hut. Conclusion: It is possible to identify similar malaria pockets of higher malaria transmission together with the potential risk factors by using serology instead of PCR prevalence or malaria incidence data. In north-eastern Cambodia, the serological markers show that malaria transmission occurs mainly in adults staying overnight in plot huts in the field. Pf.GLURP.R2 showed a shrinking pocket of malaria transmission over time, and Pf.MSP1.19, CSP, PvAMA1 were also informative for current infection to a lesser extent. Therefore, serology could contribute in future research. However, further in-depth research in selecting the best combination of antigens is required.	[Kerkhof, Karen; Sluydts, Vincent; Pareyn, Myrthe; Willen, Laura; Coosemans, Marc; Durnez, Lies] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Kerkhof, Karen; Pareyn, Myrthe; Coosemans, Marc] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Sluydts, Vincent] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Heng, Somony; Sovannaroth, Siv; Sochantha, Tho] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Kim, Saorin; Canier, Lydie; Menard, Didier] Inst Pasteur Cambodge, Mol Epidemiol Unit, Phnom Penh, Cambodia	Kerkhof, K (reprint author), Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium.	kkerkhof@itg.be	Willen, Laura/B-2977-2018; Menard, Didier/O-3294-2013	Willen, Laura/0000-0002-8027-8621; Kerkhof, Karen/0000-0002-2208-9902; Menard, Didier/0000-0003-1357-4495	Bill & Melinda Gates Foundation under the Global Health Grant [OPP1032354]; association of Les Amis des Instituts Pasteur a Bruxelles	This work is part of a larger project "MalaResT" funded by the Bill & Melinda Gates Foundation under the Global Health Grant number OPP1032354. This project aims to evaluate the effectiveness of topical repellents, in addition to long-lasting insecticidal nets, on malaria prevalence and incidence. Next, this work fits within the large-scale research project for the SOFI research program "MalaSpot" entitled 'Eco-epidemiology of asymptomatic malaria hotspots, a prerequisite for malaria elimination?'. Furthermore, KK was supported by the association of Les Amis des Instituts Pasteur a Bruxelles.	Aamodt Geir, 2006, Int J Health Geogr, V5, P15, DOI 10.1186/1476-072X-5-15; Bates D, 2015, J STAT SOFTW, V67, P1; Bejon P, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000304; Bousema T, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-36; Bousema T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001165; Bousema T, 2010, J INFECT DIS, V201, P1764, DOI 10.1086/652456; Bousema T, 2010, EMERG INFECT DIS, V16, P392, DOI 10.3201/eid1603.090732; Brooker S, 2004, TROP MED INT HEALTH, V9, P757, DOI 10.1111/j.1365-3156.2004.01272.x; Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405; Chen J, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-57; Cook J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-86; Cui LW, 2012, ACTA TROP, V121, P240, DOI 10.1016/j.actatropica.2011.04.006; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Ernst KC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-78; Fox J, 2011, R COMPANION APPL REG; Gamage-Mendis AC, 2010, AM J TROP MED HYG, V82, P185; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Gryseels C, 2015, AM J TROP MED HYG, V93, P810, DOI 10.4269/ajtmh.15-0259; Gryseels C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0689-0; Guyant P, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0773-5; Heng T, 2015, J STAT SOFTW, V5, P1; Hsiang MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029550; Hviid L, 2015, TRENDS PARASITOL, V31, P89, DOI 10.1016/j.pt.2014.12.009; Imwong M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0906-x; Incardona S, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-37; Kangoye DT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1260-3; Kerkhof K, 2016, MALAR J; Kerkhof K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0868-z; Khaireh BA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-395; Kleinman K, 2016, RSATSCAN TOOLS CLASS; Kulldorf M, 2015, SATSCAN SOFTWARE SPA; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kumar S, 2015, PROTOPLASMA, V252, P717, DOI 10.1007/s00709-014-0697-x; Kuznetsova A., 2016, LMERTEST TESTS LINEA; Lynch CA, 2016, AM J TROP MED HYG, V94, P1251, DOI 10.4269/ajtmh.15-0653; Maude RJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-385; Ministry of Health, 2016, CAMB MAL EL ACT FRAM; Mosha JF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-53; Mosha JF, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-221; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0712-5; R Core Team, 2015, R LANG ENV STAT COMP; Rosas-Aguirre A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137458; Sluydts V, 2016, LANCET INFECT DIS, V16, P1169, DOI 10.1016/S1473-3099(16)30148-7; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Souza-Silva FA, 2010, AM J TROP MED HYG, V185, P193; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Venabled W, 2002, MODERN APPL STAT S; WHO, 2015, STRAT MAL EL GREAT M; World Health Organization, 2015, WORLD MAL REP 2015; World Health Organization (WHO), 2010, MAL GREAT MEK SUBR R	50	6	6	1	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 19	2016	15								510	10.1186/s12936-016-1558-1				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DZ5CX	WOS:000385880700001	27756395	DOAJ Gold, Green Published			2019-04-02	
J	Abduselam, N; Zeynudin, A; Berens-Riha, N; Seyoum, D; Pritsch, M; Tibebu, H; Eba, K; Hoelscher, M; Wieser, A; Yewhalaw, D				Abduselam, Nuredin; Zeynudin, Ahmed; Berens-Riha, Nicole; Seyoum, Dinberu; Pritsch, Michael; Tibebu, Habtewold; Eba, Kasahun; Hoelscher, Michael; Wieser, Andreas; Yewhalaw, Delenasaw			Similar trends of susceptibility in Anopheles arabiensis and Anopheles pharoensis to Plasmodium vivax infection in Ethiopia	PARASITES & VECTORS			English	Article						Experimental infection; Anopheles arabiensis; Anopheles pharoensis; Anopheles coustani; Plasmodium vivax; Direct membrane feeding assay; Malaria	SOUTH-CENTRAL ETHIOPIA; GAMBIAE COMPLEX; MALARIA TRANSMISSION; FALCIPARUM-MALARIA; INOCULATION RATES; POPULATION; MOSQUITOS; AREA; PREVALENCE; DYNAMICS	Background: Around half of the global population is living in areas at risk of malaria infection. Plasmodium vivax malaria has become increasingly prevalent and responsible for a high health and socio-economic burden in Ethiopia. The availability of gametocyte carriers and mosquito species susceptible to P. vivax infection are vital for malaria transmission. Determining the susceptibility of vector species to parasite infection in space and time is important in vector control programs. This study assesses the susceptibility of Anopheles arabiensis, An. pharoensis and An. coustani group to Plasmodium vivax infection in Ethiopia. Methods: Larvae of An. arabiensis, An. pharoensis and An. coustani group were collected from an array of breeding sites and reared to adult under controlled conditions. Batches of adult female mosquitoes of the three species were allowed to feed in parallel on the same infected blood with gametocytes drawn from Plasmodium vivax infected patients by Direct Membrane Feeding Assays (DMFA). Fed mosquitoes were kept in an incubator under controlled laboratory conditions. Seven days after each feeding assay, mosquitoes were dissected for midgut oocyst microscopy and enumeration. Data were analysed using R statistical software package version 3.1.0. Results: Over all, 8,139 adult female mosquitoes were exposed to P. vivax infection. Of the exposed mosquitoes 16. 64 % (95 % CI: 1,354-8,139) were properly fed and survived until dissection. The infection rate in An. arabiensis and An. pharoensis was 31.72 % (95 % CI: 28.35-35.08) and 28.80 % (95 % CI: 25.31-32.28), respectively. The intensity of infection for An. arabiensis and An. pharoensis was 2.5 (95 % CI: 1.9-3.2) and 1.4 (95 % CI: 1.1-1.8), respectively. Gametocyte density was positively correlated to infection rate and intensity of infection in An. arabiensis as well as An. pharoensis. No An. coustani group mosquitoes were found infected, though almost four hundred mosquitoes were successfully fed and dissected. All groups received blood from the same infected blood source containing gametocytes in parallel. There was no significant difference in susceptibility rates between An. arabiensis and An. pharoensis (P = 0.215). Conclusions: Anopheles arabiensis and An. pharoensis showed similar susceptibility to P. vivax infection. However, An. coustani group was not permissive for the development of P. vivax parasites.	[Abduselam, Nuredin; Zeynudin, Ahmed; Yewhalaw, Delenasaw] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Zeynudin, Ahmed; Pritsch, Michael; Wieser, Andreas] Max von Pettenkofer Inst LMU, Dept Bacteriol, Munich, Germany; [Berens-Riha, Nicole; Pritsch, Michael; Hoelscher, Michael; Wieser, Andreas] Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany; [Seyoum, Dinberu] Jimma Univ, Dept Stat, Coll Nat Sci, Jimma, Ethiopia; [Pritsch, Michael; Hoelscher, Michael; Wieser, Andreas] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany; [Tibebu, Habtewold] Imperial Coll London, Div Cell & Mol Biol, Dept Life Sci, London, England; [Eba, Kasahun; Yewhalaw, Delenasaw] Jimma Univ, Trop & Infect Dis Res Ctr, Jimma, Ethiopia; [Seyoum, Dinberu] Catholic Univ Louvain, Inst Hlth & Soc IRSS, Brussels, Belgium	Wieser, A (reprint author), Max von Pettenkofer Inst LMU, Dept Bacteriol, Munich, Germany.; Wieser, A (reprint author), Univ Munich LMU, Div Infect Dis & Trop Med, Med Ctr, Munich, Germany.; Wieser, A (reprint author), German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany.	wieser@mvp.uni-muenchen.de	Hoelscher, Michael/D-3436-2012		Jimma University; German Center for Infection Research (DZIF); Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU); German Center for Infection Research	The study was partly funded by Jimma University funds allocated to NA, as well as by funds given by the German Center for Infection Research (DZIF), partner site Munich given to AW as well as by funds of the Division of Infectious Diseases and Tropical Medicine, Medical Center of the University of Munich (LMU) given to AW, MP and MH. This study was supported by Clinical Leave Scholarships from the German Center for Infection Research (to MP and AW).	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Animut A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-76; Animut A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-117; Bayoh NM, 2010, MALARIA J, V9, P62; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; Bousema T, 2011, INT J PARASITOL, V41, P293, DOI 10.1016/j.ijpara.2010.09.908; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; Degefa T, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0532-z; Derua YA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-188; Federal Democratic Ethiopia MoH, 2014, NAT MAL STRAT PLAN 2; Federal Democratic Ethiopia MoH, 2006, NAT 5 YEAR STRAT PLA; Federal Democratic Ethiopia MoH, 2012, ETH NAT MAL IND SURV; Fornadel CM, 2010, AM J TROP MED HYG, V83, P838, DOI 10.4269/ajtmh.2010.10-0088; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Gerberg EJ, 1970, AM MOSQ CONTROL ASS, V5, P109; Gillies MT, 1987, JOHANNESBURG S AFR I, V55, P1; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hunt RH, 1998, T ROY SOC TROP MED H, V92, P231, DOI 10.1016/S0035-9203(98)90761-1; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kibret S, 2010, TROP MED INT HEALTH, V15, P41, DOI 10.1111/j.1365-3156.2009.02423.x; KRAFSUR ES, 1978, T ROY SOC TROP MED H, V72, P348, DOI 10.1016/0035-9203(78)90125-6; Lensen A, 1996, T ROY SOC TROP MED H, V90, P20, DOI 10.1016/S0035-9203(96)90464-2; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Massebo F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-44; Meyrowitsch DW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-188; Mwangangi JM, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-114; Mwangangi JM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-13; Nyanjom SRG, 2003, J HERED, V94, P457, DOI 10.1093/jhered/esg100; PONNUDURAI T, 1991, T ROY SOC TROP MED H, V85, P175, DOI 10.1016/0035-9203(91)90012-N; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; Reddy MR, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-184; Rios-Velasquez CM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-460; Sinden R, 2007, METHODS MOL MED, V72, P25; Snow Robert W., 2002, ESSENTIAL MALARIOLOG, P85; Stone WJR, 2013, SCI REP-UK, V3, DOI 10.1038/srep03418; Vaughan JA, 2007, TRENDS PARASITOL, V23, P63, DOI 10.1016/j.pt.2006.12.009; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; WHITE GB, 1972, B ENTOMOL RES, V62, P295, DOI 10.1017/S0007485300047738; WHITE GB, 1980, T ROY SOC TROP MED H, V74, P683; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2015, WORLD MALARIA REPORT; WHO, 2015, CONTR EL PLASM VIV; Woyessa A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-84; Yewhalaw D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-21; Zhu GD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-176	47	1	1	0	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 18	2016	9								552	10.1186/s13071-016-1839-0				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DZ5DZ	WOS:000385883500003	27756355	DOAJ Gold, Green Published			2019-04-02	
J	Lempereur, L; Martinelle, L; Marechal, F; Bayrou, C; Dalemans, AC; Schnyder, M; Losson, B				Lempereur, Laetitia; Martinelle, Ludovic; Marechal, Francoise; Bayrou, Calixte; Dalemans, Anne Catherine; Schnyder, Manuela; Losson, Bertrand			Prevalence of Angiostrongylus vasorum in southern Belgium, a coprological and serological survey	PARASITES & VECTORS			English	Article						Angiostrongylus vasorum; Crenosoma vulpis; Serology; Coprology; Dog; Belgium	CANINE ANGIOSTRONGYLOSIS; SEROEPIDEMIOLOGICAL SURVEY; CRENOSOMA-VULPIS; INFECTED-DOGS; ANTIGEN; ANTIBODIES; HEARTWORM; GERMANY; EUROPE	Background: Canine angiostrongylosis, a gastropod-borne helminthic infection, is increasingly being described in North America and is now reported in many European countries. In dogs, Angiostrongylus vasorum may cause a wide spectrum of clinical signs. Respiratory distress such as coughing and dyspnoea are the most frequently described manifestations. The aim of the present study was to gain additional information on the distribution, prevalence and risk factors associated with A. vasorum infection in dog from southern Belgium through the combined used of a commercially available in-clinic assay for detection of circulating antigen (Angio Detect (TM), IDEXX, Westbrook, USA) and coprology in two different canine populations: dogs with clinical signs compatible with angiostrongylosis and asymptomatic dogs or dogs presented for unrelated conditions (control). Results: A total of 979 dogs were enrolled in the study from November 2014 until February 2016. Seven hundred fiftyseven dogs were included in the control group, whereas 222 dogs had clinical signs compatible with angiostrongylosis. Forty-six dogs out of 979 (4.7 %) had A. vasorum circulating antigen. There was a highly significant difference between the two populations (3.6 % (27/747) and 8.6 % (19/222) in control and symptomatic dogs, respectively) (P = 0.00379). First stage larvae (L1) of A. vasorum were found in seven out of 24 serologically positive control dogs and in six out of 17 serologically positive symptomatic dogs. Interestingly, L1 of Crenosoma vulpis were detected by Baermann technique in one control and nine symptomatic dogs, respectively. Out of 17 Angio Detect (TM) (IDEXX, Westbrook, USA) positive dogs with negative (14) or not performed Baermann test (three), one dog was positive in both in-house ELISAs (Ag and Ab) and one dog was positive for Ag. Statistical analysis was unable to detect any risk factors associated with the direct and/or indirect detection of A. vasorum. Conclusions: This seroepidemiological study demonstrated for the first time a high seroprevalence in Southern Belgium for A. vasorum. The Angio Detect (TM) was found to be suitable in this context as the collection, preservation and examination of stools were difficult. Nevertheless, discrepancies were observed between the different available tests. Additional research is clearly needed. Also, coproscopy remains a very useful tool in dogs infected for less than nine weeks and for the identification of other canine lung nematodes such as C. vulpis. This study also demonstrates that asymptomatic dogs may shed A. vasorum L1 in their faeces and therefore contribute to the maintenance of A. vasorum life-cycle.	[Lempereur, Laetitia; Marechal, Francoise; Losson, Bertrand] Univ Liege, Lab Parasitol & Parasit Dis, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Fac Vet Med, Liege, Belgium; [Martinelle, Ludovic] Univ Liege, Expt Stn CARE FePex, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Fac Vet Med, Liege, Belgium; [Bayrou, Calixte] Univ Liege, Pathol Unit, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Fac Vet Med, Liege, Belgium; [Dalemans, Anne Catherine] Bayer Anim Hlth Benelux, Diegem, Belgium; [Schnyder, Manuela] Univ Zurich, Vetsuisse Fac, Inst Parasitol, Zurich, Switzerland	Lempereur, L (reprint author), Univ Liege, Lab Parasitol & Parasit Dis, Ctr Fundamental & Appl Res Anim & Hlth FARAH, Fac Vet Med, Liege, Belgium.	llempereur@ulg.ac.be	Schnyder, Manuela/J-3188-2015	Schnyder, Manuela/0000-0002-6523-7952	Bayer Animal Health; IDEXX Laboratories	This study was performed with the financial support of Bayer Animal Health and IDEXX Laboratories.	Alho AM, 2016, PARASITOL RES, V115, P2567, DOI 10.1007/s00436-016-5001-x; Barutzki D, 2003, PARASITOL RES, V90, pS148, DOI 10.1007/s00436-003-0922-6; Barutzki D, 2009, PARASITOL RES, V105, pS39, DOI 10.1007/s00436-009-1494-x; Blehaut TRW, 2014, VET REC, V175, P148, DOI 10.1136/vr.102186; BOLT G, 1994, VET REC, V135, P447, DOI 10.1136/vr.135.19.447; Canonne AM, 2016, J SMALL ANIM PRACT, V57, P130, DOI 10.1111/jsap.12419; Caron Y., 2014, VET RECORD CASE REPO, V2, P1; Chapman PS, 2004, J SMALL ANIM PRACT, V45, P435, DOI 10.1111/j.1748-5827.2004.tb00261.x; Colella V, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1440-6; Conboy GA, 2011, VET PARASITOL, V176, P382, DOI 10.1016/j.vetpar.2011.01.025; Di Cesare A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1047-3; Drake J, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0698-4; ESCCAP, 2010, WORM CONTR DOGS CATS; Ferdushy T, 2009, J HELMINTHOL, V83, P379, DOI 10.1017/S0022149X09377706; Guardone L, 2013, VET PARASITOL, V192, P192, DOI 10.1016/j.vetpar.2012.10.016; GUILHON J, 1973, Annales de Parasitologie Humaine et Comparee, V48, P567; Helm JR, 2010, J VET EMERG CRIT CAR, V20, P98, DOI 10.1111/j.1476-4431.2009.00494.x; Jolly S, 2015, PARASITOL INT, V64, P97, DOI 10.1016/j.parint.2014.10.008; Koch J, 2009, VET J, V179, P348, DOI 10.1016/j.tvjl.2007.11.014; Little SE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0710-z; Lurati L, 2015, VET PARASITOL, V212, P219, DOI 10.1016/j.vetpar.2015.08.017; McGarry JW, 2009, VET REC, V165, P258, DOI 10.1136/vr.165.9.258; Morgan ER, 2010, VET PARASITOL, V173, P255, DOI 10.1016/j.vetpar.2010.06.037; Morgan ER, 2009, PARASITOL INT, V58, P406, DOI 10.1016/j.parint.2009.08.003; Oliveira SD, 2006, VET PARASITOL, V141, P101, DOI 10.1016/j.vetpar.2006.05.003; Sarre C, 2015, VLAAMS DIERGEN TIJDS, V84, P243; Schnyder M, 2015, PARASITOLOGY, V142, P1270, DOI 10.1017/S0031182015000554; Schnyder M, 2013, PARASITOLOGY, V140, P1442, DOI 10.1017/S0031182013001091; Schnyder M, 2011, VET PARASITOL, V179, P152, DOI 10.1016/j.vetpar.2011.01.054; Schnyder M, 2015, PARASITOL RES, V114, pS145, DOI 10.1007/s00436-015-4520-1; Schnyder M, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-72; Schnyder M, 2013, PARASITOL RES, V112, P109, DOI 10.1007/s00436-013-3285-7; Schucan A, 2012, VET PARASITOL, V185, P216, DOI 10.1016/j.vetpar.2011.09.040; Serres E, 1854, J VET MIDI, V7, P70; Tolnai Z, 2015, VET PARASITOL, V207, P355, DOI 10.1016/j.vetpar.2014.12.008; Traversa D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-62	36	7	7	2	8	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	OCT 6	2016	9								533	10.1186/s13071-016-1820-y				7	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DY1IB	WOS:000384847000002	27716374	DOAJ Gold, Green Published			2019-04-02	
J	Grandesso, F; Nabasumba, C; Nyehangane, D; Page, AL; Bastard, M; De Smet, M; Boum, Y; Etard, JF				Grandesso, Francesco; Nabasumba, Carolyn; Nyehangane, Dan; Page, Anne-Laure; Bastard, Mathieu; De Smet, Martin; Boum, Yap; Etard, Jean-Francois			Performance and time to become negative after treatment of three malaria rapid diagnostic tests in low and high malaria transmission settings	MALARIA JOURNAL			English	Article						Malaria; Fever; Diagnostic; Rapid diagnostic test; Sensitivity; Specificity; Performance; Negativity	UNCOMPLICATED FALCIPARUM-MALARIA; LACTATE-DEHYDROGENASE; CHILDREN; TANZANIA; AREA; INFECTIONS; PFHRP2; FEVER; BLOOD; ASSAY	Background: The performance of different malaria rapid diagnostic tests (RDT) may be influenced by transmission intensity and by the length of time each test requires to become negative after treatment and patient's recovery. Methods: Results of three RDTs (two HRP2 and one pLDH antigen-based tests) were compared to blood smear microscopy (the gold standard method) in children under 5 years of age living in a high versus low malaria intensity setting in southwestern Uganda. In each setting, 212 children, who tested positive by at least one RDT and by microscopy, were treated with artemether-lumefantrine. RDTs and microscopy were then repeated at fixed intervals to estimate each test's time to negativity after treatment and patient recovery. Results: In the two settings, sensitivities ranged from 98.4 to 99.2 % for the HRP2 tests and 94.7 to 96.1 % for the pLDH test. Specificities were 98.9 and 98.8 % for the HRP2 tests and 99.7 % for the pLDH test in the low-transmission setting and 79.7, 80.7 and 93.9 %, respectively, in the high-transmission setting. Median time to become negative was 35-42 or more days for the HRP2 tests and 2 days for the pLDH test. Conclusions: High transmission contexts and a long time to become negative resulted in considerably reduced specificities for the HRP2 tests. Choice of RDT for low-versus high-transmission settings should balance risks and benefits of over-treatment versus missing malaria cases.	[Grandesso, Francesco; Page, Anne-Laure; Bastard, Mathieu; Etard, Jean-Francois] Epicentre, 8 Rue Saint Sabin, Paris, France; [Nabasumba, Carolyn; Nyehangane, Dan; Boum, Yap] Epicentre, Mbarara Res Ctr, Mbarara, Uganda; [De Smet, Martin] Med Sans Frontieres, Brussels, Belgium; [Boum, Yap] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Etard, Jean-Francois] Univ Montpellier I, UMI TransVIHMI 233, Inst Rech Dev, F-34000 Montpellier, France	Grandesso, F (reprint author), Epicentre, 8 Rue Saint Sabin, Paris, France.	francesco.GRANDESSO@epicentre.msf.org		Grandesso, Francesco/0000-0001-9909-0285	MSF International through the International Innovation Fund; MSF Operational Centre Paris	This study was sponsored by MSF International through the International Innovation Fund and by MSF Operational Centre Paris.	[Anonymous], 2013, WHO FIND CDC TDR MAL; [Anonymous], 2011, WHO FIND CDC TDR MAL; Baiden F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034073; De Beaudrap P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-132; Desakorn V, 1997, T ROY SOC TROP MED H, V91, P479, DOI 10.1016/S0035-9203(97)90292-3; Gerstl S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-28; Hawkes M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-43; Houze S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-211; Laurent A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-294; Mahende C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1450-z; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; Moody A, 2000, BRIT J HAEMATOL, V109, P891, DOI 10.1046/j.1365-2141.2000.01974.x; Murray CK, 2008, CLIN MICROBIOL REV, V21, P97, DOI 10.1128/CMR.00035-07; Njama-Meya D, 2013, 6 MIM PAN AFR MAL C; Nyunt MH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-123; ODEMPSEY TJD, 1993, T ROY SOC TROP MED H, V87, P662, DOI 10.1016/0035-9203(93)90279-Y; Oduola AMJ, 1997, EXP PARASITOL, V87, P283, DOI 10.1006/expr.1997.4251; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Olaleye BO, 1998, T ROY SOC TROP MED H, V92, P300, DOI 10.1016/S0035-9203(98)91021-5; ROOTH I, 1992, T ROY SOC TROP MED H, V86, P479, DOI 10.1016/0035-9203(92)90076-O; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; WHO, 2009, WORLD MALARIA REPORT	23	16	16	1	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	OCT 4	2016	15								496	10.1186/s12936-016-1529-6				12	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DY1HU	WOS:000384846300001	27716244	DOAJ Gold, Green Published			2019-04-02	
J	Altare, C; Delbiso, TD; Mutwiri, GM; Kopplow, R; Guha-Sapir, D				Altare, Chiara; Delbiso, Tefera Darge; Mutwiri, George Mutembei; Kopplow, Regine; Guha-Sapir, Debarati			Factors Associated with Stunting among Pre-school Children in Southern Highlands of Tanzania	JOURNAL OF TROPICAL PEDIATRICS			English	Article						stunting; growth; maternal support; child care; diet diversity; Tanzania	DEVELOPING-COUNTRIES; DEVELOPED-COUNTRIES; EARLY-CHILDHOOD; UNDERNUTRITION; GROWTH; INTERVENTIONS; CONSEQUENCES; METAANALYSIS; ADOLESCENTS; OVERWEIGHT	Methods: A cross-sectional two-stage cluster sampling survey was conducted among children aged 6-59 months. The sample included 1360 children aged 6-23 months and 1904 children aged 24-59 months. Descriptive statistics and binary and multivariate logistic regression analyses were used. Results: Our main results are: in the younger group, stunting was associated with male sex (adjusted odds ratio [AOR]: 2.17; confidence interval [CI]: 1.52-3.09), maternal absence (AOR: 1.93; CI: 1.21-3.07) and household diet diversity (AOR: 0.61; CI: 0.41-0.92). Among older children, stunting was associated with male sex (AOR: 1.28; CI: 1.00-1.64), age of 4 and 5 (AOR: 0.71; CI: 0.54-0.95; AOR: 0.60; CI: 0.44-0.83), access to improved water source (AOR: 0.70; CI: 0.52-0.93) and to a functioning water station (AOR: 0.63; CI: 0.40-0.98) and mother breastfeeding (AOR: 1.97; CI: 1.18-3.29). Conclusions: Interventions that increase household wealth and improve water and sanitation conditions should be implemented to reduce stunting. Family planning activities and programmes supporting mothers during pregnancy and lactation can positively affect both newborns and older siblings.	[Altare, Chiara; Delbiso, Tefera Darge; Guha-Sapir, Debarati] Catholic Univ Louvain, Ctr Res Epidemiol Disasters, Clos Chapelle Aux Champs 30,Bte B1-30-15, B-1200 Brussels, Belgium; [Altare, Chiara] Act Faim, Res & Anal Unit, 14-16 Blvd Douaumont, F-75854 Paris, France; [Mutwiri, George Mutembei] Concern Worldwide Tanzania, 169 Regent Estate, Dar Es Salaam, Tanzania; [Kopplow, Regine] Concern Worldwide, 52-55 Camden St, Dublin 2, Ireland	Altare, C (reprint author), Clos Chapelle Aux Champs 30,Bte B1-30-15, B-1200 Brussels, Belgium.	chiara.altare@uclouvain.be			Irish Aid; UNICEF; Concern Worldwide; Fond National de Recherche Scientifique [PDR 14692731]; Universite catholique de Louvain; Association pour l'epidemiologie des desastres	This work was supported by Irish Aid, UNICEF, Concern Worldwide, Fond National de Recherche Scientifique (PDR 14692731), Universite catholique de Louvain and Association pour l'epidemiologie des desastres.	Abubakar A, 2012, INT J ENV RES PUB HE, V9, P3506, DOI 10.3390/ijerph9103506; Action Contre la Faim International, 2012, EM NUTR ASS STAND MO; Adair L, 2013, LANCET; Arimond M, 2004, J NUTR, V134, P2579; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Dror DK, 2014, NUTR REV, V72, P68, DOI 10.1111/nure.12078; Fewtrell L, 2005, LANCET INFECT DIS, V5, P42, DOI 10.1016/S1473-3099(04)01253-8; Fink G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102391; Greene M, 2005, INVOLVING MEN REPROD; Hoddinott J, 2013, AM J CLIN NUTR, V98, P1170, DOI 10.3945/ajcn.113.064584; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Jones AD, 2014, MATERN CHILD NUTR, V10, P1, DOI 10.1111/mcn.12070; Keino S, 2014, FOOD NUTR BULL, V35, P167, DOI 10.1177/156482651403500203; Kennedy G, 2010, GUIDELINES MEASURING; Mamiro PS, 2005, J HEALTH POPUL NUTR, V23, P222; Marriott BP, 2012, MATERN CHILD NUTR, V8, P354, DOI 10.1111/j.1740-8709.2011.00380.x; Martorell R, 2012, ADV NUTR, V3, P227, DOI 10.3945/an.111.001107; Masanja H, 2005, HEALTH POLICY PLANN, V20, pI77, DOI 10.1093/heapol/czi054; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; McDonald CM, 2013, J NUTR, V143, P204, DOI 10.3945/jn.112.168682; Mussa R, 2014, HEALTH ECON REV, V4, DOI 10.1186/s13561-014-0011-9; Onyango AW, 2014, PUBLIC HEALTH NUTR, V17, P1975, DOI 10.1017/S1368980013002401; Petrou S, 2010, SOC SCI MED, V71, P1366, DOI 10.1016/j.socscimed.2010.06.038; Prendergast AJ, 2014, PAEDIAT INT CHILD HL; Sania A, 2014, MATERN CHILD NUTR; Shrimpton R, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.5.e75; Smith LC, 2002, ECON DEV CULT CHANGE, V51, P55, DOI 10.1086/345313; Sphere Project, 2011, HUM CHART MIN STAND; Stewart CP, 2013, MATERN CHILD NUTR, V9, P27, DOI 10.1111/mcn.12088; Tanzania Commission for AIDS Zanzibar AIDS Commission National Bureau of Statistics Office of the Chief Government Statistician ICF International, 2013, TANZ HIV AIDS MAL IN; The SMART Project, 2006, MEAS MORT NUTR FOOD; UNICEF, 2012, LOOK MBEYA CIT CIT C; United Nations Children's Fund, 1990, STRAT IMPR NUTR CHIL; United Nations Children's Fund World Health Organization World Bank, 2013, JOINT CHILD MALN EST; United Republic of Tanzania, 2014, TANZ NAT NUTR SURV 2; United Republic of Tanzania, 2010, TANZ DEM HLTH SURV; United Republic of Tanzania, 2012, POP HOUS CENS; Ververs M, 2013, PLOS CURR; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Walker SP, 2011, LANCET, V378, P1325, DOI 10.1016/S0140-6736(11)60555-2; Wamani Henry, 2007, BMC Pediatr, V7, P17, DOI 10.1186/1471-2431-7-17; WHO, 2006, WHO ANTHR 2005 PERS	44	5	5	3	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0142-6338	1465-3664		J TROP PEDIATRICS	J. Trop. Pediatr.	OCT	2016	62	5					390	408		10.1093/tropej/fmw024				19	Pediatrics; Tropical Medicine	Pediatrics; Tropical Medicine	EC1YE	WOS:000387904500007	27122480	Bronze, Green Published			2019-04-02	
J	Belaid, L; Dumont, A; Chaillet, N; Zertal, A; De Brouwere, V; Hounton, S; Ridde, V				Belaid, L.; Dumont, A.; Chaillet, N.; Zertal, A.; De Brouwere, V.; Hounton, S.; Ridde, V.			Effectiveness of demand generation interventions on use of modern contraceptives in low- and middle-income countries	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Review						Systematic review; low- and middle-income countries; family planning; demand intervention; effectiveness; costs; contraception	FAMILY-PLANNING PROGRAMS; COMPLEX INTERVENTIONS; SERVICE DELIVERY; POOR WOMEN; HEALTH; VOUCHERS; TRIAL; CARE; EDUCATION; BEHAVIOR	OBJECTIVES To synthesise evidence on the implementation, costs and cost-effectiveness of demand generation interventions and their effectiveness in improving uptake of modern contraception methods. METHODS A Cochrane systematic review was conducted. Searches were performed in electronic databases (MEDLINE, EMBASE) and the grey literature. Randomised controlled trials, cluster randomised trials and quasi-experimental studies, including controlled before-after studies (CBAs) and cost and cost-effectiveness studies that aimed to assess demand interventions (including community-and facility-based interventions, financial mechanisms and mass media campaigns) in low-and middle-income countries were considered. Meta-analyses and narrative synthesis were conducted. RESULTS In total, 20 papers meeting the inclusion criteria were included in this review. Of those, 13 were used for meta-analysis. Few data were available on implementation and on the influence of context on demand interventions. Involving family members during counselling, providing education activities and increasing exposure to those activities could enhance the success of demand interventions. Demand generation interventions were positively associated with increases in current use (pooled OR 1.57; 95% CI: 1.46-1.69, P < 0.01). Financial mechanism interventions (vouchers) appeared effective to increase use of modern contraceptive methods (pooled OR 2.16; 95% CI: 1.91-2.45, P < 0.01; I-2 = 0%). Demand interventions improved knowledge (pooled OR 1.02; 95% CI 0.63-1.64, P = 0.93) and attitudes towards family planning and improved discussion with partners/husbands around modern contraceptive methods. However, given the limited number of studies included in each category of demand generation interventions, the dates of publication of the studies and their low quality, caution is advised in considering the results. Very limited evidence was available on costs; studies including data on costs were old and inconsistent. CONCLUSION Demand generation interventions contribute to increases in modern contraceptive methods use. However, more studies with robust designs are needed to identify the most effective demand generation intervention to increase uptake of modern contraceptive methods. More evidence is also needed about implementation, costs and cost-effectiveness to inform decisions on sustainability and scaling-up.	[Belaid, L.] Univ Montreal, Sch Publ Hlth ESPUM, Montreal, PQ, Canada; [Dumont, A.] Univ Paris 05, UMR IRD 216, Paris, France; [Chaillet, N.] Ctr Hosp Univ Laval, CHU Quebec, Ctr Rech, Ville De Quebec, PQ, Canada; [Zertal, A.] CHU St Justine, Montreal, PQ, Canada; [De Brouwere, V.] Inst Trop Med, Dept Publ Hlth, Antwerp, Belgium; [Hounton, S.] United Nations Populat Fund, Tech Div, New York, NY USA; [Ridde, V.] Univ Montreal, IRSPUM, ESPUM, Sch Publ Hlth, Montreal, PQ, Canada	Belaid, L (reprint author), Univ Montreal, Sch Publ Hlth, 7101 Ave Parc, Montreal, PQ H3N 1X9, Canada.	belaid.loubna@gmail.com		Ridde, Valery/0000-0001-9299-8266			Akman M, 2010, J INT MED RES, V38, P1243, DOI 10.1177/147323001003800405; Azmat SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074260; Baird SJ, 2012, LANCET, V379, P1320, DOI 10.1016/S0140-6736(11)61709-1; Barberis M, 1997, J BIOSOC SCI, V29, P219, DOI 10.1017/S0021932097002198; Belaid L, 2015, SYST REV, V4, P1; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Bertrand JT, 1982, STUD FAM PLAN, V18, P361; Chirwa Y, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-197; Cochrane IKMD, 2011, REV MAN REVMAN VERS; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Dureab F, 2013, TROP MED INT HEALTH, V18, P179; Durlak JA, 2015, PREV SCI, V16, P1123, DOI 10.1007/s11121-015-0606-3; Effective Practice Organisation of Care (EPOC)., 2015, SUGG RISK BIAS CRIT; Eva G, 2015, INT J GYNAECOL OB S3, V130, P15; FISEK NH, 1978, STUD FAMILY PLANN, V9, P280, DOI 10.2307/1965765; Fonner VA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089692; George AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138116; Guse K, 2012, J ADOLESCENT HEALTH, V51, P535, DOI 10.1016/j.jadohealth.2012.03.014; Hawe P, 2015, ANNU REV PUBL HEALTH, V36, P307, DOI [10.1146/annurev-publhealth-031912-114421, 10.1146/annurev-publhealth-031914-114421]; Higgins JP, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; HUBER SC, 1989, J BIOSOC SCI, V21, P267; Hurst TE, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0727-5; Ir P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-1; Ireland M, 2011, B WORLD HEALTH ORGAN, V89, P695, DOI 10.2471/BLT.11.087379; Kagesten A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138647; Kanya L, 2014, HEALTH POLICY PLANN, V29, pI4, DOI 10.1093/heapol/czt079; Katz KR, 1998, INT FAM PLAN PERSPEC, V24, P104, DOI 10.2307/3038206; Luck M, 2000, STUD FAMILY PLANN, V31, P325, DOI 10.1111/j.1728-4465.2000.00325.x; Lutalo T, 2010, STUD FAMILY PLANN, V41, P55, DOI 10.1111/j.1728-4465.2010.00224.x; Mahamed Fariba, 2012, Glob J Health Sci, V4, P110, DOI 10.5539/gjhs.v4n2p110; Murray SF, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-30; Mwaikambo L, 2011, STUD FAMILY PLANN, V42, P67, DOI 10.1111/j.1728-4465.2011.00267.x; Osotimehin B, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29978; Pazol K, 2015, AM J PREV MED, V49, pS46, DOI 10.1016/j.amepre.2015.03.031; Popay J, 2006, GUIDANCE CONDUCT NAR; Rogers EM, 1999, STUD FAMILY PLANN, V30, P193, DOI 10.1111/j.1728-4465.1999.00193.x; Saeed GA, 2008, CONTRACEPTION, V77, P377, DOI 10.1016/j.contraception.2008.01.011; Schwandt HM, 2013, CONTRACEPTION, V88, P281, DOI 10.1016/j.contraception.2013.03.008; Sebastian MP, 2012, INT PERSPECT SEX R H, V38, P68, DOI 10.1363/3806812; Shattuck D, 2011, AM J PUBLIC HEALTH, V101, P1089, DOI 10.2105/AJPH.2010.300091; Sinding SW., 2007, GLOBAL FAMILY PLANNI; Soliman M H, 1999, East Mediterr Health J, V5, P1002; STEVENS JR, 1992, STUD FAMILY PLANN, V23, P171, DOI 10.2307/1966726; TEREFE A, 1993, AM J PUBLIC HEALTH, V83, P1567, DOI 10.2105/AJPH.83.11.1567; UNFPA, 2014, DEV UNFPA PROGR GUID; Van de Poel E, 2014, B WORLD HEALTH ORGAN, V92, P331, DOI 10.2471/BLT.13.129122; Warren C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-177; Weeden D, 1986, Asia Pac Popul J, V1, P31; Wells M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-95; World Bank, 2016, DAT COUNTR LEND GROU; Zapata LB, 2015, AM J PREV MED, V49, pS31, DOI 10.1016/j.amepre.2015.03.023	52	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2016	21	10					1240	1254		10.1111/tmi.12758				15	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EB7TF	WOS:000387592800003	27465589	Other Gold			2019-04-02	
J	Lafort, Y; Greener, R; Roy, A; Greener, L; Ombidi, W; Lessitala, F; Haghparast-Bidgoli, H; Beksinska, M; Gichangi, P; Reza-Paul, S; Smit, JA; Chersich, M; Delva, W				Lafort, Yves; Greener, Ross; Roy, Anuradha; Greener, Letitia; Ombidi, Wilkister; Lessitala, Faustino; Haghparast-Bidgoli, Hassan; Beksinska, Mags; Gichangi, Peter; Reza-Paul, Sushena; Smit, Jenni A.; Chersich, Matthew; Delva, Wim			HIV prevention and care-seeking behaviour among female sex workers in four cities in India, Kenya, Mozambique and South Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						female sex workers; HIV prevention and care; care-seeking behaviour; condom use; peer education; Sub-Saharan Africa; India	SEXUALLY-TRANSMITTED INFECTIONS; REPRODUCTIVE HEALTH-SERVICES; SUB-SAHARAN AFRICA; VAGINAL PRACTICES; TETE PROVINCE; CONDOM USE; DRY SEX; INTERVENTIONS; COUNTRIES; RISK	OBJECTIVE To identify gaps in the use of HIV prevention and care services and commodities for female sex workers, we conducted a baseline cross-sectional survey in four cities, in the context of an implementation research project aiming to improve use of sexual and reproductive health services. METHODS Using respondent-driven sampling, 400 sex workers were recruited in Durban, 308 in Tete, 400 in Mombasa and 458 in Mysore and interviewed face-to-face. RDS-adjusted proportions were estimated by nonparametric bootstrapping and compared across cities using post hoc pairwise comparison. RESULTS Condom use with last client ranged from 88.3% to 96.8%, ever female condom use from 1.6% to 37.9%, HIV testing within the past 6 months from 40.5% to 70.9%, receiving HIV treatment and care from 35.5% to 92.7%, care seeking for last STI from 74.4% to 87.6% and having had at least 10 contacts with a peer educator in the past year from 5.7% to 98.1%. Many of the differences between cities remained statistically significant (P < 0.05) after adjusting for differences in FSWs' socio-demographic characteristics. CONCLUSION The use of HIV prevention and care by FSWs is often insufficient and differed greatly between cities. Differences could not be explained by variations in socio-demographic sex worker characteristics. Models to improve use of condoms and HIV prevention and care services should be tailored to the specific context of each site. Programmes at each site must focus on improving availability and uptake of those services that are currently least used.	[Lafort, Yves; Gichangi, Peter; Chersich, Matthew; Delva, Wim] Univ Ghent, Int Ctr Reprod Hlth, Ghent, Belgium; [Greener, Ross; Greener, Letitia; Beksinska, Mags; Smit, Jenni A.] Univ Witwatersrand, MatCH Res Unit, Durban, South Africa; [Roy, Anuradha] Ashodaya Samithi, Mysore, Karnataka, India; [Ombidi, Wilkister] Int Ctr Reprod Hlth Kenya, Mombasa, Kenya; [Lessitala, Faustino] Int Ctr Reprod Hlth Mozambique, Maputo, Mozambique; [Haghparast-Bidgoli, Hassan] UCL, Inst Global Hlth, London, England; [Gichangi, Peter] Univ Nairobi, Nairobi, Kenya; [Reza-Paul, Sushena] Univ Manitoba, Winnipeg, MB, Canada; [Smit, Jenni A.] Univ KwaZulu Natal, Coll Hlth Sci, Discipline Pharmaceut Sci, Durban, South Africa; [Chersich, Matthew] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Fac Hlth Sci, Johannesburg, South Africa; [Delva, Wim] Univ Stellenbosch, South African DST NRF Ctr Excellence Epidemiol Mo, Stellenbosch, South Africa; [Delva, Wim] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium	Lafort, Y (reprint author), Pintelaan 185 UZP114, B-9000 Ghent, Belgium.	yves.lafort@ugent.be		chersich, matthew/0000-0002-4320-9168; Delva, Wim/0000-0001-8054-1904	European Union [Health-F3-2011-282542]; International Department Flanders (DIV) [A11/TT/0382]	The research leading to these results has received funding from the European Union Seventh Framework Programme under grant agreement number Health-F3-2011-282542. In Mozambique, funding was received from the International Department Flanders (DIV) under agreement A11/TT/0382.	Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011; Chersich MF, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17980; Civic D, 1996, SOC SCI MED, V42, P91, DOI 10.1016/0277-9536(95)00081-X; Consortium D, 2013, REP SIT AN REPR HLTH; Dhana A, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-46; Dinno A, 2015, STATA J, V15, P292, DOI 10.1177/1536867X1501500117; [FHI360 WHO U], 2012, FHI360 WHO UNFPA; Francois I, 2012, INT J SEX HEALTH, V24, P205, DOI 10.1080/19317611.2012.691443; Gabbay M, 1996, CONTRACEPTION, V53, P155, DOI 10.1016/0010-7824(96)00001-7; Ghimire L, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-79; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Guerra FM, 2014, AIDS BEHAV, V18, P146, DOI 10.1007/s10461-013-0580-3; Hilber AM, 2010, SOC SCI MED, V70, P392, DOI 10.1016/j.socscimed.2009.10.023; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, THE GAP REP; Lafort Y, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-144; Laga M, 2010, SEX TRANSM INFECT, V86, pI6, DOI 10.1136/sti.2009.039255; Langhaug LF, 2010, TROP MED INT HEALTH, V15, P362, DOI 10.1111/j.1365-3156.2009.02464.x; Luchters S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068855; Luchters S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-143; Moore L, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-47; Mountain E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105645; Mtetwa S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-698; O'Brien N, 2011, SEX TRANSM INFECT, V87, pA234, DOI 10.1136/sextrans-2011-050108.313; Peters A, 2014, AFR J REPROD HEALTH, V18, P34; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Richter M, 2014, J IMMIGR MINOR HEALT, V16, P7, DOI 10.1007/s10903-012-9758-4; Rojanapithayakorn W, 1995, J Med Assoc Thai, V78, P350; Sabin K., 2010, METHODOLOGICAL INNOV, V5, P38, DOI DOI 10.4256/MI0.2010.0017; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Schwandt M, 2006, SEX TRANSM INFECT, V82, P392, DOI 10.1136/sti.2006.019794; Scorgie F, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-33; Scorgie F, 2013, CULT HEALTH SEX, V15, P450, DOI 10.1080/13691058.2012.763187; Scorgie F, 2012, AIDS BEHAV, V16, P920, DOI 10.1007/s10461-011-9985-z; Steen R, 2003, REPROD HEALTH MATTER, V11, P74, DOI 10.1016/S0968-8080(03)02295-X; Voeten HACM, 2007, TROP MED INT HEALTH, V12, P174, DOI 10.1111/j.1365-3156.2006.01776.x; Vuylsteke B, 2001, SEX TRANSM INFECT, V77, P351, DOI 10.1136/sti.77.5.351; WHO, 2012, 989241503839 WHO; Williams BG, 2015, CURR HIV-AIDS REP, V12, P196, DOI 10.1007/s11904-015-0264-x; World Health Organization, 2012, PREV TREATM HIV OTH; World Health Organization, 2014, CONS GUID HIV PREV D	41	5	5	0	8	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	OCT	2016	21	10					1293	1303		10.1111/tmi.12761				11	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EB7TF	WOS:000387592800008	27479236				2019-04-02	
J	Abello, JE; Cuesta, JG; Cerro, BR; Guha-Sapir, D				Abello, Jason Echavez; Cuesta, Julita Gil; Cerro, Boyd Roderick; Guha-Sapir, Debarati			Factors Associated with the Time of Admission among Notified Dengue Fever Cases in Region VIII Philippines from 2008 to 2014	PLOS NEGLECTED TROPICAL DISEASES			English	Article							BRAZIL; CLASSIFICATION; EPIDEMIC; CAMBODIA; CHILDREN; CARE	In cases of Dengue fever, late hospital admission can lead to treatment delay and even death. In order to improve early disease notification and management, it is essential to investigate the factors affecting the time of admission of Dengue cases. This study determined the factors associated with the time of admission among notified Dengue cases. The study covered the period between 2008 and 2014 in Region VIII, Philippines. The factors assessed were age, sex, hospital sector, hospital level, disease severity based on the 1997 WHO Dengue classification, and period of admission (distinguishing between the 2010 Dengue epidemic and non-epidemic time). We analysed secondary data from the surveillance of notified Dengue cases. We calculated the association through chi-square test, ordinal logistic regression and linear regression at p value <0.05. The study included 16,357 admitted Dengue cases. The reported cases included a majority of children (70.09%), mild cases of the disease (64.00%), patients from the public sector (69.82%), and non-tertiary hospitals (62.76%). Only 1.40% of cases had a laboratory confirmation. The epidemic period in 2010 comprised 48.68% of all the admitted cases during this period. Late admission was more likely among adults than children (p<0.05). The severe type of the disease was more likely to be admitted late than the mild type (p<0.05). Late admission was also more likely in public hospitals than in private hospitals (p<0.05); and within tertiary level hospitals than non-tertiary hospitals (p<0.05). Late admission was more likely during the non-epidemic period than the 2010 epidemic period (p<0.05). A case fatality rate of 1 or greater was significantly associated with children, severe diseases, tertiary hospitals and public hospitals when admitted late (p<0.05). Data suggests that early admission among child cases was common in Region VIII. This behavior is encouraging, and should be continued. However, further study is needed on the late admission among tertiary, public hospitals and non-epidemic period with reference to the quality of care, patient volume, out of pocket expense, and accessibility We recommend the consistent use of the 2009 WHO Dengue guidelines in order to standardize the admission criteria and time across hospitals.	[Abello, Jason Echavez; Cuesta, Julita Gil; Guha-Sapir, Debarati] Catholic Univ Louvain, Ctr Res Epidemiol Disasters, Brussels, Belgium; [Cerro, Boyd Roderick] Reg Epidemiol & Surveillance Unit VIII, Dept Hlth, Tacloban City, Philippines	Abello, JE (reprint author), Catholic Univ Louvain, Ctr Res Epidemiol Disasters, Brussels, Belgium.	jasonabello@yahoo.com		Gil Cuesta, Julita/0000-0002-8291-9701	Education, Audiovisual and Culture Executive Agency (EACEA) of the European Commission	Our gratitude to the Education, Audiovisual and Culture Executive Agency (EACEA) of the European Commission for supporting Jason Echavez Abello in completing the Erasmus Mundus Master Course in Public Health in Disasters (EMMPHID). We wish to acknowledge the Philippines-Department of Health (DOH), Region VIII Epidemiology and Surveillance Unit (RESU) for sharing the data through the authorization of Jose Llacuna, Jr. and Minerva Molon, and helping us interpret with assistance from Grace Jusayan Campo, Arlene Gomez Pallones-Lim, Elsie Jaca and Ezra Valido. We extend our gratitude to Tefera Darge Delbiso and Jose Rodriguez-Llanes who assisted in the data analysis, and Eleanor Hegarty who assisted in the manuscript revision.	Asia Pacific Dengue Prevention Board, 2009, ACC PROGR DENG CONTR; Deen JL, 2006, LANCET, V368, P170, DOI 10.1016/S0140-6736(06)69006-5; Department of Health, 2013, HOSP DISTR CY 2012; Department of Health, 2012, 20120012 DEP HLTH RE; Department of Health, 2012, 20120006 DEP HLTH RE; Department of Health-National Epidemiology Center, 2015, DENG CAS AG SEX DIST; Department of Health-Regional Epidemiology and Surveillance Unit VIII, MORBIDITY WEEK, V23, P1; Edillo FE, 2015, AM J TROP MED HYG, V92, P360, DOI 10.4269/ajtmh.14-0139; Gibson G, 2013, CAD SAUDE PUBLICA, V29, P82, DOI 10.1590/S0102-311X2013000100010; Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1; Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2; Herrera M. E., 2007, PREPRINT; Horstick O, 2014, AM J TROP MED HYG, V91, P621, DOI 10.4269/ajtmh.13-0676; Khun S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-262; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Mendez Angela, 2003, Biomedica, V23, P180; Moraes GH, 2013, AM J TROP MED HYG, V88, P670, DOI 10.4269/ajtmh.11-0774; NImmanutya S., 2002, J PAEDIATR CHILD H, V1, P1; Pan American Health Organization, 1994, SCI PUBLICATION, V548; Philippine Statistics Authority, 2014, POP ANN GROWTH RAT P; Vicente CR, 2013, REV SOC BRAS MED TRO, V46, P629, DOI 10.1590/0037-8682-1579-2013; Salama P, 2004, LANCET, V364, P1801, DOI 10.1016/S0140-6736(04)17405-9; Tomashek KM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001614; UCLA, 2015, R DAT AN ORD LOG REG; United Nations International Strategy for Disaster Reduction, 2013, IRP182013 UN INT STR; Van Damme W, 2004, TROP MED INT HEALTH, V9, P273, DOI 10.1046/j.1365-3156.2003.01194.x; Velasco JMS, 2014, SE ASIAN J TROP MED, V45, P337; World Health Organization, 2009, DENG GUID DIAGN TREA; World Health Organization, 2012, HDB CLIN MAN DENG; World Health Organization, 2014, SURV SYST PHIL	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2016	10	10							e0005050	10.1371/journal.pntd.0005050				13	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EA5QH	WOS:000386676200036	27780199	DOAJ Gold, Green Published			2019-04-02	
J	Avau, B; Borra, V; Vandekerckhove, P; De Buck, E				Avau, Bert; Borra, Vere; Vandekerckhove, Philippe; De Buck, Emmy			The Treatment of Snake Bites in a First Aid Setting: A Systematic Review	PLOS NEGLECTED TROPICAL DISEASES			English	Review							APPLY PRESSURE IMMOBILIZATION; ENVENOMATION; MANAGEMENT; MORTALITY; SEVERITY; BANDAGE; 1ST-AID; BURDEN; TRENDS; VENOM	Background The worldwide burden of snakebite is high, especially in remote regions with lesser accessibility to professional healthcare. Therefore, adequate first aid for snakebite is of the utmost importance. A wide range of different first aid techniques have been described in literature, and are being used in practice. This systematic review aimed to summarize the best available evidence concerning effective and feasible first aid techniques for snakebite. Methods A systematic literature screening, performed independently by two authors in the Cochrane Library, MEDLINE and Embase resulted in 14 studies, fulfilling our predefined selection criteria, concerning first aid techniques for snakebite management. Data was extracted and the body of evidence was appraised according to the GRADE approach. Principal findings The pressure immobilization technique was identified as the only evidence-based first aid technique with effectiveness on venom spread. However, additional studies suggest that proper application of this technique is not feasible for laypeople. Evidence concerning other first aid measures, such as the application of a tourniquet, suggests avoiding the use of these techniques. Conclusions The practical recommendation for the treatment of snakebite in a first aid setting is to immobilize the victim, while awaiting the emergency services. However, given the low to very low quality of the data collected, high quality randomized controlled trials concerning the efficacy and feasibility of different variations of the pressure immobilization technique are warranted.	[Avau, Bert; Borra, Vere; Vandekerckhove, Philippe; De Buck, Emmy] Belgian Red Cross Flanders, Ctr Evidence Based Practice CEBaP, Mechelen, Belgium; [Vandekerckhove, Philippe; De Buck, Emmy] Katholieke Univ Leuven, Fac Med, Dept Publ Hlth & Primary Care, Leuven, Belgium; [Vandekerckhove, Philippe] Univ Ghent, Fac Med & Hlth Sci, Ghent, Belgium	Avau, B (reprint author), Belgian Red Cross Flanders, Ctr Evidence Based Practice CEBaP, Mechelen, Belgium.	bert.avau@rodekruis.be		Borra, Vere/0000-0001-7320-9698	Foundation for Scientific Research of the Belgian Red Cross-Flanders	This work was made possible through funding from the Foundation for Scientific Research of the Belgian Red Cross-Flanders. All authors are employees at the Belgian Red Cross Flanders and were involved in the development of this systematic review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRAS S, 1969, COMPR PSYCHIAT, V10, P151, DOI 10.1016/0010-440X(69)90022-4; Amaral CFS, 1998, TOXICON, V36, P805, DOI 10.1016/S0041-0101(97)00132-3; Anker R L, 1983, Aust Fam Physician, V12, P365; ANKER RL, 1982, MED J AUSTRALIA, V1, P212; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Australia Healthdirect, 2015, SNAK BIT; Bhat R N, 1974, J Indian Med Assoc, V63, P383; Bush SP, 2004, ANN EMERG MED, V44, P599, DOI 10.1016/j.annemergmed.2004.06.007; Canale E, 2009, EMERG MED AUSTRALAS, V21, P184, DOI 10.1111/j.1742-6723.2009.01180.x; Chippaux JP, 2011, TOXICON, V57, P586, DOI 10.1016/j.toxicon.2010.12.022; De Buck E, 2014, INT J EVID-BASED HEA, V12, P39, DOI 10.1097/01.XEB.0000444637.88465.a3; Feitosa ES, 2015, REV SOC BRAS MED TRO, V48, P34, DOI 10.1590/0037-8682-0105-2013; Franca FOS, 2003, T ROY SOC TROP MED H, V97, P312, DOI 10.1016/S0035-9203(03)90158-1; Habib AG, 2011, INT HEALTH, V3, P50, DOI 10.1016/j.inhe.2010.08.001; Habib AG, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004088; Halesha BR, 2013, J CLIN DIAGN RES, V7, P122, DOI [10.7860/JCDR/2012/4842.2685, 10.7860/JCOR/2012/4842.2685]; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; HOWARTH DM, 1994, MED J AUSTRALIA, V161, P695, DOI 10.5694/j.1326-5377.1994.tb126923.x; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Khin Ohn Lwin, 1984, Trans R Soc Trop Med Hyg, V78, P165; Madaki JKA, 2005, NIG MED PRACT, V48, P10; Gutierrez JM, 2007, CURR PHARM DESIGN, V13, P2935, DOI 10.2174/138161207782023784; McKinney PE, 2001, ANN EMERG MED, V37, P168, DOI 10.1067/mem.2001.111574; Michael GC, 2011, T ROY SOC TROP MED H, V105, P95, DOI 10.1016/j.trstmh.2010.09.005; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; MURRELL G, 1981, MED J AUSTRALIA, V2, P295; Norris RL, 2005, WILD ENVIRON MED, V16, P16, DOI 10.1580/PR12-04.1; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; PEARN J, 1981, MED J AUSTRALIA, V2, P293; Seifert SA, 2011, J MED TOXICOL, V7, P324, DOI 10.1007/s13181-011-0188-9; Simpson ID, 2008, T ROY SOC TROP MED H, V102, P451, DOI 10.1016/j.trstmh.2008.01.014; St John Ambulance Australia, 2014, FACT SHEET SNAK BIT; SUTHERLAND SK, 1979, LANCET, V1, P183, DOI 10.1016/S0140-6736(79)90580-4; Tun-Pe, 1994, Southeast Asian J Trop Med Public Health, V25, P349; Vaiyapuri S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080090; Van de Velde S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001059; Van Strien JW, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00691; Wang W, 2014, ENVIRON TOXICOL PHAR, V37, P648, DOI 10.1016/j.etap.2013.12.018; Warrell DA, 2010, LANCET, V375, P77, DOI 10.1016/S0140-6736(09)61754-2; World Health Organization (WHO), 2010, VEN SNAK DISTR SPEC	40	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	OCT	2016	10	10							e0005079	10.1371/journal.pntd.0005079				20	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	EA5QH	WOS:000386676200055	27749906	DOAJ Gold, Green Published			2019-04-02	
J	Delamou, A; Haba, NY; Mari-Saez, A; Gallian, P; Rouse, M; Jacobs, J; Camara, BS; Kadio, KJJO; Guemou, A; Kolie, JP; De Crop, M; Chavarin, P; Jacquot, C; Lazaygues, C; De Weggheleire, A; Lynen, L; van Griensven, J				Delamou, Alexandre; Haba, Nyankoye Yves; Mari-Saez, Almudena; Gallian, Pierre; Rouse, Maya; Jacobs, Jan; Camara, Bienvenu Salim; Kadio, Kadio Jean-Jacques Olivier; Guemou, Achille; Kolie, Jean Pe; De Crop, Maaike; Chavarin, Patricia; Jacquot, Chantal; Lazaygues, Catherine; De Weggheleire, Anja; Lynen, Lutgarde; van Griensven, Johan		Ebola-Tx Consortium	Organizing the Donation of Convalescent Plasma for a Therapeutic Clinical Trial on Ebola Virus Disease: The Experience in Guinea	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							SUB-SAHARAN AFRICA; BLOOD	Although convalescent plasma (CP) transfusion was prioritized among potential Ebola treatments by the World Health Organization, there were concerns on the feasibility of its implementation. We report on the successful organization of donor mobilization and plasma collection as part of the Ebola-Tx clinical trial from November 2014 to July 2015 in Conakry, Guinea. Project implementation registers, tools and reports, mission reports, and minutes of research team meetings were used to reconstruct the sequence of events on how donor mobilization was organized, plasmapheresis was set up, and how effective this approach was in collecting CP. An initial needs assessment of the Guinean National Blood Transfusion Center resulted in targeted training of staff on site, resulting in autonomy and independent production of CP within 3 months. The Conakry Ebola Survivors Association played a direct role in donor mobilization and organization of CP donations. A total of 98 Ebola survivors were screened for plasma donation, of which 84 were found eligible for plasmapheresis. Of these, 26 (30.9%) were excluded. The remaining 58 donors made a total of 90 donations, corresponding to 50.9 L of CP. This sufficed to treat the 99 eligible patients enrolled in the trial. Within a poor resource emergency context, transfusion capacity could be rapidly improved through the strengthening of local capacities and gradual transfer of skills coupled with active involvement of Ebola survivors. However, large-scale plasma collection or multisite studies may require further adaptations of both strategy and logistics. The Ebola-Tx trial was funded by the European Union and others.	[Delamou, Alexandre] Ctr Natl Format & Rech Sante Rurale Maferinyah, Forecariah, Guinea; [Delamou, Alexandre; Mari-Saez, Almudena; Rouse, Maya; Jacobs, Jan; De Crop, Maaike; De Weggheleire, Anja; Lynen, Lutgarde; van Griensven, Johan] Inst Trop Med, Antwerp, Belgium; [Haba, Nyankoye Yves; Camara, Bienvenu Salim; Kadio, Kadio Jean-Jacques Olivier] Ctr Natl Transfus Sanguine, Conakry, Guinea; [Gallian, Pierre; Jacquot, Chantal] Etab Francais Sang, Plaine Stade De France, France; [Jacobs, Jan] Katholieke Univ Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Guemou, Achille; Kolie, Jean Pe] Assoc Personnes Gueries & Affectees Ebola Guinee, Conakry, Guinea; [Chavarin, Patricia] Etab Francais Sang Auvergne Loire, St Etienne, France; [Lazaygues, Catherine] Etab Francais Sang Alpes Mediterranee, Marseille, France	Delamou, A (reprint author), Ctr Natl Format & Rech Sante Rurale Maferinyah, POB 4099, Conakry, Guinea.	adelamou@gmail.com; nyankoyeh@yahoo.fr; almudena.mari-saez@charite.de; Pierre.gallian@efs.sante.fr; mronse@itg.be; jjacobs@itg.be; bienvenusalimcamara@gmail.com; drkadiojolivier@gmail.com; guem_achille@yahoo.fr; santekolie2000@yahoo.fr; maaikedecrop@telenet.be; patricia.chavarin@efs.sante.fr; chantal.jacquot@efs.sante.fr; catherine.lazaygues@efs.sante.fr; adeweggheleire@itg.be; llynen@itg.be; jvangriensven@itg.be	De Weggheleire, Anja/C-7345-2018; Lynen, Lutgarde/A-1212-2014	De Weggheleire, Anja/0000-0001-9377-4766; Lynen, Lutgarde/0000-0001-7183-4895	European Union [666094]; Department of Economy, Science and Innovation (EWI) of the Flemish government; Bill and Melinda Gates Foundation	The Ebola-Tx project was funded by the European Union's Horizon 2020 research and innovation programme under grant agreement No. 666094. Additional funding and support was provided by the Department of Economy, Science and Innovation (EWI) of the Flemish government and the Bill and Melinda Gates Foundation. The funders of the study had no role in study design, data collection, data analysis, interpretation of the data, or in the writing of the report. The corresponding author had full access to data and has the final responsibility to submit for publication.	Ali R, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.17288; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Bagot KL, 2013, TRANSFUSION, V53, P1108, DOI 10.1111/j.1537-2995.2012.03891.x; Bannister-Tyrrell M, 2015, LANCET, V385, P420, DOI 10.1016/S0140-6736(14)62392-8; Burnouf T, 2014, LANCET, V384, P1347, DOI 10.1016/S0140-6736(14)61693-7; Colebunders RL, 2015, J INFECT DIS, V211, P1208, DOI 10.1093/infdis/jiv043; Coordination Nationale Ebola in Guinee OMS, 2015, 350 OMS COORD NAT EB; Enserink M, 2015, SCIENCE, V348, P742, DOI 10.1126/science.348.6236.742; Falero F, 2015, RAPID EVALUATION CON; Gulland A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5539; Lund TC, 2013, TRANSFUS APHER SCI, V49, P416, DOI 10.1016/j.transci.2013.06.014; Nielsen CF, 2015, MMWR-MORBID MORTAL W, V64, P20; Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007; Tagny CT, 2008, TRANSFUSION, V48, P1256, DOI 10.1111/j.1537-2995.2008.01697.x; Thiam AB, 2015, PAN AFR MED J, V20, DOI [10.11604/pamj.2015.20.379.6070, 10.11694/pamj.supp.2015.22.1.6626]; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; van Griensven J, 2016, CLIN INFECT DIS, V62, P69, DOI 10.1093/cid/civ680; Wong HK, 2010, TRANSFUSION, V50, P1967, DOI 10.1111/j.1537-2995.2010.02651.x; World Health Organization, 2015, US CONV WHOL BLOOD P; World Health Organization, 2015, COMM ENG ED RECR RET	20	2	2	0	1	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	SEP	2016	95	3					647	653		10.4269/ajtmh.15-0890				7	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3VA	WOS:000400206400029	27430546	Other Gold, Green Published			2019-04-02	
J	Brizzi, K; Pelden, S; Tshokey, T; Nirola, DK; Diamond, MB; Klein, JP; Tshering, L; Deki, S; Nidup, D; Bruno, V; Dorny, P; Garcia, HH; Mateen, FJ				Brizzi, Kate; Pelden, Sonam; Tshokey, Tshokey; Nirola, Damber K.; Diamond, Megan B.; Klein, Joshua P.; Tshering, Lhab; Deki, Sonam; Nidup, Dechen; Bruno, Veronica; Dorny, Pierre; Hugo Garcia, Hector; Mateen, Farrah J.		Bhutan Epilepsy Project	Neurocysticercosis in Bhutan: a cross-sectional study in people with epilepsy	TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE			English	Article						Bhutan; Enzyme-linked immunoelectrotransfer blot; Epilepsy; Magnetic resonance imaging; Neurocysticercosis; Seizure	CYSTICERCOSIS TAENIA-SOLIUM; SEIZURES; PERU; COMMUNITY; DIAGNOSIS; CHILDREN; PROFILE; ELISA; ASSAY	Background: We sought to provide an assessment of the burden of neurocysticercosis among people with epilepsy (PWE) in Bhutan and evaluate the yield of various tests for Taenia solium. Methods: PWE were enrolled at the National Referral Hospital in Thimphu (2014-2015). Serum was tested for anti-Taenia solium IgG using ELISA (Ab-ELISA), enzyme-linked immunoelectrotransfer blot (EITB), and parasite antigen. Results were compared to brain MRI. Participants were categorized as definite neurocysticercosis (MRI and EITB positive), probable neurocysticercosis (MRI or EITB positive), or without neurocysticercosis. Logistic regression models were constructed to explore clinicodemographic associations. Results: There were 12/205 (6%, 95% CI 2%, 9%) definite and 40/205 (20%, 95% CI 14%, 25%) probable neurocysticercosis cases. 25/205 (12%) with positive EITB did not have neurocysticercosis on MRI, and 15/205 (7%) participants with positive MRI had negative EITB. Participants with neurocysticercosis-suggestive lesions on MRI had an average of 1.2 cysts (parenchymal 26/27; nodular/calcified stage 21/27). In a multivariable analysis, present age (OR 1.05, 95% CI 1.01,1.09, p=0.025) was positively associated with (combined probable or definite) neurocysticercosis while mesial temporal sclerosis on MRI (OR 0.294, 95% CI 0.144, 0.598, p=0.001) was negatively associated. Conclusions: Neurocysticercosis was associated with 6-25% of epilepsy in a Bhutanese cohort. Combining EITB and MRI would aid the diagnosis of neurocysticercosis among PWE since no test identified all cases.	[Brizzi, Kate; Diamond, Megan B.; Bruno, Veronica; Mateen, Farrah J.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Pelden, Sonam; Tshokey, Tshokey] Jigme Dorji Wangchuck Natl Referral Hosp, Dept Lab Med, Thimphu, Bhutan; [Nirola, Damber K.; Tshering, Lhab; Deki, Sonam] Jigme Dorji Wangchuck Natl Referral Hosp, Dept Psychiat, Thimphu, Bhutan; [Klein, Joshua P.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Klein, Joshua P.; Mateen, Farrah J.] Harvard Med Sch, Boston, MA 02115 USA; [Nidup, Dechen] Jigme Dorji Wangchuck Natl Referral Hosp, Dept Radiol, Thimphu, Bhutan; [Dorny, Pierre] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Hugo Garcia, Hector] Univ Peruana Cayetan Heredia, Dept Microbiol, Inst Ciencias Neurol, Cysticercosis Unit, Lima, Peru	Mateen, FJ (reprint author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Mateen, FJ (reprint author), Harvard Med Sch, Boston, MA 02115 USA.	fmateen@partners.org			Grand Challenges Canada; Government of Canada [338-04]; Partners Center for Expertise in Global Health Travel Grant; Massachusetts General Hospital Center for Global Health Travel Grant	This work was supported by Grand Challenges Canada, funded by the Government of Canada (338-04); Partners Center for Expertise in Global Health Travel Grant; Massachusetts General Hospital Center for Global Health Travel Grant.	Adhikari S, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-43; Bhutan Health Management Information System, 2013, ANN HLTH B MIN HLTH, V2013; Brizzi K, 2016, INT HEALTH, V8, P286, DOI 10.1093/inthealth/ihw017; Carabin Helene, 2014, Curr Trop Med Rep, V1, P181; Del Brutto Oscar H, 2014, Handb Clin Neurol, V121, P1445, DOI 10.1016/B978-0-7020-4088-7.00097-3; Del Brutto OH, 2015, J NEUROL SCI, V359, P392, DOI 10.1016/j.jns.2015.08.011; Del Brutto OH, 2012, PATHOG GLOB HEALTH, V106, P299, DOI 10.1179/2047773212Y.0000000025; DIAZ JF, 1992, AM J TROP MED HYG, V46, P610, DOI 10.4269/ajtmh.1992.46.610; Dorny P, 2004, INT J PARASITOL, V34, P569, DOI 10.1016/j.ijpara.2003.11.014; Fleury A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002096; Garcia HH, 2016, NEW ENGL J MED, V374, P2335, DOI 10.1056/NEJMoa1515520; Garcia HH, 2014, LANCET NEUROL, V13, P1202, DOI 10.1016/S1474-4422(14)70094-8; Garcia HH, 2012, TROP MED INT HEALTH, V17, P1014, DOI 10.1111/j.1365-3156.2012.03037.x; Garcia HH, 2004, NEW ENGL J MED, V350, P249, DOI 10.1056/NEJMoa031294; Garcia HH, 2003, ACTA TROP, V87, P71, DOI 10.1016/S0001-706X(03)00057-3; Gekeler F, 2002, EUR J CLIN MICROBIOL, V21, P227, DOI 10.1007/s10096-002-0695-3; Hosmer DW, 1997, STAT MED, V16, P965; Kafle D R, 2014, Kathmandu Univ Med J (KUMJ), V12, P202; Lerner A, 2012, NEUROIMAG CLIN N AM, V22, P659, DOI 10.1016/j.nic.2012.05.004; Michelet L, 2011, J CLIN MICROBIOL, V49, P195, DOI 10.1128/JCM.01554-10; Moyano LM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002692; O'Neal SE, 2012, EMERG INFECT DIS, V18, P431, DOI 10.3201/eid1803.111367; Ojha R, 2015, NEUROIMMUNOL NEUROIN, V2, P167; Poudel P, 2013, J NEPAL MED ASSOC, V52, P260, DOI 10.31729/jnma.572; Prasad KN, 2011, T ROY SOC TROP MED H, V105, P531, DOI 10.1016/j.trstmh.2011.06.001; Prasad KN, 2009, T ROY SOC TROP MED H, V103, P144, DOI 10.1016/j.trstmh.2008.07.015; Rodriguez S, 2012, PATHOG GLOB HEALTH, V106, P286, DOI 10.1179/2047773212Y.0000000048; Singh G, 2010, NEUROLOGY, V75, P2236, DOI 10.1212/WNL.0b013e31820202dc; TSANG VCW, 1989, J INFECT DIS, V159, P50, DOI 10.1093/infdis/159.1.50	29	6	6	0	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0035-9203	1878-3503		T ROY SOC TROP MED H	Trans. Roy. Soc. Trop. Med. Hyg.	SEP	2016	110	9					517	526		10.1093/trstmh/trw066				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	EA6SI	WOS:000386758800004	27794094	Green Accepted			2019-04-02	
J	Osbak, KK; Houston, S; Lithgow, KV; Meehan, CJ; Strouhal, M; Smajs, D; Cameron, CE; Van Ostade, X; Kenyon, CR; Van Raemdonck, GA				Osbak, Kara K.; Houston, Simon; Lithgow, Karen V.; Meehan, Conor J.; Strouhal, Michal; Smajs, David; Cameron, Caroline E.; Van Ostade, Xaveer; Kenyon, Chris R.; Van Raemdonck, Geert A.			Characterizing the Syphilis-Causing Treponema pallidum ssp pallidum Proteome Using Complementary Mass Spectrometry	PLOS NEGLECTED TROPICAL DISEASES			English	Article							OUTER-MEMBRANE PROTEINS; PENICILLIN-BINDING PROTEIN; GRAM-NEGATIVE BACTERIA; GENOME-SCALE IDENTIFICATION; BARREL ASSEMBLY MACHINERY; SUBSP PALLIDUM; MOONLIGHTING PROTEINS; ANTIGENIC VARIATION; SIGNAL PEPTIDES; SUBCELLULAR-LOCALIZATION	Background The spirochete bacterium Treponema pallidum ssp. pallidum is the etiological agent of syphilis, a chronic multistage disease. Little is known about the global T. pallidum proteome, therefore mass spectrometry studies are needed to bring insights into pathogenicity and protein expression profiles during infection. Methodology/Principal Findings To better understand the T. pallidum proteome profile during infection, we studied T. pallidum ssp. pallidum DAL-1 strain bacteria isolated from rabbits using complementary mass spectrometry techniques, including multidimensional peptide separation and protein identification via matrix-assisted laser desorption ionization-time of flight (MALDI-TOF/TOF) and electrospray ionization (ESI-LTQ-Orbitrap) tandem mass spectrometry. A total of 6033 peptides were detected, corresponding to 557 unique T. pallidum proteins at a high level of confidence, representing 54% of the predicted proteome. A previous gel-based T. pallidum MS proteome study detected 58 of these proteins. One hundred fourteen of the detected proteins were previously annotated as hypothetical or uncharacterized proteins; this is the first account of 106 of these proteins at the protein level. Detected proteins were characterized according to their predicted biological function and localization; half were allocated into a wide range of functional categories. Proteins annotated as potential membrane proteins and proteins with unclear functional annotations were subjected to an additional bioinformatics pipeline analysis to facilitate further characterization. A total of 116 potential membrane proteins were identified, of which 16 have evidence supporting outer membrane localization. We found 8/12 proteins related to the paralogous tpr gene family: TprB, TprC/D, TprE, TprG, TprH, TprI and TprJ. Protein abundance was semi-quantified using label-free spectral counting methods. A low correlation (r = 0.26) was found between previous microarray signal data and protein abundance. Conclusions This is the most comprehensive description of the global T. pallidum proteome to date. These data provide valuable insights into in vivo T. pallidum protein expression, paving the way for improved understanding of the pathogenicity of this enigmatic organism.	[Osbak, Kara K.; Kenyon, Chris R.; Van Raemdonck, Geert A.] Inst Trop Med, HIV STI Unit, Antwerp, Belgium; [Houston, Simon; Lithgow, Karen V.; Cameron, Caroline E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Meehan, Conor J.] Inst Trop Med, Unit Mycobacteriol, Antwerp, Belgium; [Strouhal, Michal; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Van Ostade, Xaveer; Van Raemdonck, Geert A.] Univ Antwerp, Lab Prot Sci Prote & Epigenet Signaling PPES, Antwerp, Belgium; [Van Ostade, Xaveer; Van Raemdonck, Geert A.] Univ Antwerp, Ctr Prote CFP, Antwerp, Belgium; [Kenyon, Chris R.] Univ Cape Town, Div Infect Dis & HIV Med, Cape Town, South Africa	Osbak, KK (reprint author), Inst Trop Med, HIV STI Unit, Antwerp, Belgium.	kosbak@hotmail.com	Van Ostade, Xaveer/D-1702-2015	Van Ostade, Xaveer/0000-0003-4078-3014; Osbak, Kara/0000-0002-8612-8413	Flanders Research Foundation; National Institutes of Health [AI-051334]; Grant Agency of the Czech Republic [P302/12/0574, GP14-29596P]	This work was supported by the grants from the Flanders Research Foundation, SOFI-B Grant to CRK, http://www.fwo.be/, a Public Health Service Grant from the National Institutes of Health to CEC, (grant # AI-051334), https://www.nih.gov/ and a grant from the Grant Agency of the Czech Republic to DS and MS (P302/12/0574, GP14-29596P), https://gacr.cz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2015, J BIOL CHEM, V290, P12313, DOI 10.1074/jbc.M114.629188; Anand A, 2012, J BACTERIOL, V194, P2321, DOI 10.1128/JB.00101-12; Babolin C, 2011, J IMMUNOL, V187, P1377, DOI 10.4049/jimmunol.1100615; Bagos PG, 2004, NUCLEIC ACIDS RES, V32, pW400, DOI 10.1093/nar/gkh417; Becher D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008176; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Berven FS, 2004, NUCLEIC ACIDS RES, V32, pW394, DOI 10.1093/nar/gkh351; Brinkman MB, 2006, REACTIVITY ANTIBODIE; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; Cahoon LA, 2009, SCIENCE, V325, P764, DOI 10.1126/science.1175653; Cameron CE, 2000, J INFECT DIS, V181, P1401, DOI 10.1086/315399; Cameron CE, 2004, J BACTERIOL, V186, P7019, DOI 10.1128/JB.186.20.7019-7022.2004; Carlson JA, 2011, AM J DERMATOPATH, V33, P433, DOI 10.1097/DAD.0b013e3181e8b587; Catrein I, 2011, PROTEOMICS, V11, P3614, DOI 10.1002/pmic.201100076; Cejkova D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004110; Centurion-Lara A, 2000, INFECT IMMUN, V68, P824, DOI 10.1128/IAI.68.2.824-831.2000; Centurion-Lara A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002222; Cha JY, 2004, J BIOL CHEM, V279, P14917, DOI 10.1074/jbc.M400666200; Chu Q, 2015, CRIT REV BIOCHEM MOL, V50, P134, DOI 10.3109/10409238.2015.1016215; COVER WH, 1982, SEX TRANSM DIS, V9, P1, DOI 10.1097/00007435-198201000-00001; COX CD, 1974, INFECT IMMUN, V10, P123; Cox DL, 2010, INFECT IMMUN, V78, P5178, DOI 10.1128/IAI.00834-10; COX DL, 1990, APPL ENVIRON MICROB, V56, P3063; Deka RK, 2002, J BIOL CHEM, V277, P41857, DOI 10.1074/jbc.M207402200; Desiere F, 2006, NUCLEIC ACIDS RES, V34, pD655, DOI 10.1093/nar/gkj040; Desrosiers DC, 2011, MOL MICROBIOL, V80, P1496, DOI 10.1111/j.1365-2958.2011.07662.x; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eshghi A, 2009, GLOBAL PROTEOME ANAL, P4564; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Giacani L, 2005, INFECT IMMUN, V73, P3817, DOI 10.1128/IAI.73.6.3817-3822.2005; Giacani L, 2007, FEMS IMMUNOL MED MIC, V51, P289, DOI 10.1111/j.1574-695X.2007.00303.x; Giacani L, 2007, INFECT IMMUN, V75, P104, DOI 10.1128/IAI.01124-06; Giacani L, 2015, INFECT IMMUN, V83, P2275, DOI 10.1128/IAI.00360-15; Giacani L, 2012, J BACTERIOL, V194, P4208, DOI 10.1128/JB.00863-12; Giacani L, 2010, J IMMUNOL, V184, P3822, DOI 10.4049/jimmunol.0902788; HANFF PA, 1984, SEX TRANSM DIS, V11, P275, DOI 10.1097/00007435-198410000-00003; Harman M, 2013, BIOPHYS J, V105, P2273, DOI 10.1016/j.bpj.2013.10.004; Henderson B, 2014, BIOCHEM SOC T, V42, P1720, DOI 10.1042/BST20140236; Henderson B, 2013, CURR TOP MICROBIOL, V358, P155, DOI 10.1007/82_2011_188; Izard J, 2009, J BACTERIOL, V191, P7566, DOI 10.1128/JB.01031-09; Jeffery CJ, 2003, TRENDS GENET, V19, P415, DOI 10.1016/S0168-9525(03)00167-7; Jerome JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016399; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kelesidis T., 2014, FRONT IMMUNOL, V5, P85; Kelkar YD, 2013, GENETICS, V193, P303, DOI 10.1534/genetics.112.145656; Khan I, 2014, BIOL DIRECT, V9, DOI 10.1186/s13062-014-0030-9; Khan IK, 2014, BIOCHEM SOC T, V42, P1780, DOI 10.1042/BST20140214; Kim KH, 2012, PROTEIN SCI, V21, P751, DOI 10.1002/pro.2069; Knowles TJ, 2009, NAT REV MICROBIOL, V7, P206, DOI 10.1038/nrmicro2069; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kruh NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013938; LaFond RE, 2006, INFECT IMMUN, V74, P1896, DOI 10.1128/IAI.74.3.1896-1906.2006; LaFond RE, 2006, CLIN MICROBIOL REV, V19, P29, DOI 10.1128/CMR.19.1.29-49.2006; Leader BT, 2003, INFECT IMMUN, V71, P6054, DOI 10.1128/IAI.71.10.6054-6057.2003; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; Lluch-Senar M, 2015, MOL SYST BIOL, V11; Lukehart Sheila A, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12a01s7; Luthra A, 2015, METHODS MOL BIOL, V1329, P67, DOI 10.1007/978-1-4939-2871-2_6; Luthra A, 2015, J BACTERIOL, V197, P1906, DOI 10.1128/JB.00086-15; Lyu ZX, 2015, BIOCHEM SOC T, V43, P133, DOI 10.1042/BST20140217; Maass S, 2016, J PROTEOMICS, V136, P222, DOI 10.1016/j.jprot.2016.01.015; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; McGill MA, 2010, INFECT IMMUN, V78, P2631, DOI 10.1128/IAI.00173-10; McKevitt M, 2005, INFECT IMMUN, V73, P4445, DOI 10.1128/IAI.73.7.4445-4450.2005; McKevitt M, 2003, GENOME RES, V13, P1665, DOI 10.1101/gr.288103; Mikalova L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015713; Morgan CA, 2002, J IMMUNOL, V169, P952, DOI 10.4049/jimmunol.169.2.952; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Naqvi AAT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124177; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; NORRIS SJ, 1986, INFECT IMMUN, V53, P534; NORRIS SJ, 1993, MICROBIOL REV, V57, P750; Ou Y-Y, 2013, PLOONE PUBLIC LIB, V8, DOI [10.1371/journal.pone.0046572, DOI 10.1371/JOURNAL.PONE]; Pages JM, 2008, NAT REV MICROBIOL, V6, P893, DOI 10.1038/nrmicro1994; Palmer GH, 2009, CELL MICROBIOL, V11, P1697, DOI 10.1111/j.1462-5822.2009.01366.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; RADOLF JD, 1989, P NATL ACAD SCI USA, V86, P2051, DOI 10.1073/pnas.86.6.2051; RADOLF JD, 1995, J IMMUNOL, V154, P2866; Read P, 2015, SEX HEALTH, V12, P155, DOI 10.1071/SH14153; Reid TB, 2014, INFECT IMMUN, V82, P4959, DOI 10.1128/IAI.02236-14; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Salazar JC, 2005, CLIN DIAGN LAB IMMUN, V12, P949, DOI 10.1128/CDLI.12.8.949-958.2005; Schouls L., 1992, MOL BIOL SEXUALLY TR; Selkrig J, 2014, BBA-MOL CELL RES, V1843, P1542, DOI 10.1016/j.bbamcr.2013.10.009; Semanjski M, 2015, EXPERT REV PROTEOMIC, DOI 10.1586/14789450.2016.1132168; Setubal JC, 2006, MICROBIOL-SGM, V152, P113, DOI 10.1099/mic.0.28317-0; Smajs D, 2002, GENOME RES, V12, P515, DOI 10.1101/gr.207302; Smajs D, 2005, TRANSCRIPTOME TREPON; Smajs D, 2012, INFECT GENET EVOL, V12, P191, DOI 10.1016/j.meegid.2011.12.001; Soufi B, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00103; Stamm LV, 2000, INFECT IMMUN, V68, P6482, DOI 10.1128/IAI.68.11.6482-6486.2000; STRUGNELL RA, 1986, GENITOURIN MED, V62, P4; Tomson FL, 2007, MICROBES INFECT, V9, P1267, DOI 10.1016/j.micinf.2007.05.018; Tsiatsiani L, 2015, FEBS J, V282, P2612, DOI 10.1111/febs.13287; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; Wadler CS, 2007, P NATL ACAD SCI USA, V104, P20454, DOI 10.1073/pnas.0708102104; WALKER EM, 1989, J BACTERIOL, V171, P5005, DOI 10.1128/jb.171.9.5005-5011.1989; WEIGEL LM, 1994, P NATL ACAD SCI USA, V91, P11611, DOI 10.1073/pnas.91.24.11611; Weinstock GM, 2000, RES MICROBIOL, V151, P151, DOI 10.1016/S0923-2508(00)00115-7; Weinstock GM, 1998, FEMS MICROBIOL REV, V22, P323, DOI 10.1111/j.1574-6976.1998.tb00373.x; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zobanikova M, 2012, STAND GENOMIC SCI, V7, P12, DOI 10.4056/sigs.2615838; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n; Zybailov BL, 2007, MOL BIOSYST, V3, P354, DOI 10.1039/b701483j	111	5	5	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2016	10	9							e0004988	10.1371/journal.pntd.0004988				29	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DZ1UZ	WOS:000385627900043	27606673	DOAJ Gold, Green Published			2019-04-02	
J	Wong, VK; Holt, KE; Okoro, C; Baker, S; Pickard, DJ; Marks, F; Page, AJ; Olanipekun, G; Munir, H; Alter, R; Fey, PD; Feasey, NA; Weill, FX; Le Hello, S; Hart, PJ; Kariuki, S; Breiman, RF; Gordon, MA; Heyderman, RS; Jacobs, J; Lunguya, O; Msefula, C; MacLennan, CA; Keddy, KH; Smith, AM; Onsare, RS; De Pinna, E; Nair, S; Amos, B; Dougan, G; Obaro, S				Wong, Vanessa K.; Holt, Kathryn E.; Okoro, Chinyere; Baker, Stephen; Pickard, Derek J.; Marks, Florian; Page, Andrew J.; Olanipekun, Grace; Munir, Huda; Alter, Roxanne; Fey, Paul D.; Feasey, Nicholas A.; Weill, Francois-Xavier; Le Hello, Simon; Hart, Peter J.; Kariuki, Samuel; Breiman, Robert F.; Gordon, Melita A.; Heyderman, Robert S.; Jacobs, Jan; Lunguya, Octavie; Msefula, Chisomo; MacLennan, Calman A.; Keddy, Karen H.; Smith, Anthony M.; Onsare, Robert S.; De Pinna, Elizabeth; Nair, Satheesh; Amos, Ben; Dougan, Gordon; Obaro, Stephen		Int Typhoid Consortium	Molecular Surveillance Identifies Multiple Transmissions of Typhoid in West Africa	PLOS NEGLECTED TROPICAL DISEASES			English	Article							COMMUNITY-ACQUIRED BACTEREMIA; RESISTANT SALMONELLA-ENTERICA; ANTIBIOTIC-RESISTANCE; INTERACTIVE TREE; CHILDREN; MUTATIONS; SEQUENCE; FEVER; PREVALENCE; ANNOTATION	Background The burden of typhoid in sub-Saharan African (SSA) countries has been difficult to estimate, in part, due to suboptimal laboratory diagnostics. However, surveillance blood cultures at two sites in Nigeria have identified typhoid associated with Salmonella enterica serovar Typhi (S. Typhi) as an important cause of bacteremia in children. Methods A total of 128 S. Typhi isolates from these studies in Nigeria were whole-genome sequenced, and the resulting data was used to place these Nigerian isolates into a worldwide context based on their phylogeny and carriage of molecular determinants of antibiotic resistance. Results Several distinct S. Typhi genotypes were identified in Nigeria that were related to other clusters of S. Typhi isolates from north, west and central regions of Africa. The rapidly expanding S. Typhi clade 4.3.1 (H58) previously associated with multiple antimicrobial resistances in Asia and in east, central and southern Africa, was not detected in this study. However, antimicrobial resistance was common amongst the Nigerian isolates and was associated with several plasmids, including the IncHI1 plasmid commonly associated with S. Typhi. Conclusions These data indicate that typhoid in Nigeria was established through multiple independent introductions into the country, with evidence of regional spread. MDR typhoid appears to be evolving independently of the haplotype H58 found in other typhoid endemic countries. This study highlights an urgent need for routine surveillance to monitor the epidemiology of typhoid and evolution of antimicrobial resistance within the bacterial population as a means to facilitate public health interventions to reduce the substantial morbidity and mortality of typhoid.	[Wong, Vanessa K.; Okoro, Chinyere; Pickard, Derek J.; Page, Andrew J.; Kariuki, Samuel; MacLennan, Calman A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge, England; [Wong, Vanessa K.; Okoro, Chinyere] Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Cambridge, England; [Holt, Kathryn E.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic, Australia; [Holt, Kathryn E.] Univ Melbourne, Ctr Syst Genom, Parkville, Vic, Australia; [Baker, Stephen] Univ Oxford, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Clin Res Unit, Ho Chi Minh City, Vietnam; [Baker, Stephen] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Baker, Stephen] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London, England; [Marks, Florian] Int Vaccine Inst, Dept Epidemiol, Seoul, South Korea; [Olanipekun, Grace] Int Fdn Infect Dis Nigeria, Abuja, Nigeria; [Munir, Huda] Aminu Kano Teaching Hosp, Dept Med Microbiol, Kano, Nigeria; [Alter, Roxanne; Fey, Paul D.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Feasey, Nicholas A.] Univ Liverpool Liverpool Sch Trop Med, Pembroke Pl, Liverpool, Merseyside, England; [Weill, Francois-Xavier; Le Hello, Simon] Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Hart, Peter J.; MacLennan, Calman A.] Univ Birmingham, Inst Biomed Res, Sch Immun & Infect, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Hart, Peter J.] St Georges Univ London, London, England; [Kariuki, Samuel; Breiman, Robert F.; Onsare, Robert S.] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Breiman, Robert F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Breiman, Robert F.] Emory Global Hlth Inst, Atlanta, GA USA; [Gordon, Melita A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Gordon, Melita A.; Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Heyderman, Robert S.; Msefula, Chisomo] UCL, Div Infect & Immun, London, England; [Jacobs, Jan] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, KU Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Lunguya, Octavie] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Lunguya, Octavie] Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO; [Msefula, Chisomo] Univ Malawi, Dept Microbiol, Coll Med, Blantyre, Malawi; [MacLennan, Calman A.] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England; [Keddy, Karen H.; Smith, Anthony M.] Univ Witwatersrand, Natl Inst Communicable Dis, Ctr Enter Dis, Div Natl Hlth Lab Serv, Johannesburg, South Africa; [Keddy, Karen H.; Smith, Anthony M.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [De Pinna, Elizabeth; Nair, Satheesh] Publ Hlth England, Salmonella Reference Serv, London, England; [Amos, Ben] St Augustines Hosp, Muheza, Tanzania; [Obaro, Stephen] Univ Nebraska Med Ctr, Div Pediat Infect Dis, Omaha, NE USA; [Obaro, Stephen] Univ Abuja Teaching Hosp, Gwagwalada, Nigeria; [Obaro, Stephen] Bingham Univ, Karu, Nassarawa State, Nigeria	Wong, VK (reprint author), Wellcome Trust Sanger Inst, Cambridge, England.; Wong, VK (reprint author), Cambridge Univ Hosp Natl Hlth Serv Fdn Trust, Addenbrookes Hosp, Cambridge, England.	vw1@sanger.ac.uk	Le Hello, Simon/K-6584-2018; Hatta, Mochammad/D-3742-2019; Gordon, Melita/F-5563-2012; Holt, Kathryn/A-8108-2012	Le Hello, Simon/0000-0001-7993-4305; Dufour, Muriel/0000-0003-3638-4918; Marks, Florian/0000-0002-6043-7170; Hatta, Mochammad/0000-0002-8456-4203; Watson, Conall/0000-0002-2469-791X; Cain, Amy/0000-0002-4230-6572; Thwaites, Guy/0000-0002-2858-2087; Amos, Benjamin/0000-0002-8569-1650; Connor, Thomas/0000-0003-2394-6504; Weill, Francois-Xavier/0000-0001-9941-5799; Gordon, Melita/0000-0002-0629-0884; Okoro, Chinyere/0000-0002-2466-304X; Nair, Satheesh/0000-0002-7297-1485; Heyderman, Robert/0000-0003-4573-449X; Holt, Kathryn/0000-0003-3949-2471	Wellcome Trust [098051, WT092152MA, 101113/Z/13/Z, 100087/Z/12/Z]; NHMRC of Australia [1061409]; Victorian Life Sciences Computation Initiative (VLSCI) [VR0082]; Clinical Research Fellowship from GlaxoSmithKline; UK Medical Research Council; IP; Institut de Veille Sanitaire; French Government "Investissement d'Avenir" program [ANR-10-LABX-62-IBEID]; Society in Science; Branco Weiss Fellowship; antibiotic resistance surveillance project in DR Congo; Belgian Directorate General of Development Cooperation [2.01]; Institute of Tropical Medicine, Antwerp, Belgium [2.01]; Bill & Melinda Gates Foundation; NIH [R01 AI099525-02]; Royal Society; National Institute Of Allergy And Infectious Diseases (NIAID) of the National Institutes of Health [R01AI097493]	This work was supported by a number of organizations. The Wellcome Trust Sanger Institute authors were funded by Wellcome Trust Award 098051; NAF was supported by the Wellcome Trust Research Fellowship WT092152MA. NAF, RSH and this work were supported by a strategic award from the Wellcome Trust for the MLW Clinical Research Programme (101113/Z/13/Z). KEH was supported by the NHMRC of Australia (fellowship #1061409) and the Victorian Life Sciences Computation Initiative (VLSCI) (grant #VR0082). CAM was supported by a Clinical Research Fellowship from GlaxoSmithKline and PJH by a UK Medical Research Council PhD studentship. This work forms part of an EU FP7 Marie Curie Actions Industry Academia Partnerships and Pathways (IAPP) Consortium Programme, entitled GENDRIVAX (Genome-driven vaccine development for bacterial infections), involving the Wellcome Trust Sanger Institute, KEMRI Nairobi and Novartis Vaccines Institute for Global Health. The Institut Pasteur (IP) authors were funded by the IP, the Institut de Veille Sanitaire, and by the French Government "Investissement d'Avenir" program (Integrative Biology of Emerging Infectious Diseases" Laboratory of Excellence, grant no. ANR-10-LABX-62-IBEID). CO was supported by Society in Science, The Branco Weiss Fellowship, administered by the ETH Zurich. JJ was supported by the antibiotic resistance surveillance project in DR Congo, funded by Project 2.01 of the Third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine, Antwerp, Belgium. FM was supported by a research grant from the Bill & Melinda Gates Foundation. The findings and conclusions contained within this publication are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation. SK was supported by the NIH Grant Number R01 AI099525-02. SB is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). SO was supported by the National Institute Of Allergy And Infectious Diseases (NIAID) of the National Institutes of Health (#R01AI097493). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ABUJA BEAUTIFUL CAPI; Arulogun OS, 2012, INT Q COMMUNITY HEAL, V32, P219, DOI 10.2190/IQ.32.3.e; Baucheron S, 2005, ANTIMICROB AGENTS CH, V49, P862, DOI 10.1128/AAC.49.2.862-863.2005; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; CLSI, 2014, PERF STAND ANT SUSC; Croucher NJ, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1196; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Crump JA, 2004, B WORLD HEALTH ORGAN, V82, P346; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Enwere G, 2006, PEDIATR INFECT DIS J, V25, P700, DOI 10.1097/01.inf.0000226839.30925.a5; Federal Republic of Nigeria NAftCoA, GLOB AIDS RESP COUNT; Federal Republic of Nigeria NBoSpc, 2010, KAN STAT STAT TABL; Fitzgerald C, 2007, J CLIN MICROBIOL, V45, P3323, DOI 10.1128/JCM.00025-07; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Herrera-Leon S, 2004, J CLIN MICROBIOL, V42, P2581, DOI 10.1128/JCM.42.6.2581-2586.2004; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Hooper D C, 1993, Drugs, V45 Suppl 3, P8; IBM Corp. Released, 2013, IBM SPSS STAT MAC VA; Inouye MD, 2014, GENOME MED, V6; Isendahl J, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0715-9; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Obaro S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-137; Obaro SK, 2015, CLIN INFECT DIS, V61, pS325, DOI 10.1093/cid/civ745; Olayemi I K, 2011, Pak J Biol Sci, V14, P293, DOI 10.3923/pjbs.2011.293.299; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Song YJ, 2010, J ANTIMICROB CHEMOTH, V65, P1631, DOI 10.1093/jac/dkq175; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Wong VK, 2015, NAT GENET, V47, P632, DOI 10.1038/ng.3281	37	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	SEP	2016	10	9							e0004781	10.1371/journal.pntd.0004781				22	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DZ1UZ	WOS:000385627900002	27657909	DOAJ Gold, Green Published			2019-04-02	
J	Falq, G; Van Den Bergh, R; De Smet, M; Etienne, W; Nguon, C; Rekol, H; Imwong, M; Dondorp, A; Kindermans, JM				Falq, Gregoire; Van Den Bergh, Rafael; De Smet, Martin; Etienne, William; Nguon, Chea; Rekol, Huy; Imwong, Mallika; Dondorp, Arjen; Kindermans, Jean-Marie			Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum	MALARIA JOURNAL			English	Article						Malaria; Plasmodium falciparum; Epidemiology; Artemisinin resistance; Polymerase chain reaction; k13-propeller; Cambodia	WESTERN CAMBODIA; MALARIA; INFECTIONS; PREVALENCE; PROVINCE	Background: In Cambodia, elimination of artemisinin resistance through direct elimination of the Plasmodium falciparum parasite may be the only strategy. Prevalence and incidence at district and village levels were assessed in Chey Saen district, Preah Vihear province, North of Cambodia. Molecular and clinical indicators for artemisinin resistance were documented. Methods: A cross sectional prevalence survey was conducted at village level in the district of Chey Saen from September to October 2014. Plasmodium spp. was assessed with high volume quantitative real-time polymerase chain reaction (qPCR). Plasmodium falciparum-positive samples were screened for mutations in the k13-propeller domain gene. Treatment effectiveness was established after 28 days (D28) using the same qPCR technique. Data from the provincial surveillance system targeting symptomatic cases, supported by Medecins Sans Frontieres (MSF), were used to assess incidence. Results: District P. falciparum prevalence was of 0.74 % [0.41; 1.21]; village prevalence ranged from 0 to 4.6 % [1.4; 10.5]. The annual incidence of P. falciparum was 16.8 cases per 1000 inhabitants in the district; village incidence ranged from 1.3 to 54.9 for 1000 inhabitants. Two geographical clusters with high number of cases were identified by both approaches. The marker for artemisinin resistance was found in six samples out of the 11 tested (55 %). 34.9 % of qPCR blood analysis of symptomatic patients were still positive at D28. Conclusions: The overall low prevalence of P. falciparum was confirmed in Chey Saen district in Cambodia, while there were important variations between villages. Symptomatic cases had a different pattern and were likely acquired outside the villages. It illustrates the importance of prevalence surveys in targeting interventions for elimination. Mutations in the k13-propeller domain gene (C580Y), conferring artemisinin resistance, were highly prevalent in both symptomatic and asymptomatic cases (realizing the absolute figures remain low). Asymptomatic individuals could be an additional reservoir for artemisinin resistance. The low effectiveness of dihydroartemisinin-piperaquine (DHA-PPQ) for symptomatic cases indicates that PPQ is no longer able to complement the reduced potency of DHA to treat falciparum malaria and highlights the need for an alternative first-line treatment.	[Falq, Gregoire; De Smet, Martin; Etienne, William; Kindermans, Jean-Marie] Med Sans Frontieres, 46 Rue Arbre Benit, B-1050 Brussels, Belgium; [Van Den Bergh, Rafael] Med Sans Frontieres, 68 Rue Gasperich, L-1617 Luxembourg, Luxembourg; [Nguon, Chea; Rekol, Huy] Ctr Parasitol Entomol & Malaria Control, 477 Betong St, Khan Sen Sok, Phnom Penh, Cambodia; [Imwong, Mallika] Mahidol Univ, Dept Mol Trop Med & Genet, Fac Trop Med, 3-F,60th Anniversary Chalermprakiat Bldg, Bangkok 10400, Thailand; [Dondorp, Arjen] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Res Unit, Bangkok, Thailand	Kindermans, JM (reprint author), Med Sans Frontieres, 46 Rue Arbre Benit, B-1050 Brussels, Belgium.	jean-marie.kindermans@brussels.msf.org		Van den Bergh, Rafael/0000-0001-6277-8713	Medecins Sans Frontieres	Funding was provided by Medecins Sans Frontieres.	Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Chaorattanakawee S, 2015, ANTIMICROB AGENTS CH, V59, P4631, DOI 10.1128/AAC.00366-15; DEVILLE JC, 1993, J AM STAT ASSOC, V88, P1013, DOI 10.2307/2290793; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Imwong M, 2014, J CLIN MICROBIOL, V52, P3303, DOI 10.1128/JCM.01057-14; Leang R, 2015, ANTIMICROB AGENTS CH, V59, P4719, DOI 10.1128/AAC.00835-15; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Maude RJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037166; Maude RJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-31; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Okell LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020179; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Spring MD, 2015, LANCET INFECT DIS, V15, P683, DOI 10.1016/S1473-3099(15)70049-6; Stresman G, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-353; Tripura R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1224-7; WHO, 2013, WORLD MALARIA REPORT 2013, P1; World Health Organization, 2016, ART ART BAS COMB THE; World health Organization, 2012, DIS SURV MAL CONTR O; World Health Organization (WHO), 2011, GLOB PLAN ART RES CO; World Health Organization (WHO), 2010, GLOB REP ANT DRUG EF	24	7	7	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	SEP 1	2016	15								446	10.1186/s12936-016-1487-z				11	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU9KP	WOS:000382536200001	27585957	DOAJ Gold, Green Published			2019-04-02	
J	Stassijns, J; van den Boogaard, W; Pannus, P; Nkunzimana, A; Rosanas-Urgell, A				Stassijns, Jorgen; van den Boogaard, Wilma; Pannus, Pieter; Nkunzimana, Alphonse; Rosanas-Urgell, Anna			Prevalence and diagnostics of congenital malaria in rural Burundi, a cross-sectional study	MALARIA JOURNAL			English	Article						Congenital malaria; Prevalence; Diagnosis; Rapid diagnostic test; Burundi	PLASMODIUM-FALCIPARUM MALARIA; NIGERIA; PREGNANCY; INFANTS; INFECTIONS; CALABAR; AREA	Background: Congenital malaria, defined as the presence of asexual forms of malaria parasites in the peripheral blood during the first 7 days of life, remains a neglected area of research. Knowledge gaps exist about prevalence and management of malaria in this age group. The objective of this study was to evaluate the prevalence of congenital malaria and the validity of a rapid diagnostic test (RDT) for its diagnosis in rural Burundi. Methods: A cross-sectional study was conducted in a meso-endemic malaria context in Burundi among 290 mothers, and their newborns (n = 303), who delivered at the maternity departments of Kirundo and Mukenke Hospitals during March and April 2014. Peripheral blood samples were collected from all mothers/newborns pairs in order to examine the presence of malaria parasites with two RDT (SD-Bioline HRP2 and Carestart pan-pLDH) and a blood slide. In addition, quantitative real-time polymerase chain reaction (PCR) was performed from the newborn peripheral sample. Frequencies and proportions were calculated for categorical variables. Sensitivity and specificity were calculated with a 95 % confidence interval (CI). Results: None of the newborns were found positive by PCR (0/303; 95 % CI 0.0-1.3). The prevalence in newborns born from microscopy-positive mothers was 0 % (0/44; 95 % CI 0.0-8.0). Two newborns were positive with SD-Bioline HRP2 (0.7 %, 95 % CI 0.2-2.4) but none with Carestart pan-pLDH or microscopy. Sensitivity of the diagnostic tests could not be evaluated as no congenital malaria was detected. Specificity of SD-Bioline HRP2, Carestart pan-pLDH and microscopy to detect congenital malaria was 99.3 % (95 % CI 97.6-99.8), 100.0 % (95 % CI 98.3-100.0) and 100.0 % (95 % CI 98.8-100.0), respectively. Conclusion: In Burundi or the Central African region, no recent prevalence studies for congenital malaria have been carried out. This study found that the prevalence of congenital malaria in two hospitals in Kirundo province is zero. RDT showed to have an excellent specificity and, therefore, can be used to rule out congenital malaria: the risk of overtreatment is low. However, as no cases of congenital malaria were detected, the study was not able to draw conclusions about the sensitivity of the RDT, nor about risk factors for congenital malaria. Further studies evaluating the sensitivity of RDT for diagnosis of congenital malaria are needed.	[Stassijns, Jorgen] Med Sans Frontieres, Brussels Operat Ctr, 46 Rue Arbre Benit, B-1050 Brussels, Belgium; [van den Boogaard, Wilma] Med Sans Frontieres, Brussels Operat Ctr, Operat Res Unit, Luxembourg, Luxembourg; [van den Boogaard, Wilma; Pannus, Pieter] Med Sans Frontieres, Brussels Operat Ctr, Kirundo, Kirundo Provinc, Burundi; [Pannus, Pieter; Rosanas-Urgell, Anna] Inst Trop Med, Antwerp, Belgium; [Nkunzimana, Alphonse] Minist Hlth, Prov Sanit Kirundo, Kirundo, Kirundo Provinc, Burundi	Stassijns, J (reprint author), Med Sans Frontieres, Brussels Operat Ctr, 46 Rue Arbre Benit, B-1050 Brussels, Belgium.	jorgenstassijns@gmail.com			MSF Brussels Operational Centre; Ministry of Foreign Affairs, Luxembourg	This study was funded by MSF Brussels Operational Centre and the Ministry of Foreign Affairs, Luxembourg.	Coll O, 2008, J PERINAT MED, V36, P15, DOI 10.1515/JPM.2008.002; D'Alessandro U, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-400; Enweronu-Laryea CC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-17; EZEOKE ACJ, 1985, CENT AFR J MED, V31, P241; Falade C, 2007, TROP MED INT HEALTH, V12, P1279, DOI 10.1111/j.1365-3156.2007.01931.x; Lamikanra O T, 1993, West Afr J Med, V12, P213; LARKIN GL, 1991, AM J TROP MED HYG, V45, P587, DOI 10.4269/ajtmh.1991.45.587; Malhotra I, 2006, J INFECT DIS, V194, P176, DOI 10.1086/505150; Menendez C, 2007, SEMIN FETAL NEONAT M, V12, P207, DOI 10.1016/j.siny.2007.01.018; [MSPLS ICF International ISTEEBU], 2013, BUR ENQ IND PAL 2012; MSPLS, 2014, ANN STAT DONN CTR SA; Mukhtar MY, 2006, J TROP PEDIATRICS, V52, P19, DOI 10.1093/tropej/fmi044; NYIRJESY P, 1993, CLIN INFECT DIS, V16, P127, DOI 10.1093/clinids/16.1.127; Obiajunwa PO, 2005, J TROP PEDIATRICS, V51, P219, DOI 10.1093/tropej/fmi003; Oduwole OA, 2011, AM J TROP MED HYG, V84, P386, DOI 10.4269/ajtmh.2011.10-0253; Ojukwu JU, 2004, NIG J PAEDIAT, V31, P48; Orogade AA, 2008, J PEDIAT INFECT DISE, V3, P181; Ouedraogo A, 2012, J TROP MED, V2012; Pengsaa K, 2007, ANN TROP PAEDIATR, V27, P133, DOI 10.1179/146532807X192507; Riley EM, 2000, INFECT IMMUN, V68, P5856, DOI 10.1128/IAI.68.10.5856-5863.2000; Riley EM, 2001, PARASITE IMMUNOL, V23, P51, DOI 10.1046/j.1365-3024.2001.00364.x; Rosanas-Urgell A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-361; Uneke CJ, 2007, PARASITOL RES, V101, P835, DOI 10.1007/s00436-007-0577-9; Wagner G, 1998, AM J TROP MED HYG, V59, P115, DOI 10.4269/ajtmh.1998.59.115	24	1	1	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 30	2016	15								443	10.1186/s12936-016-1478-0				6	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU9KM	WOS:000382535900004	27577552	DOAJ Gold, Green Published			2019-04-02	
J	Korba, RA; Alayat, MS; Bouiba, L; Boudrissa, A; Bouslama, Z; Boukraa, S; Francis, F; Failloux, AB; Boubidi, SC				Korba, Raouf Amara; Alayat, Moufida Saoucen; Bouiba, Lazhari; Boudrissa, Abdelkarim; Bouslama, Zihad; Boukraa, Slimane; Francis, Frederic; Failloux, Anna-Bella; Boubidi, Said Chaouki			Ecological differentiation of members of the Culex pipiens complex, potential vectors of West Nile virus and Rift Valley fever virus in Algeria	PARASITES & VECTORS			English	Article						Culex pipiens complex; Molestus; CQ11; Hybrid; Algeria; Autogeny; Stenogamy	DIPTERA-CULICIDAE; EXPERIMENTAL TRANSMISSION; POPULATION-STRUCTURE; AEDES-AEGYPTI; MOSQUITOS; MOLESTUS; METHYLATION; FORMS; HYBRIDIZATION; AUTOGENY	Background: We investigated the ecological differentiation of two members of the Culex pipiens complex, Cx. p. pipiens form pipiens and Cx. p. pipiens form molestus in three sites, El-Kala, M'Sila and Tinerkouk in Algeria. These two forms are the most widespread mosquito vectors in temperate regions exhibiting important behavioural and physiological differences. Nevertheless, this group of potential vectors has been poorly studied, particularly in North Africa. Methods: Ten larval populations of Cx. p. pipiens were sampled from various above-and underground habitats in three zones representing the three bioclimatic regions in Algeria. The reproduction characteristics were also investigated in the laboratory to define the rates of autogeny and stenogamy. Identification of Cx. p. pipiens members present in Algeria was achieved using a molecular analysis with the microsatellite CQ11 locus. Results: We detected larvae of Cx. p. pipiens in all areas suggesting that the species is a ubiquitous mosquito well adapted to various environments. To our knowledge, this study provides the first molecular evidence of the presence of the Cx. p. pipiens form molestus and hybrids (molestus/pipiens) in Algeria with a high proportion of molestus form (48.3 %) in comparison with hybrids (36.8 %) and pipiens form (14.9 %). Conclusions: Some unexpected correlations between the proportion of forms pipiens, molestus and hybrids, and mosquito biological characteristics were observed suggesting some epigenetic effects controlling Cx. p. pipiens mating and reproduction. Consequences for pathogen transmission are discussed.	[Korba, Raouf Amara; Bouslama, Zihad] Univ Badji Mokhtar, Lab Ecol Syst Terr & Aquat, Dept Biol, Fac Sci, Annaba, Algeria; [Korba, Raouf Amara; Bouiba, Lazhari; Boudrissa, Abdelkarim; Boubidi, Said Chaouki] Inst Pasteur Alger, Unite Entomol Med, Serv Ecoepidemiol Parasit & Genet Populat, Algiers, Algeria; [Alayat, Moufida Saoucen] Univ Badji Mokhtar, Lab Biol Anim Appl, Fac Sci, Dept Biol, Annaba, Algeria; [Boukraa, Slimane; Francis, Frederic] Univ Liege, Unit Funct & Evolutionary Entomol, Gembloux Agro Bio Tech, Passage Deportes 2, B-5030 Gembloux, Belgium; [Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France	Korba, RA (reprint author), Univ Badji Mokhtar, Lab Ecol Syst Terr & Aquat, Dept Biol, Fac Sci, Annaba, Algeria.; Korba, RA (reprint author), Inst Pasteur Alger, Unite Entomol Med, Serv Ecoepidemiol Parasit & Genet Populat, Algiers, Algeria.	amarakorbaraouf@hotmail.com			Institut Pasteur (ACIP grant) [A-08-2009]; French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" [ANR-10-LABX-62-IBEID]; PhD fellowship "Biodiversity, Evolution and Ecology of Health" from the Algerian Ministry of Higher Education and Scientific Research	This work was funded by the Institut Pasteur (ACIP grant A-08-2009) and the French Government's Investissement d'Avenir program, Laboratoire d'Excellence "Integrative Biology of Emerging Infectious Diseases" (grant no ANR-10-LABX-62-IBEID). AKR was supported by PhD fellowship "Biodiversity, Evolution and Ecology of Health" from the Algerian Ministry of Higher Education and Scientific Research.	Alto BW, 2012, MED VET ENTOMOL, V26, P396, DOI 10.1111/j.1365-2915.2012.01010.x; Amraoui F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-83; Amraoui F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036757; Arsevska E, 2015, TRANSBOUND EMERG DIS, V2; Bahnck CM, 2006, AM J TROP MED HYG, V75, P251, DOI 10.4269/ajtmh.2006.75.2.0750251; Becker N, 2012, J AM MOSQUITO CONTR, V28, P53, DOI 10.2987/8756-971X-28.4s.53; Ben Hassine T, 2015, TRANSBOUND EMERG DIS, P29; CHEVILLON C, 1995, GENET RES, V66, P147, DOI 10.1017/S0016672300034492; Christophers S. R., 1945, TRANS ROY ENT SOC LONDON, V95, P25; Christophers SR, 1951, T R ENTOMOL SOC LOND, V102, P372; DIGOUTTE JP, 1989, RES VIROLOGY, V140, P27, DOI 10.1016/S0923-2516(89)80081-0; El Harrak M, 1997, VIROLOGIE, V1, P248; Emberger L., 1955, RECUEIL TRAV LAB BOT, V7, P3; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; FOSTER WA, 1987, ANN ENTOMOL SOC AM, V80, P103, DOI 10.1093/aesa/80.2.103; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Garbouj M., 2003, B EPIDEMIOLOGIQUE, V3, P4; Gomes B, 2013, INFECT GENET EVOL, V16, P218, DOI 10.1016/j.meegid.2013.02.006; Gomes B, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-93; Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Huang SM, 2008, AM J TROP MED HYG, V79, P518, DOI 10.4269/ajtmh.2008.79.518; Ishii T., 1983, Journal of Science College of General Education University of Tokushima, V16, P27; Kamura T., 1959, ENDEMIC DIS B NAGASA, V1, P51; Kassim NFA, 2012, AUST J ENTOMOL, V51, P67, DOI 10.1111/j.1440-6055.2011.00834.x; Kille P, 2013, SOIL BIOL BIOCHEM, V57, P524, DOI 10.1016/j.soilbio.2012.10.014; Knight K. L., 1951, Bulletin de la Societe Fouad ler d'Entomologie, V35, P175; Korba Raouf Amara, 2015, Advances in Environmental Biology, V9, P288; Kothera L, 2010, J MED ENTOMOL, V47, P805, DOI 10.1603/ME10031; Krida G, 2015, MED VET ENTOMOL, V29, P124, DOI 10.1111/mve.12107; Krida G, 2011, Bull Soc Pathol Exot, V104, P250, DOI 10.1007/s13149-010-0122-4; LeGuenno B, 1996, LANCET, V348, P1315; LOUNIBOS LP, 1991, MEM I OSWALDO CRUZ, V86, P57, DOI 10.1590/S0074-02761991000100010; Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x; MEEGAN JM, 1980, AM J TROP MED HYG, V29, P1405, DOI 10.4269/ajtmh.1980.29.1405; Menzel S, 2011, AQUAT TOXICOL, V105, P640, DOI 10.1016/j.aquatox.2011.08.025; MITCHELL CJ, 1989, J MED ENTOMOL, V26, P332, DOI 10.1093/jmedent/26.4.332; Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Nelms BM, 2013, AM J TROP MED HYG, V89, P1168, DOI 10.4269/ajtmh.13-0219; PASTEUR N, 1977, ANN PARASIT HUM COMP, V52, P205; Pilo-Moron E, 1970, Arch Inst Pasteur Alger, V48, P181; Reusken CBEM, 2010, J VECTOR ECOL, V35, P210, DOI 10.1111/j.1948-7134.2010.00050.x; Rudolf M, PLOS ONE, V8; Schmitz RJ, 2008, P NATL ACAD SCI USA, V105, P411, DOI 10.1073/pnas.0710423104; Schuffenecker I, 2005, EMERG INFECT DIS, V11, P306, DOI 10.3201/eid1102.040817; Senevet G., 1958, Arch Inst Pasteur Alger Algiers, V36, P70; SENEVET G, 1959, MOUSTIQUES AFRIQUE N; Senevet G, 1960, ARCH I PASTEUR ALGER, V38, P306; Shute PG, 1951, T ROY ENT SOC LONDON, V102, P380; Silver J.B., 2008, MOSQUITO ECOLOGY FIE; Spielman A, 2001, ANN NY ACAD SCI, V951, P220; SPIELMAN A, 1967, B WORLD HEALTH ORGAN, V37, P271; STEINWASCHER K, 1984, AM MIDL NAT, V112, P76, DOI 10.2307/2425459; TAHORI AS, 1955, AM J TROP MED HYG, V4, P1015, DOI 10.4269/ajtmh.1955.4.1015; Tate P., 1936, Parasitology Cambridge, V28, P115; Triki H, 2001, Med Trop (Mars), V61, P487; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; URBANELLI S, 1985, B ENTOMOL RES, V75, P291; Vinogradova EB, 1992, AKAIEKA NEWSLETTER, V15, P1; Vinogradova EB, 2000, CULEX PIPIENS PIPIEN	62	3	4	1	16	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 17	2016	9								455	10.1186/s13071-016-1725-9				11	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DW7NA	WOS:000383836500001	27534938	DOAJ Gold, Green Published			2019-04-02	
J	Knols, BGJ; Farenhorst, M; Andriessen, R; Snetselaar, J; Suer, RA; Osinga, AJ; Knols, JMH; Deschietere, J; Ng'habi, KR; Lyimo, IN; Kessy, ST; Mayagaya, VS; Sperling, S; Cordel, M; Sternberg, ED; Hartmann, P; Mnyone, LL; Rose, A; Thomas, MB				Knols, Bart G. J.; Farenhorst, Marit; Andriessen, Rob; Snetselaar, Janneke; Suer, Remco A.; Osinga, Anne J.; Knols, Johan M. H.; Deschietere, Johan; Ng'habi, Kija R.; Lyimo, Issa N.; Kessy, Stella T.; Mayagaya, Valeriana S.; Sperling, Sergej; Cordel, Michael; Sternberg, Eleanore D.; Hartmann, Patrick; Mnyone, Ladslaus L.; Rose, Andreas; Thomas, Matthew B.			Eave tubes for malaria control in Africa: an introduction	MALARIA JOURNAL			English	Editorial Material						Vector control; Resistance; Eave tube; House modification; Africa; Malaria elimination	HOUSE-ENTRY; PYRETHROID RESISTANCE; MOSQUITOS; TRANSMISSION; BEHAVIOR; VECTORS; RISK; NETS	In spite of massive progress in the control of African malaria since the turn of the century, there is a clear and recognized need for additional tools beyond long-lasting insecticide-treated bed nets (LLINs) and indoor residual spraying (IRS) of insecticides, to progress towards elimination. Moreover, widespread and intensifying insecticide resistance requires alternative control agents and delivery systems to enable development of effective insecticide resistance management strategies. This series of articles presents a novel concept for malaria vector control, the 'eave tube', which may fulfil these important criteria. From its conceptualization to laboratory and semi-field testing, to demonstration of potential for implementation, the stepwise development of this new vector control approach is described. These studies suggest eave tubes (which comprise a novel way of delivering insecticides plus screening to make the house more 'mosquito proof') could be a viable, cost-effective, and acceptable control tool for endophilic and endophagic anophelines, and possibly other (nuisance) mosquitoes. The approach could be applicable in a wide variety of housing in sub-Saharan Africa, and possibly beyond, for vectors that use the eave as their primary house entry point. The results presented in these articles were generated during an EU-FP7 funded project, the mosquito contamination device (MCD) project, which ran between 2012 and 2015. This was a collaborative project undertaken by vector biologists, product developers, modellers, materials scientists, and entrepreneurs from five different countries.	[Knols, Bart G. J.; Farenhorst, Marit; Andriessen, Rob; Snetselaar, Janneke; Suer, Remco A.; Osinga, Anne J.; Knols, Johan M. H.] In2Care BV, Marijkeweg 22, NL-6709 PG Wageningen, Netherlands; [Deschietere, Johan; Hartmann, Patrick] CTF2000, Baaikensstr 11, B-9240 Zele, Belgium; [Ng'habi, Kija R.; Lyimo, Issa N.; Kessy, Stella T.; Mayagaya, Valeriana S.; Mnyone, Ladslaus L.] Ifakara Hlth Inst, Environm Hlth & Ecol Sci Themat Grp, POB 53, Ifakara, Tanzania; [Sperling, Sergej; Cordel, Michael; Rose, Andreas] Biogents AG, Weissenburgstr 22, D-93055 Regensburg, Germany; [Sternberg, Eleanore D.; Thomas, Matthew B.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Sternberg, Eleanore D.; Thomas, Matthew B.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA	Knols, BGJ (reprint author), In2Care BV, Marijkeweg 22, NL-6709 PG Wageningen, Netherlands.	bart@in2care.org	Knols, Bart/C-5765-2017				Anderson L, 2014, DURABLE HOUSING IMPR; Andriessen R, 2015, P NATL ACAD SCI USA, V112, P12081, DOI 10.1073/pnas.1510801112; [Anonymous], 2013, LARV SOURC MAN SUPPL; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Bradley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080626; Celli A, 1900, LANCET, V2, P1603; Cuzin-Ouattara N, 1999, T ROY SOC TROP MED H, V93, P473, DOI 10.1016/S0035-9203(99)90343-7; Diallo DA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P377; Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Gordon SB, 2014, LANCET RESP MED, V2, P823, DOI 10.1016/S2213-2600(14)70168-7; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Hemingway J, 2016, LANCET, V387, P1785, DOI 10.1016/S0140-6736(15)00417-1; Hemingway J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0431; Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110; Killeen GF, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1280-z; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Kirby MJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-2; Lengeler C, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000363.PUB2; Lindsay SW, 2003, TROP MED INT HEALTH, V8, P512, DOI 10.1046/j.1365-3156.2003.01059.x; LINDSAY SW, 1988, T ROY SOC TROP MED H, V82, P645, DOI 10.1016/0035-9203(88)90546-9; Manson P, 1900, Br Med J, V2, P949; Menger DJ, 2016, AM J TROP MED HYG, V94, P868, DOI 10.4269/ajtmh.15-0632; Njie M, 2009, J MED ENTOMOL, V46, P505, DOI 10.1603/033.046.0314; Paaijmans KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-183; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; Sougoufara S, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-125; Spitzen J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1293-7; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; Toe KH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1342-6; Tusting LS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0724-1; United Nations, 2011, MILL DEV GOALS REP 2; von Seidlein L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-200; Wanzirah H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117396; Wernsdorfer W. H., 1988, MALARIA PRINCIPLES P; WHO, 2012, GLOB PLAN INS RES MA; WHO, 2012, HDB INT VECT MAN; World Health Organization, 1997, VECTOR CONTROL METHO	40	18	18	0	14	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1475-2875			MALARIA J	Malar. J.	AUG 11	2016	15								404	10.1186/s12936-016-1452-x				7	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DT3CI	WOS:000381357700003	27515306	DOAJ Gold, Green Published			2019-04-02	
J	van As, J; Cook, CA; Netherlands, EC; Smit, NJ				van As, Johann; Cook, Courtney A.; Netherlands, Edward C.; Smit, Nico J.			A new lizard malaria parasite Plasmodium intabazwe n. sp (Apicomplexa: Haemospororida: Plasmodiidae) in the Afromontane Pseudocordylus melanotus (Sauria: Cordylidae) with a review of African saurian malaria parasites	PARASITES & VECTORS			English	Article						Plasmodiid taxonomy; Molecular characterisation; Morphological description; Plasmodium zonuriae; Haematozoa; Haemosporids; Malaria	CYTOCHROME-B; ADELEORINA HEPATOZOIDAE; SPECIES CONCEPTS; SOUTH-AFRICA; LIFE-CYCLE; REDESCRIPTION; HAEMOPROTEIDAE; PHYLOGENY; DIVERSITY; EVOLUTION	Background: Saurian malaria parasites are diverse apicomplexan blood parasites including the family Plasmodiidae Mesnil, 1903, and have been studied since the early 1900s. Currently, at least 27 species of Plasmodium are recorded in African lizards, and to date only two species, Plasmodium zonuriae (Pienaar, 1962) and Plasmodium cordyli Telford, 1987, have been reported from the African endemic family Cordylidae. This paper presents a description of a new malaria parasite in a cordylid lizard and provides a phylogenetic hypothesis for saurian Plasmodium species from South Africa. Furthermore, it provides a tabular review of the Plasmodium species that to date have been formally described infecting species of African lizards. Methods: Blood samples were collected from 77 specimens of Pseudocordylus melanotus (A. Smith, 1838) from Platberg reserve in the Eastern Free State, and two specimens of Cordylus vittifer (Reichenow, 1887) from the Roodewalshoek conservancy in Mpumalanga (South Africa). Blood smears were Giemsa-stained, screened for haematozoa, specifically saurian malaria parasites, parasite stages were photographed and measured. A small volume was also preserved for TEM studies. Plasmodium and Haemoproteus primer sets, with a nested-polymerase chain reaction (PCR) protocol, were employed to target a fragment of the cytochrome-b (cyt-b) gene region. Resulting sequences of the saurian Plasmodium species' isolates were compared with each other and to other known Plasmodium spp. sequences in the GenBank database. Results: The presence of P. zonuriae in both specimens of the type lizard host C. vittifer was confirmed using morphological characteristics, which subsequently allowed for the species' molecular characterisation. Of the 77 P. melanotus, 44 were parasitised by a Plasmodium species, which when compared morphologically to other African saurian Plasmodium spp. and molecularly to P. zonuriae, supported its description as a new species Plasmodium intabazwe n. sp. Conclusions: This is the first morphological and molecular account of Plasmodium species within the African endemic family Cordylidae from South Africa. The study highlights the need for molecular analysis of other cordylid Plasmodium species within Africa. Future studies should also include elucidating of the life-cycles of these species, thus promoting the use of both morphological and molecular characteristics in species descriptions of saurian malaria parasites.	[van As, Johann] Univ Free State, Dept Zool & Entomol, QwaQwa Campus, Bloemfontein, Free State, South Africa; [Cook, Courtney A.; Netherlands, Edward C.; Smit, Nico J.] North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa; [Netherlands, Edward C.] Univ Leuven, Lab Aquat Ecol Evolut & Conservat, B-3000 Leuven, Belgium	Cook, CA (reprint author), North West Univ, Unit Environm Sci & Management, Potchefstroom, South Africa.	apicomplexan@yahoo.co.za	J, Nico/L-4905-2013	J, Nico/0000-0001-7950-193X; Netherlands, Edward/0000-0003-1856-0586	National Research Foundation (NRF) of South Africa (NRF Thutuka) [TTK: 14042266483]; CAC (NRF Scarce Skills Postdoctoral Scholarship) [SFP13090332476]; ECN (NRF Scarce Skills Masters Scholarship) [UID: 89924]	The National Research Foundation (NRF) of South Africa provided funding to JVA (NRF Thutuka - Grant TTK: 14042266483), CAC (NRF Scarce Skills Postdoctoral Scholarship - Grant SFP13090332476), and ECN (NRF Scarce Skills Masters Scholarship - Grant UID: 89924). The role of the funding body was in the collection and analyses of data in this study. Opinions expressed and conclusions arrived at, are those of the authors and are not necessarily to be attributed to the NRF.	BALL GH, 1965, J PROTOZOOL, V12, P479, DOI 10.1111/j.1550-7408.1965.tb03246.x; BALL GH, 1967, J PROTOZOOL, V14, P198, DOI 10.1111/j.1550-7408.1967.tb01983.x; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; BRAY RS, 1959, J PROTOZOOL, V6, P13, DOI 10.1111/j.1550-7408.1959.tb03920.x; Cook CA, 2010, J PARASITOL, V96, P1168, DOI 10.1645/GE-2527.1; Cook CA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1600-8; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davies AJ, 2000, ADV PARASIT, V45, P1, DOI 10.1016/S0065-308X(00)45003-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Escalante AA, 1998, P NATL ACAD SCI USA, V95, P8124, DOI 10.1073/pnas.95.14.8124; Falk BG, 2015, EVOLUTION, V69, P1584, DOI 10.1111/evo.12683; GARNHAM P. C. C., 1996, MALARIA PARASITES OT; GARNHAM PCC, 1950, PARASITOLOGY, V40, P328, DOI 10.1017/S0031182000018205; GARNHAM PCC, 1984, J PROTOZOOL, V31, P518, DOI 10.1111/j.1550-7408.1984.tb05494.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; HOARE CECIL A., 1932, PARASITOLOGY, V24, P210; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; International Commission on Zoological Nomenclature, 2012, ZOOTAXA, V3450, P1; Javanbakht H, 2015, J EUKARYOT MICROBIOL, V62, P670, DOI 10.1111/jeu.12227; Lawrence RF, 1935, PARASITOLOGY, V37, P1; Martinsen ES, 2006, PARASITOLOGY, V133, P279, DOI 10.1017/S0031182006000424; Netherlands EC, 2015, INT J PARASITOL-PAR, V4, P135, DOI 10.1016/j.ijppaw.2015.01.003; Netherlands EC, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0552-0; PAPERNA I, 1991, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V13, P309; Perkins SL, 2000, P ROY SOC B-BIOL SCI, V267, P2345, DOI 10.1098/rspb.2000.1290; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.2307/3285540; Perkins SL, 2009, J PARASITOL, V95, P424, DOI 10.1645/GE-1750.1; PETIT G, 1983, PROTISTOLOGICA, V19, P537; PIENAAR UDV, 1962, HAEMATOLOGY SOME S A; Pineda-Catalan O, 2013, J PARASITOL, V99, P1089, DOI 10.1645/13-296.1; PRINGLE G., 1960, TRANS ROY SOC TROP MED AND HYG, V54, P411, DOI 10.1016/0035-9203(60)90085-7; Riding D., 1930, Transactions of the Royal Society of Tropical Medicine and Hygiene London, V23, P635, DOI 10.1016/S0035-9203(30)80029-4; SCHALL JJ, 1990, PARASITOL TODAY, V6, P264, DOI 10.1016/0169-4758(90)90188-A; Schwetz J., 1931, Annales de Parasitologie Paris, V9, P193; TELFORD S.R., 2009, HEMOPARASITES REPTIL; Telford S.R. Jr, 1984, P385; Telford Sam R. Jr, 1994, P1; TELFORD SR, 1988, INT J PARASITOL, V18, P197, DOI 10.1016/0020-7519(88)90061-6; Telford SR, 2005, J PARASITOL, V91, P135, DOI 10.1645/GE-3395; TELFORD SR, 1987, ANN PARASIT HUM COMP, V62, P395, DOI 10.1051/parasite/1987625395; TELFORD SR, 1987, ANN PARASIT HUM COMP, V62, P405, DOI 10.1051/parasite/1987625405; TELFORD SR, 1986, J PARASITOL, V72, P271, DOI 10.2307/3281603; TELFORD SR, 1983, J PARASITOL, V69, P1146, DOI 10.2307/3280880; THEILER M, 1930, AFRICAN REPUBLIC LIB, P490; Valkiunas G, 2009, PARASITOL RES, V104, P1061, DOI 10.1007/s00436-008-1289-5; Van As J, 2015, FOLIA PARASIT, V62; Van As J, 2013, ZOOTAXA, V3608, P345, DOI 10.11646/zootaxa.3608.5.3; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Wenyon C.M., 1909, REP WELL TROP RES LA, V3, P121	50	2	2	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 8	2016	9								437	10.1186/s13071-016-1702-3				15	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DT0TD	WOS:000381195000001	27502045	DOAJ Gold, Green Published			2019-04-02	
J	Kmentova, N; Gelnar, M; Koblmuller, S; Vanhove, MPM				Kmentova, Nikol; Gelnar, Milan; Koblmuller, Stephan; Vanhove, Maarten P. M.			Deep-water parasite diversity in Lake Tanganyika: description of two new monogenean species from benthopelagic cichlid fishes	PARASITES & VECTORS			English	Article						Benthochromis horii; Cichlidae; Cichlidogyrus; Monogenea; Trematocara unimaculatum	ADAPTIVE RADIATION; SEXUAL SELECTION; ANCYROCEPHALIDAE MONOGENEA; GILL PARASITES; HOST-SPECIFICITY; ANCIENT LAKE; PLATYHELMINTHES; SPECIATION; TELEOSTEI; PHYLOGENY	Background: Lake Tanganyika is the world's second deepest lake. Its diverse cichlid assemblage offers a unique opportunity for studying a deep-water host-parasite model in freshwater. Low host specificity and a broad host range including representatives of the Bathybatini tribe in the only monogenean parasite described from this habitat, Cichlidogyrus casuarinus Pariselle, Muterezi Bukinga & Vanhove, 2015 suggest a link between lower specificity and lower host density. Conversely, high host specificity and species richness are reported for monogeneans of the lake's littoral cichlids. We further investigated whether the deep-water environment in Lake Tanganyika is really monogenean species-depauperate by investigating the monogenean fauna of Trematocara unimaculatum (a representative of the tribe Trematocarini, the sister lineage of the Bathybatini) and Benthochromis horii, a member of the tribe Benthochromini, found in the same deep-water habitat as the already known hosts of C. casuarinus. Methods: Sclerotised structures of the collected monogenean individuals were characterised morphologically using light microscopy and morphometrics. Results: Both examined cichlid species are infected by a single monogenean species each, which are new to science. They are described as Cichlidogyrus brunnensis n. sp., infecting T. unimaculatum, and Cichlidogyrus attenboroughi n. sp., parasitising on B. horii. Diagnostic characteristics include the distal bifurcation of the accessory piece in C. brunnensis n. sp. and the combination of long auricles and no heel in C. attenboroughi n. sp. In addition C. brunnensis n. sp. does not resemble C. casuarinus, the only species of Cichlidogyrus thus far reported from the Bathybatini. Also Cichlidogyrus attenboroughi n. sp. does not resemble any of the monogenean species documented from the pelagic zone of the lake and is among the few described species of Cichlidogyrus without heel. Conclusions: As two new and non-resembling Cichlidogyrus species are described from T. unimaculatum and B. horii, colonisation of the deep-water habitat by more than one morphotype of Cichlidogyrus is evident. Based on morphological comparisons with previously described monogenean species, parasite transfers with the littoral zone are possible. Therefore, parasites of pelagic cichlids in the lake do not seem to only mirror host phylogeny and the evolutionary history of this host-parasite system merits further attention.	[Kmentova, Nikol; Gelnar, Milan; Vanhove, Maarten P. M.] Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CS-61137 Brno, Czech Republic; [Koblmuller, Stephan] Graz Univ, Inst Zool, Univ Pl 2, A-8010 Graz, Austria; [Koblmuller, Stephan] Acad Sci Czech Republic, Inst Vertebrate Biol, Kvetna 8, CS-60365 Brno, Czech Republic; [Vanhove, Maarten P. M.] Royal Museum Cent Africa, Biol Dept, Leuvensesteenweg 13, B-3080 Tervuren, Belgium; [Vanhove, Maarten P. M.] Univ Leuven, Dept Biol, Lab Biodivers & Evolutionary Genom, Ch Deberiotstr 32, B-3000 Leuven, Belgium; [Vanhove, Maarten P. M.] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, Capac Biodivers & Sustainable Dev, Vautierstr 29, B-1000 Brussels, Belgium	Kmentova, N (reprint author), Masaryk Univ, Fac Sci, Dept Bot & Zool, Kotlarska 2, CS-61137 Brno, Czech Republic.	kmentovan@mail.muni.cz		Vanhove, Maarten/0000-0003-3100-7566; Koblmuller, Stephan/0000-0002-1024-3220	Czech Science Foundation [GBP505/12/G112-ECIP]	This study was financially supported by the Czech Science Foundation (GBP505/12/G112-ECIP).	Barlow GW, 2000, CICHLID FISHES NATUR; Barson M, 2010, PARASITOLOGY, V137, P1585, DOI 10.1017/S0031182010000302; Boeger WA, 1997, INT J PARASITOL, V27, P1495, DOI 10.1016/S0020-7519(97)00140-9; Brown KJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-188; Bukinga FM, 2012, PARASITOL RES, V111, P2049, DOI 10.1007/s00436-012-3052-1; CAMPBELL RA, 1980, MAR BIOL, V57, P301, DOI 10.1007/BF00387573; Day JJ, 2013, SYST BIOL, V62, P351, DOI 10.1093/sysbio/syt001; Desdevises Y, 2002, BIOL J LINN SOC, V77, P431, DOI 10.1046/j.1095-8312.2002.00114.x; Ergens R, 1970, CAUSATIVE AGENTS FIS; Erpenbeck D, 2011, MOL PHYLOGENET EVOL, V61, P231, DOI 10.1016/j.ympev.2011.05.021; FRYER G, 1991, HYDROBIOLOGIA, V211, P137, DOI 10.1007/BF00037369; Gillardin C, 2012, PARASITOL RES, V110, P305, DOI 10.1007/s00436-011-2490-5; Glaubrecht Matthias, 2008, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V84, P71, DOI 10.1002/mmnz.200700016; Humason GL, 1979, ANIMAL TISSUE TECHNI; International Commission on Zoological Nomenclature, 2012, ZOOTAXA, V3450, P1; Justine Jean-Lou, 2012, Aquat Biosyst, V8, P22, DOI 10.1186/2046-9063-8-22; Kirchberger Paul C, 2012, Int J Evol Biol, V2012, P716209, DOI 10.1155/2012/716209; Kmentova N, 2016, PEERJ, V4, DOI 10.7717/peerj.1629; Knight ME, 2004, P ROY SOC B-BIOL SCI, V271, P675, DOI 10.1098/rspb.2003.2639; Koblmuller S, 2008, HYDROBIOLOGIA, V615, P5, DOI 10.1007/s10750-008-9552-4; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; Marijnissen SAE, 2006, MOL PHYLOGENET EVOL, V40, P628, DOI 10.1016/j.ympev.2006.03.025; Meixner MJ, 2007, MOL PHYLOGENET EVOL, V45, P875, DOI 10.1016/j.ympev.2007.09.007; Mendlova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037268; Meyer BS, 2015, MOL PHYLOGENET EVOL, V83, P56, DOI 10.1016/j.ympev.2014.10.009; Michel E, 1995, EVOLUTIONARY DIVERSI; Morand S, 2002, INT J PARASITOL, V32, P111, DOI 10.1016/S0020-7519(01)00347-2; Muschick M, 2012, CURR BIOL, V22, P2362, DOI 10.1016/j.cub.2012.10.048; PAPERNA I., 1969, Revue de Zoologie et de Botanique Africaines, V79, P15; PAPERNA ILAN, 1960, BAMIDGEH, V12, P20; PARISELLE A, 1995, PARASITE, V2, P203, DOI 10.1051/parasite/199502s2203; Pariselle A, 2003, SYST PARASITOL, V56, P201, DOI 10.1023/B:SYPA.0000003807.27452.bd; Pariselle A, 1996, SYST PARASITOL, V34, P109, DOI 10.1007/BF00009685; Pariselle A., 2011, INT J EVOL BIOL, V2011, DOI DOI 10.4061/2011/471480; Pariselle A, 2015, CONTRIB ZOOL, V84, P25; Pariselle A, 2015, HYDROBIOLOGIA, V748, P99, DOI 10.1007/s10750-014-1975-5; Pariselle A, 2009, ZOOSYSTEMA, V31, P849, DOI 10.5252/z2009n4a6; Peart CR, 2014, MOL PHYLOGENET EVOL, V73, P119, DOI 10.1016/j.ympev.2014.01.013; POLL M, 1986, Academie Royale de Belgique Memoires de la Classe des Sciences Collection in Octavo, V45, P1; Pugachev ON, 2009, GUIDE MONOGENOIDEA F; Rehulkova E, 2013, PARASITOL RES, V112, P1399, DOI 10.1007/s00436-013-3291-9; Santos ME, 2012, SCIENCE, V338, P619, DOI 10.1126/science.1224818; Schoelinck C, 2012, PARASITOL INT, V61, P356, DOI 10.1016/j.parint.2012.01.009; Schon I, 2012, HYDROBIOLOGIA, V682, P91, DOI 10.1007/s10750-011-0935-6; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, ECOL LETT, V2, P367; Simkova A, 2002, BIOL J LINN SOC, V76, P125, DOI 10.1046/j.1095-8312.2002.00056.x; Sirnkova A, 2004, EVOLUTION, V58, P1001; Sturmbauer C, 1998, J FISH BIOL, V53, P18; Sturmbauer C, 2011, BIODIVERSITY HOTSPOT, P333, DOI DOI 10.1007/978-3-642-20992-5_18; Takahashi T, 2014, J FISH BIOL, V84, P929, DOI 10.1111/jfb.12309; Takahashi T, 2003, ICHTHYOL RES, V50, P367, DOI 10.1007/s10228-003-0181-7; Takahashi T, 2016, MOL PHYLOGENET EVOL, V100, P234, DOI 10.1016/j.ympev.2016.04.012; Van Steenberge M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124474; Vanhove MPM, 2015, PARASITE DIVERSITY AND DIVERSIFICATION: EVOLUTIONARY ECOLOGY MEETS PHYLOGENETICS, P401; Vanhove MPM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13669; Vanhove MPM, 2013, ZOOTAXA, V3608, P398, DOI 10.11646/zootaxa.3608.5.8; Vanhove MPM, 2011, ZOOLOGIA-CURITIBA, V28, P253, DOI 10.1590/S1984-46702011000200016; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Vignon M, 2010, PARASITOL INT, V59, P183, DOI 10.1016/j.parint.2010.01.006; Weiss JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125043	61	4	4	1	30	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1756-3305			PARASITE VECTOR	Parasites Vectors	AUG 3	2016	9								426	10.1186/s13071-016-1696-x				9	Parasitology; Tropical Medicine	Parasitology; Tropical Medicine	DT0SO	WOS:000381193500001	27488497	DOAJ Gold, Green Published			2019-04-02	
J	Staedke, SG; Maiteki-Sebuguzi, C; DiLiberto, DD; Webb, EL; Mugenyi, L; Mbabazi, E; Gonahasa, S; Kigozi, SP; Willey, BA; Dorsey, G; Kamya, MR; Chandler, CIR				Staedke, Sarah G.; Maiteki-Sebuguzi, Catherine; DiLiberto, Deborah D.; Webb, Emily L.; Mugenyi, Levi; Mbabazi, Edith; Gonahasa, Samuel; Kigozi, Simon P.; Willey, Barbara A.; Dorsey, Grant; Kamya, Moses R.; Chandler, Clare I. R.			The Impact of an Intervention to Improve Malaria Care in Public Health Centers on Health Indicators of Children in Tororo, Uganda (PRIME): A Cluster-Randomized Trial	AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE			English	Article							RAPID DIAGNOSTIC-TESTS; PLASMODIUM-FALCIPARUM; ANTIMALARIAL THERAPY; 3 SITES; AFRICA; ACCESS; TRANSMISSION; MANAGEMENT; INFECTION; PROTOCOL	Optimizing quality of care for malaria and other febrile illnesses is a complex challenge of major public health importance. To evaluate the impact of an intervention aiming to improve malaria case management on the health of community children, a cluster-randomized trial was conducted from 2010-2013 in Tororo, Uganda, where malaria transmission is high. Twenty public health centers were included; 10 were randomized in a 1:1 ratio to intervention or control. Households within 2 km of health centers provided the sampling frame for the evaluation. The PRIME intervention included training in fever case management using malaria rapid diagnostic tests (mRDTs), patient-centered services, and health center management; plus provision of mRDTs and artemether lumefantrine. Cross-sectional community surveys were conducted at baseline and endline (N = 8,766), and a cohort of children was followed for approximately 18 months (N = 992). The primary outcome was prevalence of anemia (hemoglobin < 11.0 g/dL) in children under 5 years of age in the final community survey. The intervention was delivered successfully; however, no differences in prevalence of anemia or parasitemia were observed between the study arms in the final community survey or the cohort. In the final survey, prevalence of anemia in children under 5 years of age was 62.5% in the intervention versus 63.1% in control (adjusted risk ratio = 1.01; 95% confidence interval = 0.91-1.13; P = 0.82). The PRIME intervention, focusing on training and commodities, did not produce the expected health benefits in community children in Tororo. This challenges common assumptions that improving quality of care and access to malaria diagnostics will yield health gains.	[Staedke, Sarah G.; DiLiberto, Deborah D.; Webb, Emily L.; Willey, Barbara A.; Chandler, Clare I. R.] London Sch Hyg & Trop Med, Dept Clin Res, Dept Infect Dis Epidemiol, Dept Med Stat,Dept Global Hlth & Dev, London, England; [Staedke, Sarah G.; Maiteki-Sebuguzi, Catherine; Mugenyi, Levi; Mbabazi, Edith; Gonahasa, Samuel; Kigozi, Simon P.; Kamya, Moses R.] Infect Dis Res Collaborat, POB 7475, Kampala, Uganda; [Mugenyi, Levi] Hasselt Univ, Biostat 1, Diepenbeek, Belgium; [Dorsey, Grant] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kamya, Moses R.] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda; [Staedke, Sarah G.; Chandler, Clare I. R.] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [DiLiberto, Deborah D.] London Sch Hyg & Trop Med, Dept Med Stat, London, England; [Webb, Emily L.; Willey, Barbara A.] London Sch Hyg & Trop Med, Dept Infect Dis, London, England; [Chandler, Clare I. R.] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England	Staedke, SG (reprint author), Infect Dis Res Collaborat, POB 7475, Kampala, Uganda.	sarah.staedke@lshtm.ac.uk; cmaiteki@yahoo.com; deborah.diliberto@lshtm.ac.uk; emily.webb@lshtm.ac.uk; lmugenyi005@gmail.com; edithmbabazi@yahoo.com; sgonahasa1983@gmail.com; skigozi@yahoo.com; barbara.willey@lshtm.ac.uk; grant.dorsey@ucsf.edu; mkamya@infocom.co.ug; clare.chandler@lshtm.ac.uk		DiLiberto, Deborah/0000-0003-0528-5773	ACT Consortium through Bill & Melinda Gates Foundation; Medical Research Council [MR/K012126/1]	This work was supported by the ACT Consortium (http://www.actconsortium.org/) through a grant from the Bill & Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine.	Abba K, 2011, COCHRANE DB SYST REV, V7; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Chandler CIR, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-113; Chandler CIR, 2013, HUM RESOUR HEALTH, V11, DOI 10.1186/1478-4491-11-13; Chandler CIR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-95; Cundill B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0346-z; DiLiberto DD, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29067; Greenwood B, 2014, LANCET, V383, P1703, DOI 10.1016/S0140-6736(14)60044-1; Hayes RJ, 2009, INTERD STAT, P3; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hopkins H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2606; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Kamya MR, 2015, AM J TROP MED HYG, V92, P903, DOI 10.4269/ajtmh.14-0312; Kigozi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042857; Kilama M, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-111; Kizito J, 2012, MALARIA J, V11, DOI [10.1186/PREACCEPT-2317562776368437, 10.1186/1475-2875-11-55]; Klemick H, 2008, DEFINING ACCESS HLTH; Kyabayinze DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-695; Mbabazi P, 2015, AM J TROP MED HYG, V92, P530, DOI 10.4269/ajtmh.14-0180; Mbacham WF, 2014, LANCET GLOB HEALTH, V2, pE346, DOI 10.1016/S2214-109X(14)70201-3; National Academies of Sciences Engineering and Medicine, 2015, IMPR QUAL CAR LAW MI; Nayiga S, 2014, EVALUATION-US, V20, P471, DOI 10.1177/1356389014551484; Odaga J, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008998.pub2; Okwaro FM, 2015, SOC SCI MED, V131, P10, DOI 10.1016/j.socscimed.2015.02.032; Pariyo GW, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-39; Pariyo GW, 2005, HEALTH POLICY PLANN, V20, pI58, DOI 10.1093/heapol/czi051; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; Pullan RL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-2; Rafael Maria E, 2006, Nature, V444 Suppl 1, P39, DOI 10.1038/nature05445; Rao VB, 2013, TRENDS PARASITOL, V29, P164, DOI 10.1016/j.pt.2013.01.005; Staedke SG, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-114; Staedke SG, 2009, LANCET, V373, P1623, DOI 10.1016/S0140-6736(09)60328-7; Tougher S, 2012, LANCET, V380, P1916, DOI 10.1016/S0140-6736(12)61732-2; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2007, EV BUS STRENGTH HLTH; World Health Organization, 2012, T3 TEST TREAT TRACK	36	4	4	0	2	AMER SOC TROP MED & HYGIENE	MCLEAN	8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA	0002-9637	1476-1645		AM J TROP MED HYG	Am. J. Trop. Med. Hyg.	AUG	2016	95	2					358	367		10.4269/ajtmh.16-0103				10	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	ET3UY	WOS:000400206200018	27273646	Other Gold, Green Published			2019-04-02	
J	Vischer, N; Pfeiffer, C; Joller, A; Klingmann, I; Ka, A; Kpormegbe, SK; Burri, C				Vischer, N.; Pfeiffer, C.; Joller, A.; Klingmann, I.; Ka, A.; Kpormegbe, S. K.; Burri, C.			The Good Clinical Practice guideline and its interpretation - perceptions of clinical trial teams in sub-Saharan Africa	TROPICAL MEDICINE & INTERNATIONAL HEALTH			English	Article						clinical trials; Africa South of the Sahara; good clinical practice; qualitative research; guideline; essais cliniques; Afrique subsahararienne; bonnes pratiques cliniques; recherche qualitative; directive; Ensayos clinicos; africa al sur del Sahara; buenas practicas clinicas; investigacion cualitativa; guias	DEVELOPING-COUNTRIES; INFORMED-CONSENT; VACCINE TRIALS; IMPACT; RECOMMENDATIONS; DISEASES	ObjectivesTo explore the advantages and challenges of working with the Good Clinical Practice (GCP)-International Conference of Harmonization (ICH) E6 guideline and its interpretation from the perspective of clinical trial teams based in sub-Saharan Africa. MethodsWe conducted 60 key informant interviews with clinical trial staff at different levels in clinical research centres in Kenya, Ghana, Burkina Faso and Senegal and thematically analysed the responses. ResultsClinical trial teams perceived working with ICH-GCP as highly advantageous and regarded ICH-GCP as applicable to their setting and efficiently applied. Only for informed consent did some clinical trial staff (one-third) perceive the guideline as insufficiently applicable. Specific challenges included meeting the requirements for written and individual consent, conditions for impartial witnesses for illiterates or legally acceptable representatives for children, guaranteeing voluntary participation and ensuring full understanding of the consent given. It was deemed important to have ICH-GCP compliance monitored by relevant ethics committees and regulatory authorities, without having guidelines applied overcautiously. ConclusionClinical trial teams in sub-Saharan Africa perceived GCP as a helpful guideline, despite having been developed by northern organisations and despite the high administrative burden of implementing it. To mitigate consent challenges, we suggest adapting GCP and making use of the flexibility it offers. ObjectifsExplorer les avantages et les defis du travail selon la directive des bonnes pratiques cliniques (BPC) de l'ICH E6 (ICH-GCP) et son interpretation du point de vue des equipes d'essais cliniques en Afrique subsaharienne. MethodesNous avons mene 60 entretiens d'information cles avec le personnel a differents niveaux des essais cliniques dans les centres de recherche clinique au Kenya, au Ghana, au Burkina-Faso et au Senegal, et avons thematiquement analyse les reponses. ResultatsLes equipes d'essais cliniques percoivent le travail selon l'ICH-GCP comme tres avantageux et considerent l'ICH-GCP applicable a leur situation et efficacement appliquee. Seul pour le consentement eclaire, certains membres du personnel d'essai clinique (un tiers) percoivent la directive comme insuffisamment applicable. Les defis specifiques comprennent: repondre aux exigences du consentement ecrit et individuel, les conditions des temoins impartiaux pour les analphabetes ou les representants legalement acceptables pour les enfants, garantir la participation volontaire et assurer la pleine comprehension du consentement donne. Il a ete juge important de veiller a ce que le respect de l'ICH-GCP soit surveille par les comites d'ethique et les autorites reglementaires, pour ne pas avoir des directives appliquees de facon trop precautionneuse. ConclusionLes equipes d'essais cliniques en Afrique subsaharienne percoivent la directive sur les BPC comme utile, bien qu'ayant ete mise au point par des organismes du Nord et malgre la charge administrative elevee pour son implementation. Afin d'attenuer les defis lies au consentement, nous suggerons d'adapter la directive et de faire usage de la flexibilite qu'elle offre. ObjetivosExplorar las ventajas y los retos de trabajar con las guias ICH E6 de Buenas Practicas Clinicas (BPC) y su interpretacion desde la perspectiva de los equipos trabajando en ensayos clinicos en africa subsahariana. MetodosHemos llevado a cabo 60 entrevistas con informantes claves de personal de ensayos clinicos de diferentes niveles en centros de investigacion clinica de Kenia, Ghana, Burkina Faso y Senegal, y analizado tematicamente las respuestas. ResultadosLos equipos de ensayos clinicos percibian el trabajar con las guias de BPC ICH-GCP como algo altamente ventajoso y veian las ICH-GCP como pertinentes para su emplazamiento y posibles de aplicar eficientemente. Solo en el caso del consentimiento informado, una tercera parte del personal clinico percibia las guias como insuficientemente aplicables. Los retos especificos incluian el alcanzar los requerimientos para el consentimiento informado escrito e individual, condiciones de un testigo imparcial para analfabetos o representantes legalmente aceptables para ninos, garantizando la participacion voluntaria y asegurando el completo entendimiento del consentimiento que se da. Se considero importante monitorizar el cumplimiento de las guias ICH-GCP por los comites de etica relevantes y las autoridades regulatorias, sin tener que aplicar las guias de forma excesivamente cautelosa. ConclusionLos equipos de ensayos clinicos en africa subsahariana percibian las BPC como unas guias utiles, a pesar de haber sido desarrolladas por organizaciones del norte y de la alta carga administrativa para implementarlas. Para mitigar los retos del consentimiento informado, sugerimos adaptar las BPC y hacer uso de la flexibilidad que ofrece.	[Vischer, N.; Pfeiffer, C.; Joller, A.; Burri, C.] Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4051 Basel, Switzerland; [Vischer, N.; Pfeiffer, C.; Joller, A.; Burri, C.] Univ Basel, Basel, Switzerland; [Klingmann, I.] European Forum Good Clin Practice, Brussels, Belgium; [Ka, A.] Univ Cheikh Anta Diop Dakar, Dept Sociol, Dakar, Senegal; [Kpormegbe, S. K.] Univ Ghana, Dept Sociol, Legon, Ghana	Vischer, N (reprint author), Swiss Trop & Publ Hlth Inst, Socinstr 57, CH-4051 Basel, Switzerland.	nerina.vischer@unibas.ch			Rudolf Geigy Foundation; Swiss Tropical and Public Health Institute; Freiwillige Akademische Gesellschaft	We thank the clinical research centres which participated in our study and especially the study participants. Thanks to Andrea Bianchin for designing the graphic and to Julie Catusse for helping with the translation. We thank Amena Briet and Benjamin Berger for editing. The work was funded by the Rudolf Geigy Foundation, the Swiss Tropical and Public Health Institute and the Freiwillige Akademische Gesellschaft.	Acosta CJ, 2007, VACCINE, V25, P2852, DOI 10.1016/j.vaccine.2006.09.079; [Anonymous], 2014, CTR DRUG EVALUATION; Bollyky TJ, 2010, CLIN TRIALS, V7, P719, DOI 10.1177/1740774510386390; Bompart F, 2008, THERAPIE, V63, P83, DOI [10.2515/therapie:2008023, 10.2515/therapie:2008022]; Braun V., 2006, QUALITATIVE RES PSYC, V3, P77, DOI DOI 10.1191/1478088706QP0630A; Charmaz K., 2006, CONSTRUCTING GROUNDE; Clark J, 2003, QUALITATIVE RES REV; DeMets DL, 2006, CLIN TRIALS, V3, P142, DOI 10.1191/1740774506cn137oa; Department of Health Republic of South Africa, 2015, ETH HLTH RES; Fekadu A, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-493; Grimes DA, 2005, LANCET, V366, P172, DOI 10.1016/S0140-6736(05)66875-4; Hanna M, 2013, CLIN TRIALS, V10, P300, DOI 10.1177/1740774512470765; Hartmann M, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-53; Hearn J, 2007, EUR J CANCER, V43, P8, DOI 10.1016/j.ejca.2006.09.016; Idoko OT, 2013, AM J TROP MED HYG, V88, P414, DOI 10.4269/ajtmh.12-0576; International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, 1996, INT C HARMONISATION; Kalabuanga M, 2016, DEV WORLD BIOETH, V16, P64, DOI 10.1111/dewb.12090; Kuepfer I, 2009, INT J PARASITOL, V39, P947, DOI 10.1016/j.ijpara.2009.02.021; Lang TD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001228; Lang T, 2011, LANCET, V377, P1553, DOI 10.1016/S0140-6736(10)62052-1; Lang TA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000619; Lorell BH, 2015, CLIN TRIALS, V12, P692, DOI 10.1177/1740774515594362; McMahon AD, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000131; Nishimura A, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-28; O'Leary E, 2013, CLIN TRIALS, V10, P624, DOI 10.1177/1740774513491337; Owens S, 2007, TROP MED INT HEALTH, V12, P472; Singh JA, 2006, RES ETHICS REV, V2, P63; Sweatman J, 2003, BRIT J CLIN PHARMACO, V55, P1, DOI 10.1046/j.1365-2125.2003.01713.x; Uthman OA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006340; Vijayananthan A, 2008, Biomed Imaging Interv J, V4, pe5, DOI 10.2349/biij.4.1.e5; Vray Muriel, 2007, Therapie, V62, P217, DOI 10.2515/therapie:2007044; Walker L, 2004, SOC SCI MED, V59, P1251, DOI 10.1016/j.socscimed.2003.12.020; White NJ, 2006, TROP MED INT HEALTH, V11, P1483, DOI 10.1111/j.1365-3156.2006.01765.x; Yusuf S, 2010, CLIN TRIALS, V7, P622, DOI 10.1177/1740774510387850	34	5	5	2	13	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1360-2276	1365-3156		TROP MED INT HEALTH	Trop. Med. Int. Health	AUG	2016	21	8					1040	1048		10.1111/tmi.12734				9	Public, Environmental & Occupational Health; Tropical Medicine	Public, Environmental & Occupational Health; Tropical Medicine	DU9UN	WOS:000382563500012		Green Published			2019-04-02	
J	George, S; Levecke, B; Kattula, D; Velusamy, V; Roy, S; Geldhof, P; Sarkar, R; Kang, G				George, Santosh; Levecke, Bruno; Kattula, Deepthi; Velusamy, Vasanthakumar; Roy, Sheela; Geldhof, Peter; Sarkar, Rajiv; Kang, Gagandeep			Molecular Identification of Hookworm Isolates in Humans, Dogs and Soil in a Tribal Area in Tamil Nadu, India	PLOS NEGLECTED TROPICAL DISEASES			English	Article							TRANSMITTED HELMINTH INFECTIONS; TRICHURIS-VULPIS; ANCYLOSTOMA-CEYLANICUM; LARVA MIGRANS; GASTROINTESTINAL PARASITES; EOSINOPHILIC ENTERITIS; COMMUNITY; PREVALENCE; CANINUM; SCHISTOSOMIASIS	Background Hookworms (Necator americanus and Ancylostoma duodenale) remain a major public health problem worldwide. Infections with hookworms (e.g., A. caninum, A. ceylanicum and A. braziliense) are also prevalent in dogs, but the role of dogs as a reservoir for zoonotic hookworm infections in humans needs to be further explored. Methodology/Principal Findings As part of an open-label community based cluster-randomized trial in a tribal area in Tamil Nadu (India; 2013-2015), a total of 143 isolates of hookworm eggs from human stool were speciated based on a previously described PCR-RFLP methodology. The presence of hookworm DNA was confirmed in 119 of 143 human samples. N. americanus (100%) was the most prevalent species, followed by A. caninum (16.8%) and A. duodenale (8.4%). Because of the high prevalence of A. caninum in humans, dog samples were also collected to assess the prevalence of A. caninum in dogs. In 68 out of 77 canine stool samples the presence of hookworms was confirmed using PCR-RFLP. In dogs, both A. caninum (76.4%) and A. ceylanicum (27.9%) were identified. Additionally, to determine the contamination of soil with zoonotic hookworm larvae, topsoil was collected from defecating areas. Hookworm DNA was detected in 72 out of 78 soil samples that revealed presence of hook-worm-like nematode larvae. In soil, different hookworm species were identified, with animal hookworms being more prevalent (A. ceylanicum: 60.2%, A. caninum: 29.4%, A. duodenale: 16.6%, N. americanus: 1.4%, A. braziliense: 1.4%). Conclusions/Significance In our study we regularly detected the presence of A. caninum DNA in the stool of humans. Whether this is the result of infection is currently unknown but it does warrant a closer look at dogs as a potential reservoir.	[George, Santosh; Kattula, Deepthi; Velusamy, Vasanthakumar; Roy, Sheela; Sarkar, Rajiv; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [George, Santosh; Levecke, Bruno; Geldhof, Peter] Univ Ghent, Dept Virol Parasitol & Immunol, Merelbeke, Belgium	Kang, G (reprint author), Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India.	gkang@cmcvellore.ac.in		Levecke, Bruno/0000-0001-8912-5595; Kang, Gagandeep/0000-0002-3656-564X	Wellcome Trust/DBT India Alliance trough an Early Career Fellowship; Special Research Fund of Ghent University [01W01511]; FWO [1285316N]	This study is supported by the Wellcome Trust/DBT India Alliance trough an Early Career Fellowship to RS. SG is supported by the Special Research Fund of Ghent University (scholarship code - 01W01511) (http://www.ugent.be/nl/onderzoek/financiering/bof). BL is a postdoctoral fellow of FWO (Grant number - 1285316N) (www.fwo.be). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002027; Areekul P, 2010, ASIAN BIOMED, V4, P49, DOI 10.2478/abm-2010-0006; Bowman DD, 2010, TRENDS PARASITOL, V26, P162, DOI 10.1016/j.pt.2010.01.005; Brooker S, 2004, ADV PARASIT, V58, P197, DOI 10.1016/S0065-308X(04)58004-1; CROESE J, 1994, ANN INTERN MED, V120, P369, DOI 10.7326/0003-4819-120-5-199403010-00003; de Silva NR, 2003, ACTA TROP, V86, P197, DOI 10.1016/S0001-706X(03)00035-4; Diemert DJ, 2008, CLIN INFECT DIS, V46, P282, DOI 10.1086/524070; Ng-Nguyen D, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1015-y; Dunn JJ, 2002, J CLIN MICROBIOL, V40, P2703, DOI 10.1128/JCM.40.7.2703-2704.2002; Engleberg N. C., 2013, SCHAECHTERS MECH MIC; Farthing MJG, 1995, HUMAN HOOKWORM INFEC; Gasser RB, 2006, VET PARASITOL, V136, P69, DOI 10.1016/j.vetpar.2005.12.002; George S, 2015, T ROY SOC TROP MED H, V109, P283, DOI 10.1093/trstmh/trv001; Geurden T, 2008, INT J PARASITOL, V38, P259, DOI 10.1016/j.ijpara.2007.07.016; Hotez PJ, 2013, VACCINE, V31, pB227, DOI 10.1016/j.vaccine.2012.11.034; Hotez PJ, 2010, NAT REV MICROBIOL, V8, P814, DOI 10.1038/nrmicro2438; Inpankaew T, 2014, EMERG INFECT DIS, V20, P976, DOI 10.3201/eid2006.131770; Kaliappan SP, 2013, TROP MED INT HEALTH, V18, P1452, DOI 10.1111/tmi.12205; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Landmann JK, 2003, MED J AUSTRALIA, V178, P69; Levecke B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003204; Levecke B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001201; Levecke B, 2009, INT J PARASITOL, V39, P1595, DOI 10.1016/j.ijpara.2009.05.013; Liu D, 2012, MOL DETECTION HUMAN; MASUDA Y, 1987, THORAX, V42, P990, DOI 10.1136/thx.42.12.990; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngui R, 2014, AM J TROP MED HYG, V91, P86, DOI 10.4269/ajtmh.13-0756; Ngui R, 2013, ACTA TROP, V128, P154, DOI [10.1016/Lactatropica.2013.06.003, 10.1016/j.actatropica.2013.06.003]; Ngui R, 2012, AM J TROP MED HYG, V86, P837, DOI 10.4269/ajtmh.2012.11-0446; PROCIV P, 1990, LANCET, V335, P1299, DOI 10.1016/0140-6736(90)91186-E; Ranganathan RV, 2012, ASIAN J PHARM CLIN R, V5; SAKANO T, 1980, ARCH DIS CHILD, V55, P631, DOI 10.1136/adc.55.8.631; Savioli L, 2002, T ROY SOC TROP MED H, V96, P577, DOI 10.1016/S0035-9203(02)90316-0; Strunz EC, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001620; Traub RJ, 2014, VET PARASITOL, V205, P233, DOI 10.1016/j.vetpar.2014.06.037; Traub RJ, 2005, TRENDS PARASITOL, V21, P42, DOI 10.1016/j.pt.2004.10.011; Traub RJ, 2004, TROP MED INT HEALTH, V9, P688, DOI 10.1111/j.1365-3156.2004.01252.x; Traub RJ, 2002, AM J TROP MED HYG, V67, P539, DOI 10.4269/ajtmh.2002.67.539; Tun S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142231; UDONSI JK, 1987, EXP PARASITOL, V63, P136, DOI 10.1016/0014-4894(87)90154-8; Ugbomoiko Uade Samuel, 2008, BMC Vet Res, V4, P49, DOI 10.1186/1746-6148-4-49; Vercruysse J, 2011, PLOS NEGLECT TROP D, V5, pe948, DOI DOI 10.1371/J0URNAL.PNTD.0000948; WALKER NI, 1995, AM J SURG PATHOL, V19, P328, DOI 10.1097/00000478-199503000-00011; World Health Organization (WHO), 1991, BAS LAB METH MED PAR	44	10	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2016	10	8							e0004891	10.1371/journal.pntd.0004891				14	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU7JR	WOS:000382390800034	27486798	DOAJ Gold, Green Published			2019-04-02	
J	Hirve, S; Boelaert, M; Matlashewski, G; Mondal, D; Arana, B; Kroeger, A; Olliaro, P				Hirve, Siddhivinayak; Boelaert, Marleen; Matlashewski, Greg; Mondal, Dinesh; Arana, Byron; Kroeger, Axel; Olliaro, Piero			Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review	PLOS NEGLECTED TROPICAL DISEASES			English	Review							AZAR DERMAL LEISHMANIASIS; LIPOSOMAL AMPHOTERICIN-B; DIRECT AGGLUTINATION-TEST; CLUSTER-RANDOMIZED-TRIAL; RECOMBINANT K-39 ANTIGEN; ORGAN TRANSPLANT RECIPIENTS; LINKED-IMMUNOSORBENT-ASSAY; LASTING INSECTICIDAL NETS; PHLEBOTOMINE SAND FLIES; LONG-TERM EFFECTIVENESS	Background mAs Bangladesh, India and Nepal progress towards visceral leishmaniasis (VL) elimination, it is important to understand the role of asymptomatic Leishmania infection (ALI), VL treatment relapse and post kala-azar dermal leishmaniasis (PKDL) in transmission. Methodology/Principal Finding We reviewed evidence systematically on ALI, relapse and PKDL. We searched multiple databases to include studies on burden, risk factors, biomarkers, natural history, and infectiveness of ALI, PKDL and relapse. After screening 292 papers, 98 were included covering the years 1942 through 2016. ALI, PKDL and relapse studies lacked a reference standard and appropriate biomarker. The prevalence of ALI was 4-17-fold that of VL. The risk of ALI was higher in VL case contacts. Most infections remained asymptomatic or resolved spontaneously. The proportion of ALI that progressed to VL disease within a year was 1.5-23%, and was higher amongst those with high antibody titres. The natural history of PKDL showed variability; 3.8-28.6% had no past history of VL treatment. The infectiveness of PKDL was 32-53%. The risk of VL relapse was higher with HIV co-infection. Modelling studies predicted a range of scenarios. One model predicted VL elimination was unlikely in the long term with early diagnosis. Another model estimated that ALI contributed to 82% of the overall transmission, VL to 10% and PKDL to 8%. Another model predicted that VL cases were the main driver for transmission. Different models predicted VL elimination if the sandfly density was reduced by 67% by killing the sandfly or by 79% by reducing their breeding sites, or with 4-6y of optimal IRS or 10y of sub-optimal IRS and only in low endemic setting. Conclusion/Significance There is a need for xenodiagnostic and longitudinal studies to understand the potential of ALI and PKDL as reservoirs of infection.	[Hirve, Siddhivinayak] World Hlth Org, Global Influenza Programme, Geneva, Switzerland; [Boelaert, Marleen] Inst Trop Med, Epidemiol & Control Trop Dis, Antwerp, Belgium; [Matlashewski, Greg] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Mondal, Dinesh] Int Ctr Diarrheal Dis Res, Nutr & Clin Serv Div, Dhaka, Bangladesh; [Arana, Byron] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Kroeger, Axel; Olliaro, Piero] World Hlth Org, Special Programme Res & Training Trop Dis, Geneva, Switzerland	Hirve, S (reprint author), World Hlth Org, Global Influenza Programme, Geneva, Switzerland.	hirves@who.int		Hirve, Siddhivinayak/0000-0002-9651-7789; Boelaert, Marleen/0000-0001-8051-6776	Special Program for Research and Training in Tropical Diseases, World Health Organization through an APW contract [2015/572330]; WHO/TDR	The study was supported by the Special Program for Research and Training in Tropical Diseases, World Health Organization through an APW contract no. 2015/572330 with SH. AK and PO from WHO TDR contributed to the design of the study, data analysis and preparation of the manuscript. SH is a staff member of WHO, Global Influenza Programme; AK is at the Center for Medicine and Society, University of Freiburg, Germany and also a consultant to WHO TDR, TDR programme; PO is a staff member of WHO, TDR programme. WHO/TDR funded SH to conduct the systematic review, (ii) defined the objectives and terms of the review; (iii) funded a workshop of experts where the results were reviewed; (iv) both TDR and the experts participated in the interpretation of results and writing up of the paper.	Adams ER, 2013, J TROP MED, DOI 10.1155/2013/150746; ADDY M, 1992, B WORLD HEALTH ORGAN, V70, P341; Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Ansari NA, 2007, CLIN IMMUNOL, V122, P343, DOI 10.1016/j.clim.2006.11.008; Antinori S, 2008, LANCET INFECT DIS, V8, P191, DOI 10.1016/S1473-3099(08)70043-4; Basset D, 2005, MICROBES INFECT, V7, P1370, DOI 10.1016/j.micinf.2005.06.002; Bern C, 2005, EMERG INFECT DIS, V11, P655, DOI 10.3201/eid1105.040718; Bern C, 2007, AM J TROP MED HYG, V76, P909; Bern C, 2006, AM J TROP MED HYG, V75, P744, DOI 10.4269/ajtmh.2006.75.744; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Bhandari V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001657; Bhattacharya SK, 2004, CLIN INFECT DIS, V38, P217, DOI 10.1086/380638; Bhattacharya SK, 2007, J INFECT DIS, V196, P591, DOI 10.1086/519690; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003273; Bhattarai NR, 2010, EMERG INFECT DIS, V16, P231, DOI 10.3201/eid1602.090623; Bhattarai NR, 2009, TROP MED INT HEALTH, V14, P404, DOI 10.1111/j.1365-3156.2009.02242.x; Bhunia GS, 2012, GEOSPATIAL HEALTH, V7, P51, DOI 10.4081/gh.2012.104; Bhunia GS, 2012, GEOSPATIAL HEALTH, V6, P177, DOI 10.4081/gh.2012.136; Bimal S, 2005, ANN TROP MED PARASIT, V99, P743, DOI 10.1179/136485905X65107; Boelaert M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009135.pub2; Boettcher JP, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0767-5; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003053; Burza S, 2014, CLIN INFECT DIS, V59, P552, DOI 10.1093/cid/ciu333; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002611; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002536; Burza S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002603; Burza S, 2013, CLIN INFECT DIS, V57, P1363, DOI 10.1093/cid/cit508; Chapman LAC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1136-3; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; CHOWDHURY MS, 1993, PARASITOL RES, V79, P444, DOI 10.1007/BF00931580; Chowdhury R, 2011, AM J TROP MED HYG, V84, P662, DOI 10.4269/ajtmh.2011.10-0682; Clements MF, 2010, AM J TROP MED HYG, V82, P801, DOI 10.4269/ajtmh.2010.09-0336; Coleman M, 2015, P NATL ACAD SCI USA, V112, P8573, DOI 10.1073/pnas.1507782112; Costa CHN, 2000, J INFECT DIS, V182, P997, DOI 10.1086/315795; Costa CHN, 2002, AM J TROP MED HYG, V66, P334, DOI 10.4269/ajtmh.2002.66.334; Cota GF, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001153; Courtenay O, 2002, J INFECT DIS, V186, P1314, DOI 10.1086/344312; Cruz I, 2002, LANCET, V359, P1124, DOI 10.1016/S0140-6736(02)08160-6; Das ML, 2010, ACTA TROP, V113, P162, DOI 10.1016/j.actatropica.2009.10.012; Das M. L., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P619; Das VNR, 2011, T ROY SOC TROP MED H, V105, P661, DOI 10.1016/j.trstmh.2011.08.005; Das VNR, 2012, AM J TROP MED HYG, V86, P959, DOI 10.4269/ajtmh.2012.11-0467; de Ruiter CM, 2014, J CLIN MICROBIOL, V52, P3147, DOI 10.1128/JCM.00372-14; Dey A, 2006, Indian J Med Microbiol, V24, P165; Dinesh DS, 2000, ANN TROP MED PARASIT, V94, P447, DOI 10.1080/00034983.2000.11813563; DYE C, 1988, T ROY SOC TROP MED H, V82, P843, DOI 10.1016/0035-9203(88)90013-2; ELTOUM IA, 1992, AM J TROP MED HYG, V46, P57, DOI 10.4269/ajtmh.1992.46.57; Ganguly S, 2010, INT J DERMATOL, V49, P921, DOI 10.1111/j.1365-4632.2010.04558.x; Ganguly S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004138; Garg VK, 2001, INT J DERMATOL, V40, P179, DOI 10.1046/j.1365-4362.2001.01198.x; GHOSH K N, 1990, Journal of Communicable Diseases, V22, P67; Ghosh S, 2015, AM J TROP MED HYG, V93, P767, DOI 10.4269/ajtmh.14-0721; Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296; Gidwani K, 2009, AM J TROP MED HYG, V80, P345, DOI 10.4269/ajtmh.2009.80.345; Gonzalez U, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008736.pub2; Goswami R P, 2003, J Assoc Physicians India, V51, P759; Hasker E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002657; Hasker E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002053; Hati A K, 1984, J Indian Med Assoc, V82, P1; HATI AK, 1991, INDIAN J MED RES-A, V93, P388; Herwaldt BL, 2001, CLIN MICROBIOL REV, V14, P659, DOI 10.1128/CMR.14.3.659-688.2001; Higgins J. P., 2011, COCHRANE HANDBOOK FO; Huda MM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-62; Islam MZ, 2012, AM J TROP MED HYG, V87, P658, DOI 10.4269/ajtmh.2012.12-0168; Islam S, 2013, AM J TROP MED HYG, V89, P345, DOI 10.4269/ajtmh.12-0711; Jha TK, 1999, NEW ENGL J MED, V341, P1795, DOI 10.1056/NEJM199912093412403; Joshi A B, 2006, Kathmandu Univ Med J (KUMJ), V4, P488; Joshi AB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-54; Kesari S., 2009, Journal of Communicable Diseases, V41, P211; Kesari S, 2013, MEM I OSWALDO CRUZ, V108, P197, DOI 10.1590/0074-0276108022013012; Kesari S, 2011, MEM I OSWALDO CRUZ, V106, P515, DOI 10.1590/S0074-02762011000500001; Khan AM, 2014, EMERG INFECT DIS, V20, P487, DOI 10.3201/eid2003.130260; Khanal B, 2010, PARASITOLOGY, V137, P1597, DOI 10.1017/S0031182010000521; Khanal B, 2010, TROP MED INT HEALTH, V15, P1390, DOI 10.1111/j.1365-3156.2010.02631.x; Kip AE, 2015, ANTIMICROB AGENTS CH, V59, P1, DOI 10.1128/AAC.04298-14; Koirala S, 2004, TROP MED INT HEALTH, V9, P533, DOI 10.1111/j.1365-3156.2004.01212.x; Kumar R, 2006, TROP MED INT HEALTH, V11, P41, DOI 10.1111/j.1365-3156.2005.01538.x; Kumar R, 2001, CLIN DIAGN LAB IMMUN, V8, P1220, DOI 10.1128/CDLI.8.6.1220-1224.2001; Kumar V., 2001, Journal of Communicable Diseases, V33, P102; KUMAR V, 1995, INDIAN J MED RES, V101, P154; Le Rutte EA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1292-0; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; Mathur P, 2006, J MED MICROBIOL, V55, P919, DOI 10.1099/jmm.0.46574-0; Maurya R, 2005, J CLIN MICROBIOL, V43, P3038, DOI 10.1128/JCM.43.7.3038-3041.2005; Medley GF, 2015, NATURE, V528, pS102, DOI 10.1038/nature16042; Miller E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003288; Moher David, 2009, Open Med, V3, pe123; MOLINA R, 1994, AIDS, V8, P277, DOI 10.1097/00002030-199402000-00024; Mondal D, 2010, Proceedings 2010 Annual IEEE India Conference (INDICON 2010), DOI 10.1109/INDCON.2010.5712633; Mondal D, 2010, TROP MED INT HEALTH, V15, P1382, DOI 10.1111/j.1365-3156.2010.02635.x; Mubayi A, 2010, J THEOR BIOL, V262, P177, DOI 10.1016/j.jtbi.2009.09.012; Mukhopadhyay A. K., 1996, Journal of Communicable Diseases, V28, P171; MUKHOPADHYAY AK, 1987, INDIAN J MED RES, V86, P475; MUKHOPADHYAY AK, 1991, INDIAN J MED RES-A, V93, P152; Mukhopadhyay D, 2014, TRENDS PARASITOL, V30, P65, DOI 10.1016/j.pt.2013.12.004; Muniaraj Mayilsamy, 2014, Trop Parasitol, V4, P10, DOI 10.4103/2229-5070.129143; NANDY A, 1987, ANN TROP MED PARASIT, V81, P693, DOI 10.1080/00034983.1987.11812172; Nandy A, 1998, TROP MED INT HEALTH, V3, P76, DOI 10.1046/j.1365-3156.1998.00176.x; Olliaro PL, 2005, LANCET INFECT DIS, V5, P763, DOI 10.1016/S1473-3099(05)70296-6; Ostyn B, 2008, TROP MED INT HEALTH, V13, P1073, DOI 10.1111/j.1365-3156.2008.02110.x; Ostyn B, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003966; Ostyn B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100220; Ostyn B, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001284; Palit A, 2005, INT J ENVIRON HEAL R, V15, P449, DOI 10.1080/09603120500392525; Pandey BD, 2011, AM J TROP MED HYG, V84, P107, DOI 10.4269/ajtmh.2011.10-0291; PANDYA AP, 1983, INDIAN J MED RES, V77, P817; Patole S, 2014, INT J INFECT DIS, V25, P204, DOI 10.1016/j.ijid.2014.02.015; Picado A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087641; Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760; Picado A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000587; Poche D, 2011, J VECTOR ECOL, V36, pS106, DOI 10.1111/j.1948-7134.2011.00119.x; Rahman KM, 2010, CLIN INFECT DIS, V50, P73, DOI 10.1086/648727; Rai K, 2013, MBIO, V4, DOI 10.1128/mBio.00611-13; RAI R N, 1989, Journal of Communicable Diseases, V21, P214; Ramesh V, 2007, TROP MED INT HEALTH, V12, P848, DOI 10.1111/j.1365-3156.2007.01854.x; Ramesh V, 2011, BRIT J DERMATOL, V165, P411, DOI 10.1111/j.1365-2133.2011.10402.x; RAMESH V, 1995, INT J DERMATOL, V34, P85, DOI 10.1111/j.1365-4362.1995.tb03584.x; Rao J. S., 2001, Journal of Communicable Diseases, V33, P7; Rao J S, 1992, J Commun Dis, V24, P116; Ready PD, 2014, CLIN EPIDEMIOL, V6, P147, DOI 10.2147/CLEP.S44267; Rijal S, 2013, CLIN INFECT DIS, V56, P1530, DOI 10.1093/cid/cit102; Rijal S, 2010, TROP MED INT HEALTH, V15, P21, DOI 10.1111/j.1365-3156.2010.02518.x; Ritmeijer K, 2006, CLIN INFECT DIS, V43, P357, DOI 10.1086/505217; Rock KS, 2015, TRENDS PARASITOL, V31, P251, DOI 10.1016/j.pt.2015.03.007; SACKS DL, 1985, AM J TROP MED HYG, V34, P456, DOI 10.4269/ajtmh.1985.34.456; Saha S, 2009, T ROY SOC TROP MED H, V103, P737, DOI 10.1016/j.trstmh.2008.10.006; Salotra P, 2002, CLIN DIAGN LAB IMMUN, V9, P370, DOI 10.1128/CDLI.9.2.370-373.2002; Salotra P, 2001, J CLIN MICROBIOL, V39, P849, DOI 10.1128/JCM.39.3.849-854.2001; Saran R., 1992, Journal of Communicable Diseases, V24, P242; Schenkel K, 2006, TROP MED INT HEALTH, V11, P1792, DOI 10.1111/j.1365-3156.2006.01735.x; Seblova V, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002187; Sen Gupta P C, 1968, J Indian Med Assoc, V50, P1; Singh DP, 2010, J HEALTH POPUL NUTR, V28, P281; Singh R, 2005, CLIN DIAGN LAB IMMUN, V12, P1191, DOI 10.1128/CDLI.12.10.1191-1194.2005; Singh RP, 2012, TROP MED INT HLTH; Singh S, 2002, CLIN DIAGN LAB IMMUN, V9, P568, DOI 10.1128/CDLI.9.3.568-572.2002; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh S, 2014, INT J INFECT DIS, V29, P103, DOI 10.1016/j.ijid.2014.07.011; Singh SP, 2010, TROP MED INT HEALTH, V15, P12, DOI 10.1111/j.1365-3156.2010.02519.x; Singh Utpal Kant, 2006, Indian Journal of Pediatrics, V73, P1077, DOI 10.1007/BF02763048; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Sinha PK, 2008, ANN TROP MED PARASIT, V102, P119, DOI 10.1179/136485908X252278; Sinha PK, 2011, CLIN INFECT DIS, V53, pE91, DOI 10.1093/cid/cir521; Sinha PK, 2010, AM J TROP MED HYG, V83, P357, DOI 10.4269/ajtmh.2010.10-0156; Srivastava P, 2013, TROP MED INT HEALTH, V18, P548, DOI 10.1111/tmi.12085; Stauch A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002810; Stauch A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001973; Stauch A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001405; Sudarshan M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003366; Sudarshan M, 2014, DIAGN MICR INFEC DIS, V80, P40, DOI 10.1016/j.diagmicrobio.2014.01.031; Sundar S, 2006, T ROY SOC TROP MED H, V100, P533, DOI 10.1016/j.trstmh.2005.08.018; Sundar S, 2003, PEDIATR INFECT DIS J, V22, P434; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar Shyam, 2015, ScientificWorldJournal, V2015, P414378, DOI 10.1155/2015/414378; Sundar S, 2012, CLIN INFECT DIS, V55, P543, DOI 10.1093/cid/cis474; Swaminath CS, 2006, INDIAN J MED RES, V123, pA473; THAKUR CP, 1992, ANN TROP MED PARASIT, V86, P355, DOI 10.1080/00034983.1992.11812678; Tiwary P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061370; Tiwary P, 2012, VECTOR-BORNE ZOONOT, V12, P467, DOI 10.1089/vbz.2011.0808; Topno RK, 2010, AM J TROP MED HYG, V83, P502, DOI 10.4269/ajtmh.2010.09-0345; Uranw S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-21; Uranw S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001433; Vallur AC, 2014, CLIN MICROBIOL INFEC, V20, pO374, DOI 10.1111/1469-0691.12421; van Griensven J, 2014, CLIN MICROBIOL INFEC, V20, P286, DOI 10.1111/1469-0691.12556; Wells GA, THE NEWCASTLEOTTAWA; World Health Organization, 2005, REGIONAL STRATEGIC F; World Health Organization, 2015, MEETING OF MINISTERS; World Health Organization, 2010, INDICATORS FOR MONIT; World Health Organization, 2015, KALA AZAR ELIMINATIO; World Health Organization ROfS-EA, 2016, REGIONAL STRATEGIC F; Yangzom T, 2012, AM J TROP MED HYG, V87, P1028, DOI 10.4269/ajtmh.2012.12-0211; Zijistra EE, 2003, LANCET INFECT DIS, V3, P87, DOI 10.1016/S1473-3099(03)00517-6	175	25	25	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2016	10	8							e0004896	10.1371/journal.pntd.0004896				28	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU7JR	WOS:000382390800039	27490264	DOAJ Gold, Green Published			2019-04-02	
J	Terryn, S; Francart, A; Rommelaere, H; Stortelers, C; Van Gucht, S				Terryn, Sanne; Francart, Aurelie; Rommelaere, Heidi; Stortelers, Catelijne; Van Gucht, Steven			Post-exposure Treatment with Anti-rabies VHH and Vaccine Significantly Improves Protection of Mice from Lethal Rabies Infection	PLOS NEGLECTED TROPICAL DISEASES			English	Article							SINGLE-DOMAIN ANTIBODIES; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSES; HALF-LIFE; VIRUS; PROPHYLAXIS; THERAPEUTICS; REGIMENS; DISEASE; BURDEN	Post-exposure prophylaxis (PEP) against rabies infection consists of a combination of passive immunisation with plasma-derived human or equine immune globulins and active immunisation with vaccine delivered shortly after exposure. Since anti-rabies immune globulins are expensive and scarce, there is a need for cheaper alternatives that can be produced more consistently. Previously, we generated potent virus-neutralising VHH, also called Nanobodies, against the rabies glycoprotein that are effectively preventing lethal disease in an in vivo mouse model. The VHH domain is the smallest antigen-binding functional fragment of camelid heavy chain-only antibodies that can be manufactured in microbial expression systems. In the current study we evaluated the efficacy of half-life extended anti-rabies VHH in combination with vaccine for PEP in an intranasal rabies infection model in mice. The PEP combination therapy of systemic anti-rabies VHH and intramuscular vaccine significantly delayed the onset of disease compared to treatment with anti-rabies VHH alone, prolonged median survival time (35 versus 14 days) and decreased mortality (60% versus 19% survival rate), when treated 24 hours after rabies virus challenge. Vaccine alone was unable to rescue mice from lethal disease. As reported also for immune globulins, some interference of anti-rabies VHH with the antigenicity of the vaccine was observed, but this did not impede the synergistic effect. Post exposure treatment with vaccine and human anti-rabies immune globulins was unable to protect mice from lethal challenge. Anti-rabies VHH and vaccine act synergistically to protect mice after rabies virus exposure, which further validates the possible use of anti-rabies VHH for rabies PEP.	[Terryn, Sanne; Francart, Aurelie; Van Gucht, Steven] Sci Inst Publ Hlth WIV ISP, Natl Reference Ctr Rabies, Viral Dis, Brussels, Belgium; [Terryn, Sanne; Van Gucht, Steven] Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Ghent, Belgium; [Rommelaere, Heidi; Stortelers, Catelijne] Ablynx NV, Ghent, Belgium	Van Gucht, S (reprint author), Sci Inst Publ Hlth WIV ISP, Natl Reference Ctr Rabies, Viral Dis, Brussels, Belgium.; Van Gucht, S (reprint author), Univ Ghent, Fac Vet Med, Dept Virol Parasitol & Immunol, Virol Lab, Ghent, Belgium.	steven.vangucht@wiv-isp.be			WIV-ISP; Belgian Ministry of Social Affairs through a fund from the Health Insurance System	ST received a fellowship from the WIV-ISP (https://www.wiv-isp.be/). The National Reference Centre of Rabies is partially supported by the Belgian Ministry of Social Affairs through a fund from the Health Insurance System (http://nrchmweb.wiv-isp.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, WHO CONS RAB MON ANT; ARCHER BG, 1968, B WORLD HEALTH ORGAN, V39, P407; Both L, 2012, LANCET INFECT DIS, V12, P397, DOI 10.1016/S1473-3099(11)70340-1; Bourhy H, 2009, EUROPE EURO, V14; Chomchay P, 2000, J TRAVEL MED, V7, P187; Dietzschold B, 2008, FUTURE VIROL, V3, P481, DOI 10.2217/17460794.3.5.481; Dimaano EM, 2011, INT J INFECT DIS, V15, pE495, DOI 10.1016/j.ijid.2011.03.023; Hampson K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003709; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Hemachudha T, 2013, LANCET NEUROL, V12, P498, DOI 10.1016/S1474-4422(13)70038-3; Hooper DC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000535; Hultberg A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017665; Ibanez LI, 2011, J INFECT DIS, V203, P1063, DOI 10.1093/infdis/jiq168; IWASAKI Y, 1977, INFECT IMMUN, V18, P220; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Kontermann RE, 2011, CURR OPIN BIOTECH, V22, P868, DOI 10.1016/j.copbio.2011.06.012; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Lang J, 1998, BIOLOGICALS, V26, P299, DOI 10.1006/biol.1998.0156; Law M, 2008, CURR OPIN IMMUNOL, V20, P486, DOI 10.1016/j.coi.2008.06.005; Lewis CE, 2013, J VIROL METHODS, V190, P49, DOI 10.1016/j.jviromet.2013.03.020; Lewis P, 2000, MUSCLE NERVE, V23, P720, DOI 10.1002/(SICI)1097-4598(200005)23:5<720::AID-MUS9>3.0.CO;2-5; Niederkorn JY, 2006, NAT IMMUNOL, V7, P354, DOI 10.1038/ni1328; Niewiesk S., 2014, FRONT IMMUNOL, P5; PHANUPHAK P, 1987, ASIAN PAC J ALLERGY, V5, P33; Prosniak M, 2003, J INFECT DIS, V188, P53, DOI 10.1086/375247; Rosseels V, 2011, J VIROL METHODS, V173, P127, DOI 10.1016/j.jviromet.2011.01.019; Rupprecht CE, 2002, LANCET INFECT DIS, V2, P327, DOI 10.1016/S1473-3099(02)00287-6; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; SCHUMACHER CL, 1992, VACCINE, V10, P754, DOI 10.1016/0264-410X(92)90510-Q; Servat A, 2003, VACCINE, V22, P244, DOI 10.1016/S0264-410X(03)00559-0; Shantavasinkul P, 2010, CLIN INFECT DIS, V50, P77, DOI 10.1086/649873; Shuangshoti S, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-31; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Sudarshan MK, 2007, INT J INFECT DIS, V11, P29, DOI 10.1016/j.ijid.2005.10.007; Suin V, 2014, BIOMED RES INT, DOI 10.1155/2014/256175; SUNTHARASAMAI P, 1986, J HYG-CAMBRIDGE, V96, P483, DOI 10.1017/S0022172400066286; SUNTHARASAMAI P, 1987, EPIDEMIOL INFECT, V99, P755, DOI 10.1017/S0950268800066619; Terryn S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109367; Tinsa Faten, 2015, BMJ Case Rep, V2015, DOI 10.1136/bcr-2014-206191; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; WIKTOR TJ, 1971, B WORLD HEALTH ORGAN, V45, P747; Wilde H, 2002, CLIN INFECT DIS, V34, P477, DOI 10.1086/324628; Wilde H, 2007, VACCINE, V25, P7605, DOI 10.1016/j.vaccine.2007.08.054; World Health Organisation, 2007, 4950 WHO	45	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1935-2735			PLOS NEGLECT TROP D	Plos Neglect. Trop. Dis.	AUG	2016	10	8							e0004902	10.1371/journal.pntd.0004902				15	Infectious Diseases; Parasitology; Tropical Medicine	Infectious Diseases; Parasitology; Tropical Medicine	DU7JR	WOS:000382390800044	27483431	DOAJ Gold, Green Published			2019-04-02	
